Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,retrograde axonal transport (GO:0008090),0.8011775451848394,2.6915503648015706,0.0,0.0,0.0,13/16,12.22%,DST;KIF5A;MAP1A;NEFL;KIF1C;SOD1;KIF1A;HAP1;PAFAH1B1;TMEM108;ACTR10;MGARP;DLG2
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.7723649055685234,2.666370066787667,0.0,0.0,0.0,17/23,14.58%,CASQ2;GSTM2;ATP1A2;HRC;CALM1;CASQ1;CLIC2;CACNA1C;AKAP6;ANK2;PRKACA;CALM2;CAMK2D;DMD;SLC8A1;PDE4D;DHRS7C
prerank,muscle organ development (GO:0007517),0.5908812143735217,2.63714316538624,0.0,0.0,0.0,26/56,11.13%,FHL1;SMTN;SGCA;BVES;ITGA7;SPEG;CACNA1H;SGCE;POU6F1;CTF1;FHL3;MRAS;MEF2B;MEF2D;CHODL;TCF21;MYH3;SGCD;ITGB1BP2;MSTN;MEF2A;MKX;LAMA2;SGCG;CAPN3;DMD
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.8033512963745557,2.5582733922991707,0.0,0.0,0.0,13/17,11.51%,CASQ2;GSTM2;ATP1A2;HRC;CALM1;CLIC2;CACNA1C;ANK2;PRKACA;CALM2;CAMK2D;DMD;SLC8A1
prerank,myofibril assembly (GO:0030239),0.6115008945328956,2.5039048952114027,0.0,0.0,0.0,26/43,15.69%,CSRP1;PGM5;LMOD1;TPM1;TMOD1;TMOD2;CASQ1;FLII;CSRP2;MYOZ2;OBSL1;PDGFRA;MYH3;ACTC1;KLHL41;MYL2;MYOZ1;TCAP;CAPN3;KRT19;WDR1;CFLAR;TNNT3;ACTN2;FHOD3;MYOM2
prerank,anterograde axonal transport (GO:0008089),0.5876142928518129,2.4671441328109758,0.0,0.0,0.0,16/37,12.22%,AP3S2;KIF5A;HSPB1;BLOC1S1;MAP1A;NEFL;KIF1C;KIF5C;SOD1;KIF1A;SNAPIN;HAP1;TRAK2;MGARP;AP3B2;DLG2
prerank,regulation of heart contraction (GO:0008016),0.5190029946001332,2.4607295841521846,0.0,0.0,0.0,41/92,12.13%,FXYD6;DMPK;PLN;HSPB7;TPM1;ATP2B4;NPR1;FXYD1;CACNA1H;DES;CASQ2;ATP1B2;STIM1;TNNI3K;ATP1A2;HRC;CALM1;CASQ1;NPR2;ANK2;NOS1;ADORA3;NPPC;SMAD7;TRPC1;PRKACA;ATP1A3;AHCYL1;ATP2A2;RYR3;SLC8A2;CELF2;CALM2;NPPA;CAMK2D;FXYD7;ABCC9;ITPR1;ASB3;SLC8A1;PDE4D
prerank,negative regulation of ion transport (GO:0043271),0.6469487113958478,2.459012043291958,0.0,0.0,0.0,9/25,5.53%,PLN;GPM6B;CASQ2;SYT11;VIP;SNCA;INPP5K;PACSIN3;NOS1
prerank,muscle contraction (GO:0006936),0.49535029673274944,2.4491219224959626,0.0,0.0,0.0,58/128,13.34%,MYL9;CRYAB;TACR2;SMTN;TPM2;LMOD1;SGCA;SORBS1;MYLK;TPM1;TLN1;FXYD1;GNAO1;ACTA2;CACNA1H;DES;CALD1;CASQ2;VCL;TMOD1;TMOD2;SNTA1;HRC;SORBS3;PABPN1;SSPN;CALM1;GALR2;MYOM1;MYL6;DTNA;GJC1;TPCN2;MYOT;SMPX;NOS1;MYL7;ALDOA;MYH3;PXN;ACTC1;KLHL41;MYL2;P2RX6;TCAP;MYL1;MYH7;MYOF;DMD;GAMT;SLC8A1;DYSF;MYL3;TNNT3;MYBPC1;ACTN2;SCN4A;VIM
prerank,heart contraction (GO:0060047),0.5379515981997944,2.426180489969336,0.0,0.0,0.0,18/40,12.86%,TPM1;CASQ2;KCNH2;ATP1A2;SCN3B;SCN2B;SCN1B;ACTC1;SGCD;MYL2;SOD1;TCAP;SGCG;MYH7;SCN4B;DMD;SLC8A1;MYL3
prerank,regulation of cardiac conduction (GO:1903779),0.5751226180974112,2.3884586317986223,0.0,0.002071867424877654,0.01,27/55,11.51%,FXYD6;DMPK;ATP2B4;NPR1;FXYD1;CASQ2;ATP1B2;STIM1;TNNI3K;ATP1A2;CASQ1;NPR2;ANK2;NOS1;NPPC;TRPC1;PRKACA;ATP1A3;AHCYL1;ATP2A2;RYR3;SLC8A2;NPPA;FXYD7;ABCC9;ITPR1;SLC8A1
prerank,positive regulation of cation channel activity (GO:2001259),0.5791426159299528,2.3846632654009743,0.0,0.0018992118061378499,0.01,21/38,15.22%,PIRT;JPH2;GSTM2;CALM1;GALR2;CASQ1;PKD2;CTSS;AKAP6;ANK2;CCL2;LRRC55;STAC;HAP1;STAC2;CALM2;NLGN3;ARC;ACTN2;ADRB2;ANK3
prerank,protein localization to cell surface (GO:0034394),0.6032549402114442,2.3838151165240955,0.0,0.0017531185902810921,0.01,12/27,12.60%,FBLN5;PRRT1;FLNA;JAM3;VCL;RIC3;GPIHBP1;ANK2;FGF7;GGA3;ANGPT1;FGF10
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.6969233806657886,2.379360570437982,0.0,0.0032557916676648857,0.02,14/21,11.51%,CASQ2;GSTM2;ATP1A2;HRC;CALM1;CLIC2;CACNA1C;ANK2;PRKACA;ATP2A2;CALM2;CAMK2D;DMD;SLC8A1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.5796525733190104,2.344626181761685,0.0,0.0030387388898205597,0.02,24/46,17.18%,NR1D1;ATF4;TFE3;NOVA1;ALDH1A1;FLCN;MAP2K6;ARNTL;LNPEP;PLCL1;NR1H2;RBPJ;ABHD6;IP6K1;NPR3;LAMA4;ADAMTS5;IL15;DDIT3;IL18R1;NOVA2;WNT10B;NR1H3;RHEB
prerank,negative regulation of protein modification process (GO:0031400),0.46140101568993025,2.324998941493599,0.0,0.002848817709206775,0.02,24/75,12.18%,ATP2B4;FXYD1;PTEN;WWTR1;BEX4;PRNP;CRTAP;CADM4;SNTA1;MAPT;FBLN1;TARDBP;CORO1C;INPP5K;TERF2IP;OCLN;PID1;PRKAA2;DAB2IP;FKBP8;MYADM;ATG14;DMD;TINF2
prerank,lysosome localization (GO:0032418),0.5613072998018741,2.3242568658958818,0.0,0.002681240196900494,0.02,21/34,20.77%,RAB34;MAP6;KIT;RAB3A;FLCN;S100A13;BLOC1S1;HDAC6;SNAPIN;KLC2;TFEB;PLEKHM2;DEF8;ARL8B;MRGPRX2;NR4A3;VPS33A;NDEL1;CHGA;VPS33B;LAMTOR1
prerank,extracellular matrix assembly (GO:0085029),0.6010634713612804,2.3228753022416906,0.0,0.0025322824081838,0.02,13/24,11.15%,FBLN5;GPM6B;MFAP4;LAMB2;LTBP3;EMILIN1;EFEMP2;RAMP2;LAMB1;TNXB;NTN4;NTNG1;PXDN
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.660509268871779,2.313711529233855,0.0,0.002399004386700442,0.02,15/24,12.13%,JPH2;CASQ2;GSTM2;HRC;CALM1;CLIC2;PKD2;AKAP6;NOS1;PRKACA;JPH4;CALM2;CAMK2D;DMD;PDE4D
prerank,CENP-A containing chromatin organization (GO:0061641),-0.7314011809651599,-2.3098533213436654,0.0,0.0,0.0,15/26,9.95%,CENPN;CENPH;CENPW;CENPU;HJURP;CENPA;CENPO;CENPK;RUVBL1;OIP5;CENPL;MIS18A;MIS18BP1;CENPP;CENPM
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.7314011809651599,-2.3098533213436654,0.0,0.0,0.0,15/26,9.95%,CENPN;CENPH;CENPW;CENPU;HJURP;CENPA;CENPO;CENPK;RUVBL1;OIP5;CENPL;MIS18A;MIS18BP1;CENPP;CENPM
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.601982258033566,2.3074050440261242,0.0,0.00227905416736542,0.02,11/27,13.25%,BOC;MYOCD;CDON;MAPK14;CAMK1;RBM4;MAPK11;MEF2A;BNIP2;MEF2C;CDH2
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.5670273062947893,2.2532548351496433,0.0,0.002170527778443257,0.02,15/30,11.07%,KCNA5;KCNH2;SNTA1;GJC1;CACNA1C;ANK2;CACNA2D1;SCN3B;KCNE2;SCN2B;SCN1B;GPD1L;FGF12;KCNE4;SCN4B
prerank,regulation of potassium ion transport (GO:0043266),0.6047801581435404,2.252094976266434,0.0,0.002071867424877654,0.02,15/31,15.22%,FHL1;KCNA5;DPP6;CASQ2;KCNH2;VIP;KCNIP3;CD63;ANK2;NOS1;KCNE2;KCNIP4;ACTN2;KCNAB3;ANK3
prerank,regulation of endocytosis (GO:0030100),0.5098282602424266,2.2439626103072703,0.0,0.0019817862324916693,0.02,23/60,18.31%,CLIP3;STON1;LGALS3;SYT11;SNCA;RAB5B;PACSIN3;PACSIN2;SMPD1;RAB4B;PRKD1;FLOT1;PACSIN1;SNX33;LRSAM1;RUFY1;RIT2;RAB5C;GPC3;EPHA3;SNX17;DLL1;CD177
prerank,axonal transport (GO:0098930),0.5458303516055018,2.2428612978976465,0.0,0.0018992118061378499,0.02,14/36,12.12%,AP3S2;DST;MAPT;BLOC1S1;NEFL;DCTN1;SOD1;KIF1A;SNAPIN;HAP1;PAFAH1B1;TMEM108;MGARP;AP3B2
prerank,regulation of muscle cell differentiation (GO:0051147),0.5649095007402943,2.233708039800281,0.0,0.0027348650008385046,0.03,16/35,13.25%,BOC;MYOCD;SRF;CDK9;CDON;MAPK14;CAMK1;FGFR2;RBM4;MEGF10;ID2;MAPK11;MEF2A;BNIP2;MEF2C;CDH2
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.7531669397773846,-2.223217936604263,0.0,0.0,0.0,12/18,16.06%,GINS4;GINS1;RFC3;MCM4;GINS2;MCMDC2;POLA1;LIG1;MCM7;MCM3;LIG3;POLD2
prerank,regulation of microtubule polymerization (GO:0031113),0.5831734941359582,2.216297919245028,0.0,0.0026296778854216383,0.03,17/38,11.38%,CLIP3;STMN2;SNCA;GBA2;MAPT;RAC1;OCLN;MAPRE3;ARL2;FES;CLIP1;MAP2;DCTN1;NUMA1;TUBB4A;CDH5;SLAIN2
prerank,chromatin remodeling at centromere (GO:0031055),-0.7005060343678469,-2.212888006958807,0.0,0.0,0.0,15/28,9.95%,CENPN;CENPH;CENPW;CENPU;HJURP;CENPA;CENPO;CENPK;RUVBL1;OIP5;CENPL;MIS18A;MIS18BP1;CENPP;CENPM
prerank,mRNA splice site selection (GO:0006376),0.5729011242741654,2.205275799593606,0.0,0.0025322824081838,0.03,14/29,18.70%,SRSF5;LUC7L2;CELF6;LUC7L3;ISY1;PRPF39;SF1;CELF2;CELF4;LUC7L;PSIP1;NOL3;CELF1;SRSF1
prerank,DNA strand elongation (GO:0022616),-0.7543339622544445,-2.199122952074079,0.0,0.0013222552983516238,0.01,12/17,17.18%,GINS4;GINS1;RFC3;MCM4;GINS2;MCMDC2;POLA1;MCM7;MCM3;DCLRE1B;POLD2;TERT
prerank,cardiac muscle contraction (GO:0060048),0.5385363600187282,2.1989195486367503,0.0,0.0024418437507486646,0.03,15/33,12.86%,TPM1;GSN;CASQ2;KCNH2;ATP1A2;SCN3B;SCN2B;SCN1B;TCAP;CAMK2D;MYH7;SCN4B;DMD;SLC8A1;MYL3
prerank,negative chemotaxis (GO:0050919),0.513421052147736,2.1886633537835585,0.0,0.002357642242102159,0.03,15/33,14.54%,EPHA7;NTN1;SEMA4C;ITGB3;SEMA3G;SLIT3;RHOA;SEMA6C;SEMA3B;SEMA3E;SEMA3A;SEMA6D;SEMA3C;SEMA4B;SEMA6A
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.6528837089244806,-2.1869749645728316,0.0,0.00110187941529302,0.01,15/34,9.95%,CENPN;CENPH;CENPW;CENPU;HJURP;CENPA;CENPO;CENPK;RUVBL1;OIP5;CENPL;MIS18A;MIS18BP1;CENPP;CENPM
prerank,regulation of striated muscle contraction (GO:0006942),0.5505117729385174,2.18381823227818,0.0,0.00227905416736542,0.03,14/28,14.80%,TNNI3K;ATP1A2;CALM1;ANK2;NOS1;SMAD7;PRKACA;MYL2;CALM2;DMD;ASB3;MYL3;TNNT3;RNF207
prerank,regulation of focal adhesion assembly (GO:0051893),0.4878783881040483,2.1725474396026985,0.0,0.0022055362909987938,0.03,18/54,8.02%,FAM107A;FERMT2;GPM6B;PTEN;VCL;ARHGAP6;DUSP22;MYOC;APOD;CORO1C;RAC1;DUSP3;COL16A1;PHLDB2;DAPK3;EFNA5;RHOA;DLC1
prerank,positive regulation of cell projection organization (GO:0031346),0.415342490300741,2.168139956042032,0.0,0.002848817709206775,0.04,50/111,20.18%,RAP1A;PTN;PLXNB3;STMN2;ATP1B2;DPYSL3;MAP6;ROR2;NPTN;FZD4;CHODL;NGF;DVL3;TOX;NGFR;CAMK1;OBSL1;FES;RHOA;DLG4;SCN1B;DVL2;DAB2IP;PRKD1;ROR1;TENM3;NDRG4;CAPRIN2;SNX3;NTRK1;CX3CL1;RET;SCARF1;RIT2;INS;KIDINS220;EPHA3;PLXNB1;LRRC7;GRIP1;TIAM1;FUT9;FZD1;TWF2;SCARB2;SLIT2;DVL1;EP300;METRN;LTK
prerank,presynaptic endocytosis (GO:0140238),0.5788250497972143,2.1680035857684152,0.0,0.002762489899836873,0.04,14/27,12.02%,STON1;VAMP2;PIP5K1C;NLGN2;SNCG;SNCA;NLGN4X;AMPH;NLGN1;SYT5;PACSIN1;NLGN3;SYT1;SNCB
prerank,ruffle organization (GO:0031529),0.6760944605966857,2.167999083037997,0.0,0.002681240196900494,0.04,7/16,13.43%,LIMA1;TPM1;INPP5K;RAC1;CCL21;CORO1B;AIF1L
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.5677050540133876,2.1674215520886104,0.0,0.002604633334131908,0.04,11/27,9.80%,PLN;CASQ2;GSTM2;ATP1A2;CALM1;CLIC2;PKD2;GNB5;TLR9;CALM2;SLN
prerank,regulation of muscle contraction (GO:0006937),0.5506116916035427,2.161188889424077,0.0,0.0025322824081838,0.04,10/27,7.36%,MYL9;CNN1;TPM1;PPP1R12B;CHRNA3;ATP1A2;ANXA6;CHRM2;DAPK3;MYL2
prerank,centromere complex assembly (GO:0034508),-0.6689288512387838,-2.160003904174638,0.0,0.0009444680702511599,0.01,17/33,9.95%,CENPN;CENPE;CENPH;CENPW;CENPU;HJURP;CENPA;DLGAP5;CENPO;CENPK;RUVBL1;OIP5;CENPL;MIS18A;MIS18BP1;CENPP;CENPM
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.6221387195060564,2.157875487705871,0.0,0.0024638423430977515,0.04,10/17,11.51%,ATP1A2;CACNA1C;ANK2;CACNA2D1;SCN3B;SCN2B;SCN1B;CACNB2;SCN4B;SLC8A1
prerank,sarcomere organization (GO:0045214),0.5793626401598955,2.155313091692269,0.0,0.002399004386700442,0.04,15/28,15.69%,CSRP1;TPM1;CASQ1;CSRP2;MYOZ2;MYH3;MYOZ1;TCAP;CAPN3;KRT19;WDR1;TNNT3;ACTN2;FHOD3;MYOM2
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.5094337195398735,2.1410767679870917,0.0,0.0035062371805621847,0.06,13/37,9.44%,FHL1;FAM107A;KANK2;PTEN;CDKN1A;NACC2;PKD2;CCL2;JADE1;CDKN2C;GPNMB;ZNF655;PRMT2
prerank,platelet aggregation (GO:0070527),0.5042856616811747,2.131277153100346,0.0,0.00341858125104813,0.06,12/36,9.18%,MYL9;CSRP1;FLNA;TLN1;ACTN1;VCL;ILK;HSPB1;ITGB3;PDGFRA;P2RY12;ACTB
prerank,regulation of neuron projection development (GO:0010975),0.38259922709574823,2.119716719446791,0.0,0.0033352012205347613,0.06,67/158,21.31%,CAMK2G;NCS1;RAP1A;PTN;PSEN1;PLXNB3;PTEN;STMN2;LPAR1;ATP1B2;DPYSL3;CRMP1;ROR2;NPTN;PTPRS;DBN1;TOX;CAMK1;SPOCK1;STX1B;FES;EFHC2;EPHA4;SCN1B;DENND5A;DAB2IP;KIF1A;ZDHHC15;MYLIP;PRKD1;MARK1;LRRC4C;BRSK1;ROR1;TENM3;NDRG4;SNX3;NTNG1;SEMA3A;ARC;NTRK1;CX3CL1;CDH2;MT3;RET;SCARF1;ADCY6;ITM2C;RIT2;KIDINS220;EPHA3;KANK1;SHANK3;NDEL1;LRRC7;FUT9;FZD1;TWF2;SCARB2;EP300;LTK;CHN1;RAB29;MAG;ABI2;RAPGEF1;FBXO7
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.5476289113147736,2.1183375625083825,0.0,0.0032557916676648857,0.06,14/28,11.07%,FXYD6;ATP2B4;FXYD1;SNTA1;SLMAP;NOS1;SCN3B;SCN2B;SCN1B;GPD1L;CAMK2D;FXYD7;FGF12;SCN4B
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.5212548449907215,2.10564490965216,0.0,0.003180075582370354,0.06,13/35,9.44%,FHL1;FAM107A;KANK2;PTEN;CDKN1A;PKD2;CCL2;JADE1;CDKN2C;SUSD2;GPNMB;ZNF655;PRMT2
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.43750268222534305,2.099569023188295,0.0,0.003107801137316482,0.06,30/87,12.98%,LMOD1;PSEN1;CFL2;CLU;STMN2;SYNPO2;NCK1;MAPT;EFEMP2;RAC1;CDC42EP3;OCLN;ARL2;FES;F2RL1;CCL21;CLIP1;SYNPO;DCTN1;NUMA1;NCKAP1L;CDC42EP4;BAIAP2;TENM1;CCL11;APP;SLAIN2;WDR1;EVL;CX3CL1
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.6229698171262892,2.0962739963715085,0.0,0.00354519537145732,0.07,7/17,10.99%,MAPK1;MAPK3;CHMP3;VPS11;RDX;SNX3;MAP2K2
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.5042755991169866,2.0946736933271675,0.0,0.0034681259068604217,0.07,11/37,8.57%,FAM107A;STMN2;MAP6;MAPT;STMN4;MAPRE3;GAS2L1;PHLDB2;EFNA5;PRKAA2;MAPRE2
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.5829846405521963,-2.0938518733639206,0.0,0.002479228684409295,0.03,29/59,20.84%,CXCL8;CXCL1;CXCL2;CXCL5;CXCL3;PPBP;CXCL9;CXCL11;REG3A;CXCL10;PF4;CXCL6;DEFA6;REG1A;RPL39;REG1B;SEMG1;PGLYRP4;RNASE7;RPS19;GNLY;PGLYRP1;ROMO1;DEFA5;PF4V1;DEFB4A;PGLYRP3;GAPDH;HRG
prerank,regulation of supramolecular fiber organization (GO:1902903),0.5912486787203338,2.0919895586750434,0.0,0.0033943359939484982,0.07,9/21,15.16%,GBA2;MAPT;EFEMP2;MAPRE3;MAP1A;ARL2;MAP2;MAP1B;HSPA8
prerank,ameboidal-type cell migration (GO:0001667),0.4503620869492548,2.091926100114418,0.0,0.0033236206607412376,0.07,24/50,18.90%,PDLIM1;AMOTL1;ANXA6;RADIL;SEMA4C;CORO1C;SEMA3G;SEMA6C;PKN1;SEMA3B;SEMA3E;AMOTL2;SEMA3A;SEMA6D;SEMA3C;SEMA4B;MEGF8;GDNF;SEMA6A;GPC3;ITGA4;SRGAP2;NANOS1;SOX8
prerank,regulation of sodium ion transport (GO:0002028),0.48347549707305665,2.090770835877147,0.0,0.003255791667664886,0.07,15/36,16.13%,PER1;ATP2B4;SNTA1;SLMAP;NOS1;SCN3B;P2RX7;SCN1B;GPD1L;AHCYL1;FGF12;SCN4B;NKAIN4;ANK3;CNKSR3
prerank,regulation of cation transmembrane transport (GO:1904062),0.5089821394866917,2.0875367370248603,0.0,0.0031906758343115886,0.07,11/30,11.80%,ATP2B4;DPP6;KCNH2;KCNIP3;SNTA1;HRC;SLMAP;CD63;KCNE2;FGF12;KCNIP4
prerank,membrane depolarization during action potential (GO:0086010),0.5589116808818957,2.0871538470305504,0.0,0.0031281135630505767,0.07,13/26,13.27%,CACNA1H;SCN7A;KCNH2;ATP1A2;CACNA1C;SCN3B;SCN2B;SCN1B;SCN9A;SCN11A;SCN4B;SLC8A1;SCN4A
prerank,DNA replication (GO:0006260),-0.5284531105467365,-2.0804891161540158,0.0,0.00220375883058604,0.03,49/106,20.35%,EXO1;ORC6;DBF4;CHEK1;RFC3;BLM;MCM4;CDK1;POLE2;TICRR;FAM111B;TIPIN;TIMELESS;RMI1;DNA2;RPA3;POLB;RECQL4;FEN1;POLA1;TOP1MT;RFC5;RMI2;MCM7;MCM3;RPA4;MCM10;RAD9B;TOPBP1;WDHD1;TOP1;ATR;MCM5;RBBP8;RNASEH2A;MCM2;CDC7;RFC2;WRN;SET;BAZ1A;POLD2;BARD1;BRCA1;CLSPN;HUS1;MCM6;CDC45;CDC6
prerank,synaptic vesicle membrane organization (GO:0048499),0.6121990225691987,2.079901822017706,0.0,0.0030679575329919115,0.07,6/17,5.50%,SYNGR1;PRRT2;STX1B;SNAP25;SYP;STX2
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.5369856458026407,2.077220979536025,0.0,0.0030100715418033847,0.07,10/27,8.57%,STMN2;GBA2;MAPT;STMN4;MAPRE3;MAP1A;GAS2L1;ARL2;MAP2;MAPRE2
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.6575316865799979,2.076091188752215,0.0,0.003314987879804247,0.08,8/16,8.02%,FAM107A;PTEN;ARHGAP6;DUSP22;APOD;CORO1C;PHLDB2;DLC1
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.6575316865799979,2.076091188752215,0.0,0.003314987879804247,0.08,8/16,8.02%,FAM107A;PTEN;ARHGAP6;DUSP22;APOD;CORO1C;PHLDB2;DLC1
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.5791177630341138,2.0756153833815585,0.0,0.0036627656261229964,0.09,11/22,9.52%,JPH2;GSTM2;CALM1;CASQ1;PKD2;AKAP6;ANK2;STAC;HAP1;STAC2;CALM2
prerank,negative regulation of metabolic process (GO:0009892),0.4860428638896165,2.0747504060718285,0.0,0.003598506580050663,0.09,26/55,17.90%,NR1D1;ATF4;TFE3;NOVA1;ALDH1A1;FLCN;MAP2K6;ARNTL;LNPEP;PLCL1;NR1H2;ZDHHC7;RBPJ;ABHD6;IP6K1;NPR3;LAMA4;ADAMTS5;IL15;DDIT3;IL18R1;NOVA2;WNT10B;NR1H3;RHEB;CCDC3
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.5666430208899318,2.074636433269302,0.0,0.003536463363153238,0.09,10/22,10.46%,PRNP;CASQ2;ATP1A2;HRC;CASQ1;ANK2;NOS1;CACNA2D1;NPPA;CAMK2D
prerank,regulation of blood circulation (GO:1903522),0.5235934900885433,2.0742926046289365,0.0,0.003476523306150641,0.09,12/34,10.46%,DMPK;PLN;HSPB7;TPM1;FXYD1;CACNA1H;DES;AGTR1;ECE1;ADORA3;CELF2;CAMK2D
prerank,intracellular lipid transport (GO:0032365),0.5754948647024286,2.0619115708419034,0.0,0.0037984236122757,0.1,12/20,22.45%,PRKAB2;ACACB;CPT1B;PRKAA2;SLC25A20;PRKAG2;ABCD4;CPT1A;SGPP1;ABCD1;ARV1;MID1IP1
prerank,histone exchange (GO:0043486),-0.6256949199862558,-2.0532884666565807,0.0,0.001983382947527436,0.03,15/34,9.95%,CENPN;CENPH;CENPW;CENPU;HJURP;CENPA;CENPO;CENPK;RUVBL1;OIP5;CENPL;MIS18A;MIS18BP1;CENPP;CENPM
prerank,regulation of myoblast differentiation (GO:0045661),0.5071084207704676,2.0404164452985327,0.0,0.0056042315590952956,0.13,20/33,18.90%,SMYD1;BOC;RBM24;ZFP36L1;EID2B;MAPK14;KLHL41;MSTN;BTG1;MEF2C;AKIRIN1;LRRC8A;FLOT2;TRIP4;XKR8;ANKRD2;DLL1;RANBP3L;HIF1AN;SOX8
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.47972535112991577,2.0387525597797205,0.0,0.005881430109330115,0.14,11/27,10.79%,PTEN;TMEM25;NLGN2;STX1B;NLGN4X;DLG4;TMEM108;SLC8A2;NLGN1;NLGN3;APP
prerank,substantia nigra development (GO:0021762),0.5461428924843971,2.036002548302567,0.0,0.005788074075848686,0.14,14/40,12.20%,NDRG2;PLP1;SYPL2;MAOB;INA;CALM1;SIRT2;RHOA;SYNGR3;CKB;ACTB;CALM2;MAPKAP1;CNP
prerank,central nervous system neuron development (GO:0021954),0.5744729019314261,2.0340871934315157,0.0,0.00569763541841355,0.14,6/15,8.88%,PTEN;GBA2;MAPT;MAP2;LHX6;NPY
prerank,cell projection organization (GO:0030030),0.49829277519684495,2.028300573773141,0.0,0.005960603206955714,0.15,17/30,21.25%,GSN;ATP1B2;PARVA;RHOJ;RAC1;PACSIN2;NCKAP1L;RHOQ;P2RY12;RHOU;NPHP1;NEFH;PDGFA;RHOG;PARVB;SCIN;ITGB1
prerank,lamellipodium organization (GO:0097581),0.5534136668138546,2.0228636965282183,0.0,0.006215602274632964,0.16,13/28,16.61%,VCL;WASF1;KIT;S1PR1;SNX1;RAC1;ARHGEF6;ABLIM3;P2RY12;WHAMM;GOLPH3;SNX2;DMTN
prerank,embryonic organ morphogenesis (GO:0048562),0.4458277984216619,2.01779015077188,0.0,0.006122832091429486,0.16,20/43,16.53%,RBPMS2;FOXF1;MFAP5;FGFR2;TCF21;PDGFRA;ID2;HOXD9;HOXD3;EFEMP1;HOXD4;HOXA4;HOXC4;OSR2;DSCAML1;MEGF8;SOX17;HOXB4;FUZ;RARG
prerank,cell-cell junction assembly (GO:0007043),0.40474429941424933,2.0154700738870996,0.0,0.006032790443026111,0.16,25/65,13.25%,JAM3;CDH19;TLN1;PIP5K1C;CLDN5;VCL;CNTNAP1;CLDN11;FLCN;EPB41L3;GJC1;SMAD7;RHOA;GJA4;DCHS1;RAMP2;CDHR3;RHOC;ACTB;CDH5;FBF1;WDR1;CTNND2;PRKCA;CDH2
prerank,myelination (GO:0042552),0.46273219889019407,2.015297567452147,0.0,0.005945358697475008,0.16,20/47,14.90%,LGI4;MAL;PLP1;PMP22;MPZ;CNTNAP1;MYOC;EPB41L3;SIRT2;MARVELD1;NFASC;DEGS1;GPC1;ARHGEF10;TNFRSF21;PARD3;EIF2B4;ZNF24;FAM126A;SKI
prerank,striated muscle contraction (GO:0006941),0.44878947044952794,2.013809704619679,0.0,0.0058604250017967935,0.16,22/51,13.07%,TPM1;CASQ2;KCNH2;ATP1A2;DTNA;SMPX;NOS1;ALDOA;SCN3B;SCN2B;MYH3;SCN1B;KLHL41;STAC;STAC2;TCAP;MYH7;SCN4B;DMD;SLC8A1;MYL3;TNNT3
prerank,glycogen metabolic process (GO:0005977),0.5376387363959678,2.0121536741829438,0.0,0.005777883804588388,0.16,9/26,13.01%,GYG1;PYGM;NR1D1;PPP1R3C;CALM1;UGP2;PGM1;PRKAG2;PYGL
prerank,negative regulation of cell communication (GO:0010648),-0.6786098770331273,-2.010566473018536,0.0,0.00661127649175812,0.09,10/20,19.11%,IL11;OSM;IL1B;SRMS;GLRA1;IGFBP3;FGF23;NLRP12;OPRM1;LIF
prerank,positive regulation of dephosphorylation (GO:0035306),0.51313099721551,2.0097317989863925,0.0,0.00569763541841355,0.16,9/28,11.46%,CALM1;PRKCD;MTMR9;SMPD1;DLC1;CDH5;CALM2;CHP2;PIN1
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.7214471225651745,-2.007947644048366,0.0,0.0066112764917581205,0.1,8/16,11.98%,CENPE;TACC3;PTTG1;UBE2C;HECW2;ANAPC1;NEK6;PLK1
prerank,positive regulation of myoblast differentiation (GO:0045663),0.6491869910511294,1.9980309262377522,0.0,0.008117179226233003,0.24,11/17,18.69%,SMYD1;BOC;RBM24;MAPK14;BTG1;MEF2C;AKIRIN1;LRRC8A;XKR8;RANBP3L;HIF1AN
prerank,blood vessel diameter maintenance (GO:0097746),0.4998490818504649,1.9953527565954732,0.0,0.008315467907954911,0.25,17/35,17.40%,NPR1;SCPEP1;AGTR1;ECE1;NOS1;F2RL1;GPER1;KLF2;KCNMB4;NPPB;EDNRB;ITGB1BP1;ADCY6;AGTR2;INS;EDN3;KCNMB2
prerank,aerobic electron transport chain (GO:0019646),0.4379965374948439,1.994914154884925,0.0,0.008204595002515512,0.25,37/69,28.47%,SDHA;COX4I2;NDUFA11;COX6A2;NDUFC2;NDUFB8;NDUFS2;NDUFA5;SDHAF2;UQCRFS1;SDHD;NDUFB10;NDUFS4;NDUFV2;UQCR11;COX7C;UQCRC2;NDUFAF1;NDUFA13;UQCR10;NDUFA8;NDUFA9;NDUFC1;NDUFV1;COX6C;UQCRB;COX8A;NDUFA6;NDUFS5;NDUFS8;NDUFA7;NDUFA10;NDUFB6;NDUFB4;NDUFV3;NDUFB5;NDUFB1
prerank,cellular response to catecholamine stimulus (GO:0071870),0.5726253419214646,1.9924109941555757,0.0,0.008096639805113992,0.25,11/23,15.10%,ATP2B4;MAPK1;ATF4;MAPK3;SNCA;GNG2;SIRT2;PRKACA;APLP1;ADCY6;NR4A3
prerank,cardiac muscle cell contraction (GO:0086003),0.6092716907978608,1.9882032195923902,0.0,0.00799148863881381,0.25,10/19,11.07%,GSN;CACNA1C;CACNA2D1;SCN3B;KCNE2;SCN2B;SCN1B;CAMK2D;FGF12;SCN4B
prerank,DNA replication initiation (GO:0006270),-0.6035057066977264,-1.9879889192302846,0.0,0.00813695568216384,0.13,25/38,26.28%,ORC6;DBF4;MCM4;POLE2;PRIM1;PRIM2;RPA3;POLA1;MCM7;MCM3;RPA4;MCM10;TOPBP1;CDT1;MCM5;MCM2;CDC7;NOC3L;MCM6;CDC45;CDC6;ORC2;MCM8;ORC5;ORC1
prerank,positive regulation of protein polymerization (GO:0032273),0.42097727779944016,1.9870940609624708,0.0,0.007889033656264916,0.25,24/65,16.81%,LMOD1;NCK1;MAPT;RAC1;CDC42EP3;OCLN;ARL2;FES;CCL21;CLIP1;DCTN1;NUMA1;NCKAP1L;TPPP3;CDC42EP4;BAIAP2;TENM1;CCL11;SLAIN2;EVL;PFN2;CDC42EP2;SNX9;FCHSD1
prerank,synaptic vesicle endocytosis (GO:0048488),0.48104873574550366,1.986479136024486,0.0,0.008077660340029337,0.26,14/38,12.02%,STON1;VAMP2;PIP5K1C;NLGN2;SNCG;SNCA;NLGN4X;AMPH;NLGN1;SYT5;PACSIN1;NLGN3;SYT1;SNCB
prerank,cellular response to copper ion (GO:0071280),0.6022400505600396,1.9858951181104976,0.0,0.008261571356699648,0.27,8/19,13.56%,PRNP;AQP1;SNCA;MT1X;MT1M;MT1A;MT1E;MT3
prerank,actin polymerization or depolymerization (GO:0008154),0.4604165937477504,1.9839267565782746,0.0,0.00872230607263309,0.28,16/48,13.19%,FAM107A;GSN;CFL2;DSTN;WASF1;ARHGAP6;GAS7;RAC1;FLII;CORO7;WASF3;MICAL3;ENAH;WDR1;EVL;JAK2
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.49373414535535237,1.9828144013778641,0.0,0.008615936486381467,0.28,24/39,28.47%,NDUFA11;NDUFC2;NDUFB8;NDUFS2;NDUFA5;NDUFB10;NDUFS4;NDUFV2;NDUFAF1;NDUFA13;NDUFA8;NDUFA9;NDUFC1;NDUFV1;NDUFA6;NDUFS5;NDUFS8;NDUFA7;NDUFA10;NDUFB6;NDUFB4;NDUFV3;NDUFB5;NDUFB1
prerank,protein polymerization (GO:0051258),0.44147893924540443,1.9755585080919345,0.0,0.009061299701573357,0.28,16/55,7.70%,FAM107A;GSN;CASQ2;WASF1;ARHGAP6;GAS7;MAPT;CHMP3;TRIM6;RAC1;CASQ1;CORO7;MAP7D3;WASF3;CHMP4A;TPPP3
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.5336312321832263,1.9755479501393172,0.0,0.008953427086078436,0.28,19/30,23.76%,VPS11;ABLIM3;RHOU;LEPROT;SAE1;BAP1;HSPA1L;CSNK2A2;RNF31;TOMM7;SH3GLB1;UBE2D3;ATG13;UBE2L3;PINK1;GSK3A;ARIH2;UBL4B;NPEPPS
prerank,actomyosin structure organization (GO:0031032),0.45170697374513935,1.9723962441547966,0.0,0.00884809264977163,0.28,30/76,15.95%,CSRP1;PGM5;LMOD1;SORBS1;TPM1;PDLIM1;TMOD1;TMOD2;EPB41L3;CASQ1;FLII;CSRP2;MYOZ2;RHOA;MYH3;ACTC1;KLHL41;MYOZ1;FRMD6;TCAP;CAPN3;KRT19;WDR1;TNNT3;ACTN2;FRMD3;FHOD3;MYOM2;ITGB5;CDC42BPB
prerank,cellular response to hormone stimulus (GO:0032870),0.42128711705284705,1.9711618028455575,0.0,0.008745207851518473,0.28,35/75,17.50%,KLF9;CACNA1H;RAMP1;ATP1A2;ZFP36L1;THRB;INPP5K;CTSS;GAS2L1;SLIT3;WBP2;SOCS2;GPER1;ARID5A;RAMP3;RAMP2;ATP1A3;BRD8;RDX;AKR1C2;SFRP1;AKR1C1;TFPI;MGARP;MEF2C;NKX3-1;NCOA1;NCOA4;NR4A3;STAT3;NR3C1;RARA;CYP11B1;AKR1C3;GHR
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.5168556308533574,1.970197529058307,0.0,0.009430568968408635,0.29,14/30,20.28%,VAMP2;RAB34;OPTN;VAMP4;BBS1;RAB31;GGA3;GOLPH3;GOLGA7;BBS2;ANK3;GGA2;KIF13A;GGA1
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.5565652374393099,1.9686357936379102,0.0,0.009323403411949444,0.29,7/17,11.46%,CLU;PRNP;RTN1;HAP1;RTN4;GGA3;PIN1
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.48481298807294887,1.9635787146637276,0.0,0.009730793074144489,0.3,14/35,14.54%,FLNA;PLXNB3;NRP2;SEMA4C;RAC1;SEMA3G;SEMA6C;SEMA3B;SEMA3E;SEMA3A;SEMA6D;SEMA3C;SEMA4B;SEMA6A
prerank,synaptic vesicle recycling (GO:0036465),0.4937478723335988,1.9578516365384804,0.0,0.010382357873553578,0.33,15/34,12.02%,STON1;VAMP2;PIP5K1C;NLGN2;SNCG;SNCA;RAB3A;NLGN4X;AMPH;NLGN1;SYT5;PACSIN1;NLGN3;SYT1;SNCB
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.5137035585082965,1.9573936608948272,0.0,0.010518711541686553,0.34,16/33,20.28%,VAMP2;RAB34;OPTN;VAMP4;BBS1;RAB31;GORASP1;GGA3;GOLPH3;GOLGA7;BBS2;ANK3;GGA2;RILPL2;KIF13A;GGA1
prerank,cellular response to nutrient levels (GO:0031669),0.4607055861987202,1.9545372342697516,0.0,0.010899824278704184,0.36,28/62,17.48%,FAM107A;MAP1LC3C;WDR45;ZFYVE1;ULK1;FLCN;KCNB1;KLF10;CARTPT;MTOR;GAS2L1;PRKAA2;RRAGA;PDK2;RRAGD;TFEB;MAP1LC3A;SFRP1;LPL;ATG14;RRAGC;TSC1;RRAGB;HSPA8;MAP1LC3B;CDKN2B;SREBF1;AKR1C3
prerank,fatty acid beta-oxidation (GO:0006635),0.4835414336451162,1.9526759677717287,0.0,0.011027681454993967,0.36,28/51,26.16%,ETFDH;PPARD;ACAD11;ECI2;ACADVL;ACAT1;CROT;BDH2;HADHB;ACADS;ACOX2;ACAA2;ECHDC2;SLC27A2;ACADM;IVD;HADH;HADHA;ABCD4;ABCD1;SCP2;ACAA1;ACADL;ECHDC1;ACAD10;CRAT;ECI1;AMACR
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.4710734278266517,1.9512037954351813,0.0,0.01115281826583078,0.36,22/56,13.46%,PALLD;PLXNB3;CADM3;IGSF11;NEXN;TRO;ROBO3;L1CAM;NPTN;AMIGO2;MYOT;OBSL1;PKD1;KIRREL3;CEACAM1;PTPRM;ROBO4;TENM3;CADM1;DSCAML1;CDH2;CNTN2
prerank,regulation of stress fiber assembly (GO:0051492),0.41471906899309025,1.9469436994536575,0.0,0.011275320617492078,0.36,33/72,18.15%,TPM1;FERMT2;LPAR1;ARHGAP6;ASAP3;MYOC;SORBS3;INPP5K;RAC1;RAPGEF3;PHLDB2;ARHGEF15;ARHGEF18;PIK3R1;RHOA;PXN;ARHGEF10;DLC1;RHOC;TESK1;SFRP1;WASF2;PTGER4;TMEFF2;EVL;TSC1;PPM1F;ITGB1BP1;PFN2;RGCC;TGFB3;SLC9A1;LIMCH1
prerank,cellular response to amino acid starvation (GO:0034198),0.39127103074956404,1.94299236560536,0.0,0.011870073788361564,0.39,27/70,18.48%,ATP6V1G2;MAPK1;ATF4;MAPK3;CDKN1A;FAS;MAPK8;FLCN;MTOR;ATF2;ATP6V1E1;RRAGA;PRKD1;RRAGD;TFEB;KPTN;RRAGC;TCIRG1;RRAGB;LAMTOR3;ATP6V0E2;SH3GLB1;RHEB;ATP6V1D;RNF152;ATP6V1H;WDR59
prerank,positive regulation of potassium ion transport (GO:0043268),0.49859799620887923,1.9428779494832478,0.0,0.011747701893636185,0.39,10/38,5.30%,FHL1;KCNMB1;FLNA;KCNH2;KCNN3;KCNMA1;GABBR1;GNG2;AKAP6;ANK2
prerank,regulation of cation channel activity (GO:2001257),0.3826529431431904,1.942758924806564,0.0,0.01162782738451745,0.39,43/88,20.50%,PRRT1;VAMP2;PIRT;JPH2;NLGN2;HRC;CALM1;SLMAP;DAPK1;CTSS;NEFL;ANK2;NOS1;KCNE2;DLG4;PRKACA;STAC;NLGN1;JPH4;CALM2;CACNB2;CAMK2D;APP;FGF12;DMD;PDE4D;DLG2;MEF2C;AHNAK;GRIA4;ACTN2;ANK3;GRIA1;SHISA7;KCNG1;JPH3;SHISA9;LRRC7;CAMK2A;FGF11;CACNB3;FGF13;CACNB1
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.4178310054809907,1.937164854788853,0.0,0.012200997057612855,0.4,37/70,28.47%,SDHA;COX4I2;NDUFA11;COX6A2;NDUFC2;NDUFB8;NDUFS2;NDUFA5;SDHAF2;UQCRFS1;SDHD;NDUFB10;NDUFS4;NDUFV2;UQCR11;COX7C;UQCRC2;NDUFAF1;NDUFA13;UQCR10;NDUFA8;NDUFA9;NDUFC1;NDUFV1;COX6C;UQCRB;COX8A;NDUFA6;NDUFS5;NDUFS8;NDUFA7;NDUFA10;NDUFB6;NDUFB4;NDUFV3;NDUFB5;NDUFB1
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.6659850645959,-1.936566112848098,0.0,0.019361595440148777,0.35,13/23,20.44%,CCND1;CDK1;FBXO5;ATAD5;RCC2;CDC25C;RAD51B;CDK4;DYRK3;CDC7;STOX1;CDC25A;NPM1
prerank,positive regulation of actin filament polymerization (GO:0030838),0.45402653241760477,1.9345795330677658,0.0,0.013218514170719438,0.43,21/44,22.00%,LMOD1;GSN;NCK1;CDC42EP3;CCL21;NCKAP1L;CDC42EP4;BAIAP2;TENM1;WHAMM;CCL11;EVL;PFN2;CDC42EP2;SNX9;FCHSD1;PRKCE;FER;SCIN;VASP;PFN1
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.4942167205247684,1.9327527845698527,0.0,0.013313286720253444,0.43,13/40,7.68%,KCNMB1;FLNA;PIRT;KCNH2;KCNN3;KCNMA1;GABBR1;GNG2;CTSS;AKAP6;ANK2;NOS1;STAC
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.5619525708005187,1.9327427966191337,0.0,0.01318276430142743,0.43,12/22,21.17%,RAP1A;STMN2;WASF1;MAPT;NGF;TMEM108;NTRK1;NTF3;KIDINS220;SH3GL2;EHD1;RAPGEF1
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.4697702131237366,1.9304602779125266,0.0,0.013276043693390797,0.44,15/34,14.12%,CAP2;PDE2A;AQP1;PDE9A;MAPK7;AKAP6;RAPGEF3;CD36;PDE3A;NPPA;PDE7B;PDE4D;ADCY2;NPPB;ADCYAP1
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.5946116120715382,1.9281303684500022,0.0,0.013586669074678466,0.46,7/16,20.86%,WASF1;WASF3;CORO1B;BRK1;WASF2;ARF1;ABI2
prerank,regulation of regulatory T cell differentiation (GO:0045589),-0.6468865021634016,-1.923725661530548,0.0,0.020715333007508777,0.36,16/25,21.97%,FOXP3;IL4I1;SOCS1;CBFB;RUNX1;BCL6;IFNG;TNFSF4;FANCA;CD46;IL2RA;CTLA4;HLA-G;MDK;LILRB4;CR1
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.39120849930202,1.9227008854760474,0.0,0.014542536115569823,0.49,20/66,11.83%,NCK1;NRP2;VEGFB;HSPB1;SHC2;CLEC14A;ITGB3;RAC1;MAPK14;PIK3R1;RHOA;PXN;NCKAP1L;MAPK11;DAB2IP;PRKD1;BAIAP2;FLT4;BRK1;WASF2
prerank,negative regulation of transport (GO:0051051),0.43568241061850105,1.9213275076315928,0.0,0.014405342378630486,0.49,20/46,18.13%,CRYAB;PTEN;LGALS3;SYT11;SNCA;ITGB3;PACSIN3;NR1H2;PRKD1;SNX3;SNX33;LRSAM1;DYSF;ARL6IP5;PXK;PPM1F;EPHA3;NR1H3;ERBB3;PRTN3
prerank,synaptic vesicle exocytosis (GO:0016079),0.5005456546616895,1.920835556441769,0.0,0.014270713010605902,0.49,15/40,10.95%,VAMP2;PIP5K1C;SNCA;PRRT2;CPLX3;RAB3A;SNPH;STX1B;SNAP25;STX2;RIMS3;SNAPIN;SYT10;SYT5;SYT1
prerank,striated muscle cell differentiation (GO:0051146),0.5967431139868938,1.919962531244951,0.0,0.014349600313041534,0.49,9/18,14.90%,BVES;POPDC2;MYOCD;CBY1;MYEF2;POPDC3;MEF2C;PLD3;SKI
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.45827365701280015,1.9198031435084923,0.0,0.014217952603747575,0.49,24/49,18.15%,TPM1;FERMT2;SYNPO2;LPAR1;MYOC;SORBS3;RAC1;RAPGEF3;ARHGEF15;SYNPO;RHOA;PXN;ARHGEF10;RHOC;TESK1;SFRP1;EVL;CX3CL1;PPM1F;ITGB1BP1;PFN2;RGCC;TGFB3;LIMCH1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.41010861764375095,1.9128945038453127,0.0,0.014917445459119112,0.52,17/69,10.51%,CRYAB;LIMA1;CLIP3;CLU;STMN2;CHADL;SNCA;EMILIN1;PRKCD;KANK3;MAP2;PLEKHH2;TUBB4A;PFDN5;SMAD4;CDH5;MYADM
prerank,chemokine-mediated signaling pathway (GO:0070098),-0.536337637421344,-1.9120007741973917,0.0,0.02313946772115342,0.44,24/54,17.22%,CXCL8;CXCL1;CXCL2;CXCL5;CXCL3;PPBP;CXCL9;CXCL11;CCL24;CCL20;RBM15;CXCL10;CCL22;PF4;CCL4;TFF2;CXCL6;CCL3;CCL25;GPR35;CCL26;CCL17;PF4V1;STK39
prerank,regulation of interleukin-4 production (GO:0032673),-0.6114684227131237,-1.9113845683754855,0.0,0.021778322561085573,0.44,13/23,21.79%,CEBPB;FOXP3;LEF1;ZP3;SLC7A5;SYK;ZFPM1;PRKCZ;TNFSF4;PRKCQ;NLRP3;CD86;GATA3
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.5382816469252335,1.9093968606384186,0.0,0.014988374253844654,0.53,8/19,14.42%,CLU;PRNP;RTN1;HAP1;RTN4;GGA3;PIN1;FLOT2
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.38459094592824605,1.9091430425990448,0.0,0.014854549483721042,0.53,34/124,11.71%,LIMA1;PLP1;TPM1;GPM6B;STMN2;ATP1B2;GPM6A;FRYL;MYOC;MAPT;STMN4;L1CAM;ULK1;MICALL1;RAC1;BLOC1S1;PKD2;CCL21;ATCAY;LGI1;BTG2;MAP2;PTPRM;VAPA;NCDN;SNAPIN;CORO1B;NPY;TMEM108;NLGN1;LAMB1;APP;MARK4;RAB13
prerank,positive regulation of heart rate (GO:0010460),0.5934482030180931,1.9057787136684943,0.0,0.01492477950310098,0.53,14/17,24.14%,TPM1;HRC;SCN3B;ATP2A2;NPPA;PDE4D;ADM;EDN3;ADRA1A;TRPM4;EDN2;ADRA1B;ADRB1;RYR2
prerank,cardiac muscle cell action potential (GO:0086001),0.49464215770058284,1.9053215883317416,0.0,0.014793860384652727,0.53,14/30,11.51%,KCNH2;ATP1A2;CACNA1C;ANK2;CACNA2D1;SCN3B;KCNE2;SCN2B;SCN1B;FGF12;SCN4B;DMD;KCND3;SLC8A1
prerank,autophagosome assembly (GO:0000045),0.4256826399939547,1.9020058895385616,0.0,0.015457932613435024,0.56,17/56,11.25%,GABARAPL1;MAP1LC3C;WDR45;MFN2;ULK1;ATG9A;ULK2;ATG12;TP53INP2;RAB23;STX12;GABARAPL2;EMC6;ATP2A2;MAP1LC3A;ATG14;GABARAP
prerank,negative regulation of calcium ion transport (GO:0051926),0.5285470905948808,1.8996351289949758,0.0,0.01591408513418957,0.57,6/18,9.80%,PLN;ATP1A2;INPP5K;PACSIN3;NOS1;SLN
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.48156006827746145,1.8983871450664729,0.0,0.01577806731252983,0.57,22/36,23.76%,VPS11;ABLIM3;RHOU;LEPROT;SAE1;BAP1;HSPA1L;CSNK2A2;RNF31;TOMM7;PARL;SH3GLB1;SREBF1;UBE2D3;ATG13;UBE2L3;PINK1;GSK3A;LRRK2;ARIH2;UBL4B;NPEPPS
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.5746038703463492,1.8982245319870146,0.0,0.015644354877677884,0.57,15/27,12.50%,PLN;JPH2;HRC;CALM1;ANK2;NOS1;PRKACA;JPH4;CALM2;SLN;CACNB2;CAMK2D;DMD;PDE4D;AHNAK
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.5616448135825042,1.897230285209924,0.034482758620689655,0.01570440686756004,0.57,12/19,17.06%,PTEN;NCK1;INPP5K;SMAD7;GPD1L;DMD;PDE4D;PPM1F;RASSF2;CNKSR3;DMTN;INPP5J
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.5753531565885536,1.8965132283543333,0.0,0.015763457990944155,0.58,7/21,6.57%,GPM6B;VCL;CORO1C;DUSP3;DAPK3;EFNA5;RHOA
prerank,cellular respiration (GO:0045333),0.4493201092973048,1.8928593132879052,0.0,0.016198236230861664,0.61,17/39,21.14%,ETFDH;MTFR1L;SDHA;COQ10A;BLOC1S1;COX4I2;OXA1L;NDUFA5;SIRT3;SURF1;NR4A3;UQCRFS1;ME3;NDUFS4;UQCRC2;COQ10B;UQCR10
prerank,mitochondrion localization (GO:0051646),0.5386227283181864,1.888205390556757,0.0,0.016812694677285883,0.62,7/18,9.13%,MFN2;ATCAY;MUL1;HAP1;TRAK2;MARK1;MEF2A
prerank,homotypic cell-cell adhesion (GO:0034109),0.4459146385908111,1.8880969551436522,0.0,0.016676006102673804,0.62,13/43,9.18%,MYL9;CSRP1;FLNA;TLN1;ACTN1;VCL;ILK;HSPB1;ITGB3;PDGFRA;MEGF10;P2RY12;ACTB
prerank,double-strand break repair via homologous recombination (GO:0000724),-0.5000054709233847,-1.8838673439330424,0.0,0.026812399105463486,0.52,38/94,20.15%,RAD54B;FANCB;GINS4;XRCC2;BLM;RAD51AP1;MCM4;RFWD3;ERCC5;MMS22L;GINS2;MCMDC2;RAD51B;RMI1;RAD51AP2;RAD54L;RPA3;PSMD14;RECQL4;FEN1;MCM7;PALB2;MCM3;RPA4;TONSL;FANCM;BRCA2;MCM5;RBBP8;MCM2;CDC7;WRN;LIG3;SLX1A;BRCA1;HUS1;MCM6;CDC45
prerank,plasma membrane organization (GO:0007009),0.4009389296426761,1.8819975786479404,0.0,0.01709290625524065,0.65,22/60,12.74%,EHD2;PLSCR4;SYT11;ANXA6;RAB3A;MICALL1;EPB41L3;DEGS1;ANK2;PACSIN3;STX2;PACSIN2;P2RX7;CHMP4A;A4GALT;SMPD1;PACSIN1;WHAMM;MYOF;SNX33;ARL8B;DYSF
prerank,positive regulation of T cell differentiation (GO:0045582),-0.5632792746945667,-1.8814747566596215,0.0,0.02540122020517593,0.52,24/42,23.42%,IL4I1;SOX4;LEF1;SHH;IL23A;SOCS1;IL23R;BCL6;TNFSF9;PNP;IL12B;VNN1;ZAP70;TNFSF4;CD46;ADAM8;HLA-G;MDK;IL36B;LILRB4;GATA3;CR1;IL12RB1;XBP1
prerank,positive regulation of macroautophagy (GO:0016239),0.45228696436997096,1.8809005221824369,0.0,0.016956163005198723,0.65,25/50,22.94%,HSPB8;SLC25A4;EPM2A;DCN;OPTN;CALCOCO2;BAG3;FYCO1;GPSM1;PRKAA2;BNIP3;PIP4K2B;LRSAM1;BNIP3L;ADRB2;PIP4K2A;SH3GLB1;WAC;SUPT5H;SIRT1;PINK1;SCOC;SESN1;TSC2;RAB3GAP1
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.4958672940774526,1.878690349658712,0.0,0.01754509954241633,0.65,16/32,13.44%,CNN1;TPM1;PTEN;VIP;CDKN1A;MFN2;APOD;EFEMP2;OGN;HMOX1;GPER1;IGFBP5;PRKG1;NDRG4;MEF2C;PDCD4
prerank,regulation of cardiac muscle contraction (GO:0055117),0.4638720210864722,1.8778632622043416,0.0,0.017406949152318562,0.65,14/36,12.13%,PLN;RGS2;TNNI3K;CALM1;ANK2;NOS1;SMAD7;PRKACA;ATP2A2;CALM2;NPPA;ASB3;SLC8A1;PDE4D
prerank,regulation of amyloid-beta formation (GO:1902003),0.41612901169779665,1.870836267820206,0.0,0.01851731510984404,0.68,10/34,11.46%,CLU;PRNP;CASP3;RTN1;IFNGR1;EPHA4;HAP1;RTN4;GGA3;PIN1
prerank,cell projection assembly (GO:0030031),0.5086447980008678,1.8708093454359198,0.0,0.018550440897160396,0.69,12/22,21.01%,GSN;PARVA;RHOJ;RAC1;NCKAP1L;RHOQ;RHOU;NEFH;PDGFA;RHOG;PARVB;SCIN
prerank,autophagosome maturation (GO:0097352),0.5340376060512829,1.870698708703456,0.0,0.01840774519795147,0.69,20/33,20.63%,GABARAPL1;MAP1LC3C;CHMP3;CALM1;LIX1L;TSG101;GABARAPL2;VTI1B;ATP2A2;LIX1;MAP1LC3A;ATG14;GABARAP;MAP1LC3B;VPS33A;VIPAS39;VPS16;SNAP29;VPS33B;CLN3
prerank,negative regulation of protein polymerization (GO:0032272),0.52827263216033,1.8674099362511332,0.0,0.019659016863533777,0.71,14/26,19.72%,CLIP3;STMN2;SNCA;PRKCD;KANK3;MAP2;TUBB4A;CDH5;MYADM;PFN2;KANK1;TWF2;SSH3;SLIT2
prerank,positive regulation of cytokinesis (GO:0032467),-0.5505686388794155,-1.8655974101356607,0.0,0.029750744212911538,0.6,18/37,22.59%,KIF14;KIF20B;KIF23;SSTR5;RACGAP1;TAS2R13;AURKB;CXCR5;DRD2;ECT2;CDC14C;CSPP1;SPAST;OR2A4;PKP4;CDC6;RXFP3;CIT
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.6718475439992403,-1.8643096437464157,0.0,0.0283340421075348,0.6,12/15,30.12%,TNFSF11;POU4F1;IL23A;IL17A;IL23R;IL12B;IFNG;POU4F2;OCSTAMP;TNF;TYROBP;TRAF6
prerank,regulation of actin filament polymerization (GO:0030833),0.3917062414017664,1.8617439929084758,0.0,0.020200707392557134,0.71,30/67,22.00%,LMOD1;NCK1;GBA2;CDC42EP3;DBN1;PRKCD;KANK3;CCL21;ESAM;NCKAP1L;CDC42EP4;BAIAP2;TENM1;MYADM;CCL11;EVL;PLEKHG2;PFN2;CDC42EP2;SNX9;HCLS1;FCHSD1;KANK1;TWF2;SSH3;SLIT2;PRKCE;FER;VASP;PFN1
prerank,cellular response to chemokine (GO:1990869),-0.5197798235350137,-1.8593830587127564,0.0,0.0282481813738756,0.62,25/57,17.22%,CXCL8;CXCL1;CXCL2;CXCL5;CXCL3;PPBP;SLC12A2;CXCL9;CXCL11;CCL24;CCL20;DUSP1;CXCL10;CCL22;PF4;CCL4;TFF2;CXCL6;CCL3;CCL25;GPR35;CCL26;CCL17;PF4V1;STK39
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.6421677085849601,-1.858933837103097,0.013888888888888888,0.027594893182990413,0.62,10/20,20.23%,CCND1;CDK1;FBXO5;RCC2;CDC25C;RAD51B;CDK4;CDC7;STOX1;CDC25A
prerank,DNA replication checkpoint signaling (GO:0000076),-0.6715975646949569,-1.8554209716043495,0.0,0.029475274359088283,0.65,11/17,20.35%,TICRR;TIPIN;TIMELESS;DNA2;RAD9B;TOPBP1;CDT1;CLSPN;HUS1;CDC45;CDC6
prerank,response to amino acid starvation (GO:1990928),0.3830017277269377,1.8535498414637186,0.0,0.021076967111725315,0.73,27/71,18.48%,ATP6V1G2;MAPK1;ATF4;MAPK3;CDKN1A;FAS;MAPK8;FLCN;MTOR;ATF2;ATP6V1E1;RRAGA;PRKD1;RRAGD;TFEB;KPTN;RRAGC;TCIRG1;RRAGB;LAMTOR3;ATP6V0E2;SH3GLB1;RHEB;ATP6V1D;RNF152;ATP6V1H;WDR59
prerank,neuron projection organization (GO:0106027),0.574325480572124,1.8512964424732292,0.0,0.021429912320003203,0.73,8/16,17.94%,PSEN1;PRNP;MAP1A;DCTN1;ATP1A3;APP;INS;ARF1
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.6421241403091064,-1.8478014410834518,0.014084507042253521,0.0319985782201093,0.68,9/19,15.15%,SHH;IL23A;IL23R;SYK;PNP;CD55;IL12B;HSPH1;TNFSF4
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.5532648612569521,1.847751974495108,0.0,0.021946447537592936,0.74,11/21,11.07%,FLNA;KCNA5;KCNH2;SNTA1;ANK2;CACNA2D1;KCNE2;SCN1B;NPPA;KCNE4;SCN4B
prerank,tRNA aminoacylation (GO:0043039),-0.5996706586237739,-1.8469813719990855,0.0,0.031022143538249645,0.68,11/20,22.37%,DARS2;YARS2;AIMP2;LARS2;MARS2;FARSB;WARS2;FARS2;FARSA;PPA1;RARS2
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.441849889814725,1.8459082507144813,0.0,0.022287809136735358,0.74,13/54,6.27%,FHL1;KCNMB1;FLNA;DPP6;KCNH2;KCNN3;KCNIP3;KCNMA1;GABBR1;GNG2;CD63;AKAP6;KCNE2
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.5459149627623822,1.8455256451423294,0.0,0.022125124398511012,0.74,9/24,14.93%,OR51E2;RASD2;PDE2A;PRKAR2B;PDE3B;PDE3A;GNAI1;PDE4D;UBE2B
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.6023051675575929,1.8432954083353197,0.0,0.02246024396823892,0.74,9/16,13.44%,CNN1;TPM1;PTEN;CDKN1A;EFEMP2;GPER1;PRKG1;MEF2C;PDCD4
prerank,dendrite self-avoidance (GO:0070593),0.6021906184167197,1.842879720091229,0.0,0.022462620210723927,0.74,8/16,17.04%,PALLD;NEXN;ROBO3;NPTN;ROBO4;DSCAML1;CNTN2;CNTN4
prerank,peptidyl-asparagine modification (GO:0018196),-0.5633059706053278,-1.8406920396846924,0.0,0.03183207199735391,0.73,15/31,15.33%,MGAT5;FUT8;UGGT1;ALG8;RPN2;MGAT2;STT3B;STT3A;ASGR1;RPN1;MAGT1;ALG5;ST6GAL1;DPM1;NUDT14
prerank,cellular response to starvation (GO:0009267),0.3409624624211575,1.8392618251740471,0.0,0.023604489590570422,0.76,50/149,18.48%,GABARAPL1;ATP6V1G2;MAPK1;MAP1LC3C;ATF4;MAPK3;WDR45;CDKN1A;ZFYVE1;FAS;NIM1K;MAPK8;FLCN;KLF10;CARTPT;MTOR;GAS2L1;ATF2;GABARAPL2;ATP6V1E1;PRKAA2;RRAGA;PRKD1;RRAGD;BRSK1;TFEB;MAP1LC3A;SFRP1;KPTN;ATG14;GABARAP;RRAGC;ASNS;PRKAG2;TCIRG1;RRAGB;LAMTOR3;ATP6V0E2;HSPA8;SH3GLB1;MAP1LC3B;SREBF1;RHEB;ATP6V1D;AKR1C3;RNF152;RRP8;ATP6V1H;NUAK1;WDR59
prerank,positive regulation of axonogenesis (GO:0050772),0.4073062754956816,1.8374176437746839,0.0,0.023598716910308605,0.76,10/43,6.57%,PLXNB3;NTN1;MAP6;MAPT;L1CAM;CHODL;NGF;DBN1;NGFR;RHOA
prerank,selective autophagy (GO:0061912),0.3780649280154993,1.83688359517901,0.0,0.02343252876305291,0.76,20/54,23.14%,DYNC1I1;MAP1LC3C;ULK1;ULK2;CALCOCO2;HDAC6;UBB;UBE2V1;ATG14;VIM;MAP1LC3B;DYNC1LI2;SQSTM1;ATG13;ATG2B;DYNC1I2;KLHL3;WDR81;NBR1;DYNLL2
prerank,positive regulation of neuron projection development (GO:0010976),0.4084133351759443,1.8368160911355789,0.0,0.023268664925549045,0.76,39/84,20.18%,RAP1A;PTN;PLXNB3;STMN2;ATP1B2;DPYSL3;ROR2;NPTN;DBN1;TOX;CAMK1;FES;SCN1B;DAB2IP;ZDHHC15;PRKD1;ROR1;TENM3;NDRG4;PACSIN1;CAPRIN2;BHLHB9;SNX3;NTRK1;CX3CL1;RET;SCARF1;VLDLR;RIT2;KIDINS220;EPHA3;LRRC7;FUT9;FZD1;TWF2;SCARB2;BMP5;EP300;LTK
prerank,DNA metabolic process (GO:0006259),-0.42729258498813916,-1.8366460414765748,0.0,0.03376473351147897,0.74,96/267,22.04%,EXO1;ORC6;DBF4;CHEK1;RFC3;XRCC2;BLM;RAD51AP1;MCM4;UBE2T;CDK1;POLE2;TICRR;NEIL3;ERCC5;TDP1;PRIM1;PRIM2;RAD51B;ZRANB3;TIMELESS;POLH;PRKDC;DNMT1;MSH3;RNASEH1;DNA2;RAD54L;RPA3;POLB;RECQL4;FEN1;POLA1;TOP1MT;UHRF1;DDX21;LIG1;TOP3B;AXIN2;RFC5;RMI2;FANCL;MCM7;RAD18;HMGB3;MCM3;RPA4;RAG1;MCM10;RAD9B;DCLRE1B;TOPBP1;PARP4;PARP2;MSH6;WDHD1;TOP1;CDT1;NUDT1;ATR;MCM5;RBBP8;RNASEH2A;MCM2;CDC7;RFC2;DCTPP1;FANCA;WRN;LIG3;NUDT15;SLX1A;POLD2;FANCC;TERT;TRRAP;BARD1;BRCA1;PARG;NOC3L;HUS1;RIF1;NTHL1;UNG;RAN;ENDOG;MCM6;CDC45;CDC6;NPM1;GTF2H3;SMC1A;TOP2A;HMGB1;SMARCB1;PDS5A
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.5744854883097869,-1.834303387957105,0.0,0.03328435751023053,0.74,15/30,15.33%,MGAT5;FUT8;UGGT1;ALG8;RPN2;MGAT2;STT3B;STT3A;ASGR1;RPN1;MAGT1;ALG5;ST6GAL1;DPM1;NUDT14
prerank,regulation of calcium ion transport (GO:0051924),0.3986556402510181,1.8300385379961517,0.0,0.0240566828777461,0.78,19/56,16.01%,CAMK2G;PLN;MYLK;STIM1;HRC;INPP5K;CASQ1;PKD2;ANK2;PACSIN3;NOS1;CACNA2D1;WFS1;SLN;CACNB2;TRPC6;BCL2;HOMER3;HOMER2
prerank,vesicle transport along microtubule (GO:0047496),0.5478432746890738,1.8292245006793817,0.0,0.02404795086944202,0.79,13/21,21.96%,DYNC1I1;KIF5A;KIF1C;FYCO1;KIF1A;HAP1;TRAK2;PAFAH1B1;KIFAP3;NDEL1;KIF13A;CLN3;FBXW11
prerank,negative regulation of phosphorylation (GO:0042326),0.3800530934813271,1.8280845886280743,0.0,0.024039338477690048,0.79,23/81,10.97%,PTEN;WWTR1;PRNP;CADM4;CDKN1A;MAPT;CDKN1C;FBLN1;TARDBP;CORO1C;INPP5K;TERF2IP;OCLN;HDAC4;NUPR1;CDKN2C;PID1;DAB2IP;PRKRIP1;FKBP8;TESK1;MYADM;ATG14
prerank,action potential (GO:0001508),0.4346884720905355,1.8266392225996368,0.0,0.024185880959796298,0.79,21/44,18.66%,CACNA1H;SCN7A;KCNH2;KCNB1;AKAP6;SCN3B;KCNE2;GPER1;KCNA2;SCN9A;SCN11A;KCNE4;DMD;KCNMB4;SCN4A;GNAQ;ANK3;KCNA1;KCNMB2;GNA14;GNA11
prerank,DNA-dependent DNA replication (GO:0006261),-0.4673588696109719,-1.8265772103019364,0.0,0.03614164482161105,0.76,54/128,26.28%,ORC6;GINS4;DBF4;GINS1;RFC3;BLM;MCM4;HMGA1;POLE2;GINS2;PRIM1;PRIM2;MCMDC2;PSMB9;DNA2;RPA3;POLB;PSMD14;RECQL4;POLA1;DDX21;RFC5;MCM7;MCM3;RPA4;MCM10;TOPBP1;WDHD1;CDT1;MCM5;MGME1;MCM2;CDC7;RFC2;WRN;BAZ1A;POLD2;NOC3L;PSMA3;MCM6;CDC45;CDC6;TEFM;PSMB3;SSBP1;ORC2;PSMA5;PSMD12;PSMB11;PSMB2;MCM8;PSMA7;ORC5;ORC1
prerank,eye photoreceptor cell development (GO:0042462),-0.6911997587588979,-1.8248310277373223,0.0,0.03518905229484161,0.76,7/15,9.53%,THY1;RP1;CRB2;RPGRIP1L;TH;NRL;TULP1
prerank,positive regulation of stress fiber assembly (GO:0051496),0.4587821860327634,1.8243357435607206,0.0,0.025100393870308345,0.8,21/42,18.15%,TPM1;FERMT2;LPAR1;MYOC;SORBS3;RAC1;RAPGEF3;ARHGEF15;RHOA;PXN;ARHGEF10;RHOC;TESK1;SFRP1;EVL;PPM1F;ITGB1BP1;PFN2;RGCC;TGFB3;LIMCH1
prerank,actin filament polymerization (GO:0030041),0.5117632056759224,1.823461806604665,0.0,0.024931934851044533,0.8,8/27,7.18%,FAM107A;GSN;WASF1;ARHGAP6;GAS7;RAC1;CORO7;WASF3
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.525673810732553,1.8216601732614712,0.0,0.02522153278551065,0.81,8/16,14.44%,CACNA1H;RAB3A;KCNB1;SYT4;SYT10;NLGN1;RAB27A;DOC2B
prerank,tRNA export from nucleus (GO:0006409),-0.566080610979008,-1.819123796498744,0.0,0.03385774930627643,0.77,23/32,31.47%,NUP155;NUP37;NUP210;NUP107;NUP35;XPOT;RANBP2;SEH1L;NUP50;NUP205;NUP93;RAE1;NUP88;RAN;POM121;NUP43;NUP160;NUP62;NUP153;NDC1;NUP98;SEC13;SSB
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.566080610979008,-1.819123796498744,0.0,0.03385774930627643,0.77,23/32,31.47%,NUP155;NUP37;NUP210;NUP107;NUP35;XPOT;RANBP2;SEH1L;NUP50;NUP205;NUP93;RAE1;NUP88;RAN;POM121;NUP43;NUP160;NUP62;NUP153;NDC1;NUP98;SEC13;SSB
prerank,sister chromatid segregation (GO:0000819),-0.5435157644203508,-1.812091531704541,0.0,0.035973122087507414,0.79,22/32,31.65%,KIF18A;NDC80;CENPK;SMC4;KNSTRN;DSN1;SPAG5;ZWINT;PLK1;KIF18B;ESPL1;RAN;SMC1A;TOP2A;NCAPG2;CHAMP1;ZW10;NSL1;KIFC1;TUBG1;KIF25;CDCA8
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.6478194162459324,-1.810799901367764,0.0,0.03588978666954408,0.82,9/19,12.41%,RGPD3;RGPD4;KPNA7;RGPD8;RGPD1;RGPD5;RGPD2;NUP35;RANBP2
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.5875991276991122,-1.809837186169751,0.0,0.034892848150945635,0.82,15/24,25.68%,DARS2;NARS2;YARS2;AIMP2;LARS2;MARS2;FARSB;EARS2;WARS2;FARS2;FARSA;PPA1;RARS2;AARS2;TARS2
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.5423515035215992,-1.806224520733968,0.0,0.03627267913045671,0.83,16/34,24.55%,IL1B;AZGP1;IL23A;ZP3;CD1A;IL23R;HSPD1;CD55;IL12B;CD1B;HLA-F;TNFSF4;TRAF2;HLA-G;IL12RB1;XCL1
prerank,Golgi to plasma membrane transport (GO:0006893),0.43865219090106816,1.8054700956028753,0.0,0.027318463860472916,0.81,21/46,20.28%,VAMP2;RAB34;OPTN;VAMP4;BBS1;ARL3;OSBPL5;RAB31;GGA3;GOLPH3;GOLGA7;BBS2;RABEP1;ANK3;EXOC6B;GOPC;GGA2;STEAP2;LLGL1;KIF13A;GGA1
prerank,neurotrophin signaling pathway (GO:0038179),0.5237024857480757,1.8043441038268264,0.0,0.027438612672886303,0.81,10/21,21.17%,RAP1A;CASP3;NGF;NGFR;HAP1;NTRK1;NTF3;KIDINS220;GRB2;RAPGEF1
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.5584985811320926,-1.802148456047621,0.0,0.03775386838714505,0.85,24/42,28.81%,CST1;CST4;CST2;LPO;AZGP1;TAS2R30;PKD1L3;TAS2R38;TAS2R13;TAS2R3;TAS2R31;TAS2R46;TAS2R43;TAS2R50;TAS2R19;CA6;TAS2R39;TAS2R42;TAS2R41;TAS2R60;TAS2R40;TAS1R3;PKD2L1;GNAT3
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.5981701181664564,-1.8021110022971802,0.0,0.036785820479782357,0.85,12/23,20.24%,OSM;IL23A;SLC7A5;IL23R;IL21;IL12B;TGFB1;PRKCQ;NOD2;PHB;CARD9;CCL1
prerank,tRNA transport (GO:0051031),-0.5585816626562252,-1.8017695738525736,0.0,0.03636202070466966,0.86,24/35,31.47%,NUP155;TOMM20L;NUP37;NUP210;NUP107;NUP35;XPOT;RANBP2;SEH1L;NUP50;NUP205;NUP93;RAE1;NUP88;RAN;POM121;NUP43;NUP160;NUP62;NUP153;NDC1;NUP98;SEC13;SSB
prerank,circulatory system development (GO:0072359),0.35028031623508377,1.8006512621391124,0.0,0.02889781101103866,0.81,37/122,11.11%,PDLIM7;BVES;PDLIM4;POPDC2;FOXF1;PTEN;POU6F1;CITED2;LDB3;PDLIM1;RBM20;OSR1;HEY1;CDKN1A;NXN;HAND1;ECE1;SRF;HAND2;KAT2B;PKD2;CACNA1C;PDLIM2;TCF21;ID2;KAT2A;PKD1;DVL2;MYL2;RAMP2;PDGFB;SOX18;MEF2A;CDH5;FLT4;FGF12;POPDC3
prerank,nuclear membrane organization (GO:0071763),0.5270092777264354,1.7990673131518011,0.0,0.028710162887590356,0.81,8/19,13.38%,TOR1AIP1;TMEM43;TARDBP;DCTN1;GPER1;AKAP8L;CHMP7;VPS4A
prerank,glutathione derivative metabolic process (GO:1901685),0.49312278613033533,1.7971163455764665,0.0,0.028488177092067753,0.81,7/21,11.72%,GSTM2;GSTM3;GSTM5;GSTA4;GSTM4;HPGDS;GSTT2B
prerank,glutathione derivative biosynthetic process (GO:1901687),0.49312278613033533,1.7971163455764665,0.0,0.028488177092067753,0.81,7/21,11.72%,GSTM2;GSTM3;GSTM5;GSTA4;GSTM4;HPGDS;GSTT2B
prerank,regulation of dendritic spine development (GO:0060998),0.483119193323323,1.7961460971954775,0.0,0.028451886420612887,0.81,13/21,24.95%,PSEN1;PTPRS;CAMK1;KIF1A;NLGN1;MEF2C;SHANK3;CPEB3;FOXO6;SRGAP2C;NEURL1;DLG5;APOE
prerank,response to unfolded protein (GO:0006986),0.3965263543080985,1.7936275300208533,0.0,0.028560299059389442,0.82,12/48,7.58%,HSPB8;DNAJB5;HSPB7;HSPA2;OPTN;HSPB1;BAG3;DNAJB4;DNAJC4;DNAJB2;DAB2IP;HSPB2
prerank,autophagosome organization (GO:1905037),0.41602084645068227,1.7915244242990545,0.0,0.028380674537003346,0.82,16/53,11.25%,GABARAPL1;MAP1LC3C;WDR45;ULK1;ATG9A;ULK2;ATG12;TP53INP2;RAB23;STX12;GABARAPL2;EMC6;ATP2A2;MAP1LC3A;ATG14;GABARAP
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.5269732489085572,-1.789992910011347,0.0,0.03870015507370607,0.87,20/37,30.49%,CHEK1;INTS7;E2F1;TIPIN;CHEK2;TIMELESS;DNA2;RPA4;RAD9B;CDT1;ATR;CLSPN;HUS1;CDC45;CDC6;RHNO1;ERCC6;PRPF19;BRIP1;CDC5L
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.4449707909554658,1.7893444002961394,0.0,0.02877305886298843,0.83,17/48,12.11%,BVES;FERMT2;LAMB2;ILK;PARVA;LAMA5;RADIL;ITGB3;RAC1;LAMC1;PIK3R1;RHOA;PXN;LAMB1;NTN4;NTNG1;TMEFF2
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.5064871869080696,1.7877936312530962,0.0,0.028594344211665523,0.83,17/36,13.44%,CNN1;TPM1;PTEN;CDKN1A;MFN2;EFEMP2;FOXJ2;MEF2D;FGF2;ADAMTS1;BMPR1A;GPER1;PDGFB;IGFBP5;PRKG1;MEF2C;PDCD4
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.37853694719072906,1.7875298602943521,0.0,0.028417835914062647,0.83,31/72,16.35%,ATP2B4;NPR1;YJEFN3;CLDN5;DCN;EMILIN1;THBS4;FOXJ2;FOXO4;PRL;ADAMTS1;ECSCR;SERPINF1;ATF2;STAB1;HOXA5;PDE3B;HHEX;COL4A2;PTPRM;DAB2IP;SEMA3E;SPINK5;MECP2;NPPB;SEMA6A;SYNJ2BP;KLF4;ANGPT4;RGCC;HSPG2
prerank,heart development (GO:0007507),0.3269154155682221,1.7868162937764802,0.0,0.028243493362442633,0.83,44/159,11.11%,PDLIM7;BVES;PDLIM4;POPDC2;FOXF1;PTEN;POU6F1;CITED2;LDB3;PDLIM1;RBM20;OSR1;DAND5;CDKN1A;HAND1;MYOCD;CRELD1;ECE1;MEF2D;SRF;HAND2;KAT2B;PKD2;CACNA1C;TGFBR3;PDLIM2;ID2;KAT2A;PKD1;SGCD;DVL2;MYL2;RAMP2;DLC1;TBX19;PDGFB;SOX18;MEF2A;TCAP;SGCG;NDRG4;FGF12;MYH7;POPDC3
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.3867543567272756,1.7855581125451212,0.0,0.02834921037454547,0.83,24/77,12.73%,PALM;DPYSL3;GPM6A;RAC1;CDC42EP3;OCLN;ARPC2;F2RL1;PIK3R1;CCL21;P2RX7;RHOQ;CROCC;CDC42EP4;MSTN;P2RY12;NLGN1;TENM1;DEF8;BRK1;MARK4;TAPT1;WASF2;AKIRIN1
prerank,cellular response to cadmium ion (GO:0071276),0.45051157570428657,1.7834685930262977,0.0,0.028453645968319792,0.84,9/27,13.56%,MAPK1;MAPK3;MAPK8;MT1X;MT1M;EGFR;MT1A;MT1E;MT3
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.5578408967792517,1.7794148417655322,0.0,0.029655162659694624,0.84,8/17,10.88%,KCNH2;SNTA1;KCNJ8;ANK2;SCN3B;KCNE2;GPD1L;KCNE4
prerank,detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580),-0.5764844731616932,-1.778857536265281,0.0,0.04297329719642778,0.9,20/38,24.87%,CST1;CST4;CST2;LPO;AZGP1;TAS2R30;TAS2R38;TAS2R13;TAS2R3;TAS2R31;TAS2R46;TAS2R43;TAS2R50;TAS2R19;CA6;TAS2R39;TAS2R42;TAS2R41;TAS2R60;TAS2R40
prerank,cell junction assembly (GO:0034329),0.3391925677131686,1.7770505923037483,0.0,0.030159938382500473,0.85,25/102,10.67%,LIMS2;FLNA;FERMT2;CDH19;TLN1;PTEN;FLNC;CLDN5;NLGN2;GPM6A;ILK;FLCN;DNER;GJC1;OBSL1;RHOA;KIRREL3;GJA4;DCHS1;CDHR3;ACTB;NLGN1;CDH5;PCDHB4;NLGN3
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.6909295268008957,-1.7757353553345567,0.0,0.04381892558490847,0.9,8/16,9.97%,CD80;IL1B;IL23A;PAEP;IL23R;IL17F;RASGRP1;IL12B
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.4881157856744264,1.7742213850768798,0.0,0.03160831077357993,0.85,9/25,6.54%,STMN2;MAPT;RAC1;OCLN;ARL2;FES;CLIP1;DCTN1;NUMA1
prerank,autophagy of mitochondrion (GO:0000422),0.4714039428780118,1.7740712692132734,0.0,0.031421279348884196,0.85,17/39,18.14%,GABARAPL1;MAP1LC3C;WDR45;ULK1;ATG9A;ULK2;ATG12;GABARAPL2;BNIP3;MAP1LC3A;FUNDC2;ATG14;GABARAP;MAP1LC3B;SQSTM1;ATG13;ATG2B
prerank,negative regulation of cell projection organization (GO:0031345),0.4066827804780001,1.7735192981339853,0.0,0.031638634323425834,0.85,17/46,14.94%,PTEN;STMN2;PRNP;LPAR1;DPYSL3;CRMP1;PTPRS;SPOCK1;STX1B;EPHA4;DENND5A;MYLIP;GORASP1;SEMA3A;MT3;ADCY6;ITM2C
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.3726872871103446,1.7692130278490428,0.0,0.032519837241939326,0.86,33/74,19.82%,APBB1;S100B;MAP6;SDC2;RAB3A;MAP1A;FGFR2;MAP2;SLITRK2;SLITRK3;ZDHHC17;MEF2A;ACTB;BAIAP2;BRSK1;ISL2;ATL1;APP;NTNG1;PARD3;MEF2C;MAP1B;DSCAML1;CCK;ANK3;NEFH;TAOK2;BTBD3;CNTN4;KLF7;LLGL1;SLITRK4;DVL1
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.4463055879671036,1.7667828342886138,0.0,0.03352329676415415,0.88,14/33,10.97%,KIT;FGF2;TNFAIP8L3;WDR91;PIK3R1;CCL21;PDGFRA;DAB2IP;PIK3IP1;P2RY12;PDGFB;PRKD1;PIK3R3;ATG14
prerank,DNA repair (GO:0006281),-0.4065391766867173,-1.766463210972903,0.0,0.047931754565246364,0.93,88/278,20.87%,FANCB;EXO1;TP73;CHEK1;RFC3;XRCC2;BLM;RAD51AP1;UBE2T;EME1;CDK1;POLE2;TICRR;RFWD3;NEIL3;ERCC5;CDCA5;TDP1;DCLRE1C;CHEK2;RAD51B;ZRANB3;TIMELESS;POLH;PRKDC;MSH3;RAD51AP2;TRAIP;DNA2;RAD54L;RPA3;FANCF;POLB;ASCC3;HMGA2;RECQL4;FEN1;POLA1;LIG1;EYA1;RFC5;ERCC8;RMI2;FANCL;BRCC3;RAD18;GTF2H2C;RPA4;RAD9B;PMS2;DCLRE1B;TOPBP1;PARP4;PARP2;XRCC4;FANCM;BRCA2;MSH6;WDHD1;TRIP13;NUDT1;ATR;MGME1;RBBP8;RNASEH2A;FAAP24;RFC2;GTF2H2;FANCA;WRN;LIG3;SLX1A;POLD2;FANCC;TRRAP;VCPIP1;BARD1;BRCA1;ACTR8;FANCE;HUS1;DTX3L;UNG;APTX;NPM1;GTF2H3;ERCC6L2;SMC1A
prerank,DNA unwinding involved in DNA replication (GO:0006268),-0.6714919432272202,-1.7654322356562435,0.0,0.04716043897454125,0.93,10/15,22.46%,BLM;MCM4;HMGA1;MCMDC2;RECQL4;MCM7;MCM2;WRN;MCM6;SSBP1
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.4861755686761342,1.7638329532160713,0.0,0.034119943892927385,0.88,11/27,16.65%,PER1;CRY2;FBXL22;USP2;RBM4;PER3;ID2;PPP1CB;CRY1;FBXL12;CRTC1
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.49342029386983405,1.7636586346454288,0.03571428571428571,0.03392385226135884,0.88,8/16,18.04%,ANK2;BCAP29;GABARAPL2;VAPA;TAPT1;GBF1;SEC16B;PPP1R15A
prerank,neutrophil migration (GO:1990266),-0.47545120359081894,-1.7627987874856355,0.0,0.047428722658264776,0.94,27/72,14.85%,CXCL8;CXCL1;CXCL2;CXCL5;CXCL3;PPBP;CXCL9;CXCL11;TGFB2;CCL24;CCL20;CXCL10;CCL22;PF4;CCL4;SYK;CXCL6;PECAM1;CXADR;UMODL1;CCL3;CXCR2;PIK3CG;CCL25;PPIB;CCL26;CCL17
prerank,embryonic organ development (GO:0048568),0.3659680305363629,1.7626599322300327,0.0,0.033730001677008216,0.88,26/66,13.15%,RNF112;TEAD3;PBX3;ATF4;HEY1;KIT;HAND1;KITLG;TPO;RARRES2;FGFR2;BMPR1A;TEAD2;FLT3LG;PBX2;TEAD1;RARB;RBPJ;GLI3;SOX18;NDRG4;TAL1;ERCC3;PKDCC;HEY2;SOX17
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.5349395000662335,1.760708363504524,0.0,0.03392682908237159,0.88,12/22,13.56%,CADM4;EMILIN1;ITGB3;TMEM204;HHEX;DAB2IP;MMRN2;EPN2;GRB10;ARNT;PRKCB;MT3
prerank,granulocyte chemotaxis (GO:0071621),-0.4667571828754178,-1.7606005809987106,0.0,0.047826255472292786,0.94,26/69,14.85%,CXCL8;CXCL1;CXCL2;CXCL5;CXCL3;PPBP;CXCL9;CXCL11;TGFB2;CCL24;CCL20;ADGRE2;CXCL10;CCL22;PF4;CCL4;SYK;CXCL6;CXADR;CCL3;CXCR2;PIK3CG;CCL25;PPIB;CCL26;CCL17
prerank,muscle cell differentiation (GO:0042692),0.43423998815975484,1.7605141654273841,0.0,0.033735152081906215,0.88,12/31,13.10%,BVES;POPDC2;SPEG;MYOCD;SEMA4C;TMEM204;WNT5B;MEGF10;POPDC3;DMD;MEF2C;HEY2
prerank,neutrophil chemotaxis (GO:0030593),-0.47332657211463475,-1.7591139209155602,0.0,0.048069489492157995,0.96,25/66,14.85%,CXCL8;CXCL1;CXCL2;CXCL5;CXCL3;PPBP;CXCL9;CXCL11;TGFB2;CCL24;CCL20;CXCL10;CCL22;PF4;CCL4;SYK;CXCL6;CXADR;CCL3;CXCR2;PIK3CG;CCL25;PPIB;CCL26;CCL17
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.49065672046854775,1.7563198858666178,0.043478260869565216,0.03380170225755454,0.89,10/20,14.54%,SEMA4C;SEMA3G;SEMA6C;SEMA3B;SEMA3E;SEMA3A;SEMA6D;SEMA3C;SEMA4B;SEMA6A
prerank,sensory perception of bitter taste (GO:0050913),-0.5689589035725934,-1.7556862396714734,0.0,0.04897741564302444,0.96,20/39,24.87%,CST1;CST4;CST2;LPO;AZGP1;TAS2R30;TAS2R38;TAS2R13;TAS2R3;TAS2R31;TAS2R46;TAS2R43;TAS2R50;TAS2R19;CA6;TAS2R39;TAS2R42;TAS2R41;TAS2R60;TAS2R40
prerank,cell junction organization (GO:0034330),0.37508650734455584,1.754798884375437,0.0,0.03386750885582133,0.9,27/72,13.52%,LIMS2;FLNA;FERMT2;PSEN1;FLNC;NLGN2;SNCG;ILK;SNCA;MAPT;L1CAM;OCLN;MYOT;NLGN4X;RHOA;CBLN2;SLC8A2;ACTB;SEMA3E;NLGN3;APP;SMAD3;PIN1;SNCB;CTNND2;FBLIM1;RAB8B
prerank,interstrand cross-link repair (GO:0036297),-0.5126051657698129,-1.753839942693552,0.0,0.04918789709868041,0.97,19/52,16.29%,FANCB;RAD51AP1;UBE2T;EME1;RFWD3;NEIL3;DCLRE1C;RAD51AP2;RPA3;FANCF;FANCL;DCLRE1B;FANCM;MSH6;ATR;FAAP24;FANCA;SLX1A;FANCC
prerank,folic acid-containing compound metabolic process (GO:0006760),-0.5883798775523226,-1.7510803244731004,0.0,0.04990865586915444,0.97,8/19,18.25%,MTHFD1L;DHFR;MTHFD1;SHMT2;GGH;MTHFD2;SLC19A1;SLC46A1
prerank,DNA recombination (GO:0006310),-0.5250516019212829,-1.7498210227443791,0.0,0.05022027335085495,0.97,16/37,23.70%,RAD54B;EXO1;XRCC2;BLM;HDAC10;RAD51B;MSH3;RAD54L;RECQL4;HMGB3;RAG1;WRN;ENDOG;HMGB1;TSN;RHNO1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.4557260619419403,-1.747726725028825,0.0,0.050520131682302606,0.97,53/122,22.05%,ERCC6L;CENPN;KIF18A;CENPE;NUF2;INCENP;CENPH;MAD2L1;CENPU;TACC3;KIF2A;WDR62;CENPA;NDC80;SKA1;DLGAP5;CENPO;CENPK;RCC2;SPDL1;SPC24;DSN1;CENPL;NUP37;GPSM2;AURKB;KNTC1;KIF4B;ZWINT;NEK6;CENPP;AURKA;CENPM;RCC1;NUP107;BUB1;KIF2C;PLK1;RANBP2;EML4;SEH1L;CENPF;ESPL1;KIF3B;CENPQ;CKAP5;NDE1;RAN;MAP4;BIRC5;CDC20;NUP43;STMN1
prerank,mitochondrion disassembly (GO:0061726),0.4759317302729782,1.7466544659433811,0.0,0.036718094918665095,0.93,12/35,11.25%,GABARAPL1;MAP1LC3C;WDR45;ULK1;ATG9A;ULK2;ATG12;GABARAPL2;BNIP3;MAP1LC3A;FUNDC2;GABARAP
prerank,protein localization to plasma membrane (GO:0072659),0.33052233462808067,1.746021870385679,0.0,0.03651523251579955,0.93,41/131,15.43%,RAP1A;FLNA;EHD2;RAB34;RAMP1;DPP6;KCNIP3;P2RY1;TMEM88;RAB3A;INPP5K;EPB41L3;KCNB1;SLMAP;ANK2;SCN3B;TMEM150A;RAMP3;RAMP2;RDX;GORASP1;PLEKHF1;ZDHHC22;FLOT1;CACNB2;PACSIN1;MYADM;TNFRSF1A;ASB3;RAB13;KCNIP4;RAB3C;ACTN2;RAB8B;FLOT2;ITGB1BP1;FAM126A;SLC9A3R2;ANK3;PACS1;TTC7B
prerank,establishment of skin barrier (GO:0061436),-0.6063648070186788,-1.7440772175570092,0.0,0.050966931500098955,0.97,15/19,34.72%,CLDN1;HRNR;MET;KRT16;ABCA12;ALOX12;ALOX12B;ALOXE3;FLG;LSR;STMN1;CLDN4;SFN;KDF1;FA2H
prerank,regulation of water loss via skin (GO:0033561),-0.6063648070186788,-1.7440772175570092,0.0,0.050966931500098955,0.97,15/19,34.72%,CLDN1;HRNR;MET;KRT16;ABCA12;ALOX12;ALOX12B;ALOXE3;FLG;LSR;STMN1;CLDN4;SFN;KDF1;FA2H
prerank,basement membrane organization (GO:0071711),0.5639871204362219,1.7436364394176365,0.0,0.03744160417814619,0.93,8/16,11.15%,LAMB2;NID1;CTSS;RAMP2;LAMB1;NTN4;NTNG1;PXDN
prerank,muscle filament sliding (GO:0030049),0.4402481460399263,1.741907943552537,0.0,0.03715849185921881,0.93,17/38,13.34%,TPM2;TPM1;DES;TMOD1;MYL6;MYH3;ACTC1;MYL2;TCAP;MYL1;MYH7;DMD;MYL3;TNNT3;MYBPC1;ACTN2;VIM
prerank,actin-myosin filament sliding (GO:0033275),0.4402481460399263,1.741907943552537,0.0,0.03715849185921881,0.93,17/38,13.34%,TPM2;TPM1;DES;TMOD1;MYL6;MYH3;ACTC1;MYL2;TCAP;MYL1;MYH7;DMD;MYL3;TNNT3;MYBPC1;ACTN2;VIM
prerank,fatty acid transmembrane transport (GO:1902001),0.5264245013311266,1.7405660314305897,0.0,0.03781997996655049,0.93,12/19,22.45%,PRKAB2;ACACB;CD36;CPT1B;PRKAA2;SLC25A20;SLC27A1;PRKAG2;ABCD4;CPT1A;ABCD1;MID1IP1
prerank,positive regulation of phospholipase activity (GO:0010518),0.48177195101397635,1.73966502208926,0.0,0.037739176534868246,0.93,7/24,5.96%,FGFR1;PLA2G5;AGTR1;KIT;FGF2;FGFR2;PDGFRA
prerank,positive regulation of filopodium assembly (GO:0051491),0.4753056414760549,1.7374987892770812,0.0,0.038146735528629766,0.93,8/24,9.94%,PALM;DPYSL3;GPM6A;PIK3R1;CCL21;RHOQ;NLGN1;TENM1
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.45233774689512735,1.7365604045337277,0.0,0.03830750621741876,0.93,14/31,15.49%,MAP3K3;RHOJ;FGF2;STARD13;HMOX1;HDAC7;MEOX2;RHOA;HDAC5;MMRN2;GATA2;TBXA2R;ITGB1BP1;KLF4
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.6119646676496915,-1.7363853365769095,0.0,0.05501526509213007,0.98,7/16,15.15%,IL23A;CD81;SYK;CD55;IL12B;TGFBR2;TNFSF4
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.5356545854593063,1.7345652087848595,0.0,0.038587160505657914,0.93,6/18,5.85%,FAM107A;KLF9;AQP1;ZFP36L1;BCL2L11;ZFP36
prerank,lamellipodium assembly (GO:0030032),0.49907034770585945,1.7320114743148436,0.0,0.039463622161222275,0.93,13/25,21.25%,VCL;KIT;S1PR1;RAC1;ARHGEF6;ABLIM3;P2RY12;WHAMM;GOLPH3;DMTN;SRGAP2;PARVB;ITGB1
prerank,response to nutrient levels (GO:0031667),0.4757203819922988,1.73200394303327,0.038461538461538464,0.039257006338388654,0.93,8/22,8.54%,FAM107A;ATF4;ULK1;PRL;KCNB1;MTOR;PRKAA2;GH1
prerank,axonogenesis (GO:0007409),0.30790953057977877,1.7314898188654941,0.0,0.03917124350159316,0.93,73/237,14.54%,APBB1;S100B;PALLD;PDLIM7;GFRA1;EPHA7;GFRA3;PTEN;MAPK1;NRP2;NCAM1;NEXN;MAPK3;ROBO3;PPP3CB;L1CAM;LAMA5;ULK1;KIF5A;NPTN;RAB3A;ULK2;SEMA4C;MAPK7;SEMA3G;NRXN3;MAP1A;FGFR2;SLIT3;PIK3R1;EPHA4;EFNA5;LGI1;GFRA2;SLITRK2;KIF5C;SCN1B;GPC1;SLITRK3;SEMA6C;ZDHHC17;SEMA3B;ACTB;BAIAP2;BRSK1;ROBO4;LAMA2;ISL2;FEZ2;GRB10;SEMA3E;NLGN3;ATL1;APP;NTN4;NTNG1;PARD3;SEMA3A;EPHB6;ENAH;SEMA6D;MAP1B;SEMA3C;EVL;DSCAML1;PRKCA;SEMA4B;CCK;CNTN2;RET;GDNF;EPHA10;SEMA6A
prerank,cardiac atrium morphogenesis (GO:0003209),-0.584165781770929,-1.7301800028531702,0.0,0.057065754981491135,0.98,8/19,22.32%,TBX20;TGFB2;PROX1;ENG;ZFPM1;GATA4;SHOX2;NOTCH1
prerank,hippo signaling (GO:0035329),0.5009956560966743,1.729708192363849,0.041666666666666664,0.039440626523318666,0.95,11/26,11.46%,TEAD3;WWTR1;AMOTL1;CASP3;TEAD2;TEAD1;DVL2;DCHS1;LATS2;AMOTL2;SAV1
prerank,regulation of protein localization (GO:0032880),0.3868013183758688,1.729629190066449,0.0,0.03923732432474486,0.95,21/64,14.83%,VIP;MAPK8;ITGB3;TRIM6;DVL3;CAMK1;ATCAY;MAP2;ZDHHC7;TRIM34;TESK1;TRIM21;PLEKHM2;CSNK1E;MMD;NKX3-1;VPS4A;ADCYAP1;PPM1F;DNAJB6;MMD2
prerank,ncRNA export from nucleus (GO:0097064),-0.5304644476342762,-1.7294301319814094,0.0,0.05642382523138396,0.98,24/36,31.47%,NUP155;NUP37;NUP210;NUP107;NUP35;XPOT;RANBP2;SEH1L;NUP50;NUP205;NUP93;RAE1;NUP88;RAN;NPM1;POM121;NUP43;NUP160;NUP62;NUP153;NDC1;NUP98;SEC13;SSB
prerank,inositol phosphate metabolic process (GO:0043647),0.3904405749056219,1.7294008352148744,0.0,0.03903610727692565,0.95,12/47,8.12%,INPP5A;PTEN;PLCD4;ITPKB;NUDT10;IP6K3;INPPL1;CALM1;FGF2;NUDT11;PLCD1;IP6K1
prerank,inositol phosphate-mediated signaling (GO:0048016),0.47612134823384344,1.7278236943470757,0.0,0.03918577828582381,0.95,9/20,19.84%,NFATC4;INPP5A;PPP3CB;NFATC1;PPP3CC;EDN3;NFATC3;HRH1;NMUR1
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.5867301982818917,1.7273940374754981,0.0,0.03910255373449299,0.95,7/17,11.17%,CADM4;CALM1;INPP5K;SIRT2;SMAD7;CALM2;PARD3
prerank,mitotic chromosome condensation (GO:0007076),-0.5552385609564217,-1.7254204354250675,0.0,0.05838093308823696,0.98,13/24,21.74%,NCAPD3;CDK1;NCAPG;CDCA5;SMC2;SMC4;NCAPD2;PLK1;SET;CSNK2A1;NCAPH;TTN;NCAPG2
prerank,regulation of smoothened signaling pathway (GO:0008589),0.4209040502395339,1.7254074826021983,0.0,0.03959568856432851,0.96,23/46,19.00%,RAB34;TTC23;FGFR2;TULP3;IFT81;GLI3;INTU;TXNDC15;SFRP1;SMO;KIF7;SUFU;MEGF8;STK36;GLIS2;GAS1;GPC3;FUZ;BTRC;PTCH2;KCTD21;KCTD6;RORA
prerank,photoperiodism (GO:0009648),0.46783048655571313,1.725172072563536,0.0,0.039511240590003514,0.96,11/28,16.65%,PER1;CRY2;FBXL22;USP2;RBM4;PER3;ID2;PPP1CB;CRY1;FBXL12;CRTC1
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.4769963648973415,1.7198046255806074,0.08333333333333333,0.042048549387892,0.96,8/18,18.09%,PDE9A;HAND2;AKAP6;MEF2A;CAMK2D;PRKCA;NR4A3;SLC9A1
prerank,mitotic sister chromatid segregation (GO:0000070),-0.4450425982067714,-1.7193478300010905,0.0,0.06324787843781934,0.99,40/96,22.78%,KIF18A;CENPE;KIF14;CEP55;KIF23;NCAPD3;CDK1;NCAPG;CDCA5;NDC80;SMC2;DLGAP5;CENPK;SMC4;SPDL1;KNSTRN;DSN1;SPAG5;NCAPD2;ZWINT;CHMP4C;KIF2C;PLK1;KIF22;EML4;KIF18B;SEH1L;RRS1;SET;ESPL1;CSNK2A1;PSRC1;PIBF1;RAN;NCAPH;TTN;SMC1A;NCAPG2;PDS5A;PRC1
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.34685140129638226,1.7190789955058865,0.0,0.041952738404239076,0.96,40/95,17.59%,ATP2B4;PTEN;NCK1;SNCA;HRC;INPP5K;TRIM6;NGF;TERF2IP;CAMK1;RAPGEF3;NOS1;SMAD7;HDAC6;MTCP1;EGFR;RAMP3;GPD1L;PRKD1;TENM1;RAF1;CAPRIN2;APP;DMD;PDE4D;TFRC;NTF3;BCAR3;PPM1F;TXN;SH2D3C;PFN2;RASSF2;HCLS1;CNKSR3;DMTN;INPP5J;ARAF;CREBL2;SFRP2
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.5107226781004737,-1.7183035766514754,0.0,0.06318646220811448,0.99,23/41,32.77%,AZGP1;IL23A;CD1A;IL23R;IL21;RAET1E;RASGRP1;IL12B;NOS2;CD1B;HLA-F;HLA-G;IL12RB1;SPI1;CRTAM;XCL1;CD160;KLRC2;TYROBP;NCR3;CD226;CD1E;SLAMF6
prerank,neuronal action potential (GO:0019228),0.5100428402447409,1.7181937487707009,0.0,0.04197070050791764,0.96,11/22,17.40%,CACNA1H;SCN7A;GPER1;KCNA2;SCN9A;SCN11A;KCNMB4;SCN4A;ANK3;KCNA1;KCNMB2
prerank,regulation of filopodium assembly (GO:0051489),0.4104088169730572,1.718040676237932,0.0,0.04198848564505749,0.96,11/38,9.94%,PALM;DPYSL3;GPM6A;GAP43;PRKCD;CAPZB;PIK3R1;CCL21;RHOQ;NLGN1;TENM1
prerank,protein localization to cell periphery (GO:1990778),0.31975407127149175,1.7179383682894276,0.0,0.0417826597350327,0.96,42/137,15.43%,RAP1A;FLNA;EHD2;RAB34;RAMP1;DPP6;KCNIP3;P2RY1;TMEM88;RAB3A;INPP5K;EPB41L3;KCNB1;SLMAP;WDR19;ANK2;SCN3B;ARL3;TMEM150A;RAMP3;RAMP2;RDX;PLEKHF1;ZDHHC22;FLOT1;CACNB2;PACSIN1;MYADM;TNFRSF1A;RAB13;KCNIP4;RAB3C;ACTN2;RAB8B;FLOT2;ITGB1BP1;FAM126A;RABEP1;SLC9A3R2;ANK3;PACS1;TTC7B
prerank,regulation of membrane depolarization (GO:0003254),0.5388046761071357,1.7167199662780255,0.0,0.04180118863070234,0.96,7/18,10.46%,FHL1;SCN3B;SMAD7;SCN2B;SCN1B;GPD1L;CAMK2D
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.4532360599972766,1.7143555497002165,0.0,0.04237270612140563,0.96,21/43,20.84%,CALCOCO1;EGLN2;PGR;WBP2;DDX17;GPER1;RBFOX2;RHOXF1;RNF14;ZMIZ1;NKX3-1;UBE3A;KDM3A;PPARGC1B;TRIP4;NCOA4;NR3C1;TADA3;PADI2;DAXX;TRERF1
prerank,negative regulation of signaling (GO:0023057),-0.5706224357828646,-1.7133941301054778,0.0,0.06643266539298885,0.99,11/24,19.11%,IL11;OSM;IL1B;SRMS;GLRA1;PCSK9;IGFBP3;FGF23;NLRP12;OPRM1;LIF
prerank,neural crest cell development (GO:0014032),0.3931691872911266,1.7058104868147137,0.0,0.0451406864067547,0.96,17/44,14.54%,ANXA6;RADIL;SEMA4C;CORO1C;SEMA3G;SEMA6C;SEMA3B;SEMA3E;TAPT1;SEMA3A;SEMA6D;SEMA3C;SEMA4B;CDH2;PEF1;GDNF;SEMA6A
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.4837193921316196,1.704628499534235,0.0,0.045142803699738124,0.96,8/29,7.56%,PTEN;CLU;BAG2;ECSCR;KCNE2;NUPR1;PSMC5;DAB2IP
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.42603675923105416,1.7019271398744402,0.0,0.046017265963072124,0.97,10/44,5.30%,KCNMB1;FLNA;ATP1B2;KCNH2;KCNN3;KCNMA1;GABBR1;GNG2;AKAP6;ANK2
prerank,neuron development (GO:0048666),0.339779847036002,1.7004764654136537,0.0,0.04634076806976354,0.97,34/141,10.79%,LGI4;PLP1;GPM6B;PBX3;STMN2;GPM6A;FRYL;GBA2;MYOC;MAPT;STMN4;L1CAM;ULK1;MICALL1;SRF;BLOC1S1;ATCAY;ARL3;LGI1;PBX2;BTG2;MAP2;PTPRM;VAPA;NCDN;SNAPIN;NPY;TMEM108;NLGN1;TENM1;LAMB1;ISL2;TENM3;APP
prerank,regulation of gene silencing by RNA (GO:0060966),-0.5007383912930856,-1.699000743444304,0.0,0.07613298085040208,1.0,26/49,31.15%,POLR2F;NUP155;TRIM71;NUP37;NUP210;NUP107;NUP35;RANBP2;SEH1L;NUP50;NUP205;POLR2D;NUP93;RAE1;NUP88;POLR2J;POM121;NUP43;POLR2I;NUP160;FMR1;NUP62;NUP153;NDC1;NUP98;SEC13
prerank,regulation of posttranscriptional gene silencing (GO:0060147),-0.5007383912930856,-1.699000743444304,0.0,0.07613298085040208,1.0,26/49,31.15%,POLR2F;NUP155;TRIM71;NUP37;NUP210;NUP107;NUP35;RANBP2;SEH1L;NUP50;NUP205;POLR2D;NUP93;RAE1;NUP88;POLR2J;POM121;NUP43;POLR2I;NUP160;FMR1;NUP62;NUP153;NDC1;NUP98;SEC13
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.5196135012882308,1.6986441574028357,0.0,0.046661203805775424,0.97,12/20,18.19%,TULP3;GLI3;GPR161;KIF7;SUFU;MEGF8;GLIS2;GPC3;BTRC;PTCH2;KCTD21;KCTD6
prerank,negative regulation of endocytosis (GO:0045806),0.458506395220304,1.6979379175220985,0.0,0.04687111400808128,0.98,10/24,17.09%,LGALS3;SYT11;RAC1;PACSIN3;NR1H2;PRKD1;SNX33;LRSAM1;EPHA3;NR1H3
prerank,response to ethanol (GO:0045471),-0.6115342818861152,-1.6977679010868736,0.0136986301369863,0.0756736878441237,1.0,6/15,14.54%,GRIN2B;TH;GLRA1;ADCY7;CHRNB2;GLRA2
prerank,striated muscle tissue development (GO:0014706),0.4193802436570477,1.6962400985124233,0.0,0.047507044615504535,0.98,11/34,12.74%,PGM5;BVES;POPDC2;MYL6;MYOZ2;SGCD;MYOZ1;SGCG;POPDC3;MEF2C;CFLAR
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.520128798083638,-1.6941249800088547,0.0,0.07693121735863993,1.0,18/29,31.40%,GRIN2B;USP50;EFNA3;SEMG1;FYN;PRELID1;SERPINB3;CR1;TTBK1;ROCK2;MEFV;EFNA1;LYN;SEMG2;PSME2;AIM2;PSME3;AGER
prerank,negative regulation of cellular protein localization (GO:1903828),0.42888959326926157,1.6938464053280444,0.0,0.048030534087934784,0.98,12/33,16.03%,GPM6B;MAPT;FLCN;MAP1A;TAX1BP3;LATS2;LEPROT;SNX33;ACTN2;ANKRD13A;GOPC;SIN3A
prerank,neuron cell-cell adhesion (GO:0007158),0.5471369942887614,1.6923269067675806,0.05,0.04801914129379234,0.98,12/16,21.74%,NLGN2;NRXN3;NLGN4X;NLGN1;NLGN3;NCAM2;RET;NRXN2;ASTN1;CNTN4;NRXN1;ASTN2
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.5056016320423811,-1.690290995350984,0.0,0.07913796636403002,1.0,14/40,16.43%,BLM;EME1;RFWD3;TIPIN;MMS22L;ZRANB3;TIMELESS;MSH3;TRAIP;TONSL;FANCM;ATR;WRN;ALYREF
prerank,synapse organization (GO:0050808),0.3353766977241377,1.6900604837169437,0.0,0.04927399519257644,0.98,57/126,22.48%,PSEN1;PDZRN3;PTEN;NLGN2;GPM6A;SNCG;SNCA;MAPT;L1CAM;PTPRS;DNER;MYOT;OBSL1;ZC4H2;NLGN4X;DCTN1;KIRREL3;SLITRK2;SLITRK3;CBLN2;LRRC4C;SLC8A2;NLGN1;PCDHB4;CACNB2;SEMA3E;NLGN3;APP;NTNG1;PIN1;SNCB;CTNND2;CX3CL1;CDH2;CNTN2;LRFN5;GPC4;ANK3;NRXN2;CDH1;PPFIBP1;SDK1;SHANK3;PCDHB5;CACNB3;NRXN1;DVL1;GPC6;RAB39B;RAB29;CACNB1;PPFIA4;PCDHB6;ADGRL3;APBB2;C1QB;SPOCK2
prerank,calcium-ion regulated exocytosis (GO:0017156),0.47294519626004666,1.688966488244815,0.03571428571428571,0.04957205377863955,0.98,11/26,14.44%,VAMP2;SYT11;PPP3CB;RIMS3;SYT4;SYT10;SYT5;SYT1;ARL8B;SYT6;DOC2B
prerank,cytosolic calcium ion transport (GO:0060401),0.4578282164352835,1.6884144171705706,0.0,0.0495537465748261,0.98,15/26,19.67%,JPH2;SLC25A23;CACNA1C;CACNA2D1;ATP2A2;SLC8A2;JPH4;SLC8A1;SMDT1;MICU3;MICU1;ATP2B3;JPH3;ADRA1A;CACNB3
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.4510950774882526,-1.6859740193429629,0.0,0.0816687096040709,1.0,30/85,20.35%,MYC;CCND1;INHBA;DBF4;CDKN3;E2F1;FBXO5;TRIM71;CDKN2A;USP37;SPDYA;CCNE1;DHFR;POLA1;E2F3;CDK4;TFDP1;RCC1;CDK7;CDT1;USP26;CDC7;CRLF3;NPAT;EIF4E;CDK5;EIF4EBP1;CDC45;CDC25A;CDC6
prerank,positive regulation of immune effector process (GO:0002699),-0.519553101637378,-1.685095279530277,0.012987012987012988,0.08086836752237468,1.0,17/32,23.42%,IL1B;IL23A;IL23R;CD81;IL12B;USP17L2;IFNG;RPS19;TNFSF4;MYB;CD46;IL10;PHB;PTPRJ;ANKRD17;IL12RB1;XBP1
prerank,axoneme assembly (GO:0035082),-0.522032336029124,-1.6849465410852706,0.0,0.0797131051291979,1.0,17/28,30.22%,RP1;SPAG17;CFAP74;CCDC103;RSPH9;RP1L1;SPAG1;TTC26;DNAAF3;DNAAF2;DNAAF1;DNAJB13;LRGUK;RSPH6A;CFAP46;CCDC65;FOXJ1
prerank,cellular protein localization (GO:0034613),0.3034426404103018,1.6822334020459055,0.0,0.05172100096715132,0.98,113/304,20.91%,TBC1D1;FBLN5;PRRT1;FLNA;JAM3;FERMT2;ARL4D;REEP1;RAB6B;SNX15;VCL;COPZ2;RIC3;CNTNAP1;SEC31B;WDR45;WLS;MFN2;SNX1;RAB5B;ATG9A;GPIHBP1;EPB41L3;DNAJC27;NGFR;VPS45;SGSM2;CD63;RAB23;OCLN;STX1B;ANK2;STX2;TBC1D17;STX12;EVI5L;RABL2B;HDAC6;FGF7;ESAM;RABGAP1;EGFR;HHEX;RRAGA;STX16;RAB28;ZDHHC15;TICAM2;CROCC;CORO1B;TRIM23;RAB31;ADPRH;RRAGD;TBC1D25;OXA1L;GGA3;USP6;TBC1D10A;CAPN3;ANGPT1;PACSIN1;SGSM1;RAB24;DMD;TM9SF1;RRAGC;SGSM3;CPE;FGF10;NAPB;HEY2;VPS26B;RRAGB;CNTN2;TBC1D26;BBS2;LAMTOR3;NPHP1;SNX27;RAB5C;STX8;SNX9;RABL2A;BBS4;VPS33A;ARMCX3;SNX17;VIPAS39;GGA2;UNC50;ATG13;ITSN1;CEP68;ARF1;CD177;RTP5;STXBP1;AP2A1;ARL6;STX7;STXBP3;CNTLN;RAB14;KIF13A;GGA1;VPS33B;RAB29;EHD1;SAR1A;LAMTOR1;IFT22;STX4
prerank,protein localization to cell junction (GO:1902414),0.47369244965520785,1.682157151334575,0.0,0.05148590550820972,0.98,7/21,9.32%,JAM3;FERMT2;NLGN2;ARHGEF18;DLG4;JAK1;NLGN1
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.5867521475958482,-1.6821306502752662,0.0,0.08110453273692003,1.0,6/15,15.94%,IL4I1;ACMSD;KYNU;IDO1;TDO2;KMO
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.41215655102856946,1.6810587429294517,0.0,0.051562311478855656,0.98,6/26,6.27%,FHL1;VAMP2;CASQ2;ATP1B2;ANK2;KCNE2
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.43390674882974234,1.676420366737754,0.0,0.0531779305718598,0.98,17/28,23.99%,LIMA1;PRKCD;KANK3;PLEKHH2;SMAD4;IQCJ-SCHIP1;MYADM;PFN2;ARPIN;KANK1;SHANK3;TWF2;SSH3;SLIT2;PFN1;TJP1;KANK4
prerank,positive regulation of lamellipodium organization (GO:1902745),0.45439363412460826,1.676131512959722,0.0,0.053041664253930636,0.98,11/30,12.73%,CORO1C;RAC1;ENPP2;OCLN;ARPC2;PIK3R1;CORO1B;MSTN;BRK1;WASF2;AKIRIN1
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),-0.4872503141842511,-1.6755870669091326,0.0,0.08668118066971757,1.0,30/47,37.00%,NUP155;NUP37;NUP210;NUP107;KHK;NOS2;NUP35;PNPT1;RANBP2;SEH1L;NUP50;NUP205;NUP93;RAE1;NUP88;POM121;NUP43;NUP160;EIF6;NUP62;GCKR;NUP153;TIGAR;NDC1;NUP98;SEC13;JMJD8;NOA1;NUP214;HIF1A
prerank,negative regulation of cell junction assembly (GO:1901889),0.45530359249562535,1.6749196143408305,0.0,0.05321184506839798,0.98,8/25,8.02%,FAM107A;PTEN;ARHGAP6;DUSP22;APOD;CORO1C;PHLDB2;DLC1
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.5498247012896695,-1.6748861768727616,0.028985507246376812,0.08621829068703739,1.0,11/26,24.18%,CENPE;DLGAP5;FBXO5;UBE2C;DUSP1;HECW2;NEK6;PLK1;ESPL1;CDC6;NSMCE2
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.4229429344857977,1.6745936549357356,0.0,0.05307663927553244,0.98,8/33,8.60%,NR1D1;TLR3;PTPRS;F2RL1;DAB2IP;TICAM2;TLR9;GPS2
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.5135942501730759,1.674399108345211,0.03571428571428571,0.05260900368720176,0.98,4/15,12.12%,AP3S2;BLOC1S1;SNAPIN;AP3B2
prerank,anterograde synaptic vesicle transport (GO:0048490),0.5135942501730759,1.674399108345211,0.03571428571428571,0.05260900368720176,0.98,4/15,12.12%,AP3S2;BLOC1S1;SNAPIN;AP3B2
prerank,T cell migration (GO:0072678),-0.5697164331662002,-1.6733510062032,0.013333333333333334,0.08630396068970735,1.0,12/18,24.21%,SLC12A2;CXCL11;CCL20;CXCL10;CCL3;PIK3CG;ZAP70;CXCL16;CCL26;MSN;PIK3CD;DEFA1
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.4092881000624673,1.6724300786632509,0.0,0.05347780612019736,0.98,13/31,13.73%,FSTL3;LTBP4;SMAD2;FST;TGFBR3;FSTL1;SMAD7;LATS2;TWSG1;SMAD4;SMAD3;DKK3;ITGA3
prerank,protein N-linked glycosylation (GO:0006487),-0.4513665849375182,-1.6719214255764363,0.012195121951219513,0.08629919580574932,1.0,26/67,19.71%,PMM2;ALG10;ALG11;ALG1;MGAT5;FUT8;UGGT1;ALG8;RPN2;MGAT2;GFPT1;STT3B;STT3A;ASGR1;SRD5A3;RPN1;MAGT1;ALG5;ST6GAL1;DPM1;PGM3;NUDT14;ALG2;SLC39A8;ALG14;UGGT2
prerank,regulation of osteoblast proliferation (GO:0033688),0.5077881053451117,1.67083346771729,0.0,0.054339020759018315,0.98,7/16,18.90%,FGFR2;RHOA;MN1;NPR3;SFRP1;PLXNB1;SOX8
prerank,protein deacetylation (GO:0006476),0.4086859416358299,1.6705012072644758,0.0,0.05440003208189634,0.98,22/44,22.04%,FLNA;MORF4L1;SIRT2;SIN3B;HDAC4;HDAC7;HDAC6;HDAC5;BRMS1L;SIRT3;TBL1X;SIN3A;HDAC11;RCOR3;SIRT1;HDAC9;MSL3;TRERF1;ZNF541;MTA3;MIER3;RBM14
prerank,regulation of fat cell differentiation (GO:0045598),0.35026505903587013,1.6699449273841036,0.0,0.054361854814647025,0.98,26/80,12.53%,PPARD;FERMT2;WWTR1;NR1D1;LMO3;ZFP36L1;SIRT2;RARRES2;ARNTL;ZFP36;ID2;ZADH2;GPER1;MEDAG;TRIB2;GPS2;ZNF385A;SFRP1;CREB1;LPL;GATA2;SMAD3;GNB3;BBS12;RUNX1T1;TMEM64
prerank,negative regulation of reproductive process (GO:2000242),-0.5645560030427483,-1.6696949723115628,0.028985507246376812,0.08759941351579507,1.0,12/21,22.88%,TIMP1;ZP3;DUSP1;PAEP;CALR;ARHGDIB;HYAL3;SEMG1;WDR77;ASTL;WEE2;NODAL
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.4710550559468877,1.668866440080819,0.04,0.05452047684861242,0.98,8/26,15.53%,TLR3;CD36;TLR9;GPS2;FLOT1;NFKBIL1;FLOT2;GPR108
prerank,negative regulation of neuron projection development (GO:0010977),0.37687764326357515,1.668682720940199,0.0,0.05428648338574284,0.98,20/55,14.94%,PTEN;STMN2;LPAR1;DPYSL3;CRMP1;PTPRS;NGFR;SPOCK1;STX1B;EPHA4;RHOA;DENND5A;MYLIP;RTN4;GDI1;NLGN1;SEMA3A;MT3;ADCY6;ITM2C
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.5998036335284558,-1.668295955408342,0.0,0.08766380906603947,1.0,9/16,18.88%,MUC6;SOX9;VSIG1;TFF1;TFF2;SERPINA3;RBP4;NOD2;MUC4
prerank,cellular response to mechanical stimulus (GO:0071260),0.40036516648211223,1.6678018840503208,0.0,0.05434667629871387,0.98,24/49,20.11%,TLR3;BCL10;PDE2A;MAPK3;AQP1;MAP2K4;FAS;MAPK8;MAP3K14;BNIP3;TMEM150C;TNFRSF1A;NFKB1;PTGER4;BAD;MAP3K1;PIEZO2;PIEZO1;SLC9A1;CRADD;KCNK4;CASP1;CD40;TNFSF14
prerank,negative regulation of protein phosphorylation (GO:0001933),0.317429848833586,1.6662362198143381,0.0,0.054600318988371546,0.98,49/141,17.78%,PTEN;WWTR1;NCK1;PRNP;DBNDD2;CADM4;SNCA;EMILIN1;HSPB1;CALM1;FBLN1;TARDBP;CORO1C;INPP5K;SIRT2;TERF2IP;PRKCD;OCLN;SMAD7;PID1;CEACAM1;DAB2IP;GPD1L;TRIB2;PRKRIP1;FKBP8;TESK1;CALM2;TAB1;SFRP1;MYADM;DEPTOR;DUSP19;ATG14;DMD;PARD3;PDE4D;PRKAG2;GNAQ;NTF3;PPM1F;ITGB1BP1;RASSF2;CNKSR3;ERRFI1;DMTN;INPP5J;SFRP2;CDK5RAP3
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.5664343074752962,-1.6662352669454343,0.0,0.08857415299855428,1.0,8/19,13.95%,CLDN1;CLDN2;CLDN16;CLDN14;CLDN20;CLDN18;CLDN12;CLDN6
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.35888728167693884,1.6611805145638758,0.0,0.05630036354127288,0.98,18/71,9.44%,FHL1;FAM107A;KANK2;PTEN;CDKN1A;PKD2;ADAMTS1;LSM11;ID2;CCL2;JADE1;PKD1;CDKN2C;EGFR;GPNMB;RDX;ZNF655;PRMT2
prerank,fibrinolysis (GO:0042730),-0.5956756750284096,-1.660349563693427,0.0,0.09431529881280254,1.0,11/15,29.16%,PLAU;SERPINE1;PLAUR;PLG;CPB2;SERPINB2;FGA;HRG;FGB;GP1BA;F2
prerank,regulation of metal ion transport (GO:0010959),0.5610325375540143,1.6589587628405844,0.0,0.056928272872587705,0.98,6/17,9.80%,CAMK2G;PLN;STIM1;ANK2;CACNA2D1;SLN
prerank,nucleotide biosynthetic process (GO:0009165),-0.5563548412644351,-1.6574622613240242,0.02857142857142857,0.09619407295508063,1.0,5/18,8.63%,PPAT;GART;MTHFD1;HPRT1;PNP
prerank,regulation of neurotransmitter secretion (GO:0046928),0.4315858371581699,1.6560791157767263,0.0,0.057550905654899905,0.98,12/32,14.56%,CHRNA3;SYT11;CPLX3;STX1B;CHRNB4;RIMS3;GPER1;SNAPIN;SYN1;MEF2C;KCNMB4;RIMS4
prerank,cellular response to reactive oxygen species (GO:0034614),0.35128155907613956,1.65512105848501,0.0,0.057500822716374404,0.98,16/62,9.12%,TPM1;MAPK1;RHOB;MAPK3;AQP1;MAPT;MAPK8;MAPK7;PKD2;PRKCD;PDGFRA;HDAC6;PXN;EGFR;PDK2;ZNF580
prerank,folic acid metabolic process (GO:0046655),-0.5575709114088362,-1.6543647136519706,0.013513513513513514,0.09867942319179712,1.0,7/18,18.25%,MTHFD1L;DHFR;MTHFD1;SHMT2;MTHFD2;SLC19A1;SLC46A1
prerank,long-chain fatty acid transport (GO:0015909),0.43245708608396416,1.654246843051735,0.041666666666666664,0.05754611772597685,0.98,16/32,22.45%,PRKAB2;ACACB;FABP4;CD36;CPT1B;PRKAA2;SLC25A20;SLC27A1;PRKAG2;SLC27A2;ACSL1;ABCD4;SLC27A6;CPT1A;ABCD1;MID1IP1
prerank,regulation of protein dephosphorylation (GO:0035304),0.41976358592606244,1.6539097170071069,0.0,0.057401903717461,0.98,15/38,21.64%,CALM1;PRKCD;HSP90B1;SMPD1;DLC1;CDH5;CALM2;PIN1;TSC1;PPP6R2;ARPP19;PPP1R15A;CNEP1R1;ENSA;CALM3
prerank,endoplasmic reticulum organization (GO:0007029),0.34155951148284763,1.6534151456607034,0.0,0.05754140893637486,0.98,16/69,11.34%,RNF112;REEP2;VAMP2;REEP1;PRNP;SEC31B;CAV2;HMOX1;ATL2;TRAM1L1;VAPA;RTN4;ATL3;ATL1;APP;LMAN2L
prerank,endothelial cell development (GO:0001885),0.4208732479151404,1.6533310691502443,0.0,0.057304613014826,0.98,10/25,12.13%,RAP1A;GSTM3;PDE2A;RAPGEF3;F2RL1;SOX18;RDX;ROBO4;MYADM;PDE4D
prerank,regulation of cell-substrate adhesion (GO:0010810),0.40297239536113716,1.6531299540687794,0.0,0.05725656576209027,0.98,18/42,14.41%,CORO2B;FZD7;CORO1C;FZD4;RAC1;SPOCK1;ARL2;GCNT2;RHOA;RSU1;PDGFB;FBLN2;VIT;MYADM;CX3CL1;TSC1;JAK2;PPM1F
prerank,base-excision repair (GO:0006284),-0.4623915754743289,-1.6504365843526148,0.0,0.1026360362683913,1.0,17/47,19.48%,RFC3;NEIL3;ERCC5;DNA2;RPA3;POLB;HMGA2;FEN1;LIG1;RFC5;RFC2;WRN;LIG3;POLD2;PARG;NTHL1;UNG
prerank,regulation of protein autophosphorylation (GO:0031952),0.4311930272052516,1.6465415874229583,0.0,0.05972052144688162,0.99,14/36,17.80%,EPHA7;PPP2R5B;CALM1;PPP2R5D;GPNMB;PDGFB;TESK1;CALM2;PDGFD;RASSF2;TAOK2;ERRFI1;INS;PDGFA
prerank,regulation of interleukin-17 production (GO:0032660),-0.5204978086165262,-1.6464570308360877,0.014285714285714285,0.1047449227308666,1.0,16/32,20.77%,OSM;FOXP3;IL23A;SLC7A5;IL23R;IL21;IL12B;IFNG;TGFB1;TNFSF4;PRKCQ;NOD2;PHB;CARD9;CCL1;IL36RN
prerank,stress-activated MAPK cascade (GO:0051403),0.35345723642554533,1.6463629966147397,0.0,0.05947775509953657,0.99,30/61,22.26%,MAPK1;MAPK3;MAP2K4;MAPK8;ZFP36L1;SKP1;MAPK14;ZFP36;UBB;ARHGEF6;MAPK11;GPS2;MAP4K2;UBE2V1;TAB1;LGALS9;NFKB1;PTGER4;MAPK10;SH2D3C;TAOK2;BTRC;MAP3K12;TNIP2;CUL1;MAP3K10;FBXW11;MAP3K8;MAP2K7;MINK1
prerank,cytoskeleton organization (GO:0007010),0.3493016053312805,1.6462750791244711,0.0,0.05923695447160322,0.99,43/117,14.79%,PALLD;TPM1;DES;ARHGAP10;RHOB;DST;CNTNAP1;RND2;EPB41L3;RAC1;ZNF135;OBSL1;CAPZB;PACSIN3;PACSIN2;CCL2;RHOA;MAST1;WASF3;MAST2;RHOC;RHOU;FGD6;MARK1;ZMYM3;KLHL20;MICAL3;SIPA1;PACSIN1;CCL11;DPYSL2;CCL13;ZMYM6;KRT13;ARC;KRT4;PPP2R3C;KRT25;SEMA6A;PLD2;WTIP;RANBP10;SPRYD3
prerank,detection of visible light (GO:0009584),-0.6081472764418507,-1.6461777340255868,0.0,0.1038914877276276,1.0,5/16,9.53%,RP1;CEP250;EYS;REEP6;TULP1
prerank,ribosome biogenesis (GO:0042254),-0.39964098746470794,-1.646046329581849,0.0,0.10282479437769688,1.0,113/184,43.50%,WDR43;DKC1;DDX47;DCAF13;WDR3;WDR12;WDR74;NOB1;UTP14A;BOP1;URB2;NIP7;DDX31;NOP16;ABCE1;UTP18;HEATR1;NAF1;RRP12;LYAR;UTP20;BYSL;RCL1;RPL39;DDX10;EXOSC3;EXOSC8;EMG1;PDCD11;DDX27;PAK1IP1;RRP1;RPS19;DIS3;MRTO4;FBL;GTF3A;RRP9;RRS1;EXOSC5;EXOSC4;PIH1D2;NOP14;WDR36;RRP1B;NOLC1;NOP58;ESF1;DHX37;IMP4;VCX;RPL36;UTP15;RAN;DDX52;NPM1;PWP2;HEATR3;EBNA1BP2;PES1;RPF2;RPL26L1;MDN1;XRN2;RPL37;EXOSC7;RPL8;NOM1;RPL23A;EIF6;RRP7A;RPS7;NOP56;XPO1;EXOSC2;BMS1;UTP6;NOC2L;DDX54;RIOK1;NOL11;ZNF658;NOC4L;KRR1;EXOSC1;RPS2;CUL4A;IMP3;WDR75;RPL4;RPL35;WDR18;WDR46;NOL6;RPL18;RPL32;RPL41;RPS24;LSG1;MALSU1;NVL;RPL27A;NOL8;RPL19;RPL38;MPHOSPH6;RPL37A;MRPL22;MRPL36;RPS14;RPL12;ZNF622;RPLP2
prerank,regulation of protein import into nucleus (GO:0042306),0.40255344555946493,1.6454711996522433,0.0,0.059181890475134294,0.99,15/36,17.96%,FLNA;PSEN1;APOD;BAG3;RAB23;PRKCD;DMAP1;PIK3R1;CHP2;SMAD3;MDFIC;SUFU;HCLS1;CDH1;EFCAB7
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.45307574000400586,1.6452765415793755,0.0,0.0591272687597615,0.99,8/24,13.60%,CHMP3;TMEM50B;CHMP4A;UBXN6;LEPROT;CHMP7;TMEM50A;RILP
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.4935711944827389,1.64508273764164,0.0,0.059164246184806306,0.99,8/17,12.43%,FGF2;AKAP6;TGFBR3;FGFR2;BMPR1A;RBPJ;PIM1;MEF2C
prerank,neuron projection development (GO:0031175),0.3177966233121107,1.6444004557222591,0.0,0.059200928969014105,0.99,48/168,14.31%,PLP1;GPM6B;PTEN;STMN2;GPM6A;CNTNAP1;FRYL;GAS7;MYOC;MAPT;STMN4;L1CAM;ULK1;MICALL1;EPB41L3;NGF;DBN1;BLOC1S1;ATCAY;EPHA4;LGI1;BTG2;MAP2;UBB;DLG4;NCKAP1L;DCLK1;PTPRM;DAB2IP;NYAP1;VAPA;NCDN;SNAPIN;NPY;TMEM108;NLGN1;NBL1;LAMB1;PACSIN1;APP;SGK1;RAB13;CTNND2;ARC;SVBP;NTF3;ADCYAP1;GDNF
prerank,branched-chain amino acid catabolic process (GO:0009083),0.5032947283042688,1.6430676469878658,0.0,0.05891309982043418,0.99,10/20,18.92%,DLD;ACAT1;ACADSB;ACAD8;BCKDHA;BCKDK;ALDH6A1;BCAT2;IVD;DBT
prerank,branched-chain amino acid metabolic process (GO:0009081),0.5032947283042688,1.6430676469878658,0.0,0.05891309982043418,0.99,10/20,18.92%,DLD;ACAT1;ACADSB;ACAD8;BCKDHA;BCKDK;ALDH6A1;BCAT2;IVD;DBT
prerank,regulation of microtubule-based process (GO:0032886),0.4075606748956952,1.6420453925716902,0.0,0.059129791192669756,0.99,8/36,6.94%,FAM107A;MAP6;MAPT;PHLDB2;KLHL42;EFNA5;HDAC6;PRKAA2
prerank,recombinational repair (GO:0000725),-0.4455261602697026,-1.6417157685415658,0.0,0.10777918187726611,1.0,31/76,26.99%,RAD54B;XRCC2;BLM;RAD51AP1;RFWD3;ERCC5;MMS22L;RAD51B;RMI1;RAD51AP2;RPA3;PSMD14;RECQL4;FEN1;PALB2;RPA4;TONSL;BRCA2;RBBP8;WRN;LIG3;SLX1A;BRCA1;HUS1;NABP1;RHNO1;NSMCE2;SFR1;MCM8;SMC6;SAMHD1
prerank,positive regulation of cell differentiation (GO:0045597),0.3022759718977439,1.639493654983737,0.0,0.060417279103491144,0.99,71/252,13.25%,TGFB1I1;IL6R;RAP1A;TMEM100;PPARD;GLIPR2;PTN;FERMT2;FGFR1;WWTR1;CD34;SMYD1;PLA2G5;AGTR1;BOC;DDR2;LMO3;RBM24;KITLG;RRAS;ZFP36L1;SMAD2;SRF;NGF;CDON;MAPK14;MTOR;CAMK1;RARRES2;FES;ARNTL;RBM4;ZFP36;ZHX3;ZC4H2;BMPR1A;PCP4;ID2;GCNT2;RHOA;HOXA5;CD36;HOXD3;GPC1;CEACAM1;GPRC5B;MAPK11;MEDAG;PRKD1;MEF2A;SMAD4;NBL1;BNIP2;ZNF385A;SFRP1;CREB1;LPL;HOXA11;ADRA2B;SMAD3;NFKB1;BTG1;MMD;OLFM1;PKDCC;MEF2C;TMEM64;GDF5;AKIRIN1;LRRC8A;CDH2
prerank,cell cycle G1/S phase transition (GO:0044843),-0.4550019352442721,-1.639152181389453,0.0,0.10920004963972894,1.0,19/63,16.56%,MYC;CCND1;INHBA;DBF4;CDKN3;E2F1;TRIM71;CDKN2A;USP37;SPDYA;CCNE1;E2F3;CDK4;RCC1;CDK7;USP26;CDC7;CRLF3;EIF4E
prerank,adherens junction organization (GO:0034332),0.39108651785148946,1.6380563022108203,0.045454545454545456,0.06107152964112024,0.99,13/43,9.43%,JAM3;FERMT2;CDH19;CADM3;PIP5K1C;VCL;CADM2;SMAD7;DCHS1;RAMP2;CDHR3;ACTB;CDH5
prerank,myotube differentiation (GO:0014902),0.4787695222998532,1.6377096255557604,0.06896551724137931,0.06109993468150873,0.99,11/18,18.87%,CACNA1H;JAM2;NOS1;ADGRB3;MYEF2;MEF2C;PLD3;ADAMTS5;SKI;ADAMTS15;KLHL40
prerank,cellular response to topologically incorrect protein (GO:0035967),0.4059733127492315,1.6363438779975301,0.0,0.061834802990534656,0.99,7/31,7.56%,HSPB8;HSPA2;OPTN;DNAJC18;BAG3;HDAC6;DAB2IP
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.5005400595226128,1.6360465860767983,0.0,0.06168405294684013,0.99,15/26,22.15%,MAPK1;MAPK3;MAPK8;SKP1;UBB;MAPK11;NFKB1;TAOK2;BTRC;TNIP2;CUL1;FBXW11;KAT7;MAP3K8;MAP2K7
prerank,regulation of cytoskeleton organization (GO:0051493),0.3435758428571564,1.6355362577108454,0.0,0.0617974303074085,0.99,27/111,9.92%,FAM107A;CORO2B;GPM6B;MAPK1;CLIC4;MAP6;RHOB;SYDE1;NEXN;MAPK3;MAPT;SORBS3;RND2;RAC1;MTOR;PRKCD;PHLDB2;EFNA5;P2RX7;RHOA;PRKAA2;RHOQ;DLC1;RHOC;TESK1;BAIAP2;IQCJ-SCHIP1
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.5913907526832365,-1.6353296098833052,0.013888888888888888,0.11164041894037005,1.0,10/18,21.79%,CEBPB;ZP3;SLC7A5;SYK;PRKCZ;TNFSF4;PRKCQ;NLRP3;CD86;GATA3
prerank,positive regulation of cell division (GO:0051781),-0.46301650187594356,-1.6326801523686096,0.0,0.11402594848144622,1.0,19/44,22.59%,KIF14;KIF20B;KIF23;SSTR5;SHH;RACGAP1;TAS2R13;AURKB;CXCR5;DRD2;ECT2;CDC14C;CSPP1;SPAST;OR2A4;PKP4;CDC6;RXFP3;CIT
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.5899979197532657,-1.631687994442397,0.0,0.11408124879667066,1.0,11/15,24.75%,THY1;IL1B;SKAP1;CD44;CEACAM6;BMP7;IL10;FGA;FGB;LCK;TNF
prerank,positive regulation of immune response (GO:0050778),-0.45196332035021636,-1.6313194744496085,0.0,0.11304556287006191,1.0,41/73,34.49%,TGFB2;EREG;IL23A;SKAP1;ZP3;GBP5;IL23R;CD81;IFNK;POLR3B;IL12B;IFNG;FPR2;TNFSF4;MYB;CD46;POLR3C;ADAM8;IL10;GPR151;NOD2;CYBA;POLR3G;NLRP3;HRG;NMI;IL12RB1;XBP1;ITGB2;IFNB1;CCL5;NLRP10;DHX9;PLSCR1;IFNL1;CD226;AKIRIN2;IFI35;TLR8;EIF2AK4;CD74
prerank,regulation of receptor recycling (GO:0001919),0.47403138959855357,1.630928138086543,0.02857142857142857,0.06374366061979911,0.99,10/17,20.77%,BVES;OPTN;SNCA;ECE1;RAMP3;ANXA2;INPP5F;VAMP3;RAB29;LAMTOR1
prerank,positive regulation of cell cycle process (GO:0090068),-0.4181486894019964,-1.6306829001097822,0.0,0.11311031736986175,1.0,37/100,20.63%,IL1A;DBF4;KIF14;PDGFRB;KIF20B;KIF23;SSTR5;MAD2L1;EREG;IL1B;NDC80;RCC2;RACGAP1;SPAG5;GPSM2;TAS2R13;FEN1;AURKB;EPGN;CXCR5;AURKA;DRD2;ECT2;CDC14C;CSPP1;RANBP1;DMRT1;SPAST;E2F8;CDC7;CEP295;OR2A4;PKP4;PLK4;ANKRD31;CDC6;RXFP3
prerank,macroautophagy (GO:0016236),0.3483680991954036,1.6296039060718532,0.0,0.0641962586074687,0.99,40/115,18.06%,GABARAPL1;MAP1LC3C;PRKAB2;MFN2;CHMP3;ZFYVE1;ULK1;VPS39;LIX1L;TSG101;ATG12;GABARAPL2;VTI1B;PRKAA2;CHMP4A;PIP4K2B;TMEM74;CSNK2B;UBXN6;LIX1;MAP1LC3A;ATG14;GABARAP;ATG4B;CSNK2A2;ARL8B;PRKAG2;TCIRG1;VPS4A;TOMM7;VPS28;PIP4K2A;VPS37A;MAP1LC3B;VPS37D;SQSTM1;VPS33A;VIPAS39;ATG13;VPS16
prerank,polyol metabolic process (GO:0019751),0.3651656201012476,1.6295507529331998,0.0,0.06395216636941749,0.99,11/47,8.12%,INPP5A;PTEN;PLCD4;ITPKB;NUDT10;IP6K3;INPPL1;CALM1;NUDT11;PLCD1;IP6K1
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.49697212234259236,1.6294520486581423,0.1111111111111111,0.06379625112435779,0.99,9/18,17.31%,DCN;CADM4;CCBE1;MYO1C;CD63;DAB2IP;SEMA6A;DLL1;IL12A
prerank,mitotic spindle organization (GO:0007052),-0.4093423793560335,-1.6270864226550152,0.0,0.11708357399920025,1.0,58/147,22.05%,ERCC6L;CENPN;KIF18A;CENPE;NUF2;INCENP;CENPH;KIF23;MAD2L1;CENPU;KIF2A;WDR62;CENPA;NDC80;SKA1;DLGAP5;CENPO;CENPK;RCC2;CHEK2;SPDL1;SPC24;DSN1;CENPL;NUP37;GPSM2;AURKB;KNTC1;KIF4B;ZWINT;TPX2;NEK6;CENPP;AURKA;CENPM;RCC1;NUP107;BUB1;KIF2C;PLK1;RANBP2;EML4;SPAST;MZT1;SEH1L;CENPF;KIF3B;CENPQ;CKAP5;PIBF1;NDE1;RAN;MAP4;SMC1A;BIRC5;CDC20;NUP43;STMN1
prerank,regulation of protein polymerization (GO:0032271),0.41623045790543284,1.62584040514788,0.038461538461538464,0.06587756574346837,0.99,12/33,16.81%,GBA2;MAPT;DBN1;MAPRE3;ARL2;MAP2;ESAM;TPPP3;PLEKHG2;PFN2;HCLS1;FCHSD1
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.3125093774367872,1.625645279177664,0.0,0.0656299057218764,0.99,37/104,17.80%,PTEN;FGFR1;PIP5K1C;DCN;MAPK1;PPP2R5B;MAPK3;KIT;MYOC;ROR2;FGF2;F2RL1;PIK3R1;PDGFRA;GPER1;EGFR;CEACAM1;DAB2IP;PIP4K2B;PIK3IP1;GH1;PDGFB;PDGFD;ROR1;SELP;NKX3-1;NTRK1;JAK2;NTF3;PIP4K2A;HCLS1;WNT16;INS;EPOR;ERBB3;PLXNB1;PDGFA
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.37487054956677185,1.6255781969637848,0.0,0.06538410083153227,0.99,16/54,17.33%,RBFOX3;CELF6;RBM24;NOVA1;RBM4;DDX17;MBNL1;RBFOX2;CELF2;CELF4;RBM5;ZC3H10;FXR2;NOVA2;NSRP1;CELF1
prerank,axon guidance (GO:0007411),0.28307463341793043,1.62464249650071,0.0,0.06539524830985105,0.99,56/202,14.54%,PALLD;PDLIM7;GFRA1;PLXNB3;EPHA7;GFRA3;NTN1;MAPK1;NRP2;NCAM1;NEXN;MAPK3;ROBO3;L1CAM;LAMA5;KIF5A;GAP43;NPTN;SEMA4C;MAPK7;RAC1;SEMA3G;NRXN3;SLIT3;PIK3R1;EPHA4;EFNA5;LGI1;GFRA2;KIF5C;SCN1B;GPC1;PTPRM;SEMA6C;SEMA3B;ROBO4;LAMA2;FEZ2;GRB10;SEMA3E;NTN4;SEMA3A;EPHB6;SMO;ENAH;SEMA6D;SEMA3C;EVL;DSCAML1;PRKCA;SEMA4B;CNTN2;RET;GDNF;EPHA10;SEMA6A
prerank,negative regulation of angiogenesis (GO:0016525),0.3363435060658522,1.6245853759189648,0.0,0.06515214329754677,0.99,33/81,16.35%,ATP2B4;NPR1;YJEFN3;CLDN5;DCN;EMILIN1;THBS4;FOXJ2;FOXO4;PRL;ADAMTS1;ECSCR;SERPINF1;ATF2;STAB1;HOXA5;PDE3B;HHEX;COL4A2;PTPRM;DAB2IP;EPN2;SEMA3E;KLF2;SPINK5;MECP2;NPPB;SEMA6A;SYNJ2BP;KLF4;ANGPT4;RGCC;HSPG2
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.5757141651864555,-1.6238927693949203,0.0,0.11997727022937893,1.0,8/23,7.97%,IL1A;HSPA1A;IFI6;CSF2;IL1B;PF4;EYA1;BCL2L1
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.5757141651864555,-1.6238927693949203,0.0,0.11997727022937893,1.0,8/23,7.97%,IL1A;HSPA1A;IFI6;CSF2;IL1B;PF4;EYA1;BCL2L1
prerank,actin filament bundle organization (GO:0061572),0.4390805522891995,1.62182113735069,0.037037037037037035,0.06626138968080944,0.99,7/31,9.22%,FAM107A;LIMA1;CALD1;ADD1;DPYSL3;CORO1B;BAIAP2
prerank,chromosome condensation (GO:0030261),-0.5082129704153887,-1.620448532686186,0.0,0.12354822943972987,1.0,15/32,21.74%,INCENP;NCAPD3;CDK1;NCAPG;CDCA5;SMC2;SMC4;NCAPD2;PLK1;SET;CSNK2A1;NCAPH;TTN;TOP2A;NCAPG2
prerank,regulated exocytosis (GO:0045055),0.29904712292236946,1.6177895600343255,0.0,0.06778293944267634,0.99,48/176,12.06%,FLNA;VAMP2;TLN1;SYNGR1;CLU;ACTN1;PIP5K1C;CFD;VCL;SYT11;F8;MMRN1;PPP3CB;CYB5R1;SNCA;VEGFB;CPLX3;CALM1;RAB3A;TIMP3;ITGB3;CD63;RARRES2;SNAP25;ALDOA;CLEC3B;F13A1;RIMS3;CD36;VTI1B;SOD1;SNAPIN;SYNGR3;PDGFB;PCDH7;SYT4;RAB31;SYT10;ENDOD1;SYT5;CDC37L1;SCG3;ISLR;APP;SYT1;SELP;TMX3;WDR1
prerank,positive regulation of organelle organization (GO:0010638),0.4271110359706571,1.6175791654444,0.0,0.0675337374594312,0.99,10/31,14.44%,PLA2G5;SORBS3;CALCOCO2;FYCO1;P2RX7;ATL3;MGARP;ADRB2;ANXA2;DOC2B
prerank,protein localization to membrane (GO:0072657),0.3088407427249867,1.6151525288373096,0.0,0.0686220705338599,0.99,76/192,20.83%,RAP1A;FLNA;PTN;FERMT2;EHD2;RAB34;RAMP1;NLGN2;DPP6;KCNIP3;P2RY1;TMEM88;RAB3A;INPP5K;EPB41L3;KCNB1;SLMAP;WDR19;ANK2;SCN3B;ARL3;DLG4;TMEM150A;RAMP3;RAMP2;ZDHHC15;RDX;NLGN1;PLEKHF1;ZDHHC22;FLOT1;CAPN3;CACNB2;PACSIN1;MYADM;TNFRSF1A;TM9SF1;SAV1;RAB13;CPE;KCNIP4;RAB3C;DLG2;CYP46A1;RAB11B;ACTN2;RAB8B;FLOT2;ITGB1BP1;FAM126A;RABEP1;SYNJ2BP;SLC9A3R2;ANK3;PACS1;NRXN2;TTC7B;SH3GLB1;PDZD3;ITGA4;CDH1;LIN7A;SHANK3;LRRC7;STXBP1;RAB12;GAS6;CACNB3;NRXN1;DVL1;FGF13;LIN7B;RAB29;SYNE3;EHD1;BSG
prerank,rRNA processing (GO:0006364),-0.3992904736131949,-1.6107329329482423,0.0,0.13645129419071914,1.0,95/167,42.08%,WDR43;DKC1;DDX47;DCAF13;WDR3;WDR12;PRKDC;WDR74;NOB1;UTP14A;BOP1;TFB1M;UTP18;HEATR1;SRFBP1;RRP12;LYAR;UTP20;BYSL;RCL1;RPL39;NAT10;DDX10;EXOSC3;EXOSC8;EMG1;PDCD11;DDX27;RRP1;RPS19;DIS3;MRTO4;FBL;RRP9;EXOSC5;EXOSC4;PIH1D2;NOP14;WDR36;RRP1B;NOLC1;NOP58;ESF1;DHX37;IMP4;RPL36;UTP15;MAK16;DDX52;PWP2;EBNA1BP2;PES1;MDN1;XRN2;RSL1D1;RPL37;EXOSC7;RPL8;RPL23A;EIF6;RRP7A;RPS7;NOP56;EXOSC2;ERI1;BMS1;UTP6;DDX54;RIOK1;NOL11;NOC4L;KRR1;EXOSC1;RPS2;IMP3;WDR75;NHP2;RPL4;RPL35;WDR18;WDR46;NOL6;RPL18;RPL32;RPL41;RPS24;RRP15;NVL;RPL27A;NOL8;RPL19;RPL38;MPHOSPH6;LSM6;RPL37A
prerank,autophagy of nucleus (GO:0044804),0.5209192884720394,1.610481935000916,0.0,0.07078376264335666,0.99,5/16,4.24%,WDR45;ULK1;ATG9A;ULK2;ATG12
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.4490588854836853,-1.610413129013141,0.010869565217391304,0.13559863008605938,1.0,31/58,32.58%,WDR12;WDR74;BOP1;URB2;NIP7;DDX31;NOP16;TGS1;NAF1;BYSL;EMG1;PAK1IP1;RPS19;MRTO4;GTF3A;SHQ1;RRS1;NOP14;DHX37;NPM1;HEATR3;EBNA1BP2;PES1;RPF2;RPL26L1;NOM1;RPS7;XPO1;NOC2L;RIOK1;ZNF658
prerank,skeletal muscle tissue development (GO:0007519),0.3936383797731676,1.6101108886411335,0.0,0.07060924183983047,0.99,12/35,14.90%,BVES;POPDC2;CAV2;MYL6;MYOZ2;TCF21;KLHL41;MYOZ1;POPDC3;MEF2C;CFLAR;SKI
prerank,amino acid import across plasma membrane (GO:0089718),-0.530033957380273,-1.610073115311562,0.0,0.13436250809512462,1.0,8/24,8.94%,SLC6A20;SLC6A14;SLC7A5;TSPO2;SLC6A6;SLC7A1;SLC1A5;SLC1A4
prerank,visual perception (GO:0007601),-0.41790237285195736,-1.6096818100094563,0.0,0.13361389789843162,1.0,30/92,23.72%,COL1A1;COL11A1;GRM8;ZIC2;GPR143;CEP250;POU6F2;EYS;PAX6;PAX2;TH;REEP6;FSCN2;CRYBA1;SIX3;BEST1;SLC24A1;TULP1;CHRNB2;ARR3;RP2;TRPM1;TYR;ADGRV1;COL2A1;CRYBB3;RDH12;CRYBA4;RBP3;RPE65
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.3802133257588336,1.6091542544877462,0.0,0.07068370895886955,0.99,14/39,13.24%,FHL1;FXYD6;FXYD1;ANK2;SCN3B;SCN2B;SCN1B;GPD1L;AHCYL1;FXYD7;FGF12;SCN4B;TRPC6;RIPK1
prerank,amino acid transport (GO:0006865),-0.45997346760405516,-1.6053689637615003,0.0,0.13818222449605339,1.0,24/50,29.57%,SLC6A20;SLC7A11;SLC6A14;SLC7A5;SLC6A6;SLC38A5;SLC7A1;SLC1A5;SLC1A4;SH3BP4;SLC16A10;SLC7A6;SLC25A47;SLC36A3;SLC6A18;SLC38A9;SLC7A7;SLC7A4;SLC25A48;SLC3A2;SLC38A8;SLC38A3;SLC6A12;SLC43A2
prerank,O-glycan processing (GO:0016266),-0.44322819549119846,-1.6051160861660536,0.024691358024691357,0.13702194611349675,1.0,29/60,30.46%,MUC5AC;GALNT6;CHST4;MUC6;B3GNT4;MUC16;MUC12;C1GALT1;GCNT1;GALNT5;MUC19;MUC17;ST6GAL1;GALNT3;POFUT1;MUC5B;MUC4;B3GNT5;B3GNT2;MUC20;B3GNT3;MUCL1;MUC3A;MUC15;C1GALT1C1;GXYLT1;GALNT7;MUC2;GALNT14
prerank,mitotic metaphase plate congression (GO:0007080),-0.46078593859495276,-1.6033268325547403,0.011627906976744186,0.13858005772529886,1.0,17/51,18.40%,KIF18A;CENPE;KIF14;CEP55;NUF2;CDCA5;NDC80;SPDL1;CHMP4C;KIF2C;CDT1;KIF22;EML4;SEH1L;RRS1;PSRC1;PIBF1
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.4271835661358358,1.6019208397194875,0.0,0.07388413871098005,0.99,15/28,20.63%,SYNGR1;RAB3A;DBN1;SYP;DLG4;NCDN;SLC8A2;APP;GRIK2;ARC;SHISA7;SHISA9;CAMK2A;SLC4A10;CLN3
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.34878079130915485,1.6018636688758217,0.0,0.07370034879357959,0.99,27/89,17.33%,CIRBP;RBFOX3;CELF6;RBM24;NOVA1;JMJD6;RBM4;DDX17;SRSF4;MBNL1;SF1;RBFOX2;QKI;PCBP4;PRDX6;CELF2;CELF4;RBM5;ZC3H10;SRSF7;SF3B4;TIA1;FXR2;NOVA2;NSRP1;SNW1;CELF1
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.46300516824676974,1.6012665044089442,0.0,0.07400799554240396,0.99,8/28,10.95%,CAMK2G;NCS1;PSEN1;PTEN;EFHC2;MARK1;BRSK1;NTNG1
prerank,peripheral nervous system development (GO:0007422),0.4469058926672775,1.6000524204370095,0.0,0.07463902398121751,0.99,11/24,18.90%,PMP22;GFRA3;GSTM3;NGF;NFASC;GPC1;NTF3;GDNF;ERBB3;ALDH3A2;SOX8
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.3443704258791592,1.5995244275101874,0.0,0.0748600354618606,0.99,21/72,13.49%,BVES;FERMT2;ACTN1;LAMB2;ATF4;ILK;PARVA;LAMA5;RADIL;ITGB3;RAC1;LAMC1;PIK3R1;RHOA;PXN;LAMB1;NTN4;NTNG1;TMEFF2;MEF2C;METTL3
prerank,membrane depolarization (GO:0051899),0.41430829082734094,1.5993852509859634,0.037037037037037035,0.07459457434320152,0.99,9/31,9.16%,CACNA1H;SCN7A;KCNH2;SCN3B;BEST2;P2RX7;SCN1B;SCN9A;SCN11A
prerank,positive regulation of macrophage activation (GO:0043032),-0.6126852608677695,-1.5992929992315337,0.015151515151515152,0.14265100430293484,1.0,8/15,22.10%,WNT5A;HSPD1;SPACA3;CCL3;CEBPA;THBS1;MMP8;TTBK1
prerank,neuron projection morphogenesis (GO:0048812),0.3314717137574027,1.5974315368550593,0.0,0.07513630876861968,0.99,57/138,19.82%,APBB1;S100B;PTEN;MAP6;GPM6A;CNTNAP1;SDC2;GAS7;RAB3A;EPB41L3;NGF;DBN1;MAP1A;FGFR2;MAP2;UBB;DLG4;SLITRK2;NCKAP1L;DCLK1;SLITRK3;DAB2IP;NYAP1;ZDHHC17;MEF2A;ACTB;BAIAP2;NLGN1;NBL1;BRSK1;ISL2;PACSIN1;ATL1;APP;NTNG1;PARD3;SGK1;CTNND2;MAP1B;ARC;DSCAML1;CCK;NTF3;ANK3;NRK;NEFH;TAOK2;BTBD3;CNTN4;PLXNB1;SHANK3;SRGAP2;KLF7;LLGL1;ZNF335;SLITRK4;DVL1
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.3532724669458821,1.5971462710736493,0.0,0.07503224107347421,0.99,23/80,12.17%,CLU;ZER1;BAG2;SIRT2;ECSCR;SMAD7;KCNE2;NUPR1;DNAJB2;PSMC5;DAB2IP;RNF185;TRIB2;RNF217;RNF14;RNF144B;PIAS1;CSNK1E;GABARAP;CSNK1A1;RNF180;OSBPL7;TMEM259
prerank,mismatch repair (GO:0006298),-0.5215963473275234,-1.5970777349339533,0.014084507042253521,0.1442517565963605,1.0,9/29,16.06%,EXO1;TP73;MSH3;RPA3;LIG1;PMS2;MSH6;RNASEH2A;POLD2
prerank,response to ATP (GO:0033198),0.502230616454613,1.5959034229341809,0.04,0.07492890367794382,0.99,8/19,12.86%,P2RY1;P2RX7;HSP90B1;TRPV1;P2RY12;RYR3;ABCC9;P2RY11
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.43240203262861043,1.5958303865725998,0.0,0.07466691450424472,0.99,7/18,16.03%,APOD;FLCN;RAB23;LATS2;MDFIC;SUFU;SIN3A
prerank,regulation of fibroblast migration (GO:0010762),0.4873428949192008,1.595613473577163,0.038461538461538464,0.07456557014481288,0.99,10/20,21.25%,DDR2;FGF2;CORO1C;RAC1;GNA12;ITGB1BP1;DMTN;PRKCE;CLN3;ITGB1
prerank,regulation of macroautophagy (GO:0016241),0.3459254011907248,1.5949859115311837,0.0,0.07446492956565488,0.99,47/109,22.84%,EPM2A;UCHL1;ATP6V1G2;NRBP2;DCN;PRKAB2;ULK1;CASP3;MAPK8;MTOR;ATP6V1E1;HDAC6;GPSM1;PRKAA2;PRKACA;RRAGA;BNIP3;RRAGD;TBC1D25;RRAGC;BNIP3L;PRKAG2;TSC1;VPS26B;RRAGB;LAMTOR3;ATP6V0E2;EXOC7;SH3GLB1;RHEB;ATP6V1D;ATG13;ATP6V1H;WAC;SUPT5H;ATP6V0A1;ATP6V0D1;SIRT1;CLN3;LAMTOR1;PINK1;SCOC;SESN1;PRKAG1;ATP6V0E1;TSC2;LRRK2
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.5592987206737234,-1.5949553833839152,0.04,0.14507385962103195,1.0,15/22,31.53%,WDR12;RPP40;UTP20;EXOSC3;EXOSC8;RRS1;NOP14;RPS21;URB1;ERI2;PES1;EXOSC7;NOP9;EXOSC2;ERI1
prerank,negative regulation of axon extension (GO:0030517),0.4086007639709988,1.593559071382602,0.0,0.07499586550742264,0.99,14/31,14.54%,PTPRS;SEMA4C;SEMA3G;MAP2;SEMA6C;SEMA3B;RTN4;SEMA3E;SEMA3A;SEMA6D;SEMA3C;SEMA4B;MT3;SEMA6A
prerank,regulation of T cell proliferation (GO:0042129),-0.4345520490293565,-1.5934977118326998,0.0,0.14606595912631956,1.0,39/75,30.74%,CEBPB;FOXP3;IL4I1;CD80;IL1B;IL23A;CD276;ZP3;JAK3;IDO1;IL23R;VTCN1;IL21;SLC7A1;TNFSF9;PLA2G2F;PNP;CD70;IL12B;TNFRSF1B;TNFSF4;TNFSF18;CD46;IL10;HLA-G;LILRB4;CD86;ARG1;CR1;TNFSF8;ANXA1;IL27;GLMN;PDCD1LG2;CD28;CD6;CCL5;PLA2G2D;CLC
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.34820664949424374,1.592224227126492,0.0,0.07575890404621603,1.0,27/79,16.81%,LMOD1;CFL2;SYNPO2;NCK1;SORBS3;CDC42EP3;FES;CCL27;F2RL1;CCL21;SYNPO;P2RX7;NUMA1;NCKAP1L;CDC42EP4;BAIAP2;TENM1;CCL11;WDR1;EVL;CX3CL1;NTF3;PFN2;CDC42EP2;SNX9;HCLS1;FCHSD1
prerank,positive regulation of signal transduction (GO:0009967),0.2762110139062089,1.5920947445337434,0.0,0.07549856416976855,1.0,69/239,13.92%,LIMS2;SLC2A4;SORBS1;FLNA;RAB34;PTEN;CITED2;AGPAT1;NLGN2;TRIM39;LMO3;ILK;CAV2;TTC23;GKAP1;WLS;NPTN;RSPO2;FAS;ITGB3;CCBE1;KAT2B;MYO1C;RWDD3;PKD2;CD63;SASH1;STX1B;FGFR2;PTGIS;RSPO1;PIK3R1;DLG4;GPER1;HHEX;RBPJ;DAB2IP;HAP1;MN1;GH1;GPS2;TMEM108;TSLP;FGF1;NLGN1;RSPO3;TXNDC15;EPN2;SFRP1;NECAB2;GRB10;ARNT;NLGN3;KLF2;ENHO;TM2D3;ZMIZ1;SMO;KIF7;NKX3-1;PRKCB;PRKCA;SPIN1;JAK2;MAML1;MT3;NTF3;STK36;IL7
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.3777143076748212,1.5916894746536319,0.0,0.07539610704366424,1.0,22/52,18.13%,GPM6A;CNTNAP1;WASF1;GAS7;SNX1;EPB41L3;NGF;DBN1;UBB;NCKAP1L;DCLK1;DAB2IP;NYAP1;NBL1;PACSIN1;SGK1;NTF3;SNX2;NRK;TAOK2;PLXNB1;SRGAP2
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.5338278561310431,-1.5912900881532654,0.0,0.14795791926462384,1.0,11/24,24.55%,AZGP1;IL23A;CD1A;IL23R;IL12B;CD1B;HLA-F;SLC22A13;HLA-G;IL12RB1;XCL1
prerank,Ras protein signal transduction (GO:0007265),0.29471427007869466,1.5910238994295804,0.0,0.07529434928360842,1.0,30/138,10.56%,RAP1A;RERG;NTN1;AGTR1;RHOB;WASF1;MRAS;CDKN1A;ARHGAP6;SHC2;RRAS;FGF2;RAC1;RASGRP2;CDC42EP3;MAPK14;NGFR;RAPGEF3;RGL2;RHOA;TAX1BP3;ERAS;MAPK11;CTNNAL1;CDC42EP4;PRKD1;GDI1;GNA12;ARHGAP1;BRK1
prerank,"base-excision repair, gap-filling (GO:0006287)",-0.4840955727249079,-1.5900283893863298,0.012987012987012988,0.14866274019540504,1.0,12/34,19.48%,RFC3;RPA3;POLB;FEN1;LIG1;RFC5;RFC2;LIG3;POLD2;PARG;NTHL1;UNG
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.4641741487545204,-1.5886517338332884,0.012195121951219513,0.1487537210645577,1.0,25/41,37.00%,NUP155;NUP37;NUP210;NUP107;NUP35;RANBP2;SEH1L;NUP50;NUP205;NUP93;RAE1;NUP88;POM121;NUP43;NUP160;EIF6;NUP62;GCKR;NUP153;NDC1;NUP98;SEC13;JMJD8;NUP214;HIF1A
prerank,regulation of gene silencing by miRNA (GO:0060964),-0.4576313785207722,-1.5883224214079803,0.0,0.14800920794611647,1.0,30/60,31.15%,POLR2F;NUP155;TRIM71;NUP37;AJUBA;NUP210;NUP107;NUP35;RANBP2;TGFB1;SEH1L;NUP50;NUP205;POLR2D;NUP93;RAE1;NUP88;POLR2J;POM121;NUP43;POLR2I;PPARG;NUP160;FMR1;NUP62;NUP153;NDC1;NUP98;DHX9;SEC13
prerank,cilium movement (GO:0003341),-0.4829686841175803,-1.588046820097241,0.02531645569620253,0.14686478492405536,1.0,20/39,29.95%,SPAG17;CCDC103;DNAH11;DNAH9;RSPH9;DNAH7;DNAAF2;DNAAF1;DNAH5;DNAAF5;ADCY10;TEKT5;SPA17;TTC29;RSPH6A;DNAI1;DNAI2;CABYR;CAMSAP3;DNAH17
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.47570337077060876,1.5879598620184385,0.0,0.07581343454705378,1.0,5/15,10.14%,EHD2;MAPK14;CAMK1;RAPGEF3;FLOT1
prerank,actin filament bundle assembly (GO:0051017),0.4379658019558882,1.5871972655722668,0.041666666666666664,0.075942720221024,1.0,8/33,9.22%,FAM107A;LIMA1;CALD1;ADD1;DPYSL3;HSP90B1;CORO1B;BAIAP2
prerank,inner ear morphogenesis (GO:0042472),-0.5121857144300449,-1.5858996788912942,0.013157894736842105,0.1483149195274941,1.0,16/24,31.07%,EPHB2;SOX9;SIX1;CHD7;PAX2;MYO3B;MYO6;PAX8;HPN;DCANP1;USH1C;ZIC1;MYO3A;TFAP2A;TIFAB;TBX18
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.2763559069211487,1.5848943988595825,0.0,0.07722605844147015,1.0,62/227,13.56%,RAP1A;GLIPR2;FERMT2;EPHA7;PTEN;CCL14;PLA2G5;LMO3;MAPK3;P2RY1;DUSP26;ROR2;EMILIN1;RRAS;ACKR3;FGF2;FBLN1;FLCN;TIMP3;MTURN;HAND2;DUSP3;FAM83D;TIRAP;SPRY1;TNFAIP8L3;TGFBR3;FGFR2;F2RL1;CCL21;PDGFRA;CCL2;GCNT2;CD36;GPER1;EGFR;CEACAM1;RAMP3;DAB2IP;ZDHHC17;GPNMB;PDGFB;YWHAZ;SMAD4;FLT4;PDGFD;ROR1;NECAB2;ANGPT1;NDRG4;CCL11;APP;CCL13;PIN1;LGALS9;CCL23;FGF10;PRKCA;NTRK1;CX3CL1;CCL8;MT3
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.6022934083095285,-1.583282956525668,0.012658227848101266,0.15095747989514371,1.0,5/15,6.28%,CDK1;MTBP;CENPA;SPDL1;AURKB
prerank,regulation of mitochondrion organization (GO:0010821),0.3733864344479736,1.5831542385351933,0.04,0.0785007546536978,1.0,16/43,17.40%,PDE2A;MAPT;FLCN;HDAC6;PID1;MUL1;RHOT2;MGARP;CSNK2A2;GOLPH3;MIEF2;PARL;SREBF1;MFF;SQSTM1;PISD
prerank,energy reserve metabolic process (GO:0006112),0.45397625581471746,1.580303916898399,0.04,0.08037872247990123,1.0,10/19,14.72%,PYGM;PPP1R3C;UGP2;ADRB3;GFPT2;PID1;PRKAG2;PYGL;MT3;LEPR
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.5236432104331434,-1.5797028679815968,0.0,0.1545888911855442,1.0,10/28,11.23%,IL1A;HSPA1A;INHBA;IFI6;CSF2;IL1B;PF4;EYA1;BCL2L1;PPP2R1B
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.3375599111283006,1.578756961004247,0.0,0.08079590024773729,1.0,11/51,9.46%,RBPMS2;CHRDL1;DAND5;GREM2;FSTL3;CHRD;FSTL1;BMPR1A;SMAD7;SMAD4;NBL1
prerank,regulation of vesicle-mediated transport (GO:0060627),0.32750182718187726,1.5764337410025697,0.0,0.08151417071943654,1.0,35/90,20.91%,STON1;VAMP2;MAPK1;MAPK3;CHMP3;RAB5B;RAB3A;FES;PACSIN3;PACSIN2;RAB4B;LGI3;HAP1;USP6;PACSIN1;SYT1;MAP2K2;RAB13;RAB3C;RAB11B;RAB8B;GAS1;RUFY1;RIT2;RAB5C;INPP5F;SLC30A8;SNX17;STXBP5L;CD177;RAB12;RAB33B;CPLX2;MAP2K1;STX4
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.488175832512994,-1.5763187013986508,0.0,0.1578157293592951,1.0,12/36,12.54%,TESC;TNFSF11;POU4F1;LEF1;IL23A;DCSTAMP;IL17A;PF4;IL23R;RUNX1;IL12B;IFNG
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.38525183118398015,1.5751669873765535,0.0,0.0820005203739784,1.0,9/25,12.86%,TPM1;HAND1;TGFBR3;FGFR2;ID2;SMAD7;MYL2;MYH7;MYL3
prerank,cellular response to metal ion (GO:0071248),0.30336920711548526,1.5748226102676919,0.0,0.08195539158141875,1.0,47/130,17.48%,CACNA1H;ADD1;PRNP;MAPK1;CLIC4;ITPKB;SYT11;MAPK3;AQP1;SNCA;MAPK8;RASGRP2;MT1X;PKD2;DLG4;SLC41A1;PRKAA2;MT1M;EGFR;MCOLN1;SMPD1;BNIP3;B2M;RYR3;SYT4;MEF2A;SYT10;NLGN1;SYT5;CAPN3;CAMK2D;SYT1;CHP2;DLG2;MEF2C;MT1A;MT1E;MT3;CPNE8;SYT6;ANK3;KCNA1;CDH1;DMTN;CARF;CYP11B1;AKR1C3
prerank,response to cadmium ion (GO:0046686),0.3858628053678881,1.57469077420893,0.0,0.08176012805037002,1.0,9/29,13.56%,MAPK1;MAPK3;MAPK8;MT1X;MT1M;EGFR;MT1A;MT1E;MT3
prerank,multivesicular body organization (GO:0036257),0.40746816687245735,1.5729316340055095,0.0,0.08209093135740576,1.0,10/31,16.43%,CHMP3;TSG101;CHMP4A;CHMP7;VPS4A;RAB27A;VPS28;IST1;VPS37A;VPS37D
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.3715959122681376,1.5723242996561275,0.0,0.08249428854988275,1.0,6/35,3.84%,LIMS2;FLNA;FERMT2;ILK;MYOC;RAC1
prerank,maintenance of blood-brain barrier (GO:0035633),0.4035742214132987,1.5720882684905686,0.041666666666666664,0.08222469937161515,1.0,11/30,11.13%,JAM3;JAM2;CLDN5;VCL;LAMC1;OCLN;ESAM;ACTB;CDH5;LAMA2;DMD
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.3998798534949996,1.5718270400095231,0.0,0.08217957535092899,1.0,15/38,11.18%,KCNA5;KCNH2;CACNA1C;CTNNA3;ANK2;CACNA2D1;SCN3B;KCNE2;SCN2B;SCN1B;CACNB2;CAMK2D;KCNE4;SCN4B;KCND3
prerank,tube closure (GO:0060606),-0.5030637008130276,-1.570018479188944,0.013333333333333334,0.16658156493763193,1.0,10/31,12.77%,GRHL3;CELSR1;MTHFD1L;TGFB2;FOLR1;PAX2;MTHFD1;GRHL2;LRP2;TGFB1
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.4441644844549305,-1.5697189470086832,0.0125,0.16550602336147022,1.0,16/54,11.98%,CCND1;CHEK1;BLM;EME1;CDK1;TICRR;RFWD3;TIPIN;CHEK2;PRKDC;HMGA2;BRCC3;RAD9B;TOPBP1;CDC14C;PLK1
prerank,epithelial structure maintenance (GO:0010669),-0.567019803292199,-1.5692959144927894,0.023529411764705882,0.16494857062209964,1.0,9/17,18.88%,MUC6;VSIG1;TFF1;TFF2;CXADR;SERPINA3;RBP4;NOD2;MUC4
prerank,cellular response to insulin stimulus (GO:0032869),0.3009842484798317,1.567923367260837,0.0,0.08413261650306761,1.0,49/125,21.22%,SLC2A4;SORBS1;VAMP2;ATP6V1G2;CAV2;ZFP36L1;FOXO4;INPP5K;CPEB1;KAT2B;RARRES2;PIK3R1;ATP6V1E1;HDAC5;ZDHHC7;PDE3B;PLA2G1B;CEACAM1;RHOQ;GRB14;PDK2;RAB31;PIK3R3;BAIAP2;SLC27A1;GRB10;USF1;RAB13;TCIRG1;LPIN1;RAB8B;BCAR3;ATP6V0E2;ZNF106;INS;SOGA1;ATP6V1D;ATP6V1H;CPEB2;RAB12;GRB2;PCK1;ATP6V0A1;LPIN3;ATP6V0D1;HDAC9;FER;GOT1;MYO5A
prerank,rRNA metabolic process (GO:0016072),-0.38330268072212653,-1.5674902880316195,0.0,0.16671435553383393,1.0,86/154,42.08%,WDR43;DKC1;DDX47;DCAF13;WDR3;WDR12;WDR74;NOB1;UTP14A;BOP1;UTP18;HEATR1;NIFK;RRP12;LYAR;UTP20;BYSL;RCL1;RPL39;DDX10;EXOSC3;EXOSC8;EMG1;PDCD11;DDX27;RRP1;RPS19;DIS3;MRTO4;FBL;RRP9;EXOSC5;EXOSC4;PIH1D2;NOP14;WDR36;RRP1B;NOLC1;NOP58;ESF1;DHX37;IMP4;RPL36;UTP15;DDX52;PWP2;EBNA1BP2;PES1;MDN1;XRN2;RPL37;EXOSC7;RPL8;RPL23A;RRP7A;RPS7;NOP56;EXOSC2;XRN1;BMS1;UTP6;DDX54;NOL11;SLFN14;NOC4L;KRR1;EXOSC1;RPS2;IMP3;WDR75;RPL4;RPL35;WDR18;WDR46;NOL6;RPL18;RPL32;RPL41;RPS24;NVL;RPL27A;NOL8;RPL19;RPL38;MPHOSPH6;RPL37A
prerank,negative regulation of nervous system development (GO:0051961),-0.5400890733371069,-1.5670487758132559,0.0273972602739726,0.1662654079704129,1.0,9/18,25.80%,IL1B;ROBO2;PAX6;SORL1;WNT7A;NOTCH1;TNF;WNT3A;REST
prerank,cAMP-mediated signaling (GO:0019933),0.435219359473703,1.566405486482774,0.03225806451612903,0.08467165644451465,1.0,10/25,14.12%,CAP2;PDE2A;MAPK7;AKAP6;RAPGEF3;PDE3A;PDE7B;PDE4D;ADCY2;ADCYAP1
prerank,fatty acid oxidation (GO:0019395),0.3693932846746157,1.5647437855424535,0.0,0.08520721870892005,1.0,25/58,23.35%,PPARD;ACAD11;ADH5;ECI2;ACADVL;ACAT1;CROT;BDH2;HADHB;ACADS;ACAA2;ECHDC2;SLC27A2;ACADM;PHYH;ALDH3A2;HADH;HADHA;ABCD4;CYP4V2;ABCD1;SCP2;ACAA1;ACADL;ECHDC1
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.5429159507808926,-1.5645841536208418,0.029411764705882353,0.1687501229125802,1.0,9/18,20.85%,SCARB1;LIPG;CETP;PLA2G3;APOA2;APOC1;APOM;ALB;APOC2
prerank,Wnt signaling pathway (GO:0016055),0.27863035240342965,1.5632918514328014,0.0,0.08573933684300777,1.0,33/91,19.82%,WNT9A;FERMT2;DIXDC1;PTEN;FZD7;NXN;WNT6;WLS;FZD4;DVL3;SKP1;WNT5B;UBB;DVL2;CSNK1E;SFRP1;CD24;SNX3;CSNK1A1;CPE;SFRP5;FRZB;GPC4;WNT16;RARG;BTRC;WNT10B;PORCN;SFRP2;ARL6;FZD1;CUL1;DVL1
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.44538749599748007,1.5621409841473493,0.038461538461538464,0.08663327700305731,1.0,6/17,10.97%,MAP3K3;RHOJ;FGF2;HMOX1;HDAC7;GATA2
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.40033999594443087,1.5618833194566333,0.043478260869565216,0.08650211983482808,1.0,11/34,13.41%,ATP2B4;PTEN;TRIM39;CDKN1A;FAM83D;ID2;PKD1;SUSD2;MN1;PAGR1;PAF1
prerank,histone deacetylation (GO:0016575),0.36121587127466687,1.5613285513802302,0.0,0.0865169607483943,1.0,20/46,22.04%,PER1;MORF4L1;SIRT2;SIN3B;HDAC4;HDAC6;HDAC5;BRMS1L;TBL1X;SIN3A;HDAC11;RCOR3;SIRT1;HDAC9;MSL3;TRERF1;ZNF541;MTA3;MIER3;RBM14
prerank,regulation of RNA splicing (GO:0043484),0.32173406180006703,1.5612838607317174,0.0,0.08624230373014542,1.0,27/74,20.28%,RBM20;RBM38;PTBP2;CLK1;SNRNP70;HNRNPH3;JMJD6;CLK4;PIK3R1;MBNL1;PRX;SF1;CLK2;QKI;HNRNPH2;AKAP17A;AHNAK;SLC38A2;CLK3;TIA1;POLR2A;CELF1;AHNAK2;RBM23;FASTK;MBNL2;LARP7
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.3558762773737725,1.5607323544012224,0.0,0.08632999488406354,1.0,16/46,14.62%,AGPAT1;PLA2G5;PLA2G4B;ABHD4;PLD6;PLA2G1B;GPD1L;DGKG;DDHD2;SLC27A1;AGPAT4;DGKE;ABHD8;DGKB;PLA2G4A;PLD2
prerank,signal release from synapse (GO:0099643),0.39409134756342923,1.5592362354156695,0.0,0.08727986622024038,1.0,23/43,20.39%,VAMP2;PIP5K1C;SNCA;CPLX3;RAB3A;SYN2;SNPH;SNAP25;SNAPIN;SYT10;BRSK1;SYN1;SYT1;HSPA8;NRXN2;NAAA;LIN7A;STXBP1;STXBP3;NRXN1;DVL1;LIN7B;CPLX2
prerank,positive regulation of T cell activation (GO:0050870),-0.43893223228055245,-1.559223511249192,0.0,0.17565570386232143,1.0,35/73,29.22%,THY1;TNFSF11;CD80;IL1B;IL23A;CD276;ZP3;JAK3;IL23R;CD81;HSPD1;IL21;SLC7A1;PNP;CD70;IL12B;ZAP70;TNFSF4;CD46;PRKCQ;NOD2;MDK;IL36B;DOCK8;CD86;GATA3;SIRPB1;XBP1;ANXA1;LCK;PDCD1LG2;CD28;CD6;RHOH;CCL5
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.38536985002959184,1.5586315969912805,0.0,0.08743541145238404,1.0,13/27,21.41%,PLXNB3;PRKCD;CAPZB;EVI5L;CCL21;TESK1;EVL;PFN2;TCHP;KANK1;SLIT2;ARHGAP24;SRGAP2C
prerank,regulation of autophagy (GO:0010506),0.2750066537685711,1.5573541842675238,0.0,0.08830441852237177,1.0,70/224,18.29%,UCHL1;ATP6V1G2;DCN;OPTN;PRKAB2;WDR6;MAPT;ULK1;HSPB1;CASP3;MAPK8;FLCN;TRIM6;DAPK1;SIRT2;MTOR;TPCN2;DAPK3;ATP6V1E1;HDAC6;NUPR1;PRKAA2;PRKACA;MTMR9;RRAGA;BNIP3;PIP4K2B;EEF1A2;PRKD1;TRIM34;TRIM21;RRAGD;TFEB;PLEKHF1;ITPR1;RRAGC;KLHL22;OSBPL7;RASIP1;BOK;CSNK2A2;PRKAG2;BAD;VPS26B;RRAGB;MT3;LAMTOR3;ATP6V0E2;BCL2;EXOC7;LEPR;KAT8;PIP4K2A;TPCN1;DDIT3;SH3GLB1;STAT3;GOLGA2;SREBF1;TP53INP1;SOGA1;RHEB;KAT5;ATP6V1D;RNF152;TRIM8;ATG13;TRIM68;ATP6V1H;ZKSCAN3
prerank,protein import into nucleus (GO:0006606),-0.4187236133877845,-1.5573415617960944,0.0,0.1775447638512463,1.0,32/75,29.40%,NUP62CL;RGPD3;RGPD4;NUP155;KPNA7;RGPD8;CSE1L;RGPD1;RGPD5;RGPD2;E2F3;SYK;NUP107;NXT2;RANBP17;NUP35;RANBP2;NUP50;MMP12;NUP93;NUP88;RAN;POM121;TNPO3;HEATR3;NXT1;IPO11;KPNA2;NUP62;KPNB1;GCKR;NUP153
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.37571333071973106,1.5565258555719532,0.0,0.08831334898541003,1.0,16/51,12.46%,TSPYL2;TLN1;ADD1;PPP2R5B;PLA2G4B;CXXC1;PARP16;ACADVL;CTDSP2;EXTL2;DCTN1;ZBTB17;WFS1;TPP1;EXTL1;KLHDC3
prerank,replication fork processing (GO:0031297),-0.4862432249967917,-1.5562850362060672,0.0,0.17824001421779892,1.0,13/35,16.43%,BLM;EME1;RFWD3;MMS22L;ZRANB3;TRAIP;DNA2;TONSL;FANCM;BRCA2;ATR;WRN;ALYREF
prerank,protein insertion into membrane (GO:0051205),0.39567823953064113,1.5558264194968945,0.0,0.08846422095131817,1.0,15/32,20.94%,VAMP2;REEP1;PRNP;HMOX1;EGFR;TRAM1L1;VAPA;OXA1L;APP;CYB5A;ALDH3A2;WDR83OS;RTP5;EMD;SGTA
prerank,response to interferon-alpha (GO:0035455),-0.5517242628820898,-1.551560901138639,0.014705882352941176,0.18443362594071264,1.0,5/17,4.85%,IFITM3;IFITM1;IFITM2;LAMP3;BST2
prerank,cell-matrix adhesion (GO:0007160),0.31381467008917735,1.5512106881458398,0.0,0.09123294477434865,1.0,23/100,8.02%,LYVE1;FBLN5;SORBS1;ITGA7;FERMT2;SGCE;ACTN1;CD34;VCL;ILK;ITGA10;L1CAM;EMILIN1;ITGB3;RAC1;CD63;SIGLEC1;BCAM;CCL21;PKD1;HOXD3;THBS3;DLC1
prerank,DNA methylation or demethylation (GO:0044728),-0.5123701165659722,-1.5509692126533232,0.038461538461538464,0.18248156129204246,1.0,11/19,31.38%,DNMT1;DNMT3B;FOS;SPOCD1;BEND3;DNMT3L;ATF7IP;GATAD2A;ATRX;TEX15;HELLS
prerank,DNA alkylation (GO:0006305),-0.5123701165659722,-1.5509692126533232,0.038461538461538464,0.18248156129204246,1.0,11/19,31.38%,DNMT1;DNMT3B;FOS;SPOCD1;BEND3;DNMT3L;ATF7IP;GATAD2A;ATRX;TEX15;HELLS
prerank,positive regulation of autophagy (GO:0010508),0.33269144845561355,1.550828805482212,0.0,0.0912327256471668,1.0,37/87,22.97%,EPM2A;DCN;OPTN;ULK1;FLCN;TRIM6;DAPK1;GPSM1;PRKAA2;BNIP3;PRKD1;TRIM34;TRIM21;TFEB;PLEKHF1;BNIP3L;BAD;TPCN1;SH3GLB1;TP53INP1;KAT5;CAMKK2;RNF152;TRIM8;TRIM68;WAC;SUPT5H;SIRT1;PINK1;TMEM59;FBXO7;SCOC;SESN1;TSC2;GSK3A;LRRK2;NPRL2
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.3488277526226829,1.5507265832794765,0.0,0.09074141823294934,1.0,30/55,28.47%,TIMM21;NDUFA11;OXA1L;NDUFC2;NDUFB8;NDUFS2;NDUFA5;ECSIT;NDUFB10;NDUFS4;NDUFV2;NDUFAF1;NDUFA13;NDUFA8;BCS1L;TIMMDC1;NDUFA9;NDUFC1;NDUFV1;NDUFA6;NDUFS5;TMEM126B;NDUFS8;NDUFA7;NDUFA10;NDUFB6;NDUFB4;NDUFV3;NDUFB5;NDUFB1
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.3488277526226829,1.5507265832794765,0.0,0.09074141823294934,1.0,30/55,28.47%,TIMM21;NDUFA11;OXA1L;NDUFC2;NDUFB8;NDUFS2;NDUFA5;ECSIT;NDUFB10;NDUFS4;NDUFV2;NDUFAF1;NDUFA13;NDUFA8;BCS1L;TIMMDC1;NDUFA9;NDUFC1;NDUFV1;NDUFA6;NDUFS5;TMEM126B;NDUFS8;NDUFA7;NDUFA10;NDUFB6;NDUFB4;NDUFV3;NDUFB5;NDUFB1
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.4643552946529085,-1.5501192417738334,0.013157894736842105,0.18265573191182896,1.0,25/41,37.00%,NUP155;NUP37;NUP210;NUP107;NUP35;RANBP2;SEH1L;NUP50;NUP205;NUP93;RAE1;NUP88;POM121;NUP43;NUP160;EIF6;NUP62;GCKR;NUP153;NDC1;NUP98;SEC13;JMJD8;NUP214;HIF1A
prerank,blood circulation (GO:0008015),0.3721054931906549,1.550085166423994,0.0,0.09088252814647381,1.0,19/49,15.55%,PLN;NPR1;HOXB2;SCPEP1;AGTR1;CYB5R3;MEOX2;ACTC1;SGCD;MYL2;SOD1;SGCG;AVPR1A;MYOF;ELN;NPPB;ITGB1BP1;ADCY6;ADORA2A
prerank,phosphatidic acid metabolic process (GO:0046473),0.35072139943255226,1.549592589378077,0.0,0.0908833833102296,1.0,17/48,14.62%,AGPAT1;PLA2G5;PLA2G4B;ABHD4;PLD6;PLA2G1B;GPD1L;DGKG;DDHD2;SLC27A1;PLA2G6;AGPAT4;DGKE;ABHD8;DGKB;PLA2G4A;PLD2
prerank,lytic vacuole organization (GO:0080171),0.39599224909009206,1.5488336825710347,0.03571428571428571,0.09102319997709452,1.0,16/31,23.36%,MTOR;TPCN2;AKTIP;SNAPIN;TPP1;TFEB;HPS1;CLVS2;VPS18;GAA;ZKSCAN3;ACP2;CLN3;LAMTOR1;LRRK2;ABCA1
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.4377485152183377,1.5479414603195718,0.047619047619047616,0.09185488832603486,1.0,11/24,14.54%,SEMA4C;SEMA3G;SEMA6C;SEMA3B;SEMA3E;SEMA3A;SEMA6D;SEMA3C;SEMA4B;MEGF8;SEMA6A
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.48661590312587466,-1.545860274833571,0.02702702702702703,0.1879636762579847,1.0,18/28,38.22%,DCAF13;RPP40;HEATR1;NOL10;UTP20;RPS19;RRS1;NOP14;RPS21;DHX37;PWP2;NOP9;BMS1;UTP6;HELB;TSR1;MRPS11;WDR46
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.49960568591791216,-1.5447775544262143,0.043478260869565216,0.1881438073379715,1.0,14/26,32.74%,IL1A;CD80;CARD11;IL1B;RUNX1;PNP;TRAF2;CD86;ANXA1;CLEC7A;GLMN;CD28;TRAF6;PDE4B
prerank,neurotransmitter secretion (GO:0007269),0.38647595425309805,1.5423672909848842,0.0,0.09496059030689251,1.0,23/44,20.39%,VAMP2;PIP5K1C;SNCA;CPLX3;RAB3A;SYN2;SNPH;SNAP25;SNAPIN;SYT10;BRSK1;SYN1;SYT1;HSPA8;NRXN2;NAAA;LIN7A;STXBP1;STXBP3;NRXN1;DVL1;LIN7B;CPLX2
prerank,response to muscle stretch (GO:0035994),0.5416035366657617,1.5418609461048476,0.04,0.09508682190730046,1.0,7/15,18.09%,GSN;NPPA;TCAP;DMD;SLC8A1;CDH2;SLC9A1
prerank,axonemal dynein complex assembly (GO:0070286),-0.5216961703883105,-1.5411178135474486,0.04411764705882353,0.1931294102440857,1.0,13/22,29.95%,CCDC103;DNAH8;DNAH7;SPAG1;DNAAF3;DNAAF2;DNAAF1;DNAH5;DNAAF5;DNAI1;DNAI2;CCDC65;DNAH17
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.46277728673294016,-1.5410353080581254,0.0,0.19177672710678814,1.0,22/54,27.68%,WDR12;WDR74;BOP1;BRIX1;NIP7;NOP16;NLE1;PAK1IP1;MRTO4;GTF3A;RRS1;MAK16;NPM1;HEATR3;EBNA1BP2;PES1;RPF2;RPL26L1;MDN1;RSL1D1;RPL23A;EIF6
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.507271064201376,-1.5409430828422508,0.01282051282051282,0.19049357115431417,1.0,21/30,36.04%,THY1;TNFSF11;SKAP1;CD44;HSPD1;RELA;IRAK1;FUT7;NFAT5;PRKCQ;MDK;SIRPB1;LCK;TNF;HAS2;ITGB2;TRAF6;ETS1;CD47;CCDC88B;SIRPG
prerank,in utero embryonic development (GO:0001701),0.41674953520399893,1.5401268638999592,0.047619047619047616,0.09610469380456592,1.0,13/25,18.90%,EGFL8;FOXF1;FLCN;FGFR2;ARNT2;PKD1;MBNL1;FOXD3;HINFP;LMX1B;ZNF568;TGFB3;SOX8
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.5216742497399952,1.539844086141929,0.04,0.09615829144589835,1.0,8/17,11.07%,KCNH2;SNTA1;ANK2;CACNA2D1;KCNE2;SCN1B;KCNE4;SCN4B
prerank,endocrine system development (GO:0035270),-0.490706359877742,-1.5395394977658459,0.03529411764705882,0.1915311285871556,1.0,10/24,19.07%,STRA6;SIX1;SIX3;PAX8;NKX2-1;NF1;GCM2;WNT11;TG;MDK
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.36240489357449546,1.5393103494286344,0.0,0.09621156814327073,1.0,13/45,12.85%,FGFR1;MAP3K3;RHOJ;HSPB1;FGF2;MAPK14;HMOX1;HDAC7;PDGFB;PRKD1;ANGPT1;GATA2;PRKCA
prerank,regulation of mRNA processing (GO:0050684),0.37846442563971283,1.5381313349052408,0.0,0.09646862117385568,1.0,12/35,20.28%,PABPN1;ZFP36L1;JMJD6;SRPK3;SF1;QKI;AHCYL1;SAFB2;TIA1;SUPT6H;RBM23;LARP7
prerank,regulation of amyloid fibril formation (GO:1905906),0.4993911523364692,1.538081895932615,0.0,0.09624934117534319,1.0,5/15,10.79%,CRYAB;PSEN1;CLU;PFDN5;APP
prerank,protein stabilization (GO:0050821),0.28844361249965883,1.538076035007179,0.0,0.09596373482170716,1.0,48/170,15.50%,CRYAB;FLNA;PTEN;CLU;TRIM39;ATP1B2;BAG2;CRTAP;CDKN1A;PARVA;TMEM88;GPIHBP1;USP2;DVL3;BAG3;PRKCD;ANK2;STX12;PIK3R1;PER3;EPHA4;SMAD7;USP19;CAMLG;MTMR9;PEX19;MUL1;RTN4;WFS1;CDC37L1;ZSWIM7;FLOT1;CREB1;PRKRA;PIN1;WIZ;IFT46;GBA3;GOLGA7;SOX17;TSC1;MT3;GNAQ;FLOT2;UBE2B;TBL1X;PFN2;RASSF2
prerank,peptide cross-linking (GO:0018149),-0.4636701156100357,-1.5380684176074977,0.013157894736842105,0.19250481549530996,1.0,16/30,33.96%,FN1;COL3A1;DSP;FCGR3A;TGM6;EVPL;FLG;THBS1;CD3G;SPRR1A;ANXA1;CSTA;PI3;TGM4;SPRR1B;EPB42
prerank,amino acid import (GO:0043090),-0.5320699717587248,-1.537623734016753,0.024096385542168676,0.1918235332462666,1.0,7/22,9.09%,SLC6A20;SLC6A14;SLC7A5;TSPO2;SLC6A6;SLC7A1;SH3BP4
prerank,negative regulation of protein metabolic process (GO:0051248),0.33409791906021147,1.5351461901857295,0.0,0.09750036467486382,1.0,16/52,14.42%,CRYAB;FLNA;CLU;PRNP;PTX3;ITGB3;SIRT2;EGFR;PFDN5;SNX3;PIN1;NFKB1;RILP;AZIN2;EDNRB;FLOT2
prerank,sensory perception of mechanical stimulus (GO:0050954),-0.403931718142846,-1.5341752109751334,0.010752688172043012,0.1963740749254821,1.0,37/84,30.57%,CEMIP;COL1A1;COL11A1;CACNA1D;KCNQ1;MYO3B;LHFPL5;EYA1;DCDC2;GRAP;CEACAM16;LRP2;ATP6V0A4;TSPEAR;MARVELD2;CHRNB2;SLC52A3;SLC26A5;GRM7;MYH14;ADGRV1;PDZD7;LOXHD1;USH1C;COL2A1;PAX3;CLRN1;BIRC5;USH2A;MYO3A;TIMM13;TFAP2A;TIMM10;NIPBL;EML2;TPRN;ALDH7A1
prerank,positive regulation of protein modification process (GO:0031401),0.28648895371109256,1.5326521200964969,0.0,0.0987590139191682,1.0,56/208,14.91%,CLIP3;RAMP1;ILK;MAPK3;FAXDC2;P2RY1;VEGFB;NPTN;FAS;CALM1;FGF2;FLCN;ITGB3;RAC1;DVL3;TERF2IP;PRKCD;CAMK1;RARRES2;TRABD2B;RAPGEF3;ARNTL;RSPO1;EFNA5;FGF7;AKTIP;GPER1;EGFR;DVL2;SMPD1;SLC51B;DLC1;NNMT;GPNMB;TESK1;PIK3R3;FGF1;CDH5;CALM2;FLT4;FLOT1;ANGPT1;APP;ATG14;PIN1;FGF5;NKX3-1;FGF10;TFRC;NTRK1;RIPK1;MT3;RALBP1;VEGFC;LEPR;TXN
prerank,negative regulation of organelle assembly (GO:1902116),0.38864471532863176,1.5318381458829586,0.058823529411764705,0.0992058872853183,1.0,9/34,10.48%,MDM1;KAT2B;EVI5L;KAT2A;NUPR1;CHMP4A;TESK1;SMAD4;FEZ2
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.42950115516914683,1.5302861815186422,0.03333333333333333,0.10038531845697539,1.0,9/24,18.09%,RGS2;PDE9A;HAND2;MEF2A;SMAD4;CAMK2D;PRKCA;NR4A3;SLC9A1
prerank,regulation of protein phosphorylation (GO:0001932),0.2793839247480456,1.5290705359549883,0.0,0.10122465731661032,1.0,64/256,13.85%,CLIP3;TSPYL2;EPHA7;PTEN;WWTR1;PRNP;ATF4;PPP2R5B;ILK;MAPK3;CADM4;FAXDC2;P2RY1;VEGFB;HRC;NPTN;HSPB1;FAS;FGF2;FBLN1;FLCN;TARDBP;ITGB3;CORO1C;INPP5K;RAC1;DVL3;TERF2IP;OCLN;RARRES2;RSPO1;PPP2R5D;EFNA5;FGF7;PID1;AKTIP;GPER1;EGFR;DVL2;DAB2IP;SOD1;AKAP8L;GPNMB;FKBP8;TESK1;PIK3R3;FGF1;CDH5;ANKRD54;FLT4;FLOT1;ANGPT1;MYADM;APP;ATG14;PIN1;FGF5;NKX3-1;FGF10;TFRC;NTRK1;RIPK1;MT3;RALBP1
prerank,regulation of immune response (GO:0050776),-0.3655184681264101,-1.5287586592878466,0.0,0.20437881356176002,1.0,86/172,37.48%,ULBP3;COL1A1;IFITM1;FOXP3;COL1A2;IL4I1;TGFB2;LRP8;TREM1;CD276;LAIR2;CD1A;ICAM1;C3;SELL;ULBP1;FCGR3B;NCR3LG1;CD81;SYK;BCL6;RAET1E;CXADR;CD300LD;AMBP;XIAP;ADCY7;COL3A1;FCGR1A;CD1B;HLA-F;TREML2;FCGR3A;TNFSF4;TREML4;MICB;NCR1;GPR151;COL2A1;TREML1;KIR2DL3;HLA-G;CD3G;CD3D;KIR3DL1;SLA2;ICAM5;ERAP1;SH2D1A;TKFC;CRTAM;LYN;KIR2DL1;ITGB2;CD160;ICAM2;SAMHD1;CD8B;CD300LF;TYROBP;HCST;DENND1B;KIR3DL2;PDCD1;PLSCR1;IFNL1;NCR3;CD226;IRF7;SLAMF6;PTPN22;CXCL13;OSCAR;CD300LB;ITGAL;CD3E;CD96;CD300A;SIGLEC7;FCGR2A;ICAM3;CD300E;FCRLB;FCGR2C;FGL1;LILRB2
prerank,negative regulation of lymphocyte proliferation (GO:0050672),-0.4596941825873554,-1.5287324624920773,0.047619047619047616,0.20301341170048684,1.0,20/38,30.17%,CEBPB;FOXP3;IL4I1;CD80;VTCN1;PLA2G2F;LST1;CTLA4;IL10;HLA-G;LILRB4;CD86;ARG1;CR1;MNDA;LYN;GLMN;PDCD1LG2;TYROBP;PLA2G2D
prerank,cellular calcium ion homeostasis (GO:0006874),0.30397168540661285,1.5281892997923632,0.0,0.10185976788837287,1.0,36/132,13.30%,DMPK;PLN;PSEN1;ATP2B4;SCGN;CCL14;STIM1;CAV2;ANXA6;HRC;NPTN;TPCN2;TMEM178A;ANK2;SLC24A3;TRPC1;PTH1R;GPER1;PRKACA;CALB2;TRPC4;ELANE;WFS1;ATP2A2;RGN;SLC8A2;CDH5;CAMK2D;CCL11;CCL13;SLC8A1;CCL23;TRPC6;SMDT1;CCL8;MICU3
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.4176025692444434,1.5255328610444905,0.0,0.10341870800166922,1.0,10/27,18.09%,ATP2B4;PRNP;MYOZ2;AKAP6;MYOZ1;CHP2;RCAN1;HOMER3;HOMER2;SLC9A1
prerank,negative regulation of protein kinase activity (GO:0006469),0.30952013135302126,1.5246630598464597,0.0,0.10377953904148042,1.0,25/84,14.74%,WWTR1;ADARB1;DBNDD2;CDKN1A;SNCA;DUSP26;HSPB1;CDKN1C;CORO1C;INPP5K;DUSP3;CEACAM1;DAB2IP;TRIB2;PRKRIP1;TESK1;TAB1;DEPTOR;DUSP19;SH3BP5L;SLC8A1;PRKAG2;GNAQ;PPM1F;ITGB1BP1
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.4715759191479721,1.5242520404298063,0.034482758620689655,0.10380894126496827,1.0,7/17,11.51%,ATP1B2;ATP1A2;GJC1;CACNA1C;PRKACA;ATP1A3;SLC8A1
prerank,nuclear envelope organization (GO:0006998),0.4095451740876503,1.5231714350317807,0.0,0.1044292831732282,1.0,7/21,13.38%,DMPK;TOR1AIP1;TMEM43;SUN2;SUN1;CTDNEP1;VPS4A
prerank,protein insertion into ER membrane (GO:0045048),0.38732077745781696,1.522603466215389,0.04,0.10432566921302053,1.0,21/35,26.06%,VAMP2;PRNP;HMOX1;CAMLG;TRAM1L1;EMC6;VAPA;APP;EMC4;CYB5A;ALDH3A2;WDR83OS;EMD;BAG6;SGTA;EMC7;TRAM2;STX1A;EMC9;UBE2J2;STX5
prerank,regulation of angiogenesis (GO:0045765),0.27286097673337045,1.5213773045642767,0.0,0.10507158038082982,1.0,62/193,15.67%,ATP2B4;NPR1;CD34;YJEFN3;CLDN5;DCN;RHOB;AQP1;STIM1;VEGFB;RHOJ;EMILIN1;HSPB1;HSPB6;RRAS;THBS4;FOXJ2;FGF2;FOXO4;PRL;GLUL;SASH1;ADAMTS1;ECSCR;RAPGEF3;SERPINF1;HMOX1;TIE1;PTGIS;ATF2;STAB1;HOXA5;PDE3B;HHEX;CEACAM1;COL4A2;PTPRM;DAB2IP;RAMP2;ANGPTL4;GPNMB;PRKD1;HK2;EGLN1;FGF1;CDH5;SFRP1;SEMA3E;GATA2;SPINK5;BTG1;PRKCB;MECP2;PRKCA;NPPB;RNH1;SEMA6A;VEGFC;SYNJ2BP;KLF4;NINJ1;ANGPT4
prerank,insulin receptor signaling pathway (GO:0008286),0.302165133002244,1.5209286732358276,0.0,0.10490160753216263,1.0,33/73,24.25%,SORBS1;ATP6V1G2;CAV2;FOXO4;RARRES2;PIK3R1;ATP6V1E1;RHOQ;GRB14;PDK2;PIK3R3;BAIAP2;GRB10;TCIRG1;BCAR3;ATP6V0E2;ZNF106;INS;SOGA1;ATP6V1D;ATP6V1H;GRB2;ATP6V0A1;ATP6V0D1;FER;SHC1;GAB1;ATP6V0E1;GSK3A;FOXO1;AP3S1;AKT2;PIK3R2
prerank,regulation of TORC1 signaling (GO:1903432),0.40037959501665416,1.5208816390889983,0.08695652173913043,0.10460274255343852,1.0,8/28,13.42%,FLCN;RRAGA;SIK3;RRAGD;KPTN;RRAGC;KLHL22;RRAGB
prerank,sensory perception of light stimulus (GO:0050953),-0.3938022645720826,-1.5207672265116745,0.0,0.21667169268378916,1.0,30/93,23.72%,COL1A1;COL11A1;GRM8;ZIC2;GPR143;POU6F2;PAX6;PAX2;TH;FSCN2;CRYBA1;SIX3;BEST1;SLC24A1;TULP1;CHRNB2;ARR3;RP2;TRPM1;TYR;ADGRV1;USH1C;COL2A1;CRYBB3;CLRN1;RDH12;USH2A;CRYBA4;RBP3;RPE65
prerank,sensory perception of sound (GO:0007605),-0.4024665565426854,-1.520468763538162,0.0,0.21561141854459048,1.0,40/87,30.57%,CEMIP;COL1A1;COL11A1;CACNA1D;KCNQ1;MYO3B;LHFPL5;EYA1;DCDC2;GRAP;CEACAM16;LRP2;ATP6V0A4;TSPEAR;MARVELD2;TMC1;CHRNB2;SLC52A3;SLC26A5;GRM7;HPN;MYH14;ADGRV1;PDZD7;LOXHD1;USH1C;COL2A1;PAX3;CLRN1;BIRC5;USH2A;MYO3A;TIMM13;TFAP2A;TIMM10;TMC2;NIPBL;EML2;TPRN;ALDH7A1
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.5472409597507969,-1.5202612637253592,0.04225352112676056,0.2148433696307691,1.0,12/15,38.12%,DKC1;RUVBL1;NAF1;SHQ1;CCT6A;CCT2;RUVBL2;CCT3;NOP10;CCT8;NHP2;CCT7
prerank,skin development (GO:0043588),-0.40913902025667426,-1.5202513574789274,0.011627906976744186,0.2133973134284149,1.0,39/79,32.50%,CLDN1;COL1A1;COL1A2;EREG;CDSN;WNT5A;HRNR;EPHA2;MET;KRT16;ABCA12;COL3A1;DSP;GATA6;ALOX12;SCEL;MED1;ABCB6;ALOX12B;EVPL;ALOXE3;FLG;ADAM9;LSR;STMN1;SPRR1A;ANXA1;CSTA;ST14;DHCR24;S100A7;OPN3;SPRR1B;CLDN4;KRT9;BCR;SFN;KDF1;ATP7A
prerank,negative regulation of cell growth (GO:0030308),0.2984299725208973,1.5200930823672736,0.0,0.10482354252740382,1.0,35/123,14.33%,FHL1;APBB1;TSPYL2;RERG;NPR1;DACT3;CDKN1A;CGRRF1;ULK1;WFDC1;PTPRS;ULK2;FLCN;SEMA3G;SLIT3;PRDM11;JADE1;MAP2;CDKN2C;MYL2;DNAJB2;MUL1;RTN4;SMAD4;SIPA1;SFRP1;CAPRIN2;SERTAD3;SMAD3;BTG1;SOX17;MT3;NPPB;OSGIN1;FRZB
prerank,negative regulation of growth (GO:0045926),0.30001419859517287,1.518875033464596,0.0,0.10523677883302081,1.0,42/123,17.99%,FHL1;APBB1;TSPYL2;RERG;NPR1;DACT3;CDKN1A;ING4;CGRRF1;WFDC1;FLCN;MT1X;SLIT3;PRDM11;JADE1;CDKN2C;MT1M;MYL2;DNAJB2;MUL1;RTN4;SMAD4;SIPA1;SFRP1;CAPRIN2;SERTAD3;SMAD3;BTG1;MT1A;MT1E;SOX17;MT3;NPPB;OSGIN1;FRZB;AGTR2;ALOX15B;TCHP;FGFR3;SFRP2;CDKN2D;NDRG3
prerank,cellular response to ATP (GO:0071318),0.5367078079306574,1.5169285672947248,0.04,0.10571206053146949,1.0,7/15,12.86%,P2RY1;P2RX7;HSP90B1;TRPV1;P2RY12;RYR3;P2RY11
prerank,positive regulation of endocytosis (GO:0045807),0.3693643418056962,1.5165121748097834,0.0625,0.10547847878820804,1.0,12/48,10.14%,CLIP3;CLU;SNCA;F2RL1;CCL21;ANKFY1;NCKAP1L;SMPD1;B2M;RAB31;NLGN1;FLOT1
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.3083251898704426,1.5163529861205618,0.0,0.10518219092644339,1.0,44/102,21.22%,SLC2A4;SORBS1;VAMP2;ADCY5;ZFP36L1;INPP5K;CPEB1;KAT2B;PRKCD;PRKAR2B;ADCY4;PIK3R1;HDAC5;GPER1;PRKACA;PDE3B;PLA2G1B;CEACAM1;RHOQ;RAB31;USF1;RAB13;NFKB1;MGARP;ADCY9;ADCY2;LPIN1;RAB8B;ADCY6;NR4A3;NR4A1;CYP11B1;CPEB2;PRKACB;RAB12;CYP11A1;SLC30A10;PCK1;LPIN3;GCGR;HDAC9;FER;GOT1;MYO5A
prerank,neural crest cell migration (GO:0001755),0.3640028373575827,1.514828927592305,0.13333333333333333,0.10610050493449098,1.0,14/36,14.54%,ANXA6;RADIL;SEMA4C;CORO1C;SEMA3G;SEMA6C;SEMA3B;SEMA3E;SEMA3A;SEMA6D;SEMA3C;SEMA4B;GDNF;SEMA6A
prerank,response to interferon-beta (GO:0035456),-0.49257239608735226,-1.5142820877820005,0.013333333333333334,0.2226404352362407,1.0,8/25,12.24%,IFITM3;IFITM1;IFITM2;BST2;IKBKE;XAF1;STAT1;PNPT1
prerank,regulation of axon extension (GO:0030516),0.32714661558666674,1.5139169593693353,0.0,0.1062497599254996,1.0,11/38,13.56%,NTN1;MAPT;L1CAM;PTPRS;SEMA3G;DBN1;MAP2;RTN4;SEMA3A;OLFM1;MT3
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.3449484801266702,1.5136824590627769,0.0,0.10620773320340803,1.0,21/51,12.98%,JPH2;CASQ2;GSTM2;SNCA;HRC;CALM1;CASQ1;CLIC2;AKAP6;ANK2;NOS1;TRPC1;GPER1;PRKACA;JPH4;CALM2;CAPN3;CAMK2D;DMD;PDE4D;CX3CL1
prerank,positive regulation of apoptotic process (GO:0043065),0.2849844434119004,1.5118875794924609,0.0,0.10711554586617474,1.0,87/301,17.05%,APBB1;CLIP3;ARHGEF26;PSEN1;EPHA7;CLU;PNMA1;TNFSF10;PRNP;BCL10;MOAP1;TRIM39;ATF4;RHOB;SNCA;ING4;GADD45B;APAF1;ARHGEF17;CALHM2;CASP3;PHLDA3;KCNMA1;FAS;MAPK8;FLCN;NGF;DAPK1;SIRT2;RPS6KA2;NGFR;KLF11;RNF122;BCL2L11;PTGIS;ARHGEF18;JMY;DAPK3;MLLT11;PRDM11;HOXA5;ADAMTSL4;NUPR1;UBB;GPER1;ARHGEF6;SMPD1;DAB2IP;BNIP3;SOD1;LATS2;DLC1;PRMT2;APH1B;SFRP1;MTCH1;PIDD1;ARHGEF9;RBM5;ERCC3;BTG1;BNIP3L;OLFM1;BOK;FAM162A;NKX3-1;QRICH1;BAD;ARL6IP5;RIPK1;GADD45G;PLEKHG2;FRZB;ING3;PSEN2;RASSF2;DDIT3;PNMA3;ARHGEF3;RYBP;FGD1;RARG;CASP9;BACE1;STPG1;SQSTM1;WNT10B
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.3881826254944159,1.5108490573096167,0.0,0.10751327554081191,1.0,8/30,7.14%,PSEN1;BCL10;FZD7;ILK;SNCA;PTH1R;EGFR;NCKAP1L
prerank,establishment of endothelial barrier (GO:0061028),0.3949761953783602,1.510723654131666,0.0,0.10746810673184454,1.0,9/28,12.13%,RAP1A;PDE2A;RAPGEF3;F2RL1;SOX18;RDX;ROBO4;MYADM;PDE4D
prerank,negative regulation of chemokine production (GO:0032682),0.4578793777518366,1.5100356855333,0.03333333333333333,0.1074231867868384,1.0,8/17,15.49%,APOD;F2RL1;OAS1;MUL1;C1QTNF3;ELANE;LGALS9;KLF4
prerank,amino acid transmembrane transport (GO:0003333),-0.4435864602492305,-1.506995421262148,0.03571428571428571,0.23547012162426179,1.0,22/45,28.93%,LRRC8E;SLC6A20;SLC7A11;SLC6A14;SLC7A5;TSPO2;SLC6A6;SLC38A5;SLC7A1;MFSD12;SLC7A6;SFXN2;LRRC8D;SLC36A3;SLC25A13;SLC38A9;SLC7A7;SLC3A2;SLC25A22;SLC38A8;SLC22A4;SLC38A3
prerank,negative regulation of protein ubiquitination (GO:0031397),-0.43344642694283597,-1.5059079064020489,0.0,0.23598209355275412,1.0,12/49,12.85%,GNL3L;HSPA1A;PRR7;SOX4;FBXO5;TNFAIP3;PRMT3;ISG15;CAV1;PRKCG;LIMK1;GTPBP4
prerank,negative regulation of TOR signaling (GO:0032007),0.3987187216398185,1.5039905794529098,0.0625,0.11126041910462503,1.0,17/33,24.87%,EPM2A;FLCN;ARNTL;PRKAA2;TNFAIP8L1;KPTN;DEPTOR;TSC1;RNF152;SIRT1;SESN1;TSC2;GSK3A;NPRL2;TMEM127;SESN2;AKT1S1
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.4841873134550716,-1.5038423979027704,0.014285714285714285,0.23836332000014412,1.0,8/24,11.98%,MAD2L1;CENPA;NDC80;SAPCD2;SPDL1;GPSM2;PKHD1;PLK1
prerank,cellular response to lipopolysaccharide (GO:0071222),-0.37921633941644733,-1.5033850114706886,0.011363636363636364,0.23760661485479687,1.0,52/117,30.14%,CXCL8;CXCL1;CXCL2;IL1A;CXCL5;CXCL3;PPBP;CD68;CXCL9;CXCL11;SERPINE1;CD80;IL1B;WNT5A;TNFAIP3;CARD17;CXCL10;PF4;CXCL6;TNIP3;DEFA6;CCL3;RELA;IRAK1;TGFB1;TNFRSF1B;TNFSF4;DEFA5;PF4V1;IL10;ADAM9;NOD2;IL36B;NLRP3;IL36RN;CD86;HMGB1;PLAA;XBP1;AXL;DEFA1;TNF;LYN;PDCD1LG2;CARD16;CD6;ZC3H12A;CCL5;LBP;CDC73;TRAF6;IL37
prerank,epidermis development (GO:0008544),-0.3843268370036722,-1.5028242944349752,0.012195121951219513,0.23659554805171726,1.0,30/82,25.75%,GRHL3;LAMC2;KLK7;CDSN;GJB5;EDAR;ZNF750;OVOL3;RBP2;GRHL2;KRT32;LAMA3;DSP;GATA6;COL7A1;SCEL;LAMB3;KRT15;ATP2C1;EVPL;NTF4;GRHL1;KRT83;HDAC2;OVOL1;SPRR1A;FOXN1;KRT34;SPRR2D;HOXB13
prerank,endoderm formation (GO:0001706),-0.44305361535792886,-1.5027212226923325,0.04938271604938271,0.2352038232696995,1.0,16/36,20.39%,COL11A1;INHBA;DUSP4;TBX20;ITGA5;FN1;DUSP1;HMGA2;MMP2;LAMA3;MMP9;COL7A1;LAMB3;DUSP2;LHX1;MMP8
prerank,cellular component disassembly (GO:0022411),-0.39881128625327383,-1.5021072395716835,0.024096385542168676,0.23513526785818678,1.0,20/65,15.56%,MMP7;MMP13;TIMP1;KLK7;MMP1;MMP10;MMP11;CD44;CTSV;KIF9;MMP2;MMP3;CAPG;PLG;MMP9;TMPRSS6;DYRK3;NOXO1;MMP12;ADAM10
prerank,actin filament organization (GO:0007015),0.3255463328826606,1.5019187558087312,0.0,0.1123292725230244,1.0,32/147,10.65%,TPM2;CORO6;LMOD1;FLNA;TPM1;GSN;DSTN;EFS;ACTN1;DPYSL3;TMOD1;RHOB;TMOD2;INPPL1;RND2;CORO1C;RAC1;MYO1C;DBN1;FLII;CORO7;GAS2L1;ALDOA;RHOA;ACTC1;PLA2G1B;RHOC;CORO1B;MYO5C;BAIAP2;TCAP;WHAMM
prerank,negative regulation of execution phase of apoptosis (GO:1900118),-0.5852605411696261,-1.501650431456187,0.04477611940298507,0.23489476476599436,1.0,13/17,34.44%,MTRNR2L2;MTRNR2L3;MTRNR2L8;BCL2L1;MTRNR2L6;MTRNR2L1;MTRNR2L10;MTRNR2L5;RNF34;MTRNR2L4;MTRNR2L9;PAK2;MTRNR2L7
prerank,ncRNA processing (GO:0034470),-0.36411413093645717,-1.5009835927811128,0.010526315789473684,0.23470031545741324,1.0,90/189,38.53%,WDR43;DKC1;POP1;INTS7;DDX47;DCAF13;WDR3;WDR12;WDR74;PUS10;NOB1;UTP14A;BOP1;ADAT1;SMAD1;UTP18;HEATR1;RRP12;LYAR;UTP20;BYSL;RCL1;RPL39;DDX10;EXOSC3;EXOSC8;EMG1;PDCD11;DDX27;RRP1;RPS19;DIS3;MRTO4;FBL;RRP9;EXOSC5;EXOSC4;PIH1D2;NOP14;WDR36;LIN28A;RRP1B;NOLC1;NOP58;ESF1;DHX37;IMP4;RPL36;UTP15;FARS2;DDX52;PWP2;INTS2;INTS6;EBNA1BP2;PES1;MDN1;XRN2;RPL37;EXOSC7;RPL8;RPL23A;LIN28B;DROSHA;RRP7A;RPS7;NOP56;EXOSC2;SSB;BMS1;UTP6;DDX54;NOL11;NOC4L;KRR1;EXOSC1;RPS2;IMP3;WDR75;POP7;RPL4;MRPL44;TARBP2;AGO2;RPL35;WDR18;WDR46;NOL6;RPL18;RPL32
prerank,primary neural tube formation (GO:0014020),-0.4768179236256766,-1.5005586481476947,0.013333333333333334,0.23395388101479536,1.0,9/30,12.77%,GRHL3;CELSR1;MTHFD1L;TGFB2;PAX2;MTHFD1;GRHL2;LRP2;TGFB1
prerank,regulation of cellular catabolic process (GO:0031329),0.31810082761128594,1.5003315087102664,0.0,0.11289413129599746,1.0,25/61,21.68%,MAPT;HSPB1;DAPK1;TPCN2;WDR91;DAPK3;HDAC6;NUPR1;RRAGA;PIP4K2B;RRAGD;ITPR1;RRAGC;OSBPL7;BOK;RRAGB;KAT8;PIP4K2A;DDIT3;SOGA1;SCARB2;EP300;RAB39B;ABCD1;GPR137
prerank,double-strand break repair (GO:0006302),-0.37584955676544646,-1.5001682445602444,0.0,0.23351367608709767,1.0,44/150,19.30%,RAD54B;XRCC2;BLM;RAD51AP1;EME1;RFWD3;ERCC5;CDCA5;TDP1;MMS22L;DCLRE1C;CHEK2;RAD51B;PRKDC;RMI1;RAD51AP2;DNA2;RPA3;POLB;PSMD14;RECQL4;FEN1;POLA1;EYA1;PALB2;BRCC3;RPA4;DCLRE1B;TONSL;PARP2;XRCC4;BRCA2;TRIP13;RBBP8;PAXIP1;WRN;LIG3;SLX1A;BARD1;BRCA1;ACTR8;HUS1;RIF1;DTX3L
prerank,positive regulation of DNA recombination (GO:0045911),-0.5154982768528513,-1.499757998792925,0.02531645569620253,0.23261586841064874,1.0,13/24,30.33%,FANCB;RAD51AP1;TIMELESS;PAXIP1;ACTR2;FUS;RIF1;PRDM7;ERCC6;ARID2;PRDM9;WRAP53;ERCC2
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.4135964059240525,1.4989058251272902,0.034482758620689655,0.11345591181952651,1.0,8/27,12.85%,MEIS2;USP2;DUSP3;TAL1;APP;ASNS;NKX3-1;PRKCA
prerank,axon development (GO:0061564),0.32241488896988235,1.4965164212500683,0.07692307692307693,0.11457201656592464,1.0,25/78,13.35%,APBB1;S100B;PLP1;MAPT;L1CAM;GAP43;RAB3A;MAP1A;FGFR2;SLITRK2;SLITRK3;ZDHHC17;RTN4;ACTB;BAIAP2;BRSK1;ISL2;ATL1;APP;NTNG1;PARD3;MAP1B;DSCAML1;SVBP;CCK
prerank,positive regulation of hydrolase activity (GO:0051345),0.27189457687311896,1.4961609717883309,0.0,0.11444681225279467,1.0,43/143,14.12%,RAP1A;FERMT2;CCL14;RGS10;CAV2;ASAP3;CALM1;MAPK8;FLCN;RASGRP2;DVL3;SGSM2;PLIN5;MTCL1;RAPGEF3;TBC1D20;GNB5;EVI5L;F2RL1;CCL21;CCL2;RHOA;MTMR9;RSU1;RHOC;MAPRE2;CALM2;SFRP1;CCL11;SNX18;CHP2;CCL13;PIN1;SGSM3;CCL23;GBA3;NTRK1;CX3CL1;CCL8;RGS1;BCAR3;RALBP1;ADCYAP1
prerank,regulation of protein localization to cell surface (GO:2000008),0.3932835307140562,1.4961312850699544,0.0,0.11413749654400333,1.0,11/32,15.70%,GPM6B;RIC3;MAP1A;TAX1BP3;GPD1L;LEPROT;SNX33;RAB11B;ACTN2;GBF1;GOPC
prerank,negative regulation of viral life cycle (GO:1903901),-0.5165743501193261,-1.4942899022142566,0.05405405405405406,0.24265058465636286,1.0,5/20,4.85%,IFITM3;IFITM1;LY6E;IFITM2;BST2
prerank,positive regulation of DNA biosynthetic process (GO:2000573),-0.405383099196139,-1.4941275857413763,0.024691358024691357,0.24145712319270063,1.0,20/61,19.23%,MYC;RFC3;PDGFRB;DSCC1;DKC1;NEK2;MAPK15;AURKB;RFC5;GRHL2;NAF1;ATR;RFC2;CCT6A;FBXO4;HMBOX1;CCT2;PRKCQ;FGFR4;CHTF18
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.41984527844172315,1.4932389163019535,0.04,0.11634203935018636,1.0,4/23,3.53%,TGFB1I1;CITED2;CDKN1C;FLCN
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.41984527844172315,1.4932389163019535,0.04,0.11634203935018636,1.0,4/23,3.53%,TGFB1I1;CITED2;CDKN1C;FLCN
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.41391964146426635,1.492899360012773,0.0,0.11664113687669135,1.0,6/18,10.67%,PTEN;NLGN2;STX1B;DLG4;NLGN1;NLGN3
prerank,positive regulation of innate immune response (GO:0045089),-0.466164454327263,-1.4928800779234914,0.012048192771084338,0.24275780868174346,1.0,22/35,33.10%,EREG;WNT5A;GBP5;IFNK;NLRC5;POLR3B;FPR2;RPS19;POLR3C;ADAM8;ZBP1;POLR3G;NMI;SPI1;IFNB1;CCL5;LBP;DHX9;PLSCR1;AKIRIN2;IFI35;TLR8
prerank,skeletal muscle organ development (GO:0060538),0.3732345318506803,1.4922572236820737,0.0,0.11675582311957608,1.0,10/30,12.74%,BVES;POPDC2;MYL6;DISP1;MYOZ2;TCF21;MYOZ1;POPDC3;MEF2C;CFLAR
prerank,embryonic digestive tract development (GO:0048566),0.42897696417287084,1.4907476891027427,0.038461538461538464,0.11711299681368437,1.0,9/20,7.90%,RBPMS2;FOXF1;RARRES2;FGFR2;TCF21;PDGFRA;ID2;RARB;GLI3
prerank,extracellular matrix disassembly (GO:0022617),-0.39662149951489867,-1.4905795943705453,0.024691358024691357,0.24605446421499783,1.0,21/65,17.30%,MMP7;MMP13;TIMP1;KLK7;MMP1;MMP10;MMP11;CD44;CTSV;KIF9;MMP2;MMP3;CAPG;PLG;MMP9;TMPRSS6;NOXO1;MMP12;ADAM10;HPN;ADAM8
prerank,oxoacid metabolic process (GO:0043436),-0.4514544951539332,-1.4902663630446613,0.025,0.2451069543796251,1.0,13/32,31.78%,SULT2B1;SULT1C2;SULT1C3;MIF;LIPT2;SULT1A3;SULT1E1;SULT2A1;PPA1;SULT1A4;MINPP1;AGXT;HAO1
prerank,response to lipopolysaccharide (GO:0032496),-0.3631747615649875,-1.4902408836276222,0.0,0.24360323073312434,1.0,57/154,24.61%,CXCL8;CXCL1;CXCL2;IL1A;CXCL5;CXCL3;PPBP;CD68;CXCL9;CXCL11;SERPINE1;CD80;IL1B;CYP27B1;WNT5A;TNFAIP3;CARD17;CXCL10;PF4;SCARB1;IL23R;NOCT;MAPKAPK2;CXCL6;TNIP3;DEFA6;PALM3;RELA;IRAK1;NOS2;F2R;CPS1;CITED1;TNFRSF1B;TNFSF4;TRIB1;DEFA5;PF4V1;IL10;ADAM9;NOD2;IRAK3;SLPI;IL36B;NLRP3;SRR;IL36RN;CD86;HMGB1;GCH1;SMAD6;PLAA;XBP1;AXL;DEFA1;RPS6KA3;MAPKAPK3
prerank,chloride transmembrane transport (GO:1902476),-0.42323537355300767,-1.488704420353904,0.022988505747126436,0.2457056720564984,1.0,22/50,26.35%,SLC12A2;GABRP;SLC12A8;GABRB1;CLCN1;GABRD;GLRA1;GLRA2;GABRR1;CLCN3;CFTR;GABRE;SLC4A8;SLC12A1;SLC12A5;SLC12A3;GABRB2;GABRA1;GABRA3;SLC5A1;GABRG3;ANO9
prerank,regulation of mitotic nuclear division (GO:0007088),-0.4122976564833996,-1.4885970433189768,0.0,0.24453709351030187,1.0,16/57,10.10%,IL1A;CHEK1;PDGFRB;KIF20B;EREG;IL1B;NEK2;FBXO5;CDC25C;DUSP1;EPGN;TOM1L1;PKMYT1;AURKA;BMP7;RCC1
prerank,response to interferon-gamma (GO:0034341),-0.4003983952460578,-1.4877094559790764,0.0,0.2451748077304999,1.0,25/75,15.62%,IFITM3;IFITM1;TDGF1;IFITM2;UBD;CCL24;CCL20;CYP27B1;WNT5A;GBP5;KYNU;BST2;CCL22;IL23R;CCL4;STAT1;CCL3;GBP7;GBP1;CCL25;CITED1;CXCL16;CCL26;CCL17;IRF8
prerank,negative regulation of synaptic transmission (GO:0050805),0.4084371193702253,1.4869074065787524,0.037037037037037035,0.11971095692943362,1.0,6/24,8.74%,PRRT1;PTEN;TMEM25;SYT11;NLGN4X;GRIK3
prerank,response to peptide (GO:1901652),-0.4516497383154998,-1.4866461128995712,0.023809523809523808,0.24616118099252687,1.0,15/37,18.53%,MMP13;IRS1;REG3A;MMP2;MMP3;STAT1;REG1A;REG1B;CALCR;MMP9;FYN;MMP12;STAT5A;NOD2;STAT5B
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.29753752509649417,1.4851543965799114,0.0,0.12054201617312062,1.0,42/95,24.53%,CLU;ZER1;TRIM39;BAG2;SIRT2;MAP1A;SMAD7;CAMLG;DNAJB2;TRIB2;RNF217;GNA12;RNF14;RNF144B;PIAS1;CSNK1E;UBXN1;GABARAP;CSNK1A1;RNF180;ZYG11B;BBS7;RYBP;RNF19A;FOXF2;ARAF;CBFA2T3;KLHL40;WAC;DVL1;BAG6;HERPUD1;SDCBP;HFE;GSK3A;LRRK2;DDA1;DET1;ARIH2;RNF144A;CSNK1D;UBQLN4
prerank,maturation of SSU-rRNA (GO:0030490),-0.470999564363454,-1.4849993043034266,0.04,0.24867057232987833,1.0,20/32,38.22%,DCAF13;WDR3;NOB1;HEATR1;SRFBP1;NOL10;NAT10;RPS19;NOP14;DHX37;DDX52;PWP2;BMS1;UTP6;HELB;RIOK1;NOL11;TSR1;MRPS11;WDR46
prerank,regulation of T cell differentiation (GO:0045580),-0.4504392060455465,-1.4849215266573994,0.024096385542168676,0.2473556287419325,1.0,21/39,28.62%,TCF7;FOXP3;CBFB;RUNX1;PRDM1;IFNG;ZAP70;FANCA;PRELID1;ZNF683;IL2RA;CTLA4;MDK;IL36B;GATA3;CR1;CRTAM;XBP1;CD2;IFNB1;RHOH
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.2777298432444156,1.484284864045947,0.0,0.12112750852479179,1.0,52/163,16.03%,GLP2R;GNAO1;RAMP1;CNR1;LPAR1;ADCY5;PDE2A;VIP;AKAP12;ADCYAP1R1;S1PR1;PTGER3;GNAZ;GALR2;GABBR1;CHRM2;ADRB3;ADCY4;VIPR2;ADGRD1;GNAI2;ADGRB3;PTH1R;GPER1;RAMP3;RAMP2;GRK5;CORT;P2RY12;GNA12;GPR161;GNAI1;ADGRL4;TBXA2R;WASF2;PTGER4;ADM;ADGRL2;ADCY9;AVPR2;NPY1R;ADCY2;RGS1;GNAQ;ADRB2;ADCYAP1;S1PR2;ADCY6;GPR4;ADORA2A;GNAL;ADGRL1
prerank,DNA biosynthetic process (GO:0071897),-0.5073620927673108,-1.484192032850076,0.03125,0.2473006306534699,1.0,6/16,17.18%,RFC3;POLH;POLA1;WRN;POLD2;TERT
prerank,protein K63-linked deubiquitination (GO:0070536),-0.45661155391321884,-1.483394083402219,0.05,0.2473236006887526,1.0,7/29,11.43%,OTUB2;USP50;TNFAIP3;PSMD14;SHMT2;BRCC3;USP17L2
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.5819480315730359,-1.4833882176562279,0.015151515151515152,0.24588567277777146,1.0,8/15,19.12%,TACSTD2;SOX9;SIX1;PAX2;PAX8;AGT;BMP4;LHX1
prerank,response to calcium ion (GO:0051592),0.3017273717872685,1.4821841217629337,0.0,0.12213084469443715,1.0,33/107,14.37%,KCNMB1;ADD1;CASQ2;CLIC4;ITPKB;SLC25A12;SYT11;STIM1;KCNMA1;CALM1;RASGRP2;PKD2;TRPC1;PRKAA2;MCOLN1;SMPD1;AHCYL1;RYR3;SYT4;MEF2A;SYT10;NLGN1;SYT5;CALM2;CAPN3;CAMK2D;SYT1;CHP2;MEF2C;KCNMB4;PEF1;CPNE8;SYT6
prerank,DNA damage checkpoint signaling (GO:0000077),-0.451303921347685,-1.4818508211575854,0.0945945945945946,0.24706302034229044,1.0,13/30,30.49%,CHEK1;INTS7;E2F1;CHEK2;RPA4;ATR;CLSPN;HUS1;RHNO1;ERCC6;PRPF19;BRIP1;CDC5L
prerank,protein sumoylation (GO:0016925),-0.39791108755279453,-1.4808550646631509,0.0,0.2477708850733029,1.0,27/53,33.91%,NUP155;RNF212B;NUP37;NUP210;EYA1;NUP107;NUP35;RANBP2;SEH1L;NUP50;NUP205;NUP93;RAE1;NUP88;POM121;NUP43;SUMO4;NSMCE2;NUP160;NUP62;NUP153;NDC1;NUP98;UBA2;RANGAP1;ZNF451;EGR2
prerank,positive regulation of microtubule polymerization (GO:0031116),0.3837316005005172,1.4807144226863453,0.06666666666666667,0.12282902459906263,1.0,10/27,12.75%,MAPT;RAC1;OCLN;ARL2;FES;CLIP1;DCTN1;NUMA1;SLAIN2;MECP2
prerank,digestive tract morphogenesis (GO:0048546),0.47826629519987096,1.4803937561290628,0.03333333333333333,0.12274590948645255,1.0,6/15,6.12%,RBPMS2;FOXF1;FGFR2;TCF21;PDGFRA;ID2
prerank,regulation of viral genome replication (GO:0045069),-0.40521218553726857,-1.4801240941044778,0.022988505747126436,0.24797953652514457,1.0,35/66,37.66%,CXCL8;IFITM3;IFITM1;IFITM2;OAS2;PROX1;SRPK1;BST2;ISG15;MX1;PPIH;PABPC1;APOBEC3F;HACD3;OAS3;FKBP6;TMEM39A;SLPI;IFI16;STAU1;TNF;PDE12;IFNB1;CD28;LTF;CCL5;LARP1;PLSCR1;SRPK2;OASL;EIF2AK2;VAPB;ZC3HAV1;TARBP2;APOBEC3A
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.2697974913247859,1.4763798212966839,0.0,0.1252883181012404,1.0,27/139,11.17%,ARHGEF26;ARHGAP10;RHOB;SYDE1;ARHGAP6;RHOJ;ARHGEF17;ARHGAP33;FLCN;RAC1;TRIP10;STARD8;STARD13;ARHGEF18;RHOA;ARHGEF6;RHOQ;ARHGAP20;DLC1;RHOC;RHOT2;RHOU;ARHGAP23;ARHGAP1;ARHGAP19;ARHGEF9;INPP5B
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.40279149073199794,1.4740276630162783,0.045454545454545456,0.12650833315454002,1.0,13/23,27.81%,UBB;COPS4;COPS7A;COPS7B;XPA;COPS8;CETN2;DDB2;COPS3;COPS2;RPS27A;COPS6;GPS1
prerank,regulation of cytokinesis (GO:0032465),-0.40077287307091397,-1.473764873024223,0.011363636363636364,0.2611454214244457,1.0,31/83,22.78%,KIF14;KIF20B;KIF23;SSTR5;KIF20A;RACGAP1;TAS2R13;AURKB;BCL2L1;CHMP4C;CXCR5;AURKA;DRD2;ECT2;CDC14C;CSPP1;PLK1;SPAST;RAB11FIP4;E2F8;BIRC6;PRPF40A;OR2A4;PDXP;PKP4;PLK4;CDC6;DCDC1;RXFP3;CIT;PRC1
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.48766522236857124,-1.4734620930695563,0.036585365853658534,0.26037970861042853,1.0,9/31,9.33%,ETV4;CYP27B1;REG3A;CTSV;ZBED2;CBFB;RUNX1;ABCA12;GRHL2
prerank,organic hydroxy compound transport (GO:0015850),-0.44695095897233106,-1.4730479399822056,0.012345679012345678,0.25984545132775166,1.0,13/40,15.61%,STRA6;ABCC11;SLCO1B3;SLCO1B1;ABCG5;SLC10A1;ABCC2;SLCO1A2;AKR1C4;AQP9;GHRL;RBP4;ABCG8
prerank,neural tube closure (GO:0001843),-0.4569082938230519,-1.4721914619759853,0.025974025974025976,0.260425198566405,1.0,10/34,12.77%,GRHL3;CELSR1;MTHFD1L;TGFB2;FOLR1;PAX2;MTHFD1;GRHL2;LRP2;TGFB1
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.4071897079299787,1.4716255701642946,0.045454545454545456,0.127543942855945,1.0,10/25,15.22%,PIRT;ATP1B2;CTSS;ANK2;STAC;DMD;TRPC6;SLC6A9;ACTN2;ANK3
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.44804780672225347,1.4713480267292005,0.09375,0.1275086409481848,1.0,6/17,11.10%,DPYSL3;CRMP1;NT5E;NT5M;DPYSL4;DPYSL2
prerank,negative regulation of protein secretion (GO:0050709),-0.436359781776705,-1.470738854866227,0.03896103896103896,0.26257786466432664,1.0,10/37,11.67%,IRS1;BMP8A;IL1B;CYP51A1;SIRT4;RAB11FIP1;IL12B;DRD2;RHBDF2;F2R
prerank,regulation of myotube differentiation (GO:0010830),0.40354728279443763,1.4706615535242897,0.0967741935483871,0.12770969336817106,1.0,6/24,6.74%,DMPK;SMYD1;RBM24;MAPK14;HDAC4;HDAC5
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.4125508288449552,1.4703204800426792,0.0,0.1278508164690007,1.0,10/24,14.41%,FERMT2;MYOC;RAC1;DUSP3;COL16A1;PIK3R1;MAPRE2;SFRP1;TSC1;PPM1F
prerank,negative regulation of endothelial cell migration (GO:0010596),0.3605364840883527,1.4693569327704645,0.05,0.12799121213116624,1.0,14/38,16.31%,ATP2B4;DCN;FGF2;NR2F2;PTPRM;DAB2IP;CSNK2B;MEF2C;MECP2;SVBP;SYNJ2BP;AGTR2;ANGPT4;RGCC
prerank,calcium ion import (GO:0070509),0.3680818455371891,1.469040930406382,0.037037037037037035,0.1278965359218178,1.0,10/26,16.04%,CACNA1H;SLC25A23;CACNA1C;TRPC4;ATP2A2;CACNB2;SLC8A1;SMDT1;MICU3;MICU1
prerank,sulfation (GO:0051923),-0.5480272331936107,-1.468486668349352,0.025974025974025976,0.26631390553264334,1.0,4/17,1.72%,SULT2B1;SULT1C2;SULT1C3;CHST4
prerank,chemical synaptic transmission (GO:0007268),0.2569912558915826,1.4669880964729727,0.0,0.1289710909583457,1.0,68/304,13.08%,KCNMB1;PLP1;PMP22;NPTX1;MPZ;PDLIM4;VAMP2;PTEN;NLGN2;CHRNA3;MAPK1;RIC3;SNCG;GRIK5;SNCA;NTSR1;PENK;KIF5A;PTCHD1;NOVA1;CALM1;RAB3A;DTNA;SYN2;SNPH;CHRM2;SLC5A7;GLRB;RPS6KA2;PRKAR2B;CAMK1;SLC12A4;SNAP25;HTR3A;NLGN4X;CHRNB4;SST;AMPH;SCN2B;DLG4;PRKACA;NPFF;CBLN2;CORT;SNAPIN;HAP1;PAFAH1B1;GRIK3;NPY;SYT10;NLGN1;BRSK1;SYT5;PCDHB4;SYN1;CACNB2;NLGN3;SYT1;GABARAP;GRIK2;PDE7B;SLC17A7;SNCB;CNP;DLG2;KCNMB4;NAPB;GRIA4
prerank,protein destabilization (GO:0031648),0.3429710407034229,1.4664703229396887,0.05263157894736842,0.12893268077269332,1.0,9/33,13.15%,GSN;NR1D1;PRNP;SNCA;MUL1;TRIM21;GGA3;CAPN3;SOX17
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.44526554357019765,1.4661569288787744,0.03125,0.1289526056942985,1.0,9/15,19.07%,ST6GALNAC3;A4GALT;ST8SIA1;B3GALT4;ST3GAL5;ST6GALNAC5;ST6GALNAC6;ST8SIA3;B4GALNT1
prerank,regulation of endopeptidase activity (GO:0052548),-0.3937574841354185,-1.4648579765273522,0.023255813953488372,0.2728059695225466,1.0,31/69,30.79%,SERPINB5;TIMP1;SERPIND1;SERPINE1;SERPINA4;PSMB9;SERPINA10;SERPING1;SERPINE3;CRB2;SERPINB7;SERPINA7;SERPINA3;AGT;PRELID1;AHSG;KNG1;ATP13A2;SERPINB2;PSMA3;SERPINB3;GAPDH;HRG;SERPINB1;SERPINB4;PSME2;SERPINC1;FETUB;PSME3;SERPINB9;SERPINA11
prerank,placenta development (GO:0001890),-0.5444127462076542,-1.464584188726048,0.0547945205479452,0.27196551601068375,1.0,11/15,33.27%,ASCL2;PHLDA2;PLAC1;CITED1;E2F8;TEX19;NODAL;PPARG;E2F7;PTK2;ANG
prerank,water-soluble vitamin metabolic process (GO:0006767),-0.38574567794317616,-1.4634675252008227,0.011627906976744186,0.2735056339959935,1.0,30/73,28.40%,TCN1;MTHFD1L;PNPO;MMACHC;DHFR;MTHFD1;SHMT2;GSTO2;HLCS;SLC5A6;VNN3;VNN1;MTHFD2;SLC52A3;SLC2A1;SLC19A1;PDXK;SLC46A1;SLC25A19;PANK2;MCCC2;THTPA;SLC52A2;PCCA;PRSS3;PCCB;MMAA;MMAB;ACP5;TPK1
prerank,regulation of Ras protein signal transduction (GO:0046578),0.2901910634396526,1.462618573728981,0.0,0.13158203322524525,1.0,28/85,17.57%,KANK2;CADM4;MFN2;FLCN;NGF;STARD8;SPRY1;STARD13;LZTR1;ARHGEF18;DENND3;DAB2IP;DLC1;RDX;MAPKAP1;RAF1;GABARAP;DENND4B;SGSM3;FGF10;NTRK1;JAK2;MMD2;STK19;EPOR;SQSTM1;SYNGAP1;KANK1
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.36799103810730144,1.4626179433048723,0.058823529411764705,0.13124806867391214,1.0,17/48,16.13%,PTEN;LMO3;DUSP26;EMILIN1;FBLN1;FLCN;TIMP3;DUSP3;SPRY1;GPER1;DAB2IP;SMAD4;PIN1;SEMA6A;ITGB1BP1;SYNJ2BP;CNKSR3
prerank,response to axon injury (GO:0048678),0.4404808316867849,1.4624160503667591,0.043478260869565216,0.13114658537776203,1.0,6/18,9.62%,DPYSL3;APOD;GAP43;SOD1;P2RY12;MORN4
prerank,signal transduction in response to DNA damage (GO:0042770),-0.4000262808640607,-1.4622423668346578,0.023529411764705882,0.27485041890871187,1.0,21/50,30.49%,CHEK1;INTS7;E2F1;CHEK2;MYO6;RPA4;ATR;BATF;PAXIP1;ACER2;CLSPN;HUS1;RHNO1;ATRX;ERCC6;USP10;PRPF19;E2F7;BRIP1;BID;CDC5L
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.5294422955644091,-1.4621704859602283,0.08823529411764706,0.27347936197627404,1.0,7/15,25.72%,C2CD4A;OSM;IL1B;FFAR2;ADAM8;TNF;C2CD4B
prerank,negative regulation of cell migration (GO:0030336),0.278789471572606,1.4621297797580495,0.0,0.131333373988078,1.0,28/138,6.17%,TPM1;PLXNB3;PTEN;CITED2;ADARB1;CLDN5;ATP1B2;DPYSL3;VCL;CLIC4;RHOB;MITF;PODN;DUSP22;RECK;FGF2;FLCN;CORO1C;RAC1;DUSP3;NGFR;CHRD;HMOX1;PHLDB2;ADORA3;BMPR1A;EPHA4;SMAD7
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.2799064215882102,1.4619856836425376,0.0,0.1313470008799013,1.0,16/92,9.44%,FHL1;FAM107A;KANK2;PTEN;CDKN1A;ZFP36L1;SKP1;PKD2;FBXL7;CCL2;JADE1;CDKN2C;PSMC5;GPNMB;ZNF655;PRMT2
prerank,sulfur compound biosynthetic process (GO:0044272),0.2929403935026602,1.461970644087666,0.0,0.13101698328975078,1.0,34/108,16.79%,PRELP;CSPG4;DCN;GSTM2;GSTM3;GSTM5;UST;GSTA4;OGN;CHST3;B4GAT1;ST3GAL3;CDO1;GSTM4;MAT2A;HPGDS;CHST15;ANGPT1;CHST9;CHST14;CHST7;GSTT2B;HAGH;LIAS;GGT5;SLC26A2;ST3GAL6;KERA;FMOD;OMD;GGT7;DSEL;CSGALNACT2;UGDH
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.491244303021102,-1.461575653243604,0.056338028169014086,0.2736078543835085,1.0,8/24,16.06%,RFC3;RPA3;POLB;LIG1;RFC5;RFC2;LIG3;POLD2
prerank,cytoplasmic microtubule organization (GO:0031122),0.34013417567902127,1.4615090715544596,0.0,0.13120269229168846,1.0,15/54,13.77%,CLIP3;DST;CLIP4;MAPT;FIGN;KATNAL1;CLIP1;DCTN1;NUMA1;RHOA;TUBGCP6;SLAIN2;CEP126;CCDC13;KATNA1
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.2766728832839863,1.4610720692219763,0.0,0.13115956733187992,1.0,44/167,13.91%,S100B;FLNA;TNFSF10;LPAR1;BCL10;MAP3K3;LITAF;WLS;TRIM6;S100A13;MAP3K14;TERF2IP;TIRAP;HMOX1;F2RL1;CCL21;RHOA;GPRC5B;CASP10;APOL3;MUL1;ZDHHC17;VAPA;TICAM2;TLR9;RHOC;PRKD1;TRIM34;TRIM21;LURAP1;UBE2V1;ROR1;TNFRSF1A;SLC44A2;LGALS9;PPM1A;TFRC;TRIM52;PRKCB;CFLAR;CX3CL1;RIPK1;SECTM1;RNF31
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.27157337514145397,1.4606302274154868,0.0,0.1308893203851013,1.0,35/139,14.51%,PTN;NPR1;EPHA7;EFS;FGFR1;DDR2;ANGPTL1;KIT;LIFR;ROR2;SHC2;SHC4;NGF;PILRB;FES;NPR2;FGFR2;TIE1;PDGFRA;NPPC;EPHA4;GFRA2;EGFR;SH2D6;NPPA;FLT4;ROR1;BLNK;EPHB6;NTRK1;JAK2;NTF3;NPPB;RET;EPHA10
prerank,membrane assembly (GO:0071709),0.3666907582428014,1.4598139357349378,0.0,0.13135742551705668,1.0,18/36,22.76%,PTEN;NLGN2;STX2;NLGN4X;NLGN1;FLOT1;CHMP7;NLGN3;VPS4A;ANXA2;FLOT2;ANK3;NRXN2;UGCG;NRXN1;STX4;NSFL1C;CHMP4B
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.2982440873699746,1.4589720064666691,0.0,0.13199286418438935,1.0,22/79,13.24%,TNFSF10;SNCA;MAPT;APAF1;FAS;NGF;NGFR;CASP12;CASP10;MUL1;DLC1;NLRP1;MTCH1;PIDD1;SMAD3;BOK;FAM162A;NKX3-1;CFLAR;BAD;JAK2;RIPK1
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.2767562464842306,1.458946130083135,0.0,0.13172256140589741,1.0,56/219,13.91%,S100B;PER1;FLNA;NR1D1;TNFSF10;LPAR1;BCL10;TRIM39;OPTN;MAP3K3;LITAF;WLS;ZMYND11;HSPB1;TRIM6;S100A13;MAP3K14;TERF2IP;TIRAP;HMOX1;F2RL1;CCL21;NLRX1;RHOA;GPRC5B;CASP10;DAB2IP;APOL3;MUL1;ZDHHC17;VAPA;TICAM2;TLR9;RHOC;PRKD1;TRIM34;TRIM21;LURAP1;TLE1;TRAF1;UBE2V1;ROR1;CAPN3;TNFRSF1A;PIDD1;SLC44A2;LGALS9;PPM1A;TFRC;TRIM52;PRKCB;CFLAR;CX3CL1;RIPK1;SECTM1;RNF31
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.3188151568689285,1.4588767391790967,0.0,0.13145359345594126,1.0,26/68,22.55%,DNAJC18;FBXO17;FBXO44;USP19;HSP90B1;DNAJB2;TMUB2;RNF185;FAM8A1;WFS1;FBXO27;UBE2G2;TMEM129;ANKZF1;UBE4B;DNAJB12;RNF175;MAN1A1;DERL3;SEL1L;BAG6;SGTA;RNF5;HERPUD1;SYVN1;DERL2
prerank,neuron apoptotic process (GO:0051402),0.41796146228017833,1.458508412375484,0.041666666666666664,0.13146662216674418,1.0,9/20,14.45%,ATN1;FAS;NGFR;BNIP3;NLRP1;APP;TNFRSF21;FAM162A;BCL2
prerank,regulation of smooth muscle contraction (GO:0006940),0.47172321629465985,1.4573287378137665,0.08333333333333333,0.13192755818950685,1.0,7/20,7.15%,CNN1;CHRNA3;MYOCD;SRF;CHRM2;DAPK3;SETD3
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.3739622876418151,1.4571926084826177,0.0,0.13166006550196804,1.0,6/31,5.69%,KANK2;PER1;CRY2;VPS11;ARNTL;TCF21
prerank,Rho protein signal transduction (GO:0007266),0.3213525529839961,1.4561744567883987,0.0,0.1319511068049221,1.0,14/54,10.16%,NTN1;AGTR1;RHOB;ARHGAP6;RHOJ;CDC42EP3;NGFR;RHOA;TAX1BP3;CTNNAL1;CDC42EP4;RHOU;GNA12;ARHGAP1
prerank,anion transport (GO:0006820),-0.4456999878594642,-1.4558726558119153,0.012345679012345678,0.2859025419042208,1.0,19/43,26.01%,LRRC8E;SLC22A11;ABCC11;SLCO1B3;SLC13A4;SLC26A9;SLCO1B1;SLC26A8;SLCO1A2;LRRC8B;SLC13A5;SLC19A1;SLC13A3;LRRC8D;VDAC1;SLC22A25;SLC22A9;SLC22A10;SLC22A24
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.27281227828812643,1.454633586070114,0.0,0.13240748845523,1.0,32/120,14.71%,FERMT2;CHRNA3;SDC2;MAPT;FGF2;ZNF135;FGFR2;HMOX1;CAPZB;PHLDB2;EPHA4;EFNA5;ADGRB3;PID1;CEACAM1;KIF1A;ZDHHC15;GPNMB;EGLN1;LRRC4C;ZMYM3;BRSK1;FLT4;SFRP1;ZMYM6;MEF2C;ARC;CDH2;PHLDB1;GDNF;RNH1;WTIP
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.3657352321622857,1.453982962655783,0.06896551724137931,0.1325843920722803,1.0,6/31,9.43%,CLIP3;STMN2;SNCA;MAP2;TUBB4A;CDH5
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.4075439876246718,-1.453757997613694,0.058823529411764705,0.2886224462089748,1.0,18/58,24.18%,CCND1;CDK1;CDCA5;DLGAP5;FBXO5;RCC2;UBE2C;CDC25C;RAD51B;CDK4;TFDP1;CDC7;ESPL1;STOX1;CDC25A;ANKRD17;ANXA1;NSMCE2
prerank,cytosolic transport (GO:0016482),0.29287009189993324,1.452869730869156,0.0,0.1335901896647449,1.0,30/108,20.63%,RAB9B;RAB6B;SNX1;CORO7;WDR91;TBC1D17;ANKFY1;DCTN1;DENND2A;AKTIP;VTI1B;DENND5A;STX16;KLHL20;RBSN;TBC1D10A;VPS26B;RILP;GBF1;SNX2;STX8;VAMP3;PTPN23;AP2A1;MAGEL2;VPS52;RAB14;GGA1;RAB29;CLN3
prerank,long-term memory (GO:0007616),0.4400594503246758,1.4527001594299236,0.03571428571428571,0.13337709255501745,1.0,8/19,12.48%,SLC2A4;NFATC4;PRNP;PJA2;NPAS4;KAT2A;SGK1;ARC
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.47053150285053175,-1.4523129687099958,0.03614457831325301,0.29072218467704786,1.0,10/29,17.25%,MYC;TCF7;LEF1;RUVBL1;BCL9L;AXIN2;SMARCA4;RBBP5;TERT;TRRAP
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.3170579089112342,1.4521309375056377,0.09090909090909091,0.13355037222291086,1.0,10/49,12.13%,CRYAB;JAM3;CLU;PRRT2;ULK1;HDAC6;THRA;RAF1;PTGER4;PPM1A
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.30601685267324624,1.4505425911787484,0.0,0.13443673739061562,1.0,17/69,10.51%,LIMS2;FLNA;FERMT2;ILK;MYOC;RAC1;CCL28;ARL2;CCL21;CD36;RSU1;PDGFB;FBLN2;TESK1;VIT;SFRP1;MYADM
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.5404707371851314,-1.4503647364308978,0.08823529411764706,0.29349221661579633,1.0,4/17,0.57%,IFITM3;IFITM1;LY6E;IFITM2
prerank,negative regulation of cell aging (GO:0090344),-0.5203581141967023,-1.4502158225744273,0.058823529411764705,0.2925145510285689,1.0,7/16,17.18%,RBL1;MIF;FBXO5;HMGA2;AKT3;FOXM1;TERT
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.333700386379825,-1.4495102946294494,0.0,0.29230063370037324,1.0,98/307,29.86%,EXO1;ORC6;INHBA;DBF4;CHEK1;RFC3;BLM;MCM4;EEF1G;IGF2BP3;CDK1;POLR2F;POLE2;TICRR;FAM111B;E2F1;TIPIN;TIMELESS;RMI1;DNA2;RPA3;RECQL4;FEN1;POLA1;TOP1MT;RFC5;RMI2;MCM7;YARS2;GCNT1;MCM3;RPA4;TAF1B;MCM10;RAD9B;RPL39;TOPBP1;MRPL3;PAX8;TOP1;RRBP1;SRBD1;ATR;MCM5;RBBP8;RNASEH2A;RPS19;MCM2;CDC7;RFC2;NKX2-8;WRN;SET;FARSB;POLD2;POLR2D;MRPS18C;ASMT;TERT;RPS21;BARD1;BRCA1;CLSPN;HUS1;RPL36;POLR2J;MCM6;CDC45;MRPS16;CDC6;POLR3A;GAL3ST2;MRPL13;POLR2I;RHNO1;EEF2;PTMA;ORC2;ZAR1L;EXT1;RPL37;MCM8;MRPL42;RPL8;ABCF1;ORC5;MRPL9;ORC1;RPL23A;MRPL37;PIF1;GRWD1;HBS1L;GSPT1;RPS7;BRIP1;TUFM;ORC3
prerank,error-prone translesion synthesis (GO:0042276),-0.502235880213883,-1.4485119371424522,0.05405405405405406,0.2933498352631644,1.0,5/21,7.29%,RFC3;POLE2;POLH;RPA3;RFC5
prerank,negative regulation of signal transduction (GO:0009968),0.24148225451230265,1.4481580320524914,0.0,0.13646932526219377,1.0,80/258,17.59%,KANK2;TNS2;RGS2;PALM;PTEN;TMEM25;DACT3;NCK1;CILP;NTN1;DCN;HEY1;CADM4;NXN;SNCA;FSTL3;TMBIM1;APOD;EMILIN1;FGF2;INPP5K;PLIN5;PRKCD;SPRY1;TRABD2B;TULP3;NLGN4X;PID1;TAX1BP3;GPC1;EGFR;HHEX;SMPD1;EGFL7;DAB2IP;GRB14;PIP4K2B;GLI3;CBY1;MMRN2;TLR9;GPS2;IGFBP5;TLE1;EPN2;SFRP1;LEPROT;NDRG4;GRB10;GATA2;KIF7;CSNK2A2;DKK3;NKX3-1;SFRP5;PRKCB;CRY1;CX3CL1;SUFU;MEGF8;METTL3;NFATC1;GLIS2;CYP26B1;FRZB;NFKBIL1;BCL2;SEMA6A;AGTR2;PIP4K2A;GPR108;GPC3;BTRC;PTCH2;DLL1;IL12A;ERBB3;KCTD21;KANK1;SFRP2
prerank,multivesicular body assembly (GO:0036258),0.38833574107452057,1.447864546516122,0.0,0.13646998215614997,1.0,9/30,16.43%,CHMP3;TSG101;CHMP4A;CHMP7;VPS4A;VPS28;IST1;VPS37A;VPS37D
prerank,negative regulation of cellular component organization (GO:0051129),0.3300567198180712,1.4476164096670294,0.0,0.13641611308010243,1.0,23/73,17.05%,CRYAB;HSPA2;CLU;LGALS3;SYT11;ULK1;RAPGEF3;PACSIN3;HDAC6;DNAJB2;PRKD1;RDX;SLN;RAF1;SNX33;LRSAM1;TMEFF2;DNAJB6;HSPA8;NR1H4;RTEL1;RIOK3;EPHA3
prerank,leukotriene biosynthetic process (GO:0019370),0.4069205036314603,1.446063757424884,0.05405405405405406,0.1369608208454923,1.0,5/15,15.98%,PLA2G5;PLA2G1B;PLA2G4A;GGT5;GGT7
prerank,positive regulation of programmed cell death (GO:0043068),0.27602426642209266,1.4454239455073608,0.0,0.13723161879207493,1.0,78/278,17.05%,APBB1;CLIP3;ARHGEF26;PSEN1;CLU;PNMA1;TNFSF10;BCL10;MOAP1;ATF4;RHOB;SNCA;ING4;GADD45B;APAF1;ARHGEF17;CALHM2;CASP3;PHLDA3;KCNMA1;FAS;MAPK8;FLCN;NGF;DAPK1;RPS6KA2;NGFR;KLF11;RNF122;BCL2L11;ARHGEF18;JMY;DAPK3;MLLT11;HDAC6;HOXA5;ADAMTSL4;UBB;GPER1;ARHGEF6;SMPD1;DAB2IP;BNIP3;SOD1;LATS2;PRMT2;APH1B;SFRP1;MTCH1;PIDD1;ARHGEF9;MARK4;RBM5;ERCC3;BNIP3L;OLFM1;BOK;FAM162A;QRICH1;NTRK1;BAD;ARL6IP5;RIPK1;GADD45G;PLEKHG2;FRZB;ING3;PSEN2;RASSF2;PNMA3;ARHGEF3;RYBP;FGD1;RARG;CASP9;STPG1;SQSTM1;WNT10B
prerank,protein-containing complex disassembly (GO:0032984),0.338871757212762,1.445323583943276,0.058823529411764705,0.13701392155823938,1.0,24/54,20.63%,GABARAPL1;MAP1LC3C;CHMP3;LIX1L;TSG101;DVL3;GABARAPL2;VTI1B;DVL2;LIX1;MAP1LC3A;GABARAP;CSNK1A1;VPS4A;HSPA8;MAP1LC3B;VPS33A;VIPAS39;VPS16;FZD1;DVL1;SNAP29;VPS33B;CLN3
prerank,positive regulation of signaling (GO:0023056),0.41002911627103783,1.4437881415297373,0.041666666666666664,0.138093400615009,1.0,18/38,18.52%,BVES;ILK;SNCA;WLS;ECE1;CARTPT;LGI1;RIMS3;DLG4;RAMP3;SYT1;GRIK2;ANXA2;INPP5F;VAMP3;EDN3;PTPN23;CLSTN2
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.39277647770831553,-1.443752484620603,0.0,0.3038474867648014,1.0,14/64,14.67%,CCND1;CEBPB;CDK1;LEF1;CDKN2A;SOX9;CBFB;HNF1A;CDK4;RELA;MED1;MED13;MED14;PAXIP1
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.5145416775561148,-1.443544725211787,0.1,0.30283694052553267,1.0,7/16,23.65%,SOCS3;SOCS1;CAV1;VHL;PIBF1;PTPN2;PARP14
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.3570498127540227,1.4433605920432666,0.0,0.13825184381701341,1.0,13/45,8.84%,RBPMS2;IL6R;MFN2;FOXJ2;MEF2D;FGF2;ADAMTS1;HMOX1;BMPR1A;ID2;ELANE;PDGFB;IGFBP5
prerank,cellular response to cAMP (GO:0071320),0.41143859919508596,1.4428655184271215,0.11538461538461539,0.13835578836789128,1.0,10/31,8.84%,RAP1A;PDE2A;AQP1;ZFP36L1;INPP5K;PKD2;AKAP6;RAPGEF3;AQP8;IGFBP5
prerank,positive regulation of calcium ion transport (GO:0051928),0.3279742289986386,1.4427495714693133,0.0,0.13808387014037546,1.0,11/37,12.31%,MYLK;LGALS3;ANK2;CCL2;P2RX7;PLA2G1B;WFS1;PDGFB;CACNB2;P2RX2;TRPC6
prerank,metanephros development (GO:0001656),-0.4660621869312387,-1.4422445576625853,0.04819277108433735,0.30472279464550117,1.0,13/26,18.90%,WNT7B;FOXD1;SHH;CTSH;ROBO2;SIX1;PAX2;BMP7;PAX8;CITED1;NF1;BMP4;PTCH1
prerank,actin cytoskeleton reorganization (GO:0031532),0.3178108999381345,1.4419865232329423,0.0,0.13850871453777167,1.0,10/63,6.57%,FLNA;GSN;PDLIM4;EFS;SYDE1;KIT;S1PR1;PARVA;FGF7;RHOA
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.4835727891643669,1.4400711894477407,0.038461538461538464,0.14037265714686312,1.0,10/16,20.21%,FAM107A;ZFP36L1;BCL2L11;ZFP36;GPER1;NR3C1;AKR1C3;SSTR2;UBE2L3;ZFP36L2
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.4205701361916022,1.4390618594957072,0.05555555555555555,0.14068367079858504,1.0,12/23,20.02%,GSN;ECSCR;CCL2;GPER1;PLA2G1B;PDCD4;PIAS4;RGCC;ITGA4;AKR1C3;ANO6;CD40
prerank,cellular defense response (GO:0006968),-0.4078439664843604,-1.4388459592145457,0.047619047619047616,0.3115981425307413,1.0,28/48,39.03%,CXCL9;CLEC5A;PRF1;DCDC2;CXCR2;RELA;IL1RL2;CCR3;GNLY;ITK;NCR1;ADORA2B;NCF2;HLA-G;MNDA;KLRC2;TYROBP;LBP;CCR9;KIR3DL2;TRAT1;CX3CR1;FOSL1;CD5L;LILRB2;CCR6;ZNF148;NCF1
prerank,small GTPase mediated signal transduction (GO:0007264),0.2974303226153803,1.438450304980638,0.0,0.1409401096974466,1.0,28/105,15.52%,RERG;NTN1;DIRAS3;MRAS;CDKN1A;SHC2;ARHGAP33;RRAS;FGF2;RAC1;RASGRP2;MAPK14;RRAD;RGL2;ARHGEF18;ARL3;ERAS;RGL1;MAPK11;PRKD1;ARHGAP1;RRAGC;NUCB1;RALGDS;RALBP1;PLD2;RIT2;RASSF1
prerank,cortical cytoskeleton organization (GO:0030865),0.34802043836293417,1.4383598557533097,0.043478260869565216,0.14066534326018199,1.0,16/41,19.47%,RHOB;RND2;EPB41L3;RAC1;RHOA;NCKAP1L;RHOQ;RHOC;NLGN1;RAB13;PPP2R3C;FHOD3;LLGL1;RHOG;FHOD1;RHOBTB1
prerank,regulation of calcium ion import (GO:0090279),0.3920947542962099,1.4380952971895526,0.09090909090909091,0.14070912156286272,1.0,7/24,9.80%,PLN;LGALS3;PRNP;PKD2;CCL2;PDGFB;SLN
prerank,cellular response to growth factor stimulus (GO:0071363),0.2523834620285932,1.4377673646182882,0.0,0.14059442953770473,1.0,30/153,10.12%,RAP1A;TMEM100;STMN2;CILP;PDE2A;DUSP22;MAPT;HSPB1;ZFP36L1;INPP5K;MAPK7;SIRT2;MAPK14;DUSP3;NOS1;ZFP36;BMPR1A;CLEC3B;CCL2;SMAD7;EGFR;DAB2IP;PDE3A;RAMP2;CORO1B;PDGFB;PRKD1;SMAD4;FLT4;SFRP1
prerank,spliceosomal complex assembly (GO:0000245),0.3223145235197682,1.4376699078957886,0.0,0.1403223651315522,1.0,12/45,11.68%,SRSF5;LUC7L2;CELF6;DDX39B;SRPK3;LUC7L3;SF1;CELF2;CELF4;LUC7L;SF3B1;RBM5
prerank,modulation of chemical synaptic transmission (GO:0050804),0.281666529509543,1.4369814525785691,0.0,0.14057668216675645,1.0,33/109,13.71%,NPTX1;PTEN;NLGN2;GRIK5;ATP1A2;CPLX3;NPTXR;NGF;NPAS4;STX1B;NLGN4X;LGI1;CHRNB4;RIMS3;DLG4;PSMC5;GRIK3;LRRC4C;TMEM108;SLC8A2;NLGN1;SYN1;NLGN3;APP;SYT1;GRIK2;MEF2C;ARC;KCNMB4;CDH2;TPRG1L;NTF3;PXK
prerank,fatty acid transport (GO:0015908),0.41023153527225387,1.4363062587521092,0.14285714285714285,0.1407250458285866,1.0,6/20,9.92%,PPARD;FABP4;CD36;CPT1B;SLC27A3;SLC27A1
prerank,organelle transport along microtubule (GO:0072384),0.4242237703864597,1.4360252733984162,0.10714285714285714,0.1406113695002977,1.0,7/28,8.52%,DYNC1I1;MAPT;UBB;HAP1;RHOT2;TRAK2;PAFAH1B1
prerank,negative regulation of catalytic activity (GO:0043086),0.3996826322854835,1.4359780101721245,0.0,0.14034175662197587,1.0,14/26,21.86%,PLN;TMBIM1;NOS1;HDAC6;PPP1R12A;SERPINA5;OXA1L;SLN;MT3;CAMK2A;SIRT1;CLN3;IFIT1;NES
prerank,regulation of protein targeting to membrane (GO:0090313),0.3677182655336921,1.4355432903048215,0.0,0.14028150765336012,1.0,12/29,16.69%,PRNP;INPP5K;KCNB1;MYO1C;MTCL1;SLC51B;GDI1;MIEF2;ITGB1BP1;ANK3;DMTN;MFF
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.33905934396757365,1.4346418087327275,0.0,0.14079259457619633,1.0,13/52,11.03%,CLIP3;SORBS1;ATP2B4;LGALS3;CNPY4;PIK3R1;NUMA1;GPER1;EGFR;RAMP3;STAC;STAC2;GNAI1
prerank,hemopoiesis (GO:0030097),0.2910640242932927,1.4340006665636533,0.0,0.1408869848916805,1.0,24/94,10.49%,CD34;YJEFN3;MEIS1;ATF4;KIT;FSTL3;KITLG;MFAP5;RRAS;FLCN;TOX;TPO;FST;TIRAP;TGFBR3;FGFR2;FLT3LG;KIRREL3;SBDS;PDGFB;FLT4;SFRP1;SNRK;TAL1
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.4262281776511034,1.433643895076554,0.09375,0.14082590943471135,1.0,5/16,14.90%,FSTL3;FST;SMAD7;CSNK2B;SKI
prerank,ceramide catabolic process (GO:0046514),-0.5114944823606007,-1.4326280808344305,0.05405405405405406,0.3259458977921554,1.0,6/16,18.28%,ASAH2;ASAH2B;NEU1;GLA;ACER2;HEXB
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.44283865011652523,1.4323564118421743,0.08,0.14189948118981077,1.0,7/16,18.09%,PDE9A;HAND2;MEF2A;CAMK2D;PRKCA;NR4A3;SLC9A1
prerank,regulation of kinase activity (GO:0043549),0.2912589797787438,1.4318771591658817,0.0,0.1420421795958448,1.0,20/93,9.90%,TSPYL2;EPHA7;FGFR1;DDR2;KIT;MAPT;ROR2;CDKN1C;PIFO;FGFR2;TIE1;PDGFRA;EPHA4;EGFR;SOD1;LDB2;LMO4;ANKRD54;FLT4;ROR1
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.3234479281051334,1.431563073392276,0.047619047619047616,0.14192758497219338,1.0,5/35,3.89%,GNAO1;PPP3CB;CALM1;FZD4;GNG2
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.3483054460649511,1.4314257894890718,0.043478260869565216,0.1416598612793877,1.0,12/51,9.48%,CLIP3;SORBS1;ATP2B4;LGALS3;CNPY4;PIK3R1;GPER1;EGFR;RAMP3;STAC;CNST;STAC2
prerank,response to organophosphorus (GO:0046683),-0.506068953541984,-1.4313672520770648,0.04225352112676056,0.327092904429733,1.0,6/16,14.52%,RFC3;DUOX2;STAT1;VGF;CITED1;DUOX1
prerank,macrophage differentiation (GO:0030225),-0.5175247588452616,-1.430959948546565,0.05555555555555555,0.3264194423094905,1.0,4/15,16.38%,CSF2;IFNG;MMP9;BMP4
prerank,cardiac ventricle morphogenesis (GO:0003208),0.32841685335251963,1.430702030792625,0.0,0.14226203591805672,1.0,16/44,13.10%,TPM1;FOXF1;HEY1;HAND1;TGFBR3;FGFR2;BMPR1A;SMAD7;RBPJ;MYL2;NPY2R;MYH7;CPE;MEF2C;MYL3;HEY2
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.269044113543142,1.4294903705437496,0.0,0.14270855960751253,1.0,51/173,17.94%,PTEN;PIP5K1C;AGPAT1;PLA2G5;PLA2G4B;ABHD4;INPPL1;FGF2;INPP5K;PI4KB;LCAT;PITPNM2;PLD6;PIK3R1;CHKB;MTMR9;PLA2G1B;CDIPT;PIP4K2B;GPD1L;DGKG;CSNK2B;PIK3R3;DDHD2;PI4K2A;SLC27A1;PLA2G4C;AGPAT4;BMX;INPP5E;SLC44A2;DGKE;CSNK2A2;ABHD8;PLEKHA4;DGKB;PLA2G4A;LPIN1;ETNK2;PLD2;PIP4K2A;RUFY1;PCYT1A;INPP5F;CDS2;PITPNM3;INPP5J;PISD;ABHD3;LPCAT4;ARF1
prerank,maturation of LSU-rRNA (GO:0000470),-0.46731758189882566,-1.428659435742589,0.04878048780487805,0.3308256573202529,1.0,11/25,27.98%,WDR12;BOP1;NIFK;URB1;MAK16;PES1;RPF2;DDX18;RSL1D1;EIF6;RPL7L1
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.39222248950231237,1.4285778090219547,0.09523809523809523,0.14274611592918235,1.0,9/27,16.81%,GBA2;DBN1;ESAM;BRK1;WDR1;PLEKHG2;PFN2;HCLS1;FCHSD1
prerank,axon extension (GO:0048675),0.3984564315347143,1.4283205167435293,0.045454545454545456,0.14273274651740672,1.0,8/23,12.45%,NRP2;PPP3CB;ULK1;ULK2;SLIT3;NLGN3;SEMA3A;MAP1B
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.343635880221367,1.4281685006314306,0.09523809523809523,0.1426181452289116,1.0,9/32,12.48%,PTEN;DBN1;EPHA4;KIF1A;ZDHHC15;NLGN1;CAPRIN2;BHLHB9;ARC
prerank,myeloid cell development (GO:0061515),0.41134716223813333,1.42787524487848,0.03571428571428571,0.14255458550194788,1.0,7/19,18.03%,KIT;NCKAP1L;ZNF385A;APP;ANXA2;DMTN;NRROS
prerank,cellular response to alkaloid (GO:0071312),0.4421079523097444,1.4266884943646008,0.0625,0.14314678719359356,1.0,6/18,11.51%,CASQ2;GSTM2;CASP3;TRPV1;RYR3;SLC8A1
prerank,regulation of signal transduction (GO:0009966),0.26644702291280803,1.4264562467743578,0.0,0.14323327184303203,1.0,59/192,17.48%,TSPYL2;RGS2;IGFBP6;CLU;WWTR1;YJEFN3;NCK1;PRNP;NCAM1;ILK;LIFR;GNG7;RGS11;USP20;TMEM204;IGFBP4;CD63;RGS5;FGFR2;TULP3;SOCS2;CD36;PXN;IFT81;ZDHHC7;FRRS1L;ZFAND2B;ZDHHC17;GRK5;PRKD1;IGFBP5;TMEM108;SLC8A2;INTU;RSPO3;ANKRD54;RFNG;MTCH1;CD24;APP;SNX3;MDFIC;GDF5;CX3CL1;ITGA3;ADCYAP1;GDNF;MGLL;GAS1;ITGB1BP1;SYNJ2BP;FUZ;KCTD8;GIT2;RGS4;SNW1;DLL1;ERBB3;AKR1C3
prerank,positive regulation of leukocyte activation (GO:0002696),-0.5101771887408183,-1.426423475116196,0.04225352112676056,0.3354164363971275,1.0,11/17,31.85%,WNT5A;HSPD1;SPACA3;HAVCR1;CEBPA;THBS1;CRLF2;CD2;CLEC7A;LBP;CD226
prerank,negative regulation of developmental growth (GO:0048640),0.3734224539225793,1.4258255729351765,0.08333333333333333,0.14352017322682237,1.0,13/32,13.80%,PTEN;CDKN1A;ULK1;PTPRS;ULK2;SEMA3G;MAP2;MYOZ1;RTN4;MSTN;WWC3;MT3;BBS2
prerank,epidermal cell differentiation (GO:0009913),-0.40685505553100415,-1.4255691202698855,0.025,0.33652693671772704,1.0,27/52,31.84%,EREG;CDSN;WNT5A;EPHA2;OVOL3;KRT16;DSP;GATA6;SCEL;MED1;EVPL;FLG;ADAM9;HDAC2;USH2A;OVOL1;SPRR1A;ANXA1;CSTA;PITX2;ST14;OVOL2;ERCC2;S100A7;OPN3;SPRR1B;BCR
prerank,regulation of chromosome segregation (GO:0051983),-0.5125149065092471,-1.4253523916451005,0.1,0.33549809435980354,1.0,10/17,26.43%,AURKB;RMI2;RAD18;BUB1;KIF2C;HORMAD1;CSNK2A1;CDC6;MKI67;SMC6
prerank,negative regulation of fat cell differentiation (GO:0045599),0.3750323538062182,1.42424219697424,0.0,0.1442065263262647,1.0,13/36,12.50%,FERMT2;WWTR1;FLCN;SIRT2;ARNTL;ZADH2;GPER1;TRIB2;GPS2;GATA2;SMAD3;BBS12;RUNX1T1
prerank,negative regulation of ATPase activity (GO:0032780),0.447088534076743,1.4222310780612522,0.08108108108108109,0.14583947500816438,1.0,10/16,20.78%,PLN;TLR9;OXA1L;SLN;TSC1;PXK;VCPKMT;PAM16;SIRT1;IFIT1
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),-0.5373710529170377,-1.4217376282857004,0.029850746268656716,0.34247054098811114,1.0,11/17,24.75%,FOXP3;TGFB2;JAK3;TGFB1;HLA-F;APOA2;IL10;IRAK3;LILRB4;XCL1;TNF
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.4322583914309614,1.421655436802561,0.06451612903225806,0.14591931058449056,1.0,8/21,8.84%,MFN2;FOXJ2;MEF2D;FGF2;ADAMTS1;BMPR1A;PDGFB;IGFBP5
prerank,negative regulation of macroautophagy (GO:0016242),0.4122655034307881,1.4200201843022455,0.0,0.1464964076140567,1.0,13/24,24.61%,NRBP2;MTOR;NUPR1;CHMP4A;FEZ2;TSC1;PINK1;TSC2;CHMP4B;LRRK2;UBQLN4;PHF23;MTM1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.3106317737030513,1.4199243604025586,0.0,0.14622689592355473,1.0,18/77,9.88%,RBPMS2;ATP2B4;DAND5;CADM4;FSTL3;EMILIN1;FGF2;CHRD;SPRY1;BMPR1A;SMAD7;GPC1;HHEX;DAB2IP;MMRN2;SMAD4;NBL1;EPN2
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.4059470966175232,1.4194384426435191,0.1111111111111111,0.14625582395788522,1.0,8/23,12.73%,RAC1;OCLN;ARPC2;PIK3R1;MSTN;BRK1;WASF2;AKIRIN1
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.3318347054796096,1.4192953305824891,0.05,0.14598800338893894,1.0,11/32,12.86%,TPM1;HAND1;S1PR1;TGFBR3;FGFR2;SMAD7;ACTC1;MYL2;TCAP;MYH7;MYL3
prerank,regulation of peptidase activity (GO:0052547),-0.47329067073920283,-1.4191081508299057,0.04054054054054054,0.3480980796312645,1.0,11/22,30.03%,PRSS22;CTSH;CAV1;ATP13A2;PSMA3;SERPINB3;CSTB;SERPINB4;CSTA;CST7;EPPIN
prerank,positive regulation of kinase activity (GO:0033674),0.2873132718650901,1.4190892245975422,0.0,0.14567201203961222,1.0,37/111,17.51%,RAP1A;EPHA7;FGFR1;DDR2;CDKN1A;KIT;MAPT;ROR2;MAPRE3;PIFO;FGFR2;TIE1;CCL21;PDGFRA;EPHA4;EGFR;EEF1A2;LMO4;FLT4;ROR1;DUSP19;EPHB6;MMD;PRKAG2;NTRK1;CAMKK1;ADCYAP1;RET;EPHA10;MMD2;RASSF2;SNX9;FGFR3;JTB;EPHA3;ERBB3;DSTYK
prerank,negative regulation of double-strand break repair (GO:2000780),-0.48689150518961105,-1.4190258372840194,0.056338028169014086,0.3465516711040326,1.0,5/25,7.72%,PARPBP;FANCB;OTUB2;HMGA2;RMI2
prerank,positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141),-0.5186699106264516,-1.4186064710626372,0.07894736842105263,0.3461588452120053,1.0,14/18,43.17%,IFNK;IFNG;IFNE;LIF;IFNB1;IFNA1;IFNA21;IFNA4;IFNA7;IFNA10;IFNA14;IFNA17;IFNA2;IFNA16
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.4369136015220665,1.4182893091988062,0.07692307692307693,0.14599729288133556,1.0,3/16,2.97%,DDR2;EMILIN1;EFEMP2
prerank,negative regulation of peptidase activity (GO:0010466),-0.38386691047288024,-1.4180860269873232,0.03571428571428571,0.34608458320903335,1.0,29/63,30.79%,SERPINB5;TIMP1;SERPIND1;SERPINE1;SERPINA4;SERPINA10;SERPING1;SERPINE3;CRB2;SERPINB7;SERPINA7;SERPINA3;AGT;AHSG;KNG1;SERPINB2;SERPINB3;CSTB;GAPDH;HRG;SERPINB1;SERPINB4;CSTA;SERPINC1;FETUB;CST7;EPPIN;SERPINB9;SERPINA11
prerank,regulation of protein sumoylation (GO:0033233),0.41366056415829416,1.4172768032311522,0.07894736842105263,0.14666499447743847,1.0,10/18,14.44%,RASD2;PIAS3;RWDD3;HDAC4;MUL1;PIAS1;CAPN3;SAE1;ZMIZ1;PIAS4
prerank,dendritic cell differentiation (GO:0097028),-0.5023476223714243,-1.4169420700581843,0.0958904109589041,0.34779700975599587,1.0,11/24,24.96%,CSF2;UBD;DHRS2;DCSTAMP;TRPM2;BATF;TGFBR2;IRF8;AXL;LYN;BATF2
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.4683075637442268,-1.4168647207304215,0.0684931506849315,0.34625001362259616,1.0,9/28,17.56%,CDH3;IL1B;CYP27B1;DHFR;SCARB1;IFNG;FGF23;TERT;PIK3CB
prerank,response to glucagon (GO:0033762),0.38635389846962703,1.416540064966262,0.03571428571428571,0.14698674081567514,1.0,11/21,20.06%,ADCY5;PRKAR2B;ADCY4;PRKACA;CREB1;CRY1;ADCY9;ADCY2;ADCY6;PRKACB;GCGR
prerank,carboxylic acid metabolic process (GO:0019752),-0.42564255340755325,-1.4163727775196238,0.02702702702702703,0.3457728644046265,1.0,12/39,16.84%,CYP2S1;MIF;TBXAS1;CYP4F8;SIRT4;LIPT2;GSTO2;ST6GAL1;CYP4F3;SLC2A1;PON3;PON1
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.40634974152636993,1.4157324866496472,0.10714285714285714,0.14725819952655106,1.0,5/15,10.97%,AGTR1;FGF2;NGFR;HMOX1;GATA2
prerank,mammary gland development (GO:0030879),-0.5024662399051023,-1.4156249925825029,0.046153846153846156,0.3462269889866039,1.0,8/23,13.31%,WNT2;TDGF1;WNT7B;CAV1;APLN;PRLR;OXTR;FOXB1
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.5034486949644448,-1.415187733103444,0.0684931506849315,0.3458466358269933,1.0,3/18,0.92%,SULT2B1;SULT1C2;SULT1C3
prerank,regulation of ion transport (GO:0043269),0.31929366195756215,1.4129774849639665,0.14285714285714285,0.149480576330627,1.0,23/78,15.22%,PER1;VAMP2;KCNA5;CHRNA3;SYT11;SNCA;KCNJ8;ITGB3;NOS1;P2RX7;KCNA2;B2M;SYT4;SYT10;SYT5;CA2;SYT1;RAB11B;PXK;GDNF;SYT6;NKAIN4;ANK3
prerank,negative regulation of DNA recombination (GO:0045910),-0.43866313967679094,-1.4129704970249974,0.0641025641025641,0.35012218420935703,1.0,13/40,23.82%,PARPBP;FANCB;BLM;POLR2F;ZRANB3;MSH3;RMI2;MSH6;POLR2D;RIF1;POLR2J;POLR2I;ATRX
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.2360399471442283,1.4121145172328906,0.0,0.14994033720765232,1.0,94/402,14.66%,NFATC4;SORBS1;PSEN1;ATP6V1G2;EPHA7;EFS;FGFR1;NCK1;CHRNA3;MAPK1;NRP2;DDR2;ANGPTL1;MAPK3;SDC2;CAV2;KIT;VEGFB;ROR2;CASP3;SHC2;SHC4;FGF2;ITGB3;FOXO4;RAC1;NGF;PILRB;SIRT2;MAPK14;NGFR;FRS3;RARRES2;FES;FGFR2;TIE1;ARPC2;PIK3R1;PDGFRA;ATP6V1E1;EPHA4;AP2M1;EFNA5;SOCS2;GFRA2;FGF7;RHOA;KL;PXN;EGFR;NCKAP1L;COL4A2;RHOQ;MAPK11;GRB14;RBFOX2;HAP1;PDK2;GH1;PDGFB;PRKD1;ACTB;PIK3R3;BAIAP2;FGF1;SH2D6;FLT4;PDGFD;ROR1;APH1B;ANGPT1;PLAT;GRB10;BRK1;TIAL1;BLNK;AP2A2;EPHB6;WASF2;FGF5;FGF10;TCIRG1;NTRK1;JAK2;ELMO2;NTF3;BCAR3;ADRB2;GIGYF1;RET;ATP6V0E2;EPHA10;ZNF106;VEGFC
prerank,metal ion export (GO:0070839),0.38688866688572965,1.4120969905529148,0.0,0.14962063499612213,1.0,9/31,11.18%,ATP2B4;KCNA5;ATP1B2;KCNH2;ATP1A2;KCNE2;ATP1A3;KCNE4;KCND3
prerank,protein transport (GO:0015031),0.2468352701638184,1.4118943800649015,0.0,0.14954474579053095,1.0,88/358,16.05%,TBC1D1;VAMP2;ARL4D;ATP6V1G2;RAB34;ARRDC4;CLU;RAB6B;SNX15;RAMP1;OPTN;COPZ2;SEC31B;WLS;CHMP3;SNX1;RAB5B;GPIHBP1;RAB3A;VAMP4;DNAJC27;NGFR;VPS45;SGSM2;RAB23;STX1B;STX2;BBS1;TBC1D17;STX12;EVI5L;RABL2B;ATP6V1E1;HDAC6;CD36;HSP90B1;RABGAP1;MCOLN1;RAMP3;SCG2;STX16;RAB28;ZDHHC17;RAMP2;NEURL1B;TICAM2;TXNIP;TRIM23;RAB31;ADPRH;TBC1D25;ARRDC2;GGA3;USP6;ARHGAP1;TBC1D10A;SGSM1;RAB24;SNX33;LMAN2L;RAB13;SGSM3;RAB3C;LRSAM1;GOLPH3;TFRC;PRKCB;GOLGA7;TCIRG1;NAPB;RAB11B;SVBP;ARL6IP5;VPS26B;TBC1D26;RAB8B;RILP;BBS2;ATP6V0E2;ZG16;ANK3;VLDLR;RUFY1;SNX27;RAB5C;STX8;SNX9;RABL2A
prerank,regulation of GTPase activity (GO:0043087),0.24474367392826413,1.4117481104055438,0.0,0.14942079127015748,1.0,59/183,18.37%,RAP1A;BVES;FERMT2;PLXNB3;CCL14;RGS10;CAV2;ASAP3;FLCN;RASGRP2;DVL3;SGSM2;FICD;ARL2;RAPGEF3;TBC1D20;GNB5;EVI5L;F2RL1;CCL21;CCL2;EPHA4;EFNA5;GPSM1;RABGAP1;RSU1;DAB2IP;SOD1;FGD6;MAPRE2;RDX;SFRP1;PRKG1;CCL11;SNX18;CCL13;PIN1;SGSM3;RASIP1;CCL23;NTRK1;CX3CL1;CCL8;RGS1;BCAR3;RALBP1;ADCYAP1;ITGB1BP1;SNX9;FGD1;RAB11FIP2;EPHA3;KLRK1;PLXNB1;NDEL1;CPEB2;SRGAP2;PRTN3;CCL15
prerank,pulmonary valve morphogenesis (GO:0003184),-0.5081907658798561,-1.411735047584301,0.09722222222222222,0.35225612349173907,1.0,4/17,4.16%,STRA6;TBX20;TGFB2;ROBO2
prerank,regulation of blood coagulation (GO:0030193),-0.4714979176888628,-1.4116515930869062,0.039473684210526314,0.3508525584089435,1.0,12/27,20.84%,FAP;SERPINE1;F12;EPHB2;THBD;CAV1;FOXA2;PROC;F2R;KNG1;THBS1;HRG
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.4864553829550329,-1.4114096559466278,0.06944444444444445,0.3497636960434227,1.0,15/18,43.83%,DKC1;RUVBL1;NAF1;SHQ1;CCT6A;CCT2;RUVBL2;CCT3;NOP10;CCT8;NHP2;CCT7;DCP2;CCT4;PARN
prerank,DNA geometric change (GO:0032392),-0.4639204247794093,-1.4101893987584067,0.039473684210526314,0.35171990936153197,1.0,15/25,41.18%,BLM;ZRANB3;DNA2;ASCC3;RECQL4;HMGB3;WRN;HMGB1;ANXA1;PIF1;DHX9;DDX11;HMGB2;RECQL;NBN
prerank,positive regulation of neurogenesis (GO:0050769),0.2791325403914657,1.4099159641645669,0.0,0.15055277317469026,1.0,24/72,19.95%,PLXNB3;MAP6;NUMBL;NPTN;CHODL;NGF;SMARCD3;NGFR;OBSL1;SERPINF1;RHOA;GPER1;CAPRIN2;BHLHB9;CX3CL1;NUMB;SNW1;PLXNB1;SHANK3;TIAM1;SOX8;ZNF335;SLIT2;METRN
prerank,regulation of lamellipodium assembly (GO:0010591),0.37025863213712124,1.4098190753639939,0.037037037037037035,0.1502344797853146,1.0,15/33,20.86%,PLXNB3;RAC1;OCLN;CAPZB;ARPC2;PIK3R1;MSTN;BRK1;WASF2;AKIRIN1;DMTN;TWF2;SLIT2;FER;ABI2
prerank,regulation of innate immune response (GO:0045088),-0.39608230573376507,-1.4093467009625973,0.0449438202247191,0.3524917235402078,1.0,29/62,33.42%,LRP8;EREG;TNFAIP3;GBP5;IFNK;ABCE1;XIAP;USP18;POLR3B;LYAR;FPR2;POLR3C;ADAM8;IRAK3;POLR3G;IFI16;NMI;ERAP1;TKFC;SAMHD1;IFNB1;PTPN11;CCL5;DHX9;PLSCR1;AKIRIN2;IFI35;TLR8;PTPN22
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.2967645355937167,1.4091637894122984,0.0625,0.1504464238330464,1.0,19/75,10.97%,PLXNB3;FGFR1;NRP2;AGTR1;VIP;VEGFB;THBS4;FGF2;ITGB3;HMOX1;EGFL7;SCG2;PDGFB;PRKD1;ZNF580;FLT4;ARNT;CCL11;GATA2
prerank,negative regulation of axonogenesis (GO:0050771),0.39979947254845005,1.4091085400411991,0.11764705882352941,0.1502256546951817,1.0,10/28,8.74%,PTEN;ULK1;PTPRS;ULK2;SEMA3G;NGFR;MAP2;RHOA;RTN4;GDI1
prerank,negative regulation of viral genome replication (GO:0045071),-0.39330577595823935,-1.4086833202370403,0.045454545454545456,0.35242272974534045,1.0,10/51,6.65%,IFITM3;IFITM1;IFITM2;OAS2;PROX1;SRPK1;BST2;HMGA2;ISG15;MX1
prerank,mitotic cell cycle phase transition (GO:0044772),-0.3352556203142106,-1.4072691244506377,0.0,0.35463717217224494,1.0,58/207,20.23%,MYC;CCND1;INHBA;DBF4;CEP72;CDKN3;CDK1;SKP2;PHLDA1;TACC3;CEP250;NEK2;E2F1;CCNO;UBE2C;CDC25C;CHEK2;TRIM71;CDKN2A;USP37;MASTL;SPDYA;CCNI2;AJUBA;CCNE1;UBE2S;E2F3;CDK4;HAUS7;ANAPC1;PKMYT1;CCNF;AURKA;RCC1;CDK7;FOXM1;PLK1;HAUS6;USP26;SPAST;CEP76;CDC7;CEP152;CEP78;CRLF3;EIF4E;CENPJ;TAF2;CCNJ;CEP41;SDCCAG8;CKAP5;USH1C;ALMS1;NDE1;EIF4EBP1;PLK4;CDC25A
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.34384674157663514,1.4072216356976355,0.0,0.1513943125464172,1.0,13/40,11.13%,FXYD6;FXYD1;OSR1;SLMAP;SCN3B;SCN2B;SCN1B;GPD1L;CAMK2D;FXYD7;FGF12;SCN4B;DMD
prerank,regulation of DNA recombination (GO:0000018),-0.44895576425761596,-1.4068540654140396,0.075,0.35402795320820823,1.0,15/31,31.34%,CHEK1;BLM;RAD51AP1;ZRANB3;MSH3;FIGNL1;IL7R;MSH6;ALYREF;IL10;PPP4C;KPNA2;SMARCAD1;ZNF365;KDM1A
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.415596542308007,1.4067767293366702,0.1,0.15131581861732255,1.0,6/20,12.73%,JAM3;MAPK1;MAPK3;RARRES2;MSTN;AKIRIN1
prerank,positive regulation of fibroblast proliferation (GO:0048146),-0.45200302566068584,-1.4065967874195022,0.04225352112676056,0.3531596984641815,1.0,8/28,7.59%,MYC;WNT2;EREG;MIF;E2F1;WNT5A;FN1;CDK4
prerank,mitotic nuclear division (GO:0140014),-0.3834933738119849,-1.4061477579885002,0.02247191011235955,0.35270867549171525,1.0,34/68,31.65%,KIF18A;KIF2A;NDC80;CENPK;UBE2C;SMC4;CHEK2;KNSTRN;DSN1;SPAG5;UBE2S;ZWINT;TPX2;PLK1;KIF18B;SPAST;MZT1;ESPL1;KIF3B;PIBF1;NDE1;RAN;SMC1A;NCAPG2;STAG1;ZW10;NSL1;NUP62;KPNB1;STAG2;KIFC1;TUBG1;KIF25;CDCA8
prerank,regulation of cell size (GO:0008361),0.40052268813919745,1.4058508650419963,0.07692307692307693,0.1518574795619009,1.0,6/23,10.77%,PTEN;RAC1;MTOR;RHOA;RDX;DEPTOR
prerank,regulation of cell cycle process (GO:0010564),-0.36943080737272693,-1.4047094007693104,0.011111111111111112,0.35453334244128454,1.0,29/104,15.28%,DBF4;CHEK1;KIF20B;KIF20A;CEP250;NEK2;TIPIN;FBXO5;CDC25C;KNSTRN;SOX9;SND1;RACGAP1;SPAG5;HMGA2;AURKB;RMI2;BCL2L1;PKMYT1;SIX3;AURKA;RCC1;BUB1;ECT2;HORMAD1;PLK1;RAB11FIP4;BIRC6;PRPF40A
prerank,positive regulation of double-strand break repair (GO:2000781),-0.4382436721395379,-1.4042139683088533,0.0759493670886076,0.3543702193235788,1.0,13/32,28.75%,FANCB;RAD51AP1;TIMELESS;PRKDC;FOXM1;ACTR2;FUS;RIF1;DTX3L;ERCC6;ARID2;SPIRE2;WRAP53
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.47931887232072523,-1.4037522973587218,0.06329113924050633,0.3540352996437983,1.0,8/18,18.52%,PPAT;PAICS;GART;HPRT1;ATIC;GMPS;NT5C2;AMPD3
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.433597724653826,1.4037272749258956,0.03571428571428571,0.15358636434771558,1.0,5/18,5.85%,TARDBP;YBX3;MAPK14;TIRAP;ZFP36
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.4355779024987774,-1.4035586946848866,0.041666666666666664,0.3529271859382878,1.0,12/25,24.75%,THY1;IL1B;SKAP1;IL1RN;CD44;CEACAM6;BMP7;IL10;FGA;FGB;LCK;TNF
prerank,regulation of cell junction assembly (GO:1901888),0.36683530208930093,1.4034075712117173,0.1,0.15364623511655204,1.0,7/27,12.43%,RAP1A;CLDN5;MYO1C;OCLN;PRKACA;FLOT1;MEF2C
prerank,regulation of organelle organization (GO:0033043),0.30828179007384293,1.4032844980792423,0.09090909090909091,0.15342156744135613,1.0,30/76,21.22%,MAPK1;CLIC4;PDE2A;SYT11;SYDE1;NEXN;MAPK3;MAPT;VPS11;MUL1;RHOT2;RDX;TBC1D25;RBSN;SPATA4;GOLPH3;CAPN2;MIEF2;PARL;MFF;SQSTM1;PISD;PLXNB1;SCARB2;RAB33B;EP300;CLN3;SAR1A;PINK1;MYO5A
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.5287505614665172,-1.4032331268055402,0.08955223880597014,0.35240107118189495,1.0,7/15,28.54%,IL23A;IL23R;IL12B;HLA-F;AXL;KLRC2;TYROBP
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.48757829598421926,-1.4019026458817063,0.05263157894736842,0.35413074553050927,1.0,12/22,29.78%,MAD2L1;FBXO5;KNTC1;ZWINT;BUB1;PLK1;TRIP13;CENPF;CDC20;BUB1B;ZW10;TTK
prerank,positive regulation of ion transport (GO:0043270),0.31108659965431884,1.4018503648399863,0.0,0.15428534747123165,1.0,16/50,16.13%,FHL1;MYLK;ANK2;SCN3B;P2RX7;SCN1B;GPD1L;WFS1;AHCYL1;CACNB2;SCN4B;TRPC6;ACTN2;GDNF;ANK3;CNKSR3
prerank,pre-replicative complex assembly (GO:0036388),-0.3892836573543641,-1.4015522425363665,0.03488372093023256,0.3532351117849649,1.0,27/64,30.89%,ORC6;MCM4;PSMB9;PSMD14;MCM7;MCM3;CDT1;MCM5;MCM2;PSMA3;MCM6;CDC6;PSMB3;ORC2;PSMA5;PSMD12;PSMB11;PSMB2;MCM8;PSMA7;ORC5;ORC1;PSME2;PSME3;PSMC1;ORC3;PSME4
prerank,regulation of cytoplasmic translation (GO:2000765),0.4361836175479325,1.401018749739672,0.09090909090909091,0.15448495536137447,1.0,7/15,18.30%,RBM24;CPEB1;YBX3;ZNF385A;CNBP;CPEB2;CPEB3
prerank,positive regulation of blood coagulation (GO:0030194),-0.4970032168318001,-1.4010159835614442,0.07575757575757576,0.3534772657623326,1.0,9/17,30.30%,SERPINE1;F12;THBD;F2R;PLG;THBS1;HRG;F2;HPSE
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.3940588152371586,1.4007668636191275,0.0625,0.1544953868414451,1.0,16/34,16.31%,ATP2B4;FGF2;STARD13;MEOX2;RHOA;HDAC5;MMRN2;CSNK2B;TBXA2R;MEF2C;MECP2;ITGB1BP1;AGTR2;KLF4;ANGPT4;RGCC
prerank,regulation of wound healing (GO:0061041),-0.4073534518986178,-1.4005903235649924,0.02857142857142857,0.3530421646598836,1.0,13/47,11.67%,CLDN1;PLAU;SERPINE1;EPPK1;CASK;EPHB2;REG3A;TNFAIP3;DUOX2;CAV1;FOXA2;INSL3;F2R
prerank,barbed-end actin filament capping (GO:0051016),0.4292595968034311,1.4003942810572123,0.06896551724137931,0.15423475630586145,1.0,4/19,5.41%,GSN;ADD1;FLII;CAPZB
prerank,actin filament capping (GO:0051693),0.4292595968034311,1.4003942810572123,0.06896551724137931,0.15423475630586145,1.0,4/19,5.41%,GSN;ADD1;FLII;CAPZB
prerank,regulation of MAPK cascade (GO:0043408),0.24394394259060667,1.400074273472992,0.0,0.15443282858944327,1.0,39/162,14.21%,EPHA7;FGFR1;LPAR1;MAPK1;MAPK3;CAV2;KIT;MYOC;ROR2;FAS;RRAS;FGF2;DUSP3;FAM83D;ADRB3;TGFBR3;FGFR2;PRDM11;P2RX7;GPER1;EGFR;CEACAM1;DAB2IP;ZDHHC17;TLR9;PDGFB;YWHAZ;FLT4;ROR1;CD24;ADRA2B;DUSP19;MAP2K2;FGF10;NTRK1;CX3CL1;BCAR3;ADRB2;RET
prerank,cellular amide metabolic process (GO:0043603),-0.3612844041470548,-1.399846210150626,0.06741573033707865,0.35356322289186115,1.0,35/105,21.64%,MTHFD1L;CPZ;MME;NLN;BAAT;ACSL6;CPN1;DHFR;MTHFD1;THEM5;PLA2G4E;SHMT2;HLCS;MIPEP;ABCA12;SLC5A6;CPD;ASAH2;VNN3;ST6GAL1;ACSM6;VNN1;ACSM4;ENPP7;MTHFD2;FUT7;ACOT6;SLC19A1;SMPD2;SLC46A1;PANK2;MCCC2;PM20D1;ACOT12;PCCA
prerank,establishment of mitotic spindle localization (GO:0040001),-0.4270244056576243,-1.3995731340108195,0.04285714285714286,0.35282457834496495,1.0,10/29,19.20%,MAD2L1;CENPA;NDC80;SAPCD2;SPDL1;GPSM2;PKHD1;PLK1;ESPL1;NDE1
prerank,tight junction assembly (GO:0120192),-0.3928326891605699,-1.3995685817662415,0.04819277108433735,0.3513421221334315,1.0,17/53,16.57%,CLDN1;CLDN2;CLDN16;PARD6B;CLDN14;CLDN20;PECAM1;GRHL2;FRMPD2;CLDN18;ECT2;MARVELD2;CLDN12;POF1B;CLDN6;CLDN24;STRN
prerank,cellular component assembly (GO:0022607),0.24469261702378903,1.3989172831681511,0.0,0.15565753155387183,1.0,47/254,10.67%,LIMS2;FAM107A;SH3BGR;LIMA1;FLNA;FERMT2;GSN;VAMP2;GPM6B;CALD1;FLNC;ADD1;NLGN2;DPYSL3;ILK;WASF1;MITF;PARVA;RHOJ;TTLL3;FAS;RAC1;LAMC1;SKAP2;OCLN;WDR19;TEAD2;NLGN4X;TSPAN4;RHOA;TEAD1;DLG4;NCKAP1L;WASF3;RHOQ;CORO1B;RTN4;RHOU;ST13;YWHAZ;ACTB;BAIAP2;NLGN1;TRAF1;TCAP;CAPN3;NLGN3
prerank,regulation of necroptotic process (GO:0060544),0.39716307599858536,1.3982428515604266,0.07692307692307693,0.15575867131564894,1.0,6/23,14.42%,SLC25A4;YBX3;FLOT1;CFLAR;RIPK1;FLOT2
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.43190275475784795,-1.3975204204730596,0.047058823529411764,0.3557917917865813,1.0,17/39,32.15%,PARPBP;FANCB;CHEK1;RAD51AP1;TIMELESS;FIGNL1;RMI2;ACTR2;FUS;RIF1;PPP4C;ERCC6;ARID2;WRAP53;ZNF365;KDM1A;HELB
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.46332327169330323,-1.3973253910693724,0.05714285714285714,0.3548602656951171,1.0,8/26,8.63%,PPAT;PAICS;ADK;GART;MTHFD1;HPRT1;SHMT2;PNP
prerank,regulation of ATP metabolic process (GO:1903578),-0.39857959417671357,-1.3969668294964808,0.024096385542168676,0.3542930949836353,1.0,27/53,33.71%,NUP155;NUP37;NUP210;SHMT2;NUP107;BEND3;NUP35;RANBP2;SEH1L;NUP50;NUP205;NUP93;RAE1;NUP88;POM121;NUP43;UQCC2;NUP160;EIF6;NUP62;GCKR;NUP153;NDC1;NUP98;SEC13;ATP7A;JMJD8
prerank,amide biosynthetic process (GO:0043604),-0.4124019315988764,-1.3964757734310957,0.05063291139240506,0.35419504014728936,1.0,23/51,22.41%,SLC25A15;CERS6;PCSK1;SPTLC1;PNPLA1;ASAH2;NMRAL1;CPS1;ASS1;RHD;SLC25A2;RHCE;AANAT;ASMT;ALOX12B;SPTLC2;ALOXE3;SMPD2;NANP;PM20D1;ARG1;SPTSSB;DEGS2
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.39786085616456807,-1.3939973903708243,0.05813953488372093,0.35915827558723845,1.0,16/64,14.48%,CCND1;CDK1;RFWD3;SOX4;GTSE1;PML;E2F1;CDC25C;CHEK2;ARID3A;PRKDC;AURKA;TFDP1;CASP2;E2F8;CNOT1
prerank,regulation of secretion by cell (GO:1903530),0.3177499251867182,1.3928087921194412,0.058823529411764705,0.16097564231125958,1.0,23/54,20.91%,VAMP2;CPLX3;RAB3A;DISP1;CHRNB4;LGI3;HAP1;SYN1;SYT1;RAB13;RAB3C;MEF2C;KCNMB4;RAB8B;RHBDF1;VAMP3;INS;STXBP5L;RAB12;CAMK2A;LLGL1;CPLX2;STX4
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.31085485783181516,1.391989481582529,0.0,0.16143687157020228,1.0,19/57,18.80%,PRRT1;NPTX1;LYNX1;NLGN2;NPTXR;DAPK1;NEFL;DLG4;NLGN1;APP;DLG2;MEF2C;GRIA4;ACTN2;GRIA1;SHISA7;SHISA9;LRRC7;CAMK2A
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.41326114431883226,1.3914498782679727,0.12903225806451613,0.16166461471758772,1.0,9/22,17.80%,CALM1;GPNMB;PDGFB;CALM2;PDGFD;RASSF2;TAOK2;INS;PDGFA
prerank,platelet degranulation (GO:0002576),0.25541102818673783,1.3913629606447524,0.0,0.1615216077236263,1.0,31/122,12.06%,FLNA;TLN1;CLU;ACTN1;CFD;VCL;F8;MMRN1;CYB5R1;VEGFB;CALM1;TIMP3;ITGB3;CD63;RARRES2;ALDOA;CLEC3B;F13A1;CD36;VTI1B;SOD1;PDGFB;PCDH7;ENDOD1;CDC37L1;SCG3;ISLR;APP;SELP;TMX3;WDR1
prerank,regulation of hydrolase activity (GO:0051336),0.2908635133114637,1.391266283783209,0.0,0.1612869103058605,1.0,25/70,20.46%,BVES;PLXNB3;NOS1;EPHA4;EFNA5;RABGAP1;DAB2IP;SOD1;SERPINA5;PAFAH1B1;FGD6;RDX;PRKG1;RASIP1;RALBP1;ITGB1BP1;FGD1;EPHA3;PLXNB1;CDK5RAP3;CAMK2A;SCARB2;CHN1;CRK;OCRL
prerank,regulation of gluconeogenesis (GO:0006111),0.40498486115237337,1.3910014924782965,0.125,0.161375451648804,1.0,11/26,20.24%,ZNF692;CLK2;C1QTNF3;NNMT;PDK2;CRY1;ARPP19;INS;SOGA1;EP300;SIRT1
prerank,negative regulation of cell motility (GO:2000146),0.27673042013553767,1.3901217355152067,0.0,0.1619690713702239,1.0,22/110,6.17%,TPM1;PLXNB3;PTEN;CITED2;ADARB1;CLDN5;DPYSL3;VCL;CLIC4;RHOB;MITF;PODN;DUSP22;RECK;FBLN1;FLCN;DUSP3;NGFR;CHRD;ADORA3;EPHA4;SMAD7
prerank,regulation of brown fat cell differentiation (GO:0090335),0.4132895477928682,1.3900559170009634,0.06060606060606061,0.1617807465284749,1.0,7/18,16.41%,TFE3;FLCN;SOX13;FNDC5;PIM1;ZBTB7B;INS
prerank,nucleocytoplasmic transport (GO:0006913),-0.42548901028627056,-1.3898011399460455,0.0641025641025641,0.3682806150654769,1.0,25/40,40.01%,SMN1;SNRPD1;RSRC1;SNRPF;NXT2;SNRPG;CITED1;NCBP1;NUP205;NPM1;ANP32A;NXT1;SNRPB;GEMIN5;XPO1;NUP98;SNRPE;NEMF;SNRPD3;SNRPD2;NUTF2;RITA1;MALT1;HTATIP2;LSG1
prerank,regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139),-0.5052642415206887,-1.3897403324699111,0.09333333333333334,0.3669393376935793,1.0,14/19,43.17%,IFNK;IFNG;IFNE;LIF;IFNB1;IFNA1;IFNA21;IFNA4;IFNA7;IFNA10;IFNA14;IFNA17;IFNA2;IFNA16
prerank,vasculogenesis (GO:0001570),-0.4221325891585156,-1.3897311459463255,0.0975609756097561,0.3654745894773117,1.0,16/33,26.08%,TBX20;PDGFRB;WNT7B;SHH;ENG;CAV1;APELA;TNNI3;TGFB1;KDR;TGFBR2;SPRED1;NOTCH1;HAS2;RASA1;GLMN
prerank,negative regulation of endopeptidase activity (GO:0010951),-0.37952229683328775,-1.3883976952173989,0.03488372093023256,0.3673942555703318,1.0,23/63,21.97%,SERPINB5;TIMP1;SERPIND1;SERPINE1;SERPINA4;SERPINA10;SERPING1;SERPINE3;CRB2;SERPINB7;SERPINA7;SERPINA3;SORL1;AGT;AHSG;KNG1;SERPINB2;SERPINB3;GAPDH;HRG;IFI16;SERPINB1;CR1
prerank,establishment of spindle orientation (GO:0051294),-0.41600155530888827,-1.3882340800895991,0.027777777777777776,0.3665259696983161,1.0,8/30,11.98%,MAD2L1;CENPA;NDC80;SAPCD2;SPDL1;GPSM2;PKHD1;PLK1
prerank,GPI anchor biosynthetic process (GO:0006506),-0.42727780414272093,-1.3879791545292233,0.060240963855421686,0.3655053501427401,1.0,12/30,29.61%,PIGM;PIGU;PIGW;PIGF;DPM1;PYURF;PIGA;PGAP1;PIGN;DPM2;PIGB;PGAP2
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.43161670979225286,-1.3879026598348045,0.075,0.3642284444839384,1.0,10/28,24.55%,AZGP1;IL23A;CD1A;IL23R;IL12B;CD1B;HLA-F;HLA-G;IL12RB1;XCL1
prerank,bicellular tight junction assembly (GO:0070830),-0.39991571071417226,-1.3877273685204943,0.0625,0.3632777903359681,1.0,16/50,16.57%,CLDN1;CLDN2;CLDN16;PARD6B;CLDN14;CLDN20;PECAM1;GRHL2;FRMPD2;CLDN18;ECT2;MARVELD2;POF1B;CLDN6;CLDN24;STRN
prerank,negative regulation of kinase activity (GO:0033673),0.2975079450928005,1.3874676002359818,0.0,0.16342374360766898,1.0,17/58,14.74%,WWTR1;DBNDD2;SNCA;MAPT;HSPB1;CDKN1C;INPP5K;CEACAM1;TRIB2;PRKRIP1;TAB1;DEPTOR;DUSP19;PRKAG2;GNAQ;PPM1F;ITGB1BP1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.48517710754214166,1.387205877797268,0.1,0.1632789308282841,1.0,5/15,12.93%,CASP3;NGF;NGFR;HAP1;NTRK1
prerank,pyroptosis (GO:0070269),-0.48203980927271156,-1.3870961652431777,0.06756756756756757,0.36364644227087023,1.0,11/18,34.43%,GZMB;NAIP;GSDMA;GSDMC;ZBP1;GZMA;AIM2;GSDMB;DHX9;NLRC4;CASP4
prerank,negative regulation of ossification (GO:0030279),-0.46549286492654635,-1.3868916526662973,0.07792207792207792,0.36294078732817603,1.0,11/24,24.24%,KREMEN2;SOX9;LRP4;CCL3;FGF23;AHSG;SRGN;MDK;SMAD6;NOTCH1;CHSY1
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.2998481276839636,1.3868731700369756,0.125,0.163317021633406,1.0,19/77,11.84%,RGS2;UCHL1;PTEN;PKIG;MYOCD;CDKN1C;INPP5K;PRKCD;PRKAR2B;SPRY1;NR2F2;HHEX;SMPD1;DAB2IP;LATS2;TESK1;PKIB;SLC8A1;RASIP1
prerank,regulation of cell killing (GO:0031341),-0.5209422618895216,-1.3859406431674977,0.09090909090909091,0.3636982929895127,1.0,10/17,18.17%,IL11;TGFB2;WNT5A;ICAM1;CR1L;CD55;NOX1;NOXO1;IL10;CYBA
prerank,DNA methylation (GO:0006306),-0.44441420907879114,-1.385415385297834,0.06756756756756757,0.3634905741743092,1.0,11/23,31.38%,DNMT1;DNMT3B;FOS;SPOCD1;BEND3;DNMT3L;ATF7IP;GATAD2A;ATRX;TEX15;HELLS
prerank,negative regulation of phosphatase activity (GO:0010923),-0.4509752000001848,-1.3850257584704888,0.036585365853658534,0.36310370107077794,1.0,15/27,33.52%,TGFB2;MASTL;SEMA4D;SH2D4A;STYXL1;GSK3B;PPP1R35;GPATCH2;PPP1R1B;PPP4R4;BOD1L2;TMEM225;URI1;FKBP1B;PPP1R27
prerank,regulation of cell growth (GO:0001558),0.2570222574497663,1.3849508293823332,0.0,0.16494711398936154,1.0,50/206,14.45%,FHL1;FAM107A;APBB1;TSPYL2;RERG;NPR1;DACT3;AGTR1;CDKN1A;LTBP4;CGRRF1;EGLN2;WFDC1;FLCN;RASGRP2;MTOR;AKAP6;SPOCK1;SLIT3;PRDM11;JADE1;LGI1;SOCS2;CDKN2C;EGFR;CEACAM1;MYL2;DNAJB2;MUL1;RTN4;SMAD4;SIPA1;SFRP1;CAMK2D;CAPRIN2;BAP1;SERTAD3;SMAD3;SGK1;KLHL22;BTG1;USP47;TFRC;SOX17;MT3;N6AMT1;NPPB;OSGIN1;FRZB;BCL2
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.45339987362758993,-1.384652593414759,0.07692307692307693,0.3624883153516095,1.0,15/25,35.07%,TNFAIP3;CARD17;GHRL;LILRB4;NLRP3;SERPINB1;MEFV;GHSR;CARD16;ZC3H12A;IGF1;CX3CR1;PYDC1;APOA1;NLRP7
prerank,cellular response to molecule of bacterial origin (GO:0071219),-0.35927572046828027,-1.3845908206823532,0.024390243902439025,0.3612626976000231,1.0,39/111,24.21%,CXCL8;CXCL1;CXCL2;IL1A;CXCL5;CXCL3;PPBP;CD68;CXCL9;CXCL11;SERPINE1;CD80;IL1B;WNT5A;TNFAIP3;CARD17;CXCL10;PF4;CXCL6;TNIP3;DEFA6;RELA;IRAK1;TNFRSF1B;TNFSF4;DEFA5;PF4V1;IL10;ADAM9;NOD2;IL36B;NLRP3;IL36RN;CD86;HMGB1;PLAA;XBP1;AXL;DEFA1
prerank,negative regulation of stress fiber assembly (GO:0051497),0.4048824028988888,1.3829251077380826,0.13636363636363635,0.1675241011469801,1.0,9/24,12.11%,ARHGAP6;MYOC;INPP5K;PHLDB2;ARHGEF18;PIK3R1;DLC1;WASF2;TMEFF2
prerank,nuclear transport (GO:0051169),-0.5148586268206742,-1.3827791206978557,0.13513513513513514,0.3644880966247652,1.0,10/16,30.05%,HMGA1;RSRC1;NXT2;CITED1;NUP205;NPM1;ANP32A;NXT1;XPO1;NUP98
prerank,positive regulation of macrophage migration (GO:1905523),0.39495859229432706,1.3827645324461004,0.08333333333333333,0.16728166970006225,1.0,7/19,12.98%,MAPK1;MAPK3;RARRES2;MSTN;P2RY12;AKIRIN1;CX3CL1
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.38179395675430505,-1.3813168949398034,0.07317073170731707,0.36743440502271085,1.0,28/56,33.42%,IL1B;IL23A;CD276;ZP3;SLC7A5;IL12RB2;ISG15;IL23R;HSPD1;IL21;ZFPM1;RASGRP1;IL12B;TNFSF4;IL12RB1;CRTAM;IL27;CD2;CLEC7A;TLR7;CD244;IFNL1;CD226;TRIM27;PDE4B;SLAMF6;TLR8;PTPN22
prerank,regulation of axonogenesis (GO:0050770),0.3193571736448338,1.3810780826960178,0.0,0.16902985074626864,1.0,12/51,9.47%,PLXNB3;PTEN;MAP6;CHODL;NGF;NGFR;EPHA4;RHOA;RTN4;GDI1;LRRC4C;BRSK1
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.4870079010805724,-1.3807642770876203,0.09375,0.3674197912373621,1.0,6/15,20.36%,DPEP1;GGACT;CHAC1;ABHD12;CHAC2;ABHD12B
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.36836631277779075,1.3805734618911674,0.05555555555555555,0.16883052752701064,1.0,9/24,13.73%,LTBP4;SMAD2;TGFBR3;SMAD7;LATS2;SMAD4;SMAD3;DKK3;ITGA3
prerank,positive regulation by host of viral transcription (GO:0043923),-0.48454861610865774,-1.3797805442319626,0.08955223880597014,0.36874268463382215,1.0,7/16,27.02%,LEF1;TFAP4;SMARCA4;RRP1B;HPN;SMARCB1;CHD1
prerank,regulation of DNA replication (GO:0006275),-0.4203556016967394,-1.3795039854972735,0.05952380952380952,0.36809475919701196,1.0,14/50,13.86%,BLM;MCIDAS;EREG;DSCC1;ESCO2;FBXO5;ATAD5;USP37;DNA2;S100A11;CDT1;ATR;GTPBP4;ENPP7
prerank,regulation of epithelial cell migration (GO:0010632),0.31808350934679114,1.3793652442864444,0.10526315789473684,0.1704786565904766,1.0,11/51,8.43%,GLIPR2;PTN;RHOJ;CORO1C;GLUL;ENPP2;SASH1;HDAC6;CEACAM1;DAB2IP;RTN4
prerank,endoderm development (GO:0007492),-0.50006489963037,-1.379235076135151,0.0684931506849315,0.3673766141442864,1.0,8/15,19.12%,DUSP4;TBX20;DUSP1;APELA;GATA4;HOXC11;DUSP2;LHX1
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.48201687420806527,-1.3783037352889493,0.13513513513513514,0.3685599532556328,1.0,11/19,32.77%,IL21;RAET1E;RASGRP1;IL12B;HLA-F;CRTAM;CD160;KLRC2;NCR3;CD226;SLAMF6
prerank,response to progesterone (GO:0032570),-0.4688987556300366,-1.3782986862967381,0.041666666666666664,0.3671743895215891,1.0,11/20,29.06%,TGFB2;CAV1;CATSPERB;CATSPER1;TGFB1;CATSPER3;THBS1;ABHD2;CATSPER2;CATSPER4;CATSPERG
prerank,receptor signaling pathway via STAT (GO:0097696),0.3926811283471292,1.3781104987345774,0.07407407407407407,0.1714460077777458,1.0,11/25,17.50%,IFNAR1;PKD2;CCL2;PKD1;SOCS2;CLCF1;PIAS1;STAT6;JAK2;STAT3;GHR
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.3505450959759241,1.3766237360827678,0.041666666666666664,0.17263386685082946,1.0,13/39,16.71%,PER1;NR1D1;TRIM39;ZMYND11;NLRX1;DAB2IP;TLE1;PPM1A;RIPK1;MAPKBP1;NR1H4;PPM1B;RIOK3
prerank,membrane organization (GO:0061024),0.2447527575350457,1.3738275282414716,0.0,0.17489166164497705,1.0,59/240,16.22%,DMPK;BTC;FNBP1;VAMP2;REEP1;SYNGR1;PIP5K1C;TOR1AIP1;MFN2;CHMP3;VAMP4;TMEM43;CORO1C;FZD4;TRIP10;CHRM2;SUN2;ANK2;SYP;PACSIN2;ARPC2;AP2M1;AMPH;UBB;VTI1B;EGFR;DVL2;SUN1;CHMP4A;A4GALT;GLTP;VAPA;IGF2R;ACTB;OXA1L;EPN2;CHMP7;MTCH1;MYADM;AP2A2;SNX3;SYT1;MYOF;CTDNEP1;TFRC;DYSF;AVPR2;VPS4A;CNTN2;AZIN2;ADRB2;SLC18A3;RABEP1;HSPA8;ANK3;NECAP1;SH3GLB1;SNX9;VAMP3
prerank,lymphocyte chemotaxis (GO:0048247),-0.43181689459603323,-1.3737345612340095,0.0136986301369863,0.37706561204678896,1.0,20/41,24.55%,SLC12A2;CXCL11;CCL24;CCL20;CXCL10;CCL22;CYP7B1;CCL4;CCL3;PIK3CG;CCL25;CXCL16;CCL26;CCL17;ADAM8;CCL1;PIK3CD;DEFA1;XCL2;XCL1
prerank,inorganic anion transport (GO:0015698),-0.39705080215476585,-1.3733796621894616,0.0449438202247191,0.3765714016667451,1.0,13/53,9.45%,SLC4A11;RACGAP1;SLC13A4;TTYH3;SLC26A9;CLCN1;SLC34A3;SLC26A8;CLIC3;SLC34A1;CLCN4;BEST1;GLRA1
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.4165673221142509,1.373183488684057,0.043478260869565216,0.17521904686744733,1.0,6/17,10.55%,CLDN5;ADD1;VCL;PPP1R12A;CDH5;TNFRSF1A
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.4597274124113101,-1.3730535316324872,0.06578947368421052,0.3758596705890592,1.0,12/22,32.77%,IL21;RAET1E;RASGRP1;HLA-F;HLA-G;CRTAM;RAET1G;CD160;KLRC2;NCR3;CD226;SLAMF6
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.46216269459334586,-1.3724178439211971,0.12,0.3757408806149198,1.0,8/26,12.71%,BLM;DACH1;ZRANB3;MSH3;ZNF91;ZNF93;MSH6;DNMT3L
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.3954906957565532,1.372178502569051,0.13793103448275862,0.17603574948319595,1.0,6/23,8.36%,UROD;FECH;NFE2L1;ABCG2;ALAD;RSAD1
prerank,negative regulation of chemotaxis (GO:0050922),0.3604961499278506,1.371952052237177,0.10526315789473684,0.17591449354351837,1.0,13/32,14.54%,SEMA4C;SEMA3G;DUSP3;SEMA6C;ELANE;SEMA3B;CORO1B;SEMA3E;SEMA3A;SEMA6D;SEMA3C;SEMA4B;SEMA6A
prerank,regulation of amyloid-beta clearance (GO:1900221),0.4546769275161027,1.3708450996674513,0.14705882352941177,0.17685993450841594,1.0,4/16,5.14%,CLU;MYOCD;SRF;IFNGR1
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.4162613750031583,1.3684202487453512,0.06666666666666667,0.1793979214233558,1.0,8/22,13.19%,RBPMS;WWTR1;CILP;SH2B1;BMPR1A;SMAD4;GDF5;JAK2
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.5376898730526365,-1.3678892806292817,0.08108108108108109,0.3871378105081535,1.0,8/17,21.86%,ETV4;SULT2B1;CYP27B1;ZBED2;MED1;BMP4;SFRP4;IL20
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.43709481238053055,1.3676666103034738,0.07142857142857142,0.1795806176925995,1.0,12/20,20.92%,OR51E2;ATP1A2;GPER1;ATP1A3;TFPI;MGARP;NKX3-1;NR3C1;AKR1C3;UBE2L3;TRERF1;ADTRP
prerank,regulation of small molecule metabolic process (GO:0062012),0.3849285627106167,1.3668100876265248,0.10344827586206896,0.18029261843383032,1.0,16/27,28.16%,FMO5;ACADVL;PDK2;GNB3;BCKDK;NR1H4;EPHX2;RORA;SIRT1;ARV1;ACADL;PDK3;APOE;DGKQ;PDK4;ADIPOQ
prerank,keratinocyte differentiation (GO:0030216),-0.4038601147262341,-1.36663612186201,0.060240963855421686,0.38950627125155834,1.0,20/40,31.84%,EREG;CDSN;WNT5A;EPHA2;KRT16;DSP;SCEL;MED1;EVPL;FLG;ADAM9;EXPH5;SPRR1A;ANXA1;CSTA;ST14;S100A7;OPN3;SPRR1B;BCR
prerank,exogenous drug catabolic process (GO:0042738),-0.47600810167597984,-1.3657561066923238,0.0958904109589041,0.3904043528338192,1.0,10/22,22.63%,CYP2W1;CYP2S1;CYP2F1;CYP2A7;CYP2B6;NUDT15;CYP2D6;CYP2A6;CYP2A13;CYP1A2
prerank,negative regulation of DNA binding (GO:0043392),-0.42613814857307863,-1.3652188117249002,0.09090909090909091,0.39071678916437674,1.0,12/30,26.21%,MSX2;LEF1;E2F1;MDFI;HMGA2;TFAP4;ZNF675;NFKBIA;IFI16;SUMO4;ANKRD33;GZMA
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.36104158274066905,1.3649531675200497,0.0,0.18214800424669084,1.0,11/29,22.18%,TRIM39;MAP1A;CAMLG;UBXN1;RYBP;KLHL40;WAC;BAG6;SGTA;SDCBP;HFE
prerank,regulation of endothelial cell migration (GO:0010594),0.28753853806250285,1.364761334611594,0.0,0.18206035028104453,1.0,21/88,10.39%,PTN;DCN;NRP2;RHOB;RHOJ;RRAS;FGF2;ITGB3;RAC1;GLUL;SASH1;ATOH8;NR2F2;CEACAM1;PTPRM;DAB2IP;PRKD1;ZNF580;FGF1;FLT4;ANGPT1
prerank,phosphatidylinositol metabolic process (GO:0046488),0.25958922054310124,1.364476702864893,0.0,0.1818852092722075,1.0,30/109,17.06%,PTEN;PIP5K1C;PLA2G5;IP6K3;INPPL1;FGF2;INPP5K;PI4KB;PITPNM2;PIK3R1;PLCD1;MTMR9;PLA2G1B;CDIPT;PIP4K2B;PIK3R3;PI4K2A;SLC27A1;PLA2G4C;BMX;INPP5B;INPP5E;PLEKHA4;PLA2G4A;MTMR10;PIP4K2A;RUFY1;INPP5F;PITPNM3;INPP5J
prerank,synaptic vesicle cycle (GO:0099504),0.40686709403462773,1.3644553736910936,0.0,0.18153543002360711,1.0,11/30,12.00%,VAMP2;PIP5K1C;SNCA;CPLX3;RAB3A;SNAP25;SNAPIN;SYT10;NLGN1;BRSK1;SLC17A7
prerank,regulation of trans-synaptic signaling (GO:0099177),0.35120872453985286,1.3636705856519609,0.15789473684210525,0.18197438265336177,1.0,16/35,17.75%,NLGN2;GRIK5;NGF;NLGN4X;PSMC5;GRIK3;LRRC4C;NLGN1;NLGN3;GRIK2;ARC;NTF3;PXK;IQSEC2;GRID1;EIF4EBP2
prerank,GPI anchor metabolic process (GO:0006505),-0.45745046787893473,-1.3630730880278032,0.0410958904109589,0.39468118605524743,1.0,14/26,35.74%,PIGM;PIGU;PIGW;PIGF;DPM1;PYURF;PIGA;PGAP1;PIGN;DPM2;PIGB;PGAP2;GPLD1;PIGO
prerank,drug catabolic process (GO:0042737),-0.45783978750123094,-1.3629419220278616,0.11538461538461539,0.3934907207612704,1.0,10/23,22.63%,CYP2W1;CYP2S1;CYP2F1;CYP2A7;CYP2B6;NUDT15;CYP2D6;CYP2A6;CYP2A13;CYP1A2
prerank,regulation of glucose import (GO:0046324),0.3273166563155389,1.3624383145770647,0.13636363636363635,0.18280459384595812,1.0,12/34,17.55%,SORBS1;OCLN;PIK3R1;PID1;PLA2G1B;RHOQ;PEA15;GRB10;PRKAG2;ARPP19;INS;CREBL2
prerank,positive regulation of fat cell differentiation (GO:0045600),0.3338641832723901,1.3624169052767527,0.0,0.18245506307378612,1.0,22/51,18.55%,PPARD;LMO3;TFE3;ZFP36L1;SOX13;RARRES2;ZFP36;ID2;MEDAG;FNDC5;PIM1;ZNF385A;SFRP1;CREB1;LPL;TMEM64;FRZB;ZBTB7B;INS;CREBL2;SFRP2;ZBTB16
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.30996315089507287,1.3614073433659022,0.0,0.1831507079919043,1.0,9/48,6.28%,LIMS2;FLNA;FERMT2;ILK;MYOC;FBLN1;CORO1C;RAC1;EFNA5
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.3871026688485864,1.3609423848566664,0.08,0.18319254450061093,1.0,7/18,17.80%,RAP1A;RIMS3;SNAPIN;NLGN1;SYN1;RIMS4;VPS18
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.36598569468301617,1.3607773591549162,0.14285714285714285,0.18306090983115778,1.0,9/31,8.02%,FAM107A;PTEN;ARHGAP6;DUSP22;MYOC;APOD;CORO1C;PHLDB2;DLC1
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.5001756571968552,-1.3607731108301384,0.1095890410958904,0.39829957434822927,1.0,7/15,20.31%,GRM8;HOMER1;GRM5;GRM7;TRPM1;GRM1;GRM4
prerank,antibacterial humoral response (GO:0019731),-0.412319946517969,-1.3601153618600021,0.039473684210526314,0.39872180453531164,1.0,20/39,33.27%,DEFA6;WFDC13;RPL39;SEMG1;WFDC10A;RNASE7;DEFA5;SLPI;FGA;FGB;WFDC3;DEFA1;SEMG2;WFDC10B;PI3;LTF;WFDC12;WFDC9;DMBT1;ANG
prerank,positive regulation of dendritic spine development (GO:0060999),0.3459155939312444,1.3600647440338918,0.15789473684210525,0.18331898701066443,1.0,6/22,10.82%,PSEN1;DBN1;CAMK1;NLGN1;CAPRIN2;BHLHB9
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.2757556206371029,1.3592327402971733,0.0,0.18405088957663165,1.0,27/104,10.99%,FERMT2;ATP2B4;FGFR1;KIT;SNCA;CALM1;FGF2;PARP16;PKD2;MAPRE3;CAMK1;PKD1;RHOA;MTCP1;EGFR;DAB2IP;ELANE;GH1;PDGFB;SLC8A2;FGF1;CALM2;PDGFD;SLC27A1;TENM1;CD24;MAP2K2
prerank,regulation of interferon-gamma production (GO:0032649),-0.3564088058651028,-1.3587274944697993,0.044444444444444446,0.401321070481776,1.0,40/84,34.17%,INHBA;FOXP3;IL1B;IL23A;CD276;ZP3;SLC7A5;IL12RB2;ISG15;IL23R;HSPD1;IL21;ZFPM1;RASGRP1;IL12B;TNFSF4;LILRB4;IL36RN;HMGB1;CR1;IL12RB1;CRTAM;AXL;IL27;CD2;XCL1;CLEC7A;PDCD1LG2;C1QBP;ZC3H12A;TLR7;CD244;IFNL1;CD226;TRIM27;PDE4B;SLAMF6;TLR8;PTPN22;CD47
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.44480468748923274,-1.3587053358266132,0.08,0.39993500434785373,1.0,11/26,26.68%,POLR2F;POLR1C;TAF1A;POLR1B;TAF1B;CDK7;POLR1A;GTF2H2;GTF2H3;CCNH;TAF1D
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.2533223999220035,1.358310817221429,0.0,0.18478002502514718,1.0,50/192,16.16%,EPM2A;PER1;ATP2B4;BCL2L2;PTEN;NR1D1;TRIM39;PDE2A;PPP2R5B;ZMYND11;PHLDA3;FLCN;INPP5K;MAPK14;DUSP3;ARNTL;HDAC7;NLRX1;P2RX7;PRKAA2;GPER1;PDE3B;DAB2IP;MUL1;PDE3A;GPD1L;TNFAIP8L1;C1QTNF3;DGKG;PIK3IP1;MSTN;TLE1;MYADM;DEPTOR;ITPR1;PPM1A;PDE4D;SFRP5;TSC1;WWC3;RIPK1;BCL2;WTIP;MAPKBP1;UBE2B;NR1H4;DDIT3;PPM1B;PHLPP2;PDZD3
prerank,regulation of protein kinase activity (GO:0045859),0.2650072979512959,1.3581055329339802,0.0,0.18456038653457327,1.0,29/104,16.00%,TSPYL2;RAP1A;WWTR1;DBNDD2;DDR2;CDKN1A;SNCA;HSPB1;INPP5K;MAPRE3;CCL21;CEACAM1;SOD1;TRIB2;PRKRIP1;ANKRD54;TAB1;DEPTOR;DUSP19;MMD;PRKAG2;GNAQ;CAMKK1;ADCYAP1;PPM1F;ITGB1BP1;MMD2;RASSF2;SNX9
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.4646672624336689,-1.3580040423320654,0.0684931506849315,0.4004410174011502,1.0,13/23,25.20%,SOX9;SIX1;PAX2;LBX2;PAX8;ITGAX;AGT;BMP4;MDK;LIF;LHX1;PIK3CD;EGF
prerank,diol biosynthetic process (GO:0034312),-0.49692264146273796,-1.357711479090491,0.11538461538461539,0.39967745259394477,1.0,7/17,22.08%,SPTLC1;DHFR;ASAH2;ASAH2B;ACER2;SPTLC2;GCH1
prerank,purine ribonucleotide catabolic process (GO:0009154),0.4223705194385719,1.3576927877824263,0.16666666666666666,0.18464201559333404,1.0,7/23,7.37%,PDE2A;NUDT10;PDE9A;NT5E;NUDT11;NUDT16;ACAT1
prerank,positive regulation of cell adhesion (GO:0045785),0.2896141719810109,1.3571289479316992,0.0,0.18485185586807873,1.0,19/79,9.60%,TPM1;CITED2;FSTL3;DUSP26;TFE3;FLCN;RAC1;CHRD;ARL2;CCL21;MEGF10;EPHA4;SMAD7;NCKAP1L;RSU1;P2RY12;PDGFB;FBLN2;VIT
prerank,membrane repolarization (GO:0086009),0.4503126864987776,1.3568512141577227,0.06060606060606061,0.1849326317796518,1.0,6/15,11.18%,ATP1B2;KCNH2;ATP1A2;KCNE2;KCNE4;KCND3
prerank,neuron projection extension (GO:1990138),0.3253442903305512,1.3565409054902549,0.0,0.18471435274077785,1.0,8/32,12.45%,NRP2;PPP3CB;ULK1;ULK2;TMEM108;NLGN3;SEMA3A;MAP1B
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.3238883278568956,1.3557574269277453,0.15384615384615385,0.18505067856140905,1.0,33/79,21.82%,CLIP3;SORBS1;ATP2B4;LGALS3;TMBIM1;CNPY4;PIK3R1;AP2M1;PID1;VTI1B;GPER1;ZDHHC7;EGFR;RHOQ;RAMP3;STAC;ACTB;STAC2;NUMB;VPS4A;ITGA3;STX8;INS;SQSTM1;EPHA3;STX7;RHOG;PRKCE;CLN3;STX4;ITGB1;TMEM59;ZDHHC8
prerank,regulation of cell motility (GO:2000145),0.266179493234497,1.3552242768268963,0.0,0.18538574943494837,1.0,34/129,11.91%,BTC;FLNA;PLXNB3;BEX4;NTN1;RHOB;NEXN;CADM4;AMOTL1;FGF2;FBLN1;RAC1;ENPP2;FES;DAPK3;CCL21;FGF7;SST;RHOA;EGFR;CEACAM1;LDB2;LMO4;PKN1;FGF1;NRG2;CCDC25;ROBO4;RAF1;AMOTL2;TMIGD1;PIN1;SGK1;FGF5
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.40082189163738724,1.3543717635330934,0.0,0.18567713188498533,1.0,8/18,18.54%,EGLN2;DDX17;RBFOX2;PPARGC1B;TRIP4;NCOA4;TADA3;PADI2
prerank,retina homeostasis (GO:0001895),-0.40506576022343965,-1.3540885831393712,0.10975609756097561,0.4093851916663226,1.0,11/34,19.06%,CDH3;CST4;AZGP1;CRB2;POC1B;POTEF;TULP1;ZG16B;ALB;POTEE;LCN1
prerank,microglial cell activation (GO:0001774),0.3871246292197157,1.3524574410391716,0.045454545454545456,0.18715355597435737,1.0,7/22,13.19%,CLU;SNCA;MAPT;IFNGR1;APP;CX3CL1;JAK2
prerank,ribosomal large subunit assembly (GO:0000027),-0.4657681729503618,-1.3519348434325025,0.14666666666666667,0.41343757216064864,1.0,9/24,27.21%,BOP1;BRIX1;NLE1;RRS1;FASTKD2;RPF2;MDN1;DDX28;RPL23A
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.3594252998469365,1.3517208863201873,0.1111111111111111,0.187863407525131,1.0,9/33,11.46%,DUSP26;CALM1;MTOR;PRKCD;SMPD1;DLC1;CDH5;CALM2;PIN1
prerank,regulation of interleukin-1 production (GO:0032652),-0.49359535863196147,-1.350748041657278,0.13043478260869565,0.4156057179871525,1.0,8/16,24.58%,ORM2;F2R;ORM1;NLRP12;IL10;HMGB1;ANXA1;MEFV
prerank,myoblast differentiation (GO:0045445),0.4051426639613235,1.3505896541637823,0.1111111111111111,0.18873944882329927,1.0,5/15,12.78%,SOX15;DDX17;MBNL1;HINFP;EPAS1
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.34773097139958614,1.350396652052109,0.13157894736842105,0.18855908416132386,1.0,14/27,23.74%,ATF4;HSPB1;MAPK7;NME5;TXN;INS;NOL3;PDE8A;SIRT1;PINK1;FBXO7;NFE2L2;LRRK2;SOD2
prerank,chloride transport (GO:0006821),-0.3642202311554434,-1.35012581868159,0.03260869565217391,0.41590939384514714,1.0,30/75,26.35%,SLC12A2;GABRP;SLC12A8;GABRB1;TTYH3;SLC26A9;CLCN1;SLC26A8;CLIC3;GABRD;CLCN4;BEST1;GLRA1;GLRA2;GABRR1;CLIC1;CLCN3;CFTR;GABRE;SLC4A8;SLC12A1;SLC12A5;SLC12A3;GABRB2;GABRA1;SLC26A1;GABRA3;SLC5A1;GABRG3;ANO9
prerank,negative regulation of cellular metabolic process (GO:0031324),0.30735710228030616,1.3493640818194799,0.047619047619047616,0.18972495208768958,1.0,12/38,16.41%,OPTN;PTX3;ITGB3;SIRT2;PLIN5;RIN3;DLG4;NFKB1;MT3;EDNRB;ANKRD13A;INS
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.24790269620656813,1.3491809030755098,0.0,0.18958540836076618,1.0,43/164,13.56%,RAP1A;GLIPR2;FERMT2;CCL14;PLA2G5;MAPK3;P2RY1;ROR2;ACKR3;FGF2;MTURN;HAND2;TIRAP;TNFAIP8L3;FGFR2;F2RL1;CCL21;PDGFRA;CCL2;GCNT2;CD36;GPER1;EGFR;RAMP3;GPNMB;PDGFB;FLT4;PDGFD;ROR1;NECAB2;ANGPT1;NDRG4;CCL11;APP;CCL13;LGALS9;CCL23;FGF10;PRKCA;NTRK1;CX3CL1;CCL8;MT3
prerank,positive regulation of protein import into nucleus (GO:0042307),0.36695166702898807,1.3490611504112966,0.08333333333333333,0.18932069452802083,1.0,11/28,17.96%,FLNA;PSEN1;BAG3;PRKCD;DMAP1;PIK3R1;CHP2;SMAD3;HCLS1;CDH1;EFCAB7
prerank,regulation of endothelial cell proliferation (GO:0001936),0.27951032144222115,1.3488902925483022,0.0,0.18905695212218465,1.0,22/88,10.76%,PLXNB3;NRP2;VIP;CAV2;VEGFB;THBS4;FGF2;ITGB3;PRL;ATOH8;TIE1;NR2F2;EGFL7;PTPRM;SCG2;PDGFB;PRKD1;ZNF580;FLT4;ANGPT1;ARNT;CCL11
prerank,regulation of keratinocyte proliferation (GO:0010837),-0.4535219167521617,-1.348559390998993,0.10975609756097561,0.4182611402817149,1.0,5/24,3.36%,CDH3;AREG;EPPK1;CASK;REG3A
prerank,"DNA-templated transcription, termination (GO:0006353)",-0.3686945552766259,-1.348332361646446,0.07142857142857142,0.4175663867537507,1.0,30/66,30.93%,POLR2F;CSTF2;POLR1C;MAZ;TAF1A;CPSF3;SMN1;POLR1B;TTF2;POLR3K;TAF1B;CDK7;SNRPF;SNRPG;POLR1A;CSTF1;NCBP1;GTF2H2;ZNF473;GTF2H3;CPSF2;CCNH;SNRPB;TAF1D;CSTF3;SETX;CPSF4;ERCC2;SLBP;SNRPE
prerank,embryonic limb morphogenesis (GO:0030326),0.34364640061022644,1.3481808872348398,0.14285714285714285,0.18946203050680663,1.0,16/35,16.53%,OSR1;ECE1;ZNF358;CACNA1C;MYH3;AFF3;MBNL1;GLI3;INTU;FBXW4;HOXA11;OSR2;MEGF8;CYP26B1;SKI;RARG
prerank,regulation of centrosome duplication (GO:0010824),-0.4420021539775173,-1.3475801869662443,0.1232876712328767,0.4184091592880831,1.0,10/30,20.44%,CEP295NL;PKHD1;CHMP4C;CCNF;NAT10;CEP76;CEP295;CENPJ;ALMS1;NPM1
prerank,regulation of interleukin-10 production (GO:0032653),-0.3891342873042022,-1.3470825113529035,0.08433734939759036,0.4181518393511291,1.0,23/46,28.54%,FOXP3;IL23A;JAK3;ISG15;IL23R;HSPD1;SYK;IL12B;PRKCZ;TNFSF4;CD46;NOD2;PIBF1;LILRB4;MMP8;HMGB1;TIGIT;XCL1;CLEC7A;PDCD1LG2;CD28;IL13;TYROBP
prerank,embryonic skeletal system development (GO:0048706),0.3107140310162271,1.346670756082982,0.058823529411764705,0.1906572553905697,1.0,13/34,15.87%,WNT9A;OSR1;PDGFRA;HOXD9;HOXD3;HOXD4;HOXA4;HOXC4;OSR2;DSCAML1;MEGF8;HOXB4;FUZ
prerank,transepithelial transport (GO:0070633),-0.507663553512804,-1.3463212673730305,0.06666666666666667,0.41855514366893415,1.0,5/16,10.95%,SLC12A2;ABCC2;CXADR;BEST1;RHBG
prerank,protein K48-linked deubiquitination (GO:0071108),-0.46109276032219415,-1.346067214038873,0.09333333333333334,0.41786890045167074,1.0,5/22,11.43%,OTUB2;USP50;TNFAIP3;USP37;USP17L2
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.3792633518315362,1.3460410652453412,0.045454545454545456,0.19122428944427375,1.0,11/26,17.09%,TLR3;PJA2;TIRAP;F2RL1;TICAM2;TLR9;RTN4;FLOT1;TLR1;NINJ1;NR1H3
prerank,histone H3 deacetylation (GO:0070932),0.45250762923769605,1.3454517011595941,0.14285714285714285,0.19174774497378644,1.0,3/15,5.27%,PER1;SIRT2;HDAC4
prerank,microtubule depolymerization (GO:0007019),-0.4900089345954323,-1.3450071207144196,0.08955223880597014,0.420030416020742,1.0,9/18,22.05%,KIF18A;KIF14;KIF24;KIF2A;KIF2C;KIF18B;NCKAP5;CKAP5;STMN1
prerank,inorganic anion transmembrane transport (GO:0098661),-0.3616225742495202,-1.3435525791094074,0.05555555555555555,0.4229867714624838,1.0,27/65,30.27%,SLC12A2;GABRP;SLC12A8;GABRB1;CLCN1;GABRD;SLC5A6;GLRA1;GLRA2;GABRR1;CLCN3;CFTR;GABRE;SLC4A8;SLC12A1;SLC12A5;SLC12A3;GABRB2;SLC5A5;GABRA1;GABRA3;SLC5A1;GABRG3;ANO9;GABRA4;GABRR3;SLC37A1
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.3484751779259465,1.3431960898645028,0.0,0.19421685240803135,1.0,13/30,15.87%,OSR1;FGFR2;PDGFRA;HOXD9;HOXD3;HOXD4;HOXA4;HOXC4;OSR2;DSCAML1;MEGF8;HOXB4;FUZ
prerank,glycosaminoglycan catabolic process (GO:0006027),0.3027047769915501,1.3429289360386438,0.0,0.19402982031054786,1.0,21/55,18.09%,PRELP;LYVE1;CSPG4;DCN;SDC2;FGF2;OGN;SDC3;IDS;GPC1;HPSE2;HGSNAT;GUSB;KERA;GPC4;FMOD;GPC3;OMD;HSPG2;SGSH;SLC9A1
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.26574128947822184,1.3420778278193668,0.0,0.19446277406324508,1.0,22/106,12.13%,TGFB1I1;RBPMS2;CILP;DAND5;FSTL3;EMILIN1;SMAD2;CHRD;FST;SPRY1;BMPR1A;SMAD7;UBB;SMAD4;PEG10;NBL1;IL17RD;WFIKKN2;SMAD3;PIN1;SMAD9;PPM1A
prerank,negative regulation of cation channel activity (GO:2001258),0.3496941601680181,1.341879436527991,0.0,0.1943583987937671,1.0,6/26,5.40%,CASQ2;GSTM2;CALM1;CLIC2;PKD2;GNB5
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.4680920813156248,-1.3415561535496008,0.10126582278481013,0.4272901613283401,1.0,8/22,20.75%,DUSP4;DUSP1;DUSP18;PDP1;DUSP9;DUSP16;DUSP2;DUSP6
prerank,negative regulation of JNK cascade (GO:0046329),0.3365728281824344,1.341151887644935,0.09523809523809523,0.19487147275830316,1.0,9/32,13.44%,PER1;ZMYND11;DUSP3;F2RL1;GPS2;MAPK8IP1;NPPA;DUSP19;PDCD4
prerank,regulation of DNA metabolic process (GO:0051052),-0.39950039058271214,-1.3402280978415342,0.07894736842105263,0.4295766242094052,1.0,22/44,32.15%,MYC;TICRR;POLH;KDM1B;TOM1L1;GRHL2;IL7R;CDT1;ALYREF;STOX1;PARG;MPV17;KPNA2;PIF1;SMARCAD1;SMG1;XRCC5;USP1;HDAC8;UBE2N;ZNF365;HELB
prerank,aggrephagy (GO:0035973),0.35172442630158823,1.3400098469356208,0.043478260869565216,0.195793338198168,1.0,11/28,23.14%,DYNC1I1;MAP1LC3C;HDAC6;UBB;UBE2V1;VIM;DYNC1LI2;SQSTM1;DYNC1I2;WDR81;DYNLL2
prerank,synapse assembly (GO:0007416),0.28232009332540653,1.3393359255504682,0.0,0.1960970348323052,1.0,27/69,21.67%,PTEN;NLGN2;GPM6A;DNER;NPAS4;OBSL1;NLGN4X;KIRREL3;LGI2;NLGN1;PCDHB4;NLGN3;CDH2;NRXN2;CDH1;SDK1;PLXNB1;SHANK3;FZD1;PCDHB5;NRXN1;DVL1;FGF13;RAB29;PCDHB6;GABRG2;ADGRL3
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.47253753701479406,-1.3390980933598668,0.08333333333333333,0.43149152699070503,1.0,11/15,33.88%,MTHFD1L;IRX5;SIX1;MTHFD1;TGFBR2;LHX1;TFAP2A;TWIST1;NIPBL;TGFBR1;EIF4A3
prerank,protein acylation (GO:0043543),0.3249415109943168,1.3389383511624824,0.1875,0.19611322485067248,1.0,9/37,10.87%,ING4;KAT2B;GLUL;KAT2A;ZDHHC7;ZDHHC17;ZDHHC15;ZDHHC22;ZDHHC18
prerank,phospholipid dephosphorylation (GO:0046839),0.34145182057280155,1.3382851986987236,0.13636363636363635,0.1965786327514295,1.0,15/26,24.91%,PTEN;INPP5K;MTMR9;INPP5B;MTMR10;EPHX2;INPP5F;INPP5J;MTMR11;OCRL;SGPP1;MTMR12;SYNJ1;MTM1;SACM1L
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",-0.3665349911397543,-1.3381433096056352,0.09876543209876543,0.43292768275224147,1.0,12/61,14.50%,CCND1;CEBPB;CDK1;LEF1;CDKN2A;SOX9;CBFB;CDK4;RELA;MED1;MED13;MED14
prerank,neutral amino acid transport (GO:0015804),-0.4526307992050824,-1.3380365722247607,0.0821917808219178,0.4316787657143605,1.0,7/28,8.94%,SLC6A20;SLC6A14;SLC7A5;SLC6A6;SLC38A5;SLC1A5;SLC1A4
prerank,regulation of biomineral tissue development (GO:0070167),-0.44708949859928937,-1.3376872938301025,0.10810810810810811,0.431121340027547,1.0,9/25,16.27%,NOTUM;CEBPB;CYP27B1;FBXO5;SOX9;BMP2K;ANKH;TGFB1;AHSG
prerank,protein-DNA complex disassembly (GO:0032986),-0.4667261667878922,-1.3371399157283204,0.07142857142857142,0.43124851375142503,1.0,9/18,28.52%,MYC;HMGA1;SMARCA4;SET;SMARCC1;SMARCB1;NFE2;ARID2;GRWD1
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.39205363577235985,1.3360232629733348,0.16666666666666666,0.19871395369837314,1.0,7/22,7.78%,PTEN;CDKN1A;MYOCD;CDKN1C;NR2F2;HHEX;LATS2
prerank,cellular response to organic cyclic compound (GO:0071407),0.2693894661264307,1.3359571335524383,0.0,0.1984811995400206,1.0,51/148,16.72%,RAP1A;ADCY5;PDE2A;AQP1;P2RY1;ATP1A2;CASP3;ZFP36L1;INPP5K;GNG2;PKD2;AKAP6;FES;RAPGEF3;CCL2;P2RX7;HSP90B1;GPER1;EGFR;RAMP3;PDE3A;AQP8;TRPV1;ATP1A3;P2RY12;PDGFB;RYR3;IGFBP5;CYP1A1;ACTB;SFRP1;GNAI1;TFPI;MGARP;MEF2C;NKX3-1;GOLPH3;P2RY11;ARL6IP5;ADCY2;GPBAR1;NCOA4;HCN3;ADCY6;NR4A3;NR1H4;SLC26A3;CDH1;DMTN;RIOK3;NR3C1
prerank,establishment of vesicle localization (GO:0051650),0.4017906562547974,1.3358895361105634,0.09375,0.19820865031329563,1.0,5/18,9.17%,SYT11;KIF5A;KIF5C;SNAPIN;TESK1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.45281752509448875,1.335496012132933,0.14285714285714285,0.19838314923045616,1.0,5/15,11.18%,KCNA5;KCNH2;KCNJ8;KCNE2;KCND3
prerank,inflammatory response (GO:0006954),-0.31556826747629557,-1.335154229648921,0.02,0.43656316489616037,1.0,83/227,27.12%,CXCL8;CEBPB;CXCL1;CXCL2;IL1A;CXCL5;CXCL3;PPBP;CXCL9;CXCL11;ADCY1;RIPK2;OLR1;IL1B;CCL24;CXCR4;CCL20;IL1RN;CD44;NAIP;CXCL10;CCL22;TAC4;FOS;PF4;CCL4;MAPKAPK2;CXCL6;SERPINA3;CCL3;CXCR2;RELA;KRT16;PIK3CG;PARP4;NOS2;HYAL3;F2R;ORM1;IFNG;CCL25;TGFB1;MMP25;VNN1;FPR2;NOX1;CHI3L1;CCR3;CCL26;FUT7;CCL17;TNFSF4;IL2RA;PF4V1;ADAM8;PROK2;CYBA;THBS1;CCRL2;HP;CYBB;IL36B;NLRP3;FPR3;CCL1;IL36RN;PIK3CD;HMGB1;PRDX5;LY75;ANXA1;XCL2;XCL1;MEFV;TNF;NFAM1;ITCH;ITGB2;ABCF1;IL22;HPR;IKBKG;XCR1
prerank,vitamin transport (GO:0051180),-0.4118127002360784,-1.3349225991890514,0.10256410256410256,0.4358424023857044,1.0,10/30,21.57%,TCN1;FOLR1;SLC5A6;SLC2A14;TTPA;SLC2A2;SLC52A3;SLC19A1;SLC46A1;SLC52A2
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.37849353059642077,1.3344779284235908,0.037037037037037035,0.19924519736718646,1.0,7/26,14.54%,PSEN1;ITGB3;RAC1;RIN3;DLG4;APP;ANKRD13A
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.25506618556825245,1.334252035466083,0.0,0.19905356078797978,1.0,32/123,17.06%,PTEN;PIP5K1C;ITPKB;IP6K3;INPPL1;FGF2;INPP5K;PI4KB;PITPNM2;PIK3R1;SOCS2;MTMR9;TMEM150A;CDIPT;PIP4K2B;IP6K1;PIK3R3;PI4K2A;SLC27A1;BMX;INPP5E;PLEKHA4;CWH43;FAM126A;PIP4K2A;RUFY1;TTC7B;INPP5F;PIGQ;PITPNM3;PIGH;INPP5J
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.3635179906702511,1.3332869709404094,0.13043478260869565,0.19995170809965288,1.0,13/23,24.91%,PTEN;INPP5K;MTMR9;INPP5B;MTMR10;INPP5F;INPP5J;MTMR11;OCRL;MTMR12;SYNJ1;MTM1;SACM1L
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.4152961418000832,1.3332254754191828,0.17391304347826086,0.19959843653057224,1.0,7/15,17.72%,CSPG4;DCN;UST;CHST14;DSEL;CSGALNACT2;B3GAT3
prerank,response to reactive oxygen species (GO:0000302),0.3082432932601011,1.3326152033727814,0.0,0.19988953041107996,1.0,13/57,8.51%,TPM1;MAPK1;MAPK3;MAPT;APOD;MAPK8;PKD2;HMOX1;PDGFRA;PXN;EGFR;SOD1;PDK2
prerank,regulation of double-strand break repair (GO:2000779),-0.40903911230240136,-1.3307566878595358,0.08536585365853659,0.4470658251351041,1.0,16/38,31.34%,CHEK1;OTUB2;RAD51AP1;PML;TIMELESS;FIGNL1;FOXM1;ACTR2;RNF169;PPP4C;SPIRE2;WRAP53;TWIST1;DEK;ZNF365;KDM1A
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.43152431682335607,-1.3307278403822853,0.09333333333333334,0.44564338817723004,1.0,11/28,18.75%,CHEK1;BLM;CDK1;TICRR;HMGA2;BRCC3;TOPBP1;CDC14C;PLK1;BRCA1;CLSPN
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.33259860738399544,1.3306773743470988,0.058823529411764705,0.20130307671958295,1.0,13/30,18.00%,FAM107A;PTN;SCGN;EPHA4;CALB2;APP;ARC;CYP46A1;SHISA7;INS;NSG1;SQSTM1;SHANK3
prerank,import into nucleus (GO:0051170),-0.3574849012544595,-1.3297034175476554,0.022727272727272728,0.44682290564068516,1.0,42/76,42.31%,NUP62CL;NUP155;CSE1L;E2F3;SYK;SMN1;SNRPD1;NUP107;SNRPF;NXT2;SNRPG;RANBP17;NUP50;MMP12;NUP93;NUP88;RAN;POM121;TNPO3;HEATR3;NXT1;IPO11;SNRPB;NUP62;KPNB1;GCKR;NUP153;GEMIN5;SNRPE;SEC13;SNRPD3;IPO7;SNRPD2;IPO5;NUP214;NUTF2;POM121C;HTATIP2;POM121L2;RPAIN;TPR;GEMIN6
prerank,cellular response to DNA damage stimulus (GO:0006974),-0.3124320999481062,-1.3296467038542767,0.0,0.445604342565013,1.0,89/328,20.46%,MYC;CCND1;EXO1;TP73;CHEK1;RFC3;XRCC2;BLM;RAD51AP1;UBE2T;CDK1;POLE2;TICRR;RFWD3;PML;TDP1;E2F1;CCNK;CHEK2;RAD51B;ZRANB3;TIMELESS;POLH;PRKDC;MSH3;MASTL;SPDYA;TRAIP;MAPK15;RAD54L;FANCF;POLB;SIRT4;DCUN1D5;IKBKE;RECQL4;EPHA2;FEN1;POLA1;LIG1;BCL2A1;RFC5;ERCC8;MAPKAPK2;BCL6;RMI2;FANCL;MCM7;BCL2L1;RAD18;XIAP;NEK4;MCM10;RAD9B;TOPBP1;PARP4;PARP2;MSH6;WDHD1;SUV39H1;CASP2;NUDT1;ATR;RBBP8;BATF;RFC2;TNFRSF1B;FANCA;WRN;CBX3;SLX1A;FANCC;RBBP5;RNF169;TRRAP;ACER2;CTLA4;VCPIP1;BARD1;BRCA1;HUS1;RIF1;CHCHD6;DTX3L;SHPRH;UNG;APTX;NPM1;GTF2H3
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.2707506303553297,1.3290305865784104,0.0,0.20271165449976083,1.0,31/114,12.71%,FERMT2;CLDN5;CILP;PDE2A;DUSP22;ZFP36L1;SMAD2;MAPK7;TGFBR3;HPGD;ARHGEF18;BMPR1A;CLEC3B;GCNT2;SMAD7;RHOA;UBB;PXN;PDE3A;TWSG1;LRRC32;SMAD4;CDH5;WFIKKN2;SFRP1;PARD3;SMAD3;ZMIZ1;SMAD9;MEF2C;GDF5
prerank,response to cytokine (GO:0034097),-0.32433831232247856,-1.329000455002542,0.042105263157894736,0.4461967676434287,1.0,42/147,18.25%,IFITM3;IFITM1;IFITM2;UBD;TIMP1;MME;IRAK2;LAMP3;IL1B;CXCR4;PML;POU4F1;LEF1;CYP27B1;KYNU;BST2;JAK3;ISG15;IKBKE;IL23R;MX1;XAF1;SHMT2;MAPKAPK2;BCL2L1;FOXA2;STAT1;RELA;ASAH2;IRAK1;COL3A1;IL1RL2;CITED1;CHI3L1;CXCL16;ADAM10;NLRP12;FOXH1;NFAT5;PTPN7;ADAM9;POU4F2
prerank,positive regulation of phospholipase C activity (GO:0010863),0.3093209756553287,1.3286247371510937,0.03333333333333333,0.2028358208955224,1.0,11/43,13.61%,FGFR1;LPAR1;KIT;ARHGAP6;FGF2;PDGFRA;EGFR;P2RY12;AVPR1A;GNAQ;NTF3
prerank,endocardial cushion morphogenesis (GO:0003203),-0.467624144524882,-1.3285385262245335,0.12987012987012986,0.44588673814964147,1.0,6/19,16.38%,TBX20;TGFB2;SOX9;ENG;TGFBR2;BMP4
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.2680064499081313,1.3277270705778292,0.0,0.2040372137228026,1.0,19/73,15.54%,NCK1;MAPK1;MAPK3;RAC1;MYO1C;PRKCD;ARPC2;PIK3R1;NCKAP1L;ACTB;BAIAP2;PLA2G6;BRK1;WASF2;ELMO2;WIPF1;PLD2;NR4A3;MYH2
prerank,regulation of adenylate cyclase activity (GO:0045761),0.3793712770299804,1.3270564270322653,0.10344827586206896,0.20447737739369468,1.0,5/22,6.52%,CAP2;PALM;STIM1;CACNA1C;GNAI2
prerank,negative regulation of transposition (GO:0010529),-0.4246088163717101,-1.3266392994981322,0.11940298507462686,0.4497374150264362,1.0,8/24,22.06%,PIWIL1;BTBD18;ZNF91;ZNF93;SPOCD1;APOBEC3F;TEX19;MYBL1
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),-0.41614644203170426,-1.326114888132239,0.1125,0.4495242851920167,1.0,9/34,11.67%,CEMIP;THY1;CXCL9;CXCL11;NPSR1;CXCL10;CAV1;CALCR;F2R
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.4468717272554401,-1.325876661483701,0.13157894736842105,0.4488251518331049,1.0,14/27,34.98%,ALG11;GK;ALG8;ST8SIA6;GCNT1;ALG2;B3GNT5;G6PD;GAL3ST2;ALG6;TPI1;TKT;ST3GAL2;RRM2
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.3011051472973348,1.3257176358324714,0.0,0.2059103564476576,1.0,14/47,13.23%,PER1;MAPK1;MAPK3;FAS;SEMA4C;TGFBR3;F2RL1;EGFR;DAB2IP;MAPK8IP1;MID1;MAP2K2;LGALS9;ARL6IP5
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.46435732347114655,-1.3243441793458441,0.11688311688311688,0.44889517970070686,1.0,11/21,29.78%,MAD2L1;KNTC1;ZWINT;BUB1;PLK1;TRIP13;CENPF;CDC20;BUB1B;ZW10;TTK
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.46435732347114655,-1.3243441793458441,0.11688311688311688,0.44889517970070686,1.0,11/21,29.78%,MAD2L1;KNTC1;ZWINT;BUB1;PLK1;TRIP13;CENPF;CDC20;BUB1B;ZW10;TTK
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.46435732347114655,-1.3243441793458441,0.11688311688311688,0.44889517970070686,1.0,11/21,29.78%,MAD2L1;KNTC1;ZWINT;BUB1;PLK1;TRIP13;CENPF;CDC20;BUB1B;ZW10;TTK
prerank,protein glycosylation (GO:0006486),-0.3340125365853614,-1.324235017372386,0.054945054945054944,0.44776752998926356,1.0,55/126,33.89%,POMK;GALNT6;PMM2;B3GNT4;ALG10;ALG11;ALG1;ALG1L2;MGAT5;FUT8;FUT1;ALG8;RPN2;B3GALNT2;ST8SIA6;MGAT2;GFPT1;STT3B;STT3A;RPN1;MAGT1;ALG5;FUT10;DPM1;PGM3;TET3;POFUT1;FUT7;PLOD3;ALG2;SLC39A8;B3GNT5;B3GNT2;FUT2;B3GNT3;ALG3;TET1;ALG6;TMEM165;DDOST;FUT6;C1GALT1C1;GALNT7;ST8SIA5;COG3;B4GALT7;TET2;NUS1;NPC1;GALNTL5;FUT5;B4GALT1;B3GALT2;ST3GAL2;SERP1
prerank,purine nucleotide metabolic process (GO:0006163),-0.4346361390200253,-1.3240029380575367,0.10144927536231885,0.44714753307032834,1.0,9/24,21.25%,PPAT;GART;MTHFD1;HPRT1;PNP;ITPA;NUDT15;NT5C2;NT5C1B
prerank,mitotic recombination (GO:0006312),-0.5080151409360898,-1.3239948098881813,0.06756756756756757,0.44580377928543824,1.0,8/15,38.13%,RAD54B;MSH3;NSMCE2;SMC6;GEN1;DMC1;RAD51D;SMC5
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.45533410812490704,-1.3230955026506863,0.11688311688311688,0.446955450850331,1.0,9/22,30.89%,ENC1;PSMB9;PSMA3;PSMB3;PSMA5;PSMB11;PSMB2;PSMA7;PSME4
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.4155565777263952,-1.321923372025579,0.1375,0.4489056737903763,1.0,17/29,35.07%,TNFAIP3;CARD17;GHRL;NLRP12;IL10;LILRB4;NLRP3;SERPINB1;MEFV;GHSR;CARD16;ZC3H12A;IGF1;CX3CR1;PYDC1;APOA1;NLRP7
prerank,negative regulation of response to wounding (GO:1903035),-0.4370578192077186,-1.3218922685563732,0.1506849315068493,0.4476513848858652,1.0,5/21,7.75%,SERPINE1;EPPK1;CASK;KLK8;RTN4R
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.4055545060228442,1.3217084783953734,0.07692307692307693,0.21075295331664898,1.0,7/23,7.73%,DYNC1I1;MAP6;KIF5A;TUBA1A;KIF1C;KIF5C;KIF1A
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),-0.3364933102784925,-1.3215113823374125,0.07317073170731707,0.44759573764076716,1.0,26/83,20.44%,CEP72;KIF14;CDK1;GTSE1;CEP250;NEK2;ATAD5;HAUS7;TPX2;AURKA;USP17L2;PLK1;HAUS6;DYRK3;CEP76;CENPF;CEP152;CEP78;CENPJ;CEP41;SDCCAG8;CKAP5;ALMS1;NDE1;PLK4;NPM1
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.48220990576295436,-1.3214910584765027,0.15492957746478872,0.44631233406435233,1.0,10/16,31.40%,FOXP3;IL23A;JAK3;IL23R;IL12B;LILRB4;MMP8;PDCD1LG2;TYROBP;AGER
prerank,regulation of mRNA polyadenylation (GO:1900363),0.40022410722857504,1.3205412876115223,0.09375,0.21217003405055815,1.0,3/17,4.60%,CDK9;CPEB1;CPSF7
prerank,protein O-linked glycosylation (GO:0006493),-0.3487069986772185,-1.3204457958895892,0.075,0.44850573237297364,1.0,41/94,30.49%,POMK;MUC5AC;GALNT6;CHST4;MUC6;B3GNT4;MUC16;TMTC4;B3GALNT2;ST8SIA6;MUC12;C1GALT1;GCNT1;GALNT5;MUC19;MUC17;ST6GAL1;GALNT3;DPM1;PGM3;TET3;POFUT1;PLOD3;MUC5B;MUC4;B3GNT5;B3GNT2;MUC20;B3GNT3;TET1;GALNTL6;MUCL1;MUC3A;MUC15;C1GALT1C1;GXYLT1;GALNT7;DPM2;MUC2;GALNT14;TET2
prerank,visual system development (GO:0150063),0.31744596469559677,1.3198120945028693,0.13636363636363635,0.21283042302532282,1.0,8/41,6.44%,MAB21L2;PBX3;MEIS1;CHRDL1;SALL2;MEIS2;MAB21L1;PBX2
prerank,long-term synaptic potentiation (GO:0060291),0.36102076777257824,1.3193584746730305,0.1,0.213014542887378,1.0,5/21,2.95%,NFATC4;VAMP2;MPP2;TSHZ3;NPTN
prerank,tRNA processing (GO:0008033),-0.3822167603844718,-1.3180532023698857,0.08433734939759036,0.4542048661783855,1.0,23/56,31.78%,POP1;WDR4;CSTF2;ADAT1;RPP40;CDKAL1;DTWD2;METTL1;TRMT6;TSEN2;TRNT1;FARS2;FTSJ1;TRUB1;ANKRD16;AARS2;TRMT10C;CPSF4;TSEN54;NSUN2;TYW5;SSB;ADAT3
prerank,aorta morphogenesis (GO:0035909),0.41049948685903626,1.3178004982163505,0.25925925925925924,0.21430206573756155,1.0,5/17,7.31%,MYLK;HEY1;EFEMP2;BMPR1A;RBPJ
prerank,cellular response to unfolded protein (GO:0034620),0.3418907911603669,1.3177799022079053,0.045454545454545456,0.21401066507712932,1.0,5/26,7.56%,HSPB8;HSPA2;OPTN;BAG3;DAB2IP
prerank,regulation of RNA metabolic process (GO:0051252),0.29349917043610413,1.3166335632803576,0.13043478260869565,0.21501697247971688,1.0,19/63,13.56%,RBM20;MITF;RBM38;PTBP2;NOVA1;CLK1;SNRNP70;HNRNPH3;PCBP3;CLK4;OAS1;MBNL1;PRX;CLK2;PCBP4;HNRNPH2;AKAP17A;AHNAK;CLK3
prerank,mitotic cytokinesis (GO:0000281),-0.39323579202356107,-1.316457006212908,0.10126582278481013,0.4577396371026764,1.0,20/48,25.89%,CEP55;INCENP;KIF23;KIF20A;CENPA;RACGAP1;MYH10;KIF4B;ECT2;PLK1;SPAST;RTKN;ESPL1;CKAP2;ANLN;STMN1;CIT;ROCK2;TTC19;RASA1
prerank,regulation of cellular component organization (GO:0051128),0.255292698226576,1.316425797279832,0.0,0.2148822500658825,1.0,46/137,21.17%,FAM107A;RAP1A;STON1;AGTR1;LTBP4;RAB5B;EGLN2;WFDC1;RASGRP2;MTOR;PIFO;SPOCK1;PACSIN3;PACSIN2;SOCS2;CD36;SLITRK2;CEACAM1;DAB2IP;RAB4B;ANGPTL7;PACSIN1;CAMK2D;BAP1;MARK4;SGK1;TFRC;HSPA8;RUFY1;RIT2;RAB5C;TAOK2;SETD1A;SNX17;PTCH2;CD177;PAPPA2;STK38L;RAB33B;SLITRK4;ARHGEF11;ANKRA2;LAMTOR1;PINK1;IL17RB;RAPGEF1
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.2756269259358295,1.3156891466003862,0.0,0.21533537571035127,1.0,17/72,12.77%,FAM107A;RASD2;BCL10;TSPYL5;PIAS3;RWDD3;HDAC4;DCUN1D4;SMAD7;UBB;MUL1;WFS1;PIAS1;ANGPT1;SAE1;UBE3A;CRY1
prerank,regulation of cellular component movement (GO:0051270),0.3124743356536177,1.315683374385778,0.06666666666666667,0.21496601829060796,1.0,13/49,10.31%,BTC;ACTN1;CADM4;ZSWIM8;TGFBR3;FES;DAPK3;HDAC6;RHOA;EGFR;PKN1;NRG2;RAF1
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.38260890986780693,1.3155516680888022,0.19230769230769232,0.21479305029416562,1.0,7/18,15.78%,NCK1;BCL2L11;PIK3R1;RNF185;TMEM259;BOK;DDIT3
prerank,positive regulation of T cell proliferation (GO:0042102),-0.37380322842658475,-1.3136178208399814,0.13414634146341464,0.46444722803873867,1.0,34/65,37.75%,CD80;IL1B;IL23A;CD276;ZP3;JAK3;IL23R;IL21;SLC7A1;SYK;TNFSF9;PNP;CD70;IL12B;TNFSF4;CD46;CD86;IL27RA;HMGB1;IL12RB1;ANXA1;IGFBP2;PDCD1LG2;CD28;CD6;CCL5;AGER;IGF1;CCDC88B;CD3E;CD274;LILRB2;ZP4;RPS3
prerank,calcium ion transport (GO:0006816),0.2605993234639733,1.313426430598505,0.0,0.21703608147679923,1.0,28/114,12.31%,PSEN1;ATP2B4;CACNA1H;RAMP1;STIM1;ORAI3;PKD2;CACNA1C;ANK2;SLC24A3;CACNA2D1;PKD1;P2RX7;TRPC1;MCOLN1;RAMP3;RAMP2;TRPC4;TRPV1;ATP2A2;RYR3;SLC8A2;SLN;CACNB2;ITPR1;SLC8A1;MCOLN3;TRPC6
prerank,epithelial cell development (GO:0002064),-0.43214665984889555,-1.3129420719214917,0.1111111111111111,0.46496623814596433,1.0,11/21,25.90%,WNT7B;PKHD1;SIX3;GRHL2;POF1B;SIPA1L3;WNT7A;PDZD7;EXPH5;ROS1;RAB25
prerank,focal adhesion assembly (GO:0048041),0.37805065535775356,1.3127250941828248,0.12121212121212122,0.2177157888892768,1.0,8/21,16.34%,SORBS1;FERMT2;ACTN1;DLC1;WHAMM;ACTN2;THSD1;TAOK2
prerank,regulation of neuron projection arborization (GO:0150011),0.4225460965238741,1.3120487822266527,0.037037037037037035,0.21816022770743262,1.0,5/15,10.95%,FZD4;DVL3;DLG4;DVL2;NTNG1
prerank,anterograde trans-synaptic signaling (GO:0098916),0.25399825488571165,1.3114769901592938,0.0,0.2181768011581624,1.0,52/243,12.22%,KCNMB1;PLP1;PMP22;NPTX1;MPZ;NLGN2;CHRNA3;MAPK1;SNCG;SNCA;NTSR1;PENK;KIF5A;PTCHD1;NOVA1;CALM1;DTNA;SYN2;CHRM2;GLRB;RPS6KA2;PRKAR2B;CAMK1;SLC12A4;SNAP25;HTR3A;NLGN4X;CHRNB4;SST;AMPH;SCN2B;DLG4;PRKACA;NPFF;CORT;HAP1;PAFAH1B1;NPY;SYT10;NLGN1;SYT5;PCDHB4;SYN1;CACNB2;NLGN3;SYT1;GABARAP;GRIK2;PDE7B;SNCB;CNP;DLG2
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.41522064652514723,1.3112275107049172,0.19230769230769232,0.21803854385575797,1.0,16/16,58.51%,COX4I2;COX6A2;COX7C;COX6C;COX8A;NDUFA4;COX5A;COX10;COX4I1;COX7A2L;COX15;COX6A1;COX7B;COX5B;CYCS;COX6B1
prerank,positive regulation of cell cycle (GO:0045787),0.29307281347940345,1.3108785860612169,0.0,0.2181325234425852,1.0,20/65,12.85%,CITED2;MEIS2;USP2;CCPG1;DUSP3;PKD2;MAPRE3;FGFR2;PKD1;USP19;NUPR1;NUDT16;EGFR;PDGFB;TRIM21;TAL1;APP;ASNS;NKX3-1;PRKCA
prerank,cellular response to type I interferon (GO:0071357),-0.36978745687714126,-1.3102827536312058,0.08333333333333333,0.470021690221628,1.0,16/65,15.62%,IFITM3;IFITM1;IFITM2;IFI6;EGR1;OAS2;BST2;ISG15;IFIT3;MX1;XAF1;STAT1;IRAK1;HLA-F;OAS3;IRF8
prerank,type I interferon signaling pathway (GO:0060337),-0.36978745687714126,-1.3102827536312058,0.08333333333333333,0.470021690221628,1.0,16/65,15.62%,IFITM3;IFITM1;IFITM2;IFI6;EGR1;OAS2;BST2;ISG15;IFIT3;MX1;XAF1;STAT1;IRAK1;HLA-F;OAS3;IRF8
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.3467561888346989,1.3100740170679808,0.0967741935483871,0.21872749978505351,1.0,10/24,17.23%,COQ10A;ADRB3;ACADVL;GFPT2;PID1;COX4I2;MT3;LEPR;NR4A3;NDUFS4
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.3416197532655731,1.309893737188742,0.047619047619047616,0.21881999809636907,1.0,16/34,21.28%,MFN2;MYOC;FLCN;SPRY1;LZTR1;KCTD10;DAB2IP;DLC1;MAPKAP1;RASIP1;ITGA3;SYNGAP1;KANK1;TNFAIP1;ARHGAP24;HEG1
prerank,regulation of T cell cytokine production (GO:0002724),-0.4444746995657761,-1.3069739915469274,0.13157894736842105,0.4776497462957815,1.0,10/19,30.74%,FOXP3;CD55;HLA-F;TNFRSF1B;TNFSF4;TRAF2;LILRB4;XCL1;TRAF6;CLC
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.4646756264724506,-1.3065235137661568,0.10810810810810811,0.4774456782120261,1.0,12/17,40.19%,ALG1;ALG8;SRD5A3;ALG2;ALG14;ALG3;ALG6;DOLK;NUS1;ALG12;DPAGT1;MPDU1
prerank,regulation of acute inflammatory response (GO:0002673),-0.43396131075471245,-1.3061967278977589,0.13043478260869565,0.4768854694655557,1.0,8/20,25.72%,C2CD4A;OSM;F12;FFAR2;ADAM8;NLRP3;DNASE1;C2CD4B
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),-0.31446879135062517,-1.3055219716372235,0.054945054945054944,0.4777340063730006,1.0,48/152,24.91%,EXO1;TP73;CHEK1;RFC3;BLM;CDK1;PML;POU4F1;CHEK2;RMI1;DNA2;RPA3;AURKB;BOP1;RFC5;RMI2;TPX2;AURKA;RAD9B;PRDM1;TOPBP1;ATR;RBBP8;TP53RK;TAF4B;PAK1IP1;TAF1L;SMYD2;RFC2;RRS1;WRN;MDM2;CDK5;CSNK2A1;TAF2;BARD1;POU4F2;BRCA1;HUS1;TAF4;HDAC2;HIPK2;RPF2;MAPKAPK5;RHNO1;CHD4;RNF34;RPL37
prerank,response to fatty acid (GO:0070542),-0.4319224770063174,-1.3045101771496033,0.12658227848101267,0.4796431756886249,1.0,6/19,13.63%,IRS1;SOX9;SCD;FFAR2;UCP1;GLDC
prerank,aflatoxin metabolic process (GO:0046222),-0.5091439635238714,-1.3032137248585849,0.109375,0.4795522655279107,1.0,5/15,22.75%,DPEP1;CYP2W1;CYP2A13;CYP1A2;MGST2
prerank,mycotoxin metabolic process (GO:0043385),-0.5091439635238714,-1.3032137248585849,0.109375,0.4795522655279107,1.0,5/15,22.75%,DPEP1;CYP2W1;CYP2A13;CYP1A2;MGST2
prerank,organic heteropentacyclic compound metabolic process (GO:1901376),-0.5091439635238714,-1.3032137248585849,0.109375,0.4795522655279107,1.0,5/15,22.75%,DPEP1;CYP2W1;CYP2A13;CYP1A2;MGST2
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.3797264351747746,1.3031656023830693,0.1,0.22713676440353509,1.0,4/18,6.16%,CLU;CASP3;IFNGR1;EPHA4
prerank,myeloid leukocyte differentiation (GO:0002573),-0.36049726853326824,-1.3028044065965367,0.08433734939759036,0.47958082657470186,1.0,19/71,16.38%,CSF2;TNFSF11;UBD;DHRS2;PML;LEF1;E2F1;DCSTAMP;SNX10;EPHA2;CDK4;RUNX1;CEBPA;IFNG;MMP9;BATF;TGFBR2;EFNA2;BMP4
prerank,ERAD pathway (GO:0036503),0.26654843634636466,1.3026604441251255,0.0,0.22748336966851135,1.0,29/81,22.55%,DNAJC18;FBXO17;FBXO44;USP19;HSP90B1;DNAJB2;TMUB2;RNF185;FAM8A1;WFS1;FBXO27;UBXN6;UBE2G2;POMT2;TMEM129;ANKZF1;UBE4B;DNAJB12;RNF175;MAN1A1;DERL3;SEL1L;BAG6;SGTA;RNF5;HERPUD1;RCN3;SYVN1;DERL2
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.24373876098449665,1.3024102251484018,0.0,0.2274074721285462,1.0,75/261,19.25%,RAP1A;PMP22;MYLK;FLNA;GSN;EHD2;NTN1;RFX2;VCL;KIT;S1PR1;PARVA;TTLL3;INPP5K;BBS5;DZIP1;RAC1;EMP1;EMP3;RAB23;WDR19;BBS1;CYS1;CCL21;NPHP3;RABL2B;ARL3;PKD1;HDAC6;P2RX7;IFT81;ARHGEF6;ABLIM3;P2RY12;FGD6;INTU;FBF1;TXNDC15;UBXN10;CLUAP1;WHAMM;CC2D2A;INPP5E;CEP126;TMEM138;RAB11FIP3;GOLPH3;IFT46;ACTN2;AIF1L;RAB8B;IFT80;RILP;STK36;BBS2;EXOC7;S1PR2;GBF1;BBS7;FUZ;CEP89;FGD1;DMTN;IFT43;BBS4;ATP6V1D;PTPN23;RILPL2;SRGAP2;CEP19;ARL6;MKKS;IFT20;ANO6;IFT172
prerank,negative regulation of MAPK cascade (GO:0043409),0.27285932817729946,1.3022030793276704,0.0,0.22714063345890262,1.0,17/91,7.56%,RGS2;UCHL1;PTEN;LMO3;DUSP26;EMILIN1;FBLN1;FLCN;TIMP3;INPP5K;DUSP3;PRKCD;SPRY1;P2RX7;GPER1;SMPD1;DAB2IP
prerank,positive regulation of hormone secretion (GO:0046887),-0.43008248762067464,-1.3021005649249413,0.11594202898550725,0.48036757191880175,1.0,7/20,23.07%,TFR2;SPP1;HCAR2;CYP19A1;PLA2G3;FGA;FGB
prerank,regulation of cell differentiation (GO:0045595),0.23346996422714641,1.3019836367880264,0.0,0.22710373939123757,1.0,48/152,18.68%,FGFR1;NR1D1;LGALS3;ATF4;HEY1;LTBP4;ZFP36L1;SRF;CDK9;NGF;CAMK1;CEBPD;FES;FGFR2;PHLDB2;MEGF10;ID2;SMAD7;DDX17;PRKACA;KLHL41;GPS2;NLGN1;RAF1;CD24;GNB3;PRKCB;HEY2;NTF3;PLEKHB1;PHLDB1;NR1D2;GDNF;FLOT2;TRIP4;CASZ1;KLF4;NOTCH4;ALOX15B;INS;EDN3;EPHA3;DLL1;HOPX;CDK5RAP3;SUPT6H;TIAM1;SNAI2
prerank,regulation of JNK cascade (GO:0046328),0.26848834446760506,1.301899265899642,0.0,0.2268001897991909,1.0,26/103,13.67%,PER1;FZD7;DUSP22;ZMYND11;GADD45B;PJA2;MTURN;DUSP3;TIRAP;TGFBR3;F2RL1;CCL21;EGFR;DAB2IP;TLR9;GPS2;MAP4K2;MAPK8IP1;TRAF1;FLT4;APP;DUSP19;SEMA3A;ANKRD6;RIPK1;GADD45G
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.3893800793285793,-1.3014565465303012,0.06976744186046512,0.48097521175230334,1.0,24/43,36.88%,EREG;GBP5;IFNK;POLR3B;USP17L2;FPR2;POLR3C;ADAM8;CYBA;POLR3G;ANKRD17;NMI;IFNB1;SCIMP;CCL5;NLRP10;DHX9;PLSCR1;AKIRIN2;IFI35;TLR8;OASL;TRIM15;SLC15A4
prerank,organic acid transport (GO:0015849),-0.33943872545909537,-1.300812264615002,0.058823529411764705,0.4812120049980552,1.0,39/100,29.57%,SLC6A20;SLC7A11;SLC6A14;FOLR1;ABCC11;SLCO1B3;SLCO1B1;SLC6A6;SLC38A5;SLC10A1;SLC26A8;SLC7A1;SLC1A5;ABCC2;SLCO1A2;AKR1C4;SLC1A4;SLC5A6;SLC16A10;SLC7A6;SLC13A5;SLC22A13;SLC19A1;SLC25A47;SLC13A3;LRRC8D;SLC46A1;SLC6A18;SLC27A5;SLC26A1;SLC7A7;SLC7A4;SLC25A48;SLC3A2;SLC10A5;SLCO1C1;SLC38A3;SLC6A12;SLC43A2
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.3410051613788719,1.3006693472413653,0.03333333333333333,0.22817175027863815,1.0,5/26,4.82%,SMYD1;MYOCD;RBM24;MAPK14;AKAP6
prerank,protein autoprocessing (GO:0016540),-0.47088083407545916,-1.2996449911362802,0.1780821917808219,0.48322070451421595,1.0,6/16,23.46%,KLK6;F12;PCSK9;MYRFL;MYRF;FXN
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.28275361453721864,1.2991999455630614,0.2,0.23010850243166192,1.0,18/80,16.22%,RAB9B;RAB6B;SNX1;SGSM2;TBC1D17;ANKFY1;DCTN1;DENND2A;VTI1B;DENND5A;STX16;RBSN;TBC1D10A;SNX3;VPS26B;GBF1;SNX2;VAMP3
prerank,regulation of chemokine production (GO:0032642),0.3292247967639429,1.2987732749906205,0.15384615384615385,0.23006691569727128,1.0,11/42,11.71%,IL6R;ACKR1;TLR3;HMOX1;F2RL1;TLR9;ELANE;TSLP;LPL;APP;LGALS9
prerank,positive regulation of JNK cascade (GO:0046330),0.2760306653731265,1.298766203574654,0.05263157894736842,0.22968474474096354,1.0,23/72,16.35%,FZD7;DUSP22;GADD45B;PJA2;MTURN;TIRAP;F2RL1;CCL21;DAB2IP;TLR9;MAP4K2;MAPK8IP1;TRAF1;FLT4;APP;DUSP19;SEMA3A;ANKRD6;RIPK1;GADD45G;RASSF2;TAOK2;WNT16
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.36737313009224265,1.298713568239609,0.14285714285714285,0.22945502238931123,1.0,9/26,12.11%,ARHGAP6;MYOC;INPP5K;PHLDB2;ARHGEF18;PIK3R1;DLC1;WASF2;TMEFF2
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.43448638240638116,-1.2980056213770785,0.14492753623188406,0.4865630434355824,1.0,9/22,22.38%,WDR43;IPPK;NCL;HEATR1;SMARCA4;LYAR;UTP15;SMARCB1;EIF2AK3
prerank,positive regulation of synaptic transmission (GO:0050806),0.28597020064212064,1.297862503627978,0.0,0.22998071440550058,1.0,21/73,12.48%,NFATC4;VAMP2;MPP2;NLGN2;TSHZ3;NPTN;STX1B;CCL2;LGI1;RIMS3;DLG4;GPER1;HAP1;SLC8A2;NLGN1;FLOT1;NLGN3;APP;SYT1;GRIK2;ARC
prerank,kidney development (GO:0001822),-0.3326220459279681,-1.2963158094481986,0.0898876404494382,0.4906908575303142,1.0,20/70,14.76%,STRA6;MME;TGFB2;SOX4;SHH;CTSH;PROX1;ROBO2;LRP4;SIX1;PAX2;C1GALT1;REN;BMP7;PAX8;PCSK9;AGT;CITED1;NF1;CENPF
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.262481085379392,1.2960236812546178,0.0,0.23174778905176965,1.0,18/71,15.54%,NCK1;MAPK1;MAPK3;RAC1;MYO1C;PRKCD;ARPC2;PIK3R1;NCKAP1L;ACTB;BAIAP2;PLA2G6;BRK1;WASF2;ELMO2;WIPF1;PLD2;MYH2
prerank,regulation of regulated secretory pathway (GO:1903305),0.32301697762529435,1.295770379096033,0.047619047619047616,0.2316662321942407,1.0,12/34,14.56%,SYT11;RAB3A;RIMS3;SNAPIN;SYT4;SYT10;SYT5;SYN1;SYT1;RAB27A;SYT6;RIMS4
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.40498048897168576,1.2952735423493789,0.0967741935483871,0.23181022124075953,1.0,10/19,14.91%,NPR1;ADCY5;NPR2;ADCY4;NPPC;NPPA;ADCY9;ADCY2;NPPB;ADCY6
prerank,androgen metabolic process (GO:0008209),-0.4364907581649607,-1.294864378537938,0.1780821917808219,0.4938203169161759,1.0,12/21,31.34%,SPP1;SHH;CYP19A1;AKR1C4;SRD5A3;SRD5A1;MED1;AKR1D1;SRD5A2;UGT2B7;HSD17B10;HSD3B1
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.4397896060934905,-1.2947176091406833,0.14285714285714285,0.49285446769106356,1.0,8/25,20.82%,MIF;CD44;PMAIP1;ATR;SMYD2;MSX1;MDM2;SPRED1
prerank,glycerophospholipid catabolic process (GO:0046475),0.3641485961916782,1.2947141378606575,0.125,0.231953736639099,1.0,11/27,15.65%,PLA2G5;PLA2G4B;ENPP2;PRDX6;GDPD3;PLA2G4C;PLA2G6;ABHD16A;ENPP6;PLA2G4A;INPP5F
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.32744858092407975,1.294495013038509,0.0,0.23202193493703782,1.0,13/50,9.25%,BAG2;ECSCR;GABARAPL2;PKD1;KCNE2;USP19;NUPR1;UBB;PRKACA;PSMC5;DAB2IP;ALAD;GNA12
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.404360530209193,-1.2944718058465374,0.11842105263157894,0.4922171339797734,1.0,13/33,25.64%,THY1;TNFSF11;IL23A;PRKDC;HSPD1;IL12B;TNFSF4;PRKCQ;NOD2;SH3KBP1;SIRPB1;LCK;CLEC7A
prerank,mesenchymal cell differentiation (GO:0048762),-0.3669262346848949,-1.2939865124655605,0.06097560975609756,0.49215175718016024,1.0,9/51,5.49%,TBX20;LOXL2;AMELX;TGFB2;LEF1;WNT5A;SOX9;ENG;HMGA2
prerank,nuclear membrane reassembly (GO:0031468),-0.3636453132170831,-1.293895886883435,0.15853658536585366,0.4911422858920082,1.0,22/54,31.70%,CDK1;NUP155;VRK1;NUP37;CHMP4C;RCC1;NUP107;NUP35;SPAST;SEH1L;NUP205;NUP93;RAN;POM121;NUP43;NUP160;KPNB1;NDC1;NUP98;RANGAP1;SEC13;CCNB2
prerank,negative regulation of macrophage activation (GO:0043031),0.40945536665918975,1.2938527882283315,0.12,0.23253824815872745,1.0,5/15,17.09%,NR1D1;SYT11;CX3CL1;LRFN5;NR1H3
prerank,negative regulation of cell development (GO:0010721),-0.42487857739671386,-1.2936289397160732,0.1125,0.490741304034946,1.0,12/24,33.86%,IL1B;PAX6;SORL1;WNT7A;GSK3B;NOTCH1;TNF;WNT3A;REST;LTF;IGF1;FBXW7
prerank,dendritic cell chemotaxis (GO:0002407),-0.4682608939360187,-1.2935192230418995,0.12121212121212122,0.4897603573837634,1.0,6/16,21.77%,CXCR4;TRPM2;CXCR2;PIK3CG;CXCR1;HMGB1
prerank,renal water homeostasis (GO:0003091),0.32492379306073227,1.2934669600680462,0.09090909090909091,0.23253066578324105,1.0,13/31,18.18%,ADCY5;AQP1;PRKAR2B;ADCY4;PRKACA;WFS1;ADCY9;AVPR2;ADCY2;CYP4F12;ADCY6;RAB11FIP2;PRKACB
prerank,snRNA 3'-end processing (GO:0034472),-0.4134009972360412,-1.2931077650579934,0.14102564102564102,0.489477935161752,1.0,18/25,47.19%,INTS7;EXOSC3;EXOSC8;EXOSC5;EXOSC4;INTS2;INTS6;EXOSC7;SAGE1;EXOSC2;CT45A1;CT45A5;CT45A3;INTS12;CT45A6;CT45A7;CT45A2;EXOSC6
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.30367369892080415,1.2922843931060737,0.08695652173913043,0.23349133381341802,1.0,8/34,7.49%,CAV2;PRL;NGFR;ATOH8;NR2F2;CCL2;PTPRM;SCG2
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.3365232838214882,-1.292209954025629,0.08791208791208792,0.4907472100958421,1.0,29/83,30.89%,MAD2L1;CDK1;SKP2;PTTG1;FBXO5;UBE2C;PSMB9;PSMD14;AURKB;UBE2S;ANAPC1;AURKA;PLK1;CDC20B;PSMA3;CDC20;PSMB3;CDC26;PSMA5;PSMD12;PSMB11;PSMB2;PSMA7;BUB1B;PSME2;PSME3;PSMC1;CUL3;PSME4
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.44358900958758507,-1.2919370542383843,0.14285714285714285,0.4903146126056557,1.0,7/18,18.55%,DNMT1;DNMT3B;PAXIP1;MYB;CTCFL;AUTS2;BRCA1
prerank,regulation of epithelial cell proliferation (GO:0050678),0.26245476380012894,1.291623597534233,0.0,0.2340770805502885,1.0,30/92,15.34%,NR1D1;OSR1;CDKN1C;ZFP36L1;FGF2;LAMC1;TGFBR3;FGFR2;TIE1;ZFP36;FGF7;NUPR1;EGFR;DAB2IP;B2M;PRKD1;FGF1;LAMB1;SFRP1;ANGPT1;OSR2;TINF2;NKX3-1;KRT4;FGF10;GDF5;BAD;NME2;NR4A3;NR4A1
prerank,cellular response to organonitrogen compound (GO:0071417),0.2862572624068802,1.2909134038078367,0.0,0.23447532858709055,1.0,36/101,16.61%,RAP1A;PDE2A;AQP1;P2RY1;DEFB124;ZFP36L1;INPP5K;CPEB1;MTOR;PKD2;AKAP6;RAPGEF3;P2RX7;HSP90B1;RRAGA;PDE3A;AQP8;TRPV1;P2RY12;RYR3;IGFBP5;ACTB;RRAGD;SFRP1;RRAGC;MEF2C;GOLPH3;P2RY11;CAPN2;RRAGB;LAMTOR3;HCN3;NR1H4;SLC26A3;CDH1;DMTN
prerank,protein-DNA complex assembly (GO:0065004),-0.3234173783048337,-1.2904208289200467,0.06666666666666667,0.49367292972024185,1.0,42/115,30.89%,ORC6;CHAF1B;MCM4;CHAF1A;ERCC5;PSMB9;SOX9;RPA3;PSMD14;MCM7;MCM3;CDK7;CDT1;MCM5;MCM2;GTF2H2;SPTY2D1;PSMA3;MCM6;CDC6;NPM1;GTF2H3;PSMB3;ATRX;CCNH;ORC2;PSMA5;PSMD12;PSMB11;PSMB2;MCM8;PSMA7;ORC5;ORC1;PSME2;GRWD1;PSME3;PSMC1;ORC3;ERCC2;DMC1;PSME4
prerank,neurotransmitter transport (GO:0006836),0.2854748112655622,1.2903333684115046,0.14285714285714285,0.23502051267368285,1.0,29/72,20.85%,VAMP2;ATP1A2;RAB3A;SYN2;SNPH;SLC5A7;GLUL;SLC29A1;SNAP25;SNAPIN;BRSK1;SLC6A16;SYN1;SYT1;SLC17A7;SLC38A2;SLC18A3;HSPA8;NRXN2;SLC6A15;NAAA;LIN7A;STXBP1;STXBP3;NRXN1;DVL1;LIN7B;PPFIA4;SLC17A8
prerank,positive regulation of cytokine production (GO:0001819),-0.30557382722310145,-1.290301191432279,0.0,0.4926234340539432,1.0,141/329,34.02%,CEBPB;IL1A;HSPA1A;OSM;CSF2;SERPINE1;CD80;POLR2F;EREG;RIPK2;CARD11;IL1B;MIF;IL23A;CD276;WNT5A;EGR1;ZP3;POLR1C;SLC7A5;PRKDC;C3;PAEP;GBP5;CLEC6A;CXCL17;IL17A;IL12RB2;ISG15;IL23R;ORM2;HSPD1;IL17F;IL21;SYK;RUNX1;PNP;NFKB2;ZFPM1;RELA;RASGRP1;POLR3B;PIK3CG;IL12B;POLR3K;DRD2;FFAR2;SORL1;IRAK1;NOS2;G3BP1;F2R;AGT;ORM1;IFNG;TGFB1;PRKCZ;BATF;GATA4;NOX1;CHI3L1;APOA2;TNFSF4;ITK;CD46;POLR3C;PRKCQ;IL10;NOD2;CYBA;ZBP1;PIBF1;TRAF2;BRCA1;PHB;HLA-G;MDK;IL26;POLR3G;CARD9;NLRP3;CCL1;MMP8;POLR3A;GAPDH;IFI16;CD86;PIK3CD;HMGB1;GATA3;EIF2AK3;IL12RB1;NODAL;LTB;CRTAM;XBP1;GDF2;ANXA1;IL27;ROCK2;CRLF2;TIGIT;CD2;XCL1;TNF;NFAM1;CLEC7A;GLMN;TMEM106A;SULF2;SCIMP;CD28;CD6;PTPN11;IL13;AIRE;TYROBP;TWIST1;CREBBP;TLR7;LBP;XRCC5;TRAF6;HPSE;NLRP10;CD244;DHX9;IFNL1;AGER;CD226;TRIM27;IRF7;PDE4B;SLAMF6;NOX5;TLR8;MAPK13;PTPN22;CD58;NOD1;MYD88
prerank,positive regulation of mitochondrion organization (GO:0010822),0.295153415948078,1.2899931334222348,0.1111111111111111,0.23489796929550408,1.0,15/55,13.85%,TNFSF10;DCN;MOAP1;PLD6;BCL2L11;MLLT11;GPER1;MUL1;BNIP3;MGARP;BOK;FAM162A;BAD;MIEF2;RALBP1
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.32709765323732387,1.289845665426418,0.058823529411764705,0.23477582314059336,1.0,9/25,17.44%,SORBS1;PPP1R3C;INPP5K;PPP1R3B;EPM2AIP1;PPP1R3E;PPP1R3F;INS;PPP1R3G
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.3659807288317198,1.2882957419940138,0.13043478260869565,0.23620294404491127,1.0,9/29,14.44%,CACNA1H;SYT11;KCNB1;SYT4;SYT10;SYT5;SYT1;SYT6;DOC2B
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.3634087702861668,1.2882426173053383,0.12903225806451613,0.23585817441264753,1.0,5/21,6.63%,MEIS1;MEIS2;ZFP36L1;ZFP36;HOXA5
prerank,dendritic cell migration (GO:0036336),-0.4483293943022608,-1.2882354904868027,0.15942028985507245,0.4974339206201025,1.0,6/18,21.77%,CXCR4;TRPM2;CXCR2;PIK3CG;CXCR1;HMGB1
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.48384288134630554,-1.2879906194692583,0.16216216216216217,0.4954233497726633,1.0,11/16,31.88%,AMELX;RUNX1;F2R;TGFB1;SUCO;BMP4;HDAC2;WNT4;CREB3L1;F2;SCX
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.48384288134630554,-1.2879906194692583,0.16216216216216217,0.4954233497726633,1.0,11/16,31.88%,AMELX;RUNX1;F2R;TGFB1;SUCO;BMP4;HDAC2;WNT4;CREB3L1;F2;SCX
prerank,proteolysis (GO:0006508),-0.2976436377677362,-1.2878115421196021,0.02040816326530612,0.49450883055527073,1.0,75/284,22.31%,MMP7;FAP;ACAN;PRSS22;TMPRSS3;PRSS33;CPZ;PRSS48;PLAU;UBD;MME;GZMB;CAPN12;LRP8;OLR1;F12;MMP1;KLK12;HABP2;CTSH;NLN;PRSS56;CTSV;ADAMTS12;MMP24;F7;PCSK1;CPN1;HM13;CPA5;MMP2;BACE2;PRSS54;MMP3;MMEL1;REN;MIPEP;CPD;TMPRSS7;VHL;ERMP1;PROC;CPA4;CASP2;PLG;MMP9;TMPRSS6;CPB2;MMP25;TMPRSS11D;MMP12;CTSE;ADAM10;CTSC;MDM2;PCSK6;HPN;ADGRV1;VASH2;CELA2B;PCSK7;PTCH1;SRGN;LCN1;CNDP1;XPNPEP3;MMP8;FOLH1;F9;MMP23B;PRSS3;PRSS21;ERAP1;TASP1;HTRA4
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.329106439471326,1.2872846372257598,0.037037037037037035,0.23654376720962061,1.0,12/27,24.21%,NR1D1;ADCY5;PPP3CB;EFNA5;PLA2G6;NR1H4;KLF7;STX4;TRPM4;C2CD2L;BAIAP3;EPHA5
prerank,negative regulation of protein catabolic process (GO:0042177),0.31731292386628357,1.2871646510755352,0.0,0.2363830578422008,1.0,13/42,13.85%,FLNA;TIMP4;SNCA;TIMP3;TIMP2;SIRT2;SNRNP70;EGFR;DAB2IP;SNX3;PIN1;RILP;AZIN2
prerank,regulation of T cell activation (GO:0050863),-0.3750318567943941,-1.286777591862728,0.06097560975609756,0.49608315841333095,1.0,19/46,24.45%,THY1;TNFSF11;IL4I1;JAK3;HSPD1;VTCN1;TNFSF9;TNFRSF1B;TNFSF18;PRELID1;PRKCQ;SIT1;TNFSF8;SIRPB1;CRTAM;IL27;LCK;TIGIT;CD2
prerank,positive regulation of bone mineralization (GO:0030501),0.3401254148767571,1.2858299801200843,0.041666666666666664,0.23761521343030145,1.0,10/35,12.43%,PTN;GPM6B;OSR1;BMPR1A;P2RX7;KL;SLC8A1;OSR2;PKDCC;MEF2C
prerank,negative regulation of intracellular protein transport (GO:0090317),0.3662201221853365,1.2856297368101464,0.13043478260869565,0.2374167182375855,1.0,8/23,16.61%,APOD;INPP5K;RAB23;GDI1;MDFIC;SUFU;ITGB1BP1;DMTN
prerank,diterpenoid metabolic process (GO:0016101),0.26186729562330424,1.2854363478884379,0.0,0.23703624272758936,1.0,21/64,17.67%,RDH5;SDC2;LRAT;GPIHBP1;ALDH1A1;ADH1B;SDC3;RARRES2;CLPS;AKR1B1;GPC1;LPL;AKR1C1;RLBP1;AKR1B10;GPC4;PNLIP;GPC3;HSPG2;AKR1C3;ALDH3A2
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.3687447957040524,1.2853675276417331,0.13333333333333333,0.23669344960590305,1.0,6/24,7.14%,JAM3;THBS4;RAC1;TIRAP;CCL21;NCKAP1L
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.4559765449165871,-1.2852022225511959,0.15,0.49908763003759715,1.0,10/17,39.60%,GBP5;IL17A;NOD2;CARD9;TNF;CLEC7A;CD6;MYD88;HIF1A;IL17D
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.30229011390627114,1.285166544972541,0.05555555555555555,0.23653378475036957,1.0,10/49,10.58%,LIMS2;FLNA;FERMT2;ILK;MYOC;RAC1;OBSL1;TESK1;MYADM;CAPRIN2
prerank,positive regulation of inflammatory response (GO:0050729),-0.3219049890044589,-1.284920190456686,0.07777777777777778,0.49846118692255453,1.0,28/87,22.75%,C2CD4A;OSM;SERPINE1;IL1B;IL23A;WNT5A;ZP3;PLA2G7;CD81;IL21;CCL3;CEBPA;IL12B;FEM1A;PLA2G3;AGT;IFNG;RPS19;TNFSF4;NFKBIA;NLRP12;ADAM8;ZBP1;MDK;CCL1;MMP8;NMI;MGST2
prerank,positive regulation of MAPK cascade (GO:0043410),0.22531078027812626,1.284897026223636,0.0,0.2363746291926208,1.0,64/263,14.21%,RAP1A;GLIPR2;FERMT2;FGFR1;CCL14;LPAR1;PLA2G5;MAPK3;CAV2;KIT;P2RY1;ROR2;ACKR3;FGF2;SEMA4C;MTURN;HAND2;TIRAP;ADRB3;TNFAIP8L3;FGFR2;F2RL1;CCL21;PDGFRA;CCL2;GCNT2;CD36;GPER1;EGFR;RAMP3;DAB2IP;TLR9;ELANE;GPNMB;GH1;PDGFB;FGF1;FLT4;PDGFD;ROR1;TENM1;NECAB2;ANGPT1;NDRG4;CD24;MID1;CCL11;APP;ADRA2B;DUSP19;CCL13;LGALS9;CCL23;FGF10;PRKCA;NTRK1;CX3CL1;ARL6IP5;CCL8;MT3;BCAR3;ADRB2;ADCYAP1;RET
prerank,cellular response to organic substance (GO:0071310),0.2359362142694701,1.2847177537969852,0.0,0.23614339915679597,1.0,37/121,17.56%,CACNA1H;RAMP1;DPYSL3;MAPK8;INPP5K;MAPK7;CDK9;AKAP6;SLIT3;NOS1;BMPR1A;CLEC3B;CCL2;HDAC6;SOCS2;RHOA;PID1;RAMP3;RAMP2;PDGFB;IGFBP5;CYP1A1;SFRP1;CERS1;SMAD3;ARL6IP5;NCOA1;PTPN5;NR1H4;PTPN14;KLF4;HCLS1;IL18R1;STAT3;CYP11B1;GHR;PTPN23
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.26653383630711114,1.2833672126310782,0.0,0.23721729147442616,1.0,18/70,15.54%,NCK1;MAPK1;MAPK3;RAC1;MYO1C;PRKCD;ARPC2;PIK3R1;NCKAP1L;ACTB;BAIAP2;PLA2G6;BRK1;WASF2;ELMO2;WIPF1;PLD2;MYH2
prerank,iron ion homeostasis (GO:0055072),0.28275603995469073,1.2829542411997414,0.05555555555555555,0.23752808988764046,1.0,13/59,9.20%,SLC22A17;ISCU;SCARA5;CYBRD1;SKP1;HMOX1;FBXL5;NEDD8;SOD1;ABCG2;B2M;BDH2;SMAD4
prerank,neuromuscular synaptic transmission (GO:0007274),0.3770498550585669,1.282359117431048,0.16666666666666666,0.23791013946808276,1.0,4/19,6.43%,CHRNA3;DTNA;SLC5A7;CHRNB4
prerank,DNA duplex unwinding (GO:0032508),-0.36355815525961077,-1.2822237807291614,0.10843373493975904,0.5054818987821749,1.0,20/49,34.24%,BLM;MCM4;HMGA1;MCMDC2;ASCC3;RECQL4;MCM7;MCM2;GTF2H2;WRN;MCM6;GTF2H3;SSBP1;ANXA1;PIF1;ERCC2;DHX9;DDX11;CUL4A;UBC
prerank,regulation of actin filament bundle assembly (GO:0032231),0.38087366376160275,1.2819704400490513,0.1111111111111111,0.2381106751125612,1.0,12/25,19.42%,SYNPO2;ASAP3;RAC1;SYNPO;RDX;PTGER4;CX3CL1;TSC1;PFN2;SHANK3;SLC9A1;FHOD1
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.3737093978331712,1.2818373042044258,0.1111111111111111,0.2379145329850031,1.0,5/18,10.67%,NLGN2;TSHZ3;CCL2;NLGN1;NLGN3
prerank,chemical homeostasis (GO:0048878),-0.3591250473927395,-1.2811974147551608,0.15294117647058825,0.5073341845560616,1.0,21/60,27.62%,SLC4A11;ACOXL;TLCD1;ZBTB20;PNPLA3;ANGPTL3;CETP;PNPLA1;VGF;AQP9;CEBPA;SLC4A9;ATP13A2;SLC4A8;THADA;WNK4;PPARG;HNF4A;ABHD5;PNPLA4;FITM2
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.4680652209508943,-1.2808154237700968,0.10810810810810811,0.5068885502046049,1.0,7/16,29.58%,PIGM;PIGW;PIGF;PIGA;PIGN;DPM2;PIGB
prerank,amyloid fibril formation (GO:1990000),0.2748219981879684,1.2806227637403147,0.07142857142857142,0.23886932085399398,1.0,18/58,17.36%,GSN;SNCA;MAPT;PRL;MFGE8;CD36;UBB;B2M;NPPA;APH1B;GGA3;APP;RIPK1;HSPG2;INS;BACE1;ITM2B;GGA2
prerank,actin nucleation (GO:0045010),0.35552425582358615,1.2804111164078518,0.18181818181818182,0.2388520548632578,1.0,4/20,10.65%,LMOD1;JMY;ARPC2;WHAMM
prerank,mitotic nuclear membrane organization (GO:0101024),-0.37209758832554146,-1.279774302771471,0.16666666666666666,0.5074020331885906,1.0,22/51,31.70%,CDK1;NUP155;VRK1;NUP37;CHMP4C;RCC1;NUP107;NUP35;SPAST;SEH1L;NUP205;NUP93;RAN;POM121;NUP43;NUP160;KPNB1;NDC1;NUP98;RANGAP1;SEC13;CCNB2
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.37209758832554146,-1.279774302771471,0.16666666666666666,0.5074020331885906,1.0,22/51,31.70%,CDK1;NUP155;VRK1;NUP37;CHMP4C;RCC1;NUP107;NUP35;SPAST;SEH1L;NUP205;NUP93;RAN;POM121;NUP43;NUP160;KPNB1;NDC1;NUP98;RANGAP1;SEC13;CCNB2
prerank,error-free translesion synthesis (GO:0070987),-0.4292229480494604,-1.279586778891655,0.2054794520547945,0.5066739356764682,1.0,5/21,14.84%,RFC3;POLH;RPA3;RFC5;RFC2
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.35867578780897513,-1.2795213950223698,0.10126582278481013,0.5055755400206728,1.0,17/53,22.10%,CCND1;CDKN3;BLM;CCNO;CDC25C;CCNK;CCNI2;CCNE1;PKMYT1;CCNF;CDK7;GTPBP4;CCNJ;STOX1;CDC25A;CDC6;TTBK1
prerank,positive regulation of lyase activity (GO:0051349),0.40818633932198023,1.2790116233070803,0.12903225806451613,0.24026821056894876,1.0,4/15,5.53%,ISCU;STIM1;CACNA1C;NOS1
prerank,cellular response to cytokine stimulus (GO:0071345),-0.29281321146349126,-1.2789663057705605,0.0,0.5060470075976363,1.0,138/471,21.86%,MYC;CXCL8;CCND1;CXCL1;CXCL2;IL11;IL1A;TCF7;TDGF1;IFITM2;OSM;SLC12A2;CSF2;TNFSF11;TIMP1;MME;COL1A2;IRAK2;SOCS3;CD80;LRP8;EREG;IL20RA;IL1B;CCL24;CXCR4;MMP1;POU4F1;LEF1;IL23A;CCL20;IL1RN;WNT5A;EGR1;FN1;IL19;ICAM1;DUSP1;SOCS1;SOX9;ADAMTS12;GBP5;DCSTAMP;CXCL10;IL17A;JUNB;ABL2;IL12RB2;CCL22;JAK3;FOS;PF4;IL23R;LCN2;MMP2;IFNK;IL13RA2;DUOX2;CCL4;MMP3;IL17F;SYK;BCL6;IL5;BCL2L1;STAT1;ZEB1;CCL3;RELA;GBP7;CEBPA;IL12B;ASAH2;PRLR;ZNF675;IRAK1;NOS2;HYAL3;INPP5D;PNPT1;ITGAX;IL22RA2;MMP9;GBP1;CCL25;TGFB1;BATF;IL1RL2;CHI3L1;FYN;CCL26;DUOX1;CCL17;TNFRSF1B;CSF2RA;IRF8;NANOG;NLRP12;IFNGR2;IL2RA;FOXH1;OPRM1;NFAT5;STK39;PTPN7;PIK3CB;IL10;STAT5A;IFNE;FASLG;TEC;POU4F2;STAT5B;BRCA1;PHB;BAG4;IRAK3;LIF;GSK3B;IL36B;PTPRJ;IL26;IL24;CCL1;IL36RN;GAPDH;PTPN2;DOCK8;IL20RB;IFI16;IL31;SLA2;CD86;BIRC5;IL27RA;PIK3CD;GATA3;IL20
prerank,regulation of protein localization to membrane (GO:1905475),0.37293468982188355,1.2785644553407984,0.125,0.24046347031182086,1.0,14/29,20.63%,GSN;VTI1B;ZDHHC7;GPC1;ACTB;NECAB2;VPS4A;GPC4;STX8;GPC3;INS;STX7;GPC6;CLN3
prerank,positive regulation of developmental process (GO:0051094),0.22280508352063957,1.2785226001926555,0.0,0.24012229017288958,1.0,29/166,9.32%,PTN;PSEN1;FGFR1;DCN;SYDE1;SRF;CORO1C;FZD4;PRL;DVL3;PLD6;ENPP2;FST;CAMK1;RAPGEF3;PHLDB2;BMPR1A;NUMA1;DLG4;DVL2;DAB2IP;MUL1;BNIP3;ZDHHC15;BMP1;CORO1B;RTN4;PDGFB;NLGN1
prerank,protein polyubiquitination (GO:0000209),0.19617646852667972,1.2781427296551806,0.0,0.24024583523276166,1.0,77/307,18.29%,FBXO32;UBE2QL1;FBXO10;FBXL22;FBXO9;WSB1;FBXO17;TRIM6;UBE2D4;UBE2G1;SKP1;PELI3;FBXL7;SASH1;FBXO44;TRIM3;FBXL5;FBXO31;UBE2E1;KLHL42;LNPEP;UBB;FBXO30;AKTIP;UBE2Q2;PSMC5;MUL1;RNF146;RNF167;MYLIP;RNF217;ZFP91;TRIM34;TRIM21;FBXO27;RNF14;RNF144B;SPSB1;KLHL20;HECTD2;TRAF1;UBE2V1;NHLRC4;UBE2G2;FBXW4;RNF216;RNF4;LONRF1;PSMD9;LRSAM1;RUSC1;UBE3A;TRIM69;TMEM129;UBOX5;FBXW5;RNF31;RNF115;UBE3B;BCL2;PSMB6;MIB2;UBE2B;FBXL15;UBE2H;UBE4B;RNF19A;FBXL12;BTRC;BLMH;UBE2D3;RNF41;RNF152;ANAPC4;TRIM68;HERC5;RNF135
prerank,negative regulation of autophagy (GO:0010507),0.29390541819963295,1.2778576140457858,0.08695652173913043,0.2402265533288613,1.0,17/56,16.51%,NRBP2;SNCA;WDR6;SIRT2;SNRNP70;MTOR;NUPR1;MTMR9;RRAGA;KLHL22;RASIP1;TSC1;MT3;BCL2;LEPR;STAT3;GOLGA2
prerank,cellular response to decreased oxygen levels (GO:0036294),0.27166383565804325,1.2777793429367188,0.0,0.23999400358372208,1.0,24/67,16.31%,AQP1;EGLN2;ZFP36L1;CPEB1;SIRT2;MTOR;HMOX1;PTGIS;HP1BP3;BNIP3;EGLN1;SFRP1;ACAA2;BNIP3L;MGARP;FAM162A;NKX3-1;EPAS1;BAD;TSC1;MT3;ANGPT4;AK4;RGCC
prerank,telomere organization (GO:0032200),-0.375961363673034,-1.2777785433855122,0.1282051282051282,0.5084479288004649,1.0,12/41,18.96%,BLM;PRKDC;DNA2;RPA3;RECQL4;DCLRE1B;ATR;WRN;POLD2;TERT;HUS1;RIF1
prerank,cellular response to calcium ion (GO:0071277),0.27928366360983964,1.2777332588733215,0.05,0.2396201811482334,1.0,22/69,14.37%,ADD1;CLIC4;ITPKB;SYT11;RASGRP2;PKD2;PRKAA2;MCOLN1;SMPD1;RYR3;SYT4;MEF2A;SYT10;NLGN1;SYT5;CAPN3;CAMK2D;SYT1;CHP2;MEF2C;CPNE8;SYT6
prerank,regulation of DNA binding (GO:0051101),-0.35944071997602406,-1.2776086389509,0.08641975308641975,0.5074066321375003,1.0,23/45,32.82%,HJURP;LEF1;E2F1;MDFI;HMGA2;TFAP4;PLAUR;CDT1;MMP9;TGFB1;NFKBIA;MMP8;IFI16;NME1;HMGB1;PPARG;SUMO4;EGF;GZMA;KDM1A;CPNE1;FOXC1;IGF1
prerank,positive regulation of protein import (GO:1904591),0.3356747935765391,1.2771794008290946,0.125,0.23970829446177816,1.0,8/30,11.25%,FLNA;PSEN1;BAG3;PRKCD;DMAP1;PIK3R1;CHP2;SMAD3
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.36084177404187684,-1.2770513853650165,0.0625,0.5078694450615364,1.0,9/53,8.71%,GNL3L;HSPA1A;PRR7;SOX4;TNFAIP3;PRMT3;ISG15;CAV1;PRKCG
prerank,maintenance of protein location in nucleus (GO:0051457),0.3617490206348351,1.2766676881972068,0.11538461538461539,0.2400438574105535,1.0,5/20,7.30%,SKP1;SUPT7L;SUN2;ARL2;SUN1
prerank,regulation of cellular senescence (GO:2000772),-0.39607310713313504,-1.2759693229372064,0.16455696202531644,0.5103166957986593,1.0,11/30,18.99%,HMGA1;RBL1;FBXO5;CDKN2A;HMGA2;NEK6;NEK4;AKT3;PNPT1;TERT;HLA-G
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.3646207125404488,1.2759363044892367,0.16,0.24037837985406127,1.0,12/33,15.34%,VEGFB;HSPB1;MAPK14;DAB2IP;RAMP2;PRKD1;FLT4;SEMA6A;GAS1;VEGFC;ITGB1BP1;NR4A1
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.3789427690908374,-1.2758093321824904,0.1566265060240964,0.509366411086489,1.0,15/36,29.72%,IL1A;PDGFRB;EREG;IL1B;DLGAP5;EPGN;AURKA;DMRT1;ESPL1;NSMCE2;EGF;CD28;NUP62;LRP5;CUL3
prerank,regulation of cellular localization (GO:0060341),0.3102396885812802,1.2757401951169234,0.07142857142857142,0.24007683605141925,1.0,15/47,15.20%,GSN;NR1D1;ADCY5;DVL3;FES;EFNA5;MAP2;NUMA1;BRSK1;CSNK1E;CAMK2D;PARD6G;KIAA1614;PPM1F;NR1H4
prerank,positive chemotaxis (GO:0050918),0.41321295641322286,1.2746084325611604,0.15151515151515152,0.2408329728327261,1.0,8/18,12.98%,PLXNB3;LGALS3;FGF7;SCG2;GPNMB;ANGPT1;FGF10;CX3CL1
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.28760843348642895,1.27443967072306,0.0625,0.24067234054446868,1.0,16/73,11.61%,PTEN;CLU;ZER1;BAG2;SIRT2;SMAD7;DNAJB2;TRIB2;RNF217;RNF14;RNF144B;PIAS1;CSNK1E;GABARAP;CSNK1A1;RNF180
prerank,positive regulation of heart contraction (GO:0045823),0.3713053708432544,1.274377096615712,0.043478260869565216,0.24040685407987158,1.0,13/20,22.70%,RGS2;ATP1A2;HRC;SCN3B;ATP2A2;NPPA;ADM;EDN3;ADRA1A;CHGA;TRPM4;EDN2;GSK3A
prerank,dopaminergic neuron differentiation (GO:0071542),-0.4596533032589696,-1.2743461983772917,0.18518518518518517,0.5128461621463799,1.0,4/20,9.00%,WNT2;SHH;FOXA2;EN1
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.48623672283577557,-1.274272951126592,0.17647058823529413,0.5116848900600024,1.0,8/15,34.49%,MIF;CD44;ARMC10;MDM2;RNF34;TWIST1;KDM1A;CD74
prerank,collagen fibril organization (GO:0030199),0.25406101555245486,1.2735774868092051,0.14285714285714285,0.2412291180226783,1.0,16/89,8.80%,DPT;COL6A1;COL21A1;COL6A2;DDR2;DST;CRTAP;LOXL4;COL28A1;P3H2;COL16A1;COL24A1;COL4A2;COLGALT2;BMP1;COL5A3
prerank,negative regulation of blood coagulation (GO:0030195),-0.3777225190560071,-1.2730049377036499,0.10256410256410256,0.5146008844032149,1.0,16/40,23.07%,PLAU;SERPINE1;F12;THBD;SERPING1;F7;PROC;PLAUR;PLG;CPB2;KNG1;SERPINB2;F11;FGA;HRG;FGB
prerank,positive regulation of phosphorylation (GO:0042327),0.24218922081560673,1.2729300987702574,0.0,0.24173377919597888,1.0,63/246,14.72%,CLIP3;PSEN1;EPHA7;FGFR1;BCL10;DDR2;FZD7;ILK;MAPK3;FAXDC2;KIT;P2RY1;VEGFB;ROR2;NPTN;FAS;FGF2;FLCN;ITGB3;RAC1;DVL3;PIFO;RARRES2;FGFR2;TIE1;RSPO1;PDGFRA;EPHA4;EFNA5;FGF7;P2RX7;AKTIP;PRKAA2;GPER1;EGFR;NCKAP1L;DVL2;LMO4;GPNMB;TESK1;PIK3R3;FGF1;FLT4;ROR1;FLOT1;ANGPT1;ARNT;APP;ATG14;PIN1;EPHB6;FGF5;NKX3-1;FGF10;TFRC;NTRK1;RIPK1;MT3;RALBP1;RET;EPHA10;VEGFC;LEPR
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.4394799718218712,-1.2721784187497862,0.1625,0.5160092625601345,1.0,7/19,16.75%,PLAU;PDGFRB;SERPINE1;S100A11;SORL1;IGFBP3;TRIB1
prerank,cellular response to ketone (GO:1901655),0.32185711152485796,1.27166205508174,0.14814814814814814,0.24335544652144256,1.0,15/38,17.48%,KLF9;ADCY5;AQP1;GNG2;AKR1C2;SFRP1;GNAI1;PTGER4;GOLPH3;ADCY2;NCOA4;ADCY6;NR3C1;PTGFR;AKR1C3
prerank,modified amino acid transport (GO:0072337),-0.4741387711712325,-1.2713792816210727,0.18309859154929578,0.5169256708267841,1.0,6/17,18.25%,SLC6A20;FOLR1;SLC1A4;SLC5A6;SLC19A1;SLC46A1
prerank,negative regulation of cell death (GO:0060548),0.2617010947995809,1.270842407064969,0.0625,0.24423921995747644,1.0,17/86,8.63%,KANK2;FERMT2;INPP5A;CLU;CD34;NCK1;SNCA;FGF2;PARP16;AMIGO2;CHMP4A;TMEM109;PSMC5;BNIP3;WFS1;GPNMB;PRKD1
prerank,lysosome organization (GO:0007040),0.3202627137977542,1.2698541206711487,0.15,0.24564300956817808,1.0,17/35,23.36%,MTOR;TPCN2;AKTIP;SNAPIN;TPP1;TFEB;HPS1;CLVS2;VPS33A;VPS18;GAA;ZKSCAN3;ACP2;CLN3;LAMTOR1;LRRK2;ABCA1
prerank,regulation of BMP signaling pathway (GO:0030510),0.25863777292373014,1.269124261688783,0.2,0.24641620783636498,1.0,20/73,15.00%,RBPMS2;DAND5;FSTL3;SMAD2;CHRD;FST;FSTL1;BMPR1A;SMAD7;NUMA1;RBPJ;TWSG1;SMAD4;CDH5;NBL1;SMAD9;GDF5;ITGA3;SKI;FBXL15
prerank,response to insulin (GO:0032868),0.2838169670352922,1.2690709575570802,0.0,0.24621428177010263,1.0,32/79,21.22%,SLC2A4;SORBS1;VAMP2;ZFP36L1;INPP5K;CPEB1;KAT2B;PIK3R1;HDAC5;PDE3B;PLA2G1B;CEACAM1;RHOQ;RAB31;SLC27A1;USF1;RAB13;EPM2AIP1;TSC1;LPIN1;RAB8B;ZBTB7B;CELA2A;CPEB2;RAB12;PCK1;LPIN3;SIRT1;HDAC9;FER;GOT1;MYO5A
prerank,protein dephosphorylation (GO:0006470),0.23433576193905994,1.2689695406511219,0.0,0.246082347995286,1.0,33/138,15.84%,TNS2;PTEN;NCK1;PPP2R5B;PPP3CB;DUSP22;DUSP26;PPM1M;PPP2R2B;PTPRS;PTPRZ1;DUSP3;PPP2R5D;PTPN21;CTDSP2;PPP1R12A;PTPRM;RPRD1A;PPP1CB;PPM1L;PPP2CB;TAB1;PPP2R3A;PPP4R1;CTDNEP1;PPM1A;PTPN5;LHPP;PPM1F;CTDSP1;SDHAF2;PTPN14;PPM1B
prerank,skeletal system development (GO:0001501),-0.31169816196989003,-1.2689426122486136,0.06060606060606061,0.5234128610524535,1.0,37/151,18.59%,COL10A1;NOTUM;ACAN;COL1A1;TNFRSF11B;COL1A2;TGFB2;SOX4;CD44;WNT5A;BCAN;SOX9;CHD7;IL17F;TEAD4;ETS2;EN1;GHRL;BMP7;TBX4;DSPP;ANKH;HYAL3;VCAN;ALX4;CHI3L1;RBP4;PPIB;DLL3;WNT11;PITX1;COMP;AHSG;CDH11;WWOX;COL2A1;SHOX2
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.4470126922576966,-1.2677981078384641,0.14084507042253522,0.5256309148264984,1.0,9/22,26.63%,CHEK1;AURKB;ZWINT;CHMP4C;BUB1;WEE2;NABP1;BUB1B;ZW10
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.4435073310030043,-1.2670205906502812,0.17142857142857143,0.5267899452926333,1.0,9/22,18.41%,FAP;MTRNR2L2;MTRNR2L3;MTRNR2L8;BCL2L1;MTRNR2L6;MTRNR2L1;MTRNR2L10;MTRNR2L5
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.361726736625447,-1.266877920729623,0.16091954022988506,0.525939034280872,1.0,28/73,28.78%,CDK1;SOX4;GTSE1;PML;E2F1;CDC25C;CHEK2;ARID3A;TFAP4;MYO6;AURKA;TFDP1;FOXM1;CASP2;BATF;E2F8;CNOT1;PAXIP1;MDM2;ACER2;CNOT10;HIPK2;CARM1;ATRX;USP10;E2F7;BAX;CNOT11
prerank,mesenchyme morphogenesis (GO:0072132),-0.47520694788193696,-1.2667516344391638,0.16666666666666666,0.525143770947402,1.0,4/17,5.17%,TBX20;TGFB2;SOX9;ENG
prerank,killing by host of symbiont cells (GO:0051873),-0.493563540766044,-1.2666851605566225,0.18181818181818182,0.5240799769510425,1.0,10/16,33.19%,PF4;CFHR1;ROMO1;DEFA5;GAPDH;HRG;KRT6A;DEFA1;F2;CFHR5
prerank,positive regulation of immunoglobulin production (GO:0002639),-0.4053329407123946,-1.2666814980375969,0.17105263157894737,0.522766718791743,1.0,11/29,24.55%,EPHB2;IL21;RBP4;PAXIP1;TNFSF4;IL10;PHB;RIF1;CD86;XBP1;XCL1
prerank,epithelial cell morphogenesis (GO:0003382),-0.48050586899510894,-1.2666283905446143,0.1323529411764706,0.5216297151997157,1.0,7/16,25.90%,MET;PKHD1;GRHL2;POF1B;SIPA1L3;CCDC88C;RAB25
prerank,regulation of chondrocyte differentiation (GO:0032330),0.3374195303628563,1.2665692317838757,0.11764705882352941,0.24906806257636377,1.0,15/26,23.40%,WNT9A;CHADL;NKX3-2;EFEMP1;HOXA11;PKDCC;GDF5;GDF6;ZBTB16;SNAI2;SCIN;ADAMTS7;BMPR1B;ACVRL1;PTHLH
prerank,regulation of cellular component size (GO:0032535),0.3341323964657737,1.2665233240885883,0.04,0.24869011407473043,1.0,7/30,8.81%,PTEN;RAC1;MTOR;AP2M1;RIN3;HP1BP3;RDX
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.3882735942152129,1.2656197574387784,0.07692307692307693,0.24966002469775742,1.0,7/18,13.76%,RAB34;TTC23;TXNDC15;SFRP1;SMO;KIF7;STK36
prerank,central nervous system neuron differentiation (GO:0021953),0.30637517128498176,1.265587247511441,0.18181818181818182,0.24931680308955145,1.0,13/34,17.99%,GBA2;MAPT;TOX;SPOCK1;ZC4H2;MAP2;NPY;CEND1;CHD5;SIN3A;MDGA1;FOXN4;FAIM2
prerank,regulation of protein binding (GO:0043393),0.24465253654421937,1.2652741650997712,0.1111111111111111,0.2496631544068584,1.0,24/113,11.46%,PSEN1;CLDN5;ADD1;BAG2;CDKN1A;MAPK8;PRKCD;CAMK1;HDAC4;PKD1;HDAC5;AKTIP;PRKACA;DNAJB2;SNAPIN;B2M;PDGFB;TRIM21;ACTB;CSNK1E;FLOT1;CAPRIN2;APP;PIN1
prerank,sodium ion import across plasma membrane (GO:0098719),-0.450495713517154,-1.2650091470992961,0.16417910447761194,0.5254696663283046,1.0,4/18,7.24%,SLC12A2;SLC5A2;SLC9C1;SLC9A7
prerank,retinoid metabolic process (GO:0001523),0.2365468471836056,1.2648623151749598,0.0,0.2497678368035768,1.0,28/92,17.48%,RDH5;SCPEP1;SDC2;LRAT;GPIHBP1;ALDH1A1;ADH1B;SDC3;RARRES2;CLPS;AKR1B1;GPC1;CYP27C1;CYP1A1;LPL;AKR1C1;ALDH8A1;RLBP1;AKR1B10;CYP26B1;GPC4;ADH1C;PNLIP;GPC3;RETSAT;HSPG2;DHRS9;AKR1C3
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.24871607564568377,1.2647623214103927,0.07142857142857142,0.24946032663270895,1.0,29/97,16.35%,FZD7;DUSP22;GADD45B;PJA2;SEMA4C;MTURN;HAND2;TIRAP;SASH1;F2RL1;CCL21;DAB2IP;TLR9;MAP4K2;MAPK8IP1;TRAF1;FLT4;MID1;APP;DUSP19;SEMA3A;ANKRD6;ARL6IP5;RIPK1;GADD45G;GDF6;RASSF2;TAOK2;WNT16
prerank,amide transport (GO:0042886),-0.42120564452964054,-1.2647272020936715,0.13924050632911392,0.5248543990395732,1.0,10/27,18.25%,FOLR1;ABCA13;UPK3A;SLC38A5;ABCA12;SLC5A6;TAP1;GLTPD2;SLC19A1;SLC46A1
prerank,positive regulation of chemotaxis (GO:0050921),0.31540701492552553,1.2645682950359538,0.13636363636363635,0.24942791323436883,1.0,11/45,9.12%,IL6R;PTN;HSPB1;FGF2;RARRES2;F2RL1;CCL21;P2RY12;PDGFB;PRKD1;ZNF580
prerank,regulation of histone acetylation (GO:0035065),0.3070524083135825,1.2642388599210665,0.16666666666666666,0.2495324773037334,1.0,8/33,6.74%,MAPK3;SNCA;MYOCD;FLCN;CAMK1;RAPGEF3;NOS1;HDAC5
prerank,rRNA modification (GO:0000154),-0.4673427843050108,-1.2641215155474812,0.14473684210526316,0.525571247215031,1.0,7/19,18.13%,DKC1;TFB1M;NAT10;NSUN3;FBL;GAR1;TFB2M
prerank,response to molecule of bacterial origin (GO:0002237),-0.34283867576488797,-1.2634779979026602,0.10344827586206896,0.5262005571193982,1.0,24/68,24.61%,CXCL8;CXCL2;IL1B;CYP27B1;TNFAIP3;IL23R;NOCT;MAPKAPK2;PALM3;IRAK1;NOS2;F2R;CPS1;CITED1;TRIB1;IL10;IRAK3;SLPI;SRR;C4B;GCH1;SMAD6;RPS6KA3;MAPKAPK3
prerank,regulation of cell-cell adhesion (GO:0022407),0.29712386057207846,1.2627412342508,0.043478260869565216,0.25079846459463545,1.0,13/42,16.61%,EPHA7;CITED2;FSTL3;MEGF10;SMAD7;EFNA5;CEACAM1;TENM3;DPP4;FLOT2;B4GALNT2;MDGA1;CDH1
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.2603009313368872,1.2627171481777955,0.13333333333333333,0.2504912529460616,1.0,26/111,13.56%,DMPK;ATP2B4;CCL14;SLC39A13;STIM1;NPTN;MT1X;TPCN2;ANK2;SLC24A3;PTH1R;SLC41A1;MT1M;ELANE;ATP2A2;RGN;SLC8A2;CDH5;CCL11;CCL13;SLC8A1;CCL23;MT1A;MT1E;CCL8;MT3
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.43230421125092566,-1.261324133171003,0.2112676056338028,0.5317474788434315,1.0,3/24,0.92%,SULT2B1;SULT1C2;SULT1C3
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.2613268773873158,1.260355595348951,0.1,0.253114685553439,1.0,20/60,17.35%,FLNA;LPAR1;ADCY5;PDE2A;AKAP12;GABBR1;CHRM2;ADCY4;GNAI2;CORT;P2RY12;GNAI1;ADCY9;NPY1R;ADCY2;RGS1;ADCY6;GNAL;HTR4;CHRM3
prerank,positive regulation of neuron differentiation (GO:0045666),0.3188852421594629,1.2598008361133384,0.07692307692307693,0.25348524858518073,1.0,14/43,16.03%,FGFR1;NGF;ZC4H2;PCP4;RHOA;HOXD3;GPRC5B;NBL1;ADRA2B;MMD;MEF2C;MMD2;KCTD11;SIN3A
prerank,glial cell differentiation (GO:0010001),-0.4143747570285118,-1.2597127632135126,0.1411764705882353,0.5356636521163113,1.0,9/28,18.95%,SOX4;SHH;SOX9;MMP24;PAX2;GPR157;CDK5;MYRF;SLC8A3
prerank,histone H4 acetylation (GO:0043967),0.32849164088939825,1.2595227885557898,0.11764705882352941,0.2534471266301157,1.0,22/48,22.11%,APBB1;PER1;ING4;MORF4L1;DMAP1;ATF2;JADE1;BRD8;MSL1;KANSL3;CHD5;ING3;KAT8;TADA3;NAA60;ACTL6B;JADE2;MEAF6;EP300;MSL3;NAA40;KAT7
prerank,ethanol metabolic process (GO:0006067),0.36700499974643247,1.258929078707455,0.19230769230769232,0.2537482630986321,1.0,6/19,17.70%,ADH5;ALDH1A1;ADH1B;ALDH2;ADH1C;SULT1A2
prerank,regulation of TOR signaling (GO:0032006),0.2730928331687122,1.2580860118924515,0.08,0.25459033031579836,1.0,16/67,14.18%,EPM2A;FBXO9;FLCN;FAM83D;ARNTL;PRKAA2;RRAGA;TNFAIP8L1;GNA12;RRAGD;DEPTOR;RRAGC;GOLPH3;TSC1;RRAGB;LAMTOR3
prerank,T cell activation involved in immune response (GO:0002286),-0.42628328178564306,-1.257814988268785,0.20270270270270271,0.5399264645233798,1.0,20/28,43.17%,ICAM1;IFNK;TNFSF18;IFNE;MDK;IFNB1;LCP1;IFNA1;EIF2AK4;CD74;ITGAL;IFNA21;IFNA4;IFNA7;IFNA10;IFNA14;FCER1G;IFNA17;IFNA2;IFNA16
prerank,cellular response to hydrogen peroxide (GO:0070301),0.3002639970981674,1.2573014599915715,0.04,0.2550579463566375,1.0,9/35,13.83%,RNF112;RHOB;AQP1;MAPK7;PRKCD;HDAC6;ZNF580;RIPK1;ANKZF1
prerank,T cell differentiation (GO:0030217),-0.36853544213625633,-1.2569790746622587,0.0975609756097561,0.5410615524862952,1.0,17/41,24.13%,TCF7;SOX4;SHH;CHD7;GPR89A;GPR89B;RAG1;LFNG;ZAP70;RAG2;JAG2;PTPN2;PIK3CD;GATA3;SPI1;ANXA1;LCK
prerank,cardiac myofibril assembly (GO:0055003),-0.4622847931804931,-1.2566408318063982,0.15942028985507245,0.5406831157958878,1.0,4/15,5.86%,NEBL;PDGFRB;PROX1;NEB
prerank,natural killer cell mediated immunity (GO:0002228),-0.44136401544330883,-1.2563014856951267,0.18571428571428572,0.5404222686275382,1.0,5/20,8.12%,ULBP3;GZMB;ULBP2;ULBP1;RAET1E
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.4490390493219213,-1.2561706308340166,0.23076923076923078,0.5394372955955958,1.0,8/19,16.38%,MYC;FOXD1;SHH;SIX1;PAX2;PAX8;CITED1;BMP4
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.3716929078172867,1.2557197437861987,0.12,0.25697601878249204,1.0,4/19,9.12%,IL6R;PTN;F2RL1;ZNF580
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.19847058618444782,1.2553920106326022,0.0,0.2568993011142678,1.0,82/377,13.61%,CALCOCO1;BVES;PSEN1;GSN;ACTA2;CLU;CD34;CITED2;TLR3;CLDN5;MAPK1;PDE2A;ATF4;OSR1;MAPK3;HEY1;MITF;WNT6;SNCA;EMILIN1;MAPK8;MYOM1;ECE1;FGF2;MAPK7;NGF;HAND2;MAPK14;MTOR;CD63;OCLN;IFNGR1;ANK2;SLC24A3;ATF2;ID2;FGF7;P2RX7;HOXA5;CD36;HOXD3;PID1;GPER1;ACTC1;RBPJ;RAMP3;MAPK11;RAMP2;TLR9;WFS1;GH1;RHOXF1;PDGFB;RDX;ZNF580;PIK3R3;FGF1;TLE1;CDH5;RBMS3;ANGPT1;C1QTNF1;APP;KLF2;GATA2;SMAD3;LGALS9;OSR2;FGF5;SMO;OLFM1;MEF2C;NKX3-1;FGF10;TFRC;HINFP;AVPR2;SLC38A2;HEY2;MPHOSPH8;MT3;NTF3
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.31825235787874506,1.254631323312374,0.17647058823529413,0.2574960904900753,1.0,8/38,8.49%,PTEN;PPP2R5B;PHLDA3;FLCN;INPP5K;GPER1;MUL1;MSTN
prerank,response to ionizing radiation (GO:0010212),-0.35651299756697236,-1.2544511169699886,0.13580246913580246,0.5432594436623035,1.0,22/67,23.84%,MYC;BLM;RAD51AP1;TICRR;RFWD3;INTS7;FIGNL1;EYA1;BRCC3;RAD9B;ECT2;TOPBP1;XRCC4;PAXIP1;XRRA1;BRCA1;HUS1;IFI16;NABP1;RHNO1;AEN;ANXA1
prerank,regulation of neurotransmitter transport (GO:0051588),0.3784754127960172,1.25295252103037,0.21739130434782608,0.25953653726000603,1.0,6/16,12.75%,CPLX3;CHRNB4;FLOT1;SYN1;MEF2C;KCNMB4
prerank,protein methylation (GO:0006479),-0.3585948341570454,-1.25291078961777,0.13414634146341464,0.5471282438625932,1.0,18/34,38.12%,PRMT3;CAMKMT;EEF2KMT;NTMT1;METTL21C;CTCFL;CARM1;METTL21A;SNRPB;NSD1;GSPT1;EZH2;SNRPD3;FAM98A;PRMT5;PRMT1;PRMT8;PRMT6
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.41260646286484826,-1.2526838845143646,0.13432835820895522,0.5465921933198341,1.0,7/23,22.15%,MMP7;HM13;BACE2;ADAM10;PRKCQ;ADAM9;ERAP1
prerank,innate immune response (GO:0045087),-0.29538268949057855,-1.2524739914441425,0.010101010101010102,0.5460914382192207,1.0,119/287,34.74%,IFITM3;IFITM1;IFITM2;SIGLEC15;CLPB;RNF39;IFI6;UBD;SKP2;RIPK2;F12;CLEC5A;TREM1;SRMS;PML;CYP27B1;COLEC10;SRPK1;C3;KYNU;CLEC6A;CXCL10;BST2;SERINC5;ISG15;IL23R;LCN2;MX1;SYK;SHMT2;NLRC5;DEFA6;RELA;WFDC13;KRT16;PIK3CG;RPL39;IRAK1;NOS2;APOBEC3F;WFDC10A;PGLYRP4;VNN1;ATAD3A;CITED1;RNASE7;TRIM17;FYN;ZAP70;FRK;CXCL16;CORO1A;PGLYRP1;PPP1R14B;DEFA5;PGLYRP3;OTULIN;NCF2;NOD2;CYBA;TREML1;PHB;TRIM22;SLPI;CYBB;CARD9;POLR3A;TRIM14;PIK3CD;ANKRD17;HMGB1;CR1;KIR2DS4;GCH1;SIRPB1;TKFC;CAPZA1;PPARG;LCK;WFDC3;DEFA1;MEFV;LYN;BPIFB1;CLEC7A;WFDC10B;PI3;IKBKG;RNASE8;YES1;KLRC2;IFNL2;TYROBP;LTF;WFDC12;TRIM31;LBP;TRIM59;S100A7;PGLYRP2;IFNL1;AGER;WFDC9;TRIM27;PTK2;IRF7;TRIM11;DMBT1;TLR8;CFHR5;ANG;IFNL4;SRPK2;CX3CR1;MYD88;CD74;CD300LB;CFB;PYDC1
prerank,membrane protein proteolysis (GO:0033619),-0.36703648062780403,-1.2524095026428836,0.12195121951219512,0.5450232122639022,1.0,11/39,18.69%,MMP7;CTSH;HM13;BACE2;RELA;TMPRSS6;TGFB1;ADAM10;PRKCQ;ADAM9;MBTPS2
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",-0.37400119776709995,-1.2522378331991733,0.17073170731707318,0.5443825775633658,1.0,11/44,12.56%,ATAD2;CHEK1;POLR2F;HMGA1;POLR1C;TAF1A;DDX21;CDCA4;POLR1B;TAF1B;POLR1A
prerank,histone H4-K16 acetylation (GO:0043984),0.38993938384367094,1.2521807564402934,0.19230769230769232,0.2602619442378714,1.0,9/19,22.11%,ING4;JADE1;MSL1;KANSL3;KAT8;JADE2;MEAF6;MSL3;KAT7
prerank,tRNA modification (GO:0006400),-0.3642733834466849,-1.2521050752916187,0.09090909090909091,0.5434534092661368,1.0,35/60,42.06%,PUS7;WDR4;PUS10;METTL2A;PUS1;MOCS3;CDKAL1;DTWD2;METTL1;METTL6;TRMT6;TYW1;THUMPD3;THADA;FTSJ1;TRUB1;ANKRD16;AARS2;METTL2B;TRMT61B;TARBP1;NSUN2;TYW5;TYW1B;SSB;ADAT3;DUS2;NSUN6;CTU2;TRMT12;CTU1;PUSL1;TRDMT1;TRMT5;ADAT2
prerank,glycosphingolipid metabolic process (GO:0006687),0.27996936810907047,1.2512175312169846,0.15384615384615385,0.26175607422241076,1.0,19/46,20.29%,GBA2;ST6GALNAC3;A4GALT;SMPD1;GLTP;ST8SIA1;ESYT3;ST3GAL5;GBA3;ST6GALNAC5;ST6GALNAC6;ESYT1;ARSA;ST8SIA3;CERK;B4GALNT1;ESYT2;UGCG;CPTP
prerank,import into cell (GO:0098657),-0.37341622645236705,-1.251039951643856,0.17857142857142858,0.5454707217955447,1.0,14/41,18.25%,LRRC8E;SLC6A20;SLC6A14;SLC7A5;TSPO2;SLC6A6;SLC7A1;SLC5A6;LRP2;SLC11A2;SLC29A2;SLC19A1;LRRC8D;SLC46A1
prerank,protein mannosylation (GO:0035268),0.3551110281713764,1.250629244006405,0.07692307692307693,0.2622752938273538,1.0,7/18,11.79%,TMTC1;B4GAT1;POMT1;TMTC2;FKRP;DPY19L2;POMT2
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.40257258110106287,-1.2505020970002036,0.2073170731707317,0.545865687314624,1.0,10/25,22.88%,IL1A;IL1B;C3;CXCL17;TGFB1;GATA4;NOX1;BRCA1;EIF2AK3;NODAL
prerank,regulation of adaptive immune response (GO:0002819),-0.45274561308580685,-1.2500491213058507,0.2028985507246377,0.5459370142427709,1.0,9/18,39.49%,IL4I1;SKAP1;ADCY7;TNFSF4;TRIM27;IRF7;EIF2AK4;AHR;SAMSN1
prerank,triglyceride metabolic process (GO:0006641),-0.34028936922338776,-1.2499421130269053,0.17073170731707318,0.5449970473048084,1.0,19/52,31.68%,FABP6;DGAT2;PNPLA3;GK;LIPG;CAV1;CETP;PNPLA1;CPS1;APOA2;MOGAT1;APOC1;LPGAT1;SLC27A5;AGMO;PNPLA4;APOB;APOA5;FABP12
prerank,wound healing (GO:0042060),0.2743598333986534,1.249758540364418,0.0,0.2634279179082347,1.0,22/68,12.74%,TPM1;SYT11;FZD7;DST;ANXA6;RAB3A;FGF2;SRF;ITGB3;HMOX1;PDGFRA;SMPD1;MYOZ1;CORO1B;FGF1;RAF1;MYOF;SMAD3;FGF10;ARL8B;DYSF;CFLAR
prerank,aerobic respiration (GO:0009060),0.3526722587401544,1.2496594854450036,0.13793103448275862,0.26317569865316354,1.0,8/20,21.14%,MTFR1L;BLOC1S1;OXA1L;SIRT3;SURF1;ME3;UQCRC2;UQCR10
prerank,activation of adenylate cyclase activity (GO:0007190),0.30297532262745364,1.2492139651200602,0.11764705882352941,0.26359060698871106,1.0,13/35,14.91%,CAP2;ADCY5;ADRB3;ADCY4;ADORA3;RAF1;P2RY11;ADCY9;AVPR2;ADCY2;ADRB2;ADCYAP1;ADCY6
prerank,epoxygenase P450 pathway (GO:0019373),-0.4509612967689526,-1.2482442029607663,0.2,0.5489920757502293,1.0,9/19,27.66%,CYP2S1;CYP2F1;CYP2A7;CYP2B6;CYP2A6;CYP2A13;CYP1A2;CYP4F2;CYP4A11
prerank,negative regulation of hydrolase activity (GO:0051346),0.27340844386318713,1.2481637243368828,0.0,0.2647695337794747,1.0,13/57,8.81%,PLXNB3;PTX3;MAPK7;PLIN5;FICD;ARL2;NOS1;MAP2;GPSM1;DAB2IP;SERPINA5;EGLN1;RDX
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.3014784575152748,1.2477928889487166,0.08695652173913043,0.26501479727513055,1.0,14/33,22.71%,HACD1;ELOVL4;ACOT2;HACD4;ACOX2;SLC27A2;CYP4F12;ACSL1;ABCD4;SLC27A6;ELOVL5;ABCD1;ACAA1;ACOT1
prerank,regulation of interleukin-1 beta production (GO:0032651),-0.3443217434490738,-1.247702826473468,0.11494252873563218,0.549262934623238,1.0,43/80,38.35%,RIPK2;USP50;WNT5A;EGR1;TNFAIP3;CARD17;GBP5;IL17A;ORM2;CCL3;GHRL;F2R;ORM1;IFNG;NLRP12;NOD2;LILRB4;NLRP3;IFI16;SERPINB1;MNDA;MEFV;TNF;CLEC7A;GHSR;TMEM106A;CARD16;AIM2;TYROBP;ZC3H12A;AGER;NLRC4;IGF1;TLR8;CX3CR1;MYD88;PYDC1;APOA1;NLRP7;NLRP2;PYHIN1;PYDC2;LILRA5
prerank,alpha-amino acid catabolic process (GO:1901606),-0.38117861350296844,-1.247060015097072,0.19117647058823528,0.5498033115266415,1.0,13/29,34.10%,IL4I1;ACMSD;KYNU;IDO1;TDO2;KMO;HAAO;IDO2;HOGA1;CBS;HSD17B10;TAT;ALDH4A1
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.39573379635079065,1.245983504139849,0.06666666666666667,0.2675483531266683,1.0,9/18,23.74%,HSPB1;MAPK7;SOD1;NME5;INS;NOL3;SIRT1;NFE2L2;SOD2
prerank,sprouting angiogenesis (GO:0002040),0.2785143220975269,1.2457325252984857,0.05263157894736842,0.2672919778556915,1.0,14/50,10.64%,YJEFN3;VEGFB;PARVA;RECK;FGF2;SRF;CCBE1;JMJD6;RAMP2;PIK3R3;RSPO3;FLT4;ANGPT1;SEMA3E
prerank,regulation of cell morphogenesis (GO:0022604),0.3067520098056849,1.2456184517488842,0.125,0.2670032690707354,1.0,9/32,14.71%,FERMT2;ZNF135;CAPZB;EFNA5;ZMYM3;NTNG1;ZMYM6;ARC;WTIP
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.44690000441012256,-1.245537418114599,0.20270270270270271,0.5535990512353421,1.0,9/16,32.59%,RELA;IRAK1;FUT7;NFAT5;MDK;TNF;ITGB2;TRAF6;ETS1
prerank,positive regulation of telomerase activity (GO:0051973),-0.3794387155101481,-1.2452828375000455,0.19480519480519481,0.5530800489567914,1.0,10/34,17.57%,MYC;DKC1;NEK2;MAPK15;AURKB;GRHL2;NAF1;HMBOX1;CCT2;PRKCQ
prerank,ureteric bud morphogenesis (GO:0060675),-0.4344873363312597,-1.2449035636658516,0.2289156626506024,0.552753327353978,1.0,8/19,16.38%,MYC;SHH;SIX1;PAX2;PAX8;CITED1;WNT11;BMP4
prerank,artery morphogenesis (GO:0048844),-0.38972902178614277,-1.2441050633736477,0.21518987341772153,0.5537693550232529,1.0,9/30,16.38%,STRA6;PDGFRB;TGFB2;FOLR1;ENG;ANGPTL3;LRP2;NF1;BMP4
prerank,positive regulation of defense response (GO:0031349),-0.3210520777862477,-1.2438615313851518,0.15053763440860216,0.5532064310151127,1.0,46/96,34.17%,OSM;SERPINE1;EREG;IL1B;IL23A;WNT5A;ZP3;GBP5;PLA2G7;IFNK;IL21;CCL3;POLR3B;CEBPA;IL12B;FEM1A;AGT;IFNG;FPR2;TNFSF4;POLR3C;NFKBIA;NLRP12;ADAM8;CYBA;ZBP1;MDK;POLR3G;CCL1;NPAS2;NMI;MGST2;TNF;IFNB1;CCL5;TLR7;NLRP10;DHX9;PLSCR1;ETS1;AKIRIN2;IFI35;TLR8;MAPK13;ABCC1;CD47
prerank,regulation of nuclear division (GO:0051783),-0.4256467614944951,-1.243408410432605,0.18055555555555555,0.5535255909299054,1.0,9/20,21.84%,KIF20B;NEK2;FBXO5;CDC25C;PKMYT1;RCC1;PDXP;FBXO43;MKI67
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.42643615232953214,-1.2427279023145292,0.21875,0.5543759003254806,1.0,5/16,16.95%,PDX1;NOS2;MAFA;AGT;DDAH1
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.35852688891603024,1.2427008729974134,0.09090909090909091,0.27104229706377736,1.0,6/21,10.14%,NR1D1;TIRAP;F2RL1;DAB2IP;TICAM2;FLOT1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.3612438875273386,1.2426732397130922,0.1875,0.27065005061361275,1.0,4/19,7.10%,NXF1;PABPN1;POLDIP3;HHEX
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.44281033442025564,-1.241765213082842,0.18055555555555555,0.555753592184244,1.0,3/16,5.65%,IRS1;BMP8A;SIRT4
prerank,mesenchyme development (GO:0060485),0.38796769149184135,1.241298326496075,0.1724137931034483,0.2723337992766569,1.0,5/16,8.61%,FOXF1;CRELD1;PKD2;FGFR2;MEOX1
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.39962802492114147,-1.2407759296396537,0.21518987341772153,0.5576237497600327,1.0,10/26,22.88%,IL1A;IL1B;C3;CXCL17;TGFB1;GATA4;NOX1;BRCA1;EIF2AK3;NODAL
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.2614325028141819,1.2407108786229712,0.07142857142857142,0.2728616511779349,1.0,19/89,9.22%,FAM107A;CORO2B;GPM6B;RHOB;RND2;RAC1;MTOR;PRKCD;RAPGEF3;DAPK3;PDGFRA;EFNA5;RHOA;ESAM;RHOQ;DLC1;RHOC;TESK1;BAIAP2
prerank,granulocyte differentiation (GO:0030851),-0.4250725319408053,-1.239689564192497,0.15,0.5595939982070938,1.0,5/20,9.90%,PML;LEF1;E2F1;CDK4;CEBPA
prerank,histone mRNA metabolic process (GO:0008334),-0.4069280896466777,-1.2395125062524188,0.1095890410958904,0.558761499552252,1.0,15/24,32.60%,CPSF3;SNRPF;SNRPG;NCBP1;EXOSC4;ZNF473;MTPAP;CPSF2;SNRPB;SLBP;XRN1;SNRPE;SSB;ERI1;SNRPD3
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.2858049739766328,1.2394772678574224,0.15789473684210525,0.27414328802833615,1.0,14/48,12.98%,RBPMS2;IL6R;VIP;MFN2;APOD;OGN;HMOX1;ID2;ELANE;PDGFB;IGFBP5;NDRG4;ELN;CX3CL1
prerank,negative regulation of protein depolymerization (GO:1901880),0.3433743006189451,1.2389802723017829,0.21212121212121213,0.2743063037411761,1.0,3/23,6.98%,LIMA1;STMN2;PLEKHH2
prerank,skeletal system morphogenesis (GO:0048705),0.2869319867688522,1.2389213277378786,0.11764705882352941,0.2739449305198148,1.0,16/39,16.52%,FGFR1;FGFR2;PDGFRA;HOXD9;HOXD3;HOXD4;HOXA4;HOXC4;OSR2;DSCAML1;MEGF8;HOXB4;CYP26B1;SKI;FUZ;FGFR3
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.3919749365006239,-1.238658528934312,0.16,0.560162464157651,1.0,16/31,27.99%,IL23A;ISG15;HSPD1;SYK;IL12B;PRKCZ;TNFSF4;CD46;NOD2;PIBF1;HMGB1;TIGIT;XCL1;CLEC7A;CD28;IL13
prerank,bile acid and bile salt transport (GO:0015721),-0.4024859554044279,-1.23836226066747,0.19230769230769232,0.5597341470919328,1.0,7/28,8.87%,ABCC11;SLCO1B3;SLCO1B1;SLC10A1;ABCC2;SLCO1A2;AKR1C4
prerank,regulation of interleukin-12 production (GO:0032655),-0.36304192338091884,-1.2383499087606196,0.15730337078651685,0.5584756381930595,1.0,23/51,28.34%,RIPK2;IL23A;IL17A;JAK3;IL23R;HSPD1;SYK;IL12B;IFNG;TNFSF4;IL10;PIBF1;THBS1;HLA-G;MDK;IRAK3;HMGB1;LTB;TIGIT;MEFV;CLEC7A;SCIMP;C1QBP
prerank,ear morphogenesis (GO:0042471),-0.4108853636567059,-1.2367507043847237,0.20833333333333334,0.5622352529083975,1.0,13/23,29.60%,EPHB2;SIX1;CHD7;PAX2;MYO6;PAX8;DCANP1;USH1C;ZIC1;TFAP2A;TIFAB;TWIST1;NIPBL
prerank,piRNA metabolic process (GO:0034587),-0.42684753310070417,-1.2362769292698443,0.22950819672131148,0.5624186834577991,1.0,9/19,29.44%,PIWIL1;BTBD18;HENMT1;FKBP6;MYBL1;TDRD1;EXD1;TEX15;ASZ1
prerank,chondroitin sulfate metabolic process (GO:0030204),0.31794770483323775,1.2362053051546784,0.2413793103448276,0.27701788961147544,1.0,10/30,16.79%,CSPG4;DCN;CHST3;IDS;CHST15;CHST9;CHST7;DSEL;CSGALNACT2;UGDH
prerank,negative regulation of cell cycle process (GO:0010948),-0.3595388206651699,-1.2357583249352238,0.14634146341463414,0.5626624803147662,1.0,21/62,20.83%,CHEK1;NEK2;E2F1;FBXO5;AURKB;TOM1L1;CHMP4C;TFDP1;BMP7;DMRT1;RBBP8;E2F8;CDC7;CBX3;BMP4;ESPL1;RNF2;BRCA1;HLA-G;NME6;FBXO43
prerank,negative regulation of insulin secretion (GO:0046676),-0.451917557990894,-1.2355087564993916,0.22535211267605634,0.5619890388733051,1.0,3/15,5.65%,IRS1;BMP8A;SIRT4
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.3713972238788687,1.2353322067590367,0.18181818181818182,0.2783188785476051,1.0,8/15,23.08%,NLGN2;NPAS4;HAP1;NLGN1;ADRA1A;STXBP1;CLN3;BAIAP3
prerank,regulation of hormone secretion (GO:0046883),-0.4344550078116841,-1.2352270249280344,0.2,0.5615319678322299,1.0,6/16,23.84%,IL11;OSM;FFAR2;FGF23;LIF;ANXA1
prerank,microtubule polymerization or depolymerization (GO:0031109),-0.39478984583319504,-1.2351071511902056,0.1794871794871795,0.5606818415113765,1.0,10/26,18.20%,KIF18A;KIF14;KIF24;KIF2A;TRPV4;KIF2C;KIF18B;NCKAP5;CENPJ;CKAP5
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.36065948907982354,-1.2351023160568173,0.1375,0.5594110374631663,1.0,23/58,27.08%,CEP55;INCENP;KIF23;KIF20A;CENPA;RACGAP1;MYH10;AURKB;KIF4B;ECT2;PLK1;SPAST;RTKN;ESPL1;CKAP2;ANLN;STMN1;CIT;ROCK2;TTC19;RASA1;BIN3;SPIRE2
prerank,positive regulation of response to stimulus (GO:0048584),-0.35374315224420394,-1.234736267600549,0.1728395061728395,0.5593109654469054,1.0,7/44,5.49%,MYC;TGFB2;CD80;HMGA1;WNT5A;CDKN2A;HMGA2
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.33220898003804145,1.2343755578011428,0.07407407407407407,0.2790618686477916,1.0,5/19,14.45%,SLC25A4;MUL1;BNIP3;BAD;BCL2
prerank,sphingosine metabolic process (GO:0006670),-0.4665558837129057,-1.234258269037823,0.15384615384615385,0.5596792717760258,1.0,6/16,17.61%,SPTLC1;ASAH2;SGPP2;ASAH2B;ACER2;SPTLC2
prerank,positive regulation of lipid kinase activity (GO:0090218),0.3276682835100791,1.2342475730508558,0.12903225806451613,0.27872832466879083,1.0,10/30,10.97%,KIT;FGF2;TNFAIP8L3;CCL21;PDGFRA;EEF1A2;P2RY12;PDGFB;PRKD1;ATG14
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.41087929353612557,-1.234221306805146,0.21686746987951808,0.558494735072551,1.0,10/25,24.18%,SULT2B1;CTSV;CBFB;RUNX1;ABCA12;BMP4;SFRP4;IL20;AQP3;ROCK2
prerank,sodium ion transmembrane transport (GO:0035725),0.24635437797070572,1.2339269912211714,0.047619047619047616,0.27885089291716414,1.0,27/87,15.61%,ASIC3;SCNN1D;SCN7A;ATP1B2;ATP1A2;SCNN1B;PKD2;SLC9A9;SLC24A3;SCN3B;SCN2B;SCN1B;SCNN1G;SCN9A;ATP1A3;SLC8A2;SCN11A;SLC6A16;SCN4B;SLC8A1;SLC6A17;SLC6A9;SCN4A;SLC6A8;HCN3;SLC6A15;SLC6A19
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.4567724849083928,-1.2331410962957694,0.22857142857142856,0.5605460927307464,1.0,4/15,8.89%,POP1;RNASEH1;RPP40;LACTB2
prerank,carboxylic acid transport (GO:0046942),-0.34853790463065465,-1.2331379041489885,0.12048192771084337,0.5592750131553932,1.0,27/56,37.18%,SLC6A20;SLC6A14;SLC7A5;SLC16A13;SLC6A6;SLC38A5;SLC7A1;SLC1A5;SLC1A4;AQP9;SLC7A6;SLC16A3;SLC13A3;SLC16A6;SLC36A3;SLC3A2;SLC38A3;SLC6A12;SLC16A4;SLC17A2;SLC6A13;SLC17A1;SLC6A11;SLC36A2;SLC17A3;SLC15A4;SLC16A11
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.34139305526116803,1.2327783002208437,0.1724137931034483,0.2794840110506015,1.0,10/22,21.82%,CLIP3;ZDHHC7;ZDHHC15;ZDHHC22;ZDHHC18;GOLGA7;ZDHHC1;ZDHHC20;ZDHHC11;ZDHHC8
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.34139305526116803,1.2327783002208437,0.1724137931034483,0.2794840110506015,1.0,10/22,21.82%,CLIP3;ZDHHC7;ZDHHC15;ZDHHC22;ZDHHC18;GOLGA7;ZDHHC1;ZDHHC20;ZDHHC11;ZDHHC8
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.35538660509070774,1.2326964017648103,0.10526315789473684,0.2791841355022639,1.0,3/16,2.40%,PSEN1;HEY1;HAND1
prerank,response to organic cyclic compound (GO:0014070),-0.3501470546420389,-1.2326398231410154,0.17045454545454544,0.5597447712094397,1.0,16/57,13.63%,IL1B;SPP1;CYP27B1;CYP24A1;KYNU;TRPM2;DHFR;PMAIP1;HLCS;CCL3;CYP19A1;DRD2;CHRNB2;WNT8B;TGFB1;GLDC
prerank,inositol lipid-mediated signaling (GO:0048017),0.2946682102557797,1.2324594050812865,0.18181818181818182,0.27924070776882975,1.0,12/51,6.57%,PIRT;FGFR1;PLCD4;PI4KB;NGF;PITPNM2;TNFAIP8L3;PIK3R1;PDGFRA;PLCD1;PLCL1;RHOA
prerank,defense response to virus (GO:0051607),-0.31146894238451006,-1.2322490997202735,0.16494845360824742,0.5596751489704582,1.0,29/128,15.46%,IFITM3;IFITM1;IFITM2;IFI44L;CLPB;IFI6;SKP2;OAS2;CXCL10;BST2;SERINC5;ISG15;IFIT3;PMAIP1;MX1;IL21;PRF1;NLRC5;BCL2L1;ABCE1;STAT1;RELA;G3BP1;APOBEC3F;ATAD3A;NT5C3A;OAS3;EXOSC5;EXOSC4
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.3540026241171949,1.2315861310928748,0.08,0.28020099394804315,1.0,4/21,3.20%,BCL2L2;MOAP1;CASP3;FAS
prerank,sulfur amino acid metabolic process (GO:0000096),-0.41450320801899604,-1.2306946301102692,0.22077922077922077,0.5632837351502655,1.0,10/23,30.67%,DPEP1;MAT1A;MTHFD1;AHCY;CPS1;SMS;CTH;GADL1;CBS;NOX4
prerank,mucosal immune response (GO:0002385),-0.4258591200859355,-1.2301011759996099,0.2054794520547945,0.5637264611309439,1.0,9/23,28.58%,DEFA6;FFAR2;RPL39;NOS2;DEFA5;DEFA1;BPIFB1;IFNL2;LTF
prerank,post-translational protein modification (GO:0043687),0.20189284005758845,1.229897669514774,0.0,0.28270587054872326,1.0,72/340,13.37%,SPARCL1;ASB2;FBXO32;HIF3A;LAMB2;CHRDL1;FBXO10;KCTD7;SDC2;FBXL22;DCAF8;FSTL3;HRC;PENK;DCAF5;FBXO9;WSB1;RAB3A;KLHL21;FBXO17;MFGE8;LAMC1;SKP1;IGFBP4;FBXL7;FBXO44;OBSL1;UBE2F;FSTL1;FBXL5;ASB8;ASB5;TNC;FBXO31;NEDD8;KLHL42;SOCS2;WDTC1;MXRA8;FBXO30;HSP90B1;ASB1;KLHL41;PSMC5;SCG2;FAM20C;WFS1;IGFBP5;FBXO27;SPSB1;KLHL20;LAMB1;SCG3;FBXW4;COPS4;APP;BTBD6;NUCB1;ASB3;RNF7;KLHL22;KLHL5;RAB13;COPS7A;PSMD9;COPS7B;EPAS1;LRRC41;RAB11B;FBXW5;CDH2;DCAF6
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.3671484246150036,-1.229809295154851,0.14102564102564102,0.5632926158897053,1.0,13/39,20.35%,CHEK1;BLM;CDK1;TICRR;HMGA2;BRCC3;TOPBP1;CDC14C;PLK1;BRCA1;CLSPN;HUS1;CDC6
prerank,negative regulation of DNA replication (GO:0008156),-0.4799204509907913,-1.2296978675851207,0.2236842105263158,0.5624170019588238,1.0,8/15,23.63%,MCIDAS;S100A11;ATR;GTPBP4;ENPP7;CDC6;PDS5A;GDF2
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.3401871628127766,-1.2296682809035782,0.13793103448275862,0.5612944226875448,1.0,18/74,15.68%,CD80;IL1B;MIF;EPHB2;IL23A;CD276;ZP3;JAK3;IL23R;CD81;IL21;SLC7A1;PNP;CD70;IL12B;CHRNB2;TNFSF4;CD46
prerank,negative regulation of transferase activity (GO:0051348),0.32684865562398474,1.228823554650336,0.058823529411764705,0.2836907397880148,1.0,7/29,11.97%,MAPT;CDKN1C;INPP5K;ZFP36;SMAD7;CERS1;EIF4A2
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.3093019294238126,-1.2282237137650889,0.14942528735632185,0.5648592177657572,1.0,22/92,14.13%,IL11;TDGF1;OSM;ITGA5;CD80;LRP8;RIPK2;MIF;IL23A;CD44;CLEC6A;IL23R;CD81;PECAM1;IL5;IL12B;SEMA4D;AGT;IL22RA2;TGFB1;PRKCZ;FYN
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.3241737821469838,1.227973466111058,0.23076923076923078,0.28438352917745935,1.0,9/28,10.97%,KIT;FGF2;TNFAIP8L3;CCL21;PDGFRA;P2RY12;PDGFB;PRKD1;ATG14
prerank,cellular response to inorganic substance (GO:0071241),-0.4359157332887281,-1.2269870940243122,0.265625,0.5672475229928466,1.0,11/18,35.23%,DPEP1;BLM;TIMELESS;MMP3;ADCY10;DDI1;ATRX;FMR1;DDI2;DDX11;CDK2
prerank,regulation of glycolytic process (GO:0006110),-0.33288973486343726,-1.226822027411738,0.14285714285714285,0.56651749734032,1.0,36/68,37.00%,PFKFB3;NUP155;ZBTB20;NUP37;NUP210;GAPDHS;PFKFB4;NUP107;NUP35;RANBP2;IFNG;SEH1L;NUP50;MLXIPL;NUP205;NUP93;RAE1;NUP88;PFKFB1;POM121;NUP43;NUP160;EIF6;NUP62;GCKR;NUP153;TIGAR;NDC1;NUP98;SEC13;IGF1;JMJD8;FBP1;NCOR1;NUP214;HIF1A
prerank,zinc ion transmembrane transport (GO:0071577),-0.41540602375780317,-1.2263915865925727,0.1643835616438356,0.56658054465651,1.0,8/22,25.87%,SLC30A2;SLC39A10;TRPM2;SLC39A11;SLC39A8;SLC30A6;SLC39A2;SLC30A5
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.3666250807401294,-1.2261320216371483,0.17073170731707318,0.5661471030204878,1.0,14/55,16.86%,CDK1;SOX4;GTSE1;PML;E2F1;CDC25C;CHEK2;ARID3A;AURKA;TFDP1;CASP2;E2F8;CNOT1;MDM2
prerank,gliogenesis (GO:0042063),-0.432299712981944,-1.2260510258770585,0.18823529411764706,0.5651476417811473,1.0,5/17,14.40%,TGFB2;MMP24;PAX2;GCM2;GCM1
prerank,response to purine-containing compound (GO:0014074),-0.4158475256492416,-1.2259641750990014,0.2535211267605634,0.5641380435000197,1.0,6/17,14.52%,TRPM2;DUOX2;STAT1;VGF;CITED1;DUOX1
prerank,negative regulation of cell cycle (GO:0045786),0.2699984988423506,1.2252724287779282,0.08333333333333333,0.2880917063676711,1.0,26/78,15.99%,TSPYL2;PTEN;RHOB;MYOCD;CDKN1C;RPS6KA2;HPGD;NR2F2;NPPC;BTG2;NUPR1;ZBTB17;GPER1;HHEX;LATS2;RNF167;SIPA1;SMAD3;BTG1;NKX3-1;PDCD4;BTG3;GAS1;HEXIM1;NR4A1;ALOX15B
prerank,natural killer cell activation (GO:0030101),-0.3694096819044307,-1.2252205652765364,0.19318181818181818,0.5654671178323469,1.0,27/42,43.17%,ULBP3;ULBP2;ULBP1;IFNK;IL21R;RASGRP1;IL12B;NCR1;IFNE;PIK3CD;ELF4;AXL;CD2;IFNB1;CD244;NCR3;IFNA1;IFNA21;PBX1;IFNA4;IL2;IFNA7;IFNA10;IFNA14;IFNA17;IFNA2;IFNA16
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.3546993300762436,1.2251374092165146,0.15384615384615385,0.2879429477558871,1.0,6/20,7.78%,PTEN;MYOCD;CDKN1C;NR2F2;HHEX;LATS2
prerank,negative regulation of cell differentiation (GO:0045596),0.22989284728314774,1.224811311725367,0.0,0.2883387631970183,1.0,61/185,19.25%,WNT9A;FERMT2;PTEN;WWTR1;MEIS1;CHADL;OSR1;HEY1;TWIST2;MEIS2;MYOCD;ITGB3;EID2B;SIRT2;CHRD;SPRY1;ARNTL;HDAC7;NPHP3;NKX3-2;ID2;SMAD7;NR1H2;ZADH2;GPER1;EGFR;DAB2IP;EFEMP1;TRIB2;MSTN;GPS2;IL17RD;SFRP1;GATA2;SMAD3;BBS12;RUNX1T1;TMEM64;GDF5;SUFU;PAF1;PDCD4;VASN;SKI;SDHAF2;NOTCH4;GDF10;ANKRD2;CNTN4;WNT10B;NR1H3;DLL1;RANBP3L;SFRP2;HOPX;ZBTB16;SNAI2;SOX8;RORA;HOXA9;BMP5
prerank,cellular response to oxidative stress (GO:0034599),0.2501450054316131,1.2248003128689706,0.14285714285714285,0.28796632529866856,1.0,23/123,8.82%,TPM1;MAPK1;ATF4;MAPK3;SNCA;MAPT;MAPK8;DAPK1;SIRT2;PKD2;PRKCD;HMOX1;ARNTL;STX2;PDGFRA;CCS;PXN;PRKAA2;EGFR;SOD1;PDK2;PRKD1;PRDX6
prerank,serine family amino acid metabolic process (GO:0009069),-0.45728353119427145,-1.2235548932672633,0.16176470588235295,0.5690471790006688,1.0,6/15,22.52%,BAAT;PSPH;MTHFD1;SHMT2;SRR;CTH
prerank,positive regulation of MAP kinase activity (GO:0043406),0.26822812260031437,1.2222459832851686,0.0,0.291489112834468,1.0,17/69,10.92%,FGFR1;KIT;FGF2;DVL3;SASH1;EGFR;DVL2;DAB2IP;TLR9;ELANE;GH1;PDGFB;FGF1;PDGFD;TENM1;CD24;DUSP19
prerank,regulation of NMDA receptor activity (GO:2000310),0.32239879214683653,1.2222134693016167,0.09523809523809523,0.2911133106370403,1.0,14/32,18.80%,DAPK1;NEFL;CCL2;DLG4;NLGN1;APP;DLG2;MEF2C;SLC6A9;GRIA4;ACTN2;GRIA1;LRRC7;CAMK2A
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.35758160302986236,-1.2220104222850956,0.16666666666666666,0.5725249961050449,1.0,18/41,34.68%,RFC3;POLH;RPA3;ISG15;POLA1;RFC5;RFC2;WRN;POLD2;USP10;USP43;SYCP1;SPRTN;RFC4;POLD1;DTL;UBC;WRNIP1
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.28829109237569506,1.2219242805598456,0.15384615384615385,0.291247844013877,1.0,25/71,17.41%,IL6R;BCL2L2;TLR3;MOAP1;CASP3;FAS;NGF;BAG3;MLLT11;P2RX7;DAB2IP;TNFRSF1A;SMAD3;GABARAP;BOK;DEDD;BAD;JAK2;RIPK1;BCL2;FGFR3;CASP9;IL12A;RNF41;ERBB3
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.3909697859539435,-1.2214782086065492,0.16216216216216217,0.5729052776899328,1.0,14/32,28.17%,E2F1;FBXO5;CCNE1;DHFR;POLA1;TFDP1;CDT1;NPAT;CDK5;CDC45;CDC6;ZPR1;ORC1;E2F7
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.42934430589889394,-1.2214758581491119,0.20512820512820512,0.5716742037742848,1.0,8/27,11.67%,CEMIP;THY1;CXCL9;CXCL11;NPSR1;CXCL10;CALCR;F2R
prerank,protein palmitoylation (GO:0018345),0.34609806205961424,1.2214075585672144,0.1111111111111111,0.29182700572638665,1.0,13/29,21.82%,CLIP3;GLUL;ZDHHC7;ZDHHC17;ZDHHC15;ZDHHC22;ZDHHC18;GOLGA7;PORCN;ZDHHC1;ZDHHC20;ZDHHC11;ZDHHC8
prerank,acyl-CoA biosynthetic process (GO:0071616),0.38788167043569444,1.2209410889701198,0.14285714285714285,0.29199191205563374,1.0,3/16,7.45%,PPT2;ACAT1;SCD5
prerank,regulation of complement activation (GO:0030449),-0.35941605439681606,-1.2206606734474383,0.16049382716049382,0.5731159272020168,1.0,23/50,30.03%,IL1B;C3;SERPING1;CPN1;CD81;CR1L;C4BPA;CD55;CFHR1;C2;CPB2;C4BPB;C9;CD46;PHB;C4B;C4A;CR1;CFHR4;C8B;C1QBP;F2;C8A
prerank,ncRNA catabolic process (GO:0034661),-0.41831077699562386,-1.2204600174690825,0.2571428571428571,0.5724621315504151,1.0,13/25,32.57%,POP1;SND1;EXOSC3;EXOSC8;DIS3;EXOSC5;EXOSC4;LIN28A;EXOSC7;LIN28B;EXOSC2;XRN1;SLFN14
prerank,cellular response to glucagon stimulus (GO:0071377),0.3437563579462749,1.2203413718614722,0.10714285714285714,0.29244163766499814,1.0,9/19,20.06%,ADCY5;PRKAR2B;ADCY4;PRKACA;ADCY9;ADCY2;ADCY6;PRKACB;GCGR
prerank,protein alkylation (GO:0008213),-0.40065411787386573,-1.2203105810880064,0.2361111111111111,0.5717540432105548,1.0,11/19,37.68%,PRMT3;CAMKMT;EEF2KMT;METTL21C;METTL21A;SNRPB;GSPT1;SNRPD3;FAM98A;PRMT1;PRMT8
prerank,organic anion transport (GO:0015711),-0.3277907941959977,-1.2200108607070141,0.17045454545454544,0.5714479633156274,1.0,32/99,21.91%,LRRC8E;CA9;SLC4A11;SLC22A11;ABCC11;SLCO1B3;SLCO5A1;SLC26A9;SLCO1B1;SLCO1A2;AQP9;CA5A;SLC2A14;SLC4A9;HBA1;SLCO4A1;SLC35A2;SLC22A13;CYB5R2;SLC2A2;SLC52A3;CA6;SLC19A1;CFTR;LRRC8D;SLC39A8;SLC4A8;SLC25A19;SLC22A25;SLCO3A1;SLC52A2;SLC22A9
prerank,negative regulation of T cell proliferation (GO:0042130),-0.3754912653815346,-1.2200018760710876,0.18181818181818182,0.5702474785622251,1.0,15/34,26.67%,CEBPB;FOXP3;IL4I1;CD80;VTCN1;PLA2G2F;IL10;HLA-G;LILRB4;CD86;ARG1;CR1;CRTAM;GLMN;PDCD1LG2
prerank,gland development (GO:0048732),-0.3271000737204248,-1.2182640244385663,0.16853932584269662,0.5742730683119853,1.0,23/71,20.50%,STRA6;TDGF1;SHH;PROX1;SOX9;EPHB3;SIX1;CAV1;MET;SIX3;CEBPA;PAX8;PCSK9;NKX2-1;PTF1A;NF1;GCM2;WNT11;NKX2-8;MSN;TG;MDK;LSR
prerank,cellular response to lipid (GO:0071396),-0.29063771304636676,-1.2181317330157628,0.07692307692307693,0.5734822257058452,1.0,58/214,21.10%,CXCL8;CXCL1;CXCL2;IL1A;CXCL5;CXCL3;WNT2;PPBP;TESC;IRS1;CD68;CXCL9;WNT7B;CXCL11;SERPINE1;CD80;ADCY1;PTK7;IL1B;SPP1;POU4F1;WNT5A;TNFAIP3;CARD17;SOX9;CXCL10;ABL2;PAX2;PF4;CXCL6;TNIP3;DEFA6;RELA;FFAR2;IRAK1;UCP1;FZD10;WNT8B;MED1;TNFRSF1B;WNT11;TNFSF4;BRINP2;MSN;DEFA5;CFTR;PF4V1;IL10;ADAM9;NOD2;POU4F2;IL36B;NLRP3;WNT3;RUVBL2;IL36RN;LCOR;CD86
prerank,positive regulation of immune system process (GO:0002684),-0.43064368574939305,-1.2177899369356335,0.19402985074626866,0.5734858556825057,1.0,10/21,23.84%,TGFB2;ZP3;HCAR2;TNFSF18;PIK3CB;GPR151;HLA-G;PIK3CD;AQP3;ANXA1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.3901841881663922,1.2165491173845238,0.1724137931034483,0.29817625356364247,1.0,6/16,14.84%,TMEM50B;CHMP4A;LEPROT;CHMP7;TMEM50A;VPS28
prerank,potassium ion homeostasis (GO:0055075),0.3207645995660481,1.216490246379865,0.1111111111111111,0.29788913277741635,1.0,6/24,8.44%,ATP1B2;KCNH2;ATP1A2;KCNMA1;SLC12A4;ATP1A3
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.26243584759663846,1.2157459424046597,0.16666666666666666,0.2988970070745591,1.0,28/89,16.23%,FERMT2;CLDN5;DUSP22;SMAD2;TGFBR3;HPGD;ARHGEF18;BMPR1A;GCNT2;SMAD7;RHOA;UBB;PXN;TWSG1;LRRC32;SMAD4;CDH5;WFIKKN2;PARD3;SMAD3;ZMIZ1;SMAD9;GDF5;SKI;FMOD;GDF10;ITGB5;FNTA
prerank,positive regulation of catabolic process (GO:0009896),-0.33142236676305586,-1.2154337175453123,0.14942528735632185,0.5801289397480035,1.0,21/65,25.34%,IL1B;ASB9;WNT5A;TNFAIP3;HECW1;ANGPTL3;CSNK2A3;HECW2;C4BPA;OAZ3;SORL1;SCT;C4BPB;APOA2;CSNK2A1;BARD1;GSK3B;AXIN1;IDE;TNF;ITCH
prerank,negative regulation of anoikis (GO:2000811),-0.46418002071438547,-1.2151885652589736,0.2361111111111111,0.5795557505040985,1.0,8/15,32.49%,ITGA5;CEACAM6;CAV1;CEACAM5;PTRH2;NOTCH1;MCL1;PTK2
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),-0.4331314358599383,-1.2146419262589445,0.1917808219178082,0.5800237095380659,1.0,11/18,34.00%,WNT5A;CCL4;CCL3;ADAM10;STK39;XCL2;XCL1;CCL5;S100A7;CCL7;CXCL13
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.336501882340661,1.2139640506872533,0.13636363636363635,0.3017619024092554,1.0,9/24,16.69%,PRNP;KCNB1;MYO1C;MTCL1;SLC51B;MIEF2;ITGB1BP1;ANK3;MFF
prerank,calcium ion homeostasis (GO:0055074),0.2649115191099492,1.2137613494389907,0.06666666666666667,0.30178580528359505,1.0,22/96,12.27%,DMPK;ATP2B4;JPH2;CCL14;STIM1;SNCA;NPTN;TPCN2;ANK2;SLC24A3;PTH1R;TMTC2;ELANE;WFS1;ATP2A2;RGN;SLC8A2;CDH5;CCL11;CCL13;SLC8A1;CCL23
prerank,oligodendrocyte development (GO:0014003),0.399847812567114,1.2128478436987635,0.23333333333333334,0.3024697820467596,1.0,4/15,13.97%,PLP1;CNTNAP1;EIF2B1;EIF2B4
prerank,protein maturation (GO:0051604),-0.3236673592452828,-1.2127834664462136,0.15476190476190477,0.584747795977598,1.0,26/94,19.60%,TESC;CPZ;MME;F12;DUOXA2;CIAO1;F7;PCSK1;CPN1;LIPT2;MMEL1;HSPD1;CPD;PRSS37;SORL1;NAA15;CASP2;ADAM10;AANAT;PCSK6;NAA35;PCSK7;PTCH1;SRGN;BOLA2;XPNPEP3
prerank,regulation of macrophage chemotaxis (GO:0010758),0.2989096064528426,1.2122348589719874,0.15789473684210525,0.303026306853697,1.0,5/22,12.73%,MAPK1;MAPK3;RARRES2;MSTN;AKIRIN1
prerank,regulation of glucose transmembrane transport (GO:0010827),0.38173678586382936,1.2114106146644148,0.25,0.30433367065726963,1.0,8/17,15.10%,CLIP3;INPP5K;OCLN;PLA2G1B;GH1;PRKAG2;PRKCB;NR4A3
prerank,regulation of mononuclear cell migration (GO:0071675),0.32373288416128176,1.2107285352625397,0.13636363636363635,0.3050113290197979,1.0,5/23,8.49%,LGALS3;MAPK1;MAPK3;RARRES2;MSTN
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.4152029700263307,-1.210196495981507,0.19444444444444445,0.591506574745691,1.0,10/21,30.12%,IL1B;CD81;CD55;PRKCZ;TNFSF4;TRAF2;NLRP3;XCL1;DENND1B;TRAF6
prerank,regulation of presynapse assembly (GO:1905606),0.3476983099466572,1.2098031104483706,0.21212121212121213,0.3059552169887824,1.0,7/18,16.35%,SNCA;SLITRK2;SLITRK3;APP;LRFN5;GPC4;MDGA1
prerank,regulation of presynapse organization (GO:0099174),0.3476983099466572,1.2098031104483706,0.21212121212121213,0.3059552169887824,1.0,7/18,16.35%,SNCA;SLITRK2;SLITRK3;APP;LRFN5;GPC4;MDGA1
prerank,histone H4-K5 acetylation (GO:0043981),0.41597113171564887,1.209696736388603,0.16666666666666666,0.3053372161113754,1.0,7/15,22.11%,ING4;JADE1;KANSL3;KAT8;JADE2;MEAF6;KAT7
prerank,histone H4-K8 acetylation (GO:0043982),0.41597113171564887,1.209696736388603,0.16666666666666666,0.3053372161113754,1.0,7/15,22.11%,ING4;JADE1;KANSL3;KAT8;JADE2;MEAF6;KAT7
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.40954206821559824,-1.209422175792041,0.21951219512195122,0.5929506038346438,1.0,10/20,31.85%,CARD11;SLC39A10;CD81;RELA;KCNN4;LCK;NFAM1;IKBKG;TRAT1;CD226
prerank,DNA double-strand break processing (GO:0000729),-0.43883870949416054,-1.2092873855452648,0.20253164556962025,0.5920920041250325,1.0,9/18,31.79%,BLM;DNA2;RBBP8;SLX1A;BARD1;BRCA1;SMARCAD1;UBE2N;SLX4
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.4130780034766823,-1.2075304244582201,0.19696969696969696,0.5958482384378642,1.0,12/29,22.08%,SPTLC1;CYB5B;ASAH2;NOS2;GCHFR;CPS1;NQO1;ASAH2B;ACER2;SPTLC2;PM20D1;GCH1
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.3357683010843858,-1.2074672269011235,0.1744186046511628,0.5948069824817603,1.0,25/71,32.31%,OSM;TP73;PUS7;PSMB9;PRKDC;PSMD14;CBFB;RUNX1;MYB;PSMA3;GATA3;PSMB3;PSMA5;PSMD12;PSMB11;PSMB2;ITCH;PSMA7;PSME2;PSME3;PSMC1;PSME4;KMT2A;FOXC1;TCF3
prerank,endodermal cell differentiation (GO:0035987),-0.3726766995481854,-1.2066292986816767,0.2054794520547945,0.5963841653726326,1.0,10/32,14.60%,COL11A1;INHBA;ITGA5;FN1;HMGA2;MMP2;LAMA3;MMP9;COL7A1;LAMB3
prerank,cellular response to acid chemical (GO:0071229),0.33133559870019247,1.2062185411781199,0.18518518518518517,0.31054833592968367,1.0,9/26,14.18%,CPEB1;MTOR;RRAGA;RRAGD;KLF2;RRAGC;CAPN2;RRAGB;LAMTOR3
prerank,rRNA transcription (GO:0009303),-0.43139712207064884,-1.2059908572149218,0.2608695652173913,0.5973198595695536,1.0,7/15,33.46%,NIFK;TAF1B;GTF3A;GTF3C4;GTF3C3;ANG;TCOF1
prerank,cellular glucose homeostasis (GO:0001678),0.2766574125284056,1.2059272914820445,0.2,0.3106841416710953,1.0,9/42,8.70%,NR1D1;KCNB1;CARTPT;NGFR;PIK3R1;PRKAA2;GPER1;PRKACA;HK2
prerank,negative regulation of wound healing (GO:0061045),-0.37178614169569524,-1.205732319945143,0.21686746987951808,0.5968880792642289,1.0,5/29,2.75%,SLC12A2;SERPINE1;EPPK1;CASK;THBD
prerank,positive regulation of wound healing (GO:0090303),-0.3433578200241483,-1.2055906334317692,0.25,0.5959220448579315,1.0,20/39,33.43%,CLDN1;SERPINE1;FERMT1;F12;REG3A;DUOX2;INSL3;F2R;DUOX1;ARFGEF1;THBS1;XBP1;ANXA1;CLEC7A;F2;RREB1;HPSE;CLDN4;PTK2;ACTG1
prerank,homologous chromosome pairing at meiosis (GO:0007129),-0.3884671312380544,-1.2054556868576642,0.1780821917808219,0.5952617784010765,1.0,11/24,31.19%,RNF212B;HORMAD1;TRIP13;ANKRD31;SYCE3;PRDM9;SYCP1;P3H4;SYCE2;RAD21L1;MEIOB
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.30523326611809326,1.2053136265842026,0.125,0.3114707362066074,1.0,11/34,12.86%,TPM1;HAND1;TGFBR3;FGFR2;BMPR1A;SMAD7;RBPJ;MYL2;SMAD4;MYH7;MYL3
prerank,cholesterol biosynthetic process (GO:0006695),-0.37982970667094385,-1.2052492305232931,0.1927710843373494,0.5945358062515816,1.0,17/34,35.67%,SQLE;CYP51A1;IDI2;DHCR7;SC5D;FDPS;NSDHL;G6PD;MVK;TM7SF2;ACAT2;DHCR24;HMGCS1;APOA5;MSMO1;APOA1;INSIG1
prerank,regulation of cell adhesion (GO:0030155),-0.3054512548823357,-1.2050891303693687,0.15555555555555556,0.5938947919600404,1.0,52/131,29.89%,CXCL8;C2CD4A;TESC;KIF14;PLAU;TGFBI;CXCR4;EPHB2;IBSP;DUSP1;ADGRG1;EPHB3;FUT1;ABL2;EPHA2;ARHGDIB;PKHD1;SEMA5A;PIK3CG;IL12B;SEMA4D;P4HB;PLXNC1;FUT7;TNFSF18;ADAM10;CXCR3;ADAM8;KNG1;MDK;PTPRJ;EPHA8;PKP4;HRG;PRKX;FUT2;FRMD5;ROCK2;EFNA1;TNF;LYN;DSCAM;C2CD4B;RASA1;MIP;ZFHX3;PTPN11;CYTIP;C1QBP;CCL5;RHOD;STX3
prerank,regulation of cell cycle (GO:0051726),-0.2786131485009578,-1.2049083443871604,0.05154639175257732,0.5933245785160081,1.0,70/288,18.85%,FAP;MYC;CXCL8;CCND1;DDIAS;INHBA;TP73;CHEK1;CDKN3;KIF20B;ZBED6;MCIDAS;TGFB2;SKP2;PML;POU4F1;MIF;CKS2;DLGAP5;FBXO5;MYBL2;WDR12;DUSP1;CDKN2A;PROX1;SOX9;SND1;MASTL;CALR;JUNB;FOXE3;HMGA2;NANOS3;CSNK2A3;TFAP4;LIN9;BOP1;FIGNL1;CDK4;CKS1B;NEK6;XIAP;IL12B;ASAH2;BMP7;CDK7;FOXM1;CDC14C;PLK1;PRR11;PNPT1;IFNG;GATA6;TGFB1;LIN54;CENPF;MLXIPL;ADAM10;PTPRK;GADD45GIP1;CRLF3;BMP4;MDM2;CDK5;CSNK2A1;BARD1;BIRC7;BRCA1;RNF40;THBS1
prerank,peptidyl-lysine methylation (GO:0018022),-0.4260589183761963,-1.2044421871186746,0.22727272727272727,0.5934912979062207,1.0,7/19,14.72%,SUV39H2;SMYD3;EEF2KMT;SUV39H1;SETD6;METTL21C;SMYD2
prerank,positive regulation of viral genome replication (GO:0045070),-0.39531895068525275,-1.2042301579452461,0.21951219512195122,0.5928292261161917,1.0,15/29,37.58%,SRPK1;PPIH;PABPC1;HACD3;FKBP6;TMEM39A;TOP2A;STAU1;PDE12;CD28;CCL5;LARP1;SRPK2;VAPB;TARBP2
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.21648911506323673,1.2040322563337242,0.14285714285714285,0.31306029391391843,1.0,40/164,14.07%,PALLD;MPZ;CDH19;PLXNB3;CADM3;CLDN5;IGSF11;NEXN;TRO;ROBO3;L1CAM;CLDN11;NPTN;PTPRS;AMIGO2;MYOT;OBSL1;PKD1;KIRREL3;SLITRK2;CEACAM1;SLITRK3;DCHS1;PTPRM;CDHR3;LRRC4C;NLGN1;CDH5;ROBO4;TENM1;PCDHB4;TENM3;NTNG1;CADM1;SELP;DSCAML1;CDH2;CNTN2;PCDHGC3;LRFN5
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),-0.3478703645186536,-1.2039289462970468,0.20987654320987653,0.5924814647829055,1.0,26/52,38.13%,DCLRE1C;PRKDC;POLB;PSMD14;POLA1;ERCC8;BRCC3;DCLRE1B;XRCC4;PAXIP1;LIG3;BARD1;BRCA1;RIF1;HMGB1;NSMCE2;ERCC6;PRPF19;XRCC5;UBE2N;SMARCAL1;DNTT;POLQ;HMGB2;RNF168;SMC5
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.3790025326523869,-1.203739496699688,0.25,0.5918106459585444,1.0,10/21,28.58%,GRIN2B;USP50;PSMB9;FYN;NLRP12;IFI16;TTBK1;MEFV;AIM2;LTF
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.28527546566093986,1.2034878178818178,0.06666666666666667,0.3138724531717641,1.0,15/71,7.59%,PIRT;PTEN;FGFR1;PLCD4;ZFP36L1;PI4KB;NGF;PITPNM2;SIRT2;PIK3R1;PDGFRA;PLCD1;PLCL1;RHOA;NYAP1
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.3978238377162945,-1.2025872041791539,0.2318840579710145,0.5942997870050406,1.0,13/20,40.40%,IL23A;IL23R;TNFSF9;IL12B;IL27RA;HMGB1;IL12RB1;IGFBP2;AGER;IGF1;RPS3;IGF2;IL2
prerank,positive regulation of cellular catabolic process (GO:0031331),0.21921355761084818,1.2020608036273515,0.14285714285714285,0.31607207863123404,1.0,39/138,18.42%,PSEN1;DCN;OPTN;SNCA;ULK1;FLCN;ZSWIM8;TRIM6;DAPK1;PLIN5;PRKCD;VPS11;PACSIN3;P2RX7;PRKAA2;BNIP3;PRKD1;RDX;TRIM34;TRIM21;TFEB;PLEKHF1;ARNT;APP;DXO;SNX33;BAD;PNPLA2;TPCN1;SH3GLB1;SNX9;INS;PTTG1IP;TP53INP1;KAT5;RNF152;TRIM8;TRIM68;SLC4A4
prerank,mRNA stabilization (GO:0048255),0.2971334572615433,1.2018185009273568,0.10526315789473684,0.3161069717929033,1.0,8/38,5.85%,CIRBP;VIP;RBM24;TARDBP;YBX3;MAPK14;TIRAP;ZFP36
prerank,negative regulation of response to stimulus (GO:0048585),-0.3308511260054916,-1.2016585199171665,0.17073170731707318,0.5962401921212654,1.0,16/59,18.99%,THY1;FOXP3;CASK;RBL1;SRMS;FBXO5;HMGA2;FOXA2;AMBP;COL3A1;AKT3;IGFBP3;NLRP12;DDAH1;TERT;HLA-G
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.3107129142076931,1.2014295822240821,0.2608695652173913,0.31638815488304,1.0,9/28,12.72%,TNS2;NCK1;INPP5K;PRKCD;PID1;GRB14;PIP4K2B;GRB10;PRKCB
prerank,regulation of humoral immune response (GO:0002920),-0.3502072552473387,-1.2013316839194075,0.15853658536585366,0.5962377016581292,1.0,30/54,38.10%,ZP3;C3;SERPING1;CPN1;CD81;CR1L;C4BPA;CD55;CFHR1;C2;GATA6;CPB2;C4BPB;C9;CD46;C4B;C4A;CR1;CFHR4;C8B;C1QBP;F2;C8A;CFHR5;C8G;CXCL13;CFB;CR2;ZP4;CFHR2
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.36939124982088944,1.2012172186344952,0.2222222222222222,0.31620723204701595,1.0,7/17,21.71%,HEY1;BMPR1A;RBPJ;HEY2;SNAI2;HEYL;NOG
prerank,positive regulation of type I interferon production (GO:0032481),-0.33505254140935564,-1.2009035367180452,0.13333333333333333,0.5962084007040046,1.0,21/73,20.93%,POLR2F;RIPK2;OAS2;POLR1C;PRKDC;ISG15;HSPD1;STAT1;NFKB2;RELA;POLR3B;POLR3K;IRAK1;G3BP1;OAS3;POLR3C;ZBP1;POLR3G;POLR3A;GAPDH;IFI16
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.3035202587745514,-1.199589724834769,0.07954545454545454,0.599190427305657,1.0,42/116,31.31%,TNFSF11;TNFRSF11B;CARD14;EDAR;PSMB9;PSMD14;TNFSF15;TNFRSF9;TNFSF9;STAT1;CD70;RELA;TNFRSF1B;TNFSF4;TNFSF18;NFKBIA;TRAF2;PSMA3;BAG4;EIF5A;TNFRSF12A;LTA;TXNDC17;ST18;PSMB3;TNFSF13B;TNFSF8;LTB;TNF;PSMA5;PSMD12;PSMB11;PSMB2;PSMA7;ACTN4;PSME2;AIM2;PSME3;PSMC1;TRAF6;PSME4;TNFRSF4
prerank,potassium ion transport (GO:0006813),0.22659557621038218,1.1989153340761831,0.07692307692307693,0.31992760387167407,1.0,18/121,7.97%,KCNMB1;KCNQ4;KCNA5;KCNH2;KCNN3;AQP1;KCNJ8;ATP1A2;KCNMA1;KCNB1;PKD2;SLC9A9;SLC24A3;LRRC55;KCNE2;TMEM175;KCNA2;KCNS3
prerank,heme biosynthetic process (GO:0006783),0.3638673549077297,1.1973568878958818,0.2413793103448276,0.3225337088808532,1.0,5/21,8.07%,UROD;FECH;NFE2L1;ABCG2;ALAD
prerank,regulation of chemotaxis (GO:0050920),0.3332052356492702,1.1971273263060107,0.16666666666666666,0.32246778521311525,1.0,9/31,8.61%,ZSWIM8;DUSP3;RARRES2;F2RL1;CCL21;PDGFRA;ELANE;P2RY12;PDGFB
prerank,positive regulation of TOR signaling (GO:0032008),0.3243792758466284,1.196578752002659,0.2608695652173913,0.3231974131304116,1.0,15/39,21.68%,FLCN;NCKAP1L;RRAGA;SIK3;RRAGD;RRAGC;KLHL22;GOLPH3;RRAGB;LAMTOR3;RHEB;WDR59;GAS6;LAMTOR1;GPR137
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.31373988506472983,1.196487181580396,0.14814814814814814,0.32291692425003343,1.0,7/23,13.41%,PLA2G5;PLA2G4B;ABHD4;PLA2G1B;PLA2G4C;PLA2G6;PLA2G4A
prerank,regulation of ossification (GO:0030278),-0.38279629062963505,-1.1962907271365335,0.24358974358974358,0.6088918868338604,1.0,18/36,30.07%,NOTUM;TGFB2;CYP27B1;WNT5A;KREMEN2;SOX9;LRP4;BMP2K;ANKH;AHSG;BMP4;MDK;SMAD6;NOTCH1;CHSY1;PTPN11;TWIST1;DKK1
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.30917226227971,-1.195988896642046,0.10714285714285714,0.6083840582929755,1.0,45/117,30.89%,MUC5AC;CARD11;MUC6;MUC16;PSMB9;CLEC6A;PSMD14;MUC12;SYK;RELA;FFAR2;MUC19;CLEC4C;MUC17;FYN;NRAS;MUC5B;PSMA3;MUC4;CARD9;MUC20;PSMB3;TAB3;MUCL1;PSMA5;LYN;MUC3A;PSMD12;PSMB11;PSMB2;PRKACG;CLEC7A;PSMA7;MUC15;ICAM2;IKBKG;PSME2;KLRC2;TYROBP;PSME3;PSMC1;MUC2;CREBBP;TRAF6;PSME4
prerank,cellular lipid catabolic process (GO:0044242),-0.36841124881499243,-1.1958139045089002,0.20833333333333334,0.6079314827964544,1.0,9/27,15.41%,AOAH;CEL;ANGPTL3;NUDT19;LIPG;PLBD1;ACBD5;APOA2;ABHD12
prerank,negative regulation of defense response (GO:0031348),0.23765725734589307,1.1954721109698419,0.16666666666666666,0.32407112939431715,1.0,25/80,17.46%,PPARD;NR1D1;TRAFD1;MAPK7;SIRT2;PRKCD;PTGIS;GPER1;MUL1;C1QTNF3;ELANE;GPS2;TRIM21;CDH5;FNDC4;DHX58;TNFRSF1A;PTGER4;LRFN5;MAPKBP1;NR1H4;KLF4;PPM1B;NR1H3;PCBP2
prerank,macrophage activation (GO:0042116),0.2994580166572059,1.193930286207355,0.17391304347826086,0.32708083538325916,1.0,10/36,13.92%,CLU;SNCA;MAPT;IFNGR1;CRTC3;APP;DYSF;CX3CL1;JAK2;TLR1
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.3321675602181948,-1.1939034265120179,0.14285714285714285,0.612883916703826,1.0,18/45,29.22%,SOCS3;SOCS1;JAK3;CAV1;OCIAD2;PIGU;VHL;F2R;CRLF3;CENPJ;IL10;IL26;NOTCH1;TNF;EGF;IL10RA;F2;CCL5
prerank,regulation of phagocytosis (GO:0050764),-0.3276966359375366,-1.1936344751134293,0.225,0.612609624100024,1.0,20/56,25.64%,IL1B;IL15RA;CALR;SYT7;SCARB1;FER1L5;SYK;SPACA3;TULP1;LYAR;IFNG;FPR2;APOA2;AHSG;CYBA;OLFM4;SIRPB1;LMAN2;TNF;CLEC7A
prerank,regulation of transposition (GO:0010528),-0.40560694061465646,-1.1934334065265755,0.18181818181818182,0.6119661971830986,1.0,15/21,47.74%,PIWIL1;BTBD18;SPOCD1;APOBEC3F;TEX19;MYBL1;TEX15;PIWIL4;APOBEC3A;AICDA;APOBEC3B;SMYD5;PIWIL2;APOBEC3H;APOBEC3G
prerank,vasculature development (GO:0001944),0.35461500779716565,1.1931978699338097,0.21428571428571427,0.32770912393225066,1.0,8/17,16.36%,FOXF1;TCF21;PDGFRA;SOX18;CDH5;FLT4;NOTCH4;ERRFI1
prerank,external encapsulating structure organization (GO:0045229),-0.28173687421983107,-1.1931173232273504,0.14432989690721648,0.6117344198172279,1.0,47/214,14.92%,COL10A1;MMP7;MMP13;ACAN;COL1A1;COL11A1;ADAM12;ITGA5;COL1A2;VWF;TGFBI;SERPINE1;LAMC2;SPP1;MMP1;MMP10;MMP11;CD44;FN1;IBSP;ICAM1;BCAN;ADAMTS12;MMP20;MMP24;HRNR;MMP2;MMP3;PECAM1;AGRN;ITGA11;FBN2;SMOC1;ADAMTS18;COL3A1;DSPP;DMP1;ITGAX;LAMA3;VCAN;MMP9;MMP25;COL7A1;NF1;KDR;LAMB3;MMP12
prerank,regulation of actin filament-based process (GO:0032970),0.2632317689377287,1.1930917328796191,0.06666666666666667,0.32748489015596177,1.0,15/72,9.22%,FAM107A;CORO2B;GPM6B;RHOB;RND2;RAC1;MTOR;PRKCD;EFNA5;RHOA;RHOQ;DLC1;RHOC;TESK1;BAIAP2
prerank,pulmonary valve development (GO:0003177),-0.43487994385712675,-1.1930517790774158,0.26666666666666666,0.6106343542168466,1.0,7/18,22.32%,STRA6;TGFB2;ROBO2;TNFRSF1B;BMP4;SMAD6;NOTCH1
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.35300839034739373,1.1926427399360429,0.2,0.32759506972982305,1.0,8/24,13.00%,TNFSF10;MOAP1;BCL2L11;MLLT11;GPER1;BNIP3;FAM162A;BAD
prerank,regulation of stem cell population maintenance (GO:2000036),-0.4230245550260659,-1.1922281476069128,0.28378378378378377,0.612298837710839,1.0,4/19,5.49%,MYC;LOXL2;WDR43;HMGA2
prerank,triglyceride biosynthetic process (GO:0019432),-0.42616246260675705,-1.1917998219746055,0.323943661971831,0.6123957202732695,1.0,6/16,26.57%,DGAT2;PNPLA3;GK;MOGAT1;LPGAT1;AGMO
prerank,regulation of nervous system process (GO:0031644),0.36447010791982987,1.1915521549211299,0.2916666666666667,0.32906875198475705,1.0,5/19,10.79%,NPTX1;NPTXR;TMEM108;SLC8A2;APP
prerank,regulation of dendrite development (GO:0050773),0.28091330535236614,1.19154540502878,0.2,0.32863174168995657,1.0,9/39,10.45%,PTN;CHRNA3;SDC2;DBN1;ADGRB3;DAB2IP;ZDHHC15;MARK1;PACSIN1
prerank,nucleosome disassembly (GO:0006337),-0.4170050722166854,-1.191427423735595,0.2361111111111111,0.6112164313921835,1.0,8/16,28.52%,HMGA1;SMARCA4;SET;SMARCC1;SMARCB1;NFE2;ARID2;GRWD1
prerank,chromatin disassembly (GO:0031498),-0.4170050722166854,-1.191427423735595,0.2361111111111111,0.6112164313921835,1.0,8/16,28.52%,HMGA1;SMARCA4;SET;SMARCC1;SMARCB1;NFE2;ARID2;GRWD1
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.3129062621029421,1.1911827364440433,0.18181818181818182,0.32886086659066005,1.0,9/27,12.72%,TNS2;NCK1;INPP5K;PRKCD;PID1;GRB14;PIP4K2B;GRB10;PRKCB
prerank,RNA modification (GO:0009451),-0.3424521880863617,-1.1910505379340899,0.23529411764705882,0.6113931155672017,1.0,22/53,31.78%,PUS7;WDR4;RBM15;HENMT1;TFB1M;NAT10;APOBEC3F;NSUN3;CDKAL1;DTWD2;PUS7L;METTL1;TRMT6;FTSJ1;TRUB1;ANKRD16;AARS2;NOP10;NSUN2;TYW5;SSB;ADAT3
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.4401861754376629,-1.1901085194331764,0.2571428571428571,0.6136904389150672,1.0,6/15,18.55%,DNMT1;DNMT3B;PAXIP1;MYB;AUTS2;BRCA1
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.3670618508431072,-1.1888452261282667,0.1875,0.6167710495307158,1.0,15/34,27.31%,RIPK2;IL23A;IL17A;IL23R;HSPD1;SYK;IL12B;IFNG;TNFSF4;HLA-G;MDK;HMGB1;LTB;CLEC7A;SCIMP
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.43381186552746875,-1.1887781063441554,0.25,0.6158209602764108,1.0,10/16,35.47%,GAD1;GLS2;NOS2;DDAH1;ARG1;GLUD2;ARHGAP11B;PRODH2;ALDH4A1;GLS
prerank,pharyngeal system development (GO:0060037),-0.4308465802050073,-1.1881365481594233,0.23376623376623376,0.6165565190112196,1.0,11/17,39.38%,TGFB2;FOLR1;BMP7;BMP4;PTCH1;GATA3;SIX4;TGFBR1;HES1;NKX2-5;NKX2-6
prerank,histone methylation (GO:0016571),-0.39336657861046537,-1.1879218899658919,0.2463768115942029,0.6160366774781179,1.0,16/25,38.12%,SUV39H2;SMYD3;NTMT1;SUV39H1;SETD6;FBL;SMYD2;CTCFL;CARM1;NSD1;CREBBP;EZH2;PRMT5;PRMT1;PRMT8;PRMT6
prerank,apoptotic process (GO:0006915),0.20918385545818005,1.1878269288273553,0.0,0.3338889820560121,1.0,69/222,18.08%,MAL;DMPK;PPARD;ATN1;RHOB;ING4;MAGEH1;APAF1;CASP3;FAS;PRUNE2;DAPK1;NGFR;MTOR;PRKCD;CDIP1;CASP12;BCL2L11;DAPK3;ATCAY;JADE1;EFNA5;ARHGEF6;PDE1B;CASP10;DPF2;BNIP3;DLC1;RTN4;AHCYL1;HK2;NLRP1;BNIP2;ZNF385A;CSRNP1;CIDEC;RAF1;CAPN3;APP;PIDD1;TNFRSF21;RRAGC;ERCC3;BOK;FAM162A;SFRP5;PLAGL1;CFLAR;BAD;JAK2;RIPK1;PDCD4;FEM1B;BCL2;SEMA6A;GDF6;ADORA2A;BCL2L13;ALOX15B;TCHP;TAOK2;AKAP1;NSG1;CASP9;KREMEN1;ERBB3;RNF152;PPP1R15A;ADRA1A
prerank,cellular response to amyloid-beta (GO:1904646),0.3119023354758006,1.1875658717023547,0.20833333333333334,0.3339598156888112,1.0,10/35,13.93%,PSEN1;PRNP;NGFR;CACNA2D1;EPHA4;CD36;ATP1A3;APP;NTRK1;ADRB2
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.24007133549445075,1.1875272415065805,0.0,0.33360897263640976,1.0,24/99,14.90%,TGFB1I1;CITED2;DAND5;LTBP4;EMILIN1;CDKN1C;SMAD2;FLCN;SPRY1;TGFBR3;SMAD7;UBB;LATS2;SMAD4;PEG10;IL17RD;WFIKKN2;SMAD3;PIN1;PPM1A;DKK3;ITGA3;VASN;SKI
prerank,neural tube development (GO:0021915),-0.4437158053792433,-1.1874667323326888,0.23684210526315788,0.6163694362013948,1.0,6/16,18.90%,SOX4;TRIM71;PROX1;GRHL2;TGFB1;PTCH1
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.28393483845799794,-1.1865088487525475,0.13829787234042554,0.6184501873087819,1.0,47/148,27.24%,CCND1;CEP72;KIF14;CDK1;CEP250;NEK2;FBXO5;RCC2;CDC25C;RAD51B;PSMB9;PSMD14;CDK4;HAUS7;TPX2;AURKA;PLK1;HAUS6;RFPL1;CEP76;CDC7;CENPF;CEP152;CEP78;CENPJ;CEP41;SDCCAG8;STOX1;CKAP5;PSMA3;ALMS1;NDE1;PLK4;CDC25A;HAUS2;PSMB3;PSMA5;PSMD12;PSMB11;PSMB2;CEP135;GPR132;PSMA7;TUBB4B;HAUS8;PSME2;AKAP9
prerank,cellular response to lectin (GO:1990858),-0.3063150753896163,-1.1864421014770925,0.10588235294117647,0.6162452818296322,1.0,44/114,30.89%,MUC5AC;CARD11;MUC6;MUC16;PSMB9;CLEC6A;PSMD14;MUC12;SYK;RELA;MUC19;CLEC4C;MUC17;FYN;NRAS;MUC5B;PSMA3;MUC4;CARD9;MUC20;PSMB3;TAB3;MUCL1;PSMA5;LYN;MUC3A;PSMD12;PSMB11;PSMB2;PRKACG;CLEC7A;PSMA7;MUC15;ICAM2;IKBKG;PSME2;KLRC2;TYROBP;PSME3;PSMC1;MUC2;CREBBP;TRAF6;PSME4
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.3063150753896163,-1.1864421014770925,0.10588235294117647,0.6162452818296322,1.0,44/114,30.89%,MUC5AC;CARD11;MUC6;MUC16;PSMB9;CLEC6A;PSMD14;MUC12;SYK;RELA;MUC19;CLEC4C;MUC17;FYN;NRAS;MUC5B;PSMA3;MUC4;CARD9;MUC20;PSMB3;TAB3;MUCL1;PSMA5;LYN;MUC3A;PSMD12;PSMB11;PSMB2;PRKACG;CLEC7A;PSMA7;MUC15;ICAM2;IKBKG;PSME2;KLRC2;TYROBP;PSME3;PSMC1;MUC2;CREBBP;TRAF6;PSME4
prerank,tRNA metabolic process (GO:0006399),-0.4460609833132187,-1.1863488126781818,0.25757575757575757,0.615309073411848,1.0,4/15,9.05%,POP1;DARS2;ADAT1;YARS2
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.30872339694141815,1.186087537103085,0.20689655172413793,0.3356343228271792,1.0,6/22,9.17%,CDKN1A;CDKN1C;INPP5K;CDKN2C;PRKRIP1;TESK1
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.38774094152936056,-1.1860387284326268,0.23076923076923078,0.6153720000967523,1.0,13/28,30.99%,POLR2F;POLR1C;TAF1A;POLR1B;TAF1B;CDK7;POLR1A;GTF2H2;GTF2H3;CCNH;TAF1D;ERCC2;TAF1
prerank,calcium ion transport into cytosol (GO:0060402),-0.4140951100658349,-1.1859272129406278,0.22727272727272727,0.6145684669458005,1.0,5/21,8.11%,GRIN2D;GRIN2B;JPH1;TRPM2;TRPV4
prerank,regulation of fibroblast proliferation (GO:0048145),-0.34159429951598635,-1.1856527361916303,0.17721518987341772,0.6142003000775826,1.0,7/46,3.39%,MYC;WNT2;EREG;MIF;E2F1;WNT5A;FN1
prerank,apical junction assembly (GO:0043297),-0.33776628081698623,-1.1855295958494712,0.19753086419753085,0.6134782379924113,1.0,16/57,16.57%,CLDN1;CLDN2;CLDN16;PARD6B;CLDN14;CLDN20;PECAM1;GRHL2;FRMPD2;CLDN18;ECT2;MARVELD2;POF1B;CLDN6;CLDN24;STRN
prerank,fatty acid catabolic process (GO:0009062),0.2688374974850199,1.184886740712619,0.1,0.3372339572289991,1.0,26/68,21.91%,PPARD;ACAD11;ECI2;ACADVL;ACAT1;CROT;BDH2;HADHB;ACADS;ACAA2;ECHDC2;LPIN1;SLC27A2;ACADM;PHYH;ABHD3;ALDH3A2;HADH;HADHA;ABCD4;LPIN3;ADTRP;ABCD1;SCP2;MCEE;ACAA1
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.371991065440158,1.1847488637836208,0.21428571428571427,0.3370301287765784,1.0,8/15,18.54%,WNT5B;NPHP3;RSPO3;CSNK1E;SFRP1;GPC3;DAAM2;TIAM1
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.24121966535101802,1.184469717397964,0.2222222222222222,0.3370065249062164,1.0,34/131,16.23%,TGFB1I1;TMEM100;RGMA;FERMT2;CLDN5;MAPK3;DUSP22;SMAD2;TGFBR3;HPGD;ARHGEF18;BMPR1A;GCNT2;SMAD7;RHOA;UBB;PXN;TWSG1;LRRC32;SMAD4;CDH5;WFIKKN2;PARD3;SMAD3;ZMIZ1;SMAD9;GDF5;MEGF8;PDCD4;GDF6;SKI;GDF10;ITGB5;FNTA
prerank,polyol biosynthetic process (GO:0046173),0.3830059253435797,1.1840777234578186,0.27586206896551724,0.33719234491965544,1.0,6/16,14.48%,ITPKB;IP6K3;FGF2;IP6K1;CYP27A1;ISYNA1
prerank,detection of chemical stimulus involved in sensory perception (GO:0050907),-0.4150660792951542,-1.182953555617942,0.3026315789473684,0.619826169023277,1.0,22/22,58.54%,OR2A7;OR2A4;PKD2L1;OR1K1;OR2A25;OR13G1;OR6K3;OR10K1;OR4E2;GPR148;OR10J1;OR5AN1;OR10Z1;OR12D2;OR12D3;OR6K2;OR10K2;OR6N2;OR10J3;OR6K6;OR10T2;OR10R2
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.35787951463204465,1.1827517780243486,0.23529411764705882,0.3389607692170745,1.0,4/15,5.85%,RBM24;ZFP36L1;TARDBP;ZFP36
prerank,cellular response to retinoic acid (GO:0071300),-0.33931031603564116,-1.1824932410815145,0.20238095238095238,0.6199557036047676,1.0,12/42,15.91%,WNT2;TESC;WNT7B;PTK7;WNT5A;SOX9;ABL2;PAX2;FZD10;WNT8B;WNT11;BRINP2
prerank,chromosome organization (GO:0051276),-0.29628672840606207,-1.182145192982888,0.1724137931034483,0.6199081066212818,1.0,18/100,12.19%,MYC;NUF2;CENPH;CENPW;RFWD3;NDC80;PADI1;PADI3;NUP155;HDAC10;MSH3;HMGA2;AXIN2;SOX1;SMARCA4;MSH6;CDT1;SUV39H1
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.2409334340868726,1.1817061712947339,0.11764705882352941,0.34036659750836973,1.0,19/69,12.71%,KLF9;CAV2;CDKN1C;PRL;TGFBR3;ATOH8;FGFR2;NR2F2;NUPR1;CEACAM1;PTPRM;SCG2;DAB2IP;B2M;SFRP1;TINF2;NKX3-1;KRT4;GDF5
prerank,regulation of activated T cell proliferation (GO:0046006),-0.35147896109404436,-1.1816670551981177,0.28378378378378377,0.6202384781877384,1.0,21/34,40.40%,FOXP3;IL23A;IDO1;IL23R;TNFSF9;IL12B;LILRB4;IL27RA;HMGB1;IL12RB1;CRTAM;IGFBP2;PDCD1LG2;CLC;AGER;IGF1;CD274;RPS3;RC3H1;IGF2;IL2
prerank,regulation of MAP kinase activity (GO:0043405),0.24708479735826414,1.1813560999416743,0.125,0.34057708812184945,1.0,21/97,10.92%,RGS2;UCHL1;FGFR1;KIT;FGF2;TSG101;INPP5K;PRKCD;SPRY1;EGFR;SMPD1;DAB2IP;TRIB2;ELANE;GH1;PDGFB;FGF1;PDGFD;TENM1;CD24;DUSP19
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.2446522940775069,1.1804229679424179,0.14285714285714285,0.3414415877896287,1.0,29/117,13.24%,GSN;TNFSF10;BCL10;SNCA;MAPT;APAF1;FAS;NGF;DAPK1;NGFR;SOX7;CASP12;GPER1;CASP10;MUL1;DLC1;NLRP1;MTCH1;PIDD1;SMAD3;LGALS9;BOK;FAM162A;NKX3-1;CFLAR;BAD;JAK2;ARL6IP5;RIPK1
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.3453853218296159,-1.179675174160788,0.20987654320987653,0.6253312319732889,1.0,9/45,13.23%,TDGF1;AREG;EREG;FAM83A;SOX9;EPGN;GRB7;TGFB1;REPS2
prerank,lymphocyte activation involved in immune response (GO:0002285),-0.4081325204764509,-1.1790708757699515,0.2876712328767123,0.6260515029311142,1.0,17/24,43.17%,IFNK;IFNE;MDK;IFNB1;CD244;LCP1;IFNA1;EIF2AK4;CD74;IFNA21;IFNA4;IFNA7;IFNA10;IFNA14;IFNA17;IFNA2;IFNA16
prerank,regulation of osteoclast differentiation (GO:0045670),-0.3528487214574179,-1.1787075159135063,0.2625,0.6261805418112345,1.0,10/35,12.54%,CEBPB;TNFSF11;POU4F1;IL23A;IL17A;IL23R;CCL3;IL12B;ZNF675;IFNG
prerank,T cell activation (GO:0042110),-0.3059874450557855,-1.1776724039643982,0.21176470588235294,0.6284461973309207,1.0,43/91,34.49%,FOXP3;SOX4;CD276;CD44;CHD7;GPR89A;GPR89B;IFNK;HSPD1;CXADR;RASGRP1;PIK3CG;LFNG;TREML2;ZAP70;TNFSF4;ITK;MICB;MSN;IFNE;MDK;CD3G;JAG2;PTPN2;SLA2;PIK3CD;GATA3;CRTAM;LCK;CD2;CLEC7A;DDOST;IFNB1;CD8B;CD28;RHOH;TNFRSF4;LCP1;PTPN22;PPP3CA;IFNA1;EIF2AK4;CD74
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.35025744390333613,1.1775667155778997,0.16666666666666666,0.3460477813968407,1.0,4/20,4.64%,TLR3;FSTL3;CARTPT;TMEM178A
prerank,regulation of interleukin-2 production (GO:0032663),-0.33443419469195246,-1.1773781813984892,0.24675324675324675,0.6282459042092564,1.0,23/48,32.74%,IL1A;FOXP3;CD80;CARD11;IL1B;TNFAIP3;IL17F;RUNX1;PNP;GBP1;TRAF2;LILRB4;CD86;CR1;ANXA1;XCL1;CLEC7A;GLMN;CD28;TRAF6;EZR;TRIM27;PDE4B
prerank,receptor clustering (GO:0043113),0.31225715750285643,1.1769491650384316,0.1111111111111111,0.34672485535804126,1.0,15/28,22.59%,FLNA;PTN;DLG4;NLGN1;SAV1;DLG2;ITGB1BP1;SYNJ2BP;NRXN2;ITGA4;LRRC7;NRXN1;DVL1;MADCAM1;ITGB7
prerank,histone acetylation (GO:0016573),0.2710504476203904,1.1765761353807995,0.0,0.34707416585196926,1.0,23/69,19.84%,APBB1;PER1;ING4;MORF4L1;KAT2B;SUPT7L;DMAP1;ATF2;KAT2A;JADE1;BRD8;CHD5;ING3;KAT8;KAT5;TADA3;NAA60;ACTL6B;JADE2;BRD1;MEAF6;BRPF3;EP300
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.35520633557554404,-1.1764543580631428,0.2375,0.6299637601760556,1.0,17/34,32.60%,CSTF2;MAZ;CPSF3;TTF2;SNRPF;SNRPG;CSTF1;NCBP1;ZNF473;CPSF2;SNRPB;CSTF3;SETX;CPSF4;SLBP;SNRPE;SNRPD3
prerank,glutamine family amino acid metabolic process (GO:0009064),-0.35619608656578866,-1.17638128575492,0.25316455696202533,0.6290281619987232,1.0,17/33,36.14%,GLYATL1;GLS2;SIRT4;CPS1;CAD;ALDH18A1;ALDH5A1;DDAH1;SLC39A8;GLUD2;NAGS;GCLM;PYCR1;TAT;ALDH4A1;GLS;NIT2
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.3317996322102702,1.1758004011873129,0.18518518518518517,0.34780734442481887,1.0,8/21,16.79%,CSPG4;DCN;CHST3;CHST15;CHST9;CHST7;CSGALNACT2;UGDH
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.3205518032530365,-1.175656872975159,0.20224719101123595,0.6297209848659967,1.0,27/75,32.31%,OSM;TP73;PUS7;PSMB9;PRKDC;PSMD14;CBFB;RUNX1;MYB;PSMA3;GATA3;PSMB3;SPI1;PSMA5;PSMD12;PSMB11;PSMB2;ITCH;PSMA7;PSME2;PSME3;PSMC1;PDCD2;PSME4;KMT2A;FOXC1;TCF3
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.3949715232804073,-1.1753782347473576,0.2608695652173913,0.6293712368137154,1.0,11/23,35.84%,SLC39A10;CBFB;CD81;RUNX1;LYN;NFAM1;ELF1;GCSAM;PAX5;PTPN22;CD300A
prerank,regulation of phospholipase C activity (GO:1900274),0.3917287686385209,1.175078883767127,0.2962962962962963,0.3487159794086882,1.0,4/15,5.96%,FGFR1;KIT;FGF2;PDGFRA
prerank,epithelial to mesenchymal transition (GO:0001837),-0.3384636954447332,-1.174931430536303,0.20238095238095238,0.629529454803054,1.0,8/46,5.49%,LOXL2;AMELX;TGFB2;LEF1;WNT5A;SOX9;ENG;HMGA2
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.3899866196640552,1.1748551398380374,0.21875,0.3486185318966094,1.0,4/15,8.63%,FGFR1;HSPB1;FGF2;PRKD1
prerank,negative regulation of mitotic cell cycle (GO:0045930),-0.33826393236338603,-1.1737163237683235,0.1951219512195122,0.6321909800533034,1.0,19/48,26.63%,CHEK1;MAD2L1;TOM1L1;BCL6;ZWINT;BMP7;BUB1;PTPN3;TGFB1;RFPL1;BRINP2;BMP4;IL10;NME6;WEE2;NABP1;BTG4;BUB1B;ZW10
prerank,glucose homeostasis (GO:0042593),0.2609247431248644,1.1735956670313197,0.2,0.3503787804006553,1.0,25/84,17.39%,SLC2A4;NR1D1;CRY2;INPP5K;KCNB1;CARTPT;NGFR;PIK3R1;OAS1;CRTC2;PRKAA2;WFS1;PDK2;HK2;USF1;CRY1;BAD;PYGL;LRRC8A;HK1;LEPR;STAT3;INS;SLC30A8;CYP11B1
prerank,glycerolipid catabolic process (GO:0046503),0.34832691933835863,1.173528910335124,0.2413793103448276,0.35010276550355096,1.0,8/19,14.36%,PLA2G4B;ABHD6;PRDX6;GDPD3;PLA2G4C;ENPP6;PLA2G4A;MGLL
prerank,ncRNA 3'-end processing (GO:0043628),-0.41790183147949844,-1.1731113091003436,0.2638888888888889,0.6328727524372926,1.0,14/19,46.84%,INTS7;TRNT1;INTS2;INTS6;SAGE1;SSB;ERI1;CT45A1;CT45A5;CT45A3;INTS12;CT45A6;CT45A7;CT45A2
prerank,RNA export from nucleus (GO:0006405),-0.29947297148427043,-1.1730978530705098,0.21176470588235294,0.6317578521213474,1.0,44/104,31.20%,NUP62CL;ZC3H11A;U2AF1;NUP155;THOC3;NUP37;XPO5;NUP210;CPSF3;MAGOHB;NUP107;NUP35;RANBP2;SEH1L;NCBP1;NUP50;NUP205;ALYREF;EIF4E;SRSF9;NUP93;RAE1;NUP88;RAN;NXF2;NXF3;POM121;NUP43;CPSF2;MAGOH;DDX39A;NUP160;NXT1;GLE1;NUP62;SMG1;NUP153;NDC1;CPSF4;NUP98;THOC2;SLBP;SEC13;AGFG1
prerank,negative regulation of epithelial cell migration (GO:0010633),0.30371618272020756,1.1719108329542658,0.15,0.3527387708070738,1.0,10/35,15.39%,PTEN;DCN;CORO1C;NR2F2;PTPRM;DAB2IP;EVL;SVBP;SYNJ2BP;PFN2
prerank,transport across blood-brain barrier (GO:0150104),0.2405248467068215,1.1717551172343494,0.14285714285714285,0.3526660108469583,1.0,21/86,13.04%,SLC2A4;ATP2B4;ATP1B2;KCNJ8;ATP1A2;SLC29A1;SLC24A3;SLC16A12;SLC16A2;CD36;SLC7A2;ABCG2;SLC8A2;SLC27A1;ABCC5;AVPR1A;ABCC9;SLC6A17;TFRC;SLC6A9;SLC38A2
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.3638040593205891,1.1711369221726742,0.25,0.35320939875694196,1.0,9/16,20.02%,ECSCR;CCL2;GPER1;PDCD4;RGCC;ITGA4;AKR1C3;ANO6;CD40
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.40147681760200127,1.1711053285701956,0.23333333333333334,0.35278469585580663,1.0,6/17,7.82%,FSTL3;TMEM204;FST;FSTL1;ZDHHC17;TWSG1
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.22564972565460478,1.1709517645622858,0.0,0.35259513254285035,1.0,41/190,13.10%,PSEN1;ATP2B4;TCEAL1;CD34;CITED2;CLDN5;CILP;OPTN;MAPT;EMILIN1;FGF2;FLCN;TARDBP;TRIM6;HAND2;OCLN;ATOH8;PGR;SLC24A3;BMPR1A;ID2;RIN3;DLG4;PRKAA2;GPER1;PDGFB;RBMS3;SFRP1;MYADM;APP;GATA2;MAP2K2;LGALS9;NFKB1;SMO;OLFM1;MEF2C;NKX3-1;HINFP;MECP2;HEY2
prerank,response to copper ion (GO:0046688),0.35296669957421156,1.1708585456374658,0.25925925925925924,0.3523476180033282,1.0,8/22,13.56%,PRNP;AQP1;SNCA;MT1X;MT1M;MT1A;MT1E;MT3
prerank,regulation of defense response to virus by host (GO:0050691),-0.35540520659658065,-1.1707587861216953,0.2564102564102564,0.6378348587159814,1.0,17/33,37.58%,IL23A;TNFAIP3;IL23R;STAT1;IL12B;USP17L2;APOBEC3F;MICB;DTX3L;IL12RB1;AIM2;ZC3H12A;DHX9;PTPN22;EIF2AK4;HSP90AA1;TARBP2
prerank,organonitrogen compound catabolic process (GO:1901565),0.26034262701106503,1.1706936260723542,0.1111111111111111,0.3521299185351924,1.0,16/62,14.15%,PLA2G5;CPQ;MTOR;ENPP2;LNPEP;GNPDA2;ELANE;RENBP;NAALADL1;TPP1;PLA2G6;CAPN3;LVRN;LRSAM1;PLA2G4A;BCKDK
prerank,response to retinoic acid (GO:0032526),-0.3247927028173544,-1.1705320564795392,0.2345679012345679,0.6373270538054827,1.0,17/60,17.42%,WNT2;TESC;WNT7B;PTK7;WNT5A;CTSH;SOX9;ABL2;PAX2;FZD10;GATA6;WNT8B;RBP4;WNT11;BRINP2;MICB;ACER2
prerank,regulation of programmed necrotic cell death (GO:0062098),0.34815066588545757,1.1700795726466775,0.2692307692307692,0.35261222980759865,1.0,11/20,29.20%,NUPR1;FLOT1;CFLAR;RIPK1;FLOT2;SDCBP;CYLD;PDCD6IP;BIRC2;OGT;CDC37
prerank,negative regulation of interleukin-2 production (GO:0032703),0.31554455647521357,1.1694872494403143,0.1935483870967742,0.3531224158170789,1.0,5/22,5.85%,CD34;PRNP;VSIG4;HDAC7;ZFP36
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.4267960244804808,-1.1694843109075992,0.28378378378378377,0.6381101607257242,1.0,7/17,18.53%,IRS1;SOCS1;JAK3;SMARCA4;IL7R;STAT5A;STAT5B
prerank,cellular response to interleukin-7 (GO:0098761),-0.4267960244804808,-1.1694843109075992,0.28378378378378377,0.6381101607257242,1.0,7/17,18.53%,IRS1;SOCS1;JAK3;SMARCA4;IL7R;STAT5A;STAT5B
prerank,innate immune response in mucosa (GO:0002227),-0.45450409240483186,-1.1694532271656237,0.2459016393442623,0.6370445830603468,1.0,7/16,28.58%,DEFA6;RPL39;NOS2;DEFA5;DEFA1;BPIFB1;LTF
prerank,triglyceride catabolic process (GO:0019433),-0.3587048195411264,-1.1692572025256396,0.2857142857142857,0.6363596684952917,1.0,5/23,12.02%,FABP6;PNPLA3;LIPG;PNPLA1;CPS1
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.37795533325906505,1.1685873287810096,0.26666666666666666,0.3540092047216338,1.0,6/15,17.38%,PRKCD;ORMDL1;PLA2G6;TNFRSF1A;SIRT3;SAMD8
prerank,regulation of intracellular pH (GO:0051453),-0.35945726763249697,-1.1682113757964077,0.19480519480519481,0.6381883393667943,1.0,12/35,24.87%,SLC9C1;GPR89A;GPR89B;SLC9A7;SLC9B1;SLC4A9;NOX1;CFTR;TM9SF4;SLC4A8;SLC9A4;TMEM165
prerank,cellular metal ion homeostasis (GO:0006875),0.2459837310922931,1.166907858585023,0.13333333333333333,0.3567808492070528,1.0,25/103,13.56%,DMPK;ATP2B4;CCL14;ATP1B2;STIM1;ATP1A2;NPTN;KCNMA1;TPCN2;ANK2;SLC24A3;PTH1R;SLC41A1;ELANE;ATP1A3;ATP2A2;RGN;SLC8A2;CDH5;CCL11;CCL13;SLC8A1;CCL23;CCL8;MT3
prerank,regulation of sprouting angiogenesis (GO:1903670),0.29688264976014284,1.1667271311509082,0.2,0.3565588943523228,1.0,14/32,20.35%,RHOJ;FGF2;GLUL;CEACAM1;JAK1;FGF1;EPN2;KLF2;SEMA6A;SYNJ2BP;KLF4;DLL1;FGF16;E2F2
prerank,B cell activation involved in immune response (GO:0002312),-0.45483092152466265,-1.1666914405317306,0.26865671641791045,0.6415844252606149,1.0,11/15,50.27%,MSH6;EXOSC3;BATF;IFNB1;RNF168;MSH2;RNF8;CD180;CD40LG;EXOSC6;CD19
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.3748196548800141,-1.1666331911368673,0.2345679012345679,0.6406048932653818,1.0,10/23,23.73%,SOCS3;SOCS1;NLRC5;STAT1;IFNG;IFNGR2;PTPN2;ARG1;PARP14;PPARG
prerank,regulation of immune effector process (GO:0002697),-0.33682888920530774,-1.1664370069462917,0.17073170731707318,0.6401477042503241,1.0,22/53,30.03%,C3;SERPING1;CPN1;CD81;CR1L;C4BPA;CD55;CFHR1;C2;CPB2;C4BPB;C9;CD46;ZNF683;C4B;C4A;CR1;CFHR4;C8B;C1QBP;F2;C8A
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.3892607048417597,-1.1663011288151013,0.23684210526315788,0.6393309088295784,1.0,7/28,18.13%,MYC;PDGFRB;DACH1;TOM1L1;PARP4;HMBOX1;FGFR4
prerank,detection of chemical stimulus involved in sensory perception of smell (GO:0050911),-0.4150295128182539,-1.1660938575541449,0.3076923076923077,0.6387695141309572,1.0,20/20,58.54%,OR2A7;OR2A4;OR1K1;OR2A25;OR13G1;OR6K3;OR10K1;OR4E2;GPR148;OR10J1;OR10Z1;OR12D2;OR12D3;OR6K2;OR10K2;OR6N2;OR10J3;OR6K6;OR10T2;OR10R2
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.3445611070434873,1.165193520838121,0.28125,0.3589437916708308,1.0,7/19,14.41%,FERMT2;MYOC;RAC1;COL16A1;SFRP1;TSC1;PPM1F
prerank,protein localization to organelle (GO:0033365),0.2145600769378136,1.1642985722416535,0.0,0.3601657556624565,1.0,48/137,21.18%,VAMP2;TUB;PRNP;OPTN;TOR1AIP1;MICALL1;GBP2;OBSL1;ANK2;HMOX1;PACSIN2;BBS1;GABARAPL2;ARL3;TULP3;HHEX;TRAM1L1;VAPA;CROCC;SCG3;APP;CTDNEP1;PAF1;RPA1;BBS2;XPA;TMEM30A;LAMP5;GBF1;TIA1;BBS4;CYB5A;ATP6V1D;ALDH3A2;CEP68;PPP1R15A;WDR83OS;ARL6;IFT20;RAB33B;CNTLN;TTC21A;DVL1;EMD;CNEP1R1;EHD1;SGTA;TOLLIP
prerank,aminoglycan catabolic process (GO:0006026),0.3143902673107919,1.1635010872867517,0.2727272727272727,0.36092245654285077,1.0,11/31,17.60%,SDC2;SDC3;IDS;GPC1;HPSE2;HGSNAT;GUSB;GPC4;GPC3;HSPG2;SGSH
prerank,regulation of mitochondrial fission (GO:0090140),0.3257676955169382,1.1632199345328704,0.2,0.3612156611339547,1.0,7/22,16.69%,DCN;MAPT;MUL1;BNIP3;MIEF2;RALBP1;MFF
prerank,response to lipid (GO:0033993),-0.29562545281102404,-1.1628203889190967,0.2,0.6479290935661315,1.0,36/109,24.61%,IL1B;SPP1;CYP27B1;CTSH;SOX9;CYP24A1;IL23R;SCD;NOCT;MAPKAPK2;CYP19A1;PALM3;IRAK1;NOS2;F2R;CPS1;GATA6;WNT8B;TGFB1;CITED1;RBP4;MICB;TRIB1;ACER2;FGFR4;STAT5B;IRAK3;SLPI;SRR;GCH1;SMAD6;AQP3;PPARG;ANXA1;RPS6KA3;MAPKAPK3
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.2771153686213701,1.1625460662507021,0.1875,0.3622860568957369,1.0,11/53,9.12%,IL6R;PTN;MAPK1;MAPK3;DEFB124;VEGFB;RARRES2;F2RL1;MSTN;CREB3;ZNF580
prerank,positive regulation of cell motility (GO:2000147),-0.28113946428631653,-1.1624231181649547,0.11702127659574468,0.6480607965444567,1.0,43/211,15.56%,CLDN1;MMP7;CEMIP;COL1A1;TDGF1;PLAU;PDGFRB;LAMC2;DUOXA2;IL1B;CCL24;GTSE1;LEF1;EPHB2;CTSH;MGAT5;MAZ;CEACAM6;F7;ANGPTL3;EPHA1;FAM83H;LGR6;DUOX2;CAV1;IGF1R;GRB7;PECAM1;PLET1;CCL3;C1QTNF8;SEMA5A;SEMA4D;F2R;ITGAX;MMP9;TGFB1;KDR;CXCL16;CCL26;DUOX1;WNT11;ADAM10
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.3190451837898664,1.161897576568891,0.25,0.36272067903587274,1.0,6/21,14.21%,NAB2;MTOR;ZNF76;MAF1;TENM1;ZNF345
prerank,regulation of immunoglobulin production (GO:0002637),-0.37139904771855403,-1.1618033424738448,0.2727272727272727,0.6488854301386324,1.0,9/28,23.42%,EPHB2;IL21;RBP4;TNFSF4;IL10;PHB;CD86;CR1;XBP1
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.4067564981441405,-1.1614775153042762,0.29850746268656714,0.6487404560378247,1.0,8/19,23.52%,CEBPB;SOX9;CAV1;DSPP;IFNG;PRKX;GATA3;FOXN1
prerank,extracellular structure organization (GO:0043062),-0.27507531713767636,-1.1610584005637747,0.18556701030927836,0.6491201416015918,1.0,46/213,14.92%,COL10A1;MMP7;MMP13;ACAN;COL1A1;COL11A1;ADAM12;ITGA5;COL1A2;VWF;TGFBI;SERPINE1;LAMC2;SPP1;MMP1;MMP10;MMP11;CD44;FN1;IBSP;ICAM1;BCAN;ADAMTS12;MMP20;MMP24;MMP2;MMP3;PECAM1;AGRN;ITGA11;FBN2;SMOC1;ADAMTS18;COL3A1;DSPP;DMP1;ITGAX;LAMA3;VCAN;MMP9;MMP25;COL7A1;NF1;KDR;LAMB3;MMP12
prerank,positive regulation of cilium assembly (GO:0045724),0.3551965765241422,1.1608860971323702,0.23809523809523808,0.36430379099021515,1.0,6/16,16.87%,HAP1;CROCC;MARK4;TAPT1;FUZ;BBS4
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.32757042538340336,1.160789872671918,0.16666666666666666,0.363988487359709,1.0,13/41,15.43%,ITPKB;IP6K3;PI4KB;PIK3R1;SOCS2;TMEM150A;PIP4K2B;IP6K1;PIK3R3;PI4K2A;FAM126A;PIP4K2A;TTC7B
prerank,translesion synthesis (GO:0019985),-0.3462259602288406,-1.1597997036257062,0.26582278481012656,0.6518647276163163,1.0,6/40,7.29%,RFC3;POLE2;POLH;RPA3;ISG15;RFC5
prerank,postsynaptic membrane organization (GO:0001941),0.34417008747189937,1.1597414319933705,0.22857142857142856,0.36530801578286226,1.0,9/19,19.81%,NLGN2;NLGN4X;DLG4;NLGN1;NLGN3;NRXN2;SHISA7;SHANK3;NRXN1
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.3871726389946172,-1.159727338732311,0.23076923076923078,0.6508605860422917,1.0,9/20,28.62%,PRKDC;SYK;ZAP70;MDK;IL36B;GATA3;XBP1;AXL;RHOH
prerank,protein phosphorylation (GO:0006468),0.20583353894260425,1.159306448279711,0.0,0.36545034412377164,1.0,116/480,14.98%,DMPK;PRRT1;NRBP2;FGFR1;TLR3;MAP3K6;MAPK1;MAP3K3;DDR2;ILK;MAPK3;IP6K3;PPP3CB;KIT;TNNI3K;PNCK;CDK3;ULK1;NIM1K;MAPK8;SMAD2;ULK2;CDK20;CDK9;MAP2K6;DAPK1;MAPK14;RPS6KA2;MTOR;PRKCD;CAMK1;TGFBR3;FES;FGFR2;DAPK3;STRADA;PDGFRA;BMPR1A;PRKG2;CCL2;EPHA4;SMAD7;PKD1;EEF2K;PRKAA2;PRKACA;EGFR;MAST1;DCLK1;SIK3;DAB2IP;MAST2;LATS2;GRK5;EFEMP1;FAM20C;MKNK1;CLK2;NEK7;TRIB2;TLR9;PKN1;PDK2;PDGFB;PRKD1;MARK1;JAK1;CSNK2B;YWHAZ;MAP4K2;BRSK1;PIM1;FLT4;NRBP1;STK32A;CSNK1E;PPP4R1;CREB1;PRKG1;SNRK;CAMK2D;CCL11;APP;HIPK4;BMX;FAM20B;CSNK1A1;ERG;TSSK3;MEX3B;MARK4;STK33;SGK1;MKNK2;PKDCC;CSNK2A2;GTF2H4;PRKAG2;PRKCB;CRY1;PRKCA;NTRK1;JAK2;RIPK1;MAML1;CLK3;PXK;STK36;BCKDK;CTSG;RET;MAPK10;GDF6;COPS8;MAP3K1;STK19
prerank,regulation of protein kinase A signaling (GO:0010738),0.35371793211509733,1.1592604399409658,0.3181818181818182,0.36502040710689576,1.0,5/19,7.42%,AKAP12;PJA2;PRKAR2B;AKAP6;RAMP3
prerank,response to glucocorticoid (GO:0051384),0.28984466765889505,1.1589675191654607,0.22727272727272727,0.36519129872307804,1.0,13/27,21.10%,FAM107A;ZFP36L1;BCL2L11;SLIT3;ZFP36;HSD3B2;PDCD7;NR3C1;SSTR2;SLIT2;UBE2L3;ZFP36L2;GOT1
prerank,telomere maintenance (GO:0000723),-0.3285573262186447,-1.1587861923577933,0.2345679012345679,0.6528457813124805,1.0,13/51,18.96%,BLM;PRKDC;DNA2;RPA3;RECQL4;DCLRE1B;ATR;WRN;SLX1A;POLD2;TERT;HUS1;RIF1
prerank,renal system development (GO:0072001),-0.31596641401628167,-1.158695827728496,0.2558139534883721,0.652032708885719,1.0,24/57,27.66%,STRA6;MME;TGFB2;PROX1;LRP4;SIX1;PAX2;C1GALT1;REN;STAT1;PAX8;PCSK9;AGT;RBP4;CENPF;BMP4;LHX1;CYP4A22;GATA3;HAS2;WNT4;SULF2;TFAP2A;CYP4A11
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.36236342423468576,1.1584385628663996,0.25,0.36610338220444516,1.0,6/18,16.14%,GRIK5;GRIK3;GRIK2;SLC17A7;NAPB;GRID1
prerank,respiratory tube development (GO:0030323),-0.3661061285496807,-1.157607059924763,0.2857142857142857,0.6551775003332296,1.0,10/30,16.38%,STRA6;WNT7B;SHH;PROX1;CEBPA;NKX2-1;CHI3L1;RBP4;DNAAF1;BMP4
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.36602009761219356,-1.15755221730681,0.2926829268292683,0.6542099677129564,1.0,16/33,35.67%,SQLE;CYP51A1;IDI2;DHCR7;FDPS;NSDHL;G6PD;MVK;TM7SF2;ACAT2;DHCR24;HMGCS1;APOA5;MSMO1;APOA1;INSIG1
prerank,protein depolymerization (GO:0051261),0.30187169575307,1.1574778315260044,0.20689655172413793,0.3675829490189502,1.0,5/28,2.71%,GSN;CFL2;DSTN;STMN2;STMN4
prerank,positive regulation of cell killing (GO:0031343),-0.4259101029167284,-1.157269379153443,0.29577464788732394,0.6538811254766607,1.0,8/15,18.17%,WNT5A;SYK;PRF1;NOS2;IFNG;NOX1;NOXO1;CYBA
prerank,histone H3 acetylation (GO:0043966),0.2885672529672264,1.1569024994187336,0.38461538461538464,0.3681767905831278,1.0,6/40,6.25%,PER1;ING4;KAT2B;SUPT7L;KAT2A;JADE1
prerank,regulation of cell death (GO:0010941),0.22393308304718426,1.1564793129342352,0.1,0.3685133970373412,1.0,20/93,13.56%,CRYAB;FERMT2;CLU;NCK1;SNCG;SNCA;FGF2;PARP16;CD36;UBB;RAMP3;TMEM109;BNIP3;PRKD1;ACOX2;SNCB;BNIP3L;NKX3-1;TSC1;MT3
prerank,positive regulation of leukocyte migration (GO:0002687),0.30434210114329835,1.1564456886310754,0.18181818181818182,0.36811123973511206,1.0,7/29,9.12%,IL6R;PTN;JAM3;LGALS3;F2RL1;NCKAP1L;ZNF580
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.26918790388761293,1.1563718413043398,0.23076923076923078,0.3678801614933883,1.0,9/43,6.67%,FERMT2;MYOC;EFEMP2;RRAS;RAC1;COL16A1;CCL28;CCL21;CD36
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),-0.35851597505244764,-1.1562482537079988,0.275,0.6561016698890048,1.0,14/33,24.88%,TESC;PLAU;TGFB2;SERPINE1;EPHA2;SYK;PIK3CG;ACER2;ADAM9;LIF;EPHA8;HRG;EFNA1;LYN
prerank,digestive tract development (GO:0048565),0.2645489972704033,1.1560444773518137,0.23529411764705882,0.36770627982288295,1.0,14/39,14.24%,FOXF1;CLMP;KIT;RARRES2;FGFR2;PKD1;RARB;GLI3;NPY;SMO;PKDCC;PYY;MEGF8;EDNRB
prerank,positive regulation of cell migration (GO:0030335),-0.27510370605773665,-1.1550097722389359,0.15625,0.6592052212597689,1.0,51/259,15.56%,CLDN1;MMP7;CEMIP;COL1A1;TDGF1;PLAU;PDGFRB;KIF20B;TGFB2;LAMC2;FERMT1;IL1B;CCL24;GTSE1;LEF1;EPHB2;FBXO5;ZP3;FN1;CTSH;SOX9;MGAT5;MAZ;CEACAM6;F7;ANGPTL3;EPHA1;FAM83H;LGR6;CAV1;IGF1R;GRB7;PECAM1;PLET1;CCL3;APELA;SEMA5A;S100A11;SEMA4D;INSL3;F2R;ITGAX;IFNG;MMP9;TGFB1;KDR;CXCL16;CCL26;WNT11;TNFSF18;ADAM10
prerank,positive regulation of cell death (GO:0010942),-0.31536612185943885,-1.1546282669438463,0.2345679012345679,0.6593373389045925,1.0,19/65,19.21%,GRIN2B;PRR7;RIPK2;WNT5A;EGR1;SLC6A6;FOS;AXIN2;MMP3;CALCR;IFNG;HBA1;FYN;BMP4;ACER2;POU4F2;PHB;GSK3B;HP
prerank,defense response to symbiont (GO:0140546),-0.29652532079347677,-1.1545757219820005,0.23157894736842105,0.6583943652551911,1.0,26/119,15.46%,IFITM3;IFITM1;IFITM2;IFI44L;IFI6;SKP2;OAS2;BST2;SERINC5;ISG15;IFIT3;PMAIP1;MX1;IL21;PRF1;NLRC5;BCL2L1;ABCE1;STAT1;RELA;G3BP1;APOBEC3F;NT5C3A;OAS3;EXOSC5;EXOSC4
prerank,positive regulation of monocyte chemotaxis (GO:0090026),-0.40954453149742065,-1.1541225873338978,0.2916666666666667,0.6586673681533058,1.0,9/19,30.49%,SERPINE1;CXCL10;CXCL17;PLA2G7;FPR2;CCL1;HMGB1;CCL5;S100A7
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.2998321238422881,1.1540116812453753,0.2608695652173913,0.3714632083955276,1.0,7/21,12.50%,GNB5;STAC;STAC2;NPPA;CACNB2;DMD;AHNAK
prerank,negative regulation of actin filament polymerization (GO:0030837),0.30213530066991257,1.153877895292418,0.2,0.3712853176995437,1.0,11/24,22.00%,GSN;PRKCD;KANK3;MYADM;PFN2;KANK1;TWF2;SSH3;SLIT2;SCIN;PFN1
prerank,inorganic cation transmembrane transport (GO:0098662),0.2044561285876981,1.1532995805908997,0.14285714285714285,0.3718976385731815,1.0,57/269,13.27%,ATP2B4;KCNQ4;KCNA5;ASIC3;CACNA1H;SCNN1D;SCN7A;SCARA5;KCNH2;SLC39A13;KCNN3;KCNJ8;ATP1A2;SLC25A27;KCNB1;SCNN1B;PKD2;CACNA1C;SLC9A9;SLC24A3;SCN3B;LRRC55;PKD1;KCNE2;P2RX7;TRPC1;SCN2B;SLC41A1;SCN1B;TMEM175;KCNA2;MCOLN1;SCNN1G;KCNS3;TRPC4;TRPV1;SCN9A;ATP1A3;ATP2A2;RYR3;SLC8A2;SCN11A;OTOP2;SLC6A16;ABCC9;SCN4B;KCND3;SLC8A1;KCND1;MCOLN3;UCP3;SLC6A17;TRPC6;ABCC8;SLC6A9;KCNF1;SCN4A
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.3868275482179808,-1.1532684757180724,0.2375,0.6601266460450177,1.0,10/21,30.39%,IRS1;IL1B;ANGPTL3;SCT;APOA2;AADAC;APOC2;ABHD5;TWIST1;APOA5
prerank,positive regulation of protein localization to membrane (GO:1905477),0.24740605013159406,1.1530963605690094,0.09090909090909091,0.3718323356620047,1.0,29/100,17.05%,CLIP3;SORBS1;ATP2B4;LGALS3;PRNP;MAPK8;KCNB1;MYO1C;MTCL1;CNPY4;PIK3R1;GPER1;EGFR;RAMP3;SLC51B;STAC;YWHAZ;STAC2;NECAB2;BAD;MIEF2;ITGA3;BCL2;ITGB1BP1;ANK3;PPP3CC;MFF;SQSTM1;EPHA3
prerank,activation of protein kinase B activity (GO:0032148),0.30557149486551105,1.1530453225078423,0.1111111111111111,0.3715139657517655,1.0,12/31,20.88%,MTOR;PDGFB;FGF1;MAPKAP1;ADRA2B;MT3;NTF3;ITGB1BP1;TXN;INS;GAS6;PINK1
prerank,carboxylic acid transmembrane transport (GO:1905039),-0.3459368595857913,-1.1530257836938251,0.3013698630136986,0.6597682127091411,1.0,17/41,34.70%,SLC7A11;SLC6A14;SLC7A5;SLC38A5;SLC5A6;SLC7A6;SLC19A1;SLC13A3;SLC36A3;SLC38A9;SLC7A7;SLC38A8;SLC38A3;ABCC1;SLC7A10;ABCB1;SLC36A2
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.24239578449394092,1.1529863361937749,0.07692307692307693,0.3711682791931254,1.0,28/86,21.29%,VAMP2;SORCS1;AP1S2;BLOC1S1;CORO7;ARL3;OSBPL5;AP1M1;KLHL20;TXNDC5;APP;GOLGA7;GBF1;RABEP1;HSPA8;EXOC6B;GOPC;CLVS2;STEAP2;ARF1;AP2A1;LLGL1;BLOC1S6;RAB14;SH3GL2;STX4;MYO5A;AP4S1
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.3342718608228388,1.15275720523533,0.16129032258064516,0.37118831728334584,1.0,3/16,7.28%,BCL10;KIT;GPRC5B
prerank,regulation of intracellular signal transduction (GO:1902531),0.18843842593538337,1.1526113029422869,0.0,0.371012077553276,1.0,77/427,11.65%,ARHGEF26;PTEN;PIP5K1C;RASD2;MAPK1;OPTN;PDE2A;PPP2R5B;ARHGAP10;RHOB;SYDE1;AKAP12;MAPK3;PRKAB2;ARHGAP6;MYOC;MAPT;RHOJ;ARHGEF17;HSPB1;FBXO9;ARHGAP33;RRAS;PJA2;FLCN;TRIM6;MAP2K6;RAC1;TRIP10;USP2;MAPK14;STARD8;MTOR;FAM83D;PRKAR2B;AKAP6;STARD13;ARHGEF18;JMY;F2RL1;PRDM11;RHOA;PRKAA2;EGFR;ARHGEF6;CEACAM1;RHOQ;MAPK11;DAB2IP;ARHGAP20;PIP4K2B;CHD3;DLC1;RHOC;RHOT2;RHOU;CSNK2B;RGN;ARHGAP23;GNA12;FGF1;NLGN1;TRAF1;ANKRD54;ZNF385A;MAPKAP1;ARHGAP1;CAPN3;CD24;PIDD1;ARHGAP19;ARHGEF9;GNAI1;INPP5B;RRAGC;PIN1;SGK1
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.28535655479880423,-1.1522446619423985,0.2,0.6610464580610009,1.0,26/134,12.77%,IL11;TDGF1;OSM;ITGA5;CSF2;SOCS3;CD80;LRP8;RIPK2;MIF;IL23A;CD44;DOK7;CLEC6A;IL23R;CD81;ARL2BP;IL21;PECAM1;IL5;IL12B;SEMA4D;FCGR1A;AGT;IFNG;TGFB1
prerank,myeloid cell differentiation (GO:0030099),-0.3315143202643258,-1.152192424372493,0.24358974358974358,0.6600740131674933,1.0,17/49,25.11%,IL11;INHBA;CSF2;JAK3;RUNX1;ZFPM1;CEBPA;DYRK3;RPS19;KLF1;PTPN2;IFI16;PRKX;HIPK2;SPI1;LYN;NCOA6
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.3513703014552408,-1.1519063178556939,0.3170731707317073,0.6599833897830077,1.0,14/44,16.38%,MYC;SHH;SIX1;ENG;PAX2;EPHA2;MET;PKHD1;PAX8;NKX2-1;CITED1;KDR;TGFBR2;BMP4
prerank,cilium-dependent cell motility (GO:0060285),-0.3889329402984424,-1.1518938067271112,0.28125,0.6588546623191343,1.0,7/22,20.51%,DNAH2;DNAH8;RSPH9;DNAH7;DNAAF2;DNAH3;TEKT5
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.3639106992814709,1.15163905762083,0.20689655172413793,0.3723201758922034,1.0,9/17,21.28%,MYOC;FLCN;KCTD10;DLC1;RASIP1;ITGA3;KANK1;TNFAIP1;HEG1
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.35160641379843144,-1.1512833248500425,0.28378378378378377,0.6597109470704352,1.0,10/27,23.07%,IL11;SERPINE1;ICAM1;TNFAIP3;SEMA5A;KDR;IL10;FGA;GATA3;FGB
prerank,regulation of Golgi organization (GO:1903358),0.3586665836892039,1.151222515171247,0.21739130434782608,0.3727861485294284,1.0,10/16,26.50%,MAPK1;MAPK3;RBSN;MAP2K2;RAB33B;MAP2K1;MYO5A;EHD3;STX5;CAMSAP2
prerank,intrinsic apoptotic signaling pathway (GO:0097193),-0.29837813609129193,-1.150754854252612,0.26666666666666666,0.6600238534484923,1.0,27/99,19.34%,CEBPB;TP73;IFI6;TRIB3;PML;POU4F1;E2F1;ERO1A;CHEK2;PRKDC;IKBKE;EPHA2;PMAIP1;BCL2A1;BCL2L1;TNFRSF10B;MSH6;CHAC1;CASP2;STK24;TNFRSF1B;POU4F2;TRAF2;BRCA1;PDK1;ATP2A1;BBC3
prerank,blood vessel morphogenesis (GO:0048514),-0.3202269001805415,-1.1503628873965115,0.21839080459770116,0.6599454243864872,1.0,14/56,15.06%,STRA6;TBX20;SHH;PROX1;ENG;ANGPTL3;CAV1;SYK;APELA;TNNI3;TGFB1;NF1;KDR;TGFBR2
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.30937114491487583,1.150259248702919,0.19230769230769232,0.37450781041915343,1.0,10/27,17.72%,CSPG4;DCN;CHST3;CHST15;CHST9;CHST7;B3GAT1;CSGALNACT2;UGDH;B3GAT3
prerank,positive regulation of DNA repair (GO:0045739),-0.32745462102208084,-1.1501824874662954,0.25,0.6593287403210355,1.0,18/43,33.58%,HDAC10;TIMELESS;EYA1;ERCC8;BRCC3;PRKCG;FOXM1;BRCA1;NPAS2;HMGB1;ERCC6;SPIRE2;WRAP53;TIGAR;DHX9;UBE2N;EYA3;DDX11
prerank,ribosome assembly (GO:0042255),-0.3362198483208398,-1.1500667266442646,0.2696629213483146,0.6585998081642573,1.0,15/47,28.96%,BOP1;BRIX1;NLE1;RPS19;RRS1;DHX37;VCX;NPM1;PWP2;RPF2;MDN1;RPL23A;EIF6;C1QBP;RRP7A
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.2367026835362927,1.1497347584472588,0.0,0.37530470951939243,1.0,33/147,12.31%,PLN;ATP2B4;SCGN;LPAR1;ADCY5;AGTR1;CAV2;P2RY1;ATP1A2;HRC;NPTN;PTGER3;ACKR3;CACNA1C;TMEM178A;F2RL1;PDGFRA;TRPC1;CD36;DLG4;GPER1;PRKACA;CALB2;TRPC4;SLC8A2;C1QTNF1;CD24;TBXA2R;SMAD3;SLC8A1;TAC1;PTGER4;TRPC6
prerank,regulation of cellular protein localization (GO:1903827),0.2736954699747962,1.1496965924982319,0.15789473684210525,0.37495734699760175,1.0,17/46,19.84%,MAPT;DVL3;MAP1A;MAP2;PRKAA2;GPC1;CSNK1E;PIN1;RAB11B;PPM1F;GPC4;GBF1;GPC3;NDEL1;RAB11FIP5;DVL1;GPC6
prerank,sensory perception of smell (GO:0007608),-0.3206952004865722,-1.1494994425462857,0.17391304347826086,0.6593463726080845,1.0,94/103,59.83%,OBP2B;OR2A7;OR6A2;OR2D2;DRD2;OR10A5;OR2A4;OR51B5;GFY;OR5B21;OR5M11;OMP;OR1K1;OR8D4;OR51M1;OR52D1;OR51I2;OR1Q1;OR51I1;ADCY3;OR4D1;OR8B12;OR51B6;OR2A25;OR2S2;OR13G1;OR52A1;OR8A1;OR8B2;OR1D2;OR8B3;OR9Q2;OR6K3;OR8B8;OR1D5;OR10K1;OR8G1;OR4E2;OR5AK2;OR10A3;OR9Q1;OR9I1;GPR148;OR10J1;OR8D2;OR2M4;OR10Z1;OR8B4;OR12D2;OR51B4;OR1C1;OR5M1;OR12D3;OR6K2;OR10K2;OR6C2;OR6N2;OR5M10;OR9G4;OR10J3;OR52A5;OR5B12;OR6C3;OR8H2;OR6K6;UBR3;OR51V1;OR5L1;OR5B3;OR5B17;OR8H3;OR5AP2;OR10T2;OR5D18;OR8K3;OR8U1;OR5I1;OR5D16;OR5M8;OR5D14;OR8H1;OR5M9;OR8J3;OR10R2;OR8K1;OR8I2;OR5L2;OR5AC2;OR5D13;OR5M3;OR8J1;OR8D1;OR5F1;OR8K5
prerank,second-messenger-mediated signaling (GO:0019932),-0.28792337908299437,-1.1493488105995031,0.22727272727272727,0.6587909048985527,1.0,24/87,22.40%,PDX1;CXCL8;CCR8;TNFSF11;CXCR4;CCR4;CCL3;CXCR2;NUDT4;CXCR5;NOS2;MAFA;CXCR6;AGT;FPR2;CCR3;CXCR3;DDAH1;CXCR1;CCRL2;KSR2;SAMD14;EIF2AK3;NMUR2
prerank,liver development (GO:0001889),-0.35404892804725474,-1.1492211445878404,0.28169014084507044,0.657998387497269,1.0,15/32,28.17%,CEBPB;PROX1;MET;AURKA;CEBPA;PCSK9;E2F8;NF1;NKX2-8;DNAAF1;LSR;XBP1;ANXA1;WNT4;E2F7
prerank,miRNA metabolic process (GO:0010586),-0.4155323238079654,-1.148382344251144,0.2692307692307692,0.6594237119356682,1.0,11/17,37.62%,TRIM71;SND1;XPO5;LIN28A;RAN;KHSRP;LIN28B;DROSHA;DIS3L2;TARBP2;AGO2
prerank,regulation of exocytosis (GO:0017157),0.2558895492974588,1.147974845409884,0.21052631578947367,0.37806141535807813,1.0,12/47,14.30%,VAMP2;SNCA;CHMP3;RAB3A;LGI3;HAP1;RAB2B;SYT1;RAB13;RAB3C;RAB8B;RAB27A
prerank,sulfur compound transport (GO:0072348),-0.3494990147344626,-1.1479555773099044,0.24675324675324675,0.6595513757069366,1.0,7/28,18.64%,RACGAP1;SLC13A4;SLC6A6;SLC26A8;SLC5A6;LRRC8D;SLC25A19
prerank,contractile actin filament bundle assembly (GO:0030038),0.35559570303749893,1.1479008883761095,0.27586206896551724,0.37727923494108917,1.0,3/15,6.57%,SORBS1;PDLIM1;RHOA
prerank,stress fiber assembly (GO:0043149),0.35559570303749893,1.1479008883761095,0.27586206896551724,0.37727923494108917,1.0,3/15,6.57%,SORBS1;PDLIM1;RHOA
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.3247215172768705,-1.1472286876967228,0.29069767441860467,0.6603352016511149,1.0,22/61,25.80%,MYC;GRIN2B;RIPK2;USP50;PMAIP1;SYK;F2R;PERP;FYN;ASPH;BLID;CARD9;NLRP3;IFI16;FOXL2;HMGB1;TTBK1;NODAL;MEFV;TNF;CLEC7A;REST
prerank,fat cell differentiation (GO:0045444),0.25214073334713527,1.1470993936753,0.17647058823529413,0.3782897209189026,1.0,22/58,20.92%,CLIP3;WNT5B;STEAP4;PID1;BSCL2;CBY1;C1QTNF3;ZNF516;BBS2;TMEM120A;GDF6;NR4A3;NR4A1;KLF4;BBS7;OSBPL11;BBS4;MKKS;SOX8;EP300;SIRT1;SENP2
prerank,cell-cell junction organization (GO:0045216),0.2389165775829139,1.1467862609090205,0.09090909090909091,0.37835622222009396,1.0,21/77,13.25%,LIMS2;CDH19;TLN1;CADM3;CLDN5;NLGN2;FLCN;CADM2;GJC1;OCLN;F2RL1;NLGN4X;GJA4;DCHS1;CDHR3;CDH5;MYADM;SMAD3;CADM1;CTNND2;CDH2
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.3854029853847428,-1.1464002128616781,0.33783783783783783,0.6617153181973016,1.0,14/24,35.86%,HSD17B12;DGAT2;ACSL6;THEM5;ACSF3;ACSL5;ELOVL7;TECR;ACSL3;ACSBG2;ACSL4;FAR2;HACD2;ACOT7
prerank,steroid metabolic process (GO:0008202),-0.2953280516019516,-1.14604268655004,0.18888888888888888,0.6617481614745265,1.0,38/103,31.34%,SULT2B1;DHRS2;SHH;CYP27B1;BAAT;CYP24A1;CYP51A1;CYP7B1;CYP3A7;CYP19A1;AKR1C4;LRP2;PRLR;SRD5A1;CYP26C1;CYP39A1;CYP2B6;CYP2D6;CYP26A1;RDH8;CYP2A6;SULT1E1;SULT2A1;CYP1A2;UGT2B4;AKR1D1;SLC22A24;SRD5A2;UGT2B28;UGT2B7;FDXR;GC;UGT2A1;DHCR24;MSMO1;HSD17B10;NPC1;HSD3B1
prerank,positive regulation of axon extension (GO:0045773),0.32197309959269266,1.1460324756779725,0.1935483870967742,0.37936294853864205,1.0,4/22,4.18%,NTN1;MAPT;L1CAM;DBN1
prerank,regulation of steroid metabolic process (GO:0019218),0.32780408219799645,1.1456853282390282,0.25,0.37953848733858797,1.0,13/23,27.90%,FMO5;ACADVL;GNB3;NR1H4;EPHX2;RORA;LAMTOR1;ARV1;ACADL;APOE;ABCA2;DGKQ;UGT1A8
prerank,transcription by RNA polymerase I (GO:0006360),-0.3632101907433756,-1.1456599542948847,0.2716049382716049,0.6619836236449324,1.0,14/30,33.46%,POLR2F;POLR1C;TAF1A;POLR1B;TAF1B;CDK7;POLR1A;GTF2H2;GTF2H3;CCNH;TAF1D;ERCC2;TAF1;TCOF1
prerank,regulation of cellular respiration (GO:0043457),-0.429954030951136,-1.1451312467819603,0.3472222222222222,0.662364452601141,1.0,6/16,15.33%,SHMT2;NOS2;TRAP1;PNPT1;IFNG;PRELID1
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.27001586956176815,-1.1451039319280665,0.1958762886597938,0.661340916159417,1.0,56/187,27.24%,CEP72;CENPE;KIF14;UBD;MAD2L1;CDK1;CEP250;NEK2;E2F1;FBXO5;UBE2C;PSMB9;PSMD14;TFAP4;HECW2;UBE2S;KNTC1;HAUS7;ANAPC1;TPX2;NEK6;AURKA;CDC14C;PLK1;HAUS6;CEP76;CENPF;CEP152;CEP78;CENPJ;ANLN;CEP41;SDCCAG8;CKAP5;PSMA3;ALMS1;NDE1;PLK4;CDC6;CDC20;HAUS2;PSMB3;CDC26;PSMA5;PSMD12;PSMB11;PSMB2;TM4SF5;CEP135;PSMA7;BUB1B;ZW10;TUBB4B;HAUS8;PSME2;AKAP9
prerank,positive regulation of protein processing (GO:0010954),0.33093770523354216,1.1449096003761239,0.21212121212121213,0.38051375329463083,1.0,4/18,6.09%,GSN;BAG2;CCBE1;CLEC3B
prerank,zymogen activation (GO:0031638),-0.34446240800612166,-1.1445197736084658,0.24691358024691357,0.6619792712323775,1.0,13/42,23.07%,PLAU;RIPK2;F12;CTSH;PERP;ASPH;F11;HP;FGA;IFI16;F9;PRSS3;FGB
prerank,cellular response to gamma radiation (GO:0071480),0.3680076384336748,1.1443914167506675,0.2857142857142857,0.3809630569487251,1.0,3/16,7.43%,CRYAB;TSPYL5;TMEM109
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.23505224976291159,1.1443464322541972,0.1111111111111111,0.38072315510867744,1.0,38/117,18.08%,RAMP1;CNR1;LPAR1;ADCY5;VIP;S1PR1;PTGER3;GNG2;ADRB3;ADCY4;ADGRD1;ADGRB3;PTH1R;GPER1;RAMP3;RAMP2;GPR161;ADRA2B;ADGRL4;TBXA2R;PTGER4;ADM;ADGRL2;ADCY9;ADCY2;GNAQ;ADRB2;ADCYAP1;S1PR2;ADCY6;GPR4;ADORA2A;GNAL;ADGRL1;PTGFR;MC1R;S1PR3;ADRA1A
prerank,positive regulation of cell communication (GO:0010647),0.3314306899039056,1.143129015412809,0.13043478260869565,0.38257319412614216,1.0,12/28,18.52%,ILK;WLS;CARTPT;LGI1;RIMS3;DLG4;SYT1;GRIK2;ANK3;EDN3;PTPN23;CLSTN2
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.3718231803324261,-1.14168735532478,0.3157894736842105,0.6697525124163289,1.0,18/33,41.54%,CALR;HLA-F;TAP1;CANX;PDIA3;HLA-G;ERAP1;SEC24A;IDE;SEC13;SEC24D;TAP2;MFSD6;TAPBP;BCAP31;ERAP2;SEC24C;FCER1G
prerank,glycoprotein biosynthetic process (GO:0009101),-0.31439309555801254,-1.141278916984216,0.25882352941176473,0.6696932726034783,1.0,37/81,34.59%,PMM2;B3GNT4;ALG1;ALG1L2;FUT1;B3GALNT2;ST8SIA6;GCNT1;ALG5;FUT10;FUT7;B3GNT5;B3GNT2;GAL3ST2;FUT2;B3GNT3;ALG3;CANT1;DDOST;FUT6;TMEM106A;FOXL1;ST8SIA5;COG3;B4GALT7;NUS1;NPC1;CHST13;GALNTL5;ATP7A;IGF1;FUT5;B3GALT2;ST3GAL2;B3GALT6;SERP1;ST8SIA4
prerank,midbody abscission (GO:0061952),-0.4180745711692965,-1.1411852540966325,0.30985915492957744,0.6688426632269023,1.0,3/17,9.41%,CEP55;KIF20A;CHMP4C
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.3489811084771699,-1.1401006940898577,0.25301204819277107,0.6713450764812564,1.0,17/37,33.42%,EPHB2;WNT5A;SLC7A5;IL21;FFAR2;RBP4;TNFSF4;IL10;NOD2;PHB;CD86;XBP1;XCL1;SCIMP;CD244;TNFRSF4;PTPN22
prerank,heart trabecula morphogenesis (GO:0061384),0.30898110689778485,1.1396122074427408,0.2857142857142857,0.38927892687638027,1.0,5/19,7.31%,HEY1;S1PR1;TGFBR3;BMPR1A;RBPJ
prerank,establishment of protein localization to organelle (GO:0072594),-0.30525069974353825,-1.1394511592730714,0.24444444444444444,0.6724168204625788,1.0,27/75,29.40%,CD68;LAMP3;NUP62CL;NUP155;CSE1L;E2F3;SYK;NUP107;NXT2;RANBP17;NUP50;MMP12;RALA;NUP93;NUP88;RAN;POM121;TNPO3;HEATR3;NXT1;IL10RA;IPO11;LAMP2;NUP62;KPNB1;GCKR;NUP153
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.2670857834781789,1.1393619150502576,0.16666666666666666,0.3892492875742167,1.0,12/38,20.81%,WDR19;IFT81;CLUAP1;IFT46;IFT80;KIFAP3;DYNLRB2;IFT43;IFT20;IFT172;DYNLRB1;IFT22
prerank,negative regulation of mitochondrion organization (GO:0010823),0.28683833383919827,1.1389802417778268,0.25,0.3894662518221339,1.0,8/33,12.60%,CLU;MAPT;FLCN;VAT1;MUL1;BNIP3;ACAA2;TFRC
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.3915674399644956,-1.138911618585177,0.2608695652173913,0.673052350901718,1.0,10/19,32.82%,POU4F1;PAX6;IFNG;TGFB1;POU4F2;GATA3;TWIST1;TRAF6;FOXC1;IGF1
prerank,negative regulation of cellular catabolic process (GO:0031330),0.24631557234056023,1.1385645771714505,0.16666666666666666,0.3897647739290249,1.0,21/67,18.29%,TIMP4;WDR6;TIMP3;TIMP2;SIRT2;MTOR;PLIN5;NUPR1;MTMR9;RRAGA;DAB2IP;KLHL22;RASIP1;MT3;BCL2;LEPR;STAT3;INS;GOLGA2;CDK5RAP3;ZKSCAN3
prerank,male meiosis I (GO:0007141),-0.4252232421459051,-1.1384721146609302,0.2898550724637681,0.6734421206311471,1.0,4/15,12.71%,SYCP3;BTBD18;HSF2BP;DNMT3L
prerank,cellular response to radiation (GO:0071478),-0.3453774479937081,-1.1384144895023338,0.24691358024691357,0.6724707422870893,1.0,14/43,23.70%,BLM;RAD51AP1;INTS7;GPR52;FIGNL1;RAD9B;ECT2;RRH;TRPM1;ADIRF;HUS1;IFI16;OPN5;RHNO1
prerank,positive regulation of GTPase activity (GO:0043547),0.2318767209296511,1.1382035110829118,0.0,0.3901172337327186,1.0,52/201,14.12%,TBC1D1;RAP1A;ARHGEF26;FERMT2;CCL14;RGS10;SYDE1;CAV2;ASAP3;FLCN;CORO1C;RASGRP2;DVL3;SGSM2;RAPGEF3;TBC1D20;GNB5;ARHGEF15;TBC1D17;EVI5L;F2RL1;CCL21;CCL2;TAX1BP3;RABGAP1;RSU1;ARHGEF10;MAPRE2;ADPRH;TBC1D25;SIPA1;SFRP1;USP6;TBC1D10A;CCL11;SGSM1;SNX18;CCL13;PIN1;SGSM3;CCL23;SIPA1L2;NTRK1;CX3CL1;TSC1;CCL8;TBC1D26;RGS1;NTF3;BCAR3;RALBP1;ADCYAP1
prerank,cellular iron ion homeostasis (GO:0006879),0.2575419265278288,1.1378478152650382,0.2777777777777778,0.3904688493213138,1.0,11/56,9.20%,SLC22A17;ISCU;SCARA5;CYBRD1;SKP1;HMOX1;FBXL5;NEDD8;SOD1;ABCG2;SMAD4
prerank,vitamin D metabolic process (GO:0042359),-0.4457746474445061,-1.1377390819244997,0.3116883116883117,0.6734120410544877,1.0,4/15,13.66%,CYP27B1;CYP24A1;LRP2;FGF23
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.4056761459355726,-1.137498525275193,0.3116883116883117,0.6731932287732706,1.0,6/18,21.14%,SPAG17;CCDC103;DNAAF2;DNAAF1;ADCY10;SPA17
prerank,regulation of myelination (GO:0031641),0.3327792726722849,1.1374674089171073,0.3181818181818182,0.3904652253489822,1.0,8/26,11.17%,LGI4;PTN;JAM2;PTPRZ1;SIRT2;RNF10;TNFRSF21;PARD3
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.3786206143569907,-1.1368420251025422,0.22972972972972974,0.6742401975587998,1.0,11/25,30.49%,SERPINE1;DUSP1;CXCL10;CXCL17;PLA2G7;FPR2;CCL1;HMGB1;LYN;CCL5;S100A7
prerank,regulation of spindle assembly (GO:0090169),-0.3708656065232063,-1.1357092123611834,0.3333333333333333,0.6763819067290546,1.0,5/25,11.98%,HSPA1A;SPAG5;GPSM2;CHMP4C;PLK1
prerank,mammary gland epithelium development (GO:0061180),-0.4304472135688673,-1.1350740004877253,0.3055555555555556,0.6774201149581546,1.0,3/15,6.07%,WNT2;WNT7B;EPHA2
prerank,heterochromatin assembly (GO:0031507),-0.37430748914841727,-1.134949872534438,0.2898550724637681,0.6766597706026412,1.0,5/20,12.19%,HMGA1;CDKN2A;HMGA2;BEND3;SUV39H1
prerank,neutrophil activation (GO:0042119),-0.4016520034676747,-1.1347775287886015,0.3076923076923077,0.676120494376956,1.0,4/16,8.82%,CXCL8;SYK;CXCL6;CXCR2
prerank,negative regulation of platelet activation (GO:0010544),0.36934253279773743,1.1347320417844637,0.25,0.39539003063695655,1.0,6/16,10.51%,PRKCD;PDGFRA;CEACAM1;PDGFB;PRKG1;C1QTNF1
prerank,spliceosomal snRNP assembly (GO:0000387),-0.3633902295374843,-1.1347220911428009,0.3125,0.6751793391450932,1.0,15/38,34.62%,TGS1;SMN1;SNRPD1;SNRPF;SNRPG;WDR77;CLNS1A;PRPF6;LSM4;SNRPB;PRPF19;GEMIN5;SNRPE;SNRPD3;SNRPD2
prerank,response to amino acid (GO:0043200),0.30116272009440775,1.1344085228993686,0.25,0.3954893281841043,1.0,9/29,14.18%,CPEB1;GLRB;MTOR;RRAGA;RRAGD;RRAGC;CAPN2;RRAGB;LAMTOR3
prerank,dicarboxylic acid transport (GO:0006835),-0.3623613456448573,-1.1342265152491817,0.29577464788732394,0.6756354255959468,1.0,10/29,25.77%,FOLR1;SLC26A8;ABCC2;SLC13A5;SLC19A1;SLC13A3;SLC46A1;SLC25A13;SLC26A1;SLC25A22
prerank,negative regulation of cell adhesion (GO:0007162),0.22874288919995928,1.1341875121667186,0.3333333333333333,0.39550689722098353,1.0,22/71,17.74%,JAM3;CORO2B;PLXNB3;FZD7;FBLN1;FZD4;SPOCK1;GCNT2;RHOA;PDE3B;ADAMDEC1;SIPA1;ANGPT1;CX3CL1;SEMA6A;B4GALNT2;ITGB1BP1;ARHGDIG;CDH1;DMTN;ERBB3;PLXNB1
prerank,regulation of ion transmembrane transport (GO:0034765),0.27630349979264435,1.1340898764059504,0.2777777777777778,0.39514458206559494,1.0,7/35,8.55%,CASQ2;KCNH2;KCNJ8;AKAP6;KCNE2;P2RX7;AHCYL1
prerank,regulation of neuron differentiation (GO:0045664),0.24195882374611916,1.1339284148015487,0.1111111111111111,0.3949457245562858,1.0,27/76,21.50%,FGFR1;HEY1;NGF;ZC4H2;PCP4;ID2;RHOA;HOXD3;GPRC5B;NLGN1;NBL1;ADRA2B;MMD;MEF2C;NTF3;CASZ1;MMD2;KCTD11;SIN3A;CNTN4;DLL1;CDK5RAP3;TIAM1;HEYL;LTK;ALK;BRINP3
prerank,plasma membrane invagination (GO:0099024),0.31364491051171434,1.1338436986527969,0.3333333333333333,0.39458493648281584,1.0,6/29,11.32%,GSN;RHOA;CD36;GULP1;SNX18;SNX33
prerank,base conversion or substitution editing (GO:0016553),0.3264281719931454,1.1338422241817854,0.3,0.3941168641975456,1.0,6/18,16.45%,ADARB1;NUDT16;ADARB2;APOBEC3C;METTL3;ADAD2
prerank,"transcription, DNA-templated (GO:0006351)",-0.26992650517762257,-1.1334695334454845,0.16842105263157894,0.6768620522737956,1.0,72/215,31.15%,NFE2L3;POLR2F;EREG;ETV7;E2F1;CCNK;POLR1C;FOXE3;TAF1A;CBFB;HSF2BP;DDX21;NOCT;TRIM24;SMN1;TTF2;POLR3K;TFDP1;TAF1B;CDK7;EAF1;PAX8;TRIP13;TAF4B;TAF1L;NELFCD;NCBP1;TFAM;GCM2;MLLT3;GCM1;GTF3A;GTF2H2;NKX2-8;POLR2D;NFYA;TAF2;TFB2M;ZNF141;LHX1;POLR3G;POLR2J;TAF4;GTF2H3;POLR3A;TEFM;GTF3C4;POLR2I;XBP1;RNGTT;PTMA;CCNH;BRF2;NCOA6;ERCC6;EAF2;TRIP11;GTF2A1;IVNS1ABP;SETX;TCFL5;GTF2E1;CDC73;DEK;RREB1;ERCC2;GTF3C3;GTF2F2;LEO1;TAF1;PAX5;IRF9
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.298346270127712,1.1327097053951667,0.21428571428571427,0.3959721600740109,1.0,7/26,7.56%,DUSP22;ZFP36L1;INPP5K;DUSP3;ZFP36;EGFR;DAB2IP
prerank,negative regulation of viral process (GO:0048525),-0.3168147066462723,-1.1325948398949868,0.26136363636363635,0.6785514566787212,1.0,11/69,8.23%,IFITM3;IFITM1;IFITM2;PML;OAS2;PROX1;SRPK1;BST2;ISG15;MX1;STAT1
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.2992930716354072,-1.1325365172229902,0.27058823529411763,0.6775474588233752,1.0,18/81,12.85%,CCND1;CDKN3;BLM;CCNO;CDC25C;CCNK;CDKN2A;PROX1;SPDYA;CCNI2;CCNE1;TFAP4;PKMYT1;CCNF;CEBPA;CDK7;PLK1;GTPBP4
prerank,prostanoid metabolic process (GO:0006692),0.32547299370438965,1.1320290591530546,0.22857142857142856,0.3970409041158148,1.0,5/18,10.54%,PTGS1;HPGD;HPGDS;AKR1C2;AKR1C1
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.3643925302679891,1.131365443853063,0.2857142857142857,0.3980532432268493,1.0,8/17,16.50%,VAMP2;AKAP6;KCNE2;NPPA;KCNE4;RNF207;ANK3;KCNG1
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.3973206585179792,-1.1309982895566322,0.2911392405063291,0.6816972671968138,1.0,5/20,7.97%,HSPA1A;RNF183;MAGEA3;PMAIP1;BCL2L1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.3355159898468971,-1.1309907949765459,0.2894736842105263,0.6806049882520209,1.0,10/33,17.57%,NEK2;MAPK15;AURKB;NAF1;ATR;CCT6A;FBXO4;HMBOX1;CCT2;PRKCQ
prerank,positive regulation of secretion (GO:0051047),0.35526120391937005,1.1309859130326023,0.21212121212121213,0.398148341375515,1.0,3/15,3.81%,NPR1;AQP1;PRL
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.2308134393795244,1.1304475153496711,0.05555555555555555,0.39861947417881965,1.0,30/97,16.79%,PRELP;CSPG4;DCN;SDC2;UST;OGN;CHST3;SDC3;B4GAT1;GCNT2;ST3GAL3;GPC1;CHST15;NDST2;ANGPT1;CHST9;ABCC5;CHST14;CHST7;ST3GAL6;KERA;NDST1;GPC4;FMOD;GPC3;OMD;DSEL;HSPG2;CSGALNACT2;UGDH
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.37773867847165005,-1.1301020894778109,0.2987012987012987,0.6823096182293404,1.0,7/22,18.69%,MMP7;HM13;RELA;TGFB1;ADAM10;ADAM9;MBTPS2
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.2952393163367152,1.1300939681531836,0.20833333333333334,0.39879421331426007,1.0,12/31,17.50%,IFNAR1;PKD2;CCL2;PKD1;SOCS2;CLCF1;PIAS1;STAT6;JAK2;IL15;STAT3;GHR
prerank,receptor-mediated endocytosis (GO:0006898),0.22707212243083727,1.1295392204592274,0.25,0.39931710252439057,1.0,38/141,17.30%,PDLIM7;PIP5K1C;RAMP1;MASP1;WASF1;CAV2;SNCA;SNX1;ACKR3;MICALL1;PI4KB;TPCN2;ADRB3;LMBR1L;COLEC12;AP2M1;STAB1;CD36;HSP90B1;RAMP3;RAMP2;IGF2R;RAB31;TMEM108;NLGN3;AP2A2;ADM;TFRC;ADRB2;SCARF1;SFTPD;VLDLR;INPP5F;SNX9;HSPG2;MRC1;HBB;DLL1
prerank,hexose biosynthetic process (GO:0019319),0.2712037824370369,1.129269983258696,0.2857142857142857,0.3995977347974081,1.0,10/42,12.77%,ENO2;SLC25A12;ATF4;ALDOA;CRTC2;AKR1B1;CHST15;MDH1;PGM1;CRY1
prerank,respiratory system development (GO:0060541),-0.35700022731206593,-1.129064303588033,0.25287356321839083,0.6841702089353597,1.0,11/35,16.38%,STRA6;WNT7B;SHH;PROX1;CHD7;CEBPA;NKX2-1;CHI3L1;RBP4;DNAAF1;BMP4
prerank,nucleotide-excision repair (GO:0006289),-0.288141202965906,-1.1288538721839485,0.25,0.683788739980082,1.0,38/105,34.81%,RFC3;POLR2F;ERCC5;RPA3;POLB;POLA1;LIG1;RFC5;ERCC8;GTF2H2C;RPA4;CDK7;BRCA2;RFC2;GTF2H2;HMGN1;LIG3;POLD2;POLR2D;FANCC;HUS1;POLR2J;GTF2H3;POLR2I;CCNH;ERCC6;PRPF19;COMMD1;BRIP1;ERCC2;RFC4;SLX4;POLD1;AQR;SLC30A9;CUL4A;UBC;COPS5
prerank,negative regulation of protein binding (GO:0032091),0.24064882602744694,1.1287864244647412,0.25,0.40011845346774594,1.0,19/71,16.51%,BAG2;CDKN1A;MAPK8;PRKCD;ADRB3;CAMK1;MAP2;DNAJB2;B2M;PDGFB;ATP2A2;ACTB;CSNK1E;PIN1;CCL23;ADRB2;ITGB1BP1;ITGA4;GOLGA2
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.22087542968866986,1.1287135226997613,0.08333333333333333,0.3998096900405176,1.0,16/88,9.43%,TGFB1I1;RBPMS;CITED2;BMP3;CDKN1C;SMAD2;FLCN;SH2B1;BMPR1A;NUMA1;RBPJ;TWSG1;MSTN;CSNK2B;SMAD4;CDH5
prerank,positive regulation of cellular component organization (GO:0051130),0.21810681544171062,1.1283556979571394,0.2222222222222222,0.3999820124177157,1.0,33/109,18.04%,CLIP3;CLU;LGALS3;ADD1;SNCA;TIRAP;CAMK1;TRABD2B;BCL2L11;RAPGEF3;DCTN1;SMPD1;DAB2IP;BNIP3;FRMPD4;RHOC;CDH5;PLEKHM2;FLOT1;TAL1;BRK1;TFRC;TMEM30A;MPP7;GPC3;SH3GLB1;CDC42EP2;ADGRL1;DLL1;TGFB3;PTPN23;SHANK3;PPP1R15A
prerank,response to cAMP (GO:0051591),0.3113632480996035,1.1275870465744517,0.21739130434782608,0.40092694422623726,1.0,10/38,8.84%,RAP1A;PDE2A;AQP1;ZFP36L1;INPP5K;PKD2;AKAP6;RAPGEF3;AQP8;IGFBP5
prerank,mitotic cytokinetic process (GO:1902410),0.33198351395120285,1.1275837611224173,0.21875,0.40045857162784204,1.0,6/20,13.38%,CHMP3;RHOA;CHMP4A;CNTROB;CHMP7;VPS4A
prerank,camera-type eye development (GO:0043010),-0.3783782877570291,-1.1270683448406542,0.3037974683544304,0.6885064906213882,1.0,9/26,22.79%,STRA6;PRSS56;FOXE3;PAX2;FBN2;NF1;SHROOM2;FOXL2;CRYBA4
prerank,aspartate family amino acid catabolic process (GO:0009068),0.3315692215601926,1.1269881898513252,0.24,0.4010816213792913,1.0,6/19,18.00%,DLD;ASPA;DLST;AASS;OGDH;HYKK
prerank,mRNA modification (GO:0016556),-0.3773069231153323,-1.1264760401342064,0.3,0.6892014650727426,1.0,9/21,30.72%,PUS7;DKC1;PUS1;TRMT6;TRUB1;TRMT61B;TRUB2;TRMT10C;NSUN2
prerank,DNA packaging (GO:0006323),-0.4067543011852998,-1.1264197139094725,0.3150684931506849,0.6882360223637004,1.0,2/15,2.01%,CHAF1B;CHAF1A
prerank,"phototransduction, visible light (GO:0007603)",-0.4214749081917264,-1.1263805666176019,0.2676056338028169,0.6872523378653763,1.0,3/15,7.97%,RP1;GRK1;GNGT1
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.37531580280226073,-1.1262317629683505,0.3108108108108108,0.6865917270182609,1.0,13/24,44.49%,FPR2;MICB;FPR3;SLA2;CR1;LYN;LAX1;NCR3;GPLD1;GPR33;FCER1G;FPR1;SH2B2
prerank,negative regulation of gene expression (GO:0010629),0.18615426798271298,1.125918127308193,0.0,0.40292508933293775,1.0,62/308,13.55%,PHF1;PSEN1;ATP2B4;TCEAL1;CD34;CITED2;CLDN5;CILP;SYT11;MAPT;PTBP2;EMILIN1;NPTN;SAMD4A;FGF2;FLCN;TARDBP;TRIM6;ZNF540;HAND2;KAT2B;DAPK1;OCLN;ATOH8;PGR;SLC24A3;RBM4;DAPK3;ZFP36;BMPR1A;ID2;BTG2;NUDT16;PRKAA2;GPER1;ASB1;TWSG1;GPNMB;PDGFB;IGFBP5;RBMS3;SFRP1;MYADM;APP;DXO;GATA2;MAP2K2;CREBZF;EIF4ENIF1;LGALS9;NFKB1;SMO;PTGER4;OLFM1;MEF2C;NKX3-1;HINFP;MECP2;HEY2;TSC1;METTL3;MPHOSPH8
prerank,organelle assembly (GO:0070925),0.2237667125703985,1.12490042849065,0.0,0.4046316077589059,1.0,113/404,18.96%,PGM5;LMOD1;FLNA;GABARAPL1;GSN;EHD2;CIRBP;CD34;RFX2;MAP1LC3C;TMOD1;WDR45;TMOD2;PARVA;MAPT;CHMP3;ZFYVE1;ULK1;TTLL3;ATG9A;CENPT;ULK2;TSG101;BBS5;DZIP1;ATG12;FLII;TP53INP2;RAB23;STARD9;CSDE1;MAPRE3;WDR19;BBS1;STX12;CYS1;HAUS4;NPHP3;RABL2B;GABARAPL2;ARL3;PKD1;HDAC6;SYNPO;IFT81;KLHL41;CHMP4A;ABLIM3;EMC6;MYOZ1;BSCL2;NEK7;POGZ;MAPRE2;ATP2A2;TUBGCP6;INTU;FBF1;TXNDC15;MAP1LC3A;UBXN10;PLA2G4C;CLUAP1;CHMP7;CAPN3;ATG14;HPS1;EIF4ENIF1;GABARAP;CC2D2A;INPP5E;CEP126;TMEM138;RAB11FIP3;FITM1;IFT46;GOLGA8A;VPS4A;RAB8B;IFT80;RILP;STK36;BBS2;EXOC7;VPS28;MIS12;GBF1;IST1;VPS37A;BBS7;FUZ;MAP1LC3B;CEP89;CDS2;VPS37D;GOLGA2;ATXN2L;IFT43;BBS4;TP53INP1;ATG16L2;ATP6V1D;PTPN23;RILPL2;ATG13;ATG2B;TUBGCP2;GOLGA8B;CEP19;ARL6;MKKS;IFT20;STX7
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.35196838477639486,1.1246044206016053,0.27586206896551724,0.40461161659692135,1.0,5/16,16.98%,AGTR1;ECE1;AVPR1A;AVPR2;EDN3
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.26871187001861063,1.1233653012794054,0.23809523809523808,0.40665632024663123,1.0,8/46,5.87%,FLNA;PSEN1;BAG3;PRKCD;CAMK1;DMAP1;RAPGEF3;PIK3R1
prerank,vascular transport (GO:0010232),0.23208674570325769,1.1230991508847914,0.19047619047619047,0.40679266147429644,1.0,20/84,13.04%,SLC2A4;ATP2B4;ATP1B2;KCNJ8;ATP1A2;SLC29A1;SLC24A3;SLC16A12;SLC16A2;SLC7A2;ABCG2;SLC8A2;SLC27A1;ABCC5;AVPR1A;ABCC9;SLC6A17;TFRC;SLC6A9;SLC38A2
prerank,cell-substrate junction assembly (GO:0007044),0.2839045301574834,1.121947868282218,0.2,0.40840756313216947,1.0,9/34,14.01%,SORBS1;FERMT2;ACTN1;DST;LAMC1;DLC1;WHAMM;ACTN2;THSD1
prerank,regulation of AMPA receptor activity (GO:2000311),0.30141776615426163,1.1219163352069272,0.27586206896551724,0.40806675890211863,1.0,10/25,18.00%,PRRT1;NLGN2;NLGN1;NLGN3;MEF2C;ARC;ADRB2;SHISA7;SHISA9;SHANK3
prerank,regulation of macrophage activation (GO:0043030),-0.33543029818277026,-1.121864633342888,0.23170731707317074,0.6998265059351367,1.0,5/29,9.90%,MIF;WNT5A;HSPD1;SPACA3;CEBPA
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),-0.32319666789974105,-1.1218557304785288,0.27848101265822783,0.6987545282446603,1.0,12/37,23.07%,IL11;SERPINE1;ICAM1;TNFAIP3;PKHD1;SEMA5A;KDR;IL10;MDK;FGA;GATA3;FGB
prerank,establishment of protein localization to membrane (GO:0090150),0.24894206496260854,1.1212430578664194,0.25,0.40907046245682677,1.0,25/67,21.92%,REEP1;NACAD;MICALL1;MYO1C;ZDHHC7;EGFR;ZDHHC15;GORASP1;OXA1L;ZDHHC22;ZDHHC18;PARD3;GOLGA7;RAB11B;VPS37A;TAOK2;VPS37D;RTP5;ARL6;ZDHHC1;ZDHHC20;NACA;SYNE3;ZDHHC11;SDCBP
prerank,dendrite morphogenesis (GO:0048813),0.2970177089052487,1.1211901449129946,0.32142857142857145,0.4087559968535763,1.0,18/35,23.63%,PTN;PTEN;MAP6;SDC2;MAP2;DLG4;MEF2A;CTNND2;ARC;TAOK2;BTBD3;SHANK3;KLF7;DVL1;MINK1;CELSR2;EPHB1;MAPK8IP2
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.2680876702306393,1.1209595609263165,0.22727272727272727,0.4089154166959224,1.0,16/53,16.31%,ATP2B4;FGFR1;HSPB1;FGF2;MAPK14;PDGFB;PRKD1;CSNK2B;ANGPT1;GATA2;MEF2C;MECP2;PRKCA;AGTR2;ANGPT4;RGCC
prerank,positive regulation of phagocytosis (GO:0050766),-0.3149802581054646,-1.1209531105026944,0.35064935064935066,0.700402664097155,1.0,20/53,25.64%,IL1B;IL15RA;C3;CALR;SPACA3;TULP1;LYAR;C2;IFNG;FPR2;APOA2;AHSG;CYBA;PTPRJ;C4B;C4A;SIRPB1;LMAN2;TNF;CLEC7A
prerank,clathrin-dependent endocytosis (GO:0072583),0.3143377436510245,1.1208317336471012,0.2608695652173913,0.4086543670607765,1.0,10/26,21.84%,PIP5K1C;SIGLEC1;AP2M1;AP2A2;INPP5F;DLL1;ITSN1;AP2A1;SNAP91;FCHO2
prerank,regulation of osteoblast differentiation (GO:0045667),0.2313751130573415,1.1199415860302833,0.26666666666666666,0.40960032204733177,1.0,12/79,6.96%,IL6R;FERMT2;WWTR1;ATF4;DDR2;TWIST2;CHRD;FGFR2;HDAC7;ZHX3;BMPR1A;PRKACA
prerank,sensory organ development (GO:0007423),-0.3095655281104437,-1.119669736790425,0.27380952380952384,0.7032321568332587,1.0,16/56,17.32%,STRA6;ASCL2;TGFB2;PAX6;CHD7;FOXE3;SCO2;SIX3;SMOC1;ADAMTS18;PAX8;RBP4;SIPA1L3;PBX4;SHROOM2;NTF4
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.22522135830218096,1.1192373783730325,0.23529411764705882,0.41070127857419597,1.0,17/72,13.55%,PHF1;DIRAS3;KAT2B;MYO1C;PHF2;HDAC4;WBP2;KAT2A;HDAC6;HDAC5;TAF1C;ACTB;CREBZF;SF3B1;CGGBP1;MECP2;MPHOSPH8
prerank,negative regulation of T cell activation (GO:0050868),-0.3282934805446099,-1.1183069241672485,0.32432432432432434,0.7064757168880792,1.0,20/43,31.33%,CEBPB;FOXP3;IL4I1;CD80;JAK3;VTCN1;PLA2G2F;IL10;HLA-G;LILRB4;CD86;ARG1;CR1;TIGIT;GLMN;PDCD1LG2;IFNB1;LAX1;PLA2G2D;IFNL1
prerank,gonad development (GO:0008406),-0.3229067580264746,-1.118207266264143,0.24175824175824176,0.7055478231763465,1.0,20/51,27.39%,INHBA;TGFB2;IRX5;WNT5A;SOX9;ADAM20;CYP19A1;LRP2;NUP107;GATA6;GATA4;BIK;TEX19;LHB;GATA3;NR5A1;PRKACG;WNT4;SRD5A2;ZFP42
prerank,maturation of 5.8S rRNA (GO:0000460),-0.41773719444288615,-1.117755003397555,0.29577464788732394,0.7060674584387675,1.0,7/16,27.68%,WDR12;PRKDC;EXOSC4;URB1;MAK16;PES1;EIF6
prerank,negative regulation of neuron differentiation (GO:0045665),-0.36319485628360904,-1.117443526349666,0.24615384615384617,0.7059643157019231,1.0,9/22,27.15%,SOX9;CALR;SIX3;BMP7;MED1;POU4F2;GSK3B;REST;DLX2
prerank,lipid homeostasis (GO:0055088),-0.2976310843917689,-1.1172989129046953,0.2857142857142857,0.7052939191573185,1.0,22/61,30.39%,DGAT2;ACOXL;TLCD1;ZBTB20;PNPLA3;ANGPTL3;LIPG;CETP;PNPLA1;CEBPA;ENPP7;MLXIPL;ATP13A2;THADA;XBP1;PPARG;HNF4A;ABHD5;PNPLA4;FITM2;ABCB4;APOA5
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.3190194646983868,1.116434043073378,0.3,0.415803097285923,1.0,5/19,16.05%,FES;CCL27;BAIAP2;NTF3;HCLS1
prerank,neuron migration (GO:0001764),0.2778269316968569,1.1163747172486673,0.3,0.4154046666984631,1.0,22/49,22.15%,FGFR1;GPM6A;RAC1;DNER;SPOCK1;PAFAH1B1;MARK1;SEMA3A;MEF2C;MAP1B;CCK;ASTN1;MDGA1;POMGNT2;TUBGCP2;TUBB2B;FGF13;CEP85L;NAV1;ADGRL3;ASTN2;TUBB2A
prerank,eosinophil chemotaxis (GO:0048245),0.3656510709580005,1.1160650439141366,0.25,0.41513206343772874,1.0,8/15,13.29%,LGALS3;CCL21;CCL2;SCG2;CCL11;CCL13;CX3CL1;CCL8
prerank,eosinophil migration (GO:0072677),0.3656510709580005,1.1160650439141366,0.25,0.41513206343772874,1.0,8/15,13.29%,LGALS3;CCL21;CCL2;SCG2;CCL11;CCL13;CX3CL1;CCL8
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.4000217526255952,-1.115718745593674,0.4,0.7092220621309349,1.0,8/22,24.18%,SOX9;CCL3;TGFB1;FGF23;AHSG;SRGN;NOTCH1;ROCK2
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.27996878830226013,1.1146711140287622,0.29411764705882354,0.41809574279485395,1.0,13/40,16.89%,ATP2B4;CLU;CD34;RAC1;PKD2;PTGIS;CD36;KLF2;SMAD3;JAK2;AGTR2;KLF4;HBB
prerank,mononuclear cell differentiation (GO:1903131),-0.37224585591459636,-1.1143185163022187,0.30666666666666664,0.7125719717978917,1.0,9/26,24.88%,CSF2;TRPM2;IRF8;BMP4;IFI16;AXL;PPARG;LY6D;LYN
prerank,epithelial cell differentiation (GO:0030855),-0.28832316012767045,-1.1142536559037426,0.34065934065934067,0.7116746238722917,1.0,31/100,23.84%,MCIDAS;CDK1;CCNO;UPK3A;PROX1;SIX1;ACTL8;PAX2;OVOL3;TAGLN;UPK2;SIX3;GRHL2;ANXA4;GATA6;EHF;CITED1;E2F8;KDR;PTER;KRT3;BMP4;DLX3;SETSIP;VDAC1;HDAC2;GATA3;UPK1B;OVOL1;PPARG;ANXA1
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.41854202440802346,-1.114025149836175,0.3375,0.7113441063201611,1.0,3/18,4.34%,KLK6;MRAP;C3
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),-0.28153627293692207,-1.1139527316735809,0.25882352941176473,0.7104515258414522,1.0,19/109,12.85%,THY1;CCND1;CDKN3;BLM;INCENP;TRIB3;CCNO;CDC25C;CCNK;CCNI2;HMGA2;CCNE1;SYAP1;PKMYT1;CCNF;CDK7;CDK12;IFNG;GTPBP4
prerank,regulation of telomerase activity (GO:0051972),-0.3283337759855293,-1.1137654084112838,0.3048780487804878,0.7099157462472743,1.0,11/46,17.57%,MYC;DKC1;NEK2;MAPK15;AURKB;GRHL2;NAF1;PARP4;HMBOX1;CCT2;PRKCQ
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.2773804421674744,1.113463654606601,0.25,0.41985589215688524,1.0,12/34,22.18%,TRIM39;MAP1A;GABARAPL2;CAMLG;ALAD;UBXN1;RYBP;KLHL40;WAC;BAG6;SDCBP;HFE
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.30498336460238806,1.113308124222329,0.30434782608695654,0.41963702046313345,1.0,5/20,9.85%,MFN2;SPRY1;LZTR1;DAB2IP;MAPKAP1
prerank,icosanoid metabolic process (GO:0006690),-0.30628305752166984,-1.1128435465111357,0.325,0.7115646201475264,1.0,16/56,19.45%,DPEP1;CYP2S1;FAAH2;TBXAS1;CYP4F8;MAPKAPK2;CYP4F3;ALOX12;AWAT1;CYP2D6;PON3;PON1;ALOX12B;ALOXE3;CYP4F11;CYP4A22
prerank,positive regulation of protein metabolic process (GO:0051247),-0.2867274893714876,-1.1122934134080888,0.3111111111111111,0.7120147584993443,1.0,36/114,25.34%,INHBA;CD80;IL1B;TFR2;IL23A;ASB9;WNT5A;TNFAIP3;PAEP;HECW1;CSNK2A3;IL23R;UHRF1;HECW2;IL17F;C4BPA;OAZ3;RASGRP1;IL12B;SORL1;AGT;TGFB1;C4BPB;WNT7A;NFKBIA;CSNK2A1;BARD1;GSK3B;CARD9;CD86;CHRNA7;AXIN1;ROCK2;IDE;TNF;ITCH
prerank,positive regulation of protein kinase activity (GO:0045860),0.21416964613874587,1.1119381837459388,0.2857142857142857,0.42209225302424935,1.0,29/151,10.99%,IL6R;RAP1A;CLU;PRNP;DDR2;CDKN1A;SNCA;CALM1;ITGB3;NAB2;PARP16;PRKCD;MAPRE3;CAMK1;STRADA;CCL21;EPHA4;RHOA;MTCP1;DLG4;GPRC5B;DAB2IP;GH1;PDGFB;SLC8A2;CALM2;SLC27A1;DUSP19;MAP2K2
prerank,cellular protein-containing complex assembly (GO:0034622),0.21403813684988215,1.1117152661150622,0.18181818181818182,0.42210468537780477,1.0,47/162,18.74%,VAMP2;COX7A1;CLU;NCK1;CASQ2;CHRNA3;VAMP1;SNCA;MAPT;CHMP3;CENPT;PTGES3L;VAMP4;SMAD2;CASQ1;PILRB;ARL2;AP2M1;PXN;CHMP4A;RTN4;POGZ;CSNK2B;SMAD4;ANGPT1;TBCEL;DMD;SMAD3;BBS12;HIGD1A;ADRB2;CHCHD4;MIS12;EIF4H;FMOD;SNX9;VAMP3;NSG1;DNAJC28;HIGD1B;CCDC40;HOPX;STXBP1;TIAM1;DNAJB12;ARL6;MKKS
prerank,regulation of cholesterol metabolic process (GO:0090181),0.33661661178113994,1.1116484122999797,0.26666666666666666,0.4217027159910356,1.0,13/21,27.43%,FMO5;ACADVL;GNB3;CES1;NR1H4;EPHX2;SREBF1;ARV1;ACADL;APOE;ABCA2;MBTPS1;DGKQ
prerank,cellular response to osmotic stress (GO:0071470),0.32713017976748443,1.11120524826906,0.25,0.4222588101464898,1.0,5/22,4.53%,MYLK;AQP1;ZFP36L1;YBX3;PKD2
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.23360702251508567,1.1104793630085932,0.23076923076923078,0.4233045960292553,1.0,26/77,17.80%,FGFR1;DCN;KIT;MYOC;ROR2;FGF2;F2RL1;PIK3R1;PDGFRA;GPER1;GH1;PDGFB;PDGFD;ROR1;SELP;NKX3-1;NTRK1;JAK2;NTF3;HCLS1;WNT16;INS;EPOR;ERBB3;PLXNB1;PDGFA
prerank,melanosome localization (GO:0032400),0.29258154659387664,1.1102184537559447,0.2777777777777778,0.42328978872925127,1.0,12/21,21.22%,BBS5;RAB11B;BBS2;RAB27A;BBS7;BBS4;VPS33A;ARL6;MKKS;BLOC1S6;VPS33B;MYO5A
prerank,protein K63-linked ubiquitination (GO:0070534),0.2604925576481428,1.110196647230239,0.35,0.4228109541266164,1.0,13/43,19.04%,UBE2D4;UBE2G1;PELI3;ZFP91;TRIM21;TRAF1;UBE2V1;RNF4;RNF115;UBE2B;RNF152;RNF135;MAGEL2
prerank,maintenance of protein localization in organelle (GO:0072595),0.34194168097498334,1.1096277853668837,0.28,0.42369805893404805,1.0,7/19,16.87%,SKP1;SUPT7L;ARL2;HK2;TAPT1;HK1;BBS4
prerank,negative regulation of ATP metabolic process (GO:1903579),0.3386593319762583,1.1094554505652492,0.41379310344827586,0.42355424288757343,1.0,4/17,6.86%,FLCN;HDAC4;NUPR1;PID1
prerank,negative regulation of apoptotic process (GO:0043066),-0.2529853026782811,-1.1089530731313046,0.18,0.721499587798042,1.0,109/475,19.25%,FOXQ1;MYC;DPEP1;HSPA1A;TDGF1;KIF14;MTRNR2L2;IFI6;ITGA5;MAD2L1;LAMP3;CDK1;RIPK2;DHRS2;CLEC5A;ERCC5;POU4F1;LEF1;MIF;SHH;MTRNR2L3;CARD14;CD44;WNT5A;CTSH;MTRNR2L8;NAIP;PRKDC;SOX9;MAZ;CEACAM6;SIX1;MAGEA3;FOXE3;WDR73;HMGA2;PAX2;IFIT3;FIGNL1;BCL2A1;CAV1;IGF1R;HSPD1;VTCN1;BCL2L1;FGF20;CBX4;PKHD1;PRKCG;XIAP;RELA;PRAME;GHRL;TOX3;VHL;ASAH2;LRP2;PRLR;SEMA4D;ANXA4;PROC;IRAK1;F2R;PLAUR;PLK1;NAA15;PLA2G3;CASP2;RNF213;MMP9;GATA6;MTRNR2L6;ALOX12;FOXB1;GATA4;ATAD3A;CITED1;MED1;KDR;BIRC6;WNT11;TNFSF18;PRELID1;SET;ADAM10;MTRNR2L1;NFKBIA;COMP;BMP4;CEACAM5;HPN;CSNK2A1;ADAM8;NTF4;ALB;PROK2;NAA35;PTRH2;IL10;BARD1;BIRC7;MTRNR2L10;MTRNR2L5;BAG4;PAX7;THBS1;MDK;GSK3B;VDAC1
prerank,positive regulation of defense response to virus by host (GO:0002230),-0.3621614911806038,-1.1089230040135676,0.323943661971831,0.7204635970322014,1.0,12/25,37.07%,IL23A;IL23R;STAT1;IL12B;APOBEC3F;DTX3L;IL12RB1;AIM2;ZC3H12A;PTPN22;EIF2AK4;HSP90AA1
prerank,positive regulation of nuclear division (GO:0051785),-0.3666305867804809,-1.1087132408976519,0.34328358208955223,0.7199783400719777,1.0,7/27,12.86%,IL1A;PDGFRB;EREG;IL1B;EPGN;AURKA;DMRT1
prerank,bicarbonate transport (GO:0015701),-0.3434890832521276,-1.1080794309798507,0.30952380952380953,0.7207529056482825,1.0,11/35,18.58%,CA9;SLC4A11;SLC26A9;CA5A;SLC4A9;HBA1;CYB5R2;CA6;CFTR;SLC39A8;SLC4A8
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.2860766838667273,1.1063215852412414,0.2631578947368421,0.4292432798196923,1.0,14/32,22.56%,TCF21;HDAC6;PKN1;RNF14;PRMT2;SFRP1;SAFB2;TRIM68;KDM5D;HEYL;EP300;SIRT1;KLK3;DDX5
prerank,regulation of cellular response to heat (GO:1900034),0.24546663766045895,1.1062868840741342,0.25,0.42886255784545235,1.0,10/76,4.45%,CRYAB;HSPB8;CAMK2G;CD34;MAPK1;BAG2;MAPK3;MAPT;BAG3;MTOR
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.3128525517150085,1.1062665641190916,0.41379310344827586,0.42838014776913574,1.0,9/22,17.56%,TSG101;UBAP1;VPS4A;RNF115;VPS28;VPS37A;VPS37D;MVB12B;PTPN23
prerank,regulation of dopamine secretion (GO:0014059),0.3089657707321195,1.1055999997224457,0.25925925925925924,0.42930722602113786,1.0,9/24,14.37%,SYT11;SNCA;KCNA2;SYT4;SYT10;SYT5;SYT1;GDNF;SYT6
prerank,regulation of interleukin-6 production (GO:0032675),-0.2887056434463826,-1.1054210283975126,0.30434782608695654,0.7288057007394169,1.0,49/106,34.49%,IL1A;EREG;IL1B;WNT5A;TNFAIP3;IL17A;HSPD1;IL17F;SYK;MAPKAPK2;GHRL;NOS2;F2R;ORM1;IFNG;TNFSF4;NLRP12;IL10;NOD2;CYBA;IRAK3;LILRB4;CARD9;MMP8;HMGB1;XBP1;TNF;CLEC7A;GHSR;TMEM106A;SCIMP;PTPN11;TYROBP;ZC3H12A;TWIST1;TLR7;LBP;GBA;IL37;FOXJ1;NLRP10;DHX9;AGER;TLR8;MAPK13;PTPN22;MYD88;CD47;CD74
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.2834803554382011,-1.1053432902898976,0.35714285714285715,0.7279190210116763,1.0,41/97,31.20%,ZC3H11A;U2AF1;NUP155;THOC3;NUP37;NUP210;CPSF3;MAGOHB;NUP107;NUP35;RANBP2;SEH1L;NCBP1;NUP50;NUP205;ALYREF;EIF4E;SRSF9;NUP93;RAE1;NUP88;NXF2;NXF3;POM121;NUP43;CPSF2;MAGOH;DDX39A;NUP160;NXT1;GLE1;NUP62;SMG1;NUP153;NDC1;CPSF4;NUP98;THOC2;SLBP;SEC13;AGFG1
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.24734422260018496,1.1052844361027228,0.14285714285714285,0.429388129153348,1.0,32/73,24.53%,CLU;ZER1;BAG2;SIRT2;SMAD7;DNAJB2;TRIB2;RNF217;RNF14;RNF144B;PIAS1;CSNK1E;GABARAP;CSNK1A1;RNF180;ZYG11B;BBS7;RNF19A;CBFA2T3;KLHL40;DVL1;SGTA;HERPUD1;NFE2L2;GSK3A;LRRK2;DDA1;DET1;ARIH2;RNF144A;CSNK1D;UBQLN2
prerank,ribosomal small subunit assembly (GO:0000028),-0.3950331968276618,-1.1051820945773014,0.3902439024390244,0.727476531110956,1.0,11/16,49.90%,PRKDC;RPS19;PWP2;RRP7A;XRCC5;MRPS11;ABT1;RPS14;RPS28;RPS15;RPS5
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.2818239212818396,1.1047509716239712,0.25,0.4299031997768,1.0,8/37,10.64%,FES;RAPGEF3;CCL27;DAPK3;PDGFRA;ESAM;BAIAP2;SEMA3E
prerank,regulation of T cell chemotaxis (GO:0010819),-0.4024524177757051,-1.1034533188349076,0.3194444444444444,0.73195543298674,1.0,9/15,34.00%,WNT5A;CXCL10;ADAM10;STK39;XCL2;XCL1;CCL5;S100A7;CXCL13
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.34684140691688886,-1.1028792654477733,0.3291139240506329,0.7328282731715665,1.0,6/34,4.80%,CEMIP;THY1;CXCL9;CXCL11;NPSR1;CXCL10
prerank,receptor internalization (GO:0031623),0.25321371130671777,1.1028103181776436,0.2727272727272727,0.43342863297163414,1.0,12/47,12.60%,RAMP1;SNCA;SNX1;ACKR3;AP2M1;CD36;CEACAM1;RAMP3;RAMP2;RAB31;ADM;TFRC
prerank,negative regulation of cellular protein metabolic process (GO:0032269),-0.2973171492047266,-1.1025414875458524,0.30952380952380953,0.7327787631792245,1.0,14/90,7.77%,ENC1;CST4;GZMB;IGF2BP1;IGF2BP3;PUS7;TRIM71;CALR;NANOS3;DHFR;NCL;IGF2BP2;CAPRIN1;GRB7
prerank,protein export from nucleus (GO:0006611),-0.36416961048542407,-1.101583812339245,0.3246753246753247,0.7349229622389084,1.0,7/26,13.92%,CSE1L;CALR;XPO5;RANBP17;DUSP16;TGFB1;XPO4
prerank,neuron maturation (GO:0042551),0.3873402467676786,1.101414080950734,0.35,0.435391119960112,1.0,7/18,17.69%,LGI4;ADGRB3;MTCH1;APP;CX3CL1;SCARF1;ACTL6B
prerank,DNA modification (GO:0006304),-0.3703799900380188,-1.1005957130089317,0.2972972972972973,0.7367753213295805,1.0,7/24,19.48%,NEIL3;PARP2;EXOSC3;EXOSC5;EXOSC4;NTHL1;UNG
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.31463317416922154,1.1004462695550954,0.13793103448275862,0.4368144713629767,1.0,9/23,19.84%,HDAC4;NUPR1;CLK2;C1QTNF3;CRY1;INS;SOGA1;CBFA2T3;EP300
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.3463856742967509,-1.1004327544877002,0.31645569620253167,0.7362927772898005,1.0,5/27,10.48%,OLR1;ICAM1;SYK;PECAM1;SEMA4D
prerank,intracellular protein transport (GO:0006886),0.18944389361315475,1.100106976005332,0.0,0.4369882878943964,1.0,51/322,11.25%,CLIP3;TBC1D1;ARL4D;RAB6B;SNX15;MAP1LC3C;COPZ2;SEC31B;WLS;SNX1;RAB5B;GPIHBP1;IPO13;DNAJC27;MYO1C;BAG3;NGFR;VPS45;SGSM2;RAB23;AKAP6;STX1B;STX2;TBC1D17;STX12;EVI5L;STRADA;RABL2B;PKD1;HDAC6;RABGAP1;STX16;RAB28;TICAM2;HAP1;TECPR2;TRAK2;TRIM23;FAM53C;RAB31;ADPRH;NLGN1;TBC1D25;OXA1L;GGA3;USP6;TBC1D10A;SGSM1;RAB24;EIF4ENIF1;GABARAP
prerank,acylglycerol catabolic process (GO:0046464),-0.32074596595001587,-1.1000542286809734,0.39436619718309857,0.7364007388177647,1.0,10/34,20.36%,FABP6;PNPLA3;LIPE;LIPG;PNPLA1;CPS1;APOA2;ABHD12;ABHD2;ABHD12B
prerank,peptidyl-arginine modification (GO:0018195),-0.40327859535682675,-1.0998237886859132,0.36,0.7360013694444346,1.0,2/15,3.05%,PADI1;PADI3
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.24496342947785213,1.0994789602130246,0.375,0.43789853483325547,1.0,6/39,7.56%,BTC;TSG101;DUSP3;SPRY1;EGFR;DAB2IP
prerank,growth hormone receptor signaling pathway (GO:0060396),0.3377864322318346,1.0989857931975509,0.391304347826087,0.43845144538312913,1.0,9/20,17.50%,PRL;PIK3R1;SOCS2;PXN;GH1;STAT6;JAK2;STAT3;GHR
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.2369490069508395,1.0987700658232176,0.2,0.4383693510798981,1.0,24/74,17.59%,TGFB1I1;GLIPR2;FERMT2;PTEN;WWTR1;SMAD2;MTOR;SPRY1;PHLDB2;GCNT2;SMAD7;DAB2IP;SMAD4;IL17RD;SFRP1;SMAD3;OLFM1;PHLDB1;VASN;SDHAF2;RGCC;EPHA3;TGFB3;SFRP2
prerank,protein K11-linked ubiquitination (GO:0070979),-0.36805446193218694,-1.0982457456511963,0.32051282051282054,0.7404427181443161,1.0,4/27,8.48%,UBE2T;UBE2C;UBE2S;ANAPC1
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.27828121277266993,1.098134585554364,0.2727272727272727,0.43924970652356193,1.0,11/39,12.68%,MAPK1;CADM4;CALM1;INPP5K;TRIM6;SIRT2;SMAD7;CALM2;APP;PARD3;PRKAG2
prerank,regulation of cytokine production (GO:0001817),-0.26944962773650416,-1.0980606225923855,0.3111111111111111,0.739876645920148,1.0,48/147,27.61%,IL1A;FOXP3;IGF2BP1;IGF2BP3;EREG;MIF;CD276;CLEC6A;ISG15;POLA1;BTN1A1;IGF2BP2;VTCN1;IL17F;IL21;MAPKAPK2;BCL6;PIK3CG;IL12B;NOS2;AGT;IFNG;BATF;TNFRSF1B;PLD4;TNFSF4;ITK;IRF8;NLRP12;BTNL10;IL10;ZBP1;SRGN;IL26;CARD9;GAPDH;IFI16;PIK3CD;GATA3;CRTAM;ANXA1;TNF;LYN;NFAM1;GLMN;ACE2;NLRP4;CD28
prerank,defense response to bacterium (GO:0042742),-0.26903966947716795,-1.0979457789313176,0.22105263157894736,0.7392315537456201,1.0,64/167,34.02%,CEBPB;SERPINE1;LPO;PRB3;IL23A;OAS2;NAIP;ISG15;GSDMA;IL23R;LCN2;GSDMC;SYK;LYG2;DEFA6;WFDC13;GBP7;IL12B;RPL39;NOS2;SEMG1;WFDC10A;PGLYRP4;ANXA3;FPR2;RNASE7;RPS19;OAS3;GNLY;PGLYRP1;ROMO1;DEFA5;DEFB4A;PGLYRP3;NOD2;IFNE;SLPI;ANKRD17;KRT6A;WFDC3;DEFA1;HAMP;SEMG2;WFDC10B;PI3;RNASE8;DROSHA;LTF;GBP6;WFDC12;LBP;GBP4;EPPIN;S100A7;NLRP10;PGLYRP2;GSDMB;WFDC9;NLRC4;DMBT1;ANG;NOD1;CXCL13;MYD88
prerank,cellular response to drug (GO:0035690),-0.3677005416889112,-1.0972920556042927,0.27631578947368424,0.7402009347769312,1.0,4/26,3.83%,MYC;DPEP1;IL1B;KCNQ1
prerank,gluconeogenesis (GO:0006094),0.27107024136176383,1.097280297685531,0.25,0.44116519126548603,1.0,14/39,21.36%,ENO2;SLC25A12;ATF4;ALDOA;CRTC2;MDH1;PGM1;CRY1;SLC25A11;ENO3;PCK1;ENO1;GOT1;PGK1
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.28550354789236326,1.0971906884393285,0.3888888888888889,0.44080242798067754,1.0,9/34,13.41%,FAM83D;ADAMTS1;LSM11;EGFR;RDX;LSM10;FGF10;PAGR1;PAF1
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.35758385621355215,-1.0969698600501725,0.379746835443038,0.7403120246912528,1.0,5/20,8.97%,RASSF10;TRIM71;PROX1;SHCBP1;SIX3
prerank,glutamate metabolic process (GO:0006536),-0.36958494395359126,-1.096397636579617,0.32926829268292684,0.7409552961773594,1.0,10/21,35.47%,GAD1;GLS2;ALDH18A1;ALDH5A1;GLUD2;NAGS;GCLM;PRODH2;TAT;GLS
prerank,cardiac muscle cell development (GO:0055013),0.31509606498628906,1.0960507260470147,0.32142857142857145,0.44238384768085365,1.0,9/24,14.94%,SORBS2;OBSL1;PDGFRA;ACTC1;MYL2;TCAP;SLC8A1;HEY2;FHOD3
prerank,cellular transition metal ion homeostasis (GO:0046916),0.2338600003984752,1.0957328729446774,0.2,0.4426760190793077,1.0,20/94,13.56%,SLC22A17;ISCU;PRNP;SCARA5;CYBRD1;SLC39A13;MT1X;SKP1;HMOX1;FBXL5;NEDD8;MT1M;SOD1;ABCG2;SMAD4;APP;TFRC;MT1A;MT1E;MT3
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.3014302780834177,1.0954310556591915,0.3,0.44291717895716026,1.0,10/30,17.55%,CLIP3;SORBS1;OCLN;PIK3R1;RHOQ;GH1;NR4A3;ARPP19;INS;CREBL2
prerank,response to metal ion (GO:0010038),-0.285724414609675,-1.0951024840589358,0.2839506172839506,0.7440645577605834,1.0,25/69,25.92%,IL1A;LOXL2;SLC30A2;TFR2;CAV1;ATP7B;SLC34A1;HOMER1;AQP9;KHK;SLC11A2;GPHN;ALG2;ADAM9;THBS1;FGA;TTN;SLC25A13;FGB;AQP3;FXN;HAMP;TRPV6;SLC30A5;HAAO
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.2726331742945416,1.094857536055785,0.17857142857142858,0.44330873721281233,1.0,8/37,9.15%,DYNC1I1;MYO1C;KIF1A;HAP1;TRAK2;PAFAH1B1;SYT4;MYO5C
prerank,peptidyl-tyrosine modification (GO:0018212),0.24617987060795943,1.0943555572735353,0.21052631578947367,0.44390045116513244,1.0,15/56,13.19%,FGFR1;DDR2;KIT;FES;FGFR2;PDGFRA;EPHA4;EGFR;EFEMP1;PDGFB;FLT4;TPST1;PKDCC;NTRK1;JAK2
prerank,histone H2A monoubiquitination (GO:0035518),0.32692862943806084,1.0943296590695784,0.4375,0.44346177344727133,1.0,7/17,21.21%,SKP1;RING1;PCGF6;RYBP;PCGF3;PCGF2;DDB2
prerank,positive regulation of mitochondrial fission (GO:0090141),0.3277264121568535,1.094240613075111,0.23333333333333334,0.44324970984437034,1.0,6/17,16.69%,DCN;MUL1;BNIP3;MIEF2;RALBP1;MFF
prerank,glycolipid biosynthetic process (GO:0009247),-0.34392830418962916,-1.093655988331051,0.28205128205128205,0.7477253541322497,1.0,15/37,29.61%,PIGM;PIGU;ST8SIA6;PIGW;PIGF;DPM1;PYURF;B3GNT5;B4GALT6;PIGA;PIGN;ST8SIA5;DPM2;PIGB;PGAP2
prerank,acylglycerol metabolic process (GO:0006639),-0.3191277135420232,-1.0934856526094336,0.29411764705882354,0.747154259017887,1.0,11/40,21.54%,DGAT2;PNPLA3;GK;CAV1;CETP;APOA2;ABHD12;APOC1;DGKK;ABHD2;DGAT2L6
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.3037641002293542,1.0934433739023344,0.2571428571428571,0.44459087449528506,1.0,7/21,16.86%,ATF4;RBPJ;CREB3;SMAD4;SMAD9;MT3;CARF
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.2796778454583737,1.09292429411452,0.2222222222222222,0.4451785829667141,1.0,14/44,14.91%,NPR1;ADCY5;NPR2;ADCY4;NPPC;ACAT1;PANK4;NPPA;AK5;ADCY9;ADCY2;NPPB;SLC26A2;ADCY6
prerank,nucleotide catabolic process (GO:0009166),-0.3856503231887272,-1.0923957768883772,0.3783783783783784,0.7498605670448013,1.0,7/16,26.99%,PNP;ITPA;NUDT15;NT5C2;NT5C1B;DNPH1;SAMHD1
prerank,organelle fusion (GO:0048284),0.3170594439753952,1.091656167404493,0.2903225806451613,0.44728936997449187,1.0,6/20,17.80%,MFN2;PLD6;VPS11;MIEF2;MFF;VPS18
prerank,cellular response to tumor necrosis factor (GO:0071356),-0.26450098809322803,-1.0913196301935986,0.30851063829787234,0.7521398973511911,1.0,69/189,31.31%,CXCL8;TDGF1;TNFSF11;TNFRSF11B;CCL24;CCL20;CARD14;EDAR;PSMB9;ADAMTS12;DCSTAMP;CCL22;PSMD14;CCL4;TNFSF15;TNFRSF9;TNFSF9;STAT1;CCL3;CD70;RELA;HYAL3;GBP1;CCL25;CHI3L1;CCL26;CCL17;TNFRSF1B;TNFSF4;TNFSF18;NFKBIA;TRAF2;BRCA1;PSMA3;BAG4;EIF5A;TNFRSF12A;LTA;CCL1;TXNDC17;GATA3;ST18;PSMB3;TNFSF13B;TNFSF8;LTB;XCL2;XCL1;OCSTAMP;TNF;PSMA5;PSMD12;PSMB11;PSMB2;HAS2;PSMA7;ACTN4;PSME2;GBP3;AIM2;PSME3;ZC3H12A;PSMC1;CCL5;GBA;TRAF6;PSME4;DHX9;TNFRSF4
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.2950969814641936,-1.0910924201194567,0.3103448275862069,0.7517738256531703,1.0,22/80,19.46%,IL1A;HSPA1A;IFI6;CSF2;SERPINE1;IL1B;ICAM1;TNFAIP3;PF4;EYA1;BCL2L1;RELA;TNFRSF10B;BIRC6;BMP4;TERT;FASLG;TRAF2;BRCA1;THBS1;GSK3B;FGA
prerank,positive regulation of epithelial cell migration (GO:0010634),0.2258958122161185,1.0910261850626284,0.15384615384615385,0.44854681635694665,1.0,20/93,10.39%,GLIPR2;NRP2;RHOB;RRAS;FGF2;ITGB3;RAC1;MTOR;ENPP2;SASH1;ATOH8;HDAC6;FGF7;RTN4;MAPRE2;PRKD1;ZNF580;FGF1;FLT4;ANGPT1
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.3670351966564567,-1.090781398771991,0.40963855421686746,0.7515778649983915,1.0,14/27,34.24%,IRAK2;RIPK2;TNFAIP3;RELA;IRAK1;OTULIN;NOD2;TAB3;ITCH;IKBKG;TRAF6;UBE2N;NOD1;UBC
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.28417952287441667,1.0905037769039267,0.22727272727272727,0.4490783977489193,1.0,13/35,20.82%,PPT2;HPGD;ACAT1;SCD5;HMGCLL1;PAM;BDH2;GGT5;GGT7;HMGCL;ACSS3;FAR1;HMGCS2
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.3896340101039357,-1.0903874360059262,0.38571428571428573,0.7515115417545772,1.0,8/15,28.64%,UMPS;CAD;NT5C3A;DHODH;UPP2;TYMP;DPYS;ERH
prerank,purine ribonucleotide metabolic process (GO:0009150),-0.29548260778284047,-1.0903052942373457,0.2962962962962963,0.7505434291340579,1.0,19/72,21.83%,SULT2B1;SULT1C2;ENTPD7;SULT1C3;BAAT;ACSL6;EPHA2;HPRT1;THEM5;ACSM6;ACSM4;ACOT6;SULT1A3;NT5C2;AMPD3;RAN;ACOT12;SULT1E1;SULT2A1
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.3903713922885338,1.0901939980059998,0.35,0.4490857556021697,1.0,4/19,4.09%,RGS10;CHRNA3;LY6H;CHRM2
prerank,regulation of exit from mitosis (GO:0007096),-0.3455386190298951,-1.0900265964454208,0.36363636363636365,0.750201733645607,1.0,8/39,11.65%,MAD2L1;CDCA5;NEK2;UBE2C;UBE2S;KNTC1;ANAPC1;CDC14C
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.3604576328031969,1.0895060889474524,0.35714285714285715,0.44991415402258617,1.0,3/15,3.48%,CLU;NACC2;ACKR3
prerank,positive regulation of phosphatase activity (GO:0010922),0.30023768238873183,1.0892794847040084,0.375,0.4496969040818965,1.0,8/20,18.04%,CALM1;MTOR;MTMR9;CALM2;CHP2;MEF2C;AGTR2;PPP1R15A
prerank,keratan sulfate biosynthetic process (GO:0018146),0.2780683300394459,1.0891385260494566,0.24,0.4493808222601467,1.0,8/28,15.79%,PRELP;OGN;B4GAT1;ST3GAL3;ST3GAL6;KERA;FMOD;OMD
prerank,outflow tract septum morphogenesis (GO:0003148),-0.3597211999242397,-1.0889409622210156,0.37037037037037035,0.7524403469095116,1.0,8/25,16.38%,TBX20;TGFB2;ROBO2;ENG;LRP2;GATA6;TGFBR2;BMP4
prerank,regulation of response to external stimulus (GO:0032101),-0.2689754024898399,-1.088812200451713,0.36046511627906974,0.751721872266605,1.0,41/127,29.16%,LRP8;CXCR4;EPHB2;WNT5A;ADAMTS12;CAMKMT;PIK3AP1;CAV1;GRK1;BCL6;FOXA2;XIAP;RELA;USP18;CD55;F2R;GATA6;GUCY2D;IL1RL2;STK24;SETD6;TNFSF4;AHSG;NOD2;NLRP6;ZBP1;HRG;IL20;ERAP1;PPEF1;TKFC;ANXA1;XCL1;SAG;ACE2;GP1BA;SAMHD1;GNAT1;SEMA7A;SPATA2;F2
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.3906270386023258,-1.0883343767842468,0.33783783783783783,0.7520302377197173,1.0,11/19,31.88%,AMELX;RUNX1;F2R;TGFB1;SUCO;BMP4;HDAC2;WNT4;CREB3L1;F2;SCX
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.3185297706895639,-1.0882029163969316,0.35802469135802467,0.7513440263029281,1.0,12/46,15.45%,CTAGE4;CTAGE9;CTAGE8;PDIA4;CTAGE15;MTTP;RAB15;CTAGE6;MIA2;RAB3D;RAB8A;CANX
prerank,cellular polysaccharide catabolic process (GO:0044247),0.32192931937610925,1.0877563407601298,0.3170731707317073,0.45233893376219,1.0,2/15,3.20%,PYGM;CALM1
prerank,positive regulation of DNA replication (GO:0045740),-0.39639460049524405,-1.0877356719170732,0.38271604938271603,0.7518485086132358,1.0,4/16,12.16%,EREG;ATAD5;DNA2;CDT1
prerank,regulation of type I interferon production (GO:0032479),-0.28544475770482824,-1.0874406046736256,0.3146067415730337,0.7518316161183748,1.0,21/83,20.93%,POLR2F;POLR1C;TNFAIP3;PRKDC;ISG15;IKBKE;POLA1;NLRC5;NFKB2;RELA;POLR3B;POLR3K;IRAK1;G3BP1;IRF8;POLR3C;ZBP1;POLR3G;POLR3A;GAPDH;IFI16
prerank,embryonic axis specification (GO:0000578),-0.3975809411430433,-1.0873204578655444,0.2714285714285714,0.7510410094637224,1.0,6/16,24.02%,TDGF1;WNT7A;RIPPLY1;PTCH1;SMAD6;CXXC4
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.39957950748528737,-1.087081572066829,0.35135135135135137,0.7505657017159423,1.0,4/17,8.23%,NOTCH3;DLGAP5;WWC1;STAT1
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.3554982845711602,-1.0869944503878708,0.2876712328767123,0.7497304728238495,1.0,16/32,31.85%,WNT5A;SLC7A5;CD55;FFAR2;HLA-F;TNFSF4;NOD2;TRAF2;HLA-G;XCL1;CLEC7A;RAET1G;CD160;SCIMP;TRAF6;CD226
prerank,regulation of autophagosome assembly (GO:2000785),0.2971128742460968,1.0865537664050895,0.47058823529411764,0.4541758598312784,1.0,17/33,24.61%,NUPR1;CHMP4A;PIP4K2B;ADPRH;FEZ2;LRSAM1;PIP4K2A;SH3GLB1;IFT20;PINK1;CHMP4B;LRRK2;RAB3GAP1;NPRL2;UBQLN2;PHF23;MTM1
prerank,protein localization to nucleus (GO:0034504),-0.2850395012520677,-1.0862593027179603,0.29411764705882354,0.7510624619833122,1.0,36/103,29.40%,COL1A1;NUP62CL;PML;NUP155;CSE1L;SIX1;CALR;ARL2BP;E2F3;SYK;BMP7;NUP107;NXT2;RANBP17;PLK1;NUP50;MMP12;MSX1;RRS1;WRN;BMP4;MDM2;NUP93;NUP88;RAN;POM121;TNPO3;HEATR3;RPF2;NXT1;IPO11;TOR1AIP2;NUP62;KPNB1;GCKR;NUP153
prerank,establishment of spindle localization (GO:0051293),-0.3903115330828328,-1.0861853032570665,0.3055555555555556,0.7501218570324677,1.0,9/15,45.06%,ESPL1;MAP4;KPNB1;KIF25;NLRP5;DYNC1H1;NUSAP1;LLGL2;OOEP
prerank,positive regulation of biomineral tissue development (GO:0070169),0.27657732901438703,1.086141101862559,0.36,0.4547715253837317,1.0,11/39,12.43%,PTN;GPM6B;OSR1;WNT6;BMPR1A;P2RX7;KL;SLC8A1;OSR2;PKDCC;MEF2C
prerank,osteoclast differentiation (GO:0030316),-0.3829080558907058,-1.0851776159068494,0.35526315789473684,0.7519743661449118,1.0,9/22,28.83%,TNFSF11;DCSTAMP;SNX10;EPHA2;EFNA2;OCSTAMP;GLO1;TYROBP;FARP2
prerank,regulation of protein kinase B signaling (GO:0051896),0.20402599493920942,1.0850826414138393,0.125,0.45662654700370287,1.0,36/204,9.33%,BTC;FERMT2;PTEN;FGFR1;RASD2;TSPYL5;PPP2R5B;KIT;MYOC;PHLDA3;KITLG;RRAS;FGF2;FLCN;INPP5K;RAC1;TNFAIP8L3;FGFR2;PIK3R1;CCL21;PDGFRA;FLT3LG;GCNT2;FGF7;KL;GPER1;EGFR;RAMP3;MUL1;RTN4;MSTN;P2RY12;PDGFB;AKR1C2;FGF1;NRG2
prerank,development of primary male sexual characteristics (GO:0046546),-0.31821598253880407,-1.0849004840607224,0.2840909090909091,0.7516370922487355,1.0,17/43,27.39%,INHBA;TGFB2;WNT5A;SOX9;ADAM20;LRP2;GATA6;GATA4;BIK;TEX19;LHB;GATA3;NR5A1;PRKACG;WNT4;SRD5A2;ZFP42
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.38318116987602496,-1.0847180693123883,0.2923076923076923,0.7511650920723654,1.0,5/22,8.12%,ULBP3;GZMB;ULBP2;ULBP1;RAET1E
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.247548107082432,1.0843580178956345,0.35714285714285715,0.4576133356856265,1.0,13/66,10.59%,CAMK2G;NCAM1;IRF2;GBP2;PRKCD;IFNGR1;OAS1;B2M;JAK1;TRIM34;TRIM21;CAMK2D;MID1
prerank,signal transduction by p53 class mediator (GO:0072331),-0.3224793478797432,-1.0832285421230357,0.3373493975903614,0.7547115746843296,1.0,12/33,28.17%,POU4F1;PMAIP1;MYO6;BATF;PAXIP1;ACER2;POU4F2;MAGEA2;IFI16;ATRX;USP10;E2F7
prerank,divalent inorganic cation homeostasis (GO:0072507),0.3076562521110932,1.0831723941299225,0.4,0.45978191270409946,1.0,8/23,15.27%,JPH2;SNCA;TMTC2;WFS1;SLC8A1;MT3;ANK3;KCNA1
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.31039813771627817,-1.0831366012313008,0.35555555555555557,0.7538981634563594,1.0,35/81,31.40%,IL1A;MIF;EPHB2;IL23A;WNT5A;OAS2;IL17A;PF4;ORM2;IL17F;SYK;CCL3;RASGRP1;IL12B;ARFGEF2;ORM1;IFNG;OAS3;ADAM8;NOD2;CYBA;THBS1;PTPRJ;MMP8;CD86;HMGB1;CD2;CLEC7A;TMEM106A;PTPN11;TYROBP;TWIST1;LBP;DHX9;AGER
prerank,organic cyclic compound biosynthetic process (GO:1901362),-0.3312968938987375,-1.082846496210368,0.3116883116883117,0.7536276110692569,1.0,14/33,31.34%,MOCOS;CYP51A1;CYP19A1;PRLR;MOCS3;SRD5A1;GPHN;RDH8;NOXRED1;GCH1;SRD5A2;FDXR;PYCR1;HSD3B1
prerank,protein catabolic process (GO:0030163),0.2612050905019133,1.08279280908791,0.3684210526315789,0.4600732807266431,1.0,15/61,13.24%,NR1D1;FBXO17;UBE2G1;MTOR;FBXO44;CEACAM1;DENND3;DAB2IP;ELANE;TPP1;FBXO27;UBE2G2;CAPN3;LRSAM1;RIPK1
prerank,glycosaminoglycan metabolic process (GO:0030203),0.2484755619782773,1.0819537796282857,0.3333333333333333,0.4615946102477155,1.0,22/54,21.60%,SDC2;SDC3;GCNT2;IDS;GPC1;NDST2;HPSE2;CHST9;HGSNAT;GUSB;NDST1;GPC4;B3GAT1;GPC3;HSPG2;UGDH;SGSH;B3GAT3;GPC6;HS3ST6;HS3ST5;HS6ST1
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.2905001667218809,-1.0816063158644762,0.3488372093023256,0.7563165382561253,1.0,27/73,34.81%,RFC3;POLR2F;ERCC5;RPA3;LIG1;RFC5;ERCC8;CDK7;RFC2;GTF2H2;HMGN1;LIG3;POLD2;POLR2D;POLR2J;GTF2H3;POLR2I;CCNH;ERCC6;PRPF19;ERCC2;RFC4;POLD1;AQR;CUL4A;UBC;COPS5
prerank,regulation of intracellular transport (GO:0032386),0.2548886328496101,1.0811490074468204,0.4,0.46232592898928504,1.0,13/36,18.01%,CRYAB;RBM4;MAP2;NUMA1;HAP1;RAB11B;AAAS;GAS1;INPP5F;NEFH;GRIPAP1;REEP5;NDEL1
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.20900040317164847,1.0810774436297699,0.1875,0.46197508558524697,1.0,27/92,17.59%,ATP2B4;SNCA;TRIM6;NGF;TERF2IP;CAMK1;RAPGEF3;NOS1;HDAC6;MTCP1;EGFR;RAMP3;PRKD1;TENM1;RAF1;CAPRIN2;APP;TFRC;NTF3;BCAR3;TXN;SH2D3C;PFN2;HCLS1;ARAF;CREBL2;SFRP2
prerank,ganglioside biosynthetic process (GO:0001574),0.33186282022490704,1.0807635228668047,0.26666666666666666,0.4619929825600171,1.0,7/15,19.07%,ST6GALNAC3;B3GALT4;ST3GAL5;ST6GALNAC5;ST6GALNAC6;ST8SIA3;B4GALNT1
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.3124629245896813,-1.0807149390842627,0.3373493975903614,0.7579486867064938,1.0,11/54,12.58%,DPEP1;IFI6;LAMP3;CD44;NAIP;MAGEA3;PAX2;XIAP;BCL2L12;PLAUR;MMP9
prerank,monocarboxylic acid metabolic process (GO:0032787),0.19686824689495697,1.0802171729699945,0.2857142857142857,0.46254997214002475,1.0,34/142,16.30%,PPARD;CYP4B1;DLD;CKM;SCPEP1;DLAT;GBA2;ADH1B;PDHB;PDHA1;CD36;CPT1B;PDHX;ACOT2;CROT;CYP27C1;CPT1C;CKB;CYP1A1;ACADSB;LPL;AKR1C1;ALDH8A1;GAMT;HAGH;MTHFS;GGT5;CYP26B1;SLC6A8;CYP4F12;ADH1C;NAAA;ME3;LDHB
prerank,homologous chromosome segregation (GO:0045143),-0.39365614260964354,-1.080199163274948,0.36619718309859156,0.7584998362266623,1.0,6/15,31.19%,PTTG1;RNF212B;ANKRD31;PRDM9;SYCP1;MEIOB
prerank,negative regulation of interleukin-8 production (GO:0032717),0.3078699630024847,1.0800927517749945,0.2222222222222222,0.46224897789861685,1.0,10/18,24.62%,SSC5D;TLR9;ELANE;MAPKBP1;KLF4;MAP2K5;ARRB1;TLR6;BCL3;OTUD7B
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.27359838835329553,1.0792115966252254,0.3076923076923077,0.4637337256428951,1.0,7/38,7.68%,CLU;TNFSF10;MOAP1;BCL2L11;MLLT11;GPER1;BNIP3
prerank,positive regulation of angiogenesis (GO:0045766),-0.2708057176691506,-1.0785417237111627,0.32222222222222224,0.7619664077416844,1.0,36/114,23.63%,CXCL8;IL1A;ADAM12;ITGA5;SERPINE1;IL1B;WNT5A;CTSH;FUT1;ANGPTL3;HMGA2;EPHA1;SMAD1;RUNX1;RLN2;APELA;SEMA5A;ITGAX;GATA6;ANXA3;GATA4;CHI3L1;ADM2;KDR;CCR3;JUP;BRCA1;VASH2;THBS1;MDK;CHRNA7;PIK3CD;HIPK2;NODAL;XBP1;GDF2
prerank,male gonad development (GO:0008584),-0.31591473864288416,-1.0778019807729988,0.3333333333333333,0.7632191723927435,1.0,17/43,27.39%,INHBA;TGFB2;WNT5A;SOX9;ADAM20;LRP2;GATA6;GATA4;BIK;TEX19;LHB;GATA3;NR5A1;PRKACG;WNT4;SRD5A2;ZFP42
prerank,activation of protein kinase A activity (GO:0034199),0.33726646739667343,1.0776641443311037,0.32,0.46697404627572064,1.0,7/17,14.91%,ADCY5;PRKAR2B;ADCY4;PRKACA;ADCY9;ADCY2;ADCY6
prerank,regulation of nervous system development (GO:0051960),0.2826478572502449,1.0776365745677916,0.3157894736842105,0.4665228760798658,1.0,7/40,5.95%,LGI4;PTN;HEY1;PTPRZ1;SIRT2;ARNTL;NPHP3
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.306146268007658,-1.0775243951818858,0.3698630136986301,0.7630044539286925,1.0,12/50,17.57%,GNL3L;NEK2;MAPK15;AURKB;NAF1;NAT10;ATR;CCT6A;FBXO4;HMBOX1;CCT2;PRKCQ
prerank,peptide metabolic process (GO:0006518),0.22841384011262106,1.0774957291144762,0.3333333333333333,0.466243295330115,1.0,17/79,11.76%,PSEN1;CPXM2;GSTM2;GSTM3;GSTM5;CPQ;GSTA4;LNPEP;GSTM4;HPGDS;SOD1;NAALADL1;TPP1;LVRN;DMD;GSTT2B;CPE
prerank,positive regulation of telomere maintenance (GO:0032206),-0.34068716101416513,-1.0774020752656932,0.3194444444444444,0.7623126626501042,1.0,10/31,23.82%,PML;NEK2;MAPK15;AURKB;NAF1;GNL3;SLX1A;PRKCQ;MAPKAPK5;ATRX
prerank,glucose 6-phosphate metabolic process (GO:0051156),-0.3627694451733829,-1.0773560761692462,0.3875,0.7613748257636825,1.0,11/22,36.22%,HKDC1;RPIA;RPE;PGD;G6PD;TALDO1;RPEL1;PGLS;G6PC3;TKT;PGM2L1
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.2567459449714867,1.0767315654339742,0.2222222222222222,0.4675226396109341,1.0,15/35,22.45%,SORBS1;MTOR;PLIN5;NR1H2;SLC27A1;CREB1;CTDNEP1;INS;SREBF1;NR1H3;CREBL2;ELOVL5;CNEP1R1;HSD17B13;MID1IP1
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.31026921480560987,-1.0764294955209095,0.4069767441860465,0.7630213283629084,1.0,28/54,38.35%,RIPK2;USP50;WNT5A;EGR1;GBP5;IL17A;ORM2;CCL3;ORM1;IFNG;NLRP12;NOD2;NLRP3;IFI16;MNDA;TNF;CLEC7A;TMEM106A;AIM2;TYROBP;AGER;NLRC4;TLR8;MYD88;PYDC1;NLRP2;PYHIN1;LILRA5
prerank,positive regulation of reproductive process (GO:2000243),0.26805731871625216,1.0763000727365646,0.34782608695652173,0.46806956666787775,1.0,5/35,4.24%,TACR2;CACNA1H;VIP;SYDE1;SIRT2
prerank,meiosis I (GO:0007127),-0.37363558529691615,-1.0758893744966136,0.36231884057971014,0.7637784184169082,1.0,5/22,12.71%,SYCP3;PTTG1;BTBD18;HSF2BP;DNMT3L
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.3242721679380937,-1.075868156389271,0.40540540540540543,0.7627285304342097,1.0,17/45,24.75%,THY1;TNFSF11;IL1B;SKAP1;CD44;CEACAM6;FOXA2;BMP7;PLAUR;FUT7;IL10;MDK;FGA;NODAL;FGB;LCK;TNF
prerank,epithelial cell migration (GO:0010631),-0.311774178329336,-1.0754969710631397,0.40963855421686746,0.7628768068904308,1.0,7/41,9.20%,FAP;LOXL2;S100P;FERMT1;S100A2;STAT1;KRT16
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.2288281939788325,1.0751412534804505,0.35714285714285715,0.47000025387544436,1.0,25/87,16.31%,CLU;LGALS3;SYNPO2;EMILIN1;TSG101;TIRAP;TRABD2B;BCL2L11;SYNPO;DAB2IP;RHOC;CDH5;FLOT1;TAL1;BRK1;SMAD3;TFRC;PRKCA;CX3CL1;VPS4A;PFN2;MPP7;SH3GLB1;CDC42EP2;RGCC
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.3280221845484767,-1.0749236374738715,0.36,0.7634982456269892,1.0,9/37,20.46%,RFC3;ERCC5;RPA3;RFC5;RFC2;GTF2H2;POLD2;NTHL1;GTF2H3
prerank,negative regulation of cytokine production (GO:0001818),0.18146097268665037,1.0747240039383414,0.3333333333333333,0.4703734799099238,1.0,53/175,19.36%,CD34;PRNP;SYT11;VSIG4;APOD;NPTN;RAC1;HDAC7;F2RL1;ZFP36;NLRX1;NCKAP1L;ASB1;CEACAM1;SSC5D;UBA7;TWSG1;C1QTNF3;TRIB2;CUEDC2;TLR9;TAX1BP1;ELANE;GPNMB;DHX58;RNF216;TNFRSF21;PIN1;LGALS9;PTGER4;OTUD5;CX3CL1;PDCD4;MAPKBP1;SFTPD;HOMER3;NR1H4;KLF4;DDIT3;HOMER2;RGCC;RARA;GPATCH3;KAT5;DLL1;IL12A;PCBP2;HERC5;RNF135;INHA;RPS6KA5;MAP2K5;GAS6
prerank,motor neuron axon guidance (GO:0008045),0.3363423747924748,1.0745507368439013,0.375,0.47030949721866405,1.0,9/16,20.20%,NTN1;RAC1;EPHA4;SEMA3A;NTN5;RHOG;SLIT2;RNF165;CHN1
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.2943731396839147,-1.0745177164017954,0.37209302325581395,0.7635882475094539,1.0,35/73,42.12%,PSMB9;CALR;PSMD14;FCGR1A;HLA-F;TAP1;PDIA3;NCF2;CYBA;PSMA3;HLA-G;CYBB;PSMB3;PSMA5;PSMD12;PSMB11;PSMB2;PSMA7;IKBKG;PSME2;PSME3;PSMC1;PSME4;TAP2;VAMP8;TAPBP;PSMD1;PSMC4;IKBKB;NCF1;ITGAV;CHUK;PSMD3;PSMD13;PSMC2
prerank,negative regulation of type I interferon production (GO:0032480),0.24732261529867428,1.0737775651350536,0.2857142857142857,0.4714808445919515,1.0,13/40,18.29%,PTPRS;NLRX1;UBA7;TAX1BP1;DHX58;RNF216;PIN1;OTUD5;PPM1B;GPATCH3;PCBP2;HERC5;RNF135
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.3078234124320361,-1.0735178846870779,0.3888888888888889,0.7657085985947228,1.0,32/77,31.40%,IL1A;MIF;EPHB2;IL23A;WNT5A;OAS2;IL17A;PF4;ORM2;SYK;CCL3;RASGRP1;IL12B;ARFGEF2;ORM1;IFNG;OAS3;NOD2;CYBA;THBS1;PTPRJ;MMP8;HMGB1;CD2;CLEC7A;TMEM106A;PTPN11;TYROBP;TWIST1;LBP;DHX9;AGER
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.30535772363118313,1.073187851108626,0.4074074074074074,0.47214163562777256,1.0,4/19,6.96%,CLDN5;MYO1C;OCLN;PRKACA
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.388110578995581,-1.0730546890232449,0.44594594594594594,0.7660309707418969,1.0,7/20,20.57%,FOXP3;IL1B;SOX4;DIP2B;PAXIP1;BRCA1;RUVBL2
prerank,positive regulation of RNA splicing (GO:0033120),0.2727763946004207,1.0725042567273306,0.23076923076923078,0.472849361447555,1.0,9/31,17.30%,CIRBP;RBM20;PIK3R1;PRDX6;CELF4;SLC38A2;SF3B4;POLR2A;SNW1
prerank,negative regulation of histone modification (GO:0031057),-0.38493607327271706,-1.0724193089834269,0.38235294117647056,0.7667291353611165,1.0,8/15,32.04%,FOXP3;SDR16C5;USP17L2;SET;BRCA1;JARID2;TWIST1;NOC2L
prerank,mitochondrial fusion (GO:0008053),0.33991994032167067,1.072280061965232,0.3333333333333333,0.47283131215944657,1.0,4/16,16.69%,MFN2;PLD6;MIEF2;MFF
prerank,regulation of catecholamine secretion (GO:0050433),0.2979449564753332,1.0722735329253976,0.375,0.4723550785398849,1.0,8/28,10.95%,SYT11;SNCA;KCNB1;KCNA2;SYT4;SYT10;SYT5;SYT1
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.300268851071293,1.0716216739978748,0.3333333333333333,0.4731807917676978,1.0,3/15,11.71%,MICA;CEACAM1;LGALS9
prerank,RNA methylation (GO:0001510),-0.30564052131740327,-1.0713140721312344,0.3411764705882353,0.7692027408447797,1.0,18/56,28.18%,RBM15;HENMT1;METTL2A;TGS1;TFB1M;NSUN3;METTL1;METTL6;FBL;TRMT6;TFB2M;THUMPD3;THADA;FTSJ1;METTL2B;TRMT61B;TRMT10C;TARBP1
prerank,regulation of proteolysis (GO:0030162),-0.30631812081526416,-1.0706700552970463,0.345679012345679,0.7698944166865258,1.0,19/54,26.55%,CST4;SHH;CAV1;PRSS37;PLAUR;PLK1;PERP;CDK5;KNG1;ASPH;FGFR4;SERPINB3;CSTB;HDAC2;CLN6;TM4SF20;ITCH;SERPINB4;CSTA
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.3484024299257738,-1.0706543214611592,0.4189189189189189,0.768830500959985,1.0,10/31,23.65%,THY1;SOCS3;SOCS1;CAV1;SEMA4D;PRKCZ;PIBF1;LILRB4;PTPN2;PARP14
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.2882257382837482,-1.0704908987104602,0.36470588235294116,0.7681909978022575,1.0,36/83,37.21%,KIF18A;CENPE;KIF15;KIF23;KIF2A;KDELR3;RACGAP1;KIF4B;KIF2C;KIF22;ATP9A;KIF3B;ERGIC3;KDELR2;TMED3;TMED2;COPB2;LMAN2;ERGIC2;ZW10;NBAS;COG3;COPG2;RAB41;COPA;TMED9;COPG1;KIF4A;COPZ1;NSF;SURF4;RINT1;KDELR1;TAPBP;RAB6C;GOLPH3L
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.3862596759983441,-1.0701598184995198,0.36764705882352944,0.7681330761845646,1.0,6/17,18.55%,TRIB3;SOX9;SIRT4;SLC22A13;APOC1;BRCA1
prerank,regulation of JUN kinase activity (GO:0043506),0.2556052246906736,1.0694878307594384,0.2916666666666667,0.47679642200468536,1.0,9/35,13.44%,DVL3;SASH1;DVL2;DAB2IP;TLR9;MAPK8IP1;NPPA;DUSP19;PDCD4
prerank,extracellular matrix organization (GO:0030198),-0.24775308428859666,-1.0691948818744934,0.32323232323232326,0.7701856974063812,1.0,60/296,14.92%,COL10A1;MMP7;MMP13;ACAN;COL1A1;COL11A1;ADAM12;LOXL2;ITGA5;TIMP1;COL1A2;VWF;TGFB2;TGFBI;SERPINE1;LAMC2;KLK7;SPP1;MMP1;MMP10;MMP11;CD44;FN1;IBSP;ICAM1;BCAN;CTSV;ADAMTS12;MMP20;MMP24;KIF9;MMP2;MMP3;CAPG;PECAM1;AGRN;ITGA11;FBN2;SMOC1;ADAMTS18;COL3A1;DSPP;DMP1;ITGAX;LAMA3;VCAN;PLG;MMP9;TMPRSS6;TGFB1;MMP25;COL7A1;P4HB;NOXO1;NF1;KDR;PPIB;LAMB3;PLOD3;MMP12
prerank,regulation of cell cycle phase transition (GO:1901987),-0.27203306842805464,-1.0689654639769297,0.3707865168539326,0.7698733564351676,1.0,13/94,8.97%,DBF4;UBD;MAD2L1;CDK1;GTSE1;FBXO5;UBE2C;PSMB9;PSMD14;TFAP4;UBE2S;ANAPC1;SIX3
prerank,positive regulation of protein binding (GO:0032092),0.2358689438183625,1.0681384753748202,0.18181818181818182,0.47881774104870334,1.0,12/56,11.46%,PSEN1;CLDN5;ADD1;PKD1;AKTIP;B2M;TRIM21;PPP2CB;FLOT1;CAPRIN2;APP;PIN1
prerank,regulation of cellular protein catabolic process (GO:1903362),0.32082204469612463,1.0674023854160977,0.4117647058823529,0.4800903251823194,1.0,6/18,17.78%,VPS11;WDR91;DAB2IP;RDX;PTTG1IP;CDK5RAP3
prerank,positive regulation of chemokine production (GO:0032722),0.24719866123156367,1.067255370092793,0.26666666666666666,0.47982486738395547,1.0,14/53,14.12%,IL6R;TLR3;DEFB124;TIRAP;HMOX1;F2RL1;OAS1;TLR9;TSLP;LPL;APP;LGALS9;IL7;ADCYAP1
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.3811917500364517,-1.0671204655952637,0.38461538461538464,0.7739104391309871,1.0,9/18,33.29%,FER1L5;SYK;IFNG;NMI;DNASE1;TYROBP;LBP;IFI35;DOCK2
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.20704613153727397,1.0670145088126894,0.09090909090909091,0.4797277215806622,1.0,15/78,13.87%,CIRBP;CLU;CASP3;SAMD4A;MTOR;PRKCD;IFNGR1;LARP6;EPHA4;POLDIP3;PLA2G6;TNFRSF1A;VIM;METTL3;SIRT3
prerank,endomembrane system organization (GO:0010256),0.20015369616651268,1.0668613415262638,0.2,0.47951108164211526,1.0,37/192,13.47%,RNF112;DMPK;SYNGR1;OPTN;SEC31B;CAV2;TJAP1;SUN2;OBSL1;VPS11;TBC1D20;ATL2;SYP;ATP8B2;AKTIP;SUN1;A4GALT;VAPA;TICAM2;PRKD1;ATL3;GORASP1;PI4K2A;PLEKHM2;PLEKHF1;RAB30;ATL1;MYOF;CSNK1A1;SNX33;LMAN2L;CTDNEP1;GOLPH3;DYSF;GOLGA8A;VPS4A;ANXA8L1
prerank,hexose transmembrane transport (GO:0008645),0.2953887935664229,1.0664848016749178,0.3448275862068966,0.4795579561193995,1.0,3/23,0.59%,SLC2A4;PPARD;SLC45A1
prerank,prostaglandin biosynthetic process (GO:0001516),0.33168779933294373,1.0659057275427282,0.35294117647058826,0.48027363711440674,1.0,5/18,13.41%,PTGS1;PTGIS;HPGDS;PTGDS;PLA2G4A
prerank,positive regulation of response to external stimulus (GO:0032103),-0.2674671672073203,-1.065822150199434,0.3263157894736842,0.7767087557757464,1.0,40/136,22.75%,OSM;PDGFRB;SERPINE1;EREG;IL1B;IL23A;THBD;WNT5A;ZP3;GBP5;PLA2G7;IFNK;IL21;CCL3;POLR3B;CEBPA;IL12B;FEM1A;USP17L2;AGT;PLG;IFNG;TGFB1;FPR2;CCL26;TNFSF4;POLR3C;NFKBIA;NLRP12;ADAM8;CYBA;ZBP1;THBS1;MDK;POLR3G;CCL1;HRG;ANKRD17;NMI;MGST2
prerank,alpha-amino acid metabolic process (GO:1901605),-0.31472414712650365,-1.0656846977629697,0.35,0.776175002733232,1.0,19/42,30.67%,DPEP1;GLS2;MTHFD1;GPT2;CPS1;ASS1;ALDH18A1;KMO;IYD;DDAH1;FOLH1B;SRR;FOLH1;SLC25A13;HNF4A;GADL1;PYCR1;CBS;NOX4
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.3490749262922186,-1.06547600480501,0.3875,0.7756056569840107,1.0,12/28,28.85%,INHBA;FOXP3;TNFSF4;LILRB4;IL36RN;HMGB1;CR1;AXL;XCL1;PDCD1LG2;C1QBP;ZC3H12A
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.28866589678825516,1.0654320689802121,0.42857142857142855,0.48065371711944427,1.0,5/26,8.69%,DNAJB5;HSPA2;DNAJC18;DNAJB4;ST13
prerank,primary alcohol metabolic process (GO:0034308),0.27084967580284186,1.0653388188275883,0.4090909090909091,0.4803416570946218,1.0,14/33,21.51%,LRAT;ADH1B;CYP27C1;CYP1A1;GDPD3;ADH1C;NAAA;RETSAT;CYP11B1;DHRS9;ALDH3A2;CYP11A1;CYP1B1;DHRS3
prerank,translation (GO:0006412),-0.2490443582732411,-1.0652630083297752,0.3333333333333333,0.7752045768767364,1.0,84/196,43.50%,EEF1G;IGF2BP3;DARS2;ABCE1;YARS2;RPL22L1;AIMP2;LARS2;RPL39;MRPL3;MARS2;RRBP1;SRBD1;RPS19;FARSB;MRPS18C;FASTKD2;ASMT;RPS21;WARS2;RPL36;ZC3H15;FARS2;MRPS16;FARSA;FTSJ1;GFM2;PPA1;RARS2;MRPL13;RPL26L1;EEF2;ZAR1L;RPL37;MRPL42;RPL8;ABCF1;MRPL9;RPL23A;MRPL37;QRSL1;MRPL57;HBS1L;GSPT1;RPS7;MRPL47;TUFM;MRPS12;APEH;RPS18;RPS2;NOA1;ZAR1;COPS5;EEF1D;MRPS18A;MRPL52;RPL4;TMA7;MRPS11;AGO2;RPS3;RPL35;RPS4X;MRPS33;RPL18;RPL32;RPL41;MRPS34;RPS6KB2;PTCD3;RPS24;RPL27A;RPS29;RPL19;RPL38;RPL37A;EEF1B2;MRPL36;RPS14;RPL12;MRPL11;DRG1;RPLP2
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.27699575624457384,1.0652131220850625,0.3076923076923077,0.4801016929371668,1.0,7/41,8.63%,IL6R;FERMT2;WWTR1;DDR2;ZHX3;BMPR1A;PRKD1
prerank,transition metal ion homeostasis (GO:0055076),0.2823617341707989,1.0651394987019998,0.36363636363636365,0.4797194914918966,1.0,6/27,9.07%,CYBRD1;CUTC;HMOX1;FBXL5;B2M;BDH2
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.2200806769952055,1.0650061192005646,0.375,0.4795282063514019,1.0,42/139,19.54%,TEAD3;PPARD;WWTR1;NR1D1;THRB;CDK9;KAT2B;PGR;HDAC7;TEAD2;NR1H2;TEAD1;HDAC5;RARB;RBPJ;THRA;NPPA;NRBP1;RXRG;ERCC3;RXRA;GTF2H4;RXRB;MAML1;NR1D2;TBL1X;NR4A3;NR1H4;NR4A1;NOTCH4;RARG;POLR2A;NR3C1;RARA;TAF11;NR1H3;SNW1;TAF9B;NR2C1;RORA;NR2C2;TAF13
prerank,regulation of Rho protein signal transduction (GO:0035023),0.2417311940085601,1.0640178072757325,0.2777777777777778,0.4809753899044105,1.0,22/71,18.05%,KANK2;LPAR1;MYOC;FLCN;RAC1;STARD8;GPR17;STARD13;KCTD10;ARHGEF18;F2RL1;DLC1;RAF1;RASIP1;ITGA3;RALBP1;GPR4;RIT2;ARHGEF3;GPR20;KANK1;F2RL3
prerank,positive regulation of endothelial cell migration (GO:0010595),0.22613000771354366,1.0639034739334623,0.21428571428571427,0.48071204966178005,1.0,18/82,10.97%,FGFR1;NRP2;RHOB;HSPB1;RRAS;FGF2;ITGB3;RAC1;MAPK14;SASH1;ATOH8;PDGFB;PRKD1;ZNF580;FGF1;FLT4;ANGPT1;GATA2
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.2983463528480526,1.0633414599635689,0.2857142857142857,0.4816574872838499,1.0,7/27,12.13%,PLN;CACNA1C;CTNNA3;ANK2;ATP2A2;CAMK2D;PDE4D
prerank,protein processing (GO:0016485),-0.2721709557512228,-1.062557184869384,0.2976190476190476,0.7824884938671761,1.0,25/101,21.80%,KLK6;CPZ;MME;F12;CTSH;F7;PCSK1;CPN1;HM13;MMEL1;CPD;PCSK9;USP17L2;CASP2;MYRFL;ADAM10;PCSK6;MYRF;PCSK7;PTCH1;SRGN;HP;XPNPEP3;F9;PRSS3
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.37137016358718933,-1.0620307114743246,0.4074074074074074,0.7831038537234722,1.0,13/24,34.24%,IRAK2;RIPK2;TNFAIP3;IRAK1;NOD2;TAB3;RNF34;ITCH;IKBKG;TRAF6;UBE2N;NOD1;UBC
prerank,positive regulation of ossification (GO:0045778),0.27193162777807883,1.06178278062912,0.47619047619047616,0.4846599199737948,1.0,10/39,12.43%,PTN;GPM6B;OSR1;BMPR1A;P2RX7;KL;SLC8A1;OSR2;PKDCC;MEF2C
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.2861237466799179,-1.0617639925085014,0.3411764705882353,0.782887629752752,1.0,20/63,30.93%,POLR2F;CCNK;CDK7;CDK12;EAF1;NELFCD;NCBP1;MLLT3;GTF2H2;POLR2D;POLR2J;GTF2H3;POLR2I;CCNH;EAF2;ADRM1;CDC73;ERCC2;GTF2F2;LEO1
prerank,stabilization of membrane potential (GO:0030322),-0.35970580541743225,-1.0615847402011998,0.37142857142857144,0.7823221076500743,1.0,5/17,24.44%,KCNK12;KCNN4;KCNK1;KCNK13;KCNK16
prerank,regulation of anoikis (GO:2000209),-0.38130184532323613,-1.0614397070628818,0.42857142857142855,0.7817765488258235,1.0,11/19,42.13%,ITGA5;CEACAM6;CAV1;CEACAM5;PTRH2;NOTCH1;MCL1;PTK2;SIK1;MYBBP1A;BRMS1
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.2727887165330922,1.0607958912690791,0.2692307692307692,0.48649768315400016,1.0,10/29,17.68%,PLA2G5;PLA2G4B;NR1H2;TMEM86B;PLA2G1B;PLA2G4C;PLA2G6;PLA2G4A;NR1H3;LPCAT4
prerank,hyaluronan metabolic process (GO:0030212),-0.3596544184916985,-1.0606816615455947,0.3291139240506329,0.7832158883902786,1.0,9/22,27.67%,CEMIP;IL1B;CD44;HYAL3;TGFB1;HEXB;HAS3;HAS2;HYAL4
prerank,regulation of protein catabolic process (GO:0042176),-0.2686901616255484,-1.0604195284467484,0.3404255319148936,0.7830740653531924,1.0,24/100,19.61%,MAD2L1;ASB9;WNT5A;CHEK2;TNFAIP3;HECW1;CYP51A1;CSNK2A3;HECW2;C4BPA;PRKCG;OAZ3;SF3B3;SORL1;ODC1;C4BPB;MDM2;CSNK2A1;ATP13A2;BARD1;PHB;IRAK3;GSK3B;AZIN1
prerank,postreplication repair (GO:0006301),-0.31651688334966277,-1.0599628282859543,0.3835616438356164,0.7834087935953936,1.0,17/45,34.24%,RFC3;POLH;RPA3;ISG15;RFC5;RAD18;RFC2;POLD2;BRCA1;USP10;USP43;SPRTN;UBE2N;RFC4;POLD1;DTL;UBC
prerank,positive regulation of cholesterol transport (GO:0032376),-0.31990022021555986,-1.0595790456852214,0.37333333333333335,0.7832396633818118,1.0,9/33,18.90%,ABCA13;LIPG;CAV1;CETP;ABCA12;ENPP7;NFKBIA;PON1;PTCH1
prerank,positive regulation of cell population proliferation (GO:0008284),-0.23912367714470667,-1.0592299494008928,0.29,0.7834271326759729,1.0,122/461,23.46%,MYC;IL11;CXCL5;WNT2;ESM1;TDGF1;IRS1;OSM;KIF14;TBX20;PDGFRB;CSF2;KIF20B;TIMP1;RASSF10;AREG;TGFB2;FGF19;EREG;LAMC2;IL1B;SOX4;CIAO1;LEF1;MIF;SHH;SAPCD2;E2F1;TIPIN;FBXO5;WNT5A;REG3A;FN1;CTSH;PROX1;SOX9;MAZ;CEACAM6;SPDYA;GDF9;BST2;CALR;RTKN2;MAPK15;IL12RB2;HMGA2;EPHA1;PAX2;CSNK2A3;CD81;EPGN;POU3F2;IGF1R;IL21;CDK4;FGF20;STAT1;BAMBI;PKHD1;CXCR2;RELA;PRAME;PRLR;REG1A;REG1B;IL7R;MCTS1;FOXM1;F2R;WDR77;ITGAX;AGT;IFNG;TSHR;SSR1;TGFB1;FGF23;NOX1;KDR;FGF3;CDC7;TGFBR2;TNFSF4;MLXIPL;ADAM10;ROMO1;NANOG;BMP4;MDM2;TERT;CSNK2A1;PROK2;ACER2;CDCA7L;NOD2;FGFR4;STOX1;PHB;THBS1;EGR4;MDK;LIF;SAAL1;SERPINB3;NPM1;CD86;BIRC5;ZBED9;HDAC2;CHRNA7;NME1;PRKCI;CR1;NOTCH1;CDC123;PRC1;INSL4;NODAL;KRT6A;TET1;XBP1;FXN
prerank,peptidyl-lysine trimethylation (GO:0018023),-0.3558001631308816,-1.0589463921271483,0.3698630136986301,0.7833678717579051,1.0,11/24,31.28%,SUV39H2;EEF2KMT;BEND3;SUV39H1;TET3;METTL21C;PRDM7;PRDM9;KMT2D;TET2;KMT2A
prerank,negative regulation of translation (GO:0017148),-0.2820067454112086,-1.0583439330658666,0.3522727272727273,0.7843742277425535,1.0,13/85,7.77%,ENC1;GZMB;IGF2BP1;IGF2BP3;PUS7;TRIM71;CALR;NANOS3;DHFR;NCL;IGF2BP2;CAPRIN1;GRB7
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.32299453606700484,1.0579863135447003,0.2857142857142857,0.4922284658676693,1.0,9/21,20.22%,PLN;CASQ2;OSR1;SLN;CAMK2D;ACTN2;GOPC;CAB39;PRKCE
prerank,microtubule polymerization (GO:0046785),0.2823624934922753,1.0575256546803935,0.4166666666666667,0.4928041764795952,1.0,13/29,21.44%,MAPT;TUBG2;MAP7D3;TPPP3;TUBGCP6;SLAIN2;PIN1;GOLGA2;NDEL1;TUBGCP2;FGF13;RANBP9;TUBGCP5
prerank,glucose metabolic process (GO:0006006),0.2428159741556819,1.0574022060590589,0.375,0.49255380603691745,1.0,8/60,6.21%,PPARD;ENO2;SLC25A12;ATF4;APOD;ALDOA;OAS1;CRTC2
prerank,RNA processing (GO:0006396),0.20198893276045454,1.0566936443032888,0.18181818181818182,0.4942581005733705,1.0,40/171,17.33%,SRSF5;RBPMS;ADARB1;PABPN1;NOVA1;TARDBP;HNRNPH3;DDX39B;RBM4;SNRPN;LUC7L3;RBMS1;RBM6;ALKBH5;DDX17;SRSF4;MBNL1;PRKACA;SRSF11;PRPF18;AKAP8L;TUT1;CELF2;ADARB2;RNPC3;RRAGC;SF3B1;RBM5;PDCD7;METTL3;SRRM1;SRSF7;DHX16;SF3B4;WBP4;SCNM1;ADAD2;RNASEL;NOL3;CELF1
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.3160148474170809,-1.0565903676149666,0.3918918918918919,0.788678906498232,1.0,10/36,17.57%,NEK2;MAPK15;AURKB;NAF1;ATR;CCT6A;FBXO4;HMBOX1;CCT2;PRKCQ
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.3641879595564907,-1.0551557831228806,0.3466666666666667,0.7912401098441983,1.0,5/26,10.04%,TP73;GZMB;E2F1;PMAIP1;TFDP1
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.3641879595564907,-1.0551557831228806,0.3466666666666667,0.7912401098441983,1.0,5/26,10.04%,TP73;GZMB;E2F1;PMAIP1;TFDP1
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.3588395307661949,-1.055099298126204,0.3333333333333333,0.7903464066886954,1.0,8/21,17.94%,TIMP1;IL1B;PTPN3;IFNG;TNFRSF1B;ADAM8;IL10;ADAM9
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.3309632269535064,-1.0550893962386487,0.39473684210526316,0.7892923539154896,1.0,5/29,7.97%,DDIAS;MIF;FBXO5;CD44;BCL2L1
prerank,mRNA export from nucleus (GO:0006406),-0.2694115908068683,-1.0550487204318075,0.4117647058823529,0.7883585944482118,1.0,42/103,31.20%,ZC3H11A;U2AF1;NUP155;THOC3;NUP37;NUP210;CPSF3;MAGOHB;NUP107;NUP35;RANBP2;SEH1L;NCBP1;NUP50;NUP205;POLR2D;ALYREF;EIF4E;SRSF9;NUP93;RAE1;NUP88;NXF2;NXF3;POM121;NUP43;CPSF2;MAGOH;DDX39A;NUP160;NXT1;GLE1;NUP62;SMG1;NUP153;NDC1;CPSF4;NUP98;THOC2;SLBP;SEC13;AGFG1
prerank,regulation of response to cytokine stimulus (GO:0060759),-0.3637795019905183,-1.0542878886875475,0.48,0.7896461740476557,1.0,5/21,10.91%,IRAK2;WNT5A;CBFB;RUNX1;IRAK1
prerank,regulation of receptor internalization (GO:0002090),0.2779623047542831,1.0542690804011654,0.23809523809523808,0.49946330545069206,1.0,9/36,14.54%,CD63;RSPO1;RIN3;DLG4;GH1;FLOT1;ANGPT1;NTF3;ANKRD13A
prerank,glucose transmembrane transport (GO:1904659),0.33832807248106334,1.053544604062045,0.38235294117647056,0.5006400638991997,1.0,3/20,0.59%,SLC2A4;PPARD;SLC45A1
prerank,melanosome transport (GO:0032402),0.29956484473640843,1.0534877515382757,0.2631578947368421,0.499774069726275,1.0,10/18,21.22%,BBS5;RAB11B;BBS2;RAB27A;BBS7;BBS4;ARL6;MKKS;BLOC1S6;MYO5A
prerank,pigment granule transport (GO:0051904),0.29956484473640843,1.0534877515382757,0.2631578947368421,0.499774069726275,1.0,10/18,21.22%,BBS5;RAB11B;BBS2;RAB27A;BBS7;BBS4;ARL6;MKKS;BLOC1S6;MYO5A
prerank,cellular response to nitrogen compound (GO:1901699),-0.3725076388604474,-1.0523238333146694,0.4177215189873418,0.7938575815771031,1.0,10/18,33.58%,BLM;TIMELESS;CPS1;DDI1;ATRX;ROCK2;PDE12;FMR1;DDI2;DDX11
prerank,positive regulation of multicellular organismal process (GO:0051240),-0.2380710975903629,-1.051962335480786,0.3838383838383838,0.7940367939951561,1.0,83/335,21.86%,ETV4;CEBPB;IL1A;COL1A1;INHBA;LOXL2;TGFB2;SERPINE1;EREG;IL1B;CXCR4;LEF1;FOXD1;MIF;SHH;IL23A;CYP27B1;FBXO5;WNT5A;HCAR2;DIO2;SOX9;SIX1;ZBED2;CLEC6A;PAX2;BCL9L;CRB2;LCN2;SCD;CAV1;IGF1R;AXIN2;IL17F;IL21;SYK;FOXA2;BAMBI;APELA;PIK3CG;GHRL;TRPM8;IL12B;PRLR;SORL1;PAX8;OXTR;UCP1;F2R;PLA2G3;ITGAX;AGT;IFNG;TSHR;TGFB1;BATF;MED1;RPS19;PPIB;PAXIP1;TGFBR2;TNFSF4;ITK;BMP4;ALOX12B;TERT;HCRT;IL10;ALMS1;RIF1;HLA-G;MDK;LHX1;IL26;FGA;CARD9;SERPINB3;GAPDH;APOC2;IFI16;KSR2;PIK3CD;IL20
prerank,activin receptor signaling pathway (GO:0032924),-0.37652210292106914,-1.0518439823329928,0.45454545454545453,0.7932723345973522,1.0,2/18,0.72%,TDGF1;INHBA
prerank,positive regulation of cellular protein localization (GO:1903829),0.233338540207189,1.051302969725292,0.25,0.503945019638921,1.0,17/67,12.60%,FERMT2;WWTR1;RIC3;SYT11;MAPT;NGFR;MAP1A;NUMA1;PRKAA2;GPD1L;CROCC;RTN4;TESK1;NECAB2;SNX33;MARK4;TFRC
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.2874894881181329,-1.0512918534808127,0.39759036144578314,0.7938555283780551,1.0,27/73,28.46%,IRAK2;SOCS3;VRK2;TNFAIP3;SOCS1;CBFB;SYK;RUNX1;ABCE1;STAT1;PALM3;USP18;IRAK1;IFNG;IFNGR2;OTULIN;ZBP1;TRAF2;IRAK3;IL36RN;PTPN2;AXL;TNF;ELF1;IKBKG;PTPN11;SPATA2
prerank,rRNA methylation (GO:0031167),-0.37282451125876326,-1.0509349757512894,0.4,0.7938279725801657,1.0,5/19,18.13%,TFB1M;NSUN3;EMG1;FBL;TFB2M
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.3428126616253958,1.0508269460892,0.3225806451612903,0.5044103766519134,1.0,5/18,7.14%,THBS4;RAC1;TIRAP;CCL21;NCKAP1L
prerank,peptidyl-lysine modification (GO:0018205),-0.26409935763069603,-1.0505305396692748,0.4044943820224719,0.7939794162970678,1.0,41/99,33.92%,LOXL2;NUP155;RNF212B;HDAC10;NUP37;SIRT4;LIPT2;NUP210;EYA1;NUP107;NUP35;RANBP2;SEH1L;METTL21C;NUP50;PLOD3;NUP205;NUP93;RAE1;NUP88;POM121;NUP43;CTH;SUMO4;NSMCE2;METTL21A;RNF113A;GCSH;NUP160;SENP1;NUP62;P3H4;NUP153;NDC1;NUP98;UBA2;RANGAP1;ZNF451;ATP7A;EGR2;ESCO1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.3045851767315467,-1.049287383300752,0.3764705882352941,0.7967838954607516,1.0,12/50,14.94%,TP73;PML;E2F1;CHEK2;PRKDC;IKBKE;EPHA2;BCL2A1;BCL2L1;MSH6;CASP2;TNFRSF1B
prerank,negative regulation of response to external stimulus (GO:0032102),0.21216141822472515,1.048968985443041,0.25,0.5084043911815168,1.0,33/113,17.46%,PPARD;PTEN;NR1D1;TRAFD1;PTPRS;FGF2;MAPK7;SIRT2;DUSP3;PRKCD;PTGIS;EPHA4;GPER1;MUL1;C1QTNF3;ELANE;GPS2;TRIM21;CDH5;FNDC4;DHX58;TNFRSF1A;PTGER4;LRFN5;NFKBIL1;MAPKBP1;NR1H4;KLF4;INPP5F;PPM1B;CD109;NR1H3;PCBP2
prerank,spindle assembly (GO:0051225),-0.2725315164654822,-1.0485866940491813,0.35365853658536583,0.7978053071747899,1.0,33/78,31.58%,KIF2A;NEK2;CHEK2;HAUS7;TPX2;NEK6;RCC1;HAUS6;GOLGA8H;MZT1;GOLGA8T;GOLGA8J;GOLGA6C;GOLGA6D;KIF3B;GOLGA8O;PIBF1;GOLGA8K;SMC1A;TUBGCP4;GOLGA8S;HAUS2;GOLGA8M;GOLGA8F;GOLGA6A;STAG1;HAUS8;GOLGA6B;KPNB1;STAG2;TUBGCP3;KIFC1;GOLGA8R
prerank,protein targeting to lysosome (GO:0006622),0.3043862009376575,1.048344020248445,0.40625,0.5088408746010232,1.0,6/20,19.18%,CLU;GGA3;VPS4A;NCOA4;HSPA8;SCARB2
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.3558821564264062,-1.0478407176825657,0.4,0.7987705053007168,1.0,10/23,30.74%,WNT5A;SLC7A5;FFAR2;APOA2;TNFRSF1B;IL10;NOD2;TNF;SCIMP;CLC
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.19499189467128564,1.0476703089161856,0.3333333333333333,0.509999603491404,1.0,35/151,13.96%,HACD1;GSTM2;GSTM3;GSTM5;GSTA4;ELOVL4;SPTLC3;LCAT;MOCS1;DEGS1;CHKB;CDO1;GSTM4;HPGDS;MOCS2;CERS4;VAPA;PAM;PRKD1;CSNK2B;HACD4;PPM1L;SLC27A1;PLA2G4C;KDSR;CERS1;DMD;SLC44A2;GSTT2B;CSNK2A2;GOLPH3;ARG2;PLA2G4A;LPIN1;PRKD3
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.3122359947863732,-1.0475157100791566,0.3875,0.7986564371389525,1.0,17/51,30.89%,PSMB9;PSMD14;OAZ3;ODC1;NQO1;PSMA3;AZIN1;PSMB3;PSMA5;PSMD12;PSMB11;PSMB2;PSMA7;PSME2;PSME3;PSMC1;PSME4
prerank,organophosphate ester transport (GO:0015748),-0.34789288165355375,-1.0461485472926468,0.4,0.8012618296529969,1.0,7/23,19.65%,SCARB1;MTTP;PRELID2;PRELID1;OSBPL8;SLC25A19;LDLR
prerank,positive regulation of proteolysis (GO:0045862),-0.2925969033269813,-1.0459450325427528,0.3902439024390244,0.8008341267727892,1.0,16/54,21.91%,PRSS22;IL1B;CTSH;PLK1;PERP;IFNG;NKD2;TNFRSF1B;ASTL;CTSC;ADAM8;ASPH;ADAM9;FGFR4;HDAC2;CLN6
prerank,inner mitochondrial membrane organization (GO:0007007),-0.32704679694136846,-1.045687641307394,0.38961038961038963,0.8007088887806247,1.0,14/28,42.72%,TIMM8A;MTX1;ROMO1;UQCC3;CHCHD6;APOO;TIMM13;TIMM10;HSPA9;OPA1;AGK;CHCHD3;TIMM8B;APOOL
prerank,synaptonemal complex organization (GO:0070193),-0.38664609892273927,-1.0456029156464273,0.4393939393939394,0.7988507912808588,1.0,7/15,29.68%,HORMAD1;TRIP13;SYCE3;SYCP1;P3H4;SYCE2;RAD21L1
prerank,synaptonemal complex assembly (GO:0007130),-0.38664609892273927,-1.0456029156464273,0.4393939393939394,0.7988507912808588,1.0,7/15,29.68%,HORMAD1;TRIP13;SYCE3;SYCP1;P3H4;SYCE2;RAD21L1
prerank,positive regulation of interleukin-6 production (GO:0032755),-0.28341724597598644,-1.0455858160769356,0.4,0.7978195420347788,1.0,34/74,34.49%,IL1A;EREG;IL1B;WNT5A;IL17A;HSPD1;IL17F;SYK;NOS2;F2R;IFNG;TNFSF4;NOD2;CYBA;CARD9;MMP8;HMGB1;XBP1;TNF;CLEC7A;TMEM106A;SCIMP;PTPN11;TYROBP;TWIST1;TLR7;LBP;NLRP10;DHX9;AGER;TLR8;MAPK13;MYD88;CD74
prerank,regulation of macrophage differentiation (GO:0045649),-0.37879768301180866,-1.0454272421439974,0.373134328358209,0.7971524592349046,1.0,4/15,20.87%,INHBA;PF4;LIF;PTPN2
prerank,positive regulation of cellular metabolic process (GO:0031325),0.20533513178098176,1.0449826682027277,0.3076923076923077,0.51563017956334,1.0,29/104,17.48%,PPARD;BVES;AGPAT1;AGTR1;CDKN1A;ACACB;SNCA;IFNAR1;ECE1;MAPK14;CD63;NR1H2;PID1;RAMP3;GH1;PDGFB;ANGPT1;AKR1C1;RIPK1;MT3;NTF3;ANXA2;KLF4;INPP5F;VAMP3;INS;NR1H3;RNF41;AKR1C3
prerank,regulation of T cell receptor signaling pathway (GO:0050856),-0.33067534359893236,-1.0449330801468362,0.3333333333333333,0.7976755981287549,1.0,20/34,33.42%,THY1;CARD11;CD81;RELA;KCNN4;GBP1;PVRIG;PTPRJ;LILRB4;PTPN2;SLA2;SH2D1A;LCK;CD160;IKBKG;UBASH3A;TRAT1;EZR;CD226;PTPN22
prerank,nucleobase-containing compound catabolic process (GO:0034655),-0.31136832583944746,-1.0447759734123334,0.45454545454545453,0.7969489397624758,1.0,16/40,29.31%,ENTPD7;SND1;RNASEH1;PNPT1;NUDT1;RNASEH2A;NCBP1;NUDT15;NUDT5;ENTPD1;RNASEH2B;XRN2;EXOSC7;DNASE1;DNASE1L1;ENTPD2
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.30792003462373774,1.044190440642434,0.43243243243243246,0.5173615915784381,1.0,7/17,18.11%,CLIC4;MTCL1;PARD3;DLG2;SYNJ2BP;PARD3B;LRRC7
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.343587128300683,1.0438807364134144,0.36666666666666664,0.5177173864682549,1.0,9/15,28.16%,PDK2;GNB3;BCKDK;RORA;SCARB2;SIRT1;PDK3;PDK4;ADIPOQ
prerank,protein complex oligomerization (GO:0051259),0.22885753716317467,1.0437329685472791,0.38461538461538464,0.5175381211661515,1.0,27/87,18.29%,RNF112;MPP2;BCL10;SNCA;NACC2;PKD2;CUTC;CPSF7;IKZF4;JMJD6;ATL2;MAT2A;ALAD;ATL3;OXA1L;ATL1;HGSNAT;BOK;ARC;LRRC8A;TMEM120A;NINJ1;MICU1;UGDH;NOL3;SLC9A1;RNF135
prerank,excitatory postsynaptic potential (GO:0060079),-0.36202773127031496,-1.0425149923103416,0.4177215189873418,0.8027037891885604,1.0,2/19,0.18%,GRIN2D;GRIN2B
prerank,negative regulation of immune system process (GO:0002683),-0.3609568829391724,-1.04199946290632,0.4383561643835616,0.8033928495455407,1.0,12/19,39.60%,FOXP3;SOX9;AMBP;COL3A1;HLA-G;LILRB4;LYN;PDCD1;HOXA7;FCRLB;LILRB2;IL17D
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.3070930383757112,1.041155871637799,0.4444444444444444,0.5228131693303546,1.0,5/21,7.14%,THBS4;RAC1;TIRAP;CCL21;NCKAP1L
prerank,heterotypic cell-cell adhesion (GO:0034113),0.26193688053317193,1.0406759392724263,0.39285714285714285,0.5232318865625921,1.0,5/30,5.23%,ITGA7;JAM3;PARVA;ITGB3;CTNNA3
prerank,phagosome maturation (GO:0090382),0.2569061521479523,1.0393754664010741,0.3333333333333333,0.5256647701476176,1.0,12/37,19.97%,ATP6V1G2;RAB34;ATP6V1E1;MCOLN1;RAB31;TCIRG1;ATP6V0E2;ATP6V1D;ATP6V1H;ATP6V0A1;ATP6V0D1;RAB14
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.3303057175146323,-1.0381471930245592,0.4594594594594595,0.8135805368488533,1.0,12/31,30.79%,POLR2F;CDK7;NCBP1;GTF2H2;POLR2D;POLR2J;GTF2H3;POLR2I;RNGTT;CCNH;ERCC2;GTF2F2
prerank,7-methylguanosine RNA capping (GO:0009452),-0.3303057175146323,-1.0381471930245592,0.4594594594594595,0.8135805368488533,1.0,12/31,30.79%,POLR2F;CDK7;NCBP1;GTF2H2;POLR2D;POLR2J;GTF2H3;POLR2I;RNGTT;CCNH;ERCC2;GTF2F2
prerank,neurogenesis (GO:0022008),-0.30325557882772125,-1.0380652566744377,0.4268292682926829,0.8127590658863858,1.0,10/43,14.40%,WNT2;TGFB2;CXCR4;WDR62;SIX1;PCSK9;PRDM12;CHAC1;GCM2;GCM1
prerank,cellular response to amino acid stimulus (GO:0071230),0.28420340345637335,1.0378936370582457,0.3103448275862069,0.5283935027423766,1.0,9/30,14.18%,CPEB1;MTOR;RRAGA;RRAGD;RRAGC;KLHL22;CAPN2;RRAGB;LAMTOR3
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.37426166798068716,-1.0377921296927255,0.4507042253521127,0.8124979704349968,1.0,3/18,5.67%,HSPA1A;EGR1;DCUN1D5
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.2702559554759075,1.0375132170788635,0.3870967741935484,0.5290364278160217,1.0,4/21,7.24%,PLA2G5;PLA2G4B;PLA2G1B;OSBPL5
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.3311855998719821,1.0374911185646243,0.3333333333333333,0.5285235140509331,1.0,9/18,23.74%,HSPB1;MAPK7;NME5;INS;NOL3;SIRT1;PINK1;NFE2L2;SOD2
prerank,heme catabolic process (GO:0042167),-0.39044323951746657,-1.037280438822602,0.375,0.8119517436680518,1.0,4/16,8.88%,SLCO1B3;SLCO1B1;ABCC2;AMBP
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.39044323951746657,-1.037280438822602,0.375,0.8119517436680518,1.0,4/16,8.88%,SLCO1B3;SLCO1B1;ABCC2;AMBP
prerank,regulation of viral entry into host cell (GO:0046596),-0.32078620553327103,-1.0371913297514463,0.45569620253164556,0.8111019804205167,1.0,4/38,0.57%,IFITM3;IFITM1;LY6E;IFITM2
prerank,regulation of protein-containing complex assembly (GO:0043254),0.20610998925563687,1.0371363539319196,0.3333333333333333,0.5288651305180869,1.0,21/108,12.89%,CRYAB;GSN;CLU;LGALS3;ULK1;TIRAP;TRABD2B;STX1B;BCL2L11;HDAC6;CD36;DAB2IP;RHOC;CDH5;RAF1;TAL1;BRK1;SELP;TFRC;FBLIM1;NAPB
prerank,determination of heart left/right asymmetry (GO:0061371),0.2490409569361411,1.036327336600703,0.3888888888888889,0.5304504335549505,1.0,20/47,19.80%,DAND5;HAND1;SRF;BBS5;PKD2;NPHP3;SOX18;NDRG4;SMO;MEF2C;MEGF8;SOX17;BBS7;BBS4;DLL1;CCDC40;FOXN4;MKKS;VANGL2;CCDC39
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.23954268626574046,1.0360968954771284,0.3333333333333333,0.5306052475111673,1.0,26/55,23.76%,MAPK8;VPS11;ABLIM3;RHOU;YWHAZ;LEPROT;SAE1;BAP1;HSPA1L;CSNK2A2;BAD;RNF31;TOMM7;BCL2;SH3GLB1;PPP3CC;UBE2D3;ATG13;NMT1;UBE2L3;PINK1;GSK3A;YWHAH;ARIH2;UBL4B;NPEPPS
prerank,protein localization to chromosome (GO:0034502),0.2815346673842209,1.0360633582099668,0.45,0.5301388160051228,1.0,8/29,13.52%,IFFO1;TERF2IP;PARP3;TPP1;CHMP7;TINF2;FAM47E;RPA1
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.2298730589290221,1.0360347582468135,0.42857142857142855,0.5296273762124499,1.0,14/64,13.70%,FGFR1;LGALS3;TNFSF10;BCL10;ZMYND11;FAS;PELI3;GPER1;SCG2;TRAF1;DEPTOR;CFLAR;RIPK1;FEM1B
prerank,endocardial cushion development (GO:0003197),-0.35479535083327546,-1.035953725264834,0.3466666666666667,0.8139938965620145,1.0,6/21,16.38%,TBX20;TGFB2;SOX9;ENG;GATA4;BMP4
prerank,negative regulation of cellular amide metabolic process (GO:0034249),-0.2756835402838294,-1.0356882590603615,0.4069767441860465,0.8136549100990337,1.0,13/82,7.77%,ENC1;GZMB;IGF2BP1;IGF2BP3;PUS7;TRIM71;CALR;NANOS3;DHFR;NCL;IGF2BP2;CAPRIN1;GRB7
prerank,regulation of lipid biosynthetic process (GO:0046890),0.2735966940600124,1.0354697868907812,0.37037037037037035,0.5305628921146669,1.0,8/35,12.68%,SORBS1;PRKAB2;MTOR;PRKAA2;GPER1;CEACAM1;CREB1;PRKAG2
prerank,regulation of lipid catabolic process (GO:0050994),-0.3622677353937007,-1.0351132989289256,0.4383561643835616,0.8143033104069776,1.0,6/21,16.76%,IL1B;HCAR2;ANGPTL3;SCT;APOA2;APOC1
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.29798604635047427,-1.0349705691056605,0.41975308641975306,0.8136882555928133,1.0,11/44,19.40%,HSPA1A;WDR43;IL1B;HEATR1;RELA;PNPT1;TGFB1;BMP4;LIN28A;MYCN;UTP15
prerank,phosphatidylcholine metabolic process (GO:0046470),0.23556368002639275,1.0347124176794982,0.4583333333333333,0.5317258067944814,1.0,17/72,13.48%,PLA2G5;PLA2G4B;ABHD4;LCAT;ENPP2;NR1H2;CHKB;TMEM86B;PLA2G1B;CSNK2B;SLC27A1;PLA2G4C;PLA2G6;SLC44A2;CSNK2A2;PLA2G4A;LPIN1
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.18761741433597368,1.0343688718976192,0.375,0.5321305167460647,1.0,22/123,14.55%,GNAO1;FZD7;PPP3CB;ROR2;CALM1;FZD4;RAC1;GNG2;PRICKLE2;DVL3;AP2M1;RHOA;DVL2;PSMC5;SFRP1;AP2A2;PSMD9;DAAM1;SFRP5;NFATC1;FRZB;PSMB6
prerank,protein monoubiquitination (GO:0006513),-0.32141352302536574,-1.0343541252199497,0.3902439024390244,0.8145765848768141,1.0,14/36,32.94%,UBE2T;UHRF1;UBE3D;FANCL;RAD18;RAG1;KBTBD8;RNF40;DTX3L;HUWE1;CUL3;CDC73;LEO1;DTL
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.37061142951400405,-1.0342558327315383,0.4383561643835616,0.8138421023759144,1.0,9/19,28.75%,DKC1;CEP295;CCT6A;CENPJ;CCT2;TNF;CEP135;CCT3;WRAP53
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.27815698080329676,-1.033943319385926,0.4069767441860465,0.813841249389079,1.0,26/58,37.83%,MYC;PDGFRB;PML;EYA1;ERCC8;BRCC3;GNL3;DNMT3L;WRN;USP9X;FGFR4;BRCA1;NPAS2;HMGB1;ATRX;ERCC6;WRAP53;TIGAR;DHX9;UBE2N;WT1;EYA3;APLF;USP7;RPS3;RNF168
prerank,lymphocyte migration (GO:0072676),-0.3181675223197882,-1.0337156891420358,0.40963855421686746,0.8133589532584661,1.0,16/37,24.55%,CCL24;CCL20;CCL22;CCL4;CCL3;CCL25;ZAP70;CCL26;CCL17;MSN;ADAM8;CCL1;GATA3;CRTAM;XCL2;XCL1
prerank,sensory perception of pain (GO:0019233),-0.3707859545126369,-1.0331762838661271,0.4383561643835616,0.8139511690158157,1.0,7/20,17.71%,MME;PRDM12;CHRNB2;NIPSNAP1;OPRM1;PROK2;ALOXE3
prerank,female gonad development (GO:0008585),-0.3468911285481246,-1.0330813448826133,0.4177215189873418,0.8132041583604167,1.0,4/22,10.29%,CEBPB;INHBA;CYP19A1;NUP107
prerank,positive regulation of vasculature development (GO:1904018),-0.2631902428555423,-1.032333805865774,0.42696629213483145,0.8142746148521208,1.0,32/100,23.63%,CXCL8;IL1A;ADAM12;SERPINE1;IL1B;WNT5A;CTSH;ANGPTL3;HMGA2;EPHA1;RUNX1;RLN2;APELA;SEMA5A;ITGAX;GATA6;ANXA3;GATA4;CHI3L1;ADM2;KDR;CCR3;JUP;BRCA1;VASH2;THBS1;CHRNA7;PIK3CD;HIPK2;NODAL;XBP1;GDF2
prerank,protein localization to cilium (GO:0061512),0.2609647284375425,1.0323153031164305,0.42857142857142855,0.5358523141703154,1.0,13/34,20.68%,TUB;WDR19;BBS1;ARL3;TULP3;RABEP1;BBS4;ATP6V1D;ARL6;IFT20;TTC21A;RAB29;EHD1
prerank,positive regulation of biosynthetic process (GO:0009891),-0.30319631251088874,-1.0322823399105918,0.4146341463414634,0.8133324052525616,1.0,19/44,31.88%,CXCL8;AMELX;ZBTB20;SIRT4;RUNX1;F2R;TGFB1;SUCO;MLXIPL;BMP4;CYBA;MMP8;HDAC2;WNT4;CREB3L1;F2;CCL5;APOA5;SCX
prerank,cartilage development (GO:0051216),-0.30430472198169745,-1.0322720274017951,0.3764705882352941,0.8123157549950868,1.0,14/50,18.52%,AMELX;CD44;SOX9;HMGA2;IL17F;RUNX1;TRPV4;GHRL;HYAL3;TGFB1;CHI3L1;WNT7A;BMP4;COL2A1
prerank,phospholipid catabolic process (GO:0009395),-0.3472795709215068,-1.0316881940362226,0.4358974358974359,0.8130846403341182,1.0,8/24,15.41%,ANGPTL3;LIPG;PLA2G4E;PLBD1;GDPD1;PLA2G4D;APOA2;ABHD12
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.3006960874712399,-1.0316168320274923,0.45,0.8121987248869653,1.0,11/50,14.55%,PNPO;OSBPL3;PSAT1;BAAT;SQLE;CYP7B1;AKR1C4;DHCR7;ALOX12;CYP39A1;SC5D
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.32798055621607736,-1.0315854435439924,0.46987951807228917,0.8112640374603319,1.0,14/37,32.41%,WDR3;NOB1;SRFBP1;EMG1;RPS19;NOP14;DDX52;NPM1;PWP2;NOM1;RRP7A;RPS7;RIOK1;NOL11
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.318976084343107,-1.0307730129159967,0.4050632911392405,0.812532679064828,1.0,15/33,33.59%,DCPS;LSM7;EXOSC3;EXOSC8;DIS3;EXOSC5;EXOSC4;LSM5;LSM4;EXOSC7;HBS1L;EXOSC2;PATL1;CNOT6;EXOSC1
prerank,cellular response to interleukin-12 (GO:0071349),-0.303395165000616,-1.0303785678463586,0.4875,0.8129069415745311,1.0,23/48,34.27%,MIF;IL12RB2;IL12B;IFNG;P4HB;RALA;MSN;IL10;SERPINB2;BOLA2;SNRPA1;IL12RB1;TALDO1;CNN2;CAPZA1;TYK2;PSME2;HSPA9;PAK2;LCP1;GSTA2;CD47;HNRNPF
prerank,regulation of phosphate metabolic process (GO:0019220),0.30285425361111756,1.0298311161156024,0.35714285714285715,0.5412125021719527,1.0,4/16,12.23%,PSEN1;SIRT2;CD24;GNB3
prerank,embryonic heart tube development (GO:0035050),0.33257632643782753,1.0298252951401006,0.4,0.540670205075588,1.0,6/18,13.15%,CITED2;HAND1;SOX18;NDRG4;MEGF8;SOX17
prerank,B cell proliferation (GO:0042100),-0.33219957444548065,-1.0298225093075306,0.45348837209302323,0.8133989083738051,1.0,19/32,45.76%,IFNK;HSPD1;CD70;RASGRP1;IL10;IFNE;IFNB1;IFNA1;CR2;IFNA21;IFNA4;IFNA7;IFNA10;IFNA14;IFNA17;IFNA2;IFNA16;CD180;CD40LG
prerank,muscle tissue morphogenesis (GO:0060415),0.30403720304594395,1.0297120935424156,0.43333333333333335,0.5403799405644115,1.0,6/17,13.10%,MYLK;EFEMP2;TGFBR3;ACTC1;TCAP;HEY2
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.3227373382322615,-1.0295578760156576,0.41333333333333333,0.8131785433434935,1.0,10/29,19.60%,INHBA;PML;PMAIP1;CAV1;PPP2R1B;AGT;WWOX;TRAF2;THBS1;TNFRSF12A
prerank,regulation of insulin secretion (GO:0050796),0.22010024605068507,1.029467525714841,0.5,0.5405460674157303,1.0,23/101,13.20%,RAP1A;KCNA5;NR1D1;NLGN2;ADCY5;PPP3CB;KCNB1;CACNA1C;RAPGEF3;SNAP25;ARNTL;EFNA5;GPER1;NNAT;KCNS3;SFRP1;ITPR1;PSMD9;DPP4;ABCC8;PRKCA;BAD;LRRC8A
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.3606317865461164,-1.0290594104775672,0.4375,0.8136773589165838,1.0,5/16,12.58%,FOXE3;CAV1;ZEB1;IFNG;MMP9
prerank,dorsal/ventral pattern formation (GO:0009953),-0.34538684280086607,-1.0290112786245151,0.375,0.812781719505911,1.0,7/24,19.12%,TBX20;SHH;MDFI;SIX3;WNT8B;PTCH1;LHX1
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.3387256257803282,-1.0290080945147,0.40298507462686567,0.8117534408796175,1.0,14/27,31.78%,CYP2W1;CEL;NUDT19;CYP26C1;ACBD5;CYP4F3;CYP26A1;CYP4F11;AGXT2;HAO2;CYP4F2;HOGA1;AGXT;HAO1
prerank,RNA catabolic process (GO:0006401),-0.29415573323997113,-1.0286685200219108,0.42168674698795183,0.8117805331051995,1.0,14/47,25.22%,HSPA1A;SND1;RNASEH1;DNA2;FEN1;PNPT1;RNASEH2A;NCBP1;LSM5;RNASEH2B;CNOT10;ZPR1;XRN2;EXOSC7
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.3061882185455722,-1.0283332543776398,0.4189189189189189,0.8119589596722581,1.0,10/39,17.56%,IL1A;IL1B;DHFR;SCARB1;CAV1;LYPLA1;DDAH1;GLA;TERT;PIK3CB
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.34090082386834086,-1.0277286001527244,0.41025641025641024,0.8126997733699565,1.0,13/30,33.46%,WNT5A;ISG15;NLRC5;ABCE1;USP18;OAS3;ZBP1;PTPN2;DCST1;SAMHD1;PTPN11;TTLL12;STAT2
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.37063805811346545,-1.0277135330819132,0.4305555555555556,0.8117187681486121,1.0,6/20,21.01%,CD70;CD55;IL12B;CD46;PHB;SLA2
prerank,lung development (GO:0030324),-0.3338175352476631,-1.0276415824178502,0.4074074074074074,0.8108826979219477,1.0,11/35,16.38%,STRA6;WNT7B;SHH;PROX1;CEBPA;NKX2-1;CHI3L1;RBP4;WNT11;DNAAF1;BMP4
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.19863242735176653,1.0273355385433314,0.0,0.5451515782557206,1.0,64/249,15.87%,PSEN1;IGFBP6;WWTR1;DACT3;FZD7;ILK;WLS;TMEM88;SOX13;LZTS2;FZD4;DVL3;IGFBP4;SOX7;LMBR1L;FGFR2;ARNTL;RSPO1;DAPK3;NPHP3;JADE1;EGFR;HHEX;DVL2;GPRC5B;PSMC5;DAB2IP;LATS2;GLI3;RNF146;PFDN5;TLE2;TLE1;CSNK1E;RBMS3;SFRP1;CAPRIN2;CSNK1A1;PIN1;PSMD9;NFKB1;USP47;PPM1A;CTNND2;RNF220;DKK3;SFRP5;TMEM64;FGF10;ANKRD6;PLEKHA4;SOX17;GNAQ;FRZB;TLE4;PSMB6;TMEM170B;UBE2B;TBL1X;SDHAF2;DDIT3;GPC3;PPM1B;FUZ
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.18876685897044865,1.0257932833450483,0.0,0.5485424087260663,1.0,102/455,15.16%,CRYAB;TCEAL7;PPARD;BEND5;PER1;CIPC;NR1D1;CITED2;PBXIP1;CRY2;ZNF219;TSHZ3;NFIL3;SCMH1;HEY1;EID1;TWIST2;HAND1;ING4;ZMYND11;NACC2;ZBTB4;CDKN1C;ZNF174;SMAD2;SOX13;INPP5K;EID2B;ZNF540;ZNF425;MBD1;SIRT2;KLF10;SOX7;RING1;IKZF4;DMAP1;ATOH8;HDAC4;ARNTL;NR2F2;ZHX3;FOXP2;PRDM11;ID2;HDAC6;NR1H2;ID3;PHC2;HDAC5;HHEX;ARID5A;RBPJ;DAB2IP;DPF2;GLI3;THRA;RBFOX2;CBY1;PDGFB;SOX18;PFDN5;TLE2;SMAD4;TLE1;PRMT2;SFRP1;CAPN3;BAP1;PCGF6;FOXN3;CREBZF;EIF4A2;MDFIC;USP47;CIC;ZGPAT;CIART;SMARCE1;DKK3;NKX3-1;RUNX1T1;HINFP;MECP2;CRY1;PHF12;HEY2;PDCD4;MPHOSPH8;MT3;UIMC1;GLIS2;NR1D2;PPM1F;PIAS4;ZNF24;KAT8;ZNF568;BAHD1;THAP7;HEXIM1;HSPA8
prerank,anion transmembrane transport (GO:0098656),-0.28898690963656226,-1.0256561304160405,0.4457831325301205,0.8155804579503536,1.0,17/67,18.64%,LRRC8E;SLC6A20;SLC7A5;SLC13A4;SLC38A5;SLC7A1;SLC5A6;LRRC8B;MFSD12;SLC13A5;SLC35A2;SFXN2;SLC19A1;SLC13A3;LRRC8D;SLC39A8;SLC25A19
prerank,negative regulation of MAP kinase activity (GO:0043407),0.24751100589432917,1.0252133239843104,0.2777777777777778,0.5494724613682013,1.0,10/48,10.92%,RGS2;UCHL1;INPP5K;PRKCD;SPRY1;SMPD1;DAB2IP;MAPK8IP1;NPPA;DUSP19
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.3047573067629552,1.0249960851957967,0.45454545454545453,0.5496742695493392,1.0,7/20,13.44%,HEY1;SPRY1;TGFBR3;RBPJ;OLFM1;HEY2;PDCD4
prerank,central nervous system development (GO:0007417),-0.23886963305619754,-1.024274146003416,0.4583333333333333,0.8183272550632794,1.0,64/261,20.97%,GRIN2D;KLK6;GRIN2B;ACAN;POMK;CELSR1;ZIC2;ZIC5;DMBX1;SOX4;CXCR4;SHH;POU6F2;BCAN;PROX1;ROBO2;SOX9;C3;ADGRG1;PAFAH1B3;PAX6;SHROOM4;CHD7;CAPG;SPATA5;SIX3;MNX1;GRHL2;FOXG1;PAX8;MARCKSL1;SCT;CYP26C1;VCAN;VAX1;NHLH2;CNTNAP2;NKX2-1;NF1;ABCB6;TGFBR2;PBX4;ASIC2;PTS;SLC2A1;TBR1;SHROOM2;ALDH5A1;CDK5;GSX1;MYRF;UGT8;DHX37;AMIGO3;VCX;PTCH1;SLC8A3;B3GNT5;VCX3B;LSR;NPAS2;NKX2-2;NPAS1;ZIC1
prerank,stress granule assembly (GO:0034063),0.3020761954618779,1.0240716461791708,0.42857142857142855,0.5512589826317015,1.0,3/20,4.72%,CIRBP;MAPT;CSDE1
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.26863563344874075,1.023940815318162,0.35714285714285715,0.5509375576159011,1.0,12/35,18.47%,CRY2;CALM1;MTOR;HSP90B1;PPP1R12A;CSNK2B;CALM2;TSC1;PPP6R2;AGTR2;PPP1R15A;NUAK1
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.23067264403696508,1.0239155438891268,0.375,0.5504357140466175,1.0,14/62,14.42%,TLR3;BCL10;DEFB124;MAP3K14;TBKBP1;UBB;DAB2IP;TICAM2;TLR9;TAB1;TNFRSF1A;RIPK1;RNF31;NFKBIL1
prerank,positive regulation of peptidase activity (GO:0010952),-0.3582444590400944,-1.0234724934500015,0.463768115942029,0.8196229859801193,1.0,7/21,30.98%,PRSS22;CTSH;PRELID1;SERPINB3;PSME2;PSME3;CLDN4
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.2751874401444188,-1.0234640212839474,0.4482758620689655,0.81861442462261,1.0,37/78,42.12%,PSMB9;CALR;PSMD14;FCGR1A;HLA-F;TAP1;PDIA3;NCF2;CYBA;PSMA3;HLA-G;CYBB;PSMB3;PSMA5;PSMD12;PSMB11;PSMB2;PSMA7;IKBKG;PSME2;PSME3;PSMC1;PSME4;TAP2;VAMP8;MFSD6;TAPBP;PSMD1;PSMC4;IKBKB;NCF1;ITGAV;CHUK;PSMD3;PSMD13;FCER1G;PSMC2
prerank,positive regulation of neuron death (GO:1901216),-0.2944111790737208,-1.0232661142577069,0.4024390243902439,0.8181912618509171,1.0,20/47,30.07%,GRIN2B;TGFB2;WNT5A;EGR1;FOS;CCL3;PCSK9;IFNG;NF1;FYN;CDK5;GSK3B;TNF;REST;ITGB2;TFAP2A;TYROBP;BAX;CDK5R1;DKK1
prerank,positive regulation of locomotion (GO:0040017),0.2881761329828494,1.0231900707574129,0.3888888888888889,0.5515401523681751,1.0,8/30,9.68%,BVES;NTN1;RARRES2;F2RL1;CCL21;P2RY12;PDGFB;CCDC25
prerank,cellular response to peptide (GO:1901653),0.24995806337269616,1.022971758757925,0.4375,0.5513097533900414,1.0,14/57,13.93%,PSEN1;PRNP;LDOC1;ZFP36L1;NGFR;CACNA2D1;EPHA4;CD36;GPER1;ATP1A3;APP;NTRK1;VIM;ADRB2
prerank,filopodium assembly (GO:0046847),0.3088170527613848,1.0221929425404963,0.3,0.5526593531397412,1.0,16/16,69.14%,FGD6;S1PR2;FGD1;SRGAP2;FGD5;FGD2;ARHGEF4;VSTM5;SPEF1;PPP1R9B;FGD3;RAB17;DNM3;FGD4;EZR;SPATA13
prerank,mitochondrial gene expression (GO:0140053),-0.29418356258349926,-1.0221882600482077,0.40789473684210525,0.8201641921045947,1.0,19/40,39.86%,LARS2;TFAM;FASTKD2;TFB2M;MRPS16;TEFM;GFM2;RARS2;QRSL1;MRPL57;MRPL47;MRPS12;NOA1;MRPS18A;MRPS11;FASTKD5;SLC25A33;MRPS34;PTCD3
prerank,negative regulation of innate immune response (GO:0045824),-0.31447547261622494,-1.0214647553258398,0.475,0.8212351578838789,1.0,15/37,26.99%,TNFAIP3;SERPING1;ISG15;NLRC5;USP18;LYAR;RPS19;OAS3;IRAK3;PTPN2;IFI16;CR1;NMI;DCST1;SAMHD1
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.17162735180725405,1.0210305147208933,0.0,0.5546825602590854,1.0,77/347,17.56%,TGFB1I1;ASB2;UCHL1;RNF150;TRIM9;FBXO10;FBXL22;RNF11;FBXO8;TSG101;ZSWIM8;UBE2D4;UBE2G1;SIRT2;GID4;KCTD2;FBXL7;RNF122;TRIM3;ARNTL;KCTD10;WDR91;UBE2E1;NEDD8;KLHL42;RNF130;PSMC5;ZFAND2B;RNF185;ANAPC16;RNF146;RNF167;MYLIP;NTAN1;RNF217;UBAP1;RNF14;RNF144B;SPSB1;KLHL20;UBL7;HECTD3;ARMC8;UBE2G2;FBXW4;UBXN1;RNF216;RNF4;RNF7;KLHL22;PSMD9;FBXW5;VPS4A;FEM1B;RNF115;UBE3B;PSMB6;RNF215;VPS28;UBE2B;TBL1X;UBE2H;VPS37A;DDIT3;UBE4B;RNF19A;VPS37D;MVB12B;SQSTM1;BTRC;APPBP2;KAT5;UBE2D3;KCTD21;PCBP2;USP44;PTPN23
prerank,artery development (GO:0060840),-0.3404357340604938,-1.020812072603745,0.4230769230769231,0.8224029786021123,1.0,4/23,5.40%,STRA6;ROBO2;ENG;ANGPTL3
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.3022700133552223,-1.020409814855925,0.43373493975903615,0.8226234043811266,1.0,9/42,8.42%,COL1A1;LOXL2;TGFB2;IL1B;LEF1;BCL9L;CRB2;AXIN2;BAMBI
prerank,sphingolipid biosynthetic process (GO:0030148),0.22935472148530403,1.0199774988475134,0.4,0.5565891674549047,1.0,16/68,12.09%,HACD1;ELOVL4;SPTLC3;ABCA8;DEGS1;A4GALT;SMPD1;CERS4;VAPA;PRKD1;HACD4;PPM1L;ST8SIA1;KDSR;CERS1;ST3GAL5
prerank,positive regulation of protein secretion (GO:0050714),0.22578185508367776,1.019909379800327,0.4,0.5560622191569963,1.0,15/72,13.20%,APBB1;OR51E2;APBB3;NLGN2;WLS;MYOM1;F2RL1;GPER1;NNAT;PLA2G1B;C1QTNF3;PSMD9;GOLPH3;BAD;LRRC8A
prerank,regulation of mitotic cell cycle (GO:0007346),-0.2414312636573841,-1.0198624229784514,0.4536082474226804,0.8230915115658913,1.0,47/177,27.03%,TP73;KIF20B;UBD;MCIDAS;MAD2L1;CDK1;NEK2;CKS2;DLGAP5;FBXO5;UBE2C;CDC25C;PSMB9;PSMD14;TFAP4;UBE2S;CKS1B;ANAPC1;PKMYT1;NEK6;ASAH2;RCC1;PLK1;PTPN3;TGFB1;RFPL1;BRINP2;EIF4E;MDM2;PDXP;IL10;RNF40;PSMA3;EIF4EBP1;FBXO43;CDC20;MKI67;PSMB3;CDC26;PSMA5;BTG4;PSMD12;PSMB11;PSMB2;PSMA7;BUB1B;PSME2
prerank,microtubule bundle formation (GO:0001578),-0.2909815683690136,-1.0195622228078154,0.4177215189873418,0.8229469054072066,1.0,12/41,21.93%,RP1;KIF20A;CFAP74;RSPH9;RP1L1;TTC26;PLK1;SPAST;NCKAP5;PSRC1;LRGUK;RSPH6A
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.3422624022031018,-1.0194403824220681,0.4523809523809524,0.8222826722739109,1.0,13/27,35.51%,IRAK2;RIPK2;TNFAIP3;IRAK1;NOD2;TAB3;ITCH;IKBKG;TRAF6;UBE2N;NOD1;UBC;TIFA
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.2627340447773425,-1.0192950236663751,0.4418604651162791,0.8216942869644214,1.0,21/111,14.86%,GNL3L;CSF2;FERMT1;MMP1;ERCC5;USP50;SKAP1;GBP5;RPA3;AJUBA;ISG15;MMP3;CAPG;SYK;IL5;CDT1;IFNG;ATR;TGFB1;BIK;GTF2H2
prerank,cellular response to fatty acid (GO:0071398),-0.37819039186069436,-1.0187770127770985,0.45588235294117646,0.8220212546576764,1.0,5/17,11.35%,IRS1;DGAT2;AKR1C4;FFAR2;UCP1
prerank,mitotic spindle assembly (GO:0090307),-0.3086388679119091,-1.0186141462947993,0.4146341463414634,0.8214182121781018,1.0,22/40,39.88%,KIF23;KIF2A;CHEK2;RACGAP1;AURKB;KIF4B;TPX2;MZT1;KIF3B;PIBF1;SMC1A;PRC1;STAG1;KPNB1;STAG2;KIFC1;KIF4A;SMC3;MISP;OFD1;BCCIP;SPICE1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.3355375746363909,-1.0182686514306418,0.4626865671641791,0.82135049771955,1.0,4/25,7.97%,DDIAS;MIF;CD44;BCL2L1
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.2904845814977973,1.0167798144594593,0.45454545454545453,0.5635601991372834,1.0,22/22,70.98%,MAP1LC3C;HSP90B1;TECPR2;TMEM129;SEL1L;HERPUD1;SYVN1;DERL2;SEC16A;NPLOC4;AUP1;FAF2;PREB;OS9;VCP;RANGRF;LMAN1;SEC61B;SURF4;TMED9;SEC13;DERL1
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.3689992681113999,-1.016590191804324,0.4533333333333333,0.8249577054659918,1.0,11/18,37.07%,CD81;PCSK9;RNF128;CTSC;MSN;VPS35;GBA;AMER1;EZR;VGLL4;HSP90AA1
prerank,mesonephric tubule development (GO:0072164),0.3147711657333613,1.0164074578904987,0.3684210526315789,0.563835755632641,1.0,5/17,6.25%,OSR1;PKD2;FGFR2;TCF21;PKD1
prerank,cholesterol efflux (GO:0033344),-0.32571600537097856,-1.0155308657849602,0.4225352112676056,0.8270485696065148,1.0,7/24,20.85%,ABCG5;SCARB1;APOA2;ABCG8;APOC1;APOM;APOC2
prerank,ventricular septum development (GO:0003281),-0.29088408800640664,-1.015430148937839,0.39759036144578314,0.8262950096493632,1.0,6/38,4.16%,STRA6;TGFB2;SOX4;MATR3;PROX1;ROBO2
prerank,regulation of telomere maintenance (GO:0032204),-0.32086631386434744,-1.0151922877720456,0.48,0.8258947154636082,1.0,8/25,30.06%,MYC;PML;GNL3;ATRX;PIF1;SMG1;XRCC5;HDAC8
prerank,positive regulation of translational initiation (GO:0045948),-0.3511485221318299,-1.0145172036769008,0.41025641025641024,0.8269809063517688,1.0,15/22,46.16%,BOLL;POLR2D;CDC123;UHMK1;CCL5;LARP1;YTHDF1;DAZL;DAZ1;RPS6KB2;DAZ4;DAZ2;YTHDF3;KHDRBS1;DAZ3
prerank,regulation of cell division (GO:0051302),-0.2874044470392742,-1.0143817440388883,0.40476190476190477,0.8263932574586879,1.0,16/74,15.28%,MYC;ORC6;BLM;KIF20A;SHH;AURKB;BCL2L1;AURKA;CSPP1;PLK1;KIF18B;RAB11FIP4;RFPL1;BIRC6;MLLT3;PRPF40A
prerank,regulation of inflammatory response (GO:0050727),-0.2413310743630855,-1.014284586368626,0.43157894736842106,0.8256197907558481,1.0,70/200,30.58%,OSM;SERPINE1;IL1B;IL23A;WNT5A;ZP3;TNFAIP3;AOAH;ADAMTS12;CXCL17;PIK3AP1;PLA2G7;MMP3;IL21;BCL6;CCL3;XIAP;RELA;USP18;GHRL;CEBPA;IL12B;FEM1A;FFAR2;PROC;AGT;IFNG;MMP9;FPR2;IL1RL2;SETD6;TNFRSF1B;TNFSF4;NFKBIA;AHSG;NLRP12;IL10;OTULIN;NOD2;NLRP6;ZBP1;MDK;NLRP3;CCL1;MMP8;PTPN2;GATA3;MVK;IL20;NMI;MGST2;PPARG;ANXA1;XCL1;VPS35;MEFV;TNF;DNASE1;GHSR;ACE2;IL13;SEMA7A;SPATA2;TEK;CCL5;TLR7;GPR31;GBA;IL37;NLRP10
prerank,monosaccharide transmembrane transport (GO:0015749),-0.3634545922770483,-1.0136785120959737,0.4722222222222222,0.8262713182958905,1.0,6/17,28.07%,SLC5A2;SLC5A10;SLC2A2;SLC2A12;SLC5A1;SLC2A9
prerank,cellular response to zinc ion (GO:0071294),0.2979459579604186,1.012869977622317,0.42857142857142855,0.572702086092584,1.0,5/18,13.56%,MT1X;MT1M;MT1A;MT1E;MT3
prerank,endothelial cell migration (GO:0043542),-0.30235530377064823,-1.012241276993804,0.4,0.8293497114575002,1.0,5/38,8.23%,FAP;LOXL2;S100P;S100A2;STAT1
prerank,positive regulation of B cell activation (GO:0050871),-0.28218150413156695,-1.0114032470103138,0.4935064935064935,0.8307008071926362,1.0,13/47,23.42%,MIF;EPHB2;CD81;IL21;SYK;CHRNB2;PAXIP1;TNFSF4;NOD2;RIF1;SH3KBP1;TNFSF13B;XBP1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.29828769433739977,-1.0110547726096693,0.5189873417721519,0.8306712421495012,1.0,22/46,34.27%,MIF;IL12RB2;IL12B;IFNG;P4HB;RALA;MSN;IL10;SERPINB2;BOLA2;SNRPA1;IL12RB1;TALDO1;CNN2;CAPZA1;TYK2;PSME2;HSPA9;PAK2;LCP1;GSTA2;HNRNPF
prerank,negative regulation of protein localization to membrane (GO:1905476),0.29723184194243296,1.0110448278403685,0.39285714285714285,0.5764864154914006,1.0,9/25,16.61%,TMBIM1;INPP5K;AP2M1;PID1;RHOQ;GDI1;NUMB;ITGB1BP1;DMTN
prerank,cellular senescence (GO:0090398),-0.31849893128427725,-1.0107807327311589,0.4507042253521127,0.830544643828747,1.0,5/25,5.49%,HMGA1;PML;CDKN2A;CALR;HMGA2
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.28744114382431857,-1.0105668456121824,0.47058823529411764,0.830038489519642,1.0,27/60,34.74%,RIPK2;USP50;WNT5A;EGR1;GBP5;IL17A;ORM2;CCL3;ORM1;IFNG;NLRP12;NOD2;NLRP3;IFI16;HMGB1;MNDA;TNF;CLEC7A;TMEM106A;AIM2;TYROBP;NLRP10;AGER;NLRC4;TLR8;MYD88;PYDC1
prerank,defense response to fungus (GO:0050832),-0.3378352331531113,-1.0099406871111711,0.41333333333333333,0.8308897305209564,1.0,12/24,36.83%,CLEC6A;RNASE7;CARD9;IL36RN;GAPDH;HRG;CLEC7A;RNASE8;LTF;NLRP10;CX3CR1;CLEC4D
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.30853505472323284,-1.0096661995648508,0.5,0.8305375780109603,1.0,9/39,20.46%,RFC3;ERCC5;RPA3;RFC5;RFC2;GTF2H2;POLD2;NTHL1;GTF2H3
prerank,negative regulation of inflammatory response (GO:0050728),0.18262204625818323,1.00928916276753,0.4,0.5803976354513607,1.0,44/208,15.55%,GLP2R;PPARD;NR1D1;RAMP1;POMC;ADCY5;VIP;ADCYAP1R1;MAPK7;GNG2;MAPK14;PRKCD;PRKAR2B;ADRB3;ADCY4;PTGIS;VIPR2;PTH1R;GPER1;PRKACA;RAMP3;RAMP2;C1QTNF3;ELANE;GPS2;CDH5;FNDC4;CREB1;TNFRSF1A;PTGER4;ADM;P2RY11;ADCY9;AVPR2;ADCY2;GPBAR1;ADRB2;LRFN5;GGT5;ADCYAP1;ADCY6;NR1H4;KLF4;ADORA2A
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.3085696714354718,-1.0092286049650712,0.4805194805194805,0.8308949220128944,1.0,15/32,31.33%,MGAT5;OCIAD2;IL7R;F2R;CRLF3;CENPJ;IL10;IL26;NOTCH1;CRLF2;TNF;IL10RA;F2;CCL5;IFNL1
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.38605854329510014,-1.0092150060058496,0.4861111111111111,0.8299243155170866,1.0,9/16,33.46%,ISG15;NLRC5;USP18;OAS3;PTPN2;DCST1;SAMHD1;TTLL12;STAT2
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.31349487363753514,-1.0091534580207022,0.45454545454545453,0.8290604985806764,1.0,20/35,42.62%,DCPS;LSM7;EXOSC3;EXOSC8;DIS3;EXOSC5;EXOSC4;LSM5;LSM4;EXOSC7;HBS1L;EXOSC2;PATL1;CNOT6;EXOSC1;DIS3L2;DCP2;LSM6;LSM1;DDX6
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.28434721068047514,1.0088044945613996,0.47368421052631576,0.580655586782542,1.0,4/22,6.16%,CLU;CASP3;IFNGR1;EPHA4
prerank,positive regulation of DNA binding (GO:0043388),-0.30637802889850996,-1.0085455042717377,0.410958904109589,0.8296991529280427,1.0,19/31,38.23%,POU4F1;PLAUR;MMP9;TGFB1;POU4F2;MMP8;NME1;HMGB1;GATA3;PPARG;SUMO4;EGF;TWIST1;TRAF6;FOXC1;IGF1;HMGB2;PYHIN1;HES1
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.35404581937973517,-1.0084937044500135,0.4084507042253521,0.828837703017647,1.0,8/18,32.08%,DHFR;SCARB1;TERT;PIK3CB;GCH1;TNF;NUS1;NOS1AP
prerank,stem cell differentiation (GO:0048863),0.2502444431011641,1.0084682335475512,0.3333333333333333,0.5807342829803396,1.0,11/38,14.16%,GPM6A;OSR1;KIT;FOXO4;LMBR1L;FGFR2;MEOX1;SFRP1;MEF2C;EPCAM;HOXB4
prerank,rRNA catabolic process (GO:0016075),-0.39085572867578955,-1.0083714173563845,0.45714285714285713,0.8281384182763265,1.0,9/16,32.57%,EXOSC3;EXOSC8;DIS3;EXOSC5;EXOSC4;EXOSC7;EXOSC2;XRN1;SLFN14
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.345640890694005,-1.0081326479801263,0.44871794871794873,0.8278085619365819,1.0,10/20,32.44%,ADK;HPRT1;PNP;POLD2;TERT;AMPD3;AMPD2;DCK;POLD1;APRT
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.30906665985398907,-1.0077011717144606,0.43209876543209874,0.8279585803579306,1.0,13/34,24.55%,SERPINE1;ICAM1;TNFAIP3;BCL2L1;TNFRSF10B;FASLG;TRAF2;BRCA1;GSK3B;FGA;SCRT2;FGB;RNF34
prerank,regulation of cholesterol storage (GO:0010885),0.3186074741354974,1.0075202841585413,0.4,0.5826655331120427,1.0,5/16,17.09%,PPARD;NR1H2;LPL;CES1;NR1H3
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.3310550344375634,-1.0073713009166707,0.5063291139240507,0.8278689867990674,1.0,5/27,8.94%,SLC6A20;SLC7A5;SLC38A5;SLC7A1;SLC1A4
prerank,cholesterol homeostasis (GO:0042632),-0.25593467680290044,-1.0055405325393296,0.475,0.831929579070715,1.0,18/70,20.85%,DGAT2;TMEM97;ANGPTL3;ABCG5;CYP7B1;SCARB1;MTTP;LIPG;CAV1;CETP;PCSK9;CYP39A1;APOA2;ABCG8;APOM;FGFR4;LDLR;APOC2
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.3029827188616205,1.004951258508538,0.41379310344827586,0.5883839941872466,1.0,3/15,10.53%,TLR3;TLR9;DHX58
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.33608315677482625,-1.0045767913266919,0.4714285714285714,0.8337209490701569,1.0,4/22,4.18%,MYC;CDK1;CTSH;SOX9
prerank,cellular response to UV (GO:0034644),-0.2693433202962797,-1.0044586766145986,0.38372093023255816,0.8330685154362233,1.0,27/74,33.12%,MYC;CHEK1;TIMP1;MME;MMP1;AURKB;MMP2;MMP3;HYAL3;MMP9;ATR;PTPRK;CDC25A;NPM1;RUVBL2;OPN5;RHNO1;FMR1;CARD16;CREBBP;SDE2;OPN3;TAF1;KDM1A;POLD1;NOC2L;MAPK13
prerank,regulation of tissue remodeling (GO:0034103),-0.3513184573364309,-1.0041477148115618,0.4657534246575342,0.8331636986780316,1.0,7/20,13.33%,IL23A;SYT7;IL21;RUNX1;IL12B;TGFB1;SUCO
prerank,mRNA 3'-end processing (GO:0031124),0.2064041603440784,1.0038642749959041,0.45,0.5905267723788387,1.0,14/77,9.07%,SRSF5;PABPN1;CPSF7;DDX39B;U2AF1L4;CASC3;LSM11;SRSF4;POLDIP3;SRSF11;RPRD1A;THOC5;AHCYL1;TUT1
prerank,positive regulation of JUN kinase activity (GO:0043507),0.30251099254584346,1.0034060032032683,0.48148148148148145,0.5910629054953462,1.0,6/23,10.92%,DVL3;SASH1;DVL2;DAB2IP;TLR9;DUSP19
prerank,positive regulation of histone methylation (GO:0031062),-0.3194445747923976,-1.003203297817084,0.410958904109589,0.8349788539009287,1.0,10/25,24.72%,DNMT1;DNMT3B;PRDM12;PAXIP1;MYB;AUTS2;BRCA1;RIF1;TET1;JARID2
prerank,positive regulation of intracellular protein transport (GO:0090316),0.23717384231354036,1.0029402391603086,0.75,0.5916202271732595,1.0,45/146,17.96%,FLNA;PSEN1;VAMP2;PRNP;MAPK8;KCNB1;MYO1C;BAG3;PRKCD;CAMK1;DMAP1;VPS11;MTCL1;RAPGEF3;PIK3R1;ABLIM3;SLC51B;RHOU;YWHAZ;TENM1;LEPROT;SAE1;BAP1;CHP2;SMAD3;HSPA1L;CSNK2A2;BAD;MIEF2;RNF31;TOMM7;TMEM30A;BCL2;ITGB1BP1;ANK3;SH3GLB1;HCLS1;CDH1;PPP3CC;MFF;UBE2D3;B3GAT3;ATG13;SEC16B;EFCAB7
prerank,integrated stress response signaling (GO:0140467),-0.34661772125995205,-1.0027223510068688,0.4383561643835616,0.835380311487923,1.0,3/15,9.73%,CXCL8;EIF2AK1;IGFBP1
prerank,response to dsRNA (GO:0043331),-0.3523440168783912,-1.0026871671058644,0.4430379746835443,0.8344680432222789,1.0,16/25,43.17%,PMAIP1;IFNK;IFNE;IRAK3;PDE12;SLC3A2;IFNB1;IFNA1;IFNA21;IFNA4;IFNA7;IFNA10;IFNA14;IFNA17;IFNA2;IFNA16
prerank,negative regulation of secretion by cell (GO:1903531),-0.30199282335990213,-1.0017923435916607,0.5,0.8361250573895529,1.0,13/39,23.84%,IL11;OSM;CYP51A1;IL12B;DRD2;RHBDF2;FGF23;TNFRSF1B;GRM7;HRH3;LIF;NOTCH1;ANXA1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),-0.25535869652270643,-1.0017727614986693,0.4418604651162791,0.8351667415483467,1.0,23/94,20.15%,CEP72;KIF24;CDK1;CEP250;NEK2;RPGRIP1L;RAB3IP;HAUS7;SCLT1;PLK1;HAUS6;CEP83;CEP76;CEP152;B9D1;CEP78;CENPJ;CEP41;SDCCAG8;CKAP5;ALMS1;NDE1;PLK4
prerank,acylglycerol biosynthetic process (GO:0046463),-0.3510109288381379,-1.0017135348514041,0.44155844155844154,0.8343052695087896,1.0,7/21,26.57%,DGAT2;PNPLA3;GK;MOGAT1;LPGAT1;DGAT2L6;AGMO
prerank,nucleic acid-templated transcription (GO:0097659),-0.3017161124050055,-1.0016513950880992,0.4235294117647059,0.8334379780258839,1.0,11/42,24.37%,POLR2F;E2F1;TAF1B;PAX8;NKX2-8;POLR2D;TERT;POLR2J;POLR3A;POLR2I;PTMA
prerank,endocytic recycling (GO:0032456),0.25231872359079804,1.0014333256937362,0.47368421052631576,0.5952418569482569,1.0,13/45,20.68%,EHD2;VPS39;MICALL1;SNX3;RAB13;RAB11FIP3;RAB11B;SNX27;SNX17;PTPN23;VPS52;RAB14;EHD1
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.31554152863093937,-1.001138292152382,0.4864864864864865,0.8338619872892498,1.0,15/42,24.68%,GRIN2D;GRIN2B;ERO1A;TRPM2;TRPV4;SLC24A1;DRD2;F2R;SLC8A3;IBTK;HTR2C;ITPR2;LCK;XCL1;TRPV6
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.26223322648403613,-1.001081755826524,0.42696629213483145,0.833052245450795,1.0,28/77,27.61%,SLC12A2;SLC5A2;SLC12A8;SLC9C1;SLC39A10;KCNJ13;TRPM2;SLC9A7;KCNJ15;TRPV4;SLC24A1;KCNJ14;ATP12A;SLC39A8;SLC12A1;SLC8A3;SLC12A5;ATP1B1;SLC9A4;SLC12A3;KCNJ3;KCNJ6;TRPV6;KCNJ11;SLC5A1;KCNJ4;HCN4;KCNJ18
prerank,regulation of peptide hormone secretion (GO:0090276),-0.26781531376339035,-1.0010478295035905,0.4444444444444444,0.8321659991268829,1.0,24/73,25.65%,SSTR5;IL1B;TFR2;CACNA1D;SYT7;CHD7;KCNG2;FFAR2;PAX8;NOS2;IFNG;PASK;SLC2A2;SLC2A1;FGA;UQCC2;HTR2C;ITPR2;FGB;CACNA1E;MTNR1B;TNF;HNF4A;KCNJ11
prerank,sterol homeostasis (GO:0055092),-0.2527853388707447,-1.0008830976251848,0.43209876543209874,0.8317048492759598,1.0,18/71,20.85%,DGAT2;TMEM97;ANGPTL3;ABCG5;CYP7B1;SCARB1;MTTP;LIPG;CAV1;CETP;PCSK9;CYP39A1;APOA2;ABCG8;APOM;FGFR4;LDLR;APOC2
prerank,metal ion homeostasis (GO:0055065),0.2361192438710118,1.0004039007068022,0.5555555555555556,0.5975915255402473,1.0,13/42,15.27%,JPH2;KCNH2;SNCA;SCNN1B;SLC12A4;SCNN1G;TMTC2;WFS1;SLC8A1;MT3;CYP4F12;ANK3;KCNA1
prerank,sterol biosynthetic process (GO:0016126),-0.3126576545562483,-1.000231741837386,0.4875,0.8325122782313878,1.0,15/37,30.75%,SQLE;CYP51A1;IDI2;DHCR7;SC5D;FDPS;NSDHL;G6PD;MVK;TM7SF2;ACAT2;DHCR24;HMGCS1;APOA5;MSMO1
prerank,'de novo' posttranslational protein folding (GO:0051084),0.24972361608682767,1.0000406066652803,0.38461538461538464,0.5980078512695995,1.0,8/30,15.16%,DNAJB5;HSPA2;DNAJC18;DNAJB4;ST13;HSPA1L;CHCHD4;HSPA8
prerank,nervous system development (GO:0007399),0.2375834235709147,1.0,1.0,0.5945358697475008,1.0,99/440,13.25%,S100B;MAB21L2;MAL;PMP22;GFRA1;PTN;NPTX1;MPZ;GSN;GPM6B;RBFOX3;GFRA3;PTEN;ATN1;WWTR1;NLGN2;LPAR1;TAGLN3;CHRNA3;GPM6A;NUMBL;TMOD2;CRMP1;SDHA;GBA2;L1CAM;APAF1;FGF2;NAB2;PTPRZ1;ZNF358;NGF;LY6H;CHRM2;DNER;GLRB;PKD2;NRSN2;LRCH4;SPOCK1;OBSL1;NFASC;IRF2BPL;HDAC4;TRIM3;PPP2R5D;ZC4H2;ARNT2;PKD1;EFNA5;LGI1;GFRA2;DCTN1;ROGDI;KIRREL3;TEAD1;DLG4;ADAM23;LSAMP;MBNL1;PRX;SCRG1;DCLK1;SMPD1;DCHS1;SCD5;DPF2;LDB2;RBFOX2;MYLIP;HAP1;TRAK2;TPP1;NRSN1;NLGN1;INTU;NBL1;NHEJ1;PCDHB15;TENM1;PCDHB4;FEZ2;NLGN3;FGF12;BTBD6;DPYSL4;DPYSL2;MARK4;SPINK5;APLP1;FGF5;SMO;MEF2C;EVL;CYP46A1;DSCAML1;NDUFS2;HAPLN2;CDH2
prerank,organelle organization (GO:0006996),0.19088425729874206,1.0,1.0,0.5945358697475008,1.0,88/406,14.99%,PALLD;RNF112;TPM1;RAB34;DES;OPTN;ARHGAP10;DST;CNTNAP1;SEC31B;CAV2;GEM;CHMP3;CENPT;ZNF135;PKD2;TJAP1;PLIN5;OBSL1;VPS11;TBC1D20;ATL2;CAPZB;PACSIN3;PACSIN2;ATP8B2;CCL2;NUMA1;KIF5C;MAST1;PRM2;WASF3;PEX19;MCOLN1;CHMP4A;MAST2;VAPA;BSCL2;TICAM2;RHOT2;RHOU;FGD6;PRKD1;ATL3;MARK1;ZMYM3;RAB31;GORASP1;KLHL20;PI4K2A;PYROXD2;PLEKHM2;PLEKHF1;MICAL3;CIDEC;SIPA1;CHMP7;PACSIN1;RAB30;ATL1;CCL11;DPYSL2;MTX3;CSNK1A1;LMAN2L;CCL13;MARK4;ZMYM6;KRT13;PEX11A;FITM1;ARC;GOLPH3;KRT4;GABPB1;SLC25A36;GOLGA8A;MIEF2;VPS4A;SIRT3;KRT25;KIFAP3;SEMA6A;PLD2;WTIP;RANBP10;SPRYD3;GBF1
prerank,supramolecular fiber organization (GO:0097435),0.303124653621736,1.0,1.0,0.5945358697475008,1.0,80/343,11.46%,DPT;TPM2;PGM5;CLIP3;CORO6;LMOD1;FBLN5;TPM1;GSN;COL6A1;MFAP4;DES;ACTN1;COL21A1;STMN2;COL6A2;DDR2;TMOD1;RHOB;DST;CRTAP;KRT20;TMOD2;CLIP4;SNCA;MAPT;STMN4;INPPL1;LTBP3;LOXL4;EMILIN1;EFEMP2;COL28A1;P3H2;RND2;CORO1C;PRL;RAC1;MFGE8;MYO1C;DBN1;FLII;FIGN;COL16A1;CORO7;NEFL;COL24A1;ALDOA;KATNAL1;CLIP1;MAP7D3;DCTN1;RHOA;CD36;UBB;ACTC1;PLA2G1B;KLHL41;COL4A2;TPPP3;COLGALT2;MYOZ1;BMP1;B2M;RHOC;CORO1B;COL5A3;TUBGCP6;MYO5C;NPPA;TNXB;APH1B;GGA3;NCKAP5L;CAPN3;WHAMM;APP;PXDN;SLAIN2;PIN1
prerank,positive regulation of protein phosphorylation (GO:0001934),0.24594240964218436,1.0,1.0,0.5945358697475008,1.0,113/362,17.59%,IL6R;CLIP3;RAP1A;RBPMS;ATP2B4;CSPG4;PRNP;MAPK1;DDR2;ILK;MAPK3;FAXDC2;CDKN1A;P2RY1;SNCA;VEGFB;BMP3;NPTN;FAS;CALM1;THBS4;FGF2;FLCN;ITGB3;CDK9;TRIM6;RAC1;NGF;DVL3;TERF2IP;ENPP2;MAPRE3;CAMK1;RARRES2;RAPGEF3;NOS1;RSPO1;CCL21;BMPR1A;EFNA5;HDAC6;FGF7;MTCP1;AKTIP;GPER1;EGFR;DVL2;RAMP3;TWSG1;GPNMB;MSTN;GH1;PDGFB;PRKD1;CSNK2B;TESK1;PIK3R3;SMAD4;FGF1;CALM2;FLT4;PDGFD;TENM1;FLOT1;RAF1;ANGPT1;CAPRIN2;APP;DUSP19;ATG14;PIN1;FGF5;MMD;NKX3-1;FGF10;TFRC;PRKAG2;GDF5;NTRK1;CX3CL1;TNFRSF14;JAK2;RIPK1;MT3;NTF3;BCAR3;RALBP1;CAMKK1;ADCYAP1;VEGFC;GDF6;S1PR2;LEPR;MMD2;TXN;IL15;SH2D3C;PFN2;RASSF2;ANGPT4;GDF10;SNX9;HCLS1;TAOK2;FXR2;INS;JTB;CAMKK2;GHR;ARAF;TGFB3;CREBL2;SFRP2
prerank,protein ubiquitination (GO:0016567),0.19311798473032557,1.0,1.0,0.5945358697475008,1.0,98/495,15.00%,DTX3;ASB2;RNF112;FBXO32;UBE2QL1;HIF3A;PDZRN3;ARRDC4;BCL10;TRIM39;FBXO10;FBXL22;RNF11;FBXO9;WSB1;PJA2;ZSWIM8;KLHL21;FBXO17;TRIM6;UBE2D4;UBE2G1;SKP1;PELI3;CAND2;FBXL7;RNF122;SASH1;FBXO44;VPS11;LZTR1;TRIM3;FBXL5;KCTD10;ASB5;FBXO31;UBE2E1;NEDD8;KLHL42;LNPEP;UBB;FBXO30;AKTIP;UBE2Q2;ASB1;RRAGA;KLHL41;PSMC5;RNF185;ANAPC16;RNF10;MUL1;RNF146;RNF167;MYLIP;RNF217;TRIM23;TRIM34;TRIM21;FBXO27;RNF14;RNF144B;SPSB1;KLHL20;HECTD2;UBE2V1;RNF25;TRIM47;UBE2G2;TRIM63;FBXW4;RNF4;LONRF1;RTF1;RNF7;KLHL22;PSMD9;LRSAM1;RNF220;RNF38;RUSC1;UBE3A;TRIM52;TRIM69;EPAS1;TMEM129;UBOX5;FBXW5;PAF1;RNF31;RNF115;UBE3B;BCL2;PSMB6;HLTF;MIB2;UBE2B;FBXL15
prerank,phosphorylation (GO:0016310),0.19190790731374857,1.0,1.0,0.5945358697475008,1.0,115/385,19.37%,DMPK;PRRT1;EPHA7;NRBP2;FGFR1;MAP3K6;MAPK1;ILK;MAPK3;IP6K3;PPP3CB;TNNI3K;CDK3;ULK1;NIM1K;MAPK8;CDK20;CDK9;DAPK1;MTOR;PRKCD;CAMK1;DAPK3;STRADA;BMPR1A;PRKG2;CCL2;PRKAA2;PRKACA;MAST1;DCLK1;SIK3;MAST2;LATS2;GRK5;FAM20C;MKNK1;CLK2;NEK7;TRIB2;DGKG;PKN1;PDK2;PDGFB;PRKD1;MARK1;JAK1;YWHAZ;MAP4K2;BRSK1;PIM1;NRBP1;CSNK1E;PPP4R1;CREB1;PRKG1;SNRK;CAMK2D;CCL11;APP;BMX;FAM20B;CSNK1A1;ERG;TSSK3;MEX3B;MARK4;SGK1;MKNK2;DGKE;PRKAG2;PRKCB;PRKCA;NTRK1;DGKB;JAK2;SHPK;MAML1;CLK3;HK1;PXK;STK36;BCKDK;CTSG;RET;MAPK10;COPS8;MAP3K1;STK19;GK5;AURKC;CDC42BPB;NRK;TAOK2;STAT3;HIPK3;AATK;RNASEL;RARA;BRD2;CAMKK2;CDK14;TNK2;PRKACB;CERK;NUAK1;MAP3K12;STRADB;CAMK2A;RPS6KA5;STK38L;FASTK;STK25;GAS6;PRPF4B
prerank,MAPK cascade (GO:0000165),0.20949601492305314,1.0,1.0,0.5945358697475008,1.0,70/301,14.55%,BTC;GFRA1;GFRA3;FGFR1;MAPK1;FNTB;MAP3K3;NCAM1;MAPK3;MRAS;KIT;PABPN1;SHC2;KITLG;CALM1;MAPK8;ZFP36L1;FGF2;SKP1;FRS3;NEFL;ARL2;RGL2;FGFR2;ZFP36;PIK3R1;PDGFRA;PRKG2;FLT3LG;CCL2;GFRA2;FGF7;UBB;KL;DLG4;EGFR;PSMC5;SCG2;RGL1;MAPK11;DAB2IP;PPP1CB;PEA15;PDGFB;JAK1;MEF2A;FGF1;NRG2;IL17RD;RAF1;ANGPT1;MAP2K2;LGALS9;PSMD9;NFKB1;FGF5;PTGER4;PLVAP;DLG2;MEF2C;FGF10;GOLGA7;RALGDS;JAK2;ACTN2;MT3;LAMTOR3;RET;GDNF;PSMB6
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.29212968826418695,-0.9999818556844343,0.5060240963855421,0.8322315484512777,1.0,8/52,8.91%,DPEP1;IFI6;LAMP3;CD44;NAIP;MAGEA3;PAX2;XIAP
prerank,mitochondrial translation (GO:0032543),-0.2570336574329931,-0.9999391076066328,0.4431818181818182,0.8313660674582731,1.0,52/103,45.47%,MRPL19;LARS2;MRPL3;MTIF2;GADD45GIP1;MRPS18C;FASTKD2;EARS2;MRPL17;MRPL48;MRPS16;MRPL30;GFM2;MRPS35;RARS2;MRPL13;GFM1;MRPS31;MRPS23;MRPL42;MRPL9;MRPL50;MRPL53;MRPL37;QRSL1;MRPS30;MRPL57;MRPL14;DAP3;MRPL47;TUFM;MRPS12;MRPL4;MRPL15;NOA1;MRPS18A;MRPS22;MRPL52;MRPS11;MRPL44;MRPS33;MRPS34;PTCD3;MRPL45;MTIF3;MRPL22;MRPL36;MRPL11;MTRF1L;MRPL28;MTRF1;MRPS2
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.31611336775621146,0.9988275890839697,0.5384615384615384,0.5966898188766375,1.0,3/18,5.85%,SAMD4A;PAN2;ZFP36
prerank,stem cell development (GO:0048864),-0.36125372886922924,-0.9987664525188166,0.47368421052631576,0.8338160622565223,1.0,5/17,18.33%,SHH;CYP26C1;WNT7A;NOLC1;KBTBD8
prerank,muscle cell development (GO:0055001),-0.3118269530752342,-0.9982620895904697,0.46987951807228917,0.8342122694141014,1.0,6/33,8.39%,NEBL;ENG;NEB;ALPK2;FER1L5;CXADR
prerank,nitrogen compound transport (GO:0071705),-0.25214898865726365,-0.9981040318960278,0.45977011494252873,0.8336197418319529,1.0,44/139,29.75%,TCN1;SLC12A2;SLC6A20;SLC7A11;SLC6A14;SLC7A5;SLC6A6;SLC38A5;SLC7A1;SLC1A5;ABCC2;ARRDC5;SLC1A4;AQP9;LRP2;SLC16A10;RHBG;SLC7A6;SLC22A13;ABCB6;CENPF;SLC6A4;SLC52A3;SLC25A47;LRRC8D;SLC22A1;SLC18A2;CD3G;SLC6A18;HRG;SLC52A2;ATP11B;CMTM6;SLC7A7;SLC7A4;SLC25A48;SLC3A2;SLC44A1;SLC18A1;SLC22A4;SLC38A3;SLC6A12;SLC43A2;NDC1
prerank,glycerophospholipid metabolic process (GO:0006650),-0.27635429314546034,-0.9977000585490886,0.4482758620689655,0.8338210277131695,1.0,29/77,30.39%,CPNE7;PDGFRB;PNPLA3;SERINC5;PIGM;PLA2G7;CETP;PLA2G4E;PIGW;GDPD1;PLA2G4D;PLA2G3;PIGF;ACP6;ABHD12;PON1;PDXP;PLEK;PIGA;PIGN;GPCPD1;PLCB3;DPM2;PIGB;CPNE3;DGKH;PLA2G2D;PGP;APOA5
prerank,regulation of protein processing (GO:0070613),-0.3334280525321086,-0.9968307955342444,0.44155844155844154,0.8353487522191844,1.0,8/23,17.30%,MAGEA3;RUNX1;PRSS37;USP17L2;CHAC1;NKD2;ASTL;ADAM8
prerank,protein localization to cell-cell junction (GO:0150105),0.3170575550605411,0.9963034590721734,0.4583333333333333,0.6026417003213808,1.0,4/15,9.43%,ARHGEF18;JAK1;ACTB;CDH5
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.2240849420314293,0.996230410880194,0.46153846153846156,0.6022806827071372,1.0,9/68,5.87%,FLNA;FERMT2;PSEN1;WWTR1;BAG3;NGFR;PRKCD;DMAP1;PIK3R1
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.21879753482537112,0.9960136799963881,0.5789473684210527,0.6023371264278579,1.0,13/82,7.80%,RGS2;FNTB;CALM1;GNG7;RGS11;USP20;RGS5;SYP;TULP3;GPER1;ZDHHC7;RAMP3;GRK5
prerank,organelle fission (GO:0048285),0.2640705459418791,0.9959815043718181,0.43478260869565216,0.6018236980611206,1.0,4/24,7.63%,MTFR1L;CORO1C;PEX19;MUL1
prerank,calcium ion transmembrane transport (GO:0070588),0.21438170310884513,0.9955450183190455,0.5294117647058824,0.6022088662989492,1.0,24/85,16.16%,ATP2B4;SLC25A23;PKD2;CACNA1C;SLC24A3;CACNA2D1;PKD1;P2RX7;TRPC1;MCOLN1;TRPC4;TRPV1;ATP2A2;RYR3;SLC8A2;SLC8A1;MCOLN3;TRPC6;SMDT1;MICU3;PARL;TRPV3;MICU1;ATP2B3
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.26326327464580734,0.9952743124041465,0.5294117647058824,0.602265216435453,1.0,9/43,7.86%,TNS2;SORBS1;NCK1;GKAP1;INPP5K;PRKCD;PID1;GRB14;PIP4K2B
prerank,dephosphorylation (GO:0016311),0.1888953282478154,0.9950802051580964,0.3333333333333333,0.6021466509116863,1.0,32/138,15.84%,PTEN;PPP2R5B;PPP3CB;DUSP26;PPM1M;PTPRS;INPP5K;PTPRZ1;DUSP3;PPP2R5D;PTPN21;CTDSP2;PPP1R12A;PTPRM;PPP1CB;PPM1L;FRA10AC1;PPP2CB;TAB1;PPP2R3A;PPP4R1;CTDNEP1;PPM1A;THNSL2;PTPN5;LHPP;PPM1F;CTDSP1;SDHAF2;PTPN14;EPHX2;PPM1B
prerank,BMP signaling pathway (GO:0030509),0.23109711862201884,0.9947561035680083,0.42857142857142855,0.6026177230854638,1.0,15/63,14.68%,TMEM100;RGMA;MAPK3;SMAD2;CHRD;TGFBR3;BMPR1A;SMAD7;SMAD4;SMAD3;SMAD9;GDF5;MEGF8;PDCD4;GDF6
prerank,oligodendrocyte differentiation (GO:0048709),-0.3624421560172072,-0.9947261052746768,0.463768115942029,0.8402521638311717,1.0,6/19,18.95%,SHH;SOX9;CDK5;ZNF488;MYRF;SLC8A3
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.2948247411527761,0.9944702798089925,0.4666666666666667,0.6026080928083629,1.0,10/38,6.57%,CORO2B;FZD7;MYOC;FBLN1;CORO1C;FZD4;SPOCK1;GCNT2;EFNA5;RHOA
prerank,hyaluronan catabolic process (GO:0030214),-0.36895257957801947,-0.9944323889699253,0.5068493150684932,0.8401275731130851,1.0,5/17,18.28%,CEMIP;CD44;HYAL3;TGFB1;HEXB
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.26707879622206326,0.994178477862622,0.5185185185185185,0.6028163637523812,1.0,8/25,20.05%,PLA2G5;PLA2G4B;PLA2G1B;SLC27A1;PLA2G4A;CDS2;LPCAT4;ABCA3
prerank,superoxide metabolic process (GO:0006801),-0.3093837105640901,-0.9941496067186126,0.4935064935064935,0.8397249042987797,1.0,9/31,19.30%,DUOX2;NOS2;ALOX12;NOX1;NOXO1;DUOX1;NCF2;CYBA;CYBB
prerank,carbohydrate homeostasis (GO:0033500),0.22567561282929355,0.9940449947886355,0.4666666666666667,0.6026977247947827,1.0,19/67,17.39%,SLC2A4;CRY2;INPP5K;KCNB1;NGFR;OAS1;CRTC2;PRKAA2;WFS1;PDK2;USF1;CRY1;BAD;PYGL;LEPR;STAT3;INS;SLC30A8;CYP11B1
prerank,regulation of defense response (GO:0031347),-0.2646954758415372,-0.9933063549182272,0.4444444444444444,0.8414007853839034,1.0,24/82,28.46%,LRP8;WNT5A;ADAMTS12;PIK3AP1;BCL6;XIAP;RELA;USP18;IL1RL2;SETD6;TNFSF4;AHSG;NOD2;NLRP6;ZBP1;IL20;ERAP1;TKFC;ANXA1;XCL1;ACE2;SAMHD1;SEMA7A;SPATA2
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.2922620359419762,0.9932714192837943,0.45454545454545453,0.6041450746524689,1.0,7/20,11.88%,MAPK8;MAPK7;WFS1;PDGFB;APP;KLF2;NFKB1
prerank,response to interleukin-1 (GO:0070555),-0.26864832698497154,-0.9931868269725614,0.47191011235955055,0.8407892807003801,1.0,19/82,14.85%,CXCL8;IRAK2;IL1B;CCL24;CCL20;SOX9;ADAMTS12;CCL22;CCL4;CCL3;RELA;IRAK1;HYAL3;GBP1;CCL25;CITED1;CHI3L1;CCL26;CCL17
prerank,positive regulation of insulin secretion (GO:0032024),0.25124584792571314,0.992963824111826,0.5263157894736842,0.6043078328433666,1.0,9/37,14.44%,NLGN2;PPP3CB;GPER1;NNAT;PLA2G6;PSMD9;BAD;LRRC8A;DOC2B
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.3347203129014486,-0.9929592304554214,0.4864864864864865,0.8405798848594422,1.0,5/21,11.98%,MAD2L1;FBXO5;UBE2C;UBE2S;PLK1
prerank,positive regulation of vasoconstriction (GO:0045907),-0.34436889035704465,-0.9924006559924824,0.5303030303030303,0.8412791612160708,1.0,6/16,26.36%,CAV1;OXTR;F2R;FGA;FGB;SMTNL1
prerank,acute inflammatory response (GO:0002526),-0.31465675182799085,-0.991537970834158,0.44871794871794873,0.8427840020830728,1.0,12/27,31.24%,C2CD4A;CEBPB;VNN1;TNFSF4;AHSG;HP;C2CD4B;IL22;HPR;CD6;LBP;PLSCR1
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.19957528916067663,0.9906605655365667,0.5,0.6093539685201601,1.0,11/81,8.49%,LPAR1;AGTR1;VIP;P2RY1;PTGER3;GALR2;CHRM2;GPR17;F2RL1;PTH1R;P2RY12
prerank,regulation of catabolic process (GO:0009894),-0.35723819254710165,-0.9905811881534742,0.4393939393939394,0.8444158836221143,1.0,4/17,16.86%,FAP;CHEK2;ODC1;MDM2
prerank,regulation of translational initiation (GO:0006446),0.22023581997151867,0.9905601149325857,0.38461538461538464,0.6089259759637332,1.0,8/67,5.63%,NCK1;ATF4;CTIF;EIF4EBP3;HSPB1;EIF1B;CSDE1;RBM4
prerank,protein secretion (GO:0009306),-0.27701118992539414,-0.9905213463620495,0.49382716049382713,0.8436126857980868,1.0,15/64,15.45%,PDX1;CTAGE4;CTAGE9;CTAGE8;PDIA4;CTAGE15;MTTP;RAB15;CTAGE6;MIA2;RAB3D;MAFA;RAB8A;FAM3B;CANX
prerank,protein-containing complex subunit organization (GO:0043933),0.2037018099094415,0.9894013718001882,0.5454545454545454,0.611228462719087,1.0,20/109,11.17%,SH3BGR;VAMP2;WASF1;MITF;FAS;LAMC1;SKAP2;OCLN;WDR19;TEAD2;TSPAN4;TEAD1;DLG4;NCKAP1L;WASF3;ST13;TRAF1;TCAP;CAPN3;PARD3
prerank,negative regulation of neurogenesis (GO:0050768),-0.2985217421310219,-0.9891515321926035,0.4025974025974026,0.8462740341732746,1.0,13/35,25.80%,THY1;IL1B;LRP4;PAX6;RTN4R;SORL1;NF1;OMG;WNT7A;NOTCH1;TNF;WNT3A;REST
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.2879230958056842,0.9891274217204596,0.4444444444444444,0.6113189454628328,1.0,9/25,19.58%,ABHD4;CHKB;SLC27A1;PLA2G6;LPIN1;ETNK2;NAAA;PISD;LPIN3
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.3017749629061534,-0.9889085448221625,0.4810126582278481,0.845990876912368,1.0,10/34,20.87%,DUSP4;DUSP1;DUSP18;PTPRO;DUSP9;DUSP16;DUSP2;PTPRJ;DUSP6;PTPN2
prerank,positive regulation of protein catabolic process (GO:0045732),-0.26109852975925585,-0.9888907423999839,0.4942528735632184,0.8450204958714194,1.0,24/83,25.34%,IL1B;ASB9;WNT5A;TNFAIP3;HECW1;CSNK2A3;HECW2;C4BPA;OAZ3;SORL1;IFNG;C4BPB;TNFRSF1B;MSN;CSNK2A1;ADAM8;ADAM9;BARD1;GSK3B;AXIN1;IDE;VPS35;TNF;ITCH
prerank,regulation of chromosome organization (GO:0033044),-0.33217626180765863,-0.988889638163224,0.42105263157894735,0.844044721626764,1.0,8/21,30.06%,MYC;RMI2;BUB1;CDT1;PIF1;SMG1;XRCC5;HDAC8
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.18142312620720497,0.9883934514258698,0.6,0.612360664324371,1.0,23/138,9.53%,TCEAL7;FLNA;PRNP;HAND1;MTURN;RWDD3;PKD2;HDAC4;PTGIS;ADORA3;ID2;SMAD7;PKD1;ID3;NUPR1;DAB2IP;TLR9;TAX1BP1;WFS1;EGLN1;TRIM21;PRMT2;PIM1
prerank,ncRNA metabolic process (GO:0034660),-0.3025750104244138,-0.988392554312424,0.45,0.8443827779531259,1.0,17/34,39.23%,PIWIL1;TRIM71;HENMT1;XPO5;NIFK;FKBP6;RAN;TDRD1;KHSRP;EXD1;DROSHA;ASZ1;DTD1;PIWIL4;TARBP2;AGO2;TDRKH
prerank,mRNA transport (GO:0051028),-0.2536122664144102,-0.9883782506307471,0.5176470588235295,0.8434328367682435,1.0,42/102,31.20%,ZC3H11A;U2AF1;NUP155;THOC3;NUP37;NUP210;CPSF3;MAGOHB;NUP107;NUP35;RANBP2;SEH1L;NCBP1;NUP50;NUP205;ALYREF;EIF4E;SRSF9;NUP93;RAE1;NUP88;NXF2;NXF3;POM121;NUP43;CPSF2;MAGOH;DDX39A;NUP160;NXT1;FMR1;GLE1;NUP62;SMG1;NUP153;NDC1;CPSF4;NUP98;THOC2;SLBP;SEC13;AGFG1
prerank,phosphatidylserine metabolic process (GO:0006658),0.2204905504096764,0.988340786566641,0.4482758620689655,0.6118882397215689,1.0,8/32,13.41%,PLA2G5;PLA2G4B;SERINC1;PLA2G1B;OSBPL5;SLC27A1;ABHD16A;PLA2G4A
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.3405151323925562,-0.987715281001322,0.44,0.8444250997119782,1.0,6/20,19.32%,GPR143;CCL20;TRPM2;GRM5;KDR;PTPRJ
prerank,positive regulation of nervous system development (GO:0051962),-0.28738171938908935,-0.987645647479996,0.5308641975308642,0.8437736612211066,1.0,11/45,18.34%,MME;RASSF10;EPHB2;EPHB3;GHRL;LRP2;IFNG;PTPRD;WNT7A;OPRM1;SYNDIG1
prerank,telomere capping (GO:0016233),-0.3744394383315619,-0.9875765571315848,0.5,0.842964319252227,1.0,3/15,10.61%,DCLRE1C;PRKDC;DCLRE1B
prerank,glutathione metabolic process (GO:0006749),0.2574156223703975,0.9875592901985096,0.4782608695652174,0.6132943397161282,1.0,10/40,14.09%,GSTM2;GSTM3;GSTM5;GSTA4;GSTM4;HPGDS;SOD1;GSTT2B;HAGH;GGT5
prerank,regulation of p38MAPK cascade (GO:1900744),0.24398789325877732,0.9870024891636199,0.52,0.6140293716010636,1.0,9/37,14.68%,PER1;GADD45B;PJA2;HAND2;SASH1;DAB2IP;LGALS9;GADD45G;GDF6
prerank,negative regulation of programmed cell death (GO:0043069),-0.22935020321679392,-0.9868976977055509,0.4897959183673469,0.8437110900869577,1.0,80/376,19.25%,MYC;DPEP1;HSPA1A;TDGF1;KIF14;IFI6;MAD2L1;CDK1;RIPK2;DHRS2;CLEC5A;ERCC5;POU4F1;LEF1;MIF;SHH;CDSN;CARD14;CD44;WNT5A;CTSH;NAIP;PRKDC;SOX9;FOXE3;WDR73;HMGA2;PAX2;IFIT3;FIGNL1;BCL2A1;IGF1R;MET;HSPD1;VTCN1;DCPS;BCL2L1;CBX4;PKHD1;XIAP;RELA;PRAME;GHRL;VHL;LRP2;PRLR;SEMA4D;ANXA4;PROC;IRAK1;PLAUR;PLK1;NAA15;CASP2;MMP9;GATA6;ATAD3A;MED1;KDR;BIRC6;WNT11;TNFSF18;PRELID1;ADAM10;NFKBIA;COMP;BMP4;CEACAM5;HPN;ALB;PROK2;NAA35;IL10;BARD1;BIRC7;BAG4;PAX7;THBS1;GSK3B;VDAC1
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.17966384655471676,0.9863558629509168,0.6,0.6149568844040455,1.0,37/161,16.34%,IGFBP6;WWTR1;DACT3;TMEM88;SOX13;LZTS2;FZD4;DVL3;IGFBP4;LMBR1L;NPHP3;JADE1;DVL2;PSMC5;DAB2IP;LATS2;GLI3;PFDN5;TLE2;TLE1;RBMS3;SFRP1;CSNK1A1;PSMD9;DKK3;SFRP5;TMEM64;ANKRD6;SOX17;FRZB;TLE4;PSMB6;TMEM170B;SDHAF2;DDIT3;FUZ;CTNND1
prerank,C21-steroid hormone metabolic process (GO:0008207),0.2695713398869744,0.9856879494374595,0.48484848484848486,0.6159256871576801,1.0,10/22,18.77%,AKR1B1;AKR1C2;HSD3B2;AKR1C1;CYP46A1;CYP11B1;DHRS9;AKR1C3;CYP17A1;CYP11A1
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.300372455537274,-0.9856792188459262,0.5194805194805194,0.846356986761049,1.0,13/46,23.63%,BMP8A;INHBA;TGFB2;GDF15;GDF9;ENG;BMP7;TGFB1;BMP4;INHBC;NODAL;INHBE;GDF2
prerank,eye development (GO:0001654),-0.27719166171784143,-0.9856468158910134,0.524390243902439,0.8454642588184362,1.0,15/58,16.44%,STRA6;TGFB2;PRSS56;PAX6;FOXE3;PAX2;SCO2;SIX3;FBN2;SMOC1;ADAMTS18;RBP4;SIPA1L3;PBX4;SHROOM2
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.3061397656161745,-0.9853825902904101,0.5125,0.8452611441519782,1.0,10/32,18.26%,INHBA;TMEM190;SHH;TGFB1;BATF;KDR;MLLT3;PLD4;BMP4;PRRC2C
prerank,positive regulation of glycolytic process (GO:0045821),-0.3425666937098639,-0.9853574284873855,0.47761194029850745,0.8434164483174347,1.0,7/20,19.92%,PFKFB3;ZBTB20;GAPDHS;PFKFB4;IFNG;MLXIPL;PFKFB1
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.3425666937098639,-0.9853574284873855,0.47761194029850745,0.8434164483174347,1.0,7/20,19.92%,PFKFB3;ZBTB20;GAPDHS;PFKFB4;IFNG;MLXIPL;PFKFB1
prerank,regulation of transport (GO:0051049),0.25355962152405986,0.9851228810870462,0.5789473684210527,0.6170216650476682,1.0,12/34,16.93%,VAMP2;SNCA;FES;POFUT2;MUL1;ICA1L;ACTB;USP6;ARL6IP5;LEPR;REEP5;SLC30A8
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.26664650337024853,0.984407058338012,0.35,0.6180726165105805,1.0,6/29,7.26%,PRKAB2;ACADVL;NR1H2;WDTC1;PRKAA2;CEACAM1
prerank,mitochondrial fission (GO:0000266),-0.35818899435077867,-0.9839979772236286,0.4507042253521127,0.8461304420300321,1.0,3/17,6.65%,MTFR2;MTFR1;MX1
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.3005922498426063,0.9839572821946879,0.4838709677419355,0.6183919480866473,1.0,3/18,6.74%,FZD7;HDAC4;HDAC5
prerank,epithelial tube morphogenesis (GO:0060562),0.25110249333837253,0.9836017474211273,0.5454545454545454,0.6186034796895057,1.0,10/34,13.15%,RHOB;PKD2;PKD1;CSNK2B;RASIP1;MEF2C;NKX3-1;FGF10;MEGF8;SOX17
prerank,cellular response to heat (GO:0034605),-0.30302551960145896,-0.9832475282727378,0.4675324675324675,0.8470632193154621,1.0,3/34,0.85%,IL1A;HSPA1A;CLPB
prerank,negative regulation of blood pressure (GO:0045776),0.30463492546872095,0.9824717308386773,0.4482758620689655,0.6213207164733904,1.0,4/15,13.87%,SCPEP1;NOS1;NPPA;NPPB
prerank,positive regulation of synapse assembly (GO:0051965),-0.3251298974770913,-0.982261595453664,0.4794520547945205,0.8485798761597401,1.0,10/28,25.17%,EPHB2;EPHB3;GHRL;AGRN;SEMA4D;PTPRD;WNT7A;SYNDIG1;SRPX2;BDNF
prerank,Rac protein signal transduction (GO:0016601),0.3035497156361739,0.9822054401095591,0.5333333333333333,0.6213151051200714,1.0,6/18,20.86%,WASF1;RAC1;BRK1;TIAM1;RHOG;ABI2
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.3427232214167161,-0.9819533225759406,0.46875,0.8483370869055394,1.0,3/19,11.98%,HSPA1A;CHMP4C;PLK1
prerank,response to alcohol (GO:0097305),-0.3152205932963041,-0.9805912221549357,0.4533333333333333,0.8511306384196722,1.0,7/30,15.06%,GRIN2B;TH;CCL3;GLRA1;CHRNB2;TGFB1;TGFBR2
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.2824049269334744,-0.9804638572422671,0.5,0.8505111458717689,1.0,18/44,29.08%,IL11;SERPINE1;ICAM1;TNFAIP3;SEMA5A;KDR;IL10;FASLG;THBS1;HLA-G;FGA;GATA3;PRKCI;FGB;TNF;CD160;IL13;TEK
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.29926474966284927,0.9803168337911013,0.41379310344827586,0.6250936749102265,1.0,8/15,26.16%,ECI2;CROT;ACOX2;ABCD1;SCP2;ACAA1;CRAT;AMACR
prerank,calcium ion import into cytosol (GO:1902656),0.30584594432794115,0.9802070544520172,0.4666666666666667,0.6247000677875956,1.0,5/15,11.51%,ATP2B4;CACNA2D1;TRPV1;SLC8A2;SLC8A1
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.32435212342254127,-0.9799187200694941,0.5285714285714286,0.851156975396493,1.0,5/20,12.77%,SAPCD2;MRAP;BCL2L1;GBP1;TGFB1
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.22567168628608875,0.9795940987973847,0.5625,0.6259076571441492,1.0,19/54,21.91%,PTGS1;GSTM2;PLA2G4B;DEGS1;FADS3;SCD5;EPHX1;PLA2G4C;PLA2G4A;MGLL;CYP4F12;ALOX15B;ACSL1;PTGR1;ELOVL5;ABCD1;CYP1B1;SCP2;ACAA1
prerank,response to glucose (GO:0009749),-0.28080822242032294,-0.9793497217984276,0.4642857142857143,0.8515847047208666,1.0,10/46,18.85%,PDX1;SOX4;ZBTB20;PAX2;IGF1R;KHK;MAFA;APOA2;LIN28A;THBS1
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.33834976802011046,-0.979226499956576,0.4647887323943662,0.8508921779138487,1.0,8/19,24.65%,TGFB2;SOX4;ZFPM1;GATA4;TGFBR2;SMAD6;NOTCH1;EFNA1
prerank,protein homotetramerization (GO:0051289),-0.2897472753286835,-0.978975912637997,0.5,0.8505515282756325,1.0,25/52,35.69%,GBP5;TRPM2;MAT1A;HPRT1;SHMT2;TK1;TDO2;HCN1;AQP5;AQP2;SSBP1;CTH;ACACA;SAMHD1;MIP;ACOT13;PKD2L1;SYCP1;TRPV5;HSD17B10;KIF25;KCNJ2;AQP10;GLS;OSBPL2
prerank,regulation of superoxide anion generation (GO:0032928),0.3003712508380889,0.9783136936862386,0.5172413793103449,0.6286906299479783,1.0,4/15,7.69%,MAPT;PRKCD;F2RL1;SOD1
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.2869962321390274,0.977678350826221,0.4,0.6297218360575574,1.0,4/20,7.02%,NPTN;FGF2;SPRY1;GPC1
prerank,protein deacylation (GO:0035601),0.26649740032056835,0.9773806090249082,0.5,0.6298786494305922,1.0,5/23,6.74%,SIRT2;HDAC4;HDAC7;HDAC6;HDAC5
prerank,peptide hormone secretion (GO:0030072),0.25245857470956484,0.9768193451054283,0.5714285714285714,0.6303753275797769,1.0,3/27,2.63%,CAMK2G;VIP;LTBP4
prerank,regulation of fatty acid oxidation (GO:0046320),-0.35298426298600677,-0.9765844915056224,0.49230769230769234,0.8558401650417468,1.0,2/16,5.65%,SOX9;SIRT4
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.29142481603371234,0.9765371081572771,0.5333333333333333,0.6306161997118297,1.0,5/18,11.88%,PLA2G5;AGTR1;CD36;LPL;NFKB1
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.311075818052667,0.9761400226843459,0.56,0.6310051649979341,1.0,6/18,8.84%,IGFBP6;CILP;IGFBP4;ZFAND2B;GH1;IGFBP5
prerank,nucleus organization (GO:0006997),0.22454268333233943,0.9760669646942653,0.5384615384615384,0.6305665869762762,1.0,10/46,13.38%,DMPK;CHMP3;SUN2;NUMA1;PRM2;SUN1;CHMP4A;CHMP7;CTDNEP1;VPS4A
prerank,limb development (GO:0060173),-0.3100033407697059,-0.9752634383567202,0.5131578947368421,0.8586479007181018,1.0,9/27,18.90%,KREMEN2;LRP4;CHD7;TBX4;SMOC1;ZNRF3;COMP;ZNF141;PTCH1
prerank,retinol metabolic process (GO:0042572),0.29596165753327436,0.9737226520974386,0.5,0.6347462387324062,1.0,9/21,21.51%,LRAT;ADH1B;CYP27C1;CYP1A1;ADH1C;RETSAT;DHRS9;CYP1B1;DHRS3
prerank,regulation of DNA repair (GO:0006282),-0.2897198515091293,-0.9736317536381363,0.4634146341463415,0.8622144521329943,1.0,20/41,37.83%,PML;POLH;AXIN2;EYA1;ERCC8;BRCC3;BRCA1;PARG;NPAS2;ERCC6;WRAP53;TIGAR;USP1;DEK;DHX9;UBE2N;EYA3;WRNIP1;RPS3;RNF168
prerank,protein K48-linked ubiquitination (GO:0070936),0.22117477418476206,0.973428185661417,0.625,0.6349186744441231,1.0,18/55,21.14%,UBE2D4;UBE2G1;UBE2E1;UBE2Q2;RNF146;NHLRC4;UBE2G2;RNF216;RNF4;UBE3A;RNF115;UBE2B;UBE2H;UBE2D3;RNF152;ZNRF1;KLHL3;RNF5
prerank,regulation of cell migration (GO:0030334),-0.22261343215519666,-0.9730165871454899,0.58,0.862879173093773,1.0,71/393,15.57%,CLDN1;MMP7;CEMIP;DPEP1;THY1;COL1A1;IFITM1;TDGF1;KIF14;PLAU;PDGFRB;SERPINE1;EPPK1;DACH1;FGF19;LAMC2;KIF2A;IL1B;CCL24;GTSE1;LEF1;MIF;SHH;EPHB2;PARD6B;RCC2;CTSH;MGAT5;MAZ;CEACAM6;BST2;F7;MAPK15;ENG;ANGPTL3;EPHA1;FAM83H;LGR6;CAV1;IGF1R;GRB7;PECAM1;FGF20;PLET1;CCL3;KRT16;SEMA5A;DRD2;SEMA4D;SORL1;USP17L2;F2R;ITGAX;MMP9;TGFB1;GTPBP4;NKX2-1;STK24;TMSB10;FGF23;NF1;KDR;CXCL16;CCL26;PLXNC1;FGF3;WNT11;ZMYND8;STK26;ADAM10;PTPRK
prerank,RNA transport (GO:0050658),0.21580206412279704,0.9727558269331413,0.5333333333333333,0.6359364504114271,1.0,13/75,8.25%,SRSF5;NXF1;ZFP36L1;DDX39B;SIDT2;U2AF1L4;ZFP36;CASC3;SRSF4;KIF5C;POLDIP3;SRSF11;THOC5
prerank,positive regulation of T cell migration (GO:2000406),-0.3198837818860056,-0.972671529194132,0.47297297297297297,0.8628382878789478,1.0,11/25,30.69%,CCL20;WNT5A;CXCL10;ADAM10;STK39;DOCK8;XCL2;XCL1;CCL5;S100A7;TMEM102
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.25140077296080515,0.9715484277008516,0.45454545454545453,0.6385364831661168,1.0,11/48,10.54%,AGTR1;CDKN1A;MAPT;MAPK14;PRKCD;F2RL1;CD36;PID1;SOD1;PDGFB;AKR1C1
prerank,mesoderm formation (GO:0001707),-0.3388822282898281,-0.971016917448152,0.5,0.8664177788958131,1.0,3/19,6.06%,TBX20;HMGA2;CRB2
prerank,fluid transport (GO:0042044),-0.35134134267029,-0.970971214414425,0.5375,0.8655891396054859,1.0,5/18,16.09%,SLC4A11;UPK3A;AQP5;AQP9;AQP2
prerank,defense response to Gram-positive bacterium (GO:0050830),-0.26149865601423,-0.970884676805003,0.5,0.8648288341330432,1.0,22/65,34.02%,LYG2;DEFA6;GBP7;RPL39;PGLYRP4;RNASE7;PGLYRP1;ROMO1;DEFA5;DEFB4A;PGLYRP3;KRT6A;DEFA1;RNASE8;DROSHA;GBP6;LBP;GBP4;PGLYRP2;DMBT1;ANG;MYD88
prerank,regulation of transferase activity (GO:0051338),-0.35129364005971075,-0.9706610720505076,0.453125,0.8644391586109718,1.0,10/17,40.30%,NLRC5;FEM1A;PARP4;HMBOX1;SPTSSB;JMJD8;SLAMF8;LDB1;NABP2;SMG6
prerank,pyruvate metabolic process (GO:0006090),0.22719811320431496,0.970287862448984,0.47368421052631576,0.6408995751579183,1.0,15/54,16.30%,DLD;ENO2;DLAT;PDHB;ALDOA;PDHA1;PDHX;HK2;PFKM;PGM1;HAGH;HK1;NR4A3;ME3;LDHB
prerank,regulation of lipid metabolic process (GO:0019216),0.20789268829715574,0.9702373593683155,0.5,0.640369947081936,1.0,28/87,19.43%,PPARD;NR1D1;NFYB;ACACB;C1QTNF2;SMARCD3;SIN3B;RARRES2;TNFAIP8L3;ID2;GPS2;NFYC;GNB3;RXRA;PRKAG2;NCOA1;NR1D2;PMVK;TM6SF2;TBL1X;LSS;SIN3A;SREBF1;BBS4;CCDC3;GGPS1;RORA;PCK1
prerank,amyloid precursor protein metabolic process (GO:0042982),0.31440099533258914,0.9701839190965944,0.4827586206896552,0.6398623613329641,1.0,8/18,21.88%,PSEN1;TMCC2;APH1B;PSEN2;NSG1;BACE1;CLN3;ADAM19
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.24490951757617174,-0.969703846567751,0.5773195876288659,0.8658855892176541,1.0,25/109,19.21%,NOTUM;DKK4;FOXP3;PTK7;FOLR1;SHISA2;RNF43;MDFI;TNFAIP3;ATP6V1C2;DEPDC1B;LGR6;CBFB;RUNX1;DCDC2;SMARCA4;CITED1;NKD2;WIF1;TERT;CSNK2A1;OTULIN;SFRP4;WWOX;SOX30
prerank,heart morphogenesis (GO:0003007),-0.28232531079114204,-0.9696332464905247,0.5789473684210527,0.8650465091632467,1.0,8/52,8.93%,TBX20;TGFB2;SOX9;CHD7;ENG;TH;ALPK2;ZFPM1
prerank,regulation of multicellular organismal development (GO:2000026),-0.3029640064231553,-0.9685780254168251,0.5833333333333334,0.8669155802868992,1.0,12/27,31.88%,CDK1;OAS2;RACGAP1;GBX2;DUSP9;DUSP6;GATA3;GBX1;NIPBL;HPSE;CCSAP;SCX
prerank,negative regulation of biosynthetic process (GO:0009890),0.30003105176589523,0.9679856107581722,0.5294117647058824,0.6443431168103583,1.0,3/17,7.26%,EMILIN1;GPER1;CEACAM1
prerank,regulation of centriole replication (GO:0046599),-0.33701450199723115,-0.9675789161247538,0.5066666666666667,0.8688098813702404,1.0,8/18,20.44%,CEP295NL;CEP76;CEP295;CENPJ;BRCA1;ALMS1;PLK4;NPM1
prerank,regulation of cell communication (GO:0010646),0.24045109594131012,0.9674811016724524,0.4583333333333333,0.6451363203469365,1.0,8/36,11.51%,TSPYL2;CASQ2;ANK2;SOCS2;GRK5;CAMK2D;MTCH1;SLC8A1
prerank,L-amino acid transport (GO:0015807),-0.30652789905701705,-0.9671674874553541,0.48717948717948717,0.8688949009673005,1.0,5/28,8.94%,SLC6A20;SLC7A5;SLC38A5;SLC7A1;SLC1A4
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),-0.3035903392926428,-0.9670126103799551,0.47368421052631576,0.8685399575613676,1.0,13/29,33.86%,TRIB3;FBXO5;DCUN1D5;FEM1A;LIMK1;PLK1;DTX3L;MAGEA2;AXIN1;MAGEC2;UBE2N;RPS2;FBXW7
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.1987438809661641,0.9666682500832315,0.5714285714285714,0.6464951996605797,1.0,27/135,14.12%,GLP2R;RAMP1;POMC;ADCY5;VIP;ADCYAP1R1;GNG2;MAPK14;PRKAR2B;ADRB3;ADCY4;VIPR2;PTH1R;PRKACA;RAMP3;RAMP2;CREB1;PTGER4;ADM;P2RY11;ADCY9;AVPR2;ADCY2;GPBAR1;ADRB2;GGT5;ADCYAP1
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.2663525552644802,0.9666501845319574,0.4230769230769231,0.6458999002133784,1.0,4/29,5.42%,KANK2;UFSP2;VPS11;WBP2
prerank,regulation of stem cell differentiation (GO:2000736),-0.2597451590537762,-0.966040732640306,0.5058823529411764,0.870272415802127,1.0,36/90,38.23%,TACSTD2;OSM;TP73;SLC4A11;PUS7;PSMB9;PRKDC;PSMD14;CBFB;RUNX1;MYB;PSMA3;GATA3;PSMB3;NOTCH1;PSMA5;PSMD12;PSMB11;PSMB2;ITCH;PSMA7;PSME2;PSME3;PSMC1;SP7;NSUN2;PSME4;KMT2A;TCF3;NUDT21;EIF2AK2;PSMD1;PSMC4;HNRNPU;LDB1;HES1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.2504847761062868,-0.9659686170209822,0.5,0.8694633056146545,1.0,10/67,8.82%,MCIDAS;USP6NL;TRPM2;MAPK15;TBC1D3;MYO10;EPHA2;CAV1;DCDC2;TBC1D14
prerank,response to steroid hormone (GO:0048545),-0.29574334249996104,-0.9654158815964822,0.573170731707317,0.8699563229806713,1.0,14/34,29.06%,TGFB2;CAV1;CATSPERB;CATSPER1;TGFB1;MED1;CATSPER3;THBS1;SOX30;ABHD2;CATSPER2;CATSPER4;URI1;CATSPERG
prerank,"DNA-templated transcription, elongation (GO:0006354)",-0.25923975711456015,-0.9651906948101274,0.46511627906976744,0.8695652890329632,1.0,20/65,30.93%,POLR2F;CCNK;CDK7;CDK12;EAF1;NELFCD;NCBP1;MLLT3;GTF2H2;POLR2D;POLR2J;GTF2H3;POLR2I;CCNH;EAF2;ADRM1;CDC73;ERCC2;GTF2F2;LEO1
prerank,receptor metabolic process (GO:0043112),0.22710868181021657,0.964598485154994,0.5384615384615384,0.6507779420501865,1.0,12/54,13.18%,RAMP1;SNCA;SNX1;ACKR3;AP2M1;CD36;RAMP3;RAMP2;RAB31;ADM;TFRC;RAB11B
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.3567348964957539,-0.9642108055442676,0.5303030303030303,0.8715149406660156,1.0,3/15,10.34%,MAD2L1;FBXO5;LIMK1
prerank,regulation of neuron death (GO:1901214),-0.2461899818385344,-0.9638506980959587,0.5842696629213483,0.87150167084582,1.0,32/85,30.11%,GRIN2B;KIF14;WNT5A;EGR1;FOS;SORL1;PCSK9;IFNG;HLA-F;FYN;TRIM2;TNFRSF1B;CDK5;SULT1A3;ATP13A2;TRAF2;GSK3B;PM20D1;GRM4;CHRNA7;SIGMAR1;VPS35;REST;ITGB2;IKBKG;GPR75;TYROBP;CCL5;DHCR24;KIR3DL2;DKK1;GBA
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.3169757408935232,-0.9637421761916508,0.5694444444444444,0.8709211259687306,1.0,12/29,32.77%,IL21;RAET1E;RASGRP1;HLA-F;NCR1;HLA-G;CRTAM;CD160;KLRC2;NCR3;CD226;SLAMF6
prerank,RNA stabilization (GO:0043489),-0.31297821887918287,-0.9636568563822221,0.5,0.8702328799294188,1.0,6/26,11.09%,DKC1;E2F1;AXIN2;NOCT;NAF1;PABPC1
prerank,establishment of melanosome localization (GO:0032401),0.2581169155006944,0.9635734612582075,0.5555555555555556,0.6526934632439256,1.0,10/19,21.22%,BBS5;RAB11B;BBS2;RAB27A;BBS7;BBS4;ARL6;MKKS;BLOC1S6;MYO5A
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.3340572925576374,-0.9620712284351508,0.5416666666666666,0.873457756306283,1.0,4/18,12.92%,IL4I1;JAK3;VTCN1;ASS1
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.33612498272120706,-0.9619091322477088,0.47297297297297297,0.8728407302523425,1.0,3/17,4.18%,TACSTD2;TGFB2;SOX9
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.29545241399827304,-0.9611748376652494,0.582089552238806,0.8737674456495002,1.0,15/34,24.97%,TGFB2;EGR1;FOS;APLN;RELA;SMARCA4;GNL3;TGFB1;TERT;IL10;GATA3;SPI1;PPARG;TNF;KLF5
prerank,neuron differentiation (GO:0030182),-0.22977283138389112,-0.9598772976292121,0.4895833333333333,0.876428135802924,1.0,62/172,30.52%,WNT2;ASCL2;INHBA;WNT7B;TGFB2;IRX5;IRX2;SOX4;ANOS1;SHH;WNT5A;EN2;DTNB;PAX6;POU3F2;MET;RUNX1;FOXA2;EN1;PCSK9;FZD10;WNT8B;VAX1;LHX9;LHX5;NEUROG2;PTF1A;PTPRD;NEUROD2;WNT11;PBX4;LHX2;IRX3;WNT7A;CDK5;BHLHA15;POU4F2;GSX1;LHX1;NIF3L1;WNT3;USH2A;XBP1;TENM4;WNT3A;BTG4;ERCC6;WNT4;OLIG3;LHX3;MANF;OTP;RUNX3;PITX2;EMX1;OLIG2;CDK5R1;THOC2;ERCC2;INSM1;ACSL3;INSM2
prerank,T cell receptor signaling pathway (GO:0050852),-0.24200816852640092,-0.9595178740082249,0.6236559139784946,0.8763879215719409,1.0,64/154,41.17%,THY1;RIPK2;CARD11;CD276;SKAP1;PSMB9;PSMD14;BTN1A1;VTCN1;RELA;INPP5D;FYN;ZAP70;ITK;BTNL10;PIK3CB;PRKCQ;CTLA4;LCP2;TEC;THEMIS;PSMA3;CD3G;PTPRJ;CD3D;PIK3CD;GATA3;PSMB3;LCK;PSMA5;PSMD12;PSMB11;PSMB2;PSMA7;IKBKG;PSME2;CD28;PSME3;ZC3H12A;PSMC1;DENND1B;TRAF6;PSME4;TRAT1;UBE2N;PAK2;PDE4B;PTPN22;CD3E;BTN3A2;PAK1;PSMD1;PSMC4;IKBKB;TXK;RC3H1;MALT1;GRAP2;CHUK;RC3H2;STOML2;WNK1;PSMD3;PSMD13
prerank,positive regulation of peptide hormone secretion (GO:0090277),-0.26733877667541484,-0.9593356581166109,0.4875,0.875929177201154,1.0,14/42,29.53%,TNFSF11;SOX4;TFR2;GHRL;DRD2;SCT;RBP4;FGA;FGB;TM7SF3;GHRHR;TRH;AACS;GHRH
prerank,cell chemotaxis (GO:0060326),-0.26195110915036296,-0.9593188353468064,0.5822784810126582,0.8750244332079602,1.0,18/65,19.05%,CCR8;PDGFRB;CXCR4;LEF1;CCL20;EPHA2;CCR4;CXCR2;CXCR5;SEMA5A;CXCR6;CCL25;CCR3;CXCR3;DEFB4A;PRKCQ;CXCR1;CCRL2
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.3332120238646935,-0.9587682647708483,0.5394736842105263,0.8754684018421574,1.0,7/19,24.07%,TNFSF9;IL12B;TNFRSF1B;TNFSF18;LST1;TNFSF8;IL27
prerank,regulation of fatty acid metabolic process (GO:0019217),0.3070771007497302,0.9580170306556851,0.5217391304347826,0.6650485154319405,1.0,3/18,6.94%,PPARD;PRKAB2;PRKAA2
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.26064539936974623,0.9579427351160162,0.5,0.664626557963712,1.0,11/28,19.25%,PTEN;SPRY1;SMAD7;DAB2IP;IL17RD;SFRP1;VASN;SDHAF2;FUZ;SFRP2;BMP5
prerank,reverse cholesterol transport (GO:0043691),-0.33732635140265543,-0.9577122669536783,0.47692307692307695,0.8772063224146008,1.0,6/17,20.85%,SCARB1;LIPG;CETP;APOA2;APOM;APOC2
prerank,activation of protein kinase activity (GO:0032147),0.19773940429956807,0.9572013834954942,0.6,0.6655840868982311,1.0,31/113,16.41%,TLR3;ADCY5;CHRNA3;ITGB3;PILRB;MTOR;PRKCD;TIRAP;PRKAR2B;ADCY4;STRADA;PRKACA;PDGFB;ZFP91;FGF1;MAPKAP1;ANGPT1;ADRA2B;ADCY9;JAK2;ADCY2;MT3;NTF3;ADRB2;COPS8;ITGB1BP1;ADCY6;TXN;NRK;TAOK2;INS
prerank,tRNA methylation (GO:0030488),-0.2992888784091603,-0.957153382246008,0.527027027027027,0.8777188159818878,1.0,17/32,41.55%,METTL2A;METTL1;METTL6;THUMPD3;THADA;FTSJ1;METTL2B;TRMT61B;TRMT10C;TARBP1;NSUN2;HSD17B10;DALRD3;NSUN6;TRMT12;TRDMT1;TRMT5
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.21045060327222417,0.9566508331227044,0.5,0.6661015824691827,1.0,11/46,13.43%,NLGN2;TSHZ3;ATP1A2;CCL2;GRIK3;NLGN1;NLGN3;SYT1;MEF2C;CDH2;TPRG1L
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.3073084019307516,-0.9566208155750879,0.4883720930232558,0.8781584129671421,1.0,8/34,19.34%,TP73;GZMB;E2F1;PMAIP1;TFDP1;ZNF205;GSK3B;BBC3
prerank,fatty acid biosynthetic process (GO:0006633),0.20774050979184494,0.9563856401609323,0.46153846153846156,0.6660968469944039,1.0,12/70,10.60%,HACD1;ELOVL4;HPGD;DEGS1;FADS3;GSTM4;PLA2G1B;SCD5;HACD4;CYP1A1;LPL;ACSM5
prerank,activation of GTPase activity (GO:0090630),0.20671582086421758,0.9558961489750213,0.5,0.6667795862419105,1.0,23/98,13.61%,TBC1D1;ARHGEF26;SYDE1;CORO1C;SGSM2;ARHGEF15;TBC1D17;EVI5L;CCL21;TAX1BP3;RABGAP1;ARHGEF10;ADPRH;TBC1D25;SIPA1;USP6;TBC1D10A;SGSM1;SGSM3;SIPA1L2;TSC1;TBC1D26;NTF3
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.2238584719656665,-0.9557927406772099,0.6666666666666666,0.8792854322400734,1.0,115/458,24.11%,CEBPB;POU5F1B;TCF7;FOXP3;ZNF695;SOX14;HMGA1;ZNF460;DSCC1;SOX4;PML;E2F1;ESCO2;SPIN2A;FBXO5;CHEK2;WWC1;ARNTL2;MYBL2;POU6F2;HDAC10;USP37;SIX1;CALR;CHD7;ENG;HMGA2;ZNF92;NANOS3;ZNF280A;AJUBA;IFNK;TOM1L1;SOX1;ZNF730;NFKB2;ZNF486;ZNF217;RELA;ZNF138;ZNF714;ZNF114;VHL;CEBPA;NUP107;ZNF737;ELAVL2;TBX4;ZNF675;RNF6;VGLL1;BRCA2;NUP35;ZNF430;PAK6;MAFA;ZNF680;ZNF280B;ZNF648;GATA4;NKX6-2;ZNF253;PTF1A;POFUT1;NFXL1;LIN54;GRM5;ZNF205;ZNF708;ONECUT1;GCM1;GTF2IRD1;ZNF195;MLXIPL;MYB;NANOG;SKOR2;EIF4E;NOLC1;TRRAP;ZNF488;NFYA;PRKCQ;SLC39A8;PSPC1;ZNF716;SPTY2D1;ZNF141;CRX;FUS;PHB;TRIM22;ACTR8;ZNF280C;KLF1;FOXN2;PKP3;ZNF100;ZNF492;DLX4;HES6;ANKRD17;MYCBP;ZNF221;MYBL1;SCRT2;NOTCH1;SBNO1;MAPKAPK5;SPI1;CARM1;ZNF506;ATRX;GLRX2;ZNF90
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.29026791055347856,-0.9554235503581017,0.5308641975308642,0.8792353080859254,1.0,15/39,31.44%,MYC;RFWD3;FBXO5;POLH;HMGA2;NEK4;IER3;SMYD2;PARG;NPAS2;FMR1;SMG1;USP1;UBE2N;MCL1
prerank,regulation of cellular response to stress (GO:0080135),-0.23768096498690613,-0.9552370235486003,0.6043956043956044,0.8788346944298426,1.0,49/114,31.77%,CEBPB;HSPA1A;NUP155;NUP37;RPA3;AJUBA;NUP210;MAPKAPK2;NEK6;NEK4;DNAJC2;NUP107;IER3;NUP35;HSPH1;PNPT1;RANBP2;DYRK3;ATR;SEH1L;NUP50;NUP205;OPRM1;NUP93;RAE1;MBTPS2;BAG4;NUP88;GSK3B;NPM1;NPAS2;POM121;NUP43;ROCK2;RSL1D1;NUP160;FKBP4;MANF;NUP62;SMG1;CREBBP;NUP153;ADCY8;DNAJC7;NDC1;NUP98;SEC13;MCL1;ATF3
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.3282555685545585,-0.9551257778472664,0.5915492957746479,0.8781919378835894,1.0,8/27,19.34%,CEBPB;TRIB3;ERO1A;TNFRSF10B;CHAC1;TRAF2;ATP2A1;BBC3
prerank,regulation of extracellular matrix organization (GO:1903053),-0.3454399675739119,-0.9547294557071526,0.547945205479452,0.8783573452214195,1.0,6/15,23.44%,FAP;RUNX1;AGT;FGFR4;NOTCH1;DDR1
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.3144671721629602,-0.9547042465733824,0.5063291139240507,0.8775239289092801,1.0,4/21,10.08%,RASSF10;PROX1;LRP2;DRD2
prerank,positive regulation of embryonic development (GO:0040019),-0.33734008653499864,-0.954509263135611,0.49295774647887325,0.8771340104151505,1.0,8/18,31.90%,FOXA2;LHX1;TENM4;WNT3A;WNT4;OTX2;SCX;NLRP5
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.24691687725611583,0.9544991190272895,0.6538461538461539,0.6694591533635501,1.0,7/31,11.88%,PLA2G5;AGTR1;ITGB3;NR1H2;CD36;LPL;NFKB1
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.32762645345890873,-0.9540678073005104,0.5555555555555556,0.8772146237675705,1.0,4/23,10.08%,GRIN2D;GRIN2B;GLRA1;DRD2
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.22844889491403356,0.9537804435639595,0.5384615384615384,0.6707198190544856,1.0,15/56,15.78%,TNFSF10;BCL10;TRIM39;FAS;BCL2L11;NUPR1;GPER1;DAB2IP;BOK;NKX3-1;BAD;RIPK1;BCL2;AGTR2;DDIT3
prerank,protein modification by small protein conjugation (GO:0032446),0.15906226627259296,0.9536689571455509,1.0,0.6702746089490479,1.0,61/383,13.41%,DTX3;ASB2;FBXO32;HIF3A;PDZRN3;ARRDC4;BCL10;TRIM39;FBXO10;PIAS3;FBXO9;PJA2;ZSWIM8;KLHL21;TRIM6;UBE2D4;UBE2G1;SKP1;CAND2;FBXL7;UBE2F;VPS11;LZTR1;FBXL5;KCTD10;DCUN1D4;ASB5;UBE2E1;NEDD8;UBB;UBE2Q2;ASB1;RRAGA;KLHL41;UBA7;ANAPC16;MUL1;MYLIP;TRIM23;TRIM34;TRIM21;RNF14;SPSB1;KLHL20;PIAS1;RNF25;TRIM47;UBE2G2;TRIM63;SAE1;RTF1;RNF7;RNF220;RNF38;TRIM52;TRIM69;EPAS1;TMEM129;FBXW5;PAF1;AAAS
prerank,determination of bilateral symmetry (GO:0009855),-0.3091951967401229,-0.9534989044921112,0.5,0.8777997956191408,1.0,13/26,34.05%,TDGF1;CCDC103;DNAH11;DNAH5;KIF3B;NOTCH1;DNAI1;DNAI2;PITX2;FOXJ1;CFC1;CFC1B;MMP21
prerank,negative regulation of GTPase activity (GO:0034260),0.2837169036991046,0.9534540307767678,0.5714285714285714,0.6700170175096153,1.0,6/23,8.81%,PLXNB3;FICD;ARL2;GPSM1;DAB2IP;RDX
prerank,epithelium development (GO:0060429),-0.25004094937703675,-0.9516470991221563,0.5531914893617021,0.8814372537733457,1.0,32/121,19.25%,WNT2;WNT7B;CDK1;SHH;TRIM71;UPK3A;TIMELESS;PROX1;SOX9;SIX1;ACTL8;PAX2;MTHFD1;TAGLN;STAT1;UPK2;APELA;KRT16;GRHL2;ANXA4;PAX8;RIPK4;GATA6;TGFB1;EHF;KDR;PTER;KRT3;DLX3;PTCH1;LHX1;VDAC1
prerank,sensory perception of chemical stimulus (GO:0007606),-0.26506180819446384,-0.95035171063683,0.6153846153846154,0.8840312341549058,1.0,81/94,59.83%,OBP2B;OR6A2;OR2D2;DRD2;OR10A5;OBP2A;OR51B5;GFY;OR5B21;OR5M11;OMP;OR8D4;UGT2A1;OR51M1;OR52D1;OR51I2;OR1Q1;OR51I1;ADCY3;OR4D1;OR8B12;OR51B6;OR2S2;OR52A1;OR8A1;OR8B2;OR1D2;OR8B3;OR9Q2;OR1E2;OR8B8;OR1D5;OR1D4;OR8G1;OR5AK2;OR3A2;OR10A3;OR9Q1;OR9I1;OR10J1;OR5AN1;OR8D2;OR2M4;OR8B4;OR51B4;OR1C1;OR5M1;OR6C2;OR5M10;OR9G4;OR52A5;OR5B12;OR6C3;OR8H2;UBR3;OR51V1;OR5L1;OR5B3;OR5B17;OR8H3;OR5AP2;OR5D18;OR8K3;OR8U1;OR5I1;OR5D16;OR5M8;OR5D14;OR8H1;OR5M9;OR8J3;OR8K1;OR8I2;OR5L2;OR5AC2;OR5D13;OR5M3;OR8J1;OR8D1;OR5F1;OR8K5
prerank,protein homooligomerization (GO:0051260),0.1996001057436514,0.949632020690689,0.6,0.6782622807281238,1.0,20/121,8.74%,RNF112;MPP2;SCARA5;BCL10;ACACB;NACC2;DISP1;PKD2;IKZF4;JMJD6;STEAP4;ATL2;ALDOA;MCOLN1;CBY1;ALAD;B2M;TRPV1;ATL3;RYR3
prerank,protein targeting to membrane (GO:0006612),0.20767270044401037,0.949296606036027,0.45454545454545453,0.6784329882761879,1.0,33/84,23.62%,NACAD;MICALL1;MYO1C;ZDHHC7;PEX19;CHMP4A;ZDHHC15;PXMP2;ZDHHC22;ZDHHC18;PARD3;GOLGA7;RAB8B;VPS37A;TAOK2;VPS37D;SRP14;ALDH3A2;SEC62;RTP5;ARL6;ZDHHC1;ZDHHC20;NACA;PEX11B;SGTA;ABCD1;ZDHHC11;SDCBP;SRP19;CHMP4B;PEX12;RTP1
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.27410953936221,0.9486362913714036,0.5,0.6797004781072745,1.0,4/24,4.89%,GADD45B;PJA2;HAND2;SASH1
prerank,"base-excision repair, AP site formation (GO:0006285)",-0.33607892095556713,-0.9484809696834919,0.5671641791044776,0.8879872599835678,1.0,4/18,19.48%,NEIL3;ERCC5;NTHL1;UNG
prerank,positive regulation of transferase activity (GO:0051347),-0.23995503226658185,-0.9484006271713868,0.6021505376344086,0.887277191611765,1.0,39/146,23.64%,MYC;RFC3;PDGFRB;TRIB3;DSCC1;DKC1;NEK2;EPHB2;EPHB3;MAPK15;SERINC5;EPHA1;DCUN1D5;EPHA2;AURKB;IGF1R;MET;RFC5;GRHL2;NAF1;SORL1;PLK1;TGFB1;KDR;RFC2;HMBOX1;CCT2;PRKCQ;EPHB4;FGFR4;CHTF18;DTX3L;MAGEA2;EPHA8;CHRNA7;MAPKAPK5;DDR1;AXL;AXIN1
prerank,cellular sodium ion homeostasis (GO:0006883),-0.3506764540374978,-0.9480963203062397,0.5588235294117647,0.8870777457470747,1.0,2/15,0.70%,TMPRSS3;SLC12A2
prerank,endosome organization (GO:0007032),0.23303978518476715,0.9480362912359951,0.5714285714285714,0.6802831922079685,1.0,14/37,20.77%,CORO1C;VPS11;AKTIP;PI4K2A;PLEKHF1;SNX3;SNX33;ANXA8L1;RILP;RAB27A;SQSTM1;VPS18;VPS33B;LAMTOR1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.28116426040445064,-0.9478938499502898,0.5875,0.8866950794795464,1.0,17/54,30.89%,PSMB9;PSMD14;OAZ3;ODC1;NQO1;PSMA3;AZIN1;PSMB3;PSMA5;PSMD12;PSMB11;PSMB2;PSMA7;PSME2;PSME3;PSMC1;PSME4
prerank,ERBB2 signaling pathway (GO:0038128),0.24664348535957661,0.9478502825021436,0.47058823529411764,0.680141668424003,1.0,5/31,9.33%,BTC;MYOC;PIK3R1;EGFR;NRG2
prerank,glutamate receptor signaling pathway (GO:0007215),-0.29169465446723686,-0.9477831514757573,0.5657894736842105,0.8860592215138664,1.0,9/37,20.31%,GRIN2B;GRM8;HOMER1;GRM5;GRIN3B;GRM7;TRPM1;GRM1;GRM4
prerank,cellular response to alcohol (GO:0097306),0.2289334124444339,0.9476576619274244,0.5652173913043478,0.6799591138105272,1.0,16/48,17.48%,KLF9;ADCY5;GNG2;AKR1C2;SFRP1;GNAI1;OSBPL7;SMO;PTGER4;GOLPH3;ADCY2;CES1;ADCY6;CDH1;PTGFR;AKR1C3
prerank,regulation of dephosphorylation (GO:0035303),0.2954907283792926,0.9475547610786935,0.3225806451612903,0.6795912652913176,1.0,2/15,7.06%,INPP5K;MTMR9
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.3106930949292931,-0.9461544130937359,0.5128205128205128,0.8891532537188382,1.0,7/22,28.75%,PRKDC;HMGA2;ACTR2;RIF1;DTX3L;ERCC6;WRAP53
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.3571570657680942,-0.9459040132963596,0.5833333333333334,0.8888892926602459,1.0,7/17,22.95%,PLA2G4E;PLA2G2F;PLBD1;PLA2G4D;LCLAT1;LPGAT1;PLA2G2E
prerank,protein tetramerization (GO:0051262),-0.2617498968651708,-0.9458865121427549,0.5730337078651685,0.8879788321174783,1.0,32/71,35.69%,GRIN2B;GBP5;TRPM2;MAT1A;HPRT1;SHMT2;TK1;TDO2;HCN1;AQP5;HOMER1;KCNC3;FARSB;AQP2;FARSA;SSBP1;CTH;ACACA;SAMHD1;MIP;ACOT13;PKD2L1;SYCP1;KCNC1;TRPV5;HSD17B10;KIF25;KCNJ2;AQP10;NUDT21;GLS;OSBPL2
prerank,positive regulation of exocytosis (GO:0045921),-0.26697696057320713,-0.9453304117398152,0.47297297297297297,0.8884403373950917,1.0,11/37,23.07%,CADPS;RAB15;RAB3D;IFNG;CFTR;CADPS2;ATP13A2;FGA;EXPH5;SDC1;FGB
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.24572961213866984,-0.9450414015399969,0.5591397849462365,0.8872501313483194,1.0,9/96,4.23%,SPTBN2;AP1S3;KIF18A;CENPE;KIF15;KIF23;KIF2A;CTSV;RACGAP1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.24572961213866984,-0.9450414015399969,0.5591397849462365,0.8872501313483194,1.0,9/96,4.23%,SPTBN2;AP1S3;KIF18A;CENPE;KIF15;KIF23;KIF2A;CTSV;RACGAP1
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.23819982858366395,-0.9447394374590078,0.5384615384615384,0.8871646711795126,1.0,19/153,9.55%,CDH3;COL1A1;LGR5;PTK7;SOX4;RUVBL1;TNFAIP3;ATP6V1C2;DEPDC1B;PSMB9;PSMD14;LGR6;CAV1;AXIN2;LBX2;BAMBI;XIAP;SMARCA4;SEMA5A
prerank,regulation of ruffle assembly (GO:1900027),-0.32169798019077656,-0.9444162789792683,0.6056338028169014,0.8870304194603301,1.0,4/23,11.43%,TACSTD2;CAV1;EPS8L1;USP17L2
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.2567244465510942,-0.9440691542525133,0.5714285714285714,0.8869244062288915,1.0,9/72,6.51%,FAP;GZMB;CTSH;TNFAIP3;CTSV;ADAMTS12;ISG15;HM13;PMAIP1
prerank,monocyte chemotaxis (GO:0002548),-0.2830741478348415,-0.9438235873175248,0.5357142857142857,0.8867069163370457,1.0,11/39,14.85%,TNFSF11;CCL24;CCL20;CCL22;PTPRO;CCL4;CCL3;CCL25;RPS19;CCL26;CCL17
prerank,response to amyloid-beta (GO:1904645),-0.2891807341866144,-0.9435213098076976,0.5384615384615384,0.886545676647434,1.0,14/44,21.46%,MMP13;ICAM1;MMP2;IGF1R;MMP3;CALCR;MMP9;FPR2;GRM5;FYN;MMP12;CDK5;GSK3B;CHRNA7
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.27450532829800306,-0.9426621461130972,0.6266666666666667,0.8877989908115695,1.0,19/64,28.88%,PSMB9;PSMD14;CAV1;OAZ3;ODC1;NQO1;FGFR4;PANK2;PSMA3;AZIN1;PSMB3;PSMA5;PSMD12;PSMB11;PSMB2;PSMA7;PSME2;PSME3;PSMC1
prerank,regulation of mitochondrial translation (GO:0070129),-0.3265112938986698,-0.9425156484351248,0.575,0.8873028975780634,1.0,9/20,33.02%,SHMT2;NSUN3;FASTKD2;RMND1;UQCC2;TRUB2;TRMT10C;C1QBP;MTG2
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.3630445494424183,-0.9424945813681613,0.5774647887323944,0.8864046362582745,1.0,3/17,4.80%,CCND1;PROX1;SPDYA
prerank,regulation of vasculature development (GO:1901342),0.24891683293720052,0.9424865691189211,0.5,0.6907842030071517,1.0,5/26,10.12%,FGF2;HMOX1;GPNMB;EGLN1;SFRP1
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.29499973422769454,-0.9422863536386582,0.4875,0.8859249391319153,1.0,4/26,8.23%,HSPA1A;INHBA;PRKDC;STAT1
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.3252249766851616,-0.9421313766730769,0.5068493150684932,0.8853907500667508,1.0,10/27,24.55%,ERO1A;TRPM2;DRD2;F2R;FASLG;IBTK;HTR2C;ITPR2;LCK;XCL1
prerank,regulation of protein modification process (GO:0031399),0.22328730841834352,0.9413272924573051,0.55,0.6927130584403278,1.0,6/47,4.01%,CADM4;HSPB1;FLCN;CORO1C;CDK9;KAT2B
prerank,regulation of programmed cell death (GO:0043067),-0.22969518469060474,-0.9411785310972189,0.6086956521739131,0.8868327477712735,1.0,71/187,32.85%,TP73;GLS2;LRP8;SKP2;POU4F1;SOX9;CXCL10;CALR;JAK3;PAX2;PMAIP1;ALPK2;TRIM24;BCL6;DCPS;TNFSF9;LGALS1;STAT1;TOX3;TNFRSF10C;PAX8;USP17L7;TNFRSF10B;USP17L2;PERP;AGT;CASP2;IGFBP3;CITED1;WRN;PRELID1;STK26;RTKN;CDK5;ALB;ACER2;POU4F2;TRAF2;PHB;ANP32A;BIRC5;OLFM4;USP17L1;NME1;FBXO11;USP17L8;USP17L11;USP17L4;USP17L3;RSL1D1;TNF;TM7SF3;USP17L15;ACTN4;BCL2L14;NUP62;BAX;CREBBP;USP42;TIGAR;FANK1;BID;PLK5;NAE1;ANP32B;STEAP3;USP17L12;USP17L22;NLRC4;TNFRSF10A;USP17L18
prerank,neuropeptide signaling pathway (GO:0007218),0.2053916539396638,0.9411723913354081,0.7,0.6925198168489076,1.0,14/63,14.12%,SORCS1;NTSR1;PENK;GALR2;GLRB;NXPH3;PTGDR2;NPY;NPPA;CPE;PYY;SORCS2;NPPB;ADCYAP1
prerank,triglyceride homeostasis (GO:0070328),-0.2694198387769792,-0.9407963726939657,0.5797101449275363,0.8868179370373894,1.0,13/29,34.76%,DGAT2;ANGPTL3;SCARB1;CETP;MLXIPL;APOC2;XBP1;HNF4A;FITM2;GCKR;APOA5;PLA2G12B;APOA1
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.3418891829035554,-0.9405044478781118,0.5774647887323944,0.8866026060139728,1.0,6/15,23.44%,SRMS;IGF1R;KDR;ITK;TEC;DDR1
prerank,positive regulation of neutrophil migration (GO:1902624),0.29066025479792634,0.940128648826417,0.5757575757575758,0.6940531685701743,1.0,5/21,7.14%,THBS4;RAC1;TIRAP;CCL21;NCKAP1L
prerank,cellular response to hypoxia (GO:0071456),0.17787912374351467,0.9396696475581819,0.6,0.6943518363239981,1.0,26/127,13.56%,HIF3A;AQP1;EGLN2;ZFP36L1;CPEB1;SIRT2;MTOR;HMOX1;PTGIS;UBB;PSMC5;HP1BP3;BNIP3;EGLN1;SFRP1;ARNT;ACAA2;PSMD9;BNIP3L;MGARP;FAM162A;NKX3-1;HIGD1A;EPAS1;BAD;MT3
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.298872161264417,-0.939595038594374,0.589041095890411,0.8880250003725765,1.0,4/27,7.27%,AREG;EREG;EPGN;GPRC5A
prerank,connective tissue development (GO:0061448),-0.28246702361069215,-0.9394599949037391,0.5540540540540541,0.8874500004776988,1.0,16/37,33.99%,CD44;SOX9;IL17F;GHRL;HYAL3;CHI3L1;SPTLC2;COL2A1;XBP1;GDF2;SULF2;TRIP11;LRP5;SCX;ATP7A;ITGB8
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.22313100924624057,0.9381866517206154,0.5263157894736842,0.6967833744635573,1.0,21/54,21.81%,AGTR1;CDKN1A;SNCA;RAC1;SIRT2;MAPK14;PLIN5;PID1;PDGFB;AKR1C1;RIPK1;MT3;PARL;RNF41;AKR1C3;GRB2;COQ7;BST1;PINK1;CYP1B1;CBR1
prerank,diol metabolic process (GO:0034311),-0.3381342974685183,-0.9381361214097255,0.5138888888888888,0.8898405885820344,1.0,6/16,22.41%,ASAH2;GCHFR;SGPP2;PTS;GCH1;DEGS2
prerank,water transport (GO:0006833),-0.3393339927516258,-0.9379007639930478,0.6027397260273972,0.8894783845025993,1.0,8/18,27.15%,UPK3A;AQP5;AQP9;AQP2;CFTR;AQP3;SLC5A1;MIP
prerank,negative regulation of binding (GO:0051100),-0.23926183666758913,-0.937079570609089,0.5978260869565217,0.8905822847945514,1.0,31/82,34.06%,GNL3L;LEF1;E2F1;MDFI;HMGA2;TFAP4;AURKB;CAV1;ZFPM1;AURKA;SORL1;CFHR1;GTPBP4;CYP2D6;NFKBIA;SLPI;GSK3B;IFI16;TTBK1;SUMO4;GZMA;EFHB;CARD16;BAX;DKK1;PPP1CA;KDM1A;CPNE1;CFHR5;DDX11;IFIT2
prerank,regulation of monocyte differentiation (GO:0045655),-0.35300219269747285,-0.9368564723603526,0.5714285714285714,0.8902131903153807,1.0,2/16,4.63%,MYC;DCSTAMP
prerank,female gamete generation (GO:0007292),-0.31369027321878734,-0.9365312190927801,0.6097560975609756,0.8900096294029396,1.0,13/29,32.45%,GDF9;NANOS3;DIAPH2;HORMAD1;TRIP13;USP9X;MDK;CGB7;MCM8;PRDM9;KMT2D;DMC1;STRA8
prerank,zinc ion transport (GO:0006829),-0.32487837110567025,-0.9359861062250325,0.5972222222222222,0.8904854497088688,1.0,7/21,25.87%,SLC30A2;TRPM2;SLC39A11;SLC39A8;SLC30A6;SLC39A2;SLC30A5
prerank,regulation of centrosome cycle (GO:0046605),-0.32116300631228367,-0.9359822234968284,0.5416666666666666,0.8895695179231516,1.0,4/22,11.06%,PKHD1;CHMP4C;AURKA;NAT10
prerank,metal ion transport (GO:0030001),-0.24606390433299546,-0.9359280873346928,0.5581395348837209,0.8887581420493887,1.0,29/87,25.87%,CACNG8;CACNA1D;CYP27B1;TRPM2;CAV1;TRPV4;CCL3;SLC24A1;LRP2;CATSPER1;KCNN4;MAGT1;TRPC5;CHRNB2;FYN;NDFIP2;ATP2C1;SLC39A8;SLC8A3;ATP2A1;NIPA2;CHRNA7;NMUR2;CHRNA4;CACNA1E;SLC39A2;TRPV6;SLC3A2;SLC30A5
prerank,adrenergic receptor signaling pathway (GO:0071875),0.2818960202103875,0.9359182972000533,0.5806451612903226,0.7014854944821604,1.0,6/20,18.08%,ADRB3;ADRA2B;PDE4D;ADCY9;ADRB2;ADRA1A
prerank,vesicle transport along actin filament (GO:0030050),-0.3329997211375733,-0.935914926915895,0.589041095890411,0.8878595646837484,1.0,8/19,29.80%,MYO1H;MYO6;MYO5B;FNBP1L;MYO1E;ACTN4;MYO19;MYO1F
prerank,natural killer cell activation involved in immune response (GO:0002323),-0.32399502336135183,-0.9357896144241101,0.5609756097560976,0.887297505606153,1.0,14/21,43.17%,IFNK;CORO1A;IFNE;IFNB1;CD244;IFNA1;IFNA21;IFNA4;IFNA7;IFNA10;IFNA14;IFNA17;IFNA2;IFNA16
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.2726571973673713,0.93540649361176,0.5333333333333333,0.7023500264207899,1.0,6/20,13.20%,TMBIM1;AP2M1;PID1;RHOQ;PKDCC;NUMB
prerank,regulation of B cell differentiation (GO:0045577),-0.31808142406641826,-0.9343735589777987,0.6142857142857143,0.890113884074043,1.0,3/18,7.42%,INHBA;IL4I1;SYK
prerank,calcium-mediated signaling (GO:0019722),-0.24045777575311586,-0.9341607772316459,0.6162790697674418,0.889714237815589,1.0,28/101,22.40%,CXCL8;CCR8;TNFSF11;GPR143;CXCR4;CCL20;TRPM2;CCR4;CCL3;CXCR2;NUDT4;CXCR5;CXCR6;TNNI3;FPR2;GRM5;KDR;CCR3;CXCR3;SULT1A3;CXCR1;CCRL2;PTPRJ;KSR2;ATP1B1;SAMD14;EIF2AK3;NMUR2
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.2711771724087293,-0.9340712055084198,0.6046511627906976,0.88896136077953,1.0,23/53,34.76%,IL1RN;TRAIP;ISG15;NLRC5;PALM3;USP18;ZNF675;OAS3;IRAK3;IL36RN;PTPN2;ARG1;PARP14;PPARG;RNF113A;DCST1;SAMHD1;CARD16;TTLL12;STAT2;OTOP1;PYDC1;APOA1
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.3456693465830691,-0.9340551412320691,0.6153846153846154,0.8880944035518169,1.0,4/15,16.86%,MIF;CD44;ARMC10;MDM2
prerank,RNA 3'-end processing (GO:0031123),0.22212159797583944,0.93404297949475,0.6470588235294118,0.7048292116164583,1.0,12/64,9.07%,SRSF5;PABPN1;CPSF7;DDX39B;U2AF1L4;CASC3;SRSF4;POLDIP3;SRSF11;RPRD1A;THOC5;TUT1
prerank,modulation by host of symbiont process (GO:0051851),-0.28636482081791687,-0.9340346024559053,0.5733333333333334,0.887276791493577,1.0,15/32,33.79%,LEF1;HMGA2;TFAP4;CCL4;CCL3;SMARCA4;RRP1B;HPN;CARD9;SMARCB1;REST;CHD1;CCL5;POU2F3;CX3CR1
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.3045442793396377,-0.9336280049446684,0.5616438356164384,0.8872957525694266,1.0,9/24,38.65%,GNL3L;NAT10;SLX1A;PIF1;XRN1;SLX4;HNRNPC;HNRNPU;DCP2
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.24735442041644312,-0.9333507831652492,0.5714285714285714,0.8871451548407161,1.0,19/68,24.88%,OSM;CSF2;SOCS3;IL23A;SOCS1;IL23R;ARL2BP;IL21;IL12B;IL22RA2;IFNG;TNFSF18;PIBF1;LIF;PTPN2;IL20;PARP14;TNF;LYN
prerank,transferrin transport (GO:0033572),0.24386251321771624,0.9333488896365287,0.631578947368421,0.7061388728248714,1.0,14/36,22.41%,ATP6V1G2;ATP6V1E1;MCOLN1;ARHGAP1;TFRC;TCIRG1;RAB11B;ATP6V0E2;ATP6V1D;ATP6V1H;ATP6V0A1;ATP6V0D1;HFE;ATP6V0E1
prerank,sterol metabolic process (GO:0016125),-0.25493689352564386,-0.9331967299997669,0.5925925925925926,0.8867035902127354,1.0,18/68,21.91%,SULT2B1;SQLE;CYP51A1;ANGPTL3;NR0B2;CYP7B1;CETP;CYP19A1;CYP26C1;DHCR7;CYP39A1;SC5D;APOA2;NSDHL;CYP26A1;APOF;SULT2A1;CLN6
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.20815073455497418,0.9324929336036463,0.6363636363636364,0.7079158845136406,1.0,6/44,7.56%,BTC;TSG101;DUSP3;SPRY1;EGFR;DAB2IP
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.28120401125013084,0.9316551223872249,0.5769230769230769,0.7092612440998812,1.0,3/18,7.46%,FLNA;ATF4;MAF1
prerank,cellular response to hexose stimulus (GO:0071331),-0.3153627603125308,-0.9313455239952659,0.5454545454545454,0.8907020261045591,1.0,4/24,6.95%,SOX4;ZBTB20;PAX2;IGF1R
prerank,modification-dependent protein catabolic process (GO:0019941),0.15947933341544415,0.9304744016038737,0.75,0.7113176754566098,1.0,28/196,10.29%,ASB2;RNF150;FBXO10;RNF11;FBXO8;UBE2D4;UBE2G1;FBXL7;KCTD10;WDR91;UBE2E1;NEDD8;RNF130;UBB;RNF185;ANAPC16;RNF146;RNF167;MYLIP;NTAN1;RNF217;RNF14;RNF144B;SPSB1;PCYOX1;UBL7;UBE2G2;FBXW4
prerank,negative regulation of lipid storage (GO:0010888),0.2753581997709224,0.9302797147208677,0.5357142857142857,0.7110078729466203,1.0,6/20,17.09%,PPARD;ITGB3;NR1H2;CES1;PNPLA2;NR1H3
prerank,protein localization to microtubule organizing center (GO:1905508),-0.35095162040379635,-0.9302522469899447,0.6153846153846154,0.8923195264949609,1.0,4/16,18.40%,SPAG5;SNX10;CEP83;PIBF1
prerank,phospholipid transport (GO:0015914),-0.2552849487890566,-0.9301275661014164,0.6103896103896104,0.8917187085093898,1.0,14/56,21.74%,ATP11A;SCARB1;MTTP;PRELID2;ABCA12;ATP9A;APOA2;PRELID1;APOC1;OSBPL8;LDLR;APOC2;ATP11B;ATP10B
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.24492814935583043,0.9299399587480469,0.6296296296296297,0.7114515254785463,1.0,6/24,13.78%,GPER1;RBPJ;HAP1;RTN4;AFAP1L2;BCAR3
prerank,cilium organization (GO:0044782),0.1715587500263135,0.9298716826085912,1.0,0.7108981897436811,1.0,49/211,17.58%,FLNA;GSN;EHD2;RFX2;PARVA;TTLL3;BBS5;DZIP1;PKD2;RAB23;WDR19;BBS1;CYS1;NPHP3;RABL2B;ARL3;PKD1;HDAC6;IFT81;ABLIM3;INTU;FBF1;TXNDC15;UBXN10;CLUAP1;MARK4;CC2D2A;INPP5E;CEP126;TMEM138;RAB11FIP3;IFT46;RAB8B;IFT80;RILP;STK36;BBS2;KIFAP3;EXOC7;GBF1;BBS7;FUZ;FAM161B;CEP89;IFT43;BBS4;ATP6V1D;PTPN23;RILPL2
prerank,cellular response to interleukin-1 (GO:0071347),-0.2342360949458002,-0.9295575778629871,0.6421052631578947,0.8923199403722925,1.0,56/151,34.24%,CXCL8;IL1A;IRAK2;RIPK2;IL1B;CCL24;CCL20;IL1RN;EGR1;PSMB9;SOX9;ADAMTS12;CCL22;PSMD14;CCL4;CCL3;RELA;IRAK1;HYAL3;GBP1;CCL25;CCL26;CCL17;NFKBIA;NOD2;PSMA3;IRAK3;CCL1;ST18;PSMB3;TAB3;XCL2;XCL1;PSMA5;PSMD12;PSMB11;PSMB2;HAS2;PSMA7;USP10;IKBKG;PSME2;GBP3;PSME3;ZC3H12A;PSMC1;CCL5;TRAF6;PSME4;UBE2N;MAPK13;CCL7;NOD1;MYD88;CD47;UBC
prerank,snRNA metabolic process (GO:0016073),-0.3522578202275928,-0.9291542288948452,0.582089552238806,0.8924414545036549,1.0,3/15,21.28%,INTS7;INTS2;INTS6
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.3222071197401799,-0.9284365496751231,0.5352112676056338,0.8932898269169393,1.0,2/16,4.89%,CXCL8;F7
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.3049164296180179,-0.9274342343701675,0.5789473684210527,0.8948292112669729,1.0,12/27,38.01%,WDR43;BTBD18;CDK12;EAF1;NELFCD;EAF2;CDC73;LEO1;CDK13;HNRNPU;RNF168;LDB1
prerank,body fluid secretion (GO:0007589),0.2873662371774369,0.9271105174057757,0.5555555555555556,0.716541130195923,1.0,2/15,1.93%,NPR1;VIP
prerank,sodium ion homeostasis (GO:0055078),0.24227372154950544,0.9266592733628863,0.6296296296296297,0.7166742552657386,1.0,6/25,11.51%,ATP1B2;ATP1A2;SCNN1B;SCNN1G;ATP1A3;SLC8A1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.24121780179947316,-0.9265645066712717,0.6413043478260869,0.8959959340562883,1.0,16/101,15.52%,SPTBN2;AP1S3;KIF18A;CENPE;KIF15;KIF23;KIF2A;CTSV;RACGAP1;AP1S1;KIF4B;KIF2C;KIF22;HLA-F;CANX;CTSE
prerank,positive regulation of viral process (GO:0048524),-0.260299270010782,-0.9264411620526134,0.5517241379310345,0.8953010761006333,1.0,20/62,31.05%,POLR2F;SRPK1;PPIH;PABPC1;HACD3;NELFCD;POLR2D;FKBP6;TMEM39A;POLR2J;POLR2I;STAU1;AXL;PDE12;KPNA2;CD28;CCL5;LARP1;GTF2F2;DHX9
prerank,sulfur compound catabolic process (GO:0044273),0.23167591864945006,0.9263542322553682,0.5925925925925926,0.716685485762439,1.0,11/39,15.98%,PRELP;CSPG4;DCN;OGN;IDS;ACAT1;GGT5;KERA;FMOD;OMD;GGT7
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.19088425912051293,0.926152310189202,0.5714285714285714,0.7165143719604226,1.0,27/136,14.12%,GLP2R;RAMP1;POMC;ADCY5;VIP;ADCYAP1R1;GNG2;MAPK14;PRKAR2B;ADRB3;ADCY4;VIPR2;PTH1R;PRKACA;RAMP3;RAMP2;CREB1;PTGER4;ADM;P2RY11;ADCY9;AVPR2;ADCY2;GPBAR1;ADRB2;GGT5;ADCYAP1
prerank,cellular amino acid catabolic process (GO:0009063),-0.24618227225982725,-0.9259115625890273,0.5978260869565217,0.8957877337417947,1.0,29/88,30.78%,IL4I1;GAD1;GLS2;ACMSD;KYNU;MAT1A;IDO1;SHMT2;TDO2;NOS2;GLDC;KMO;ALDH5A1;DDAH1;SDS;MCCC2;ARG1;UROC1;HAL;SDSL;GCSH;GLUD2;HAAO;ARHGAP11B;IDO2;HOGA1;CBS;ALDH7A1;HSD17B10
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.2805610081060184,0.9251286403828606,0.5294117647058824,0.7184080694180125,1.0,7/16,20.84%,PDGFRA;PDGFB;PDGFD;PLAT;NR4A3;PDGFA;FER
prerank,positive regulation of organelle assembly (GO:1902117),-0.2711053958993892,-0.9250022836550235,0.5977011494252874,0.897124096346655,1.0,8/44,14.48%,CSF2;SAXO1;SPAG5;GPSM2;CAPG;IL5;G3BP1;CNOT1
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.3047509998041986,0.924552876581079,0.5357142857142857,0.7191457346925383,1.0,6/17,18.04%,CALM1;MTOR;PPP1R12A;CALM2;AGTR2;PPP1R15A
prerank,DNA conformation change (GO:0071103),-0.3171056837010277,-0.9234309499687339,0.6133333333333333,0.9002912454227016,1.0,6/18,21.77%,TOP1MT;TOP3B;HMGB3;TOP1;TOP2A;HMGB1
prerank,histone deubiquitination (GO:0016578),0.2767400297836928,0.9221143767820126,0.5357142857142857,0.7241250120423462,1.0,4/17,13.80%,KAT2A;USP51;USP21;UIMC1
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.23969684360350121,-0.9208284403519756,0.5666666666666667,0.9058986299869498,1.0,52/93,53.34%,RPL39;SSR1;RPS19;RPS21;TRAM1;RPL36;SRP72;ARL6IP1;RPL37;RPL8;SIL1;RPL23A;RPS7;RPS18;RPS2;SEC61A1;RPL4;RPS3;RPL35;RPS4X;RPL18;RPL32;RPL41;RPS24;RPL27A;RPS29;RPL19;RPL38;RPL37A;RPS14;RPL12;RPLP2;RPL30;RPL28;RPLP0;SRP9;RPL31;RPS28;RPS3A;RPS15;UBA52;RPL18A;RPS11;SRP54;RPS5;RPL5;RPS6;RPS9;RPL7A;RPL11;RPL29;RPL35A
prerank,regulation of neurogenesis (GO:0050767),-0.2566737304057224,-0.9201077420169672,0.6190476190476191,0.9066397390172217,1.0,16/61,25.80%,ASCL2;MME;RASSF10;IL1B;PAX6;LRP2;SORL1;IFNG;WNT7A;OPRM1;WNT3;HES6;NOTCH1;TNF;WNT3A;REST
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.27075251307909276,-0.9196592036350937,0.6265060240963856,0.9068122903079777,1.0,9/42,14.13%,AREG;LRP8;EREG;DOK7;EPGN;FCGR1A;AGT;GRM5;FYN
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.3344913043943393,-0.9194250515050095,0.6142857142857143,0.9065246367796687,1.0,5/15,29.08%,KIF20B;SHTN1;ARFGEF1;ROCK2;TEK
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),-0.31373608500592653,-0.9193297100568971,0.6081081081081081,0.9058114581874964,1.0,12/27,35.93%,POP1;RNASEH1;CPSF3;LACTB2;PDE12;CSTF3;ZC3H12A;XRN1;SLFN14;ZC3H12D;POP7;NHP2
prerank,regulation of lipid storage (GO:0010883),-0.2941209981826107,-0.9181377494931253,0.589041095890411,0.9076537690621447,1.0,13/22,40.90%,MEST;C3;IKBKE;NFKBIA;PTPN2;TNF;ZC3H12A;APOB;FBXW7;HILPDA;ITGAV;CRP;PLA2G10
prerank,cellular response to oxygen-containing compound (GO:1901701),-0.20973146950650068,-0.9180922141522129,0.7083333333333334,0.9068412217036664,1.0,64/315,18.25%,DPEP1;CXCL8;CXCL1;CXCL2;IL1A;CXCL5;CXCL3;WNT2;PPBP;TESC;IRS1;CD68;CXCL9;WNT7B;CXCL11;SERPINE1;CD80;PTK7;FOLR1;IL1B;POU4F1;WNT5A;EGR1;KCNQ1;TNFAIP3;CARD17;SOX9;CXCL10;ABL2;PAX2;FOS;PF4;MMP3;CXCL6;TNIP3;DEFA6;HCN1;RELA;SH3BP4;GLRA1;AQP9;FFAR2;IRAK1;UCP1;FZD10;MMP9;TSHR;WNT8B;GLRA2;TNFRSF1B;WNT11;TNFSF4;PTPRK;ROMO1;AANAT;BRINP2;DEFA5;CFTR;PF4V1;PDXP;IL10;ADAM9;NOD2;POU4F2
prerank,regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),-0.3428176482773274,-0.917940417474576,0.5692307692307692,0.9062825434229029,1.0,3/16,11.81%,CXCL8;HMGA2;APOBEC3F
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.30495802846549364,-0.9177636490915694,0.6164383561643836,0.9057647728808677,1.0,15/31,39.20%,TOMM20L;HSPD1;PEX7;ROMO1;GRPEL2;TIMM23;TOMM40;DNAJC15;PEX10;TIMM50;AIFM1;PEX16;GRPEL1;PEX1;TIMM17B
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.1860655836477199,0.9173303034405168,0.7142857142857143,0.734989922354074,1.0,36/86,26.67%,TIMM21;NDUFA11;COX16;OXA1L;NDUFC2;COA5;NDUFB8;NDUFS2;NDUFA5;ECSIT;CHCHD4;SURF1;SDHAF2;COX14;UQCRFS1;NDUFB10;NDUFS4;NDUFV2;NDUFAF1;NDUFA13;NDUFA8;BCS1L;TIMMDC1;NDUFA9;NDUFC1;NDUFV1;UQCC1;NDUFA6;SDHAF1;SMIM20;NDUFS5;TMEM126B;NDUFS8;NDUFA7;NDUFA10;NDUFB6
prerank,negative regulation of cell population proliferation (GO:0008285),-0.21184396553609897,-0.917159075196262,0.696969696969697,0.9063675847718897,1.0,59/365,14.23%,FAP;MYC;CXCL8;SULT2B1;CXCL1;IL1A;IFITM1;HSPA1A;TESC;OSM;INHBA;TP73;CGREF1;CDKN3;FOXP3;TGFB2;SSTR5;EPPK1;HMGA1;EREG;DHRS2;IL1B;SOX4;AZGP1;FABP6;PML;E2F1;CYP27B1;WNT5A;TNFAIP3;CDKN2A;PROX1;SOX9;ADGRG1;TFAP4;IFIT3;IFNK;AXIN2;E2F3;SH3BP4;VHL;CEBPA;IL12B;TFDP1;DRD2;UTP20;S100A11;F2R;PLG;IFNG;GATA6;TGFB1;GTPBP4;IGFBP3;RFPL1;ENPP7;RBP4;NF1;FRK
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.23895216797506344,0.9168351481152311,0.5714285714285714,0.7359126412285792,1.0,11/36,15.78%,NCK1;NACC2;BCL2L11;NUPR1;UBB;SOD1;BOK;NKX3-1;BAD;BCL2;DDIT3
prerank,peptidyl-serine phosphorylation (GO:0018105),0.1928071156366255,0.9165800459577644,1.0,0.7360276968805423,1.0,34/154,13.24%,DMPK;MAPK1;PNCK;ULK1;MAPK8;ULK2;MAPK14;RPS6KA2;MTOR;PRKCD;CAMK1;PKD1;PRKACA;MAST1;MAST2;LATS2;MKNK1;PKN1;PDGFB;PRKD1;MARK1;BRSK1;STK32A;CSNK1E;CAMK2D;HIPK4;MAP2K2;CSNK1A1;SGK1;MKNK2;CSNK2A2;PRKCB;PRKCA;RIPK1
prerank,carbohydrate derivative catabolic process (GO:1901136),0.2740333146159293,0.9165200088706537,0.5555555555555556,0.7355184266462976,1.0,4/18,10.59%,FBXO17;FBXO44;FBXO27;BPGM
prerank,chordate embryonic development (GO:0043009),-0.26151871383811937,-0.9159377920516987,0.6666666666666666,0.908617045534449,1.0,16/58,19.93%,COL1A1;WNT7B;WNT5A;TRIM71;PROX1;FUT8;CHD7;GRHL2;BMP7;TGFB1;RBP4;WNT11;ADAM10;BRCA1;PTCH1;KIAA1217
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.29038354379334713,0.9155795296424081,0.5483870967741935,0.7369210010717756,1.0,4/19,6.43%,CHRNA3;RIC3;SLC5A7;CHRNB4
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.2440051474621311,-0.9150823097051958,0.6363636363636364,0.9098504820722443,1.0,18/75,19.87%,FOXP3;IRAK2;TNFAIP3;CDKN2A;NLRC5;PKHD1;BMP7;NWD1;ANXA4;ZNF675;IRAK1;SETD6;NFKBIA;NLRP12;IL10;OTULIN;IRAK3;NLRP3
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.25532213116873914,-0.9149989037061579,0.6052631578947368,0.9091594947017704,1.0,19/45,25.80%,TGFB2;EGR1;SOX9;FOS;APLN;RELA;SMARCA4;GNL3;TGFB1;BMP4;TERT;IL10;LILRB4;GATA3;SPI1;PPARG;TNF;KLF5;REST
prerank,brain development (GO:0007420),-0.2256786106226575,-0.9144013183908054,0.7021276595744681,0.9097829045334932,1.0,35/146,20.97%,GRIN2D;GRIN2B;POMK;ZIC2;DMBX1;CXCR4;PROX1;ROBO2;ADGRG1;PAFAH1B3;SHROOM4;PAX2;SPATA5;SIX3;GRHL2;FOXG1;SCT;CNTNAP2;NKX2-1;NF1;ABCB6;CENPF;SLC6A4;TGFBR2;PBX4;TBR1;SHROOM2;DHX37;AMIGO3;VCX;PTCH1;B3GNT5;VCX3B;NKX2-2;ZIC1
prerank,regulation of establishment of planar polarity (GO:0090175),0.17612190131932898,0.914175082838225,0.75,0.7392455858747994,1.0,11/88,7.43%,FZD7;ROR2;FZD4;RAC1;PRICKLE2;DVL3;NPHP3;AP2M1;RHOA;DVL2;PSMC5
prerank,protein hydroxylation (GO:0018126),0.2652793843593219,0.913891675238626,0.6071428571428571,0.7392970602119827,1.0,6/15,20.29%,P3H2;JMJD7;P3H3;VIPAS39;HIF1AN;VPS33B
prerank,positive regulation of protein kinase B signaling (GO:0051897),-0.23682662978219596,-0.9132217748966112,0.6521739130434783,0.9116838226600689,1.0,43/160,21.88%,IRS1;OSM;PDGFRB;AREG;GDF15;TRIB3;CD80;FGF19;EREG;MAZ;F7;ENG;PIK3AP1;EPGN;IGF1R;MET;FGF20;CCL3;SEMA5A;PIK3CG;LRP2;ICOS;CALCR;TGFB1;FGF23;CHI3L1;FYN;FGF3;LIN28A;STRN;ADAM8;PIK3CB;OSBPL8;FGFR4;PHB;THBS1;PTPRJ;IL26;NRG4;CD86;PIK3CD;GATA3;CASS4
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.3311660807729252,-0.9128917781895237,0.6086956521739131,0.9116515676309292,1.0,10/18,35.58%,HSD17B12;ACSL6;ACSF3;ACSL5;ELOVL7;TECR;ACSL3;ACSBG2;ACSL4;HACD2
prerank,protein homotrimerization (GO:0070207),0.29270337375768046,0.9126650697237834,0.627906976744186,0.7412438268177065,1.0,3/15,5.00%,SCARA5;DISP1;STEAP4
prerank,protein trimerization (GO:0070206),0.29270337375768046,0.9126650697237834,0.627906976744186,0.7412438268177065,1.0,3/15,5.00%,SCARA5;DISP1;STEAP4
prerank,chondrocyte differentiation (GO:0002062),-0.28921542888925056,-0.912519379178438,0.6024096385542169,0.9116522687137468,1.0,7/31,16.38%,AMELX;SOX9;HMGA2;RUNX1;TGFB1;WNT7A;BMP4
prerank,ceramide metabolic process (GO:0006672),-0.26732667136605665,-0.9119824828246014,0.5301204819277109,0.9120604228187547,1.0,22/51,34.72%,CERS6;SPTLC1;PNPLA1;ABCA12;ASAH2;ASAH2B;FUT7;ALOX12B;ACER2;SPTLC2;ALOXE3;SMPD2;SPTSSB;CLN6;DEGS2;CERS2;FUT6;GBA;CYP4F22;SGPL1;FUT5;FA2H
prerank,protein heterooligomerization (GO:0051291),0.299637863729465,0.9119215388769867,0.6451612903225806,0.7420944830555856,1.0,4/17,7.16%,PKD2;CPSF7;PKD1;MAT2A
prerank,transition metal ion transport (GO:0000041),-0.27434587088560025,-0.9118811188654726,0.5949367088607594,0.9113910539318474,1.0,12/35,28.58%,TFR2;HEPHL1;ATP7B;TRPC5;SLC11A2;ATP2C1;SLC31A1;SLC39A8;TRPC7;SLC39A2;SLC30A5;LTF
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.3184132056309686,-0.9116401085610626,0.5882352941176471,0.9110837474901988,1.0,8/21,30.30%,HS6ST2;NDST3;GLCE;HS3ST4;HS2ST1;EXT1;SULF2;HPSE
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.1830103026375141,0.9114655988489009,0.625,0.74278357156224,1.0,40/163,17.30%,TEAD3;PPARD;WWTR1;NR1D1;MAPK3;THRB;CDK9;KAT2B;PGR;HDAC7;TEAD2;NR1H2;TEAD1;HDAC5;RARB;TAF1C;RBPJ;THRA;NAT14;NPPA;NRBP1;RXRG;ERCC3;RXRA;GTF2H4;RXRB;MAML1;NR1D2;TBL1X;NR4A3;NR1H4;NR4A1;NOTCH4;RARG;POLR2A;NR3C1;RARA;TAF11;NR1H3;SNW1
prerank,regulation of bone mineralization (GO:0030500),-0.25190636210149586,-0.9113894134555838,0.6,0.9107442886505566,1.0,14/56,18.98%,NOTUM;CYP27B1;BMP2K;ISG15;CCL3;BMP7;FBN2;ANKH;TGFB1;FGF23;AHSG;BMP4;ADGRV1;SRGN
prerank,toll-like receptor signaling pathway (GO:0002224),0.20412899978464388,0.9110333009429615,0.6,0.743171575593352,1.0,19/90,15.20%,TLR3;BCL10;SCARA3;CTSS;TIRAP;OAS1;COLEC12;CD36;UBB;HSP90B1;TICAM2;TLR9;TAB1;LGALS9;RIPK1;TLR1;MAP3K1;SFTPD;NR1H4
prerank,regulation of viral life cycle (GO:1903900),0.24002743054521694,0.9110316589433073,0.7272727272727273,0.7425202420476962,1.0,9/25,20.93%,TSG101;TRIM6;TRIM34;TRIM21;VPS4A;CLEC4G;TRIM68;KPNA6;HS3ST5
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.26717829795301573,-0.9109694109020715,0.5,0.9108571634699348,1.0,5/35,8.23%,HSPA1A;TESC;INHBA;PRKDC;STAT1
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.31254660654848265,-0.9109292847135982,0.6296296296296297,0.9100804642512141,1.0,9/22,24.75%,MGAT5;MASTL;STYXL1;GSK3B;PPP1R1B;PPP4R4;ROCK2;BOD1L2;TNF
prerank,negative regulation of neuron death (GO:1901215),-0.23031040333598787,-0.9105960680507025,0.6179775280898876,0.9100500485487959,1.0,25/96,20.30%,FOXQ1;KIF14;POU4F1;NAIP;SIX1;FGF20;PRKCG;TOX3;SORL1;F2R;PLA2G3;HLA-F;FOXB1;CITED1;TNFRSF1B;SET;CDK5;SULT1A3;ADAM8;NTF4;ATP13A2;TRAF2;MDK;GSK3B;PM20D1
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.27169331283662423,-0.9100969362231025,0.632183908045977,0.9103851731375358,1.0,15/42,24.55%,SERPINE1;ICAM1;TNFAIP3;PMAIP1;BCL2L1;TNFRSF10B;FASLG;TRAF2;BRCA1;THBS1;GSK3B;FGA;SCRT2;FGB;RNF34
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.2662555776999981,0.9098416894663096,0.5909090909090909,0.7451030332115177,1.0,7/21,12.43%,FGF2;TGFBR3;FGFR2;BMPR1A;RBPJ;PIM1;MEF2C
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.35299794024292114,-0.9090816958483738,0.5846153846153846,0.9121996759456559,1.0,3/15,7.64%,ITGA5;FUT1;SMAD1
prerank,hepaticobiliary system development (GO:0061008),-0.3050918091902735,-0.9087878105768596,0.6142857142857143,0.9120304772177064,1.0,10/20,29.60%,PROX1;MET;CEBPA;PCSK9;NF1;NKX2-8;LSR;XBP1;WNT4;NIPBL
prerank,blood vessel endothelial cell migration (GO:0043534),0.25936940528621805,0.908710614872823,0.5714285714285714,0.7467641004039345,1.0,5/23,9.43%,FGF2;SRF;SOX18;PIK3R3;CDH5
prerank,regulation of protein tyrosine kinase activity (GO:0061097),-0.27315533873272063,-0.908683777913882,0.5795454545454546,0.9114061102250255,1.0,10/39,21.88%,THY1;LRP8;DOK7;CAV1;FCGR1A;AGT;GRM5;RAP2B;LILRB4;CASS4
prerank,cellular response to light stimulus (GO:0071482),-0.24894667568143594,-0.9082742931528949,0.6904761904761905,0.9115175573695656,1.0,25/67,33.12%,MYC;GPR52;AURKB;GRK1;GNGT1;RRH;ATR;PTPRK;TRPM1;CDC25A;NPM1;RUVBL2;OPN5;RHNO1;SAG;FMR1;GNAT1;CREBBP;SDE2;OPN3;TAF1;KDM1A;POLD1;NOC2L;MAPK13
prerank,regulation of mitotic spindle organization (GO:0060236),-0.2806292110288008,-0.9079111919294256,0.5571428571428572,0.9115053923848011,1.0,8/35,18.54%,HSPA1A;TACC3;GPSM2;TPX2;CHMP4C;PLK1;PSRC1;RAE1
prerank,RNA biosynthetic process (GO:0032774),-0.28504127794086304,-0.9072973604609129,0.5866666666666667,0.9121096116951163,1.0,14/32,38.80%,PRIM1;PRIM2;POLA1;SMN1;TTF2;TERT;TAF4;BRF2;NCOA6;SETX;HELB;TAF5;PRMT5;TBPL2
prerank,integrin-mediated signaling pathway (GO:0007229),-0.2373523572099649,-0.9062478884977541,0.6219512195121951,0.9135358150013461,1.0,12/69,12.44%,THY1;ITGA5;ZYX;RCC2;FN1;ITGBL1;ANGPTL3;ISG15;SYK;ITGA11;COL3A1;LAMA3
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.3279163527842636,-0.9060559665371495,0.5774647887323944,0.9130166359822672,1.0,10/20,33.42%,IL1B;CCL3;IRAK1;TGFB1;TNF;LYN;CD6;CCL5;LBP;PTPN22
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.24858443306436837,-0.9059670048270478,0.6626506024096386,0.9123238110656943,1.0,16/69,19.07%,FOXQ1;KIF14;POU4F1;NAIP;SIX1;FGF20;PRKCG;TOX3;F2R;PLA2G3;FOXB1;CITED1;SET;ADAM8;NTF4;MDK
prerank,negative regulation of cellular component movement (GO:0051271),0.27913920372936035,0.9059650095614877,0.6666666666666666,0.7524663894716721,1.0,3/15,5.00%,ACTN1;FBLN1;TGFBR3
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.28713709593296993,0.9054284208175533,0.5517241379310345,0.7530432865845933,1.0,5/19,14.45%,PSEN1;WFS1;ATP2A2;CAMK2D;BCL2
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.29882118465643026,-0.9053800530633969,0.5555555555555556,0.9128343909167653,1.0,11/25,32.82%,MSX2;POU4F1;ZNF675;TGFB1;POU4F2;GATA3;ANKRD33;NSD1;TWIST1;TRAF6;IGF1
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.2687118267440285,-0.9050201945281436,0.6626506024096386,0.912917856111432,1.0,14/48,24.57%,INHBA;NANOS3;UHRF1;AGT;TGFB1;GRM5;WNT7A;NFKBIA;EIF4E;NOLC1;CNDP1;PKP3;MAPKAPK5;VPS35
prerank,G2/M transition of mitotic cell cycle (GO:0000086),-0.22034359720128768,-0.9038850458200559,0.6888888888888889,0.9149490662525588,1.0,30/129,20.23%,CEP72;CDK1;SKP2;PHLDA1;CEP250;NEK2;CDC25C;CHEK2;MASTL;AJUBA;HAUS7;PKMYT1;AURKA;CDK7;FOXM1;PLK1;HAUS6;CEP76;CEP152;CEP78;CENPJ;TAF2;CEP41;SDCCAG8;CKAP5;USH1C;ALMS1;NDE1;PLK4;CDC25A
prerank,snRNA processing (GO:0016180),-0.3094663493049284,-0.9032645436187576,0.6714285714285714,0.9155393630623558,1.0,12/20,48.95%,INTS7;INTS2;INTS6;SAGE1;CT45A1;CT45A5;CT45A3;INTS12;CT45A6;CT45A7;CT45A2;INTS10
prerank,cellular response to interferon-gamma (GO:0071346),-0.23517575830118131,-0.9031046372525764,0.7282608695652174,0.9150470162068803,1.0,39/115,29.85%,TDGF1;CCL24;PML;CCL20;CD44;WNT5A;OAS2;ICAM1;GBP5;CCL22;CCL4;STAT1;CCL3;GBP7;FCGR1A;IFNG;GBP1;CCL25;HLA-F;CCL26;OAS3;CCL17;IRF8;IFNGR2;TRIM22;HLA-G;CCL1;GAPDH;IL12RB1;XCL2;XCL1;PDE12;IRF6;GBP3;GBP6;SYNCRIP;TRIM31;CCL5;GBP4
prerank,positive regulation of epithelial cell proliferation (GO:0050679),-0.2312456865549291,-0.9029452713329649,0.7078651685393258,0.9145942144415425,1.0,33/120,24.26%,CDH3;CLDN1;MYC;AREG;CCL24;WNT5A;REG3A;PROX1;SOX9;FOXE3;PAX2;EPGN;PKHD1;SEMA5A;AKT3;KDR;CCL26;MMP12;WNT7A;BMP4;NRAS;HPN;STAT5A;NOD2;VASH2;MDK;ZBED9;NME1;PIK3CD;NODAL;XBP1;GDF2;NRARP
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.21766838695431376,-0.902781554137672,0.6363636363636364,0.9140716182759339,1.0,39/146,23.14%,CCR8;JPH1;CXCR4;GPR18;KISS1;ABL2;TAC4;CAV1;TRPV4;CCR4;CXCR2;CXCR5;GHRL;CD55;DRD2;CALCR;F2R;GPR157;CXCR6;FPR2;GPR35;CCR3;GNA15;GPR174;CXCR3;TRPM1;PROK2;KNG1;CXCR1;GRM1;CCRL2;FPR3;P2RY10;CCL1;CD52;HMGB1;NMUR2;HTR2C;CHRNA9
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.17467149257983797,0.9027369103115906,0.75,0.7584915003779854,1.0,10/85,7.43%,FZD7;ROR2;FZD4;RAC1;PRICKLE2;DVL3;AP2M1;RHOA;DVL2;PSMC5
prerank,regulation of cellular metabolic process (GO:0031323),0.20128916866721425,0.9027348622087543,0.7058823529411765,0.7578302174657116,1.0,14/45,21.44%,AGPAT1;ACACB;RSPO1;PID1;PDK2;FLOT1;GNB3;PARL;RNF41;ARF1;COQ7;LAMTOR1;PINK1;CYP1B1
prerank,phospholipid metabolic process (GO:0006644),-0.25714891967189035,-0.9023672065938677,0.6666666666666666,0.914211164509337,1.0,17/65,18.21%,CYP2W1;PNPLA3;IDI2;ANGPTL3;LIPG;PLA2G4E;PLA2G2F;PLBD1;PLA2G4D;PLA2G3;ACP6;ENPP7;APOA2;ABHD12;AGPAT5;PDXP;SMPD2
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.32697421198881993,-0.9023425325152157,0.5217391304347826,0.9134013916222292,1.0,5/18,16.76%,IL1B;HCAR2;SORL1;APOA2;APOC1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),-0.21066942999174748,-0.9017848017151004,0.7551020408163265,0.9140346000882412,1.0,126/422,29.41%,CEBPB;POU5F1B;TCF7;FOXP3;ZNF695;SOX14;HMGA1;ZNF460;SOX4;PML;E2F1;SPIN2A;CHEK2;WWC1;ARNTL2;MYBL2;POU6F2;HDAC10;SIX1;CALR;CHD7;ENG;HMGA2;ZNF92;ZNF280A;AJUBA;IFNK;SOX1;ZNF730;NFKB2;ZNF486;ZNF217;RELA;ZNF138;ZNF714;ZNF114;VHL;CEBPA;NUP107;ZNF737;ELAVL2;TBX4;ZNF675;RNF6;VGLL1;BRCA2;NUP35;ZNF430;PAK6;MAFA;ZNF680;ZNF280B;ZNF648;GATA4;NKX6-2;ZNF253;PTF1A;POFUT1;NFXL1;LIN54;ZNF205;ZNF708;ONECUT1;GCM1;GTF2IRD1;ZNF195;MLXIPL;MYB;NANOG;SKOR2;TRRAP;ZNF488;NFYA;PRKCQ;SLC39A8;PSPC1;ZNF716;SPTY2D1;ZNF141;CRX;FUS;PHB;TRIM22;ACTR8;ZNF280C;KLF1;NIF3L1;FOXN2;ZNF100;ZNF492;DLX4;HES6;MYCBP;ZNF221;MYBL1;SCRT2;NOTCH1;SBNO1;SPI1;CARM1;ZNF506;ATRX;GLRX2;ZNF90;ZNF713;ZNF562;ZNF678;REST;ACTN4;SCRT1;ESRRG;SPIN2B;MSC;ZFHX3;SP3;ZNF281;KMT2D;RUNX3;AIRE;NSD1;SOX21;RHOH;HOXB7;TCFL5;CREBBP;EZH2
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.29944329006806825,-0.9015732422967162,0.5882352941176471,0.9136169704501097,1.0,4/21,6.99%,CXCL8;MRAP;RPGRIP1L;MET
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.20022133120090957,0.9007823983053889,0.7272727272727273,0.7618751026218008,1.0,13/68,12.13%,TGFB1I1;DAND5;EMILIN1;SMAD2;SPRY1;SMAD7;UBB;PEG10;IL17RD;WFIKKN2;SMAD3;PIN1;PPM1A
prerank,determination of left/right symmetry (GO:0007368),-0.26768605404720924,-0.9006359341931867,0.6233766233766234,0.9147986197116066,1.0,17/38,34.05%,TDGF1;SHH;CCDC103;DNAH11;PKD1L1;ENKUR;DNAAF1;DNAH5;KIF3B;NOTCH1;DNAI1;DNAI2;PITX2;FOXJ1;CFC1;CFC1B;MMP21
prerank,membrane lipid biosynthetic process (GO:0046467),0.21898581799231867,0.9001199720012628,0.6875,0.762739329433158,1.0,11/54,10.78%,HACD1;ELOVL4;SPTLC3;DEGS1;CERS4;VAPA;PRKD1;HACD4;PPM1L;KDSR;CERS1
prerank,cholesterol metabolic process (GO:0008203),-0.24561749596473254,-0.899785358169573,0.6666666666666666,0.9158821699915582,1.0,26/75,30.75%,SULT2B1;SQLE;CYP51A1;IDI2;CEL;ANGPTL3;NR0B2;CETP;DHCR7;APOA2;FDPS;NSDHL;APOF;G6PD;MVK;SULT2A1;CLN6;AKR1D1;TM7SF2;ACAT2;APOB;DHCR24;GBA;HMGCS1;APOA5;MSMO1
prerank,proteasomal protein catabolic process (GO:0010498),0.16860109560031003,0.8997465891221978,0.75,0.7628886101976682,1.0,63/202,23.21%,UCHL1;NR1D1;TRIM9;FBXL22;ZSWIM8;UBE2G1;SIRT2;GID4;KCTD2;RNF122;FBXO44;TRIM3;ARNTL;KCTD10;KLHL42;PSMC5;ZFAND2B;RNF185;UBXN6;SPSB1;KLHL20;HECTD3;ARMC8;UBXN1;RNF216;RNF4;KLHL22;PSMD9;FBXW5;FEM1B;PSMB6;UBE2B;TBL1X;DDIT3;UBE4B;BTRC;APPBP2;KAT5;UBE2D3;RNF41;PCBP2;USP44;DNAJB12;ZNRF1;SIRT1;SEL1L;TNFAIP1;BAG6;RNF5;DCAF11;NSFL1C;ANKRD9;FBXW11;RCN3;NFE2L2;SYVN1;PSMA6;SOCS6;GSK3A;SPOP;ARRB1;AGAP3;RMND5B
prerank,cellular response to interferon-beta (GO:0035458),-0.32404865794908183,-0.8997252203638867,0.6363636363636364,0.9151576523682978,1.0,7/18,28.18%,IFITM2;STAT1;PNPT1;IFI16;MNDA;IFNB1;AIM2
prerank,cardiac conduction system development (GO:0003161),-0.30011646521747143,-0.8988009517643426,0.5652173913043478,0.91649378213374,1.0,10/25,27.16%,MSX2;SMAD1;GATA6;GATA4;MSX1;BMP4;SHOX2;GJB6;MSC;HCN4
prerank,protein localization to centrosome (GO:0071539),-0.32794920288752405,-0.898279469914849,0.6410256410256411,0.9168209967303685,1.0,4/18,18.40%,SPAG5;SNX10;CEP83;PIBF1
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.2500330958910491,-0.8981038199698066,0.65,0.9163967338917509,1.0,16/64,19.16%,THY1;PLAU;CASK;SKAP1;CDKN2A;FUT1;EPHA1;PLET1;PKHD1;CCL25;NF1;ACER2;PIK3CB;JUP;THBS1;GSK3B
prerank,embryonic heart tube morphogenesis (GO:0003143),0.22263349704871263,0.8980319397967315,0.6111111111111112,0.7660671301581298,1.0,19/47,19.80%,HAND1;SRF;BBS5;PKD2;NPHP3;SOX18;NDRG4;SMO;MEF2C;MEGF8;SOX17;BBS7;BBS4;DLL1;CCDC40;FOXN4;MKKS;VANGL2;CCDC39
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),-0.22671812118252646,-0.8980058348846023,0.65625,0.9156999360882597,1.0,34/126,27.68%,MYC;IRS1;PDGFRB;TGFB2;EREG;IL1B;SOX4;ATAD5;EIF3C;PRKDC;DNA2;NLRC5;NAT10;HSPH1;CDT1;IFNG;PASK;NOX1;KDR;NLRP12;NOD2;FGFR4;THBS1;LARP4;NPM1;LARP4B;XBP1;EEF2;EGF;FMR1;NMD3;TMEM106A;CD28;EIF6
prerank,lymphocyte differentiation (GO:0030098),-0.2368981805272607,-0.8970862536718718,0.6222222222222222,0.9169224457738347,1.0,44/83,43.17%,IL11;SOX4;CHD7;JAK3;GPR89A;GPR89B;IFNK;RAG1;LFNG;ZAP70;RAG2;IL10;IFNE;PTPRJ;JAG2;PTPN2;PIK3CD;GATA3;AXL;LCK;LY6D;NFAM1;IFNB1;RHOH;ADGRG3;TPD52;TCF3;PTPN22;IFNA1;CR2;IFNA21;IKZF1;AICDA;PBX1;IFNA4;IL2;MSH2;IL4;IFNA7;IFNA10;IFNA14;IFNA17;IFNA2;IFNA16
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.2955621964756605,-0.8970497255769693,0.65,0.9160995849702379,1.0,13/30,30.22%,TNFAIP3;GHRL;ORM1;NLRP12;IL10;IRAK3;LILRB4;TNF;GHSR;ZC3H12A;GBA;IL37;FOXJ1
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.25398832294044904,-0.8964027971176681,0.6666666666666666,0.9168059316029985,1.0,25/61,34.49%,HSPA1A;SERPINE1;IL1B;SYK;RELA;FFAR2;NOS2;F2R;CHI3L1;APOA2;NOD2;HMGB1;GDF2;CD2;TNF;CLEC7A;TLR7;LBP;NLRP10;CD244;TLR8;CD58;NOD1;MYD88;CD74
prerank,morphogenesis of an epithelium (GO:0002009),-0.28998125207555997,-0.8962880311700456,0.5714285714285714,0.9162507296580527,1.0,15/29,34.80%,TIMELESS;SOX9;KRT16;RIPK4;LAMA3;LHX1;PRKX;KRT6A;AIRE;LIN7C;TBX18;KDM2B;KDF1;ACTG1;AHI1
prerank,embryonic digit morphogenesis (GO:0042733),0.27038367903068494,0.8960310324514094,0.5384615384615384,0.7701106039325842,1.0,5/17,11.78%,OSR1;ECE1;GLI3;INTU;OSR2
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.2791676465831387,0.8956785465753325,0.6764705882352942,0.7701345053676626,1.0,8/17,25.78%,ADRB3;ADRA2B;ADCY9;ADRB2;ADRA1A;ADRA1B;ADRB1;ADRA2A
prerank,positive regulation of ATPase activity (GO:0032781),0.2158153784886182,0.8955798362246179,0.6666666666666666,0.7697041344792017,1.0,13/42,18.93%,TPM1;ATP1B2;TOR1AIP1;GABARAPL2;DNAJB2;RGN;FGF10;MYL3;TNNT3;PFN2;CHTOP;MYL4;FXYD2
prerank,negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),0.2605051659805393,0.8955293376828458,0.68,0.7691363843267248,1.0,3/16,11.71%,MICA;CEACAM1;LGALS9
prerank,sphingolipid metabolic process (GO:0006665),0.19614938551372638,0.8953317931284679,0.8,0.7690427764756946,1.0,19/112,10.78%,HACD1;GBA2;SERINC1;ELOVL4;SPTLC3;ENPP2;DEGS1;ST6GALNAC3;ORMDL1;SMPD1;CERS4;GLTP;VAPA;PRKD1;HACD4;PPM1L;ESYT3;KDSR;CERS1
prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.3000369517969195,-0.8953271900031469,0.7317073170731707,0.91748068596628,1.0,11/23,29.46%,E2F1;PKP1;AXIN2;NOCT;PABPC1;FUS;PKP3;FMR1;NBAS;DHX34;LARP1
prerank,canonical Wnt signaling pathway (GO:0060070),-0.24780439241066854,-0.8948335605085457,0.6931818181818182,0.9178423776550163,1.0,8/67,6.82%,CDH3;WNT2;TCF7;WNT7B;LEF1;WNT5A;BCL9L;CAV1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.24130294202724842,-0.894476711422666,0.6179775280898876,0.91767296083498,1.0,26/87,25.80%,MYC;DPEP1;IFI6;LAMP3;CD44;NAIP;MAGEA3;PAX2;PMAIP1;SYK;XIAP;F2R;NLRP12;CSNK2A1;THBS1;BLID;CARD9;NLRP3;FOXL2;HMGB1;ARL6IP1;NODAL;RPS6KA3;TNF;CLEC7A;REST
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.34196517312592445,-0.8943797170928022,0.569620253164557,0.9170118066745646,1.0,3/15,17.56%,BMP2K;SMAP1;PIK3CB
prerank,regulation of translation (GO:0006417),-0.22056273433415374,-0.8942987820313172,0.71875,0.9163140983190783,1.0,49/169,29.53%,ENC1;GZMB;IGF2BP1;IGF2BP3;PUS7;SOX4;TRIM71;EIF3C;PRKDC;CALR;NANOS3;DHFR;NCL;IGF2BP2;CAPRIN1;SHMT2;GRB7;NAT10;TRAP1;NSUN3;MTIF2;PASK;GRM5;NCBP1;CNOT1;LIN28A;EIF4E;NOLC1;THBS1;LARP4;CNOT10;NPM1;PKP3;GAPDH;EIF2AK3;MRPL13;MAPKAPK5;LARP4B;EEF2;RPS6KA3;FMR1;GLE1;CD28;EIF6;OGFOD1;SYNCRIP;GSPT1;LARP1;GEMIN5
prerank,negative regulation of protein transport (GO:0051224),-0.2946126755133758,-0.8939269611439667,0.6233766233766234,0.9163984792032954,1.0,5/25,14.92%,CYP51A1;IL12B;DRD2;RHBDF2;NDFIP2
prerank,negative regulation of immune response (GO:0050777),0.18042607903046778,0.8937665170215181,0.75,0.7717858369191402,1.0,36/176,14.91%,GLP2R;LGALS3;RAMP1;POMC;ADCY5;VIP;ADCYAP1R1;TRAFD1;GNG2;SIRT2;MAPK14;PRKAR2B;ADRB3;ADCY4;VIPR2;PTH1R;PRKACA;RAMP3;MUL1;RAMP2;TRIM21;CREB1;DHX58;SPINK5;PTGER4;ADM;P2RY11;ADCY9;AVPR2;ADCY2;GPBAR1;ADRB2;GGT5;ADCYAP1;MAPKBP1;ADCY6
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.2567435064571312,0.8932757567330513,0.48,0.7722214884707858,1.0,8/29,14.45%,MOAP1;NGF;BAG3;DAB2IP;TNFRSF1A;GABARAP;DEDD;BCL2
prerank,positive regulation of histone modification (GO:0031058),0.23452856715033707,0.8931036626446467,0.7,0.7720664691395038,1.0,13/33,18.99%,MAPK3;CDK9;NOS1;AKAP8L;SAP30BP;GLYR1;FAM47E;PAF1;TADA2B;ZBTB7B;AKAP8;CHTOP;RPS6KA5
prerank,negative regulation of B cell activation (GO:0050869),-0.29992453631848326,-0.8929689188875001,0.6578947368421053,0.9176212732970653,1.0,12/22,39.49%,INHBA;TNFAIP3;CTLA4;IL10;MNDA;LYN;TYROBP;FOXJ1;CD300A;BANK1;RC3H1;SAMSN1
prerank,protein import (GO:0017038),-0.23653936850912588,-0.892861821685554,0.6931818181818182,0.9170192425136514,1.0,35/88,37.60%,NUP62CL;NUP155;CSE1L;E2F3;SYK;NUP107;NXT2;RANBP17;ACBD5;NUP50;MMP12;PEX13;NUP93;NUP88;RAN;POM121;TNPO3;HEATR3;NXT1;IPO11;LAMP2;NUP62;GDAP1;KPNB1;GCKR;NUP153;HSPA4;SEC13;PEX3;IPO7;PEX16;IPO5;NUP214;HSP90AA1;NUTF2
prerank,positive regulation of glial cell differentiation (GO:0045687),0.2678528418192021,0.8928334246370268,0.6296296296296297,0.7720492462137203,1.0,4/18,9.42%,PTN;PTPRZ1;ID2;CLCF1
prerank,negative regulation of RNA splicing (GO:0033119),0.27330139328634684,0.8921981552768631,0.6190476190476191,0.7730135577664331,1.0,4/19,14.28%,PTBP2;SRSF4;PCBP4;SRSF7
prerank,response to organonitrogen compound (GO:0010243),-0.27654194389818987,-0.8920418293418775,0.6625,0.9180444906219111,1.0,8/36,14.54%,KYNU;TRPM2;DHFR;HLCS;GLRA1;DRD2;GPRC6A;GLRA2
prerank,positive regulation of glucose import (GO:0046326),0.24972776141565817,0.89193266800139,0.5769230769230769,0.7730151626366033,1.0,4/24,7.32%,SORBS1;OCLN;PIK3R1;RHOQ
prerank,purine ribonucleotide transport (GO:0015868),0.2810544678831438,0.8915105436382801,0.5517241379310345,0.7733694988398649,1.0,5/17,13.20%,SLC25A4;SLC25A42;SLC25A41;ABCC5;LRRC8A
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.28814563881359373,-0.8913885454024466,0.6619718309859155,0.9186036239705816,1.0,7/24,15.50%,IL1B;ZBTB20;ANGPTL3;SIRT4;SCT;APOA2;MLXIPL
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.2765125757875754,-0.8912020796627996,0.6533333333333333,0.9181903723686176,1.0,14/33,31.33%,OCIAD2;PRLR;F2R;CRLF3;CENPJ;IL10;PIBF1;IL26;NOTCH1;TNF;IL10RA;F2;CCL5;IFNL1
prerank,positive regulation of histone acetylation (GO:0035066),-0.2958005238115839,-0.8908712683978297,0.5974025974025974,0.918072155329453,1.0,7/23,21.81%,FOXP3;IL1B;PAXIP1;BRCA1;LIF;RUVBL2;SMARCB1
prerank,arachidonic acid metabolic process (GO:0019369),-0.24748719265884062,-0.8903846134065061,0.6875,0.9183982496100551,1.0,20/57,27.66%,CYP2S1;CYP2F1;FAAH2;TBXAS1;CYP2A7;CYP4F3;ALOX12;CYP2B6;AWAT1;CYP2D6;ALOX12B;ALOXE3;CYP4F11;CYP4A22;CYP2A6;CYP2A13;CYP1A2;CYP2D7;CYP4F2;CYP4A11
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.33155951868072425,-0.8903791502512197,0.6805555555555556,0.9175426960215612,1.0,6/16,18.50%,CARD14;TNFSF15;IRAK1;TNFRSF10B;CHI3L1;TRAF2
prerank,lipid droplet organization (GO:0034389),0.25849305099596814,0.8900696902034432,0.6428571428571429,0.7760531870936064,1.0,6/22,12.37%,ZFYVE1;PLIN5;BSCL2;CIDEC;PLA2G4C;FITM1
prerank,mitochondrial membrane organization (GO:0007006),0.2359263094381202,0.8900070131566301,0.625,0.7754848605024259,1.0,6/28,14.45%,SLC25A4;MFN2;BNIP3;MTX3;BAD;BCL2
prerank,cellular response to chemical stress (GO:0062197),-0.22778559868034598,-0.8897279672167605,0.6263736263736264,0.9181933074393853,1.0,30/99,30.75%,LRRC8E;HSPA1A;SLC4A11;DHRS2;ERO1A;VRK2;CAV1;TRPV4;ERMP1;PNPT1;NOX1;GPX2;FANCC;LRRC8D;ATP13A2;NCF2;STOX1;CYBA;CYBB;G6PD;PRDX5;SUMO4;BRF2;VKORC1L1;GSR;ZC3H12A;SETX;PYCR1;NOX4;LONP1
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.31868299252457505,-0.8896660663004453,0.6025641025641025,0.9175141989368506,1.0,9/25,25.20%,CEMIP;RIPK2;BMP7;PLK1;TGFB1;CHI3L1;STOX1;AXIN1;EGF
prerank,cardiac muscle tissue development (GO:0048738),-0.2413130735606152,-0.8896655455694744,0.6022727272727273,0.9166556664934529,1.0,17/53,27.16%,TBX20;MSX2;SMAD1;ZFPM1;BMP7;GATA6;GATA4;RBP4;MSX1;BMP4;SHOX2;TTN;NOTCH1;NRG1;GJB6;MSC;HCN4
prerank,regulation of tumor necrosis factor production (GO:0032680),-0.23384277905240475,-0.8896275787126728,0.6938775510204082,0.9158672292537237,1.0,47/121,34.17%,IL1A;MIF;EPHB2;IL23A;WNT5A;OAS2;TNFAIP3;IL17A;PF4;ORM2;SYK;MAPKAPK2;CCL3;RASGRP1;GHRL;IL12B;ARFGEF2;ORM1;IFNG;OAS3;IL10;NOD2;CYBA;THBS1;IRAK3;PTPRJ;MMP8;CHRNA7;HMGB1;CD2;CLEC7A;GHSR;TMEM106A;PTPN11;TYROBP;LTF;ZC3H12A;TWIST1;LBP;IL37;DHX9;AGER;TRIM27;IGF1;PTPN22;CX3CR1;CD47
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.2733108971885031,-0.8890380398988826,0.6436781609195402,0.9162868489414457,1.0,10/33,25.85%,GRIN2D;GRIN2B;GLRA1;DRD2;GABRE;GSK3B;CHRNA4;GABRA1;GABRA3;GABRG3
prerank,N-glycan processing (GO:0006491),-0.3241578710855464,-0.8884771069224137,0.6571428571428571,0.9165316989100466,1.0,3/19,7.20%,MAN2A1;FUT8;ST8SIA6
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.25517607189852753,-0.8881517752895423,0.625,0.9163787916998593,1.0,18/49,32.04%,RTKN2;PMAIP1;CAV1;BCL2L1;PLAUR;MMP9;PTPMT1;P4HB;STYXL1;BBC3;EIF2AK3;LCK;SIAH1;URI1;BAX;BID;MCL1;NOC2L
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.2654328544403681,0.8879234619947863,0.6190476190476191,0.7798235344372055,1.0,3/18,7.24%,PLA2G5;PLA2G4B;PLA2G1B
prerank,lymphocyte proliferation (GO:0046651),-0.27978085389195895,-0.887565064605166,0.6049382716049383,0.9169455973296946,1.0,22/38,43.17%,IFNK;HSPD1;CD70;RASGRP1;PIK3CG;MSN;IL10;IFNE;ELF4;IFNB1;TNFRSF4;HELLS;IFNA1;CR2;IFNA21;IFNA4;IFNA7;IFNA10;IFNA14;IFNA17;IFNA2;IFNA16
prerank,cell cycle G2/M phase transition (GO:0044839),-0.2161137162869815,-0.8871943728426692,0.7078651685393258,0.9169289038016247,1.0,30/130,20.23%,CEP72;CDK1;SKP2;PHLDA1;CEP250;NEK2;CDC25C;CHEK2;MASTL;AJUBA;HAUS7;PKMYT1;AURKA;CDK7;FOXM1;PLK1;HAUS6;CEP76;CEP152;CEP78;CENPJ;TAF2;CEP41;SDCCAG8;CKAP5;USH1C;ALMS1;NDE1;PLK4;CDC25A
prerank,acylglycerol homeostasis (GO:0055090),-0.26123128864460343,-0.8861591261760872,0.6301369863013698,0.9184103023129384,1.0,10/23,34.76%,ANGPTL3;SCARB1;CETP;MLXIPL;APOC2;HNF4A;GCKR;APOA5;PLA2G12B;APOA1
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.27603810413078,-0.8854090897898209,0.6493506493506493,0.9192209986183282,1.0,6/33,12.58%,AREG;EREG;EPGN;PLAUR;AGT;MMP9
prerank,bone development (GO:0060348),0.2209849163944895,0.8852396369331728,0.631578947368421,0.7851507604520939,1.0,13/40,17.42%,BGLAP;MYOC;FGFR2;SBDS;GH1;VKORC1;OSR2;PTGER4;CYP26B1;SKI;LRRC17;FGFR3;RANBP3L
prerank,keratan sulfate metabolic process (GO:0042339),0.2212929737382208,0.8851377910826067,0.6818181818181818,0.7847126917360252,1.0,8/33,15.79%,PRELP;OGN;B4GAT1;ST3GAL3;ST3GAL6;KERA;FMOD;OMD
prerank,presynapse assembly (GO:0099054),-0.32679306630173743,-0.8849990326025959,0.726027397260274,0.9192516554558934,1.0,6/18,15.90%,WNT5A;LRP4;CEL;PCLO;PTPRD;WNT7A
prerank,negative regulation of multicellular organismal process (GO:0051241),-0.20609974872496956,-0.884668315720169,0.6914893617021277,0.9190785462449965,1.0,47/211,19.16%,TACSTD2;LOXL2;FOXP3;TIMP1;GDF15;IL1B;SHH;REG3A;KREMEN2;WWC1;SOX9;PAEP;ZNF750;LRP4;CALR;CYP51A1;FOXE3;PTPRO;ARHGDIB;RAB11FIP1;ALPK2;FOXA2;GRHL2;PROC;BRCA2;PGAM5;F2R;WDR77;IFNG;TGFB1;SFMBT1;NKX2-1;RPS19;APOA2;SLC6A4;WNT11;NLRP12;BMP4;PON1;HPN;APOM;DCANP1;IL10;PTCH1;SRGN;MDK;GSK3B
prerank,mesenchymal cell development (GO:0014031),-0.3143530299030126,-0.8845483468152869,0.6266666666666667,0.9184555518051101,1.0,8/19,33.46%,TBX20;CYP26C1;NOLC1;KBTBD8;NOTCH1;NRG1;FOXC1;TCOF1
prerank,protein autophosphorylation (GO:0046777),-0.21660592773383003,-0.884506520206582,0.7473684210526316,0.9176981658517671,1.0,44/156,25.87%,PDGFRB;MAK;SRMS;NEK2;CHEK2;VRK1;VRK2;EPHB3;MAPK15;EPHA1;AURKB;IGF1R;GRK1;MAPKAPK2;EIF2AK1;NEK6;AURKA;CDK12;STK4;IRAK1;ATR;CAD;PASK;STK24;MAP3K9;KDR;ITK;STK26;STK39;EPHB4;ATP13A2;FGFR4;TEC;GSK3B;EPHA8;PRKX;EIF2AK3;MAPKAPK5;DDR1;STK17B;MAPKAPK3;LYN;MYO3A;LMTK2
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.29976433048276213,-0.8842806100477244,0.6714285714285714,0.9173669371142881,1.0,3/24,7.27%,THY1;CAV1;GPRC5A
prerank,tetrapyrrole metabolic process (GO:0033013),-0.3006553358707617,-0.8840420875019047,0.6571428571428571,0.9170547746902514,1.0,6/20,28.05%,TCN1;MMACHC;ABCB6;PRSS3;MMAA;MMAB
prerank,JNK cascade (GO:0007254),0.21240406437750464,0.883313167305497,0.8333333333333334,0.7876091471975671,1.0,11/41,15.36%,MAP2K4;MAPK8;UBB;ARHGEF6;GPS2;MAP4K2;UBE2V1;TAB1;PTGER4;MAPK10;SH2D3C
prerank,sphingolipid catabolic process (GO:0030149),-0.3233675978974624,-0.8829307123676764,0.5974025974025974,0.9187892473931695,1.0,5/16,18.21%,ASAH2;ASAH2B;GLA;ACER2;SMPD2
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.2831410559341393,0.8823966805949025,0.6296296296296297,0.7887085746720159,1.0,3/18,6.15%,FGFR1;FGF2;CCL2
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.23140579905849332,0.8818639156717846,0.6666666666666666,0.7893390253274069,1.0,9/42,17.78%,PTEN;CLU;TRIM39;GNA12;CSNK2A2;UBE3A;FOXF2;ARAF;CDK5RAP3
prerank,positive regulation of binding (GO:0051099),-0.22741929711275982,-0.8814039913587524,0.6881720430107527,0.9211527753730099,1.0,29/88,25.86%,TRIB3;RIPK2;CAV1;MET;BAMBI;STK4;PLAUR;CDT1;MMP9;NCBP1;BMP4;PON1;TERT;HMBOX1;GSK3B;DTX3L;RAN;MMP8;NME1;HMGB1;STMN1;HIPK2;EPB41;PPARG;SUMO4;IDE;WNT3A;EGF;NMD3
prerank,regulation of B cell activation (GO:0050864),-0.2711085784797222,-0.8812460533797546,0.6753246753246753,0.9206233179320916,1.0,6/27,20.72%,IL4I1;TNFAIP3;TNFSF4;IL10;NOD2;SH3KBP1
prerank,negative regulation of developmental process (GO:0051093),-0.2315853384435691,-0.8812190513862417,0.6847826086956522,0.919849752850035,1.0,15/73,16.38%,THY1;LOXL2;MIF;SHH;SOX9;ALPK2;PRAME;FOXM1;HYAL3;WDR77;TGFB1;SFMBT1;NEUROD2;WNT11;BMP4
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.30154941331947344,-0.8811061590074835,0.6533333333333333,0.9192673884174305,1.0,5/23,14.67%,HNF1A;MED1;MED13;MED14;PAXIP1
prerank,regulation of multicellular organism growth (GO:0040014),-0.3140079718511074,-0.8808193847921814,0.6197183098591549,0.9190652865855241,1.0,10/18,32.82%,GDF15;GHRL;PPIB;STAT5A;STAT5B;PTCH1;GHSR;GHRHR;GHRH;IGF1
prerank,positive regulation of interferon-beta production (GO:0032728),-0.28070915733207635,-0.8806867693441163,0.6404494382022472,0.9185763771829623,1.0,15/34,37.07%,RIPK2;OAS2;ISG15;POLR3B;OAS3;POLR3C;POLR3G;POLR3A;PTPN11;TLR7;DHX9;IRF7;TLR8;IRF3;HSP90AA1
prerank,adenine nucleotide transport (GO:0051503),0.2772100751062168,0.8806317956003804,0.6071428571428571,0.7914851767927246,1.0,5/18,13.20%,SLC25A4;SLC25A42;SLC25A41;ABCC5;LRRC8A
prerank,regulation of interleukin-8 production (GO:0032677),-0.23296552117617642,-0.8799160509399079,0.6136363636363636,0.9194252769867719,1.0,30/81,34.49%,HSPA1A;SERPINE1;IL1B;IL17F;SYK;RELA;FFAR2;ANXA4;NOS2;F2R;CHI3L1;APOA2;IL10;NOD2;HMGB1;GDF2;ANXA1;CD2;TNF;CLEC7A;TLR7;LBP;NLRP10;CD244;TLR8;PTPN22;CD58;NOD1;MYD88;CD74
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.259095490316769,-0.879523317868993,0.6867469879518072,0.9193577660217888,1.0,18/51,33.09%,MYC;HMGA2;PMAIP1;EYA1;ERCC8;BRCC3;ATR;MSX1;BRCA1;NPAS2;SPRED1;ERCC6;FMR1;WRAP53;TIGAR;DHX9;UBE2N;EYA3
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.2312711530659325,0.8784353267600777,0.75,0.7958620358365076,1.0,9/36,14.45%,MAPT;RNF122;UBB;PID1;SOD1;SLC25A36;BAD;ARL6IP5;BCL2
prerank,regulation of Notch signaling pathway (GO:0008593),0.17993295637731593,0.8781174393875932,0.7142857142857143,0.7959024004072816,1.0,22/75,18.96%,YJEFN3;HEY1;KAT2B;EGFR;RBPJ;EGFL7;EPN2;RFNG;GATA2;ENHO;TM2D3;ZMIZ1;MAML1;METTL3;ITGB1BP1;SYNJ2BP;NOTCH4;STAT3;SNW1;DLL1;HIF1AN;LLGL1
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.305313427751148,-0.878093640615779,0.6538461538461539,0.9218191165922983,1.0,4/25,6.06%,TBX20;FOXD1;ENG;CRB2
prerank,lipid modification (GO:0030258),-0.259660974918708,-0.8773234041852812,0.625,0.9228148787105399,1.0,7/32,19.45%,PLA2G7;CYP3A7;SGPP2;ALOX12;ALOX12B;DGKK;CYP4A22
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.19805896617294963,0.8768919180420262,0.6153846153846154,0.7978241282233346,1.0,12/43,19.71%,CD34;POMC;SYT11;LGALS9;CX3CL1;ARG2;NFKBIL1;NR1H4;RARA;MC1R;GAS6;CIDEA
prerank,cobalamin metabolic process (GO:0009235),-0.29887031890460153,-0.8767333354490229,0.6571428571428571,0.9232005955910518,1.0,2/19,5.14%,TCN1;MMACHC
prerank,negative regulation of proteolysis (GO:0045861),-0.26408061626029194,-0.8761134727396506,0.7532467532467533,0.9237496700372956,1.0,18/42,30.03%,CST4;TIMP1;MAGEA3;USP17L2;CHAC1;PTPN3;CDK5;KNG1;IL10;SERPINB3;CSTB;TM4SF20;EFNA1;SERPINB4;CSTA;CST7;F2;EPPIN
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.24393682245029955,-0.8758000980170668,0.6744186046511628,0.9235935046103196,1.0,17/69,18.40%,PDGFRB;SRMS;EPHB2;ABL2;JAK3;EPHA1;IGF1R;IL21;SYK;PRLR;KDR;FYN;ZAP70;ITK;FGFR4;TEC;PIBF1
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.2687011274442575,0.8754756574871886,0.6153846153846154,0.7999363849178779,1.0,8/16,28.35%,PRPF39;PSIP1;WBP4;SRSF1;SFSWAP;SART1;SRSF12;CACTIN
prerank,lipid biosynthetic process (GO:0008610),-0.2320954476681764,-0.875395225456252,0.7125,0.9236984375503157,1.0,19/79,24.03%,CYP51A1;IDI2;ACSL6;LIPG;PDSS1;SCD;CYP19A1;PRLR;SRD5A1;ACSM6;ACSM4;ACSF3;AGPAT5;RDH8;MVK;ACSL5;ACACA;XBP1;AGPS
prerank,"phagocytosis, engulfment (GO:0006911)",0.2240147839158027,0.8749016787668736,0.6875,0.8004185396464263,1.0,5/36,7.50%,GSN;RAC1;MEGF10;CD36;GULP1
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.31842124081265494,-0.8746770829602121,0.6216216216216216,0.9245727767676475,1.0,5/15,18.12%,ENTPD7;NUDT1;NUDT15;NUDT5;ENTPD1
prerank,cation transmembrane transport (GO:0098655),-0.26237923372070215,-0.8746023351157617,0.6625,0.9238592926156796,1.0,20/44,33.74%,SLC6A20;SLC7A5;TRPM2;SLC38A5;SLC7A1;TRPM8;MFSD12;SFXN2;ASIC2;TRPM1;ATP13A2;SLC25A19;ATP1B1;KCNJ11;SLC3A2;PKD2L1;SLC6A5;ATP1B4;TRPM3;P2RX3
prerank,membrane lipid metabolic process (GO:0006643),-0.2911460445515265,-0.8745946187327344,0.6933333333333334,0.9230382366352142,1.0,7/22,28.90%,SPTLC1;ALOX12B;ALOXE3;FUT2;MGST2;AGMO;TECR
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.30617837787704394,-0.8745561045447383,0.647887323943662,0.9222972434576315,1.0,1/18,0.06%,GNL3L
prerank,regulation of cell development (GO:0060284),-0.25899272703231196,-0.8744333076462416,0.6625,0.9217447722504597,1.0,3/40,2.17%,ASCL2;SIGLEC15;IL1B
prerank,protein targeting (GO:0006605),0.1906482549524029,0.8742463263241302,1.0,0.8012481183483775,1.0,41/122,21.92%,NACAD;MFN2;MICALL1;MYO1C;AKAP6;ZDHHC7;PEX19;ZFAND2B;ZDHHC15;HAP1;TRAK2;NLGN1;ZDHHC22;ZDHHC18;PARD3;GABARAP;MGARP;GOLGA7;AIP;TOMM7;HOMER3;VPS37A;TAOK2;VPS37D;MFF;SRP14;TIMM22;TIMM44;RTP5;MAN1A1;ARL6;ZDHHC1;ZDHHC20;PITRM1;NACA;PEX6;RASSF9;AP4S1;FBXO7;ZDHHC11;SDCBP
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.2795304202291155,0.8742239677330446,0.56,0.8006071793873928,1.0,5/17,11.78%,RAI2;FGFR1;STOX2;CELF4;OSR2
prerank,cardiac ventricle development (GO:0003231),-0.29663955002145004,-0.874172629472483,0.6216216216216216,0.9214526932253679,1.0,3/20,5.17%,STRA6;MATR3;ENG
prerank,regulation of cellular pH (GO:0030641),-0.26987553942580933,-0.8741402787869015,0.6233766233766234,0.9206729849953701,1.0,7/30,21.67%,SLC9C1;SLC9A7;SLC9B1;SLC4A9;TM9SF4;SLC4A8;SLC9A4
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.29899904866897087,-0.8740370208933376,0.6164383561643836,0.9201656509535223,1.0,7/20,24.45%,IL4I1;PRKDC;PRDM1;PRELID1;ZNF683;CRTAM;CD2
prerank,eye morphogenesis (GO:0048592),0.2366100584957389,0.8738983386557316,0.6,0.800778515535065,1.0,6/19,16.53%,MFAP5;EFEMP1;TENM3;SKI;STAT3;RARG
prerank,regulation of vasoconstriction (GO:0019229),0.24146615117728149,0.873794768648543,0.7241379310344828,0.8003513339315278,1.0,10/30,18.08%,AGTR1;ECE1;AVPR1A;TBXA2R;ADM;KCNMB4;AVPR2;CHRM3;KCNMB2;ADRA1A
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.24435965038727786,0.873457104392959,0.7777777777777778,0.8004261899309703,1.0,6/25,10.46%,CALM1;CACNA1C;CTNNA3;ANK2;ATP2A2;CAMK2D
prerank,odontogenesis (GO:0042476),-0.27246798975980135,-0.8723970823074866,0.632183908045977,0.9226911631536491,1.0,11/37,23.13%,INHBA;COL1A2;AMELX;TGFB2;AXIN2;AQP5;MSX1;BMP4;HDAC2;AQP3;TUFT1
prerank,response to gamma radiation (GO:0010332),0.24950724866558668,0.8723159778836181,0.6666666666666666,0.8025044834807602,1.0,3/23,7.43%,CRYAB;TSPYL5;TMEM109
prerank,engulfment of apoptotic cell (GO:0043652),-0.32950959498698773,-0.8722798487982316,0.6883116883116883,0.9220627118027926,1.0,5/15,18.85%,XKR9;XKR5;XKR6;XKR7;THBS1
prerank,regulation of integrin activation (GO:0033623),-0.3415577814033357,-0.8722137942668037,0.6617647058823529,0.9213993732982133,1.0,3/15,2.96%,KIF14;FERMT1;SKAP1
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.2675997952201842,0.8708282621611276,0.8421052631578947,0.8050797343754958,1.0,7/18,22.74%,CIRBP;PRDX6;CELF4;SF3B4;SNW1;THRAP3;TRA2A
prerank,erythrocyte differentiation (GO:0030218),-0.24953460610283634,-0.8707797740663029,0.6756756756756757,0.9234249445443753,1.0,12/43,24.88%,INHBA;TSPO2;JAK3;ZFPM1;LYAR;DYRK3;MED1;RPS19;KLF1;PTPN2;HIPK2;LYN
prerank,cellular response to glucose starvation (GO:0042149),0.22106020459371795,0.8703535533408758,0.8235294117647058,0.8054773635732587,1.0,11/42,18.47%,ATF4;NIM1K;PRKAA2;BRSK1;KPTN;ATG14;ASNS;PRKAG2;SH3GLB1;RRP8;NUAK1
prerank,skeletal muscle contraction (GO:0003009),-0.31195057534261705,-0.8703207080492414,0.6447368421052632,0.9236426777429293,1.0,9/19,29.24%,CCDC78;TNNC2;TNNI3;JSRP1;MYH8;MYH14;STAC3;TNNI1;TNNT1
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.3120185438762938,-0.8702904195912241,0.7258064516129032,0.9228838950587354,1.0,12/19,33.42%,THY1;GBP1;PVRIG;PTPRJ;LILRB4;PTPN2;SLA2;SH2D1A;CD160;UBASH3A;EZR;PTPN22
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.28761720061987556,-0.8692159400248286,0.6666666666666666,0.9241966229912987,1.0,2/29,1.51%,GNL3L;DACH1
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.31622142707389556,-0.8691174400769668,0.6625,0.9235941303694064,1.0,4/19,13.60%,PMM2;GNPNAT1;GFPT1;PGM3
prerank,B cell activation (GO:0042113),-0.2319752281573807,-0.8688764985974446,0.7282608695652174,0.9232793940770971,1.0,41/84,43.17%,IL11;EPHB2;JAK3;IFNK;HSPD1;CD70;RASGRP1;RAG1;CHRNB2;ZAP70;RAG2;IL10;IFNE;PHB;PTPRJ;PTPN2;CD86;PIK3CD;CHRNA4;NFAM1;IFNB1;ADGRG3;LAX1;TPD52;TCF3;IFNA1;CR2;IFNA21;BANK1;AICDA;MALT1;IFNA4;MSH2;IL4;IFNA7;LAT2;IFNA10;IFNA14;IFNA17;IFNA2;IFNA16
prerank,positive regulation of gene expression (GO:0010628),-0.2000730063931179,-0.8685648568411664,0.87,0.9231203641578656,1.0,103/470,20.93%,CDH3;MYC;CXCL8;IL1A;HSPA1A;TESC;INHBA;CSF2;LAMP3;POLR2F;FGF19;EREG;IL1B;SOX4;TFR2;POU4F1;LEF1;FOXD1;MIF;EPHB2;E2F1;WNT5A;EGR1;FN1;CTSH;POLR1C;EIF3C;PRKDC;SOX9;DNMT1;MAZ;CLEC6A;PAX6;POU3F1;DNMT3B;ACTG2;PKP1;SLC26A9;NR0B2;HMGA2;TAF1A;PF4;DDX21;IL17F;IL21;SMAD1;RLN2;FGF20;CCL3;POLR1B;PIK3CG;BMP7;TAF1B;NWD1;NAT10;CALCR;RHOXF2;ITGAX;AGT;IFNG;POLR1A;TGFB1;BATF;NKX2-1;PASK;CITED1;FGF23;MED1;ADM2;FGF3;WNT11;TNFSF4;ITK;CD46;BMP4;LIN28A;MSN;CTCFL;ALOX12B;HPN;MYCN;PIK3CB;ATP13A2;IL10;SFRP4;FGFR4;STOX1;BRCA1;PHB;THBS1;GSK3B;IL36B;IL26;RHOXF2B;LARP4;CARD9;WNT3;MMP8;NPM1;TTN;PKP3;GAPDH;IFI16
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.30839340360477263,-0.8685338253822503,0.6891891891891891,0.9223773964240681,1.0,8/20,31.24%,CHAC1;PTDSS1;GSS;CHAC2;GGCT;MGST2;GCLM;PLSCR1
prerank,antigen receptor-mediated signaling pathway (GO:0050851),-0.2160346079921364,-0.8684642851756221,0.8064516129032258,0.9217072406302425,1.0,71/180,41.17%,THY1;RIPK2;CARD11;CD276;SKAP1;PSMB9;PSMD14;BTN1A1;VTCN1;SYK;RELA;INPP5D;FYN;ZAP70;ITK;BTNL10;PIK3CB;PRKCQ;CTLA4;LCP2;TEC;THEMIS;PSMA3;CD3G;PTPRJ;CD3D;SLA2;PIK3CD;GATA3;MNDA;PSMB3;LCK;PSMA5;PSMD12;PSMB11;PSMB2;NFAM1;PSMA7;IKBKG;PSME2;CD28;PSME3;ZC3H12A;PSMC1;VAV3;DENND1B;LAX1;TRAF6;PSME4;TRAT1;UBE2N;PAK2;PDE4B;PTPN22;CD3E;BTN3A2;PAK1;PSMD1;PSMC4;IKBKB;TXK;RC3H1;MALT1;GRAP2;CHUK;RC3H2;STOML2;WNK1;PSMD3;LAT2;PSMD13
prerank,regulation of protein localization to cell periphery (GO:1904375),0.2836935422508071,0.8682061085067097,0.5652173913043478,0.8098328817477309,1.0,8/20,20.63%,VTI1B;ZDHHC7;ACTB;VPS4A;STX8;INS;STX7;CLN3
prerank,monocarboxylic acid transport (GO:0015718),-0.24150277765801045,-0.8678657162727909,0.7283950617283951,0.9221272773742919,1.0,11/57,13.77%,ABCC11;SLCO1B3;SLC16A13;SLCO1B1;SLC10A1;ABCC2;SLCO1A2;AKR1C4;SLC5A6;SLC16A3;SLC22A13
prerank,mRNA metabolic process (GO:0016071),0.17546996813941468,0.8674533298661627,0.7142857142857143,0.8104946383066258,1.0,24/92,18.91%,SRSF5;PCBP3;ZFP36;LSM11;ALKBH5;SRSF4;NUDT16;PRKACA;SRSF11;PRPF18;AKAP8L;DXO;LSM10;RNASE4;METTL3;SRSF7;RNH1;SF3B4;HIPK3;CELF1;AGO4;PCBP2;SRSF1;SRSF2
prerank,regulation of neuroinflammatory response (GO:0150077),-0.3011460695771454,-0.8673254104023093,0.676923076923077,0.9223265791330147,1.0,6/19,24.75%,IL1B;MMP3;MMP9;TNFRSF1B;MMP8;TNF
prerank,positive regulation of translation (GO:0045727),-0.23169135931005924,-0.8672271273722062,0.7241379310344828,0.9216285750931996,1.0,33/96,31.27%,SOX4;EIF3C;PRKDC;EIF2S3;BOLL;NAT10;PASK;POLR2D;LIN28A;FASTKD2;JMJD4;THBS1;EIF5A;LARP4;EIF5AL1;NPM1;RMND1;UQCC2;CDC123;LARP4B;EEF2;FMR1;TRUB2;CD28;EIF6;TRMT10C;C1QBP;UHMK1;PKM;CCL5;LARP1;DHX9;YTHDF1
prerank,regulation of dendrite morphogenesis (GO:0048814),0.22341036901037553,0.8670666488178517,0.6956521739130435,0.8106756818562957,1.0,6/32,10.58%,CHRNA3;SDC2;OBSL1;ADGRB3;GORASP1;CAPRIN2
prerank,peptide biosynthetic process (GO:0043043),-0.21109505167546763,-0.8668890733415169,0.75,0.9214778183113029,1.0,59/155,43.50%,IGF2BP3;PCSK1;YARS2;RPL39;MRPL3;RRBP1;SRBD1;RHD;RPS19;RHCE;FARSB;MRPS18C;ASMT;RPS21;GGTLC2;RPL36;MRPS16;MRPL13;ZAR1L;RPL37;MRPL42;RPL8;ABCF1;MRPL9;RPL23A;MRPL37;HBS1L;GSPT1;RPS7;MRPS12;RPS18;GGTLC1;RPS2;ZAR1;COPS5;MRPS18A;MRPL52;RPL4;MRPS11;AGO2;RPS3;RPL35;RPS4X;MRPS33;RPL18;RPL32;RPL41;RPS6KB2;RPS24;RPL27A;RPS29;RPL19;RPL38;RPL37A;MRPL36;RPS14;RPL12;MRPL11;RPLP2
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),-0.2819927927902394,-0.8663202325116728,0.7012987012987013,0.9211771152678426,1.0,17/30,43.15%,BAAT;ACSL6;THEM5;ACSM6;ACSM4;ACOT6;ACOT12;ACOT13;DBI;ACOT7;ACOT4;ACSM2B;ACSM2A;ACOT8;ACOT11;GLYAT;ACLY
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),-0.2819927927902394,-0.8663202325116728,0.7012987012987013,0.9211771152678426,1.0,17/30,43.15%,BAAT;ACSL6;THEM5;ACSM6;ACSM4;ACOT6;ACOT12;ACOT13;DBI;ACOT7;ACOT4;ACSM2B;ACSM2A;ACOT8;ACOT11;GLYAT;ACLY
prerank,apoptotic mitochondrial changes (GO:0008637),-0.2722692287397382,-0.8657912840620537,0.6987951807228916,0.9213941318723918,1.0,14/33,34.06%,IFI6;HSPD1;BCL2L1;BIK;ATP2A1;BBC3;GGCT;ATG3;VPS35;BAX;TIMM50;BID;SFN;IFIT2
prerank,histone ubiquitination (GO:0016574),-0.2953533550708688,-0.8654896623077711,0.6,0.921155421891007,1.0,8/21,31.31%,UHRF1;RAG1;RNF40;DTX3L;HUWE1;CDC73;LEO1;UBE2N
prerank,regulation of cilium assembly (GO:1902017),-0.23216461419756995,-0.8654655273363616,0.6966292134831461,0.920391308703363,1.0,8/61,9.56%,MCIDAS;SAXO1;USP6NL;MAPK15;TBC1D3;DCDC2;TBC1D14;TBC1D30
prerank,lipid transport (GO:0006869),-0.21954438015019795,-0.8653046482445943,0.75,0.9198882887228734,1.0,15/106,9.31%,ABCA13;ABCC11;SLCO1B3;MFSD2B;SLCO1B1;ABCG5;SCARB1;SLC10A1;MTTP;CETP;PRELID2;ABCC2;SLCO1A2;AKR1C4;ABCA12
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.22582309844016663,0.8652283932180859,0.8518518518518519,0.8135974195794166,1.0,12/36,22.18%,TRIM39;MAP1A;CAMLG;UBXN1;CSNK2A2;RYBP;KLHL40;WAC;BAG6;SGTA;SDCBP;HFE
prerank,neuromuscular process (GO:0050905),-0.2969530545716971,-0.8650921644990649,0.620253164556962,0.9195159147038287,1.0,7/19,23.10%,STRA6;CHRND;SHANK1;DCANP1;GCH1;MYCBP2;AGTPBP1
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.2329086503149949,-0.8649370152405877,0.7241379310344828,0.91899100196754,1.0,29/93,31.31%,IL1A;IRAK2;RIPK2;IL1B;IL1RN;EGR1;PSMB9;PSMD14;RELA;IRAK1;NFKBIA;NOD2;PSMA3;IRAK3;ST18;PSMB3;TAB3;PSMA5;PSMD12;PSMB11;PSMB2;PSMA7;IKBKG;PSME2;PSME3;PSMC1;TRAF6;PSME4;UBE2N
prerank,monocarboxylic acid biosynthetic process (GO:0072330),-0.2332044354333482,-0.8649317987618587,0.7674418604651163,0.9181844405704036,1.0,16/63,24.32%,ACMSD;OSBPL3;BAAT;CYP7B1;LIPG;AKR1C4;ACSM6;CYP39A1;ACSM4;ACSF3;SDS;SRR;ACACA;XBP1;SLC27A5;AKR1D1
prerank,anterior/posterior pattern specification (GO:0009952),0.20529619586348544,0.8646486238473471,0.7058823529411765,0.8141968892202194,1.0,14/63,15.78%,HEY1;WLS;SMAD2;HOXD9;HOXA5;HOXD3;HHEX;HOXD4;HOXA4;HOXC4;HEY2;HOXB4;SKI;DDIT3
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.3032358410362339,-0.8641581560966167,0.7272727272727273,0.9190262515402484,1.0,5/17,16.96%,PAH;TH;SMOX;AANAT;ASMT
prerank,positive regulation of CREB transcription factor activity (GO:0032793),-0.3199947151179048,-0.8640442131416325,0.6285714285714286,0.9185149272078316,1.0,2/18,1.74%,LRP8;ADCY1
prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.26514025508571004,-0.8639106827827525,0.726027397260274,0.9179986396180198,1.0,5/31,6.04%,SERPINE1;CXCL10;CALR;CXCL17;PLA2G7
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.19923087721419025,0.8631346003112863,0.6521739130434783,0.8163836099270437,1.0,8/36,14.02%,CDH19;DCHS1;CDHR3;NLGN1;CDH5;PCDHB4;SELP;PCDHGC3
prerank,protein autoubiquitination (GO:0051865),-0.23509372097709252,-0.8630184890965253,0.6588235294117647,0.9191023563644145,1.0,15/61,20.33%,UBE2T;TRIM71;RNF183;UHRF1;UBE3D;ERCC8;RAD18;RAG1;RNF213;TRIM17;MDM2;TRAF2;BRCA1;DTX3L;ASB4
prerank,ephrin receptor signaling pathway (GO:0048013),-0.22722008075839803,-0.8617486072726809,0.7160493827160493,0.9208078054203468,1.0,27/82,29.72%,GRIN2B;EPHB2;EFNA3;EPHB3;EPHA1;ARHGEF28;EPHA2;MMP2;MMP9;EFNA4;FYN;EFNA2;ACTR2;EPHB4;EPHA8;ACTR3;KALRN;ROCK2;EFNA1;LYN;RASA1;EFNB1;VAV2;YES1;PTPN11;VAV3;CDK5R1
prerank,Fc receptor signaling pathway (GO:0038093),0.17924959773758556,0.8617475855088068,0.8333333333333334,0.81829898749222,1.0,20/112,14.92%,BCL10;MAPK1;MAPK3;PPP3CB;KIT;MAP2K4;CALM1;MAPK8;RAC1;SKP1;PIK3R1;PSMC5;TAB1;PSMD9;NFKB1;NFATC1;MAPK10;PSMB6;FCER1A;MAP3K1
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.28095339063797453,-0.8616889396287088,0.6835443037974683,0.92010932687687,1.0,10/28,22.56%,GPR18;DRD2;F2R;GPR157;GPR35;GNA15;GPR174;GRM1;P2RY10;HTR2C
prerank,generation of neurons (GO:0048699),-0.21137209094529696,-0.8616381290404572,0.7263157894736842,0.919417935265764,1.0,45/197,20.17%,CELSR1;WNT2;ASCL2;WNT7B;TGFB2;IRX5;IRX2;IL1B;ANOS1;SHH;WNT5A;RACGAP1;EN2;DTNB;SIX1;POU3F2;MET;RUNX1;DCDC2;SIX3;EN1;PCSK9;FZD10;WNT8B;VAX1;LHX9;LHX5;NEUROG2;PTPRD;NEUROD2;WNT11;LHX2;IRX3;WNT7A;CDK5;AUTS2;PEX13;BHLHA15;USP9X;SDCCAG8;POU4F2;GSX1;LHX1;NIF3L1;WNT3
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.27361571249709954,0.8613283148517389,0.5714285714285714,0.8185491447047235,1.0,7/17,22.70%,HDAC6;CSNK2A2;SREBF1;CAMKK2;PINK1;FBXO7;GSK3A
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.22996695983822565,0.8613029556807364,0.6666666666666666,0.8179208553247539,1.0,9/29,17.46%,TRAFD1;SIRT2;MUL1;TRIM21;DHX58;NFKBIL1;MAPKBP1;PPM1B;PCBP2
prerank,regulation of transforming growth factor beta production (GO:0071634),0.2438417372911033,0.8611972305863775,0.6538461538461539,0.8174652617220418,1.0,5/18,11.71%,CD34;LRRC32;SMAD4;SMAD3;LGALS9
prerank,regulation of sequestering of triglyceride (GO:0010889),0.26996098797955775,0.8609195103016677,0.6956521739130435,0.8173724870817084,1.0,6/15,19.71%,PLIN5;LPL;FITM1;PNPLA2;OSBPL11;CIDEA
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.27367550003744817,-0.8608471669066212,0.6582278481012658,0.9200663890126018,1.0,12/30,29.67%,SOX9;NOCT;BAMBI;SEMA4D;CITED1;FGF23;PTCH1;SMAD6;NOTCH1;PPARG;TWIST1;LRP5
prerank,diacylglycerol metabolic process (GO:0046339),-0.27800592252288575,-0.8605055878085017,0.7246376811594203,0.9200478971520599,1.0,5/23,19.23%,DGAT2;LIPE;APOA2;MOGAT1;DGKK
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.3050350841926219,0.8592079573864897,0.6875,0.8196598321226511,1.0,4/15,9.27%,HSPB1;FGF2;PRKD1;FGF1
prerank,regulation of neuron apoptotic process (GO:0043523),-0.22038812114098152,-0.8589402064759193,0.8023255813953488,0.9225210664086422,1.0,21/96,17.32%,FOXQ1;KIF14;TGFB2;POU4F1;NAIP;SIX1;FGF20;CCL3;PRKCG;TOX3;PCSK9;F2R;PLA2G3;FOXB1;CITED1;NF1;TRIM2;SET;CDK5;ADAM8;NTF4
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.3071930021095826,-0.8579150311289113,0.7272727272727273,0.9238122037517781,1.0,3/20,4.80%,CCND1;PROX1;SPDYA
prerank,steroid biosynthetic process (GO:0006694),-0.23514765134004528,-0.8569438400626023,0.6588235294117647,0.9249962175252769,1.0,29/65,39.27%,OSBPL3;BAAT;SQLE;CYP51A1;CYP7B1;CYP19A1;AKR1C4;PRLR;SRD5A1;DHCR7;CYP39A1;SC5D;RDH8;SLC27A5;AKR1D1;TM7SF2;SRD5A2;FDXR;HSD3B7;MSMO1;HSD17B10;HSD3B1;INSIG1;OSBPL2;HSD17B4;EBP;SERPINA6;ACOT8;STAR
prerank,prostaglandin metabolic process (GO:0006693),-0.275357995649822,-0.856650401107917,0.6764705882352942,0.9247697586415995,1.0,5/30,8.87%,CYP2S1;MIF;TBXAS1;CYP4F8;AKR1C4
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.18712734172673384,0.8556828421083502,0.6666666666666666,0.8257861710934737,1.0,12/73,12.78%,HIF3A;CITED2;EGLN2;SIRT2;UBB;RBPJ;PSMC5;EGLN1;ARNT;PSMD9;HIGD1A;EPAS1
prerank,aortic valve development (GO:0003176),-0.27338677058019506,-0.8547968625051284,0.7195121951219512,0.9278115410122185,1.0,12/36,24.65%,TBX20;ROBO2;SOX9;TGFB1;GATA4;TNFRSF1B;BMP4;GATA3;SMAD6;NOTCH1;ROCK2;EFNA1
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.32621684723446553,-0.8542080831621823,0.6527777777777778,0.9281988193011305,1.0,7/15,26.50%,OAS2;MX1;STAT1;CANX;IL27RA;IL27;TYK2
prerank,vesicle organization (GO:0016050),-0.2559868743771502,-0.8536079773025484,0.6753246753246753,0.9284983507033397,1.0,11/42,21.79%,USP50;SNX10;CAV1;LAPTM4B;ARFGEF2;CORO1A;PI4K2B;FNBP1L;SRGN;RAB22A;HOOK1
prerank,regulation of embryonic development (GO:0045995),-0.2656256194261739,-0.8533126799513463,0.7125,0.9282928118269638,1.0,4/34,8.01%,CDK1;RACGAP1;CRB2;FOXA2
prerank,positive regulation of response to wounding (GO:1903036),-0.2690853426821623,-0.8526917088021597,0.7058823529411765,0.9288177128416606,1.0,7/28,19.07%,CLDN1;REG3A;DUOX2;INSL3;DUOX1;ARFGEF1;MDK
prerank,actin filament-based transport (GO:0099515),-0.3001011560914861,-0.8526256218208046,0.6811594202898551,0.9281375391520537,1.0,9/21,29.80%,MYO1H;MYO6;MYO5B;FNBP1L;MYO1E;SYNE2;ACTN4;MYO19;MYO1F
prerank,modulation by symbiont of entry into host (GO:0052372),-0.29628052598339627,-0.8525719676446878,0.7051282051282052,0.9274527714737216,1.0,5/19,21.60%,CXCL8;CAV1;TRIM22;FUCA2;TRIM14
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.26764577824328606,-0.8524380688503511,0.6712328767123288,0.9269078990498992,1.0,13/34,37.24%,DKC1;DCLRE1B;SHQ1;SLX1A;TERT;GAR1;PIF1;WRAP53;NOP10;CDK2;NHP2;HSP90AA1;HSP90AB1
prerank,aortic valve morphogenesis (GO:0003180),-0.2741541372372199,-0.8522264960845585,0.6867469879518072,0.9266180361548847,1.0,11/32,24.65%,TBX20;ROBO2;SOX9;TGFB1;GATA4;BMP4;GATA3;SMAD6;NOTCH1;ROCK2;EFNA1
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.32728073291682813,-0.852103540515326,0.6575342465753424,0.9260344600179072,1.0,2/15,4.61%,USP50;GBP5
prerank,regulation of protein secretion (GO:0050708),-0.209975790225169,-0.8514651260524544,0.7362637362637363,0.9266392797916323,1.0,33/124,25.65%,IL1A;SLC12A2;TGFB2;SSTR5;IL1B;CACNA1D;MYH10;CYP51A1;SYT7;KCNG2;IL12B;DRD2;RHBDF2;NOS2;IFNG;TGFB1;SLC2A2;SLC2A1;ADAM8;ATP13A2;ADAM9;CD2AP;FGA;EXPH5;TTN;UQCC2;ITPR2;FGB;CACNA1E;MTNR1B;TNF;HNF4A;KCNJ11
prerank,ventricular septum morphogenesis (GO:0060412),-0.2640304527795176,-0.8514585177315306,0.6829268292682927,0.9258436206219389,1.0,7/28,16.38%,TGFB2;SOX4;PROX1;ROBO2;ZFPM1;TGFBR2;BMP4
prerank,positive regulation of secretion by cell (GO:1903532),-0.2273682598130631,-0.8512274764037736,0.7441860465116279,0.9254636300560278,1.0,16/71,20.58%,IL1A;SLC12A2;TGFB2;IL1B;CADPS;MYH10;TGFB1;CFTR;CADPS2;ADAM8;ATP13A2;ADAM9;CD2AP;FGA;EXPH5;TTN
prerank,sodium ion transport (GO:0006814),-0.22827746482076758,-0.8506684934686947,0.7386363636363636,0.9256649428873336,1.0,31/90,27.46%,SLC12A2;SLC4A11;SLC6A20;SLC6A14;SLC5A2;SLC5A10;SLC6A6;SLC34A3;HCN1;SLC24A1;SLC5A6;SLC6A4;ASIC2;CATSPER3;SLC4A8;SLC12A1;SCN8A;SLC8A3;ASIC5;KCNK1;SLC6A18;SLC5A8;ATP1B1;SLC12A3;SLC5A4;SLC5A5;SCN10A;SLC5A1;CATSPER4;HCN4;PKD2L1
prerank,mitochondrial translational elongation (GO:0070125),-0.22548738480507796,-0.8505335340555955,0.7209302325581395,0.9251594011277194,1.0,40/88,43.45%,MRPL19;MRPL3;GADD45GIP1;MRPS18C;MRPL17;MRPL48;MRPS16;MRPL30;GFM2;MRPS35;MRPL13;GFM1;MRPS31;MRPS23;MRPL42;MRPL9;MRPL50;MRPL53;MRPL37;MRPS30;MRPL57;MRPL14;DAP3;MRPL47;TUFM;MRPS12;MRPL4;MRPL15;MRPS18A;MRPS22;MRPL52;MRPS11;MRPL44;MRPS33;MRPS34;PTCD3;MRPL45;MRPL22;MRPL36;MRPL11
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.23497388518916332,0.8504056869214591,0.8,0.8354187632183284,1.0,4/31,6.90%,RAB6B;COPZ2;GABARAPL2;VTI1B
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.2760975394681012,-0.8502730590452111,0.76,0.9249015121221547,1.0,10/27,27.66%,SLC12A2;SLC12A8;SLC9A7;ATP6V0A4;CLCN3;SLC12A1;SLC12A5;SLC12A3;CYP4F2;CYP4A11
prerank,anterior/posterior axis specification (GO:0009948),-0.3021769930446726,-0.8501336218476655,0.6461538461538462,0.9244032433814269,1.0,2/19,2.71%,TDGF1;SHH
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.21695789101583043,-0.8500546840453139,0.8043478260869565,0.9238256320640934,1.0,37/130,30.89%,CDH3;COL1A1;LGR5;PTK7;SOX4;RUVBL1;PSMB9;PSMD14;LGR6;CAV1;AXIN2;BAMBI;XIAP;SEMA5A;TGFB1;SCEL;SFRP4;JUP;PSMA3;PSMB3;AXIN1;NRARP;PSMA5;WNT3A;PSMD12;PSMB11;PSMB2;EGF;PSMA7;PSME2;PSME3;PSMC1;USP34;AMER1;CSNK1G3;LYPD6;PSME4
prerank,cellular response to interleukin-6 (GO:0071354),-0.26408966242669873,-0.8496862918057271,0.6619718309859155,0.9237641853414724,1.0,5/28,9.90%,TDGF1;SOCS3;STAT1;RELA;CEBPA
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.2877373495943652,-0.8496065176963101,0.7083333333333334,0.9231309351969391,1.0,5/18,19.11%,TGFB2;SKAP1;SYK;ADAM9;LIF
prerank,protein acetylation (GO:0006473),0.21996790342604444,0.848888358426149,0.7391304347826086,0.8377043434512829,1.0,4/30,4.52%,ING4;MAPT;KAT2B;BLOC1S1
prerank,organelle disassembly (GO:1903008),-0.27042670217586534,-0.8481996852255228,0.7375,0.925150147275798,1.0,6/32,13.13%,CDK1;VRK1;KIF9;MCTS1;DYRK3;MTIF2
prerank,Golgi to endosome transport (GO:0006895),0.2816644047932524,0.8475330822680449,0.7037037037037037,0.8393978521169192,1.0,7/15,25.07%,CORO7;KLHL20;GBF1;AP2A1;RAB14;SYS1;SORT1
prerank,gene expression (GO:0010467),-0.19721899008256658,-0.8474984090105685,0.8571428571428571,0.9257499854391875,1.0,129/350,38.53%,TESC;IGF2BP3;POLR2F;DUOXA2;DKC1;E2F1;ZC3H11A;U2AF1;NUP155;THOC3;NUP37;NUP210;HSPD1;CPSF3;YARS2;NUFIP1;MAGOHB;PRSS37;TAF1B;NUP107;SORL1;RPL39;MRPL3;PAX8;NUP35;RRBP1;SRBD1;RANBP2;RPS19;SEH1L;NCBP1;NUP50;NKX2-8;NUP205;FARSB;POLR2D;MRPS18C;ALYREF;EIF4E;FASTKD2;ASMT;APOBEC1;SRSF9;RPS21;PRPF4;NUP93;RAE1;NUP88;RPL36;POLR2J;NXF2;NXF3;MRPS16;POLR3A;POM121;NUP43;TASP1;MRPL13;POLR2I;CPSF2;MAGOH;RNGTT;PTMA;ZAR1L;XRN2;RPL37;DDX39A;TSPAN33;NUP160;NXT1;MRPL42;RPL8;GLE1;ABCF1;BICD1;MRPL9;RPL23A;MRPL37;DHX8;DROSHA;NUP62;HBS1L;SYNCRIP;GSPT1;SETX;SMG1;RPS7;ANGPT2;NUP153;NDC1;CPSF4;NUP98;THOC2;MRPS12;SLBP;NOX4;SEC13;AGFG1;SNRNP40;SCX;DDX54;DUSP11;RPS18;SMG7;RPS2;THOC6;EIF4A3;HNRNPF;ZAR1;COPS5;MRPS18A;MRPL52;DNAJB11;RPL4;NUP214;STUB1;MRPS11;MRPL44;RBM8A;TFIP11;HNRNPU;CDC40;AGO2;RPS3;RPL35;RPS4X;MRPS33;RPL18;RPL32
prerank,activation of phospholipase C activity (GO:0007202),0.21732693112620613,0.8473498653560055,0.7272727272727273,0.8390408071069432,1.0,6/32,13.59%,LPAR1;ARHGAP6;EGFR;P2RY12;AVPR1A;GNAQ
prerank,translational termination (GO:0006415),-0.2209649036246445,-0.8471923253434979,0.7558139534883721,0.9254988487332078,1.0,51/95,49.00%,MRPL19;ABCE1;MRPL3;GADD45GIP1;MRPS18C;MRPL17;MRPL48;MRPS16;MRPL30;GFM2;MRPS35;MRPL13;MRPS31;MRPS23;MRPL42;MRPL9;MRPL50;MRPL53;MRPL37;MRPS30;MRPL57;MRPL14;DAP3;GSPT1;MRPL47;MRPS12;MRPL4;APEH;MRPL15;MRPS18A;MRPS22;MRPL52;MRPS11;MRPL44;MRPS33;MRPS34;PTCD3;MRPL45;MRPL22;MRPL36;MRPL11;MTRF1L;MRPL28;MTRF1;MRPS2;TRMT112;MRPS18B;MRPL39;MRPL1;MRPS10;MRPL16
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.2918884400989371,-0.845961355602809,0.6986301369863014,0.9270605466804963,1.0,2/20,0.70%,TMPRSS3;SLC12A2
prerank,regulation of neuron migration (GO:2001222),-0.28206410111991137,-0.8450456449965642,0.6708860759493671,0.92802732976901,1.0,9/27,29.74%,KIF20B;ADGRG1;COL3A1;SHTN1;ULK4;MDK;PLAA;NIPBL;PHACTR1
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.3391417311632715,-0.843756647473412,0.7027027027027027,0.9299255377959674,1.0,4/15,20.82%,PMAIP1;ATR;MSX1;SPRED1
prerank,detection of mechanical stimulus (GO:0050982),-0.29641489578609176,-0.8436206214393092,0.717948717948718,0.929376071439855,1.0,4/19,7.82%,PKD1L3;LHFPL5;PKD2L2;PKD1L1
prerank,response to hydrogen peroxide (GO:0042542),-0.23969183911413472,-0.8427321171033436,0.6951219512195121,0.9302020585577271,1.0,15/49,24.01%,TNFAIP3;TRPM2;PAX2;RELA;ECT2;HBA1;STK24;FYN;STK26;ADAM9;HP;APTX;FXN;ANXA1;GLRX2
prerank,negative regulation of leukocyte activation (GO:0002695),0.28075042938300965,0.8418597561706289,0.7428571428571429,0.8492555296313969,1.0,15/15,71.94%,GPER1;LRFN5;NR1H3;FCGR2B;BPI;CD200;IL31RA;HAVCR2;GRN;IL4;MILR1;CD300A;CD84;ZC3H12A;CD300LF
prerank,regulation of neuroblast proliferation (GO:1902692),0.2738959546838511,0.8410964604965752,0.7083333333333334,0.8499509154737716,1.0,2/15,4.15%,PTN;SMARCD3
prerank,early endosome to late endosome transport (GO:0045022),0.2435362640106288,0.8410338279247771,0.75,0.8493779552050925,1.0,5/20,17.56%,WDR91;AKTIP;RILP;STX8;PTPN23
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.2776929360650854,-0.8407238529667217,0.6944444444444444,0.9333306433420523,1.0,9/25,33.20%,CCNK;BTBD18;CDK12;HMGN1;ALYREF;ERCC6;CDC73;LEO1;CDK13
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.2788532072507167,-0.8400159928678216,0.7,0.9338342993881608,1.0,6/23,15.50%,PFKFB3;ZBTB20;GAPDHS;PFKFB4;IFNG;MLXIPL
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.25031926267187454,0.8397558666744731,0.8076923076923077,0.8512815346377287,1.0,5/21,14.42%,SASH1;CD36;PRKCA;CX3CL1;NFKBIL1
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),-0.2148109204692233,-0.8397003002924138,0.7640449438202247,0.9336685998746119,1.0,14/97,12.65%,CEBPB;CXCR4;DIO2;LCN2;SCD;CAV1;IGF1R;SYK;GHRL;TRPM8;PRLR;OXTR;UCP1;TSHR
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.27161056836523484,-0.838255947259114,0.7631578947368421,0.9354333598496906,1.0,5/29,10.78%,MYC;INHBA;CCL3;ZFPM1;ZNF675
prerank,regulation of organelle assembly (GO:1902115),-0.22321150368107365,-0.8375615589902801,0.7802197802197802,0.9359169581420597,1.0,17/73,20.44%,MCIDAS;USP6NL;MAPK15;TBC1D3;KIF9;CEP295NL;DCDC2;TBC1D14;CEP76;CEP295;TBC1D2;MSN;CENPJ;SDCCAG8;ALMS1;ATG3;NPM1
prerank,regulation of secretion (GO:0051046),-0.3067928045950571,-0.8365867436702689,0.6266666666666667,0.9369704468011661,1.0,3/15,9.53%,OAS2;KCNQ1;MYO6
prerank,cytoplasmic translation (GO:0002181),-0.21922191935940308,-0.8365308745130051,0.7717391304347826,0.9362662804933597,1.0,52/93,53.34%,RPL22L1;RPL39;RPS19;RPS21;RPL36;ZC3H15;FTSJ1;RPL26L1;RPL37;RPL8;RPL23A;GSPT1;RPS7;RPS18;RPS2;EIF3M;RPL4;TMA7;RPS3;RPL35;RPS4X;RPL18;RPL32;RPL41;RPS24;RPL27A;RPS29;RPL19;RPL38;RPL37A;RPS14;RPL12;DRG1;RPL30;EIF3I;RPL28;RPLP0;RPL31;RPS28;RPS3A;RPS15;UBA52;RPL18A;RPS11;RPS5;RPL5;RPS6;RPS9;RPL7A;RPL11;RPL29;RPL35A
prerank,translational elongation (GO:0006414),-0.21847567439290705,-0.8363064567530133,0.7558139534883721,0.9359243411719766,1.0,46/101,43.45%,EEF1G;MRPL19;MRPL3;GADD45GIP1;MRPS18C;MRPL17;MRPL48;MRPS16;MRPL30;GFM2;MRPS35;MRPL13;EEF2;GFM1;MRPS31;MRPS23;MRPL42;MRPL9;MRPL50;MRPL53;MRPL37;MRPS30;MRPL57;MRPL14;DAP3;MRPL47;TUFM;MRPS12;MRPL4;MRPL15;NEMF;EEF1D;MRPS18A;MRPS22;MRPL52;MRPS11;MRPL44;MRPS33;MRPS34;PTCD3;LTN1;MRPL45;MRPL22;EEF1B2;MRPL36;MRPL11
prerank,regulation of platelet aggregation (GO:0090330),0.27364686103004715,0.8362430996171861,0.7741935483870968,0.85790245314207,1.0,7/18,16.61%,PRKCD;CEACAM1;PRKG1;C1QTNF1;PRKCA;CELA2A;DMTN
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.2714851289579903,-0.8361777292328829,0.6933333333333334,0.9345608093609189,1.0,4/21,20.46%,ERCC5;RPA3;GTF2H2;GTF2H3
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.2714851289579903,-0.8361777292328829,0.6933333333333334,0.9345608093609189,1.0,4/21,20.46%,ERCC5;RPA3;GTF2H2;GTF2H3
prerank,ERBB signaling pathway (GO:0038127),-0.23345212772052187,-0.8360697833386028,0.7558139534883721,0.9339848765726786,1.0,9/64,13.23%,TDGF1;AREG;EREG;FAM83A;SOX9;EPGN;GRB7;TGFB1;REPS2
prerank,RNA metabolic process (GO:0016070),0.19092754218563288,0.8358575138299028,1.0,0.8579657890323663,1.0,24/131,13.49%,RBPMS;ADARB1;PABPN1;NOVA1;DDX24;HNRNPH3;DDX39B;PCBP3;SIDT2;RBM4;RBMS1;RBM6;DDX17;RBFOX2;RNASEH2C;CELF2;HNRNPH2;ALKBH1;ADARB2;RBM5;RNASE4;SKIV2L;RNASE1;METTL3
prerank,positive regulation of mRNA processing (GO:0050685),0.22924146044802435,0.8355670431133189,0.85,0.8578782142484112,1.0,6/23,17.30%,CIRBP;PRDX6;CELF4;PAF1;SF3B4;SNW1
prerank,cellular response to pH (GO:0071467),0.2608268460695376,0.8354781483596713,0.7142857142857143,0.8573575755727814,1.0,6/18,19.12%,MCOLN1;TRPV1;RAB11B;SLC9A1;RAB11FIP5;KCNK4
prerank,peptidyl-threonine modification (GO:0018210),-0.22594655172854422,-0.833505855661329,0.8235294117647058,0.9379636086006803,1.0,18/67,24.18%,CHEK1;CDK1;PRKDC;CSNK2A3;SBK1;DYRK3;CAD;GALNT3;TGFBR2;CDK5;CSNK2A1;STK39;GSK3B;TTBK1;HIPK2;CIT;GALNTL6;ROCK2
prerank,positive regulation of oxidoreductase activity (GO:0051353),-0.30310884936946647,-0.8329797121178186,0.7246376811594203,0.938065427317826,1.0,7/19,26.65%,ABL2;PDP1;AGT;NOD2;FXN;TNF;PDP2
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.22874400570345685,-0.8325113450185875,0.8,0.9381782977459645,1.0,19/65,28.88%,CHEK1;PSMB9;PSMD14;AURKB;CHMP4C;AURKA;RFPL1;PSMA3;PSMB3;NABP1;PSMA5;PSMD12;PSMB11;PSMB2;GPR132;PSMA7;PSME2;PSME3;PSMC1
prerank,response to ketone (GO:1901654),-0.2764106689977042,-0.831709329639737,0.7638888888888888,0.9388965898197802,1.0,13/28,31.34%,TGFB2;CAV1;CATSPERB;CATSPER1;TGFB1;CATSPER3;THBS1;ABHD2;CATSPER2;CATSPER4;CATSPERG;ABCB4;HSD3B1
prerank,mitochondrial translational termination (GO:0070126),-0.21937310178633077,-0.8308453569391533,0.7586206896551724,0.9397537338666013,1.0,47/88,49.00%,MRPL19;MRPL3;GADD45GIP1;MRPS18C;MRPL17;MRPL48;MRPS16;MRPL30;GFM2;MRPS35;MRPL13;MRPS31;MRPS23;MRPL42;MRPL9;MRPL50;MRPL53;MRPL37;MRPS30;MRPL57;MRPL14;DAP3;MRPL47;MRPS12;MRPL4;MRPL15;MRPS18A;MRPS22;MRPL52;MRPS11;MRPL44;MRPS33;MRPS34;PTCD3;MRPL45;MRPL22;MRPL36;MRPL11;MTRF1L;MRPL28;MTRF1;MRPS2;MRPS18B;MRPL39;MRPL1;MRPS10;MRPL16
prerank,cholesterol transport (GO:0030301),-0.2323700885187202,-0.8307682124185874,0.7402597402597403,0.9391259477200188,1.0,13/50,20.85%,TSPO2;CEL;ABCG5;SCARB1;LIPG;CAV1;CETP;APOA2;ABCG8;APOC1;APOM;LDLR;APOC2
prerank,cellular macromolecule catabolic process (GO:0044265),-0.23652508965885843,-0.8305065910079219,0.7532467532467533,0.938834821608799,1.0,17/50,27.49%,CHEK2;SND1;RNASEH1;STT3B;PNPT1;RNASEH2A;NCBP1;RNASEH2B;MAGEA2;IDE;XRN2;MANBA;EXOSC7;DNASE1;MAGEC2;DNASE1L1;NGLY1
prerank,regulation of mRNA catabolic process (GO:0061013),-0.21937585608414614,-0.8296706347480333,0.8,0.9395389528667722,1.0,39/122,31.27%,HSPA1A;IGF2BP1;IGF2BP3;PSMB9;PKP1;PSMD14;IGF2BP2;MAPKAPK2;PABPC1;EXOSC3;PNPT1;EXOSC8;DIS3;CNOT1;SET;EXOSC5;EXOSC4;PSMA3;ANP32A;PKP3;CARHSP1;PSMB3;PSMA5;PSMD12;PSMB11;PSMB2;EXOSC7;FMR1;KHSRP;PSMA7;PSME2;PSME3;ZC3H12A;PSMC1;XPO1;EXOSC2;XRN1;PSME4;YTHDF1
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.2614439101040782,0.8292654812206953,0.7586206896551724,0.867828446075323,1.0,4/15,16.41%,SORBS1;EPM2AIP1;PPP1R3E;INS
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.23126719995745762,-0.8292023367287106,0.7974683544303798,0.9395662490588514,1.0,17/61,22.34%,GPR18;ADGRG1;RTN4R;RASGRP1;PIK3CG;COL3A1;F2R;GPR35;GPR174;AUTS2;PIK3CB;LRRC59;RASGRF1;P2RY10;SYNPO2L;NOTCH1;LRRD1
prerank,retinoic acid metabolic process (GO:0042573),-0.2721030669670545,-0.8288799669895708,0.7123287671232876,0.9392922258222899,1.0,4/26,11.80%,CYP2W1;CYP2S1;CYP3A7;CYP26C1
prerank,positive regulation of transport (GO:0051050),-0.21704548942289642,-0.8283767153673938,0.7555555555555555,0.9396039800546221,1.0,36/91,36.04%,CDH3;IL1B;TFR2;IL15RA;CALR;SPAG5;SPACA3;TULP1;LYAR;IFNG;FPR2;ZNF205;APOA2;AHSG;PON1;CYBA;GSK3B;SIRPB1;PLAA;LMAN2;ANXA1;TNF;CLEC7A;FMR1;MLC1;BAX;IL2RB;BID;ACSL3;KMT2A;DOCK2;CD47;APOA1;DYNC1H1;GPLD1;SIRPG
prerank,organic cation transport (GO:0015695),0.23075083184461548,0.8283426551006392,0.72,0.8685791340328062,1.0,5/20,16.69%,SLC5A7;SLC25A42;SLC44A2;RALBP1;SLC47A1
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.23759705331364428,0.8281450429685672,0.7586206896551724,0.8682012697426932,1.0,10/32,19.58%,LCAT;CHKB;CSNK2B;SLC27A1;SLC44A2;CSNK2A2;LPIN1;PCYT1A;ABHD3;LPIN3
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.25814945842348463,-0.8276969824705493,0.7058823529411765,0.9402716721024619,1.0,7/32,15.50%,PFKFB3;ZBTB20;GAPDHS;PFKFB4;BEND3;IFNG;MLXIPL
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.20154414542040722,-0.8271476732408486,0.7938144329896907,0.9404485159050405,1.0,35/177,21.49%,CDH3;MYC;CXCL8;IRS1;PDGFRB;EREG;DUOXA2;IL1B;SOX4;ATAD5;EGR1;EIF3C;PRKDC;DNA2;SCARB1;DUOXA1;NAT10;CDT1;IFNG;ASS1;PASK;ZNF205;MLXIPL;DDAH1;FGFR4;THBS1;LARP4;LDLR;AGXT2;MMP8;NPM1;APOC2;PTPN2;ASIP;LPGAT1
prerank,acidic amino acid transport (GO:0015800),-0.3002348215567804,-0.8269580249064381,0.7246376811594203,0.9400412236948019,1.0,5/18,25.77%,LRRC8E;SLC6A6;LRRC8D;SLC25A13;SLC25A22
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.23744123697385427,-0.8268371864014951,0.8024691358024691,0.9394346110061744,1.0,6/57,5.17%,BMP8A;INHBA;TGFB2;GDF15;GDF9;ENG
prerank,protein modification process (GO:0036211),-0.21698505517412797,-0.8264981154864041,0.7640449438202247,0.9391953849454504,1.0,8/77,11.15%,LOXL2;ERO1A;PRKDC;ABL2;RPN2;UBE2S;RPN1;PARP4
prerank,positive regulation of nervous system process (GO:0031646),0.24220916505031886,0.8258297057338619,0.6923076923076923,0.8717476055665623,1.0,4/17,11.17%,NLGN2;CARTPT;RNF10;PARD3
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.2249704554981345,-0.82544880475037,0.75,0.940298782511511,1.0,17/60,25.87%,CHEK1;CDK1;PRKDC;CSNK2A3;SBK1;DYRK3;CAD;TGFBR2;CDK5;CSNK2A1;STK39;GSK3B;TTBK1;HIPK2;CIT;ROCK2;LMTK2
prerank,nucleosome organization (GO:0034728),-0.23121878262862713,-0.825318269281226,0.775,0.9397599800468149,1.0,23/56,37.47%,CHAF1B;HMGA1;CHAF1A;SOX9;SMARCA4;LIN54;SET;SPTY2D1;SMARCC1;NPM1;SMARCB1;NFE2;ATRX;ARID2;PRDM9;GRWD1;BPTF;ANP32B;BRDT;ARID1A;PADI4;ANP32E;HMGB2
prerank,histone lysine methylation (GO:0034968),-0.25623950020381153,-0.8248913812365716,0.6976744186046512,0.9397038062753453,1.0,14/34,32.11%,SUV39H2;SMYD3;SUV39H1;SETD6;PAXIP1;SMYD2;RBBP5;WDR5B;PRDM9;DYDC2;KMT2D;EZH2;KMT2A;KDM6A
prerank,protein deubiquitination (GO:0016579),-0.19463549617380874,-0.8235668523669165,0.8556701030927835,0.9415066293647741,1.0,72/257,30.94%,MYC;OTUB2;CDK1;SKP2;USP50;RUVBL1;TNFAIP3;PSMB9;USP37;POLB;PSMD14;KDM1B;SHMT2;SMAD1;TNIP3;BRCC3;USP18;USP17L7;USP17L2;USP26;RNF128;NFKBIA;ACTL6A;MDM2;CFTR;TRRAP;USP9X;UCHL5;VCPIP1;OTULIN;BARD1;TRAF2;BRCA1;PSMA3;ACTR8;CLSPN;ASXL2;NLRP3;STAMBPL1;CDC25A;CDC20;USP17L1;GATA3;PSMB3;USP17L8;USP17L11;USP17L4;USP17L3;PSMA5;PSMD12;PSMB11;PSMB2;USP32;PSMA7;USP17L15;USP10;USP38;IKBKG;PSME2;STAM;SPATA2;ADRM1;PSME3;ZC3H12A;PSMC1;USP42;USP1;USP34;TRAF6;USP31;PSME4;OTUD6B
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.2378835249807806,0.823518822236539,0.7586206896551724,0.8751755579157894,1.0,5/18,18.70%,DDX17;CELF4;RBM17;SCNM1;SRSF1
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.2564816105119453,0.8232760529398273,0.7647058823529411,0.8749056544965885,1.0,2/17,2.61%,KCNH2;ATP1A2
prerank,telomere maintenance via telomerase (GO:0007004),-0.25730095625676497,-0.8232120272813112,0.6891891891891891,0.9413993387118657,1.0,11/28,37.24%,DKC1;SHQ1;TERT;GAR1;PIF1;WRAP53;NOP10;CDK2;NHP2;HSP90AA1;HSP90AB1
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.21352688020820765,-0.8230599209549113,0.8255813953488372,0.9408945565584553,1.0,62/112,53.34%,HELZ2;MAGOHB;RPL39;PABPC1;RPS19;NCBP1;RPS21;RPL36;MAGOH;RPL37;RPL8;RPL23A;DHX34;GSPT1;SMG1;RPS7;RPS18;SMG7;RPS2;EIF4A3;RPL4;RBM8A;RPS3;RPL35;RPS4X;RPL18;RPL32;RPL41;RPS24;SMG6;RPL27A;RPS29;RPL19;RPL38;EIF3E;RPL37A;PPP2R2A;RPS14;RPL12;RPLP2;RPL30;NCBP2;RPL28;RPLP0;RPL31;UPF3B;RPS28;RPS3A;RPS15;UBA52;RPL18A;RPS11;RPS5;RPL5;RPS6;SMG9;RPS9;RPL7A;EIF4G1;RPL11;RPL29;RPL35A
prerank,cellular protein catabolic process (GO:0044257),-0.23367332218650783,-0.822238795008061,0.7875,0.9416819682809867,1.0,6/58,4.52%,FAP;GZMB;CHEK2;CTSH;CTSV;ADAMTS12
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.1718956094833831,0.8220457107699166,0.9,0.8764152426680498,1.0,14/85,12.78%,HIF3A;ATF4;EGLN2;MAPK7;BAG3;HMOX1;UBB;PSMC5;EGLN1;ARNT;KLF2;PSMD9;HIGD1A;EPAS1
prerank,regulation of cellular component biogenesis (GO:0044087),0.20979987859043248,0.8219096016810628,0.8260869565217391,0.8759015158336837,1.0,6/39,8.81%,RAP1A;VPS11;TIE1;CD36;DAB2IP;RDX
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.22095544525922037,-0.8217326074476268,0.7926829268292683,0.9418670414204933,1.0,11/62,16.86%,DDIAS;HSPA1A;MAGEA3;RTKN2;BCL2L1;HYOU1;PLAUR;MMP9;VNN1;ARMC10;MDM2
prerank,bile acid metabolic process (GO:0008206),0.19473616363569327,0.8214889981395659,0.8,0.8757251616029228,1.0,9/33,14.62%,OSBPL1A;GBA2;ACOX2;AKR1C1;OSBPL7;CYP46A1;CYP27A1;SLC27A2;OSBPL9
prerank,response to tumor necrosis factor (GO:0034612),-0.21649131132349225,-0.8213922354003065,0.8295454545454546,0.9416992046918737,1.0,28/104,24.61%,CXCL8;TDGF1;UBD;CCL24;CCL20;ADAMTS12;DCSTAMP;CCL22;CCL4;CCL3;RELA;HYAL3;GBP1;CCL25;CHI3L1;CXCL16;CCL26;CCL17;ADAM10;ADAM9;BRCA1;BAG4;CCL1;GATA3;GCH1;XCL2;XCL1;OCSTAMP
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.22337940819003058,-0.8213255724746722,0.8095238095238095,0.9410362145820709,1.0,16/59,24.88%,OSM;CSF2;SOCS3;IL23A;IL23R;ARL2BP;IL21;IL12B;IFNG;TNFSF18;PIBF1;LIF;IL20;PARP14;TNF;LYN
prerank,mitochondrial transport (GO:0006839),0.19328455223577048,0.8207850159824633,0.9411764705882353,0.8761468811770948,1.0,12/53,17.71%,SLC25A4;MFN2;BNIP3;OXA1L;MGARP;BAD;AIP;TOMM7;BCL2;MFF;TIMM22;TIMM44
prerank,regulation of response to biotic stimulus (GO:0002831),-0.257009409079796,-0.8206351304237719,0.7272727272727273,0.9415458766128372,1.0,7/29,26.99%,LRP8;XIAP;CD55;GATA6;ERAP1;TKFC;SAMHD1
prerank,regulation of phosphorylation (GO:0042325),-0.20991105008811703,-0.8205631530838116,0.8021978021978022,0.9408511422381532,1.0,48/122,33.71%,INHBA;EREG;PML;MIF;FN1;NUP155;SOCS1;CDKN2A;NUP37;NUP210;NLRC5;MCM7;BMP7;NUP107;NUP35;RANBP2;GRM5;SEH1L;NUP50;NUP205;BMP4;BARD1;NUP93;RAE1;THBS1;NUP88;POM121;CCDC88C;NUP43;SRPX2;LYN;DSCAM;EGF;NUP160;GLMN;EIF6;NUP62;CCL5;GCKR;NUP153;NDC1;NUP98;SEC13;NRP1;PTK2;ANG;STAT2;JMJD8
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.2921264194304075,-0.8205263653455676,0.75,0.9401575619072812,1.0,4/21,8.43%,HSPA1A;HSPD1;PSMG1;THEG
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.25043112546427376,-0.8205260385270688,0.7738095238095238,0.9393773481629597,1.0,15/42,29.16%,GBP5;IL17A;ADCY7;NOS2;PLD4;NOD2;LILRB4;CARD9;CHID1;MEFV;TNF;CLEC7A;CD6;ZC3H12A;F2
prerank,positive regulation of interferon-alpha production (GO:0032727),-0.2972428515051645,-0.8204817547252726,0.7848101265822784,0.9386971040739785,1.0,3/20,8.23%,RIPK2;HSPD1;STAT1
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.2551168920636098,-0.819197908546062,0.6933333333333334,0.9401925329389376,1.0,11/29,37.24%,DKC1;SHQ1;TERT;GAR1;PIF1;WRAP53;NOP10;CDK2;NHP2;HSP90AA1;HSP90AB1
prerank,response to endoplasmic reticulum stress (GO:0034976),-0.21324662969803046,-0.8190070195380835,0.7613636363636364,0.9397644941662006,1.0,21/104,19.34%,CXCL8;CEBPB;TRIB3;ERO1A;RNF183;TMEM33;PDIA4;ERP27;HYOU1;TNFRSF10B;CHAC1;P4HB;PDIA3;CFTR;TRAF2;MBTPS2;THBS1;RASGRF1;ATP2A1;GSK3B;BBC3
prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.259170615350481,-0.8180381441265269,0.7763157894736842,0.9409394000498991,1.0,7/30,14.46%,GPR18;ADGRG1;RTN4R;COL3A1;F2R;GPR35;GPR174
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.280853378873077,-0.8180094760267864,0.7222222222222222,0.9401945473713044,1.0,13/22,39.49%,IL4I1;TNFAIP3;JAK3;VTCN1;LST1;PIBF1;TIGIT;LAX1;FOXJ1;PTPN22;FGL1;BANK1;SAMSN1
prerank,negative regulation of signaling receptor activity (GO:2000272),0.2237757879128996,0.8179774254120523,0.8214285714285714,0.8801703461270792,1.0,7/26,16.36%,CNRIP1;TSG101;RAMP3;ZGPAT;SLC6A9;CBLB;ERRFI1
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.2615548066238428,-0.8170505308814002,0.7625,0.9413071048599726,1.0,8/28,25.23%,DUOX2;PRDX4;HBA1;NOX1;DUOX1;CYBA;PRDX5;HBQ1
prerank,positive regulation of telomere capping (GO:1904355),-0.2893307073988776,-0.816923443474022,0.75,0.9408031912623882,1.0,3/17,6.28%,NEK2;MAPK15;AURKB
prerank,negative regulation of lipid metabolic process (GO:0045833),0.24087684488304895,0.8166822188571368,0.7407407407407407,0.8818746015046963,1.0,5/24,7.94%,APOD;GPER1;PDE3B;CEACAM1;BSCL2
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.21674917099083038,-0.8164764143038943,0.8809523809523809,0.9407361366479334,1.0,20/71,30.58%,SERPINE1;PRB3;IL23A;IL23R;DEFA6;IL12B;NOS2;RNASE7;RPS19;ROMO1;DEFA5;DEFB4A;DEFA1;RNASE8;DROSHA;LTF;F2;LBP;S100A7;NLRP10
prerank,necroptotic process (GO:0070266),0.24915241925548937,0.8162777526363445,0.6451612903225806,0.8820107342238159,1.0,3/16,13.24%,TLR3;TICAM2;RIPK1
prerank,cation transport (GO:0006812),-0.20256642748156084,-0.8148962621508118,0.8877551020408163,0.9427222824837435,1.0,51/172,27.47%,SLC12A2;SLC4A11;SLC6A20;SLC6A14;SLC5A2;SLC5A10;PKD1L3;KCNJ13;TRPM2;SLC6A6;SLC38A5;KCNG2;SLC34A3;SLC7A1;KCNJ15;SLC5A6;TRPM8;LRP2;RHBG;KCNN4;SLC7A6;SLC11A2;KCNS1;KCNH4;NDFIP2;CNGB3;CATSPER3;TRPM1;SLC22A1;SLC18A2;SLC36A3;SCN8A;SLC8A3;KCNK1;KCNA3;SLC5A8;ATP1B1;SLC12A3;KCNJ3;KCNJ6;SLC5A4;SLC5A5;KCNK16;KCNS2;SLC5A1;SLC3A2;CATSPER4;KCNJ4;HCN4;PKD2L1;SLC22A4
prerank,non-motile cilium assembly (GO:1905515),-0.26626095780475745,-0.8139157513660201,0.7558139534883721,0.9436821795359139,1.0,6/29,18.40%,CEP250;ARL13A;RPGRIP1L;TMEM107;TBC1D32;PIBF1
prerank,ceramide biosynthetic process (GO:0046513),-0.24648530266213764,-0.8133264832097982,0.7692307692307693,0.9439010787287229,1.0,12/41,22.41%,CERS6;SPTLC1;ST8SIA6;PNPLA1;ASAH2;ALOX12B;SPTLC2;ALOXE3;SMPD2;B4GALT6;SPTSSB;DEGS2
prerank,regulation of monooxygenase activity (GO:0032768),-0.2737178834789057,-0.8131977800189869,0.7894736842105263,0.9432993201165681,1.0,5/24,16.95%,IL1A;IL1B;CAV1;LYPLA1;DDAH1
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.22913991219067859,0.8131412636172763,0.8181818181818182,0.8866712373361216,1.0,11/27,23.42%,NME4;AK1;AK5;NME3;CTPS1;NME2;AK4;DUT;AK6;TXNRD1;RRM1
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.2904500150371166,-0.8129617246153621,0.7142857142857143,0.9428776728684956,1.0,7/18,28.85%,TGFB1;BMP4;LIN28A;TERT;MYCN;TNF;ZC3H12A
prerank,response to light stimulus (GO:0009416),0.19530282497507986,0.8118787459778523,0.9333333333333333,0.887863690034122,1.0,15/59,15.85%,CIRBP;CRY2;MAPK8;GPR88;FECH;CPT1B;ELANE;BRSK1;USF1;OPN4;ERCC3;CRY1;MAPK10;UBE2B;UBE4B
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.2108293591827259,0.811145195805724,0.7692307692307693,0.8883292128539261,1.0,4/23,6.96%,EPHA4;PKD1;UBB;PRKACA
prerank,"wound healing, spreading of cells (GO:0044319)",-0.2816849453205992,-0.8109962337174096,0.7,0.9455047382396718,1.0,5/21,15.90%,ITGA5;CD44;PLET1;MMP12;WNT7A
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.180266980412403,0.8109776670921682,0.8,0.88782811854849,1.0,12/45,19.71%,CD34;POMC;SYT11;LGALS9;CX3CL1;ARG2;NFKBIL1;NR1H4;RARA;MC1R;GAS6;CIDEA
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.2596680030627476,-0.8106596030830739,0.7926829268292683,0.9453420902932202,1.0,9/37,18.99%,CHEK1;E2F1;TFDP1;RBBP8;CDC7;CBX3;RNF2;BRCA1;HLA-G
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.25821949578926684,-0.8102843823546058,0.7051282051282052,0.9452067819686782,1.0,6/26,23.84%,CCND1;MTBP;TFDP1;CDC6;ANKRD17;ANXA1
prerank,dendritic spine organization (GO:0097061),-0.2581704960564317,-0.8101311845318537,0.7162162162162162,0.9446821599855785,1.0,8/27,23.86%,EPHB2;EPHB3;IGF1R;FYN;SHANK1;WNT7A;CHRNA7;DOCK10
prerank,potassium ion import across plasma membrane (GO:1990573),-0.24060569344749166,-0.8098319330779641,0.8271604938271605,0.9444449025961252,1.0,16/42,27.61%,SLC12A2;SLC12A8;KCNJ13;KCNJ15;KCNJ14;ATP12A;SLC12A1;SLC12A5;ATP1B1;SLC12A3;KCNJ3;KCNJ6;KCNJ11;KCNJ4;HCN4;KCNJ18
prerank,regulation of protein transport (GO:0051223),0.20807001624254273,0.8097224855139693,0.7272727272727273,0.8893322202441658,1.0,9/28,18.96%,DISP1;SNX3;PPM1F;HSPA8;RHBDF1;INS;STXBP5L;NDEL1;LLGL1
prerank,protein ADP-ribosylation (GO:0006471),0.21881632312415114,0.8093814424155338,0.84375,0.8891463727976986,1.0,4/28,8.35%,PARP6;PARP16;SIRT2;PARP3
prerank,positive regulation of cell growth (GO:0030307),0.1568338669677122,0.8090755823381381,1.0,0.8886828941071568,1.0,13/96,11.98%,NTN1;MAPT;L1CAM;NGF;DBN1;AKAP6;LGI1;EGFR;SYT4;SFRP1;SYT1;KLHL22;USP47
prerank,protein localization to lysosome (GO:0061462),-0.25427916913450577,-0.8090575828444676,0.7746478873239436,0.945077653401077,1.0,5/28,17.60%,CD81;SH3BP4;SORL1;RNF128;ATP13A2
prerank,positive regulation of cellular component movement (GO:0051272),-0.2732355342276954,-0.8085029946000148,0.7105263157894737,0.9454287292026154,1.0,11/26,34.96%,DUOXA2;DUOX2;C1QTNF8;RPS19;DUOX1;LYN;ACTN4;TWIST1;ETS1;TGFBR1;CFAP20
prerank,regulation of protein metabolic process (GO:0051246),0.19769109724373185,0.8083997495744127,0.8333333333333334,0.8889977498663911,1.0,8/46,10.93%,LTBP4;MAPK8;MAPK7;FAM83D;NEDD8;WFS1;APP;KLF2
prerank,protein targeting to mitochondrion (GO:0006626),-0.23502972153928225,-0.8083677607265469,0.8461538461538461,0.9448786750484225,1.0,23/53,39.20%,TIMM8A;TOMM20L;TOMM34;HSPD1;MIPEP;ROMO1;IMMP2L;GRPEL2;TIMM23;TOMM40;TIMM13;DNAJC15;TIMM10;GDAP1;IMMP1L;HSPA4;TIMM50;AIFM1;BCAP31;HSP90AA1;GRPEL1;AGK;TIMM17B
prerank,cognition (GO:0050890),-0.22645636975745131,-0.8080639854596955,0.8117647058823529,0.9446097019748162,1.0,13/45,26.26%,STRA6;SHROOM4;CHD7;SLC1A4;MAGT1;CHRNB2;GRM5;NF1;HRH3;CHRNA7;CHRNA4;TNF;TMPRSS11E
prerank,protein localization to Golgi apparatus (GO:0034067),0.21088606348152567,0.8069591400007208,0.72,0.8904035246574656,1.0,7/27,19.23%,OPTN;OBSL1;ZDHHC15;GOLPH3;GBF1;IFT20;RAB33B
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.23051341910857895,-0.8064524200753745,0.7654320987654321,0.9464300719182697,1.0,28/53,42.62%,DCPS;LSM7;EXOSC3;EXOSC8;DIS3;CNOT1;EXOSC5;EXOSC4;POLR2D;LSM5;CNOT10;LSM4;PDE12;EXOSC7;CNOT11;HBS1L;EXOSC2;PATL1;CNOT6;PAN3;EXOSC1;DCP2;RC3H1;PATL2;RC3H2;LSM6;LSM1;DDX6
prerank,endothelial cell proliferation (GO:0001935),-0.2915967347208821,-0.8062848056601173,0.7647058823529411,0.9459020632691328,1.0,9/18,33.01%,LOXL2;SEMA5A;BMP4;PROK2;PRKX;NRARP;TEK;NOX5;DLG1
prerank,positive regulation of developmental growth (GO:0048639),0.18355899391576536,0.805520181614185,0.9047619047619048,0.892121244021833,1.0,8/52,10.95%,NTN1;MAPT;L1CAM;NGF;DBN1;GH1;SYT4;SYT1
prerank,limb morphogenesis (GO:0035108),0.22572989225485648,0.8053757508601685,0.8,0.8915829816010182,1.0,8/22,14.90%,MYH3;MBNL1;GLI3;FBXW4;HOXA11;MEGF8;CYP26B1;SKI
prerank,mRNA processing (GO:0006397),0.14582199292448353,0.8048232330879574,1.0,0.8916730227767589,1.0,69/292,19.59%,SRSF5;PABPN1;NOVA1;SNRNP70;DHX35;CPSF7;HNRNPH3;DDX39B;RBM4;U2AF1L4;SNRPN;CASC3;ISY1;RBM6;ALKBH5;SRSF4;POLDIP3;PRKACA;SRSF11;RPRD1A;SF1;PRPF18;THOC5;AKAP8L;CMTR1;HNRNPH2;SRRM2;RNPC3;SF3B1;CWC25;RBM5;ERCC3;DDX42;GTF2H4;SYF2;PDCD7;METTL3;SRRM1;PNN;SRSF7;IK;DHX16;SF3B4;HSPA8;RBM17;PLRG1;DNAJC8;WBP4;CD2BP2;NOVA2;POLR2A;SNW1;CELF1;ZMAT2;PCBP2;SARNP;CHTOP;MFAP1;SNIP1;ZRSR2;SRSF1;RAVER1;RNMT;SRSF2;RBM4B;PRPF4B;ZMAT5;SUPT5H;XAB2
prerank,canonical glycolysis (GO:0061621),0.22620024473966036,0.8046121530838836,0.75,0.8905261372644105,1.0,4/23,8.71%,ENO2;ALDOA;HK2;PFKM
prerank,glucose catabolic process to pyruvate (GO:0061718),0.22620024473966036,0.8046121530838836,0.75,0.8905261372644105,1.0,4/23,8.71%,ENO2;ALDOA;HK2;PFKM
prerank,phosphate-containing compound metabolic process (GO:0006796),-0.19402917262596203,-0.8044655544650078,0.8723404255319149,0.9481161741550325,1.0,50/196,23.51%,DUSP4;PFKFB3;CYP2W1;XYLB;EPHB2;DUSP18;MIOX;ANGPTL3;GK;PSPH;PLCH1;ALPP;PLCB4;HKDC1;IPPK;PLA2G4E;PFKFB4;ALDOB;PLA2G2F;GFPT1;PRKCG;NUDT4;PIK3CG;PLBD1;INPP5D;PLA2G4D;TOP1;DUSP16;PLA2G3;TGFB1;ACP6;PTPRD;PLD4;NUDT14;GPD2;CDK5;PIK3CB;PDXP;NUDT5;PANK2;PFKFB1;G6PD;IPMK;THTPA;PIK3CD;PPA1;PLA2G2E;PLAA;FBP2;DUSP15
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.19855602822395807,0.8042079269715179,0.782608695652174,0.8905247681109437,1.0,10/27,22.11%,MORF4L1;KAT2B;KAT2A;BRD8;KAT8;KAT5;EP300;BAG6;MSL3;KAT7
prerank,chromatin organization (GO:0006325),-0.20002101953391463,-0.8039418870691665,0.9042553191489362,0.9482160203106051,1.0,28/138,21.99%,MYC;LOXL2;FOXP3;SUV39H2;PADI1;PADI3;RUVBL1;HDAC10;SOX9;HMGA2;SOX1;SMARCA4;NPM3;TOP1;SUV39H1;HMGN1;CBX3;MYB;BAZ1A;ACTL6A;NUDT5;SMARCC1;VCX;NPM1;RUVBL2;HDAC2;SMARCB1;KDM5A
prerank,response to acidic pH (GO:0010447),0.25216946160410253,0.8035482382418705,0.6944444444444444,0.8907809214124713,1.0,6/15,18.99%,CTSS;TRPV1;RAB11B;GPR4;SLC9A1;RAB11FIP5
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.22476412075657573,0.8035196065708318,0.896551724137931,0.8900993086398381,1.0,7/22,21.40%,UBB;ERCC3;GTF2H4;XPA;CETN2;DDB2;GTF2H5
prerank,glycolytic process (GO:0006096),-0.24737876971389228,-0.8033195942635096,0.7777777777777778,0.948433762887044,1.0,11/28,30.73%,HKDC1;GAPDHS;ALDOB;ENO4;PKLR;PFKFB1;GAPDH;LDHA;PKM;PGAM4;TPI1
prerank,oligosaccharide metabolic process (GO:0009311),-0.22543593802110445,-0.8031804694593069,0.7875,0.9478897562769605,1.0,19/49,34.59%,FUT8;FUT1;AMY1A;ST8SIA6;AMY1C;FUT7;NEU1;GLA;FUT2;MANBA;FUT6;ST8SIA5;AMY1B;MAN1B1;FUT5;B4GALT1;B3GALT2;ST3GAL2;ST8SIA4
prerank,positive regulation of receptor internalization (GO:0002092),-0.2751379639185026,-0.8031094708156375,0.8157894736842105,0.9472876977801755,1.0,7/23,25.71%,APLN;APELA;PCSK9;SFRP4;WNT3A;EGF;FMR1
prerank,insulin secretion (GO:0030073),0.24840390245672317,0.8029501902782422,0.8214285714285714,0.8903921212775586,1.0,8/18,18.99%,CAMK2G;PTPRN;RAB11B;ADCYAP1;SNX19;RAB11FIP2;SLC30A8;RAB11FIP5
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.282348492149466,-0.8027866891266748,0.8072289156626506,0.9471095218419677,1.0,9/25,28.85%,CYP27B1;CYP24A1;RBP2;LRP2;TTPA;RPE65;CYP4F2;VKORC1L1;GC
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.2887384052901421,-0.8021776735448348,0.7681159420289855,0.9474023399839789,1.0,14/23,41.67%,RELA;BMP7;NLRP12;NLRP3;NMI;SPI1;TSPAN6;ZC3H12A;ADGRG3;CPNE1;IFI35;PYDC2;TMSB4X;ADIPOR1
prerank,positive regulation of lipid storage (GO:0010884),-0.26599455142002176,-0.8014238629776901,0.6973684210526315,0.9478176106102479,1.0,3/21,6.20%,C3;IKBKE;SCARB1
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.16841227843514964,0.801366707640997,1.0,0.8921524521991897,1.0,20/111,15.10%,BCL10;MAPK1;MAPK3;PPP3CB;MAP2K4;CALM1;MAPK8;RAC1;SKP1;PIK3R1;PSMC5;TAB1;PSMD9;NFKB1;NFATC1;MAPK10;PSMB6;FCER1A;MAP3K1;NR4A3
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.23599396593755892,0.8013147690869845,0.92,0.8914530459960316,1.0,5/19,16.04%,SLC25A23;SMDT1;MICU3;PARL;MICU1
prerank,cellular protein metabolic process (GO:0044267),-0.1834423501197508,-0.8010575443064509,0.9494949494949495,0.9476768204155188,1.0,104/406,30.46%,NOTUM;LOXL2;TIMP1;SERPIND1;AMELX;EVA1A;IGF2BP3;F5;SPP1;MMP1;ERO1A;FN1;CHEK2;CTSH;MSLN;PRKDC;SERPINA10;C3;ABL2;RPN2;HM13;TMEM132A;MMP2;UBE2S;SLC34A1;LGALS1;PDIA6;YARS2;VGF;AFP;IGFBP1;RPL39;MRPL3;RPN1;PROC;PCSK9;PARP4;DMP1;RRBP1;SRBD1;VCAN;PLG;GATA6;IGFBP3;P4HB;FGF23;RPS19;APOA2;CSF2RA;ADAM10;FARSB;MRPS18C;AHSG;BMP4;ASMT;ALB;RPS21;KNG1;ITIH2;ADORA2B;RPL36;FUCA2;FGA;MAGEA2;L2HGDH;ATG3;MRPS16;C4A;RCN1;FBXO11;DNAJC3;MRPL13;PGA4;IDE;AMBN;ZAR1L;IGFBP2;RPL37;MANBA;SLC34A2;MRPL42;RPL8;ABCF1;MRPL9;MAGEC2;RPL23A;MRPL37;SERPINC1;YES1;MATN3;B4GALT7;FDXR;HBS1L;GSPT1;F2;RPS7;IGFALS;CKAP4;APOB;TMEM208;APOA5;MRPS12;CSNK1G3;ENAM
prerank,leukotriene metabolic process (GO:0006691),-0.2628242256784864,-0.800868250149253,0.8028169014084507,0.9472374427283371,1.0,4/23,13.15%,DPEP1;MAPKAPK2;CYP4F3;ALOX12
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.2840800965333048,-0.8006324375959546,0.7647058823529411,0.9469214022304171,1.0,5/19,24.76%,HS6ST2;NDST3;GLCE;HS2ST1;EXT1
prerank,positive regulation of cell junction assembly (GO:1901890),-0.22782204283970509,-0.8004299657149925,0.8108108108108109,0.9465046508764559,1.0,21/57,29.08%,THY1;EPHB2;EPHB3;EPHA2;CAV1;GHRL;AGT;CNTNAP2;PTPRD;KDR;IRX3;WNT7A;SYNDIG1;PTPRJ;HRG;SRPX2;BDNF;TBX5;ACE2;CRB3;TEK
prerank,organic substance transport (GO:0071702),-0.20200555625030556,-0.8002921188229181,0.8636363636363636,0.9459767857514645,1.0,28/133,21.91%,TCN1;SLC22A11;ABCA13;ABCC11;SLCO1B3;MFSD2B;SLCO1B1;ABCG5;CETP;ARRDC5;SLCO1A2;ABCA12;AQP9;MFSD12;LRP2;TAP1;ABCB6;CENPF;SLC6A4;ABCG8;SLC19A1;SLC22A1;SLC18A2;CD3G;SLC22A25;HRG;SPNS2;SLC22A9
prerank,protein kinase B signaling (GO:0043491),-0.265262684133562,-0.8002106981845282,0.7564102564102564,0.9453487126432928,1.0,6/24,14.04%,IL1B;PAX2;EPHA2;CCL3;TGFB1;KDR
prerank,T cell mediated immunity (GO:0002456),-0.3096334002263602,-0.7988921597023143,0.7391304347826086,0.9467890018353704,1.0,8/16,35.89%,CTSH;CD70;CD55;CD46;CRTAM;AIRE;BTN3A2;MYO1G
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.1526625198641478,0.7983190100556762,1.0,0.8951516533090176,1.0,42/312,10.63%,UCHL1;TRIM9;FBXL22;FBXO9;DNAJC18;ZSWIM8;FBXO17;UBE2G1;SKP1;SIRT2;GID4;KCTD2;FBXL7;RNF122;FBXO44;TRIM3;FBXL5;ARNTL;KCTD10;FBXO31;UBE2E1;KLHL42;USP19;UBB;HSP90B1;DNAJB2;PSMC5;TMUB2;ZFAND2B;RNF185;ANAPC16;FAM8A1;WFS1;FBXO27;SPSB1;KLHL20;HECTD3;ARMC8;UBE2G2;FBXW4;UBXN1;RNF216
prerank,response to estrogen (GO:0043627),-0.2510603384606397,-0.7982645447311887,0.813953488372093,0.9469206527982459,1.0,13/34,27.29%,CYP27B1;CAV1;TRIM24;GHRL;CITED1;RBBP5;BRCA1;GATA3;SFR1;OCSTAMP;SLC34A2;GHRHR;KMT2D
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.19511955196327843,0.7973206297747027,0.8947368421052632,0.8960069424099214,1.0,9/37,14.45%,TRIM39;FAS;DAB2IP;TRAF1;DEPTOR;CSNK2A2;NKX3-1;CX3CL1;BCL2
prerank,chromatin remodeling (GO:0006338),-0.20180564992218103,-0.7971578586039736,0.8791208791208791,0.9479169705076951,1.0,26/103,25.30%,MYC;FOXP3;SUV39H2;RUVBL1;SOX9;HMGA2;SMARCA4;NPM3;TOP1;CBX3;MYB;BAZ1A;ACTL6A;NUDT5;SMARCC1;ACTR8;NPM1;RUVBL2;HDAC2;SMARCB1;KDM5A;ARID1B;ATRX;CHD4;JARID2;ERCC6
prerank,cellular glucuronidation (GO:0052695),-0.2719661924006558,-0.7971100319109083,0.726027397260274,0.9472204334967836,1.0,13/19,48.33%,UGT2B4;UGT2B28;UGT2B7;UGT1A6;UGT2A1;UGT1A7;UGT1A4;UGT2B11;UGT2A2;UGT1A3;UGT1A5;ABHD10;UGT1A9
prerank,phagosome acidification (GO:0090383),0.19900709242357392,0.7962063446579998,0.7272727272727273,0.8971352231215018,1.0,8/28,19.78%,ATP6V1G2;ATP6V1E1;TCIRG1;ATP6V0E2;ATP6V1D;ATP6V1H;ATP6V0A1;ATP6V0D1
prerank,aminoglycan biosynthetic process (GO:0006023),0.18165618607103864,0.7955214387999053,0.875,0.8975489186793567,1.0,18/49,21.60%,SDC2;SDC3;B4GAT1;GCNT2;GPC1;NDST2;NDST1;GPC4;GPC3;HSPG2;UGDH;B3GAT3;B3GALT1;GPC6;B3GNT9;HS3ST6;HS3ST5;HS6ST1
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.24214645405555535,-0.795419184309019,0.8024691358024691,0.949020133907058,1.0,6/35,13.98%,MYC;DUSP1;AMBP;ZNF675;FOXM1;KLHL31
prerank,peroxisome organization (GO:0007031),0.21110305775870458,0.7937002199687744,0.7727272727272727,0.8999524713296095,1.0,11/24,25.71%,PEX19;PEX11A;MFF;SEC16B;ABCD4;PEX11B;PEX6;ABCD1;PEX12;PEX14;FIS1
prerank,regulation of protein localization to nucleus (GO:1900180),-0.22966987650815507,-0.7935519532162594,0.8051948051948052,0.9513145185362313,1.0,12/46,19.46%,CDK1;GTSE1;SHH;BYSL;PLK1;TGFB1;BMP4;ATP13A2;LIF;GSK3B;DTX3L;LILRB4
prerank,heart looping (GO:0001947),-0.23801149784462775,-0.7934515169617304,0.8192771084337349,0.9507015595148175,1.0,9/43,16.40%,TBX20;FOLR1;SHH;CCDC103;ENG;GATA4;TGFBR2;DNAAF1;TBR1
prerank,regulation of T cell migration (GO:2000404),0.2504112130286231,0.7932089090377675,0.7307692307692307,0.8999070730674764,1.0,5/19,13.05%,APOD;CCL21;RHOA;APP;TNFRSF14
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.23513377598118934,0.7931005420272644,0.7619047619047619,0.8993147744423947,1.0,7/19,17.09%,PLIN5;NR1H2;SLC27A1;CTDNEP1;PNPLA2;SREBF1;NR1H3
prerank,regulation of myeloid cell differentiation (GO:0045637),0.18502870810750877,0.7927085181897046,0.875,0.8992153049319725,1.0,18/64,19.84%,MYL9;LGALS3;MEIS1;MEIS2;KAT2B;FES;HOXA5;KMT2C;MEF2C;PRKCB;PAF1;NR4A3;SIN3A;SETD1A;AGO4;ZBTB16;HOXA9;EP300
prerank,pore complex assembly (GO:0046931),-0.2802018456620321,-0.7925387340906616,0.7605633802816901,0.9515006202706561,1.0,8/18,30.05%,NUP107;ADAM10;NUP205;NUP93;TSPAN33;NUP153;NDC1;NUP98
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.20486342968609517,0.7922435260046461,0.8,0.8994618571714068,1.0,8/44,14.34%,CLU;CD63;CCL21;B2M;GH1;ANGPT1;NTF3;ANXA2
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.2256711486302357,0.792189025223791,0.75,0.8988713319795028,1.0,5/22,9.92%,ACADVL;WDTC1;GPER1;CEACAM1;SLC27A1
prerank,cellular response to ionizing radiation (GO:0071479),-0.22687305651826867,-0.7921760513817966,0.8,0.9512686929774492,1.0,11/47,20.93%,BLM;RAD51AP1;INTS7;FIGNL1;RAD9B;ECT2;ATR;WRN;MDM2;HUS1;IFI16
prerank,autonomic nervous system development (GO:0048483),-0.28379085209631144,-0.7915995839662167,0.7464788732394366,0.9515858771046171,1.0,5/20,21.79%,SOX4;FN1;NF1;ARX;GATA3
prerank,sympathetic nervous system development (GO:0048485),0.21810506654309308,0.7915567987105098,0.8387096774193549,0.8990450681916474,1.0,4/16,14.31%,NRP2;SEMA3A;NTRK1;GDNF
prerank,positive regulation of B cell proliferation (GO:0030890),-0.24216785040251543,-0.7908908909762776,0.7948717948717948,0.9520449034144187,1.0,5/30,12.32%,MIF;EPHB2;CD81;IL21;CHRNB2
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.1923307667823696,0.7906276196031837,0.8571428571428571,0.8995272440340935,1.0,12/40,17.30%,KAT2B;RBPJ;EPN2;ENHO;TM2D3;ZMIZ1;MAML1;ITGB1BP1;NOTCH4;STAT3;SNW1;DLL1
prerank,sterol transport (GO:0015918),-0.26756319960147984,-0.7902708173682841,0.7088607594936709,0.9521871212444398,1.0,6/21,19.65%,ABCG5;CAV1;CETP;APOA2;ABCG8;LDLR
prerank,cellular response to BMP stimulus (GO:0071773),-0.2178621744593322,-0.7888820483620181,0.7840909090909091,0.9536871614464459,1.0,9/69,10.10%,BMP8A;TGFB2;GDF15;SOX9;ADAMTS12;GDF9;ENG;SMAD1;BMP7
prerank,regulation of primary metabolic process (GO:0080090),-0.20797338532731763,-0.788838783626133,0.8351648351648352,0.9529968348219006,1.0,43/126,30.89%,PSMB9;SQLE;CYP51A1;PSMD14;SCD;HELZ2;TGS1;SERPINA3;OAZ3;ODC1;DHCR7;NQO1;MED1;SC5D;FDPS;NFYA;FGFR4;PSMA3;AZIN1;LDLR;FASN;MVK;PSMB3;ACACA;CARM1;PPARG;ROCK2;PSMA5;PSMD12;PSAPL1;PSMB11;NCOA6;PSMB2;TM7SF2;HNF4A;PSMA7;CERS2;PSME2;PSME3;PSMC1;CREBBP;HMGCS1;PSME4
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.26408020709283364,-0.7884041260589959,0.7901234567901234,0.9529908059693564,1.0,5/22,14.67%,HNF1A;MED1;MED13;MED14;PAXIP1
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.23565724243500505,0.7881888518046696,0.72,0.9021498016964488,1.0,6/15,17.09%,PLIN5;NR1H2;SLC27A1;CTDNEP1;SREBF1;NR1H3
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.24276889720730946,-0.7872029834905232,0.8243243243243243,0.9542608313226919,1.0,14/34,32.82%,IRS1;IGF1R;PIK3CG;NF1;PIK3CB;PIK3CD;GATA3;MYO16;CD160;PIK3C2B;TPTE2;C1QBP;TPTE;IGF1
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.23994390066332144,0.787020280894029,0.7714285714285715,0.9031001438064565,1.0,5/18,19.59%,PPARD;NR1H2;NR4A3;NR1H3;ELOVL5
prerank,microtubule nucleation (GO:0007020),0.22511466976202435,0.7864042855147358,0.72,0.9033424320138469,1.0,12/20,26.60%,TUBG2;TUBGCP6;SLAIN2;GOLGA2;NDEL1;TUBGCP2;RANBP9;TUBGCP5;TPPP;CSNK1D;CLASP1;CLASP2
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.19763372857494693,-0.7862348066208172,0.8469387755102041,0.9551090771759896,1.0,53/131,38.70%,PRKDC;SRPK1;BOP1;BRIX1;TGS1;SMN1;SNRPD1;EIF2S3;NAF1;SNRPF;SNRPG;MCTS1;WDR77;NLE1;RPS19;NCBP1;EIF2S2;SHQ1;RRS1;POLR2D;CLNS1A;SRSF9;PWP2;PRPF6;CRNKL1;RPF2;MDN1;LSM4;SNRPB;DENR;RPL23A;EIF6;PRPF19;RRP7A;SETX;GEMIN5;XRCC5;CDC73;SNRPE;DHX9;SNRPD3;SRPK2;CELF5;SNRPD2;NUDT21;HSP90AA1;MRPS11;EIF3A;HSP90AB1;PRMT5;TARBP2;SCAF11;GCFC2
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.2311781854765123,0.7858515886228351,0.8275862068965517,0.9033128038578382,1.0,4/20,10.51%,GPIHBP1;NR1H2;ANGPTL4;LPL
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.2164701930907341,0.7855275946754667,0.8,0.902867204906447,1.0,4/24,8.71%,ENO2;ALDOA;HK2;PFKM
prerank,transcription by RNA polymerase II (GO:0006366),-0.1852787585974591,-0.7855149582313111,0.9042553191489362,0.9555680042726685,1.0,90/312,31.15%,NFE2L3;NOTCH3;POLR2F;ETV7;INTS7;CCNK;CSTF2;HDAC10;MAZ;FOXE3;NR0B2;TAF1A;CBFB;HSF2BP;DDX21;NOCT;E2F3;TRIM24;TEAD4;GTF2I;CPSF3;TTF2;TFDP1;CDK7;SNRPF;SNRPG;CDK12;EAF1;TRIP13;TAF4B;CSTF1;TAF1L;MED1;NELFCD;NCBP1;GCM2;MLLT3;GCM1;NR1I3;GTF2H2;NR2C2AP;NKX2-8;POLR2D;NFYA;TAF2;ZNF141;ZNF473;LHX1;POLR2J;TAF4;GTF2H3;INTS2;INTS6;NOTCH1;NABP1;NR5A1;POLR2I;XBP1;PPARG;CPSF2;RNGTT;CCNH;ERCC6;HNF4A;TBX5;SNRPB;ESRRG;NR2E1;MAML2;EAF2;CSTF3;TRIP11;GTF2A1;ADRM1;SETX;TCFL5;CREBBP;GTF2E1;CPSF4;CDC73;DEK;RREB1;ERCC2;SLBP;GTF2F2;LEO1;SNRPE;TAF1;PAX5;IRF9
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.20341646105449226,0.7854705646161627,0.8695652173913043,0.9022777255938451,1.0,12/32,22.56%,UFSP2;HDAC6;PKN1;RNF14;PRMT2;SAFB2;TRIM68;KCTD6;KDM5D;EP300;KLK3;DDX5
prerank,iron ion transport (GO:0006826),0.1838824014189731,0.7852154000364885,0.8,0.9019058892754659,1.0,16/49,22.41%,ATP6V1G2;SCARA5;ATP6V1E1;MCOLN1;ARHGAP1;TFRC;TCIRG1;RAB11B;ATP6V0E2;ATP6V1D;ATP6V1H;ATP6V0A1;ATP6V0D1;HFE;ATP6V0E1;CP
prerank,RNA interference (GO:0016246),-0.2911023649253499,-0.784961394749559,0.7413793103448276,0.9556752091988707,1.0,9/17,40.35%,HENMT1;TERT;TSN;DROSHA;DHX9;MRPL44;TARBP2;AGO2;NRDE2
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.26206969357483156,-0.7842242671251161,0.8026315789473685,0.9559759238798972,1.0,3/22,7.97%,HSPA1A;MAGEA3;BCL2L1
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.23728514121597027,-0.7840445745394086,0.8181818181818182,0.9555491315500719,1.0,9/29,34.24%,ERCC5;RPA3;CDK7;GTF2H2;GTF2H3;CCNH;ERCC2;CUL4A;UBC
prerank,nucleosome assembly (GO:0006334),-0.24940318587352353,-0.7830540493973047,0.7974683544303798,0.956173501401672,1.0,3/30,4.18%,CHAF1B;CHAF1A;SOX9
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.28104087734494265,-0.7828634939765231,0.7777777777777778,0.9557785603088833,1.0,8/21,32.51%,MASTL;STYXL1;GSK3B;PPP1R1B;PPP4R4;BOD1L2;YWHAB;FKBP1B
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.26809767569810394,-0.7827935083000847,0.72,0.9551598662508541,1.0,6/18,30.69%,HSPA1A;ZNF205;GSK3B;BAX;BID;TMEM102
prerank,cellular response to glucose stimulus (GO:0071333),-0.24895185890128813,-0.7826039319956485,0.7671232876712328,0.9546933523240367,1.0,8/29,23.98%,SOX4;ZBTB20;PAX2;IGF1R;MLXIPL;LIN28A;XBP1;PTPRN2
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.23327936113179676,-0.782249707238945,0.7590361445783133,0.9545141143900491,1.0,4/36,6.51%,TP73;PML;POU4F1;PMAIP1
prerank,regulation of protein ubiquitination (GO:0031396),-0.20332295208605755,-0.7813862339342631,0.9080459770114943,0.9551784869029373,1.0,11/101,8.91%,GNL3L;HSPA1A;PRR7;RIPK2;SOX4;TNFAIP3;PRMT3;ISG15;CAV1;PRKCG;XIAP
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.21176718480872647,0.7800032207315387,0.875,0.9084818773569235,1.0,6/24,15.78%,ATF4;MAPK7;RBPJ;KLF2;MT3;DDIT3
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.26574634329555796,-0.7798412306579475,0.7361111111111112,0.956642865580031,1.0,12/20,34.80%,SULT2B1;SOX9;BMP4;SFRP4;IL20;FOXN1;IL13;FOXJ1;SFN;KDF1;NKX6-1;AHI1
prerank,intermediate filament organization (GO:0045109),-0.2867015504697216,-0.7796766977326681,0.7532467532467533,0.9561298748984592,1.0,5/18,14.88%,EPPK1;PKP1;DSP;BFSP2;TCHH
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.28007652357299573,-0.7787560043596573,0.7088607594936709,0.956760251702787,1.0,2/15,2.26%,IL1B;GTSE1
prerank,gastrulation (GO:0007369),0.25295319237545333,0.7777987685502187,0.8461538461538461,0.9107021118628165,1.0,7/19,18.74%,SMAD2;NPHP3;MEGF8;NR4A3;GPC3;UGDH;MKKS
prerank,regulation of defense response to virus (GO:0050688),-0.2894068817131976,-0.777530630673863,0.8051948051948052,0.9577736533946982,1.0,5/15,31.05%,TNFAIP3;USP17L2;ITCH;C1QBP;DHX9
prerank,potassium ion transmembrane transport (GO:0071805),-0.19052291705941304,-0.776123887030053,0.9,0.9589980633476121,1.0,40/137,27.61%,SLC12A2;SLC12A8;KCNE3;SLC9C1;KCNQ1;KCNJ13;KCNG2;SLC9A7;KCNJ15;KCNA7;HCN1;SLC24A1;KCNC3;KCNV2;KCNK12;KCNN4;KCNS1;KCNH4;KCNJ14;ATP12A;KCNH7;HPN;SLC12A1;KCNK1;KCNA3;SLC12A5;KCNK13;ATP1B1;SLC9A4;SLC12A3;KCNJ3;KCNH8;KCNJ6;KCNK16;KCNS2;KCNJ11;KCNJ4;HCN4;PKD2L1;KCNJ18
prerank,response to hexose (GO:0009746),0.2331346355315435,0.7758408505604912,0.8928571428571429,0.9127566899702314,1.0,6/23,16.93%,VAMP2;LPL;EIF2B1;SLC2A5;EIF2B4;SLC30A8
prerank,cellular polysaccharide biosynthetic process (GO:0033692),-0.26250562862259047,-0.775830522970737,0.855072463768116,0.958728353825971,1.0,8/25,25.58%,B3GNT4;NDST3;B3GNT2;HS2ST1;B3GNT3;HAS3;EXT1;HAS2
prerank,protein import into mitochondrial matrix (GO:0030150),-0.28401129468145475,-0.7756090696585746,0.8,0.9583503456455329,1.0,7/18,30.25%,TOMM20L;ROMO1;GRPEL2;TIMM23;TOMM40;DNAJC15;TIMM50
prerank,intracellular protein transmembrane transport (GO:0065002),-0.23677680182905242,-0.7753853639165035,0.7926829268292683,0.9581022575970627,1.0,18/43,39.20%,TOMM20L;HSPD1;PEX7;ROMO1;GRPEL2;TIMM23;TOMM40;DNAJC15;PEX10;TIMM50;AIFM1;PEX16;SEC61G;SEC61A1;SEC61B;GRPEL1;PEX1;TIMM17B
prerank,negative regulation of catabolic process (GO:0009895),-0.22535110331749897,-0.7749507981512856,0.85,0.9579527703534716,1.0,12/49,19.92%,MAD2L1;IL1B;HCAR2;CYP51A1;PRKCG;SF3B3;APOA2;APOC1;PHB;IRAK3;AZIN1;PFKFB1
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.20460702073713372,-0.7748790101868638,0.8314606741573034,0.957292175767539,1.0,49/90,53.34%,RPL39;RPS19;RPS21;RPL36;SRP72;RPL37;RPL8;RPL23A;RPS7;RPS18;RPS2;SEC61A1;SEC61B;RPL4;RPS3;RPL35;RPS4X;RPL18;RPL32;RPL41;RPS24;RPL27A;RPS29;RPL19;RPL38;RPL37A;RPS14;RPL12;RPLP2;RPL30;RPL28;RPLP0;SRP9;RPL31;RPS28;RPS3A;RPS15;UBA52;RPL18A;RPS11;SRP54;RPS5;RPL5;RPS6;RPS9;RPL7A;RPL11;RPL29;RPL35A
prerank,positive regulation of catalytic activity (GO:0043085),0.19746614431175638,0.7740411189326011,0.9047619047619048,0.9148980323368514,1.0,11/40,18.02%,PSEN1;MAPK3;MAPK8;MAPK14;SOD1;NHEJ1;MT3;AZIN2;PSEN2;B3GAT3;CHTOP
prerank,nucleic acid metabolic process (GO:0090304),-0.21650408240728308,-0.7737488808854763,0.872093023255814,0.9583925230027318,1.0,26/71,37.61%,POLR2F;WDR74;DNA2;FEN1;TOPBP1;NCBP1;WRN;LSM8;POLR2D;POLR2J;RAN;POLR2I;XRN2;PDE12;KPNA2;DNASE1L1;GTF2F2;DDX54;DUSP11;PTBP1;DNTT;HNRNPC;HNRNPF;DNASE1L2;HNRNPR;HNRNPU
prerank,neutrophil activation involved in immune response (GO:0002283),-0.17862475101174802,-0.7723561533661347,0.9897959183673469,0.9597180617130936,1.0,180/476,37.59%,CXCL1;TCN1;PPBP;HSPA1A;CD68;PLAU;MME;S100P;OLR1;CLEC5A;ABCA13;MIF;CD44;CTSH;ATP11A;DSN1;C3;ADGRE3;DIAPH1;CEACAM6;HRNR;BST2;TRPM2;SELL;PKP1;FCGR3B;PSMD14;LCN2;ORM2;SYK;GGH;PECAM1;PNP;SERPINA3;CXCR2;CD55;S100A11;CHIT1;PRDX4;CLEC4C;PLAUR;MAGT1;RAB3D;ITGAX;ORM1;DSP;MMP9;ANXA3;MMP25;VNN1;FPR2;DSG1;CHI3L1;FRK;TMEM63A;GLB1;TNFRSF1B;PGLYRP1;ADAM10;MLEC;TMC6;AHSG;CTSC;NEU1;NRAS;PDXK;RHOF;ACTR2;GLA;CCT2;ADAM8;CXCR1;CYBA;HEXB;JUP;RAP2B;AMPD3;SLPI;FUCA2;HP;CYBB;PTPRJ;SERPINB3;MMP8;CSTB;CRACR2A;GPR84;ILF2;ARG1;OLFM4;ATP11B;HMGB1;PRSS3;SERPINB1;CR1;MNDA;GCA;DNAJC3;SIRPB1;CNN2;CMTM6;EEF2;PTPRN2;DEFA1;CANT1;PSMA5;MANBA;FCAR;PSMD12;NFAM1;DNASE1;DDOST;ITGB2;NBEAL2;LAMP2;MGAM;TUBB4B;DNASE1L1;GDI2;FRMPD3;TYROBP;LTF;HUWE1;OSTF1;KPNB1;PKM;ADGRG3;CKAP4;ATAD3B;XRCC5;PA2G4;CPNE3;HPSE;S100A7;APEH;CEACAM8;ERP44;CPNE1;TUBB;IMPDH2;APRT;SVIP;CTSA;CDK13;B4GALT1;DOCK2;CD58;VAMP8;TARM1;GLIPR1;NHLRC3;CD47;IQGAP1;OSCAR;ADGRE5;CCT8;LAMTOR2;SURF4;PAFAH1B2;DYNC1H1;EPX;ITGAL;IMPDH1;NAPRT;AGPAT2;CD300A;NIT2;PTAFR;MCEMP1;FCGR2A;PSMD1;PTGES2;CLEC4D;SLC15A4;HSP90AA1;PLD1;HSP90AB1;RAP1B;LILRB2;AGA
prerank,nuclear export (GO:0051168),-0.20577342593959652,-0.7719511529893218,0.8333333333333334,0.9595420162172809,1.0,18/82,19.57%,NUP62CL;ZC3H11A;U2AF1;NUP155;CSE1L;CALR;THOC3;XPO5;MAGOHB;RANBP17;TGFB1;XPO4;NCBP1;ALYREF;EIF4E;SRSF9;RAE1;RAN
prerank,regulation of cartilage development (GO:0061035),-0.26368836265125895,-0.7719145527926193,0.7432432432432432,0.9588359011049107,1.0,4/18,19.07%,SOX9;WNT11;BMP4;MDK
prerank,cellular zinc ion homeostasis (GO:0006882),0.2491291229235158,0.7716372582660495,0.7619047619047619,0.917431726110012,1.0,8/28,19.34%,SLC39A13;MT1X;MT1M;MT1A;MT1E;MT3;SLC30A8;SLC30A10
prerank,mitochondrion organization (GO:0007005),0.17011101839294074,0.7710420477766777,1.0,0.9178764843771078,1.0,30/163,14.49%,MTFR1L;SLC25A4;COX7A1;WASF1;CAV2;MFN2;PLD6;ATCAY;PID1;MUL1;BNIP3;HAP1;RHOT2;TRAK2;HK2;MEF2A;PYROXD2;OXA1L;MTX3;BNIP3L;MGARP;ATPAF1;GABPB1;HIGD1A;SLC25A36;MIEF2;AIP;SIRT3;TOMM7;CHCHD4
prerank,positive regulation of cartilage development (GO:0061036),-0.27306571268601865,-0.7709779755622403,0.8933333333333333,0.9594943000007434,1.0,4/18,19.07%,LOXL2;SOX9;BMP4;MDK
prerank,Notch signaling pathway (GO:0007219),-0.21917520979621546,-0.7698958464376028,0.8875,0.9603933001386609,1.0,17/60,26.71%,MYC;NOTCH3;DLGAP5;WWC1;DTX2;STAT1;GMDS;NLE1;POFUT1;ADAM10;MDK;DTX3L;JAG2;NOTCH1;NRARP;ITCH;MAML2
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.2693948794189649,-0.7697206327746238,0.7848101265822784,0.9598987851798089,1.0,7/22,29.17%,PMAIP1;ATR;MSX1;EIF5A;SPRED1;RPL37;RPS7
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.24505235171697118,0.7695149089921814,0.8076923076923077,0.9191466763719057,1.0,9/17,24.59%,FLOT1;EPCAM;PPM1F;NOTCH4;RGCC;DENND6A;ADAM19;TJP1;PTPRU
prerank,regulation of mRNA stability (GO:0043488),-0.19848850445798025,-0.7694250532355661,0.8764044943820225,0.9595795593751785,1.0,44/139,31.27%,HSPA1A;IGF2BP1;IGF2BP3;E2F1;PSMB9;PSMD14;AXIN2;IGF2BP2;NOCT;MAPKAPK2;PABPC1;EXOSC3;EXOSC8;DIS3;MEX3D;SET;EXOSC5;EXOSC4;FUS;PSMA3;NPM1;ANP32A;CARHSP1;PSMB3;ROCK2;PSMA5;PSMD12;PSMB11;PDE12;PSMB2;EXOSC7;FMR1;KHSRP;PSMA7;PSME2;TBRG4;PSME3;PSMC1;LARP1;XPO1;EXOSC2;XRN1;PSME4;YTHDF1
prerank,chromatin assembly (GO:0031497),-0.22711361821340892,-0.7691771459400755,0.8243243243243243,0.9591838939306978,1.0,4/36,5.49%,CHAF1B;CHAF1A;SOX9;HMGA2
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.2164918688056514,0.7691526132996492,0.84,0.9190689699340155,1.0,8/27,16.89%,CLU;PKD2;CD36;KLF2;SMAD3;AGTR2;KLF4;HBB
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.20982770099315104,0.7689172053941282,0.85,0.9187941426892536,1.0,6/31,11.46%,ARRDC4;PTEN;SKP1;DCUN1D4;GORASP1;PIN1
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.2486460863836559,-0.7677264709703081,0.8142857142857143,0.9607312247042522,1.0,13/25,35.84%,THY1;GBP1;PVRIG;PTPRJ;LILRB4;PTPN2;SLA2;SH2D1A;CD160;UBASH3A;EZR;PTPN22;CD300A
prerank,peptidyl-proline modification (GO:0018208),0.1938368332156049,0.7669426654444936,0.84,0.9206877157565997,1.0,4/30,11.46%,FKBP5;P3H2;FKBP7;PIN1
prerank,regulation of macromolecule metabolic process (GO:0060255),0.1462625804246579,0.7668489007641126,1.0,0.9200897943708644,1.0,34/194,14.31%,PSEN1;HNRNPDL;TRIM39;NKAPL;PEG3;NOVA1;ZFP36L1;TARDBP;TRIM6;YBX3;STX1B;PCBP3;RSPO1;PRDM11;AFF3;MTMR9;POGZ;PCBP4;SLC8A2;TRIM34;TRIM21;TFEB;FLOT1;APP;PIN1;SLC8A1;TOB2;GNB3;CGGBP1;HINFP;MEGF8;AFF1;PRDM6;GDNF
prerank,lipid translocation (GO:0034204),-0.24544820040072388,-0.7664170018910739,0.8441558441558441,0.9621174058009735,1.0,14/23,48.17%,ATP11A;RFT1;ATP9A;ATP11B;ATP10B;ABCB4;ABCC1;ABCB1;ATP9B;ATP8B4;ATP8B1;ABCA4;ABCA7;TMEM30B
prerank,peptidyl-serine modification (GO:0018209),-0.18972200196121794,-0.766188477456659,0.9375,0.9616337043267309,1.0,42/164,24.61%,TDGF1;CDK1;VRK1;VRK2;PRKDC;MASTL;CSNK2A3;IKBKE;SBK1;MAPKAPK2;PRKCG;NEK6;AURKA;NTMT1;CAMKV;STK4;PARP2;AKT3;TOP1;PLK1;DYRK3;ATR;GALNT3;PRKCZ;CDC7;TGFBR2;CDK5;CSNK2A1;STK39;PRKCQ;CLSPN;GSK3B;PRKX;PRKCI;TTBK1;EIF2AK3;HIPK2;MAPKAPK5;CSNK1A1L;ROCK2;RPS6KA3;MAPKAPK3
prerank,cellular response to estradiol stimulus (GO:0071392),0.20105301531281916,0.7656734797704087,0.75,0.9205124826540222,1.0,4/20,10.12%,GPER1;EGFR;RAMP3;SFRP1
prerank,neutrophil degranulation (GO:0043312),-0.1772001906272381,-0.765284872889115,0.9897959183673469,0.9621324719084561,1.0,178/472,37.59%,CXCL1;TCN1;PPBP;HSPA1A;CD68;PLAU;MME;S100P;OLR1;CLEC5A;ABCA13;MIF;CD44;CTSH;ATP11A;DSN1;C3;ADGRE3;DIAPH1;CEACAM6;HRNR;BST2;TRPM2;SELL;PKP1;FCGR3B;PSMD14;LCN2;ORM2;GGH;PECAM1;PNP;SERPINA3;CXCR2;CD55;S100A11;CHIT1;PRDX4;CLEC4C;PLAUR;MAGT1;RAB3D;ITGAX;ORM1;DSP;MMP9;ANXA3;MMP25;VNN1;FPR2;DSG1;CHI3L1;FRK;TMEM63A;GLB1;TNFRSF1B;PGLYRP1;ADAM10;MLEC;TMC6;AHSG;CTSC;NEU1;NRAS;PDXK;RHOF;ACTR2;GLA;CCT2;ADAM8;CXCR1;CYBA;HEXB;JUP;RAP2B;AMPD3;SLPI;FUCA2;HP;CYBB;PTPRJ;SERPINB3;MMP8;CSTB;CRACR2A;GPR84;ILF2;ARG1;OLFM4;ATP11B;HMGB1;PRSS3;SERPINB1;CR1;MNDA;GCA;DNAJC3;SIRPB1;CNN2;CMTM6;EEF2;PTPRN2;DEFA1;CANT1;PSMA5;MANBA;FCAR;PSMD12;NFAM1;DDOST;ITGB2;NBEAL2;LAMP2;MGAM;TUBB4B;DNASE1L1;GDI2;FRMPD3;TYROBP;LTF;HUWE1;OSTF1;KPNB1;PKM;ADGRG3;CKAP4;ATAD3B;XRCC5;PA2G4;CPNE3;HPSE;S100A7;APEH;CEACAM8;ERP44;CPNE1;TUBB;IMPDH2;APRT;SVIP;CTSA;CDK13;B4GALT1;DOCK2;CD58;VAMP8;TARM1;GLIPR1;NHLRC3;CD47;IQGAP1;OSCAR;ADGRE5;CCT8;LAMTOR2;SURF4;PAFAH1B2;DYNC1H1;EPX;ITGAL;IMPDH1;NAPRT;AGPAT2;CD300A;NIT2;PTAFR;MCEMP1;FCGR2A;PSMD1;PTGES2;CLEC4D;SLC15A4;HSP90AA1;PLD1;HSP90AB1;RAP1B;LILRB2;AGA
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.26086717319257013,-0.764563923184513,0.7777777777777778,0.9622830444850783,1.0,13/24,33.86%,TGFB2;CCL3;PCSK9;NF1;CDK5;TNF;TFAP2A;TYROBP;BAX;CDK5R1;MCL1;SRPK2;FBXW7
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.23647516865680773,0.7643621840554249,0.7407407407407407,0.9215065058054078,1.0,5/19,16.04%,ANXA6;SLC25A23;SMDT1;MICU3;MICU1
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.23730598582377832,0.7641287875162283,0.7428571428571429,0.9211772623971125,1.0,4/17,9.80%,HDAC6;BNIP3;TBC1D25;SLN
prerank,xenobiotic transport (GO:0042908),-0.26828882509094026,-0.7633840963388829,0.7945205479452054,0.9631889589733816,1.0,3/20,8.02%,ABCC11;SLC7A5;ABCC2
prerank,lipid catabolic process (GO:0016042),0.1980881386988662,0.762811104430527,0.7352941176470589,0.9223298306142906,1.0,8/28,15.66%,SIRT2;HSD17B14;PLA2G1B;LPL;MT3;CES1;CYP4F12;PNLIP
prerank,negative regulation of DNA recombination at telomere (GO:0048239),-0.2796155166961151,-0.7625125122450348,0.7534246575342466,0.9629474582378708,1.0,5/20,23.82%,POLR2F;POLR2D;POLR2J;POLR2I;ATRX
prerank,regulation of DNA recombination at telomere (GO:0072695),-0.2796155166961151,-0.7625125122450348,0.7534246575342466,0.9629474582378708,1.0,5/20,23.82%,POLR2F;POLR2D;POLR2J;POLR2I;ATRX
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.24170523664722887,-0.7619294802107908,0.8375,0.9630612848883925,1.0,11/38,24.69%,REG3A;ICAM1;CEACAM6;CRB2;CXADR;PTPRD;CEACAM5;AMIGO3;CRTAM;CBLN1;TENM4
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.2847936233997859,-0.7618668263513995,0.868421052631579,0.9624064199272467,1.0,8/15,40.23%,NAA15;AANAT;NAA35;NAA20;CREBBP;NAA11;NAA25;NAA50
prerank,mesoderm development (GO:0007498),0.22822423425261548,0.7615356795272589,0.8695652173913043,0.9234270962012221,1.0,4/18,13.82%,TIE1;BMX;JAK2;SECTM1
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.2474068136805635,-0.7613886194884897,0.7733333333333333,0.9623068925565038,1.0,5/27,16.43%,WDR43;CCNK;EAF1;HMGN1;ALYREF
prerank,positive regulation of metabolic process (GO:0009893),-0.1912161860727542,-0.7606332724205751,0.9111111111111111,0.9625479913038927,1.0,16/112,12.65%,CEBPB;CXCR4;DIO2;LCN2;SCD;CAV1;IGF1R;SYK;GHRL;TRPM8;PRLR;BEND3;OXTR;UCP1;IFNG;TSHR
prerank,regulation of interferon-beta production (GO:0032648),0.2067466630242214,0.7602677476827744,1.0,0.9241840843659697,1.0,8/47,10.63%,TLR3;PTPRS;TIRAP;OAS1;TLR9;FLOT1;DHX58;RNF216
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.2242550496643513,-0.7593376660137434,0.8,0.9635249985718729,1.0,5/36,8.93%,HSPA1A;INHBA;PRKDC;STAT1;ZFPM1
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.27132690816506483,-0.7583528568273299,0.8356164383561644,0.964267107349326,1.0,7/19,24.69%,CXCR4;SOX1;NF1;TNFRSF1B;MDK;NOTCH1;TENM4
prerank,neutrophil mediated immunity (GO:0002446),-0.1749915412068664,-0.7580984891196478,0.9897959183673469,0.9639230984988719,1.0,179/478,37.59%,CXCL1;TCN1;PPBP;HSPA1A;CD68;PLAU;MME;S100P;OLR1;CLEC5A;ABCA13;MIF;CD44;CTSH;ATP11A;DSN1;C3;ADGRE3;DIAPH1;CEACAM6;HRNR;BST2;TRPM2;SELL;PKP1;FCGR3B;PSMD14;LCN2;ORM2;GGH;PECAM1;PNP;SERPINA3;CXCR2;CD55;S100A11;CHIT1;PRDX4;CLEC4C;PLAUR;MAGT1;RAB3D;ITGAX;ORM1;DSP;MMP9;ANXA3;MMP25;VNN1;FPR2;DSG1;CHI3L1;FRK;TMEM63A;GLB1;TNFRSF1B;PGLYRP1;ADAM10;MLEC;TMC6;AHSG;CTSC;NEU1;NRAS;PDXK;RHOF;ACTR2;GLA;CCT2;ADAM8;CXCR1;CYBA;HEXB;JUP;RAP2B;AMPD3;SLPI;FUCA2;HP;CYBB;PTPRJ;CARD9;SERPINB3;MMP8;CSTB;CRACR2A;GPR84;ILF2;ARG1;OLFM4;ATP11B;HMGB1;PRSS3;SERPINB1;CR1;MNDA;GCA;DNAJC3;SIRPB1;CNN2;CMTM6;EEF2;PTPRN2;DEFA1;CANT1;PSMA5;MANBA;FCAR;PSMD12;NFAM1;DDOST;ITGB2;NBEAL2;LAMP2;MGAM;TUBB4B;DNASE1L1;GDI2;FRMPD3;TYROBP;LTF;HUWE1;OSTF1;KPNB1;PKM;ADGRG3;CKAP4;ATAD3B;XRCC5;PA2G4;CPNE3;HPSE;S100A7;APEH;CEACAM8;ERP44;CPNE1;TUBB;IMPDH2;APRT;SVIP;CTSA;CDK13;B4GALT1;DOCK2;CD58;VAMP8;TARM1;GLIPR1;NHLRC3;CD47;IQGAP1;OSCAR;ADGRE5;CCT8;LAMTOR2;SURF4;PAFAH1B2;DYNC1H1;EPX;ITGAL;IMPDH1;NAPRT;AGPAT2;CD300A;NIT2;PTAFR;MCEMP1;FCGR2A;PSMD1;PTGES2;CLEC4D;SLC15A4;HSP90AA1;PLD1;HSP90AB1;RAP1B;LILRB2;AGA
prerank,regulation of phosphatase activity (GO:0010921),0.19733031879106025,0.7580914380833174,0.8,0.9262040525951701,1.0,6/25,17.78%,HSP90B1;MTMR9;CHP2;TSC1;PPP6R2;CDK5RAP3
prerank,negative regulation of Wnt signaling pathway (GO:0030178),-0.18796257986240938,-0.7573063486107459,0.9473684210526315,0.964157153662028,1.0,45/186,25.16%,NOTUM;DKK4;SHISA2;WNT5A;RNF43;MDFI;KREMEN2;PSMB9;SOX9;LRP4;HECW1;PTPRO;PSMD14;CAV1;ALPK2;AXIN2;IGFBP1;STK4;RNF213;CITED1;NKD2;MLLT3;UBAC2;WNT11;ZNRF3;WIF1;SFRP4;WWOX;PSMA3;MDK;GSK3B;SOX30;RUVBL2;DRAXIN;CCDC88C;PSMB3;AXIN1;CSNK1A1L;CXXC4;INVS;IGFBP2;PSMA5;PSMD12;PSMB11;PSMB2
prerank,programmed necrotic cell death (GO:0097300),0.22182809112476742,0.7572309095788677,0.7241379310344828,0.9267264053387773,1.0,3/18,13.24%,TLR3;TICAM2;RIPK1
prerank,regulation of synapse assembly (GO:0051963),-0.22584115336086735,-0.7556486416541818,0.8873239436619719,0.9658285246087469,1.0,13/47,25.17%,EPHB2;ROBO2;EPHB3;GHRL;CHRNB2;PTPRD;WNT7A;SYNDIG1;LRFN4;SRPX2;VPS35;WNT3A;BDNF
prerank,regulation of telomere capping (GO:1904353),-0.24744767177143395,-0.7554925096102483,0.7972972972972973,0.9653424766362748,1.0,3/23,6.28%,NEK2;MAPK15;AURKB
prerank,positive regulation of stem cell proliferation (GO:2000648),-0.27592249443787487,-0.7548820795495645,0.7808219178082192,0.965458656491375,1.0,5/17,17.18%,HMGA2;CCNE1;CITED1;NANOG;TERT
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.23327216625998937,0.7547383648604157,0.9545454545454546,0.9293634458777648,1.0,7/16,23.07%,NPPA;SLC2A5;ADM;NPPB;KLK3;GSK3A;PRCP
prerank,carbohydrate biosynthetic process (GO:0016051),-0.2464391566066793,-0.7543876661108518,0.8309859154929577,0.9652514184280772,1.0,10/24,33.62%,FUT8;FUT1;ST8SIA6;FUT7;FUT2;FUT6;FUT5;B4GALT1;B3GALT2;ST3GAL2
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.19477675470069866,-0.753621813464669,0.8777777777777778,0.9655895485611431,1.0,28/100,27.68%,INHBA;SOX4;EIF3C;PRKDC;UHRF1;NAT10;PLK1;PERP;AGT;TGFB1;PASK;WNT7A;NFKBIA;MSN;ASPH;FGFR4;THBS1;LARP4;NPM1;HDAC2;CLN6;ASPSCR1;LARP4B;EEF2;VPS35;FMR1;CD28;EIF6
prerank,hexose metabolic process (GO:0019318),-0.22285823110230418,-0.752997396840111,0.8823529411764706,0.9657557033616493,1.0,9/41,19.18%,SORD;PMM2;ALDOB;GALK2;GHRL;KHK;SLC35A2;FUOM;FUCA2
prerank,negative regulation of cellular biosynthetic process (GO:0031327),-0.21377383694955207,-0.7527139170266878,0.8354430379746836,0.9654126575255177,1.0,18/50,30.55%,TRIB3;FGF19;ACMSD;PRMT3;PROX1;CAV1;FYN;APOC1;GLA;BRCA1;PLEK;ROCK2;KHSRP;ERLIN1;WNT4;ZC3H12A;PGP;OPN3
prerank,positive regulation of protein ubiquitination (GO:0031398),-0.2062657490752356,-0.7526008129622901,0.898876404494382,0.9648435482084595,1.0,28/76,31.34%,TRIB3;RIPK2;DCUN1D5;CAV1;XIAP;FANCM;PLK1;PAXIP1;NDFIP2;FBXO4;BIRC7;BRCA1;MAGEA2;MYCBP2;AXIN1;MAGEC2;TBC1D7;SPSB4;HUWE1;DERL1;COMMD1;FANCI;CUL3;TRAF6;AMER1;SPRTN;UBE2N;KDM1A
prerank,regulation of transmembrane transport (GO:0034762),-0.2389860384579065,-0.751276973874973,0.9090909090909091,0.9661117708077831,1.0,12/33,27.61%,TRIB3;KCNJ13;KCNJ15;KCNJ14;SLC2A1;KCNJ3;KCNJ6;SCN10A;KCNJ11;KCNJ4;ACE2;KCNJ18
prerank,mRNA catabolic process (GO:0006402),-0.22911391092926237,-0.7506629698952045,0.8875,0.9662016092669775,1.0,17/40,39.78%,HSPA1A;PNPT1;MRTO4;EXOSC4;LSM5;CNOT10;XRN2;PDE12;NBAS;DHX34;XRN1;SLFN14;ZC3H12D;DIS3L2;DCP2;RC3H1;HSPA1B
prerank,acetyl-CoA metabolic process (GO:0006084),0.22877197744879937,0.750614932531924,0.896551724137931,0.9337194329960713,1.0,5/15,21.27%,ACACB;ACAT1;PMVK;HMGCS2;ACSS1
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.20843605216986377,-0.7502061176435141,0.8372093023255814,0.9661405982036254,1.0,22/74,30.89%,CARD14;PSMB9;PSMD14;TNFSF15;NFKB2;RELA;IRAK1;TNFRSF10B;CHI3L1;TRAF2;PSMA3;PSMB3;PSMA5;PSMD12;PSMB11;PSMB2;PSMA7;PSME2;PSME3;PSMC1;TRAF6;PSME4
prerank,dopamine metabolic process (GO:0042417),-0.2581417876973558,-0.7501741643260066,0.7916666666666666,0.9654170461571409,1.0,6/18,22.08%,TGFB2;TH;DRD2;SULT1A3;SNCAIP;GCH1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.21097385679522612,0.7498029931519375,0.9166666666666666,0.9340927150449578,1.0,5/24,13.59%,ZER1;HDAC6;RNF185;POMT2;ZYG11B
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.27268340048253553,-0.7497147943934872,0.8059701492537313,0.965316593798874,1.0,11/21,38.38%,DGAT2;SCD;THEM5;FASN;ACACA;FITM2;ACSL3;ACSL4;FAR2;HSD17B4;ACSM2A
prerank,regulation of exosomal secretion (GO:1903541),0.2465795282993766,0.7486683866108472,0.875,0.9348733402023243,1.0,2/18,3.57%,CHMP3;TSG101
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.2766355885377118,-0.7483550691356854,0.8831168831168831,0.9664092306822714,1.0,6/17,29.94%,ATAD5;DYRK3;NPM1;EZH2;CUL3;CDC73
prerank,histone H2A acetylation (GO:0043968),-0.2795234794813769,-0.7476501589587601,0.7534246575342466,0.9665886572662242,1.0,5/16,20.57%,RUVBL1;YEATS4;ACTL6A;TRRAP;RUVBL2
prerank,regulation of establishment of protein localization (GO:0070201),0.23170133414689723,0.7473885763580677,0.8846153846153846,0.9355818631691699,1.0,1/15,0.59%,CORO2B
prerank,response to peptide hormone (GO:0043434),-0.22340717885235567,-0.7463500418117087,0.9113924050632911,0.967633634175617,1.0,15/51,27.68%,IRS1;REG3A;CAV1;STAT1;KHK;REG1A;REG1B;CITED1;STAT5A;STAT5B;XBP1;ANXA1;ROCK2;GHRHR;EIF6
prerank,ion homeostasis (GO:0050801),-0.23612336676028592,-0.7463343903103947,0.8271604938271605,0.9669216912647179,1.0,10/30,32.13%,SLC4A11;SLC30A2;SLC4A9;SLC4A8;SLC12A5;P2RY2;WNK4;HCN4;RHCG;UNC80
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.24882212961120226,-0.7452314601415566,0.7638888888888888,0.9677149774617864,1.0,11/22,35.32%,TTLL4;TTLL10;CEP41;AGBL4;TTLL9;AGTPBP1;TTLL5;VKORC1L1;NAA11;CFAP20;GGCX
prerank,regulation of mast cell degranulation (GO:0043304),-0.2732104118565315,-0.7449612826010492,0.7714285714285715,0.9673036532306767,1.0,2/15,7.42%,ADGRE2;SYK
prerank,estrogen metabolic process (GO:0008210),-0.2281868127005583,-0.7443391822890957,0.8205128205128205,0.9673470073461421,1.0,12/30,38.65%,CYP3A7;CYP19A1;CYP2D6;SULT1E1;CYP1A2;UGT2B4;UGT2B7;HSD17B10;HSD3B1;UGT1A7;HSD17B4;CYP3A5
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.2291920461049842,-0.7436020443123539,0.8767123287671232,0.9676046888981951,1.0,6/40,12.92%,FXYD5;IL1RN;PLG;TGFB1;GTPBP4;ASS1
prerank,T cell proliferation (GO:0042098),-0.28518410696278673,-0.7435015672085045,0.7714285714285715,0.9669751642869945,1.0,6/15,23.35%,RASGRP1;PIK3CG;TNFSF18;MSN;DOCK8;CRTAM
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.27127532852921776,-0.7429304334851268,0.7285714285714285,0.9669439922572951,1.0,8/18,32.00%,IFI6;BCL2L1;BBC3;GGCT;BAX;TIMM50;BID;SFN
prerank,phospholipid biosynthetic process (GO:0008654),-0.2398302105507688,-0.7428886215592414,0.8717948717948718,0.9662611912762329,1.0,10/36,31.96%,CPNE7;IDI2;SRD5A3;AGPAT5;FDPS;DOLK;FITM2;CPNE3;NUS1;CPNE1
prerank,aspartate family amino acid metabolic process (GO:0009066),0.22842468824558543,0.7408767306785932,0.8148148148148148,0.9422569716046154,1.0,6/19,17.17%,SLC25A12;ASPA;NAALAD2;ASNS;MTHFR;MSRA
prerank,metallo-sulfur cluster assembly (GO:0031163),0.2164846112937851,0.7405822580589414,0.8571428571428571,0.941879296031532,1.0,3/19,11.09%,ISCU;ISCA1;HSCB
prerank,steroid hormone biosynthetic process (GO:0120178),-0.21973610033904306,-0.7405260601387677,0.7971014492753623,0.9684873845430211,1.0,5/29,13.72%,CYP19A1;SRD5A3;SRD5A1;DHCR7;MED1
prerank,organophosphate biosynthetic process (GO:0090407),-0.23258726883833114,-0.7399261257615716,0.8589743589743589,0.9685991939664351,1.0,10/39,21.14%,PNPO;MOCOS;GK;IPPK;MOCS3;CPS1;AGPAT5;GPHN;G6PD;IPMK
prerank,B cell receptor signaling pathway (GO:0050853),-0.23687290865760674,-0.7398086541165163,0.8441558441558441,0.9680308468596557,1.0,10/33,29.67%,SYK;ITK;CTLA4;TEC;PIK3CD;MNDA;LCK;NFAM1;BAX;VAV3
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.21835683118623933,-0.7393383721031176,0.868421052631579,0.9679097252431026,1.0,4/35,7.60%,HSPA1A;CXCR4;WNT5A;NLRC5
prerank,acyl-CoA metabolic process (GO:0006637),-0.2434426012584789,-0.7389686531701217,0.8831168831168831,0.9675508982079805,1.0,18/36,41.21%,BAAT;ACSL6;THEM5;ACSM6;ACSM4;ACOT6;ACOT12;ACACA;ACOT13;HMGCS1;DBI;ACOT7;ACOT4;ACSM2B;ACSM2A;ACOT8;ACOT11;GLYAT
prerank,positive regulation of protein transport (GO:0051222),-0.2042817572868622,-0.7386754070565795,0.9090909090909091,0.967138133804065,1.0,14/67,20.58%,IL1A;KIF20B;TGFB2;MYH10;ARHGEF5;TGFB1;ATP2C1;ADAM8;ATP13A2;ADAM9;CD2AP;FGA;EXPH5;TTN
prerank,membrane fusion (GO:0061025),0.19050148141524095,0.7381744196837491,0.9642857142857143,0.9437476671176418,1.0,10/34,21.59%,VAMP2;VTI1B;VAPA;MYOF;DYSF;RABEP1;VAMP3;SNAP29;VPS33B;NSFL1C
prerank,bile acid biosynthetic process (GO:0006699),-0.24866554704966137,-0.7375979336168167,0.868421052631579,0.9677008536798533,1.0,5/27,13.55%,OSBPL3;BAAT;CYP7B1;AKR1C4;CYP39A1
prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.25835943598469635,-0.7371601755040875,0.8533333333333334,0.9674666094906267,1.0,8/20,40.35%,AJUBA;CNOT1;EIF6;CNOT6;TNRC6B;HELZ;AGO2;NRDE2
prerank,negative regulation of immune effector process (GO:0002698),-0.26769563103123195,-0.7371193706760035,0.8356164383561644,0.966783069582139,1.0,12/16,46.73%,CD55;RPS19;CR1;IFNL1;CD47;SLAMF8;CD300A;ENPP3;RC3H1;GRN;LILRB1;HAVCR2
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.17823738267835534,-0.7369931832764053,0.9387755102040817,0.9662536123107397,1.0,84/243,35.21%,WNT2;HSPA1A;ZIC2;TNFSF11;IRAK2;LRP8;ADCY1;RIPK2;CARD11;IL1B;SHH;CARD14;WNT5A;RTKN2;IKBKE;CAV1;NFKB2;RELA;SMARCA4;ARHGEF5;TFDP1;IRAK1;RIPK4;RHEBL1;AGT;ANXA3;PRKCZ;NHLH2;NEUROG2;NEUROD2;TNFSF18;NFKBIA;ADAM8;PRKCQ;IL10;NOD2;JUP;TRAF2;TRIM22;MBTPS2;IRAK3;CARD9;NLRP3;SLCO3A1;NPM1;TRIM14;SMARCB1;PRKCI;HIPK2;NODAL;TAB3;PPARG;TNF;NFAM1;CLEC7A;IKBKG;CARD16;TSSK4;AIM2;LTF;TRIM31;ADCY8;FANK1;TRAF6;TAF1;DHX9;UBE2N;KDM1A;AGER;RELN;ESR2;TRIM27;MAP3K13;TCF3;NLRC4;BUD31;CX3CR1;NOD1;MYD88;UBC;NKX6-1;COPS5;CLOCK;EIF2AK2
prerank,regulation of cholesterol efflux (GO:0010874),-0.2225175601097164,-0.7356022961805742,0.8289473684210527,0.9673629630317335,1.0,7/32,18.90%,SHH;CAV1;CETP;ABCA12;NFKBIA;PON1;PTCH1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.25584411489691267,-0.7347048915360777,0.875,0.9677656536186753,1.0,2/21,2.49%,TP73;PML
prerank,cellular response to dsRNA (GO:0071359),0.22404473274558312,0.7344609495853727,0.8,0.9471501780358724,1.0,6/16,22.67%,COLEC12;MUL1;FLOT1;RIOK3;IFIT1;IFIH1
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.2649617599829834,-0.7340858731610853,0.9420289855072463,0.9677834820986643,1.0,9/25,24.55%,ERO1A;TRPM2;DRD2;F2R;IBTK;HTR2C;ITPR2;LCK;XCL1
prerank,zinc ion homeostasis (GO:0055069),0.24316883392621919,0.7339625287175932,0.8333333333333334,0.946946123870244,1.0,6/29,13.56%,SLC39A13;MT1X;MT1M;MT1A;MT1E;MT3
prerank,response to UV (GO:0009411),-0.19736331202115748,-0.7332733599548866,0.9294117647058824,0.9680523451610206,1.0,32/96,33.12%,MYC;CCND1;ERCC5;ZRANB3;POLH;FEN1;AURKB;ERCC8;RELA;IL12B;MSH6;ATR;GTF2H2;WRN;PTPRK;CDC25A;NPM1;RUVBL2;RHNO1;ERCC6;FMR1;CREBBP;USP1;SDE2;ERCC2;TAF1;SPRTN;KDM1A;POLD1;NOC2L;DTL;MAPK13
prerank,regulation of viral release from host cell (GO:1902186),0.23394116966464726,0.7331245593440237,0.8,0.9470775406025496,1.0,4/22,13.38%,CHMP3;TSG101;TRIM21;VPS4A
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.20922346460451147,-0.7324300329573384,0.9156626506024096,0.9683158890250018,1.0,21/51,35.21%,IL1B;IL23A;RTKN2;RELA;IL12B;IRAK1;NLRP12;NFAT5;NOD2;PHB;MMP8;CD86;NMI;TNF;ACTN4;TLR7;TRAF6;AGER;IFI35;NOD1;EIF2AK2
prerank,cilium assembly (GO:0060271),-0.17179406036420064,-0.7321796195920774,0.9791666666666666,0.9678515548157426,1.0,60/293,22.32%,CEP72;KIF24;MCIDAS;RP1;CDK1;MAK;CEP250;NEK2;CCDC113;CCNO;CFAP74;ARL13A;SNX10;POC1B;RPGRIP1L;RAB3IP;HAUS7;PKHD1;DCDC2;RSPH9;SCLT1;RP1L1;KIF27;CDC14C;TTC26;PLK1;HAUS6;PLA2G3;DNAAF3;RAB8A;CEP83;CEP76;RP2;CEP152;B9D1;DNAAF1;CEP78;DNAH5;TMEM107;TBC1D32;CENPJ;ACTR2;KIF3B;CFAP52;CEP41;EXOC4;SDCCAG8;CKAP5;PIBF1;FNBP1L;ALMS1;NDE1;LRGUK;PLK4;TEKT5;FHDC1;RSPH6A;HAUS2;ACTR3;NOTCH1
prerank,protein import into peroxisome membrane (GO:0045046),0.20913628883917426,0.7319747215929671,0.9285714285714286,0.9475436498780376,1.0,9/22,25.71%,PEX19;PXMP2;RAB8B;ALDH3A2;PEX11B;ABCD1;PEX12;PEX14;FIS1
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.19917715455730384,-0.7317509710162281,0.8928571428571429,0.9676187649330296,1.0,31/77,33.98%,IL1B;IL23A;RTKN2;RELA;IL12B;BMP7;IRAK1;NFKBIA;NLRP12;NFAT5;NOD2;PHB;NLRP3;MMP8;CD86;NMI;SPI1;TSPAN6;TNF;ACTN4;ZC3H12A;ADGRG3;TLR7;TRAF6;EZR;AGER;CPNE1;IFI35;DLG1;PTPN22;NOD1
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.2214714189735224,0.7302322678730643,0.9166666666666666,0.94857263791319,1.0,6/16,17.83%,ENTPD3;AK1;AK5;NME2;AK4;ENTPD4
prerank,response to growth factor (GO:0070848),-0.21385155326144045,-0.7295547639666352,0.925,0.9696097121182689,1.0,12/40,31.02%,MYC;IBSP;EPHA2;LRP2;GATA6;TGFBR2;STAT5B;TBC1D7;URI1;CPNE3;ACVR2B;PLK5
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.2723807326331343,-0.7291603202033459,0.8405797101449275,0.969380867857926,1.0,4/16,18.89%,PIK3CG;AUTS2;PIK3CB;RASGRF1
prerank,regulation of microtubule depolymerization (GO:0031114),0.19236674590873876,0.7289866717694939,0.9655172413793104,0.9489312795702197,1.0,2/24,4.80%,STMN2;MAP1A
prerank,histone H2A ubiquitination (GO:0033522),0.22788845387027645,0.728106771759142,0.9090909090909091,0.9490783442338868,1.0,4/17,15.95%,SKP1;RING1;UBE2B;RYBP
prerank,response to estradiol (GO:0032355),-0.22087921745471015,-0.72685570923976,0.8588235294117647,0.9714851780072178,1.0,10/35,25.19%,POU4F1;CYP19A1;WNT8B;TGFB1;POU4F2;STAT5B;RUVBL2;LCOR;ANXA1;CCDC62
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.2689011628768262,-0.7266036676432978,0.8823529411764706,0.9711279552534273,1.0,4/15,22.88%,SMARCA4;FOXH1;PHB;NODAL
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.20469281981986998,0.7249961024553772,0.7407407407407407,0.9518082273221489,1.0,7/20,19.84%,CLK2;C1QTNF3;CRY1;BCKDK;INS;SOGA1;EP300
prerank,regulation of calcium-mediated signaling (GO:0050848),-0.2413077887112255,-0.7245075616154282,0.8571428571428571,0.973061474056743,1.0,8/28,25.64%,GPR143;CCL4;CCL3;GBP1;NEUROD2;SLA2;PLEK;CLEC7A
prerank,sensory perception (GO:0007600),-0.22796032458385304,-0.7239562403064032,0.8860759493670886,0.9730067936786531,1.0,15/49,24.93%,MME;PRDM12;CHRNB2;NIPSNAP1;OBP2A;OPRM1;PROK2;ADGRV1;ALOXE3;USH1C;CLRN1;CHRNA7;USH2A;CHRNA4;SCN10A
prerank,cellular response to virus (GO:0098586),-0.23478365140808388,-0.7235213789506821,0.8734177215189873,0.9727420796506079,1.0,10/32,29.22%,IFI6;CXCL10;IL21;RRP1B;EIF5A;FMR1;IFNB1;BAX;ZC3H12A;CCL5
prerank,carbohydrate derivative transport (GO:1901264),-0.28025831613902313,-0.7232520357828539,0.921875,0.9722922112070304,1.0,10/18,40.90%,SCARB1;SLC29A2;SLC25A19;SLC10A7;SLC28A1;LBP;SLC15A4;SLC15A2;ABCG1;PLA2G10
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.2581785250302576,-0.7220125719915037,0.8591549295774648,0.9728481159694966,1.0,1/18,0.13%,MYC
prerank,peptide catabolic process (GO:0043171),0.24284923956759444,0.7209454693293582,0.92,0.9552537902582102,1.0,8/24,15.98%,CPQ;ECE1;LNPEP;NAALADL1;TPP1;LVRN;GGT5;GGT7
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.22596788340197577,-0.7207767643788184,0.8961038961038961,0.9735445924198214,1.0,13/29,35.58%,HSD17B12;ACSL6;SCD;ACSF3;FASN;ACSL5;ACACA;ELOVL7;TECR;ACSL3;ACSBG2;ACSL4;HACD2
prerank,dendritic spine morphogenesis (GO:0060997),-0.27954902194295683,-0.7207647126185207,0.7833333333333333,0.9728320402341706,1.0,4/16,15.90%,EPHB2;EPHB3;SHANK1;WNT7A
prerank,amyloid-beta metabolic process (GO:0050435),-0.253254980191238,-0.7204078196799317,0.8285714285714286,0.9724856668712396,1.0,2/17,6.66%,MME;BACE2
prerank,protein lipidation (GO:0006497),0.1605508527819151,0.7182506118356504,1.0,0.957290473702536,1.0,16/58,19.53%,WDR45;ATG12;GLUL;ZDHHC7;ZDHHC17;ZDHHC15;ZDHHC22;ZDHHC18;CWH43;PIGQ;PIGH;PORCN;ZDHHC1;ZDHHC20;PIGZ;UGCG
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.17902281054978775,0.7181428728297631,1.0,0.9567118770881977,1.0,8/59,9.81%,TLR3;BCL10;CTSS;CD36;UBB;HSP90B1;TLR9;TAB1
prerank,regulation of viral transcription (GO:0046782),-0.2160726448473086,-0.7171404261970119,0.8589743589743589,0.9755208460531926,1.0,12/41,32.86%,IFITM3;POLR2F;NELFCD;POLR2D;POLR2J;TRIM14;POLR2I;TRIM31;GTF2F2;DHX9;TRIM27;TRIM11
prerank,negative regulation of lyase activity (GO:0051350),0.24237242915082846,0.7150332488397266,0.8709677419354839,0.9586917557064362,1.0,2/16,6.52%,PALM;GNAI2
prerank,macromolecule catabolic process (GO:0009057),0.2031141801133139,0.7149027334099378,0.9,0.9580429545948093,1.0,5/28,11.89%,MTOR;ELANE;TPP1;CAPN3;LRSAM1
prerank,regulation of interleukin-13 production (GO:0032656),-0.26154376831580484,-0.7143586457357074,0.8309859154929577,0.9776182050551593,1.0,4/16,21.79%,LEF1;PRKCZ;TNFSF4;GATA3
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.18846625806927841,0.7120582984589705,0.9411764705882353,0.9598613553083616,1.0,3/30,8.16%,TLR3;UBB;TICAM2
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),-0.18897484494068878,-0.7116503476306014,0.9651162790697675,0.9799116460689983,1.0,37/76,42.77%,HSPA1A;MAZ;RTKN2;BCL2L1;RELA;ASAH2;PLAUR;MMP9;GATA4;BIRC6;PRELID1;BMP4;CSNK2A1;THBS1;FXN;TNF;BDNF;URI1;PSME3;MCL1;NOC2L;IGF1;TGFBR1;CX3CR1;OPA1;PPIF;SH3RF1;FZD9;ITGAV;CAAP1;IL4;GSTP1;TRIAP1;HTT;PHIP;SLC35F6;ITGA6
prerank,receptor catabolic process (GO:0032801),0.21312266133197164,0.7111463386517158,0.9166666666666666,0.96010400023046,1.0,7/25,18.61%,GPRASP1;AP2M1;MYLIP;AP2A2;VLDLR;SH3GLB1;AP2A1
prerank,regulation of oxidative phosphorylation (GO:0002082),0.20740397114116405,0.7105301488870895,0.9047619047619048,0.9598398168013091,1.0,2/16,6.77%,COX7A1;NUPR1
prerank,leukocyte tethering or rolling (GO:0050901),0.2128964011569888,0.7101506261786017,0.9285714285714286,0.9595062353630954,1.0,7/18,22.59%,JAM2;SELP;GOLPH3;ITGA4;ITGB1;MADCAM1;ITGB7
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.2232234969966733,0.7099721145270222,0.88,0.9588592931083174,1.0,6/19,15.25%,TIMM21;COX16;OXA1L;COA5;SURF1;COX14
prerank,ganglioside metabolic process (GO:0001573),0.22253045054560106,0.7098695574412573,0.8181818181818182,0.95821334006188,1.0,7/20,19.07%,ST6GALNAC3;B3GALT4;ST3GAL5;ST6GALNAC5;ST6GALNAC6;ST8SIA3;B4GALNT1
prerank,B cell differentiation (GO:0030183),-0.19903990967577295,-0.7084974446383778,0.8850574712643678,0.9825269436488581,1.0,29/60,43.17%,IL11;JAK3;IFNK;RAG1;RAG2;IL10;IFNE;PTPRJ;PTPN2;NFAM1;IFNB1;ADGRG3;IRF2BP2;TPD52;TCF3;IFNA1;CR2;IFNA21;AICDA;IFNA4;FNIP1;MSH2;IL4;IFNA7;IFNA10;IFNA14;IFNA17;IFNA2;IFNA16
prerank,regulation of spindle organization (GO:0090224),-0.25527860743808545,-0.7082963023025927,0.8939393939393939,0.9820049593440254,1.0,5/18,18.54%,TACC3;GPSM2;TPX2;PSRC1;RAE1
prerank,glial cell development (GO:0021782),-0.24298702036259767,-0.708255405569773,0.9066666666666666,0.9813092492436697,1.0,6/25,23.74%,SOX4;NF1;ZNF488;MYRF;MDK;CSPG5
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),-0.18991479764056132,-0.7080495785015879,0.9540229885057471,0.980861573224838,1.0,15/92,16.07%,CXCL8;TDGF1;POLR2F;FGF19;ANOS1;CD44;TRIM71;FGF20;SHCBP1;GALNT3;FGF23;NCBP1;FGF3;FGFRL1;POLR2D
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.1920775044350532,-0.7079522209853931,0.891566265060241,0.9802741961326364,1.0,9/66,12.58%,IFI6;AREG;EREG;EPGN;RHBDF2;PLAUR;PTPN3;AGT;MMP9
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.22980475628719518,-0.7075922721661412,0.8289473684210527,0.9798569502996856,1.0,6/21,24.58%,IL1B;C3;ENTPD1;NLRP3;SUGT1;MEFV
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.23815476507185618,-0.7066786994664025,0.835820895522388,0.9802570584278264,1.0,3/18,9.90%,SOCS3;STAT1;CEBPA
prerank,cortical actin cytoskeleton organization (GO:0030866),0.22971544357325327,0.7036603058352626,0.8571428571428571,0.9626000519885358,1.0,20/20,77.05%,NCKAP1L;RHOQ;RAB13;FHOD3;LLGL1;FHOD1;STRIP1;NCKAP1;ROCK1;FMNL2;FMNL1;FMNL3;ARF6;LLGL2;IKBKB;DLG1;LCP1;TNF;ROCK2;PLEK
prerank,regulation of cholesterol transport (GO:0032374),-0.2325949363009667,-0.7027565129131033,0.8918918918918919,0.9834865367589721,1.0,9/24,30.88%,ABCA13;LIPG;CETP;APOA2;APOC1;APOC2;ABCB4;APOA5;NUS1
prerank,positive regulation of viral transcription (GO:0050434),-0.2348708245355848,-0.7022657004801477,0.8732394366197183,0.9831885035604495,1.0,7/26,31.05%,POLR2F;NELFCD;POLR2D;POLR2J;POLR2I;GTF2F2;DHX9
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.24951232309761093,-0.7020910079022759,0.8356164383561644,0.9826401492013328,1.0,8/17,35.21%,TGFB2;NOD2;IL26;CARD9;LYN;SCIMP;PDCD10;EIF2AK2
prerank,NAD biosynthetic process (GO:0009435),0.20518815639061144,0.7018959152285954,0.8518518518518519,0.9632396342329864,1.0,3/19,8.19%,PARP16;PTGIS;NNMT
prerank,regulation of megakaryocyte differentiation (GO:0045652),-0.198617104316967,-0.7017393989606309,0.9523809523809523,0.9821648749122561,1.0,6/49,8.93%,TESC;RBM15;PF4;CBFB;RUNX1;ZFPM1
prerank,dicarboxylic acid metabolic process (GO:0043648),-0.20249881173278772,-0.7017152551839028,0.9166666666666666,0.9814880543274211,1.0,17/55,29.06%,MTHFD1L;DHFR;MTHFD1;GPT2;SHMT2;ASS1;MTHFD2;ALDH18A1;ALDH5A1;SLC19A1;SLC46A1;L2HGDH;GLUD2;HAAO;NAGS;GCLM;HOGA1
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.20810795516647346,-0.699968251501585,0.8414634146341463,0.9826262300151938,1.0,4/37,6.56%,AREG;EREG;EPHB2;EPGN
prerank,positive regulation of intracellular transport (GO:0032388),-0.20816900920975345,-0.6984758223163378,0.9259259259259259,0.9833829022889848,1.0,5/36,10.49%,KIF20B;SPAG5;PLA2G4E;ABCA12;SORL1
prerank,protein modification by small protein removal (GO:0070646),-0.16380386579280573,-0.6978991203909007,0.9897959183673469,0.9832832369464384,1.0,70/268,30.94%,MYC;OTUB2;CDK1;SKP2;USP50;RUVBL1;TNFAIP3;PSMB9;USP37;POLB;PSMD14;KDM1B;SMAD1;TNIP3;BRCC3;USP18;USP17L7;USP17L2;USP26;RNF128;NFKBIA;ACTL6A;MDM2;CFTR;TRRAP;USP9X;UCHL5;VCPIP1;BARD1;TRAF2;BRCA1;PSMA3;ACTR8;CLSPN;ASXL2;NLRP3;STAMBPL1;CDC25A;CDC20;USP17L1;GATA3;PSMB3;USP17L8;USP17L11;USP17L4;USP17L3;PSMA5;PSMD12;PSMB11;PSMB2;USP32;PSMA7;USP17L15;USP10;USP38;IKBKG;PSME2;SENP1;STAM;ADRM1;PSME3;ZC3H12A;PSMC1;USP42;USP1;USP34;TRAF6;USP31;PSME4;OTUD6B
prerank,negative regulation of phagocytosis (GO:0050765),0.22831816810461864,0.6971331634422688,0.8571428571428571,0.9664337019553455,1.0,3/15,12.74%,SYT11;SNX3;DYSF
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.17846822044732474,-0.6969636805591298,0.9775280898876404,0.9835438076732942,1.0,31/154,21.95%,HSPA1A;TNFSF11;IRAK2;RIPK2;CARD11;IL1B;CARD14;WNT5A;RTKN2;CAV1;NFKB2;RELA;IRAK1;RIPK4;RHEBL1;AGT;PRKCZ;TNFSF18;NFKBIA;ADAM8;PRKCQ;NOD2;TRAF2;TRIM22;IRAK3;CARD9;NLRP3;SLCO3A1;NPM1;TRIM14;PRKCI
prerank,negative regulation of dephosphorylation (GO:0035305),-0.2416130237327652,-0.696344971195231,0.9428571428571428,0.9834153838157624,1.0,8/19,38.57%,SH2D4A;PPP1R35;GPATCH2;TMEM225;URI1;YWHAB;PPP1R27;SH3RF2
prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.2646968185053601,-0.6959534264864342,0.9130434782608695,0.9831433185898203,1.0,2/16,6.51%,IRS1;PMAIP1
prerank,regulation of stem cell proliferation (GO:0072091),0.2108789880494611,0.6955418910184413,0.9259259259259259,0.9669999038787973,1.0,2/17,3.52%,ZFP36L1;FBLN1
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.16973601204238165,-0.6953154747872552,1.0,0.9829243462420388,1.0,52/184,31.66%,SPTBN2;AREG;FOLR1;F5;KDELR3;CTAGE4;CTAGE9;CTAGE8;F7;CTAGE15;COG5;CTAGE6;HYOU1;CD55;MIA2;GOLT1A;PROC;COG6;SPTB;STX17;COL7A1;SPAST;ANK1;PROZ;SPTBN5;CTSC;VTI1A;CNIH3;ERGIC3;KDELR2;TMED3;F9;TMED2;SEC24A;COPB2;CAPZA1;LMAN2;PGAP1;SPTA1;ERGIC2;ZW10;YIF1B;TRIP11;COG3;F2;COPG2;CTAGE1;CUL3;COPA;SEC13;TMED9;COPG1
prerank,protein-containing complex assembly (GO:0065003),-0.16534610284562407,-0.6949258265203222,0.968421052631579,0.9825860082406738,1.0,73/261,31.28%,CLDN1;MYC;TCF7;BLM;AREG;FOLR1;F5;PML;LEF1;PARD6B;CLDN14;FN1;RUVBL1;SOX9;BCL9L;TFAP4;AXIN2;CAPG;KNTC1;RSPH9;SMARCA4;NIFK;PPIH;TRAPPC9;COL7A1;REPS2;FANCA;ADAM10;SHANK1;FANCC;CTSC;SLC2A1;RBBP5;MDM2;TERT;TRRAP;CNIH3;USH1C;TRAF2;CD2AP;GSK3B;CD3G;FGA;TUBGCP4;TMED2;CDC123;SEC24A;FGB;CAPZA1;AXIN1;MDN1;TRAPPC10;MEFV;TNF;TSPAN33;ZW10;IKBKG;KMT2D;AIM2;FARP2;ZC3H12A;CREBBP;ADCY8;GEMIN5;CUL3;IL2RB;CDC73;AMER1;LEO1;DHX9;OTX2;SEC13;KMT2A
prerank,ion transport (GO:0006811),-0.17511696020437711,-0.6945564855323736,0.989247311827957,0.9821907537111626,1.0,30/116,27.46%,SLC12A2;GABRB1;PKD1L3;SLC26A9;SLC26A8;SLC9A7;SLC24A1;GLRA1;KCNN4;CHRNB2;SLC24A5;CNGB3;SLC12A1;SLC8A3;CHRNA2;VDAC1;SLC12A5;SLC5A8;CHRNA7;ATP11B;SLC9A4;SLC12A3;WNK4;CHRNA4;SLC5A5;SLC26A1;SLC25A22;LASP1;HCN4;PKD2L1
prerank,histone H3-K4 methylation (GO:0051568),-0.23507515863684497,-0.6944878196481584,0.9240506329113924,0.9815188082724228,1.0,12/30,32.11%,BEND3;TET3;PAXIP1;RBBP5;PRDM7;WDR5B;PRDM9;DYDC2;KMT2D;TET2;KMT2A;KDM6A
prerank,regulation of protein export from nucleus (GO:0046825),-0.23294822777463764,-0.693355624963745,0.9090909090909091,0.9819130901086394,1.0,5/23,19.16%,IL1B;GTSE1;XPO4;BARD1;GSK3B
prerank,regulation of B cell proliferation (GO:0030888),-0.20294243636263765,-0.6932424081725874,0.8888888888888888,0.9813282381943267,1.0,24/46,46.05%,MIF;EPHB2;CD81;IL21;CHRNB2;CTLA4;IL10;MNDA;TNFSF13B;LYN;TYROBP;VAV3;TNFRSF4;CD74;CD300A;RC3H1;AHR;IL2;IL4;IRS2;CD320;IKZF3;CD38;FCRL3
prerank,negative regulation of mRNA processing (GO:0050686),0.23844918014365107,0.6927768731229755,0.8695652173913043,0.9683463357881344,1.0,3/15,14.28%,SRSF4;PCBP4;SRSF7
prerank,mRNA polyadenylation (GO:0006378),-0.22410585981630823,-0.6924771358912821,0.8666666666666667,0.9805471591006101,1.0,13/24,45.24%,CPSF3;PABPC1;PNPT1;MTPAP;CPSF2;CSTF3;CDC73;LEO1;PAPOLB;PAPOLA;FIP1L1;GRSF1;PAPOLG
prerank,RNA polyadenylation (GO:0043631),-0.22410585981630823,-0.6924771358912821,0.8666666666666667,0.9805471591006101,1.0,13/24,45.24%,CPSF3;PABPC1;PNPT1;MTPAP;CPSF2;CSTF3;CDC73;LEO1;PAPOLB;PAPOLA;FIP1L1;GRSF1;PAPOLG
prerank,secondary alcohol metabolic process (GO:1902652),-0.20074081299577057,-0.6918334623106861,0.9493670886075949,0.9803503719432022,1.0,5/48,6.88%,SULT2B1;SQLE;ANGPTL3;NR0B2;CETP
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.16888678905902027,-0.6914891761182452,1.0,0.9799729980814225,1.0,82/164,49.31%,HELZ2;DCPS;MAGOHB;RPL39;PABPC1;EXOSC8;RPS19;NCBP1;CNOT1;MRTO4;EXOSC5;EXOSC4;POLR2D;RPS21;RPL36;CNOT10;MTPAP;MAGOH;XRN2;RPL37;PDE12;EXOSC7;RPL8;RPL23A;NBAS;CNOT11;DHX34;ZC3H12A;GSPT1;SMG1;RPS7;PATL1;XRN1;ERI1;CNOT6;RPS18;PAN3;SMG7;RPS2;EIF4A3;RPL4;DIS3L2;RBM8A;RPS3;RPL35;RPS4X;RPL18;RPL32;DCP2;RC3H1;RPL41;PATL2;RPS24;SMG6;RC3H2;RPL27A;RPS29;RPL19;RPL38;EIF3E;RPL37A;PPP2R2A;LSM1;RPS14;RPL12;RPLP2;PARN;RPL30;NCBP2;RPL28;RPLP0;EXOSC6;RPL31;UPF3B;CNOT4;RPS28;RPS3A;RPS15;UBA52;RPL18A;CNOT6L;RPS11
prerank,negative regulation of RNA metabolic process (GO:0051253),0.20710731256615716,0.6907135910182055,0.8076923076923077,0.969118353131985,1.0,3/19,6.92%,PTBP2;KAT2B;NUDT16
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.27092730084190014,-0.6906555112200046,0.85,0.9800099665236043,1.0,4/17,26.22%,EGR1;FGFR4;NR5A1;WNT4
prerank,regulation of developmental growth (GO:0048638),0.18995394035163127,0.688761555382973,0.95,0.9697332154113867,1.0,9/30,17.50%,PRL;SOD1;LATS2;APP;OLFM1;SIN3A;FGFR3;DLL1;GHR
prerank,regulation of lymphocyte activation (GO:0051249),-0.24986991572821093,-0.6861511733334924,0.868421052631579,0.983578282554925,1.0,12/15,55.25%,SIT1;CRTAM;LCK;CLEC7A;CCL5;IKZF3;FCRL3;LAT;CD4;CD19;DCAF15;PAG1
prerank,apoptotic nuclear changes (GO:0030262),0.20347771270359105,0.6856465213120423,0.8695652173913043,0.9713689076559757,1.0,3/22,10.14%,CASP3;GPER1;DNASE1L3
prerank,regulation of vacuole organization (GO:0044088),0.2087197390634375,0.6831845732970472,0.9354838709677419,0.9721195664838258,1.0,10/20,24.61%,ENO2;ADPRH;ANXA2;ENO3;IFT20;SCARB2;ENO1;NPRL2;UBQLN2;MTM1
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.2441972291888624,-0.6825853241295909,0.9090909090909091,0.9860633396812947,1.0,8/19,37.62%,TRIM71;HENMT1;TERT;TSN;DROSHA;MRPL44;TARBP2;AGO2
prerank,Golgi organization (GO:0007030),-0.17052907822684155,-0.6822961953307373,0.9772727272727273,0.9856639639686477,1.0,37/129,32.05%,ZFP69B;CDK1;VRK1;USP6NL;VMP1;STX17;GOLGA8H;GOLGA8T;SPTBN5;PI4K2B;GOLGA8J;GOLGA6C;VTI1A;GOLGA6D;GOLGA8O;VCPIP1;ARFGEF1;GOLGA8K;TMED3;FHDC1;TMED2;GOLGA8S;GOLGA8M;GOLGA8F;GCC2;LMAN2;STX6;GOLGA6A;ZW10;GOLGA6B;TRIP11;HUWE1;COG3;PLK5;TMED9;GOLGA8R;GORASP2
prerank,melanosome organization (GO:0032438),-0.22218235753825616,-0.6809330314298984,0.9210526315789473,0.9861425544700616,1.0,6/27,21.38%,GPR143;ABCB6;SHROOM2;PMEL;AP3B1;ASIP
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.16062408420807464,0.6807679114212485,1.0,0.9732667967387152,1.0,10/54,13.91%,CLIP3;PELI3;F2RL1;TAX1BP1;GPS2;TRAF1;TNFRSF1A;CFLAR;RIPK1;RNF31
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.18379905702873237,-0.6803494524830115,0.9404761904761905,0.9859237866737757,1.0,11/67,23.34%,POLR2F;INTS7;CCNK;CDK7;NCBP1;POLR2D;POLR2J;INTS2;INTS6;NABP1;POLR2I
prerank,regulation of platelet activation (GO:0010543),-0.23368920260226453,-0.6789587935302132,0.8493150684931506,0.9862357498965938,1.0,8/22,29.16%,THBD;SYK;PRKCQ;TEC;HRG;PLEK;LYN;F2
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.24650963016089883,-0.6775754373128687,0.9605263157894737,0.9865567314633904,1.0,4/16,25.20%,IFI6;RHBDF2;WDR54;EGF
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.12764367719725797,0.6770478983661883,1.0,0.975345334643239,1.0,54/246,19.59%,SRSF5;PABPN1;NOVA1;SNRNP70;DHX35;CPSF7;HNRNPH3;DDX39B;RBM4;U2AF1L4;SNRPN;CASC3;ISY1;RBM6;SRSF4;SRSF11;SF1;HNRNPH2;SRRM2;RNPC3;SF3B1;CWC25;RBM5;DDX42;SYF2;PDCD7;METTL3;SRRM1;PNN;SRSF7;IK;DHX16;SF3B4;HSPA8;RBM17;PLRG1;DNAJC8;WBP4;CD2BP2;NOVA2;POLR2A;SNW1;ZMAT2;PCBP2;MFAP1;SNIP1;ZRSR2;SRSF1;RAVER1;SRSF2;RBM4B;PRPF4B;ZMAT5;XAB2
prerank,positive regulation of cell development (GO:0010720),-0.1977307388063408,-0.6769189512283513,0.9240506329113924,0.9864279896898074,1.0,6/37,17.01%,MME;RASSF10;LRP2;IFNG;BMP4;OPRM1
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.23578171252919208,-0.676849547265813,0.9605263157894737,0.9857937803672103,1.0,7/20,29.55%,PIK3AP1;TNIP3;IRAK1;NMI;ITGB2;SCIMP;LBP
prerank,ureteric bud development (GO:0001657),-0.255173043822028,-0.6760782440476302,0.8461538461538461,0.9857366025807843,1.0,6/19,19.12%,ROBO2;SIX1;BMP7;WNT11;BMP4;LHX1
prerank,cellular response to misfolded protein (GO:0071218),0.21828230778087757,0.6759451048654455,0.9047619047619048,0.9753661213849039,1.0,8/19,23.46%,DNAJC18;RNF185;POMT2;DNAJB12;BAG6;RNF5;KLHL15;ATXN3
prerank,response to zinc ion (GO:0010043),-0.22233921881095414,-0.6734136963882933,0.8714285714285714,0.9870244127713206,1.0,8/29,28.69%,SLC30A2;GLRA1;KHK;GLRA2;ATP13A2;SLC30A5;HAAO;MT4
prerank,mRNA destabilization (GO:0061157),-0.20618726885812863,-0.6733019343416365,0.8974358974358975,0.9864099975363505,1.0,14/34,36.21%,PLEKHN1;TRIM71;DCPS;MEX3D;CNOT1;POLR2D;ROCK2;PDE12;KHSRP;ZC3H12A;YTHDF1;ZC3H12D;GIGYF2;DIS3L2
prerank,establishment of epithelial cell polarity (GO:0090162),-0.23871529550329829,-0.6727079865438037,0.875,0.9861875743037226,1.0,7/20,31.49%,FERMT1;SIPA1L3;MSN;SYNE4;CAMSAP3;EZR;RAP2A
prerank,histone monoubiquitination (GO:0010390),-0.22258775989843715,-0.6725937735365248,0.8607594936708861,0.9855605036837541,1.0,13/24,40.09%,UHRF1;RAG1;RNF2;RNF40;DTX3L;CDC73;LEO1;KDM2B;BCOR;TRIM37;RNF168;PCGF1;CTR9
prerank,intracellular pH reduction (GO:0051452),-0.20316312734335956,-0.6724885104567899,0.926829268292683,0.9849813810396987,1.0,10/35,30.58%,ATP6V1C2;GPR89A;GPR89B;ATP6V0A4;CLCN3;RAB39A;ATP6V1A;DMXL2;RAB20;ATP6V0A2
prerank,glycolipid metabolic process (GO:0006664),-0.1816119006811951,-0.6712315380363049,0.9629629629629629,0.9853247110540163,1.0,11/52,21.23%,ST8SIA6;PIGW;ENPP7;GLB1;NEU1;GLA;SMPD2;HEXB;UGT8;B3GNT5;FUT2
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.19448983025200345,0.670691483854489,0.9642857142857143,0.9779229929505988,1.0,3/18,9.20%,FGF2;SRF;PIK3R3
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.2247958554781586,-0.6704207612173807,0.9166666666666666,0.9851929695788555,1.0,7/21,27.51%,PAX2;MMP3;TRAP1;SLC18A2;BRCA1;AATF;TFAP2A
prerank,snRNA transcription (GO:0009301),-0.18105433682251898,-0.6700684078111223,0.9759036144578314,0.9847562071597926,1.0,11/68,23.34%,POLR2F;INTS7;CCNK;CDK7;NCBP1;POLR2D;POLR2J;INTS2;INTS6;NABP1;POLR2I
prerank,carbohydrate catabolic process (GO:0016052),-0.18970334783938586,-0.6671054463459589,0.9583333333333334,0.9866426919999624,1.0,13/40,30.73%,HKDC1;GAPDHS;ALDOB;ENO4;PKLR;NEU1;PFKFB1;GAPDH;LDHA;MANBA;PKM;PGAM4;TPI1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.17708198301148906,-0.6654800431621367,0.9882352941176471,0.9872980226482729,1.0,23/64,38.70%,HTR1D;SSTR5;AGT;TSHR;MTNR1A;OPRM1;HRH3;OR10H1;HTR6;HTR2C;MTNR1B;ANXA1;XCR1;HTR1F;MC3R;SSTR3;HTR1B;MC2R;PTGIR;OR10H5;OR6T1;GALR3;HTR5A
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.17259488159992595,0.6652313395079853,0.9629629629629629,0.980407038563324,1.0,1/25,0.48%,FKBP5
prerank,RNA splicing (GO:0008380),-0.175185200964208,-0.6650652976416098,0.975609756097561,0.9868888101180397,1.0,32/97,34.62%,DDX47;U2AF1;SRPK1;RNF113B;SNRPD1;MAGOHB;SF3B3;RSRC1;SNRPF;SNRPG;CDK12;NCBP1;PRPF4;FUS;PRPF6;SNRPA1;WDR83;MAGOH;LSM4;RNF113A;KHSRP;SNRPB;DHX8;IVNS1ABP;SYNCRIP;SNRNP40;WT1;SNRPD3;PTBP1;SRPK2;HNRNPC;SNRPD2
prerank,apoptotic cell clearance (GO:0043277),-0.2103027347616752,-0.663912962576154,0.9605263157894737,0.987093546345229,1.0,10/33,28.62%,XKR9;SCARB1;XKR5;XKR6;XKR7;THBS1;HMGB1;ANXA1;TYROBP;RHOH
prerank,TOR signaling (GO:0031929),-0.21657504699050428,-0.6623052815805404,0.975,0.9875038640962561,1.0,9/25,33.31%,CARD11;SYAP1;RHEBL1;EIF4EBP1;GATA3;SMG1;LARP1;PRR5;NPRL3
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.17431686575950464,0.6622794738756891,0.9565217391304348,0.9814058576642128,1.0,10/29,21.72%,NGF;FGF10;NTRK1;JAK2;MMD2;STK19;EPOR;GRB2;RAPGEF1;SHC1
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.21901312074837118,-0.6618331556210663,0.9078947368421053,0.9871655079617223,1.0,8/21,30.66%,TIMM8A;PMAIP1;ROMO1;TIMM13;TIMM10;BAX;HSPA4;COX18
prerank,fatty acid metabolic process (GO:0006631),-0.15841669130298722,-0.6614745576298215,0.9659090909090909,0.9867995963878377,1.0,26/123,23.78%,AOAH;BAAT;PNPLA3;ACSL6;CEL;ANGPTL3;NUDT19;LIPG;ACBD5;ACSM6;ALOX12;ACSM4;ACSF3;ACOT6;PON3;PON1;ALOX12B;ALOXE3;CYP4F11;FASN;ACOT12;ACSL5;ACACA;XBP1;PPARG;SLC27A5
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.24151609253005268,-0.659198947540177,0.9411764705882353,0.9878489027519122,1.0,5/15,29.56%,BRCA2;ATR;TERT;ATRX;XRCC5
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.22235929436238985,-0.65879368430687,0.9577464788732394,0.9874970224115016,1.0,8/24,30.99%,LAMP3;PML;PRKCG;CSNK2A1;HIPK2;EFNA1;RPS7;TAF1
prerank,regulation of leukocyte migration (GO:0002685),0.206492175261152,0.6574685147057782,0.8484848484848485,0.9837974533794248,1.0,3/17,7.14%,RAC1;HMOX1;NCKAP1L
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.16119858859026653,0.6571626718240068,1.0,0.9831753675970372,1.0,17/47,21.31%,MFN2;TIMM21;HK2;MGARP;HK1;AIP;TOMM7;CHCHD4;MFF;TIMM22;PAM16;TIMM44;TOMM40L;PITRM1;DNLZ;PINK1;FBXO7
prerank,RNA destabilization (GO:0050779),0.19816841463516233,0.6552290055748601,0.9615384615384616,0.9833448422132562,1.0,4/17,17.33%,RBM24;DXO;METTL3;CELF1
prerank,regulation of G0 to G1 transition (GO:0070316),-0.209941233442901,-0.6547212936363878,0.9875,0.9898684772134517,1.0,9/40,18.99%,CHEK1;E2F1;TFDP1;RBBP8;CDC7;CBX3;RNF2;BRCA1;HLA-G
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.20443108030693358,-0.6546315925564655,0.958904109589041,0.9892268047967412,1.0,9/28,26.42%,IL1B;IFNG;ASS1;DDAH1;AGXT2;MMP8;TNF;CLEC7A;TMEM106A
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.18489771074461459,0.6540874461697255,0.9310344827586207,0.983101873762859,1.0,1/20,1.20%,STMN2
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.19703977798334857,0.6536672707766332,0.9259259259259259,0.9824645555221052,1.0,21/21,80.31%,CASP3;MUS81;DNASE1L3;SETMAR;CECR2;KPNA1;DNASE2;DFFB;DICER1;DFFA;EXOG;REXO4;DNASE2B;HMGB2;DNASE1L2;KPNB1;DNASE1L1;DNASE1;HMGB1;FOXL2;ENDOG
prerank,glycoprotein catabolic process (GO:0006516),0.19766283541103163,0.6531910991181491,0.9259259259259259,0.981948236851101,1.0,3/17,9.35%,FBXO17;FBXO44;FBXO27
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.24146176876627584,-0.651203838379161,0.95,0.9903794540799208,1.0,3/15,14.48%,NANOS3;PABPC1;CNOT1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.24146176876627584,-0.651203838379161,0.95,0.9903794540799208,1.0,3/15,14.48%,NANOS3;PABPC1;CNOT1
prerank,neuromuscular junction development (GO:0007528),-0.2208109600346133,-0.6504396849838272,0.922077922077922,0.9901525620064944,1.0,5/24,16.43%,LRP4;DOK7;AGRN;F2R;GPHN
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.23298827683342346,0.6482259765197651,0.9642857142857143,0.9837802917489934,1.0,7/15,25.14%,CAMLG;EMC6;EMC4;BAG6;SGTA;EMC7;EMC9
prerank,posttranscriptional regulation of gene expression (GO:0010608),-0.19146815501535464,-0.6475005566337029,0.9529411764705882,0.9913523148150895,1.0,10/44,23.03%,TRIM71;MATR3;NANOS3;GRM5;MEX3D;EIF4E;NOLC1;LARP4;PKP3;MAPKAPK5
prerank,regulation of synapse organization (GO:0050807),-0.20534084731169572,-0.6473227762644536,0.9090909090909091,0.99075363819396,1.0,2/26,3.22%,KLK8;WNT5A
prerank,regulation of hippo signaling (GO:0035330),-0.23191692511530115,-0.6452261985948665,0.9054054054054054,0.9913713487967486,1.0,8/20,36.30%,WWC1;AJUBA;NEK8;CIT;SCHIP1;SHANK2;VGLL4;NF2
prerank,proteoglycan biosynthetic process (GO:0030166),0.1763696580763056,0.6436482214292866,1.0,0.9853869964203246,1.0,9/31,17.72%,CHST10;CHST9;FAM20B;CHST8;B3GAT1;CSGALNACT2;UGDH;GAL3ST4;B3GAT3
prerank,respiratory chain complex IV assembly (GO:0008535),0.20196610287581887,0.6436451387698576,0.9523809523809523,0.9846472163929819,1.0,6/22,15.25%,TIMM21;COX16;OXA1L;COA5;SURF1;COX14
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.16447293333405538,0.6418796271356318,1.0,0.98448985045188,1.0,3/31,8.16%,TLR3;UBB;TICAM2
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.20706240221236202,0.6414507131523963,0.92,0.9839397800680408,1.0,6/15,22.55%,HSP90B1;TMEM129;SEL1L;HERPUD1;SYVN1;DERL2
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.21332756694887073,-0.6396284784580851,0.9487179487179487,0.9941625890302727,1.0,4/28,12.27%,NOTCH3;DLK2;LFNG;CHAC1
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.21648491190950644,-0.6394223831642128,0.918918918918919,0.9935909995952673,1.0,3/20,14.01%,LRP8;CAPRIN1;PTPRD
prerank,glucuronate metabolic process (GO:0019585),-0.236871974846533,-0.6388740043623642,0.9090909090909091,0.9932007707779428,1.0,10/15,48.33%,UGT2B4;UGT2B7;UGT1A6;UGT2A1;UGT1A7;UGT1A4;UGT2A2;UGT1A3;ABHD10;UGT1A9
prerank,cytoplasmic translational initiation (GO:0002183),0.20503007919403843,0.6386225200790027,0.9230769230769231,0.984448970901081,1.0,5/18,15.06%,RBM4;EIF4A1;EIF4A2;EIF5;EIF4H
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.21116786979872282,0.6378785363415437,0.9615384615384616,0.9840362248837894,1.0,3/15,13.92%,AGPAT1;TSLP;IL7
prerank,long-chain fatty acid biosynthetic process (GO:0042759),-0.20111613365001285,-0.6365152311275314,0.9506172839506173,0.9938936904257731,1.0,6/29,17.71%,ASAH2;ALOX12;ASAH2B;CYP2D6;ALOX12B;ALOXE3
prerank,regulation of glucose metabolic process (GO:0010906),-0.2044981140886188,-0.6342505951254939,0.9594594594594594,0.9944469428469962,1.0,3/31,10.36%,IRS1;PMAIP1;KHK
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.1732294905112362,-0.6332564413053946,0.9759036144578314,0.9943156561867219,1.0,10/72,16.06%,RFC3;ERCC5;DNA2;RPA3;FEN1;RFC5;HORMAD1;RFC2;GTF2H2;POLD2
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.19483287262731636,-0.6326073056995009,0.9259259259259259,0.9939998803600022,1.0,8/39,20.85%,SERPINE1;C3;BMP2K;SMAP1;APOC1;PIK3CB;MKLN1;APOC2
prerank,smoothened signaling pathway (GO:0007224),0.16671661131387994,0.6324447899983434,1.0,0.9861639547089877,1.0,11/32,21.85%,PTCHD1;GLI3;CC2D2A;SMO;STK36;EVC2;PTCH2;GLI2;MAP3K10;TMEM17;TTBK2
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.21326169876281748,0.6305443957650417,0.92,0.9862445093021315,1.0,3/16,8.60%,PELI3;F2RL1;GPS2
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.22842585609662253,0.6304804830949785,0.9090909090909091,0.9855419974082145,1.0,2/17,4.09%,RGS10;CHRM2
prerank,global genome nucleotide-excision repair (GO:0070911),0.1699295140337709,0.6302333264835724,0.96,0.9849255733741156,1.0,7/26,21.40%,UBB;ERCC3;GTF2H4;XPA;CETN2;DDB2;GTF2H5
prerank,acute-phase response (GO:0006953),-0.22941488255042777,-0.6300432567757663,0.9571428571428572,0.9947548984605271,1.0,1/15,0.22%,CEBPB
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.20015066187195565,-0.6299597445075302,0.9629629629629629,0.9941119201780645,1.0,12/32,34.17%,CXCL8;C3;MFSD12;MED1;TNFRSF1B;FGFR4;FITM2;EIF6;CCL5;NOS1AP;CX3CR1;CD47
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.20768011328154584,-0.6293985830846784,0.9428571428571428,0.9937048032598144,1.0,9/23,33.62%,FUT8;FUT1;FUT7;FUT2;FUT6;FUT5;B4GALT1;B3GALT2;ST3GAL2
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.17327355609167933,0.6288093107653652,0.9166666666666666,0.9847689386563899,1.0,3/23,7.76%,UBB;RNF185;MAN1C1
prerank,histone modification (GO:0016570),-0.1595817203576269,-0.6286011820734209,1.0,0.993394936369533,1.0,12/110,11.18%,INCENP;PADI1;PADI3;RUVBL1;HDAC10;AURKB;UHRF1;EYA1;HLCS;NTMT1;CPA4;PARP2
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.22883106849862453,-0.6237606356717603,0.921875,0.9951788416000107,1.0,8/17,48.47%,USP17L2;ANKRD17;C1QBP;OASL;TRIM15;PUM1;DDX60;PUM2
prerank,phosphate ion transport (GO:0006817),-0.22511061952263367,-0.623257787225316,0.9295774647887324,0.9947856247226562,1.0,7/17,39.33%,SLC34A3;SLC34A1;SLC34A2;SLC37A1;SLC17A1;SLC17A3;SLC37A4
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.17548304811559615,-0.6232515806607352,0.9770114942528736,0.9940943213003334,1.0,16/56,30.89%,PSMB9;PSMD14;AURKA;RFPL1;PSMA3;PSMB3;PSMA5;PSMD12;PSMB11;PSMB2;GPR132;PSMA7;PSME2;PSME3;PSMC1;PSME4
prerank,proteoglycan metabolic process (GO:0006029),-0.20442459586578998,-0.6222971657050863,0.9,0.993872276773152,1.0,10/25,33.78%,ADAMTS12;HS3ST4;CANT1;SULF2;FOXL1;B4GALT7;HPSE;CHST13;IGF1;B3GALT6
prerank,regulation of interferon-alpha production (GO:0032647),-0.2184316041787787,-0.6213764772859443,0.922077922077922,0.9937377120116875,1.0,10/25,36.60%,RIPK2;HSPD1;STAT1;IL10;TLR7;DHX9;IRF7;TLR8;IRF3;LILRA4
prerank,protein targeting to ER (GO:0045047),-0.16183225050204214,-0.6211010198521829,1.0,0.9932182109840754,1.0,53/101,53.34%,SRPRB;RPL39;RPS19;RPS21;RPL36;SRP72;RPL37;RPL8;RPL23A;RPS7;RPS18;RPS2;SEC61G;SEC61A1;RPL4;RPS3;RPL35;RPS4X;RPL18;RPL32;RPL41;EDEM1;RPS24;RPL27A;RPS29;RPL19;RPL38;RPL37A;RPS14;RPL12;RPLP2;RPL30;SPCS2;SPCS1;RPL28;RPLP0;SRP9;RPL31;RPS28;RPS3A;RPS15;UBA52;RPL18A;RPS11;SRP54;RPS5;RPL5;RPS6;RPS9;RPL7A;RPL11;RPL29;RPL35A
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.2085174032756751,-0.6196049808934407,0.9487179487179487,0.9931255205703156,1.0,3/26,7.64%,TRIM71;PUS10;SMAD1
prerank,microvillus assembly (GO:0030033),-0.23727030202538163,-0.6184414013919701,0.918918918918919,0.9929459680564754,1.0,3/15,18.47%,FXYD5;STK26;RAP2B
prerank,neural crest cell differentiation (GO:0014033),0.175480956300149,0.6170468843512326,1.0,0.9882977441865174,1.0,6/19,18.90%,TAPT1;MEF2C;CDH2;PEF1;SNAI2;SOX8
prerank,response to cholesterol (GO:0070723),-0.21171629553913718,-0.614673316928884,0.9615384615384616,0.9941072204679728,1.0,8/19,35.28%,CCL3;TGFB1;TGFBR2;PTCH1;MLC1;GRAMD1B;TGFBR1;GPLD1
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.14745279972471484,0.6144198719260412,1.0,0.9883933799257745,1.0,4/43,6.45%,RBM24;ZFP36L1;ZFP36;BTG2
prerank,gene silencing by miRNA (GO:0035195),-0.19871173863476554,-0.6137601398213937,0.9047619047619048,0.9938860883667912,1.0,3/31,5.77%,TRIM71;XPO5;AJUBA
prerank,cardiac muscle cell differentiation (GO:0055007),-0.21135979702960628,-0.6104215053546698,0.9305555555555556,0.9947298281984237,1.0,6/24,20.58%,ALPK2;CXADR;MYH11;IRX3;SHOX2;TTN
prerank,spermatid development (GO:0007286),-0.18059254629234306,-0.6093284734519462,0.9759036144578314,0.9945861901282032,1.0,14/40,32.40%,PIWIL1;SYCP3;RIMBP3C;RIMBP3;RIMBP3B;ZMYND15;SOX30;TDRD5;FAM9A;TOPAZ1;TSSK1B;FAM9B;SPANXB1;GALNTL5
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.16818346675321638,0.6091765700857955,1.0,0.9896080517357035,1.0,2/25,3.20%,FNTB;CALM1
prerank,regulation of leukocyte activation (GO:0002694),-0.21906812209282248,-0.606891996059443,0.9333333333333333,0.9949857053903911,1.0,6/16,34.49%,MIF;LILRB4;LCK;LYN;PLSCR1;CD74
prerank,proton transmembrane transport (GO:1902600),-0.1812303691618241,-0.606425033021512,0.987012987012987,0.9944910073954003,1.0,6/33,18.80%,SLC4A11;ATP6V0A4;UCP1;ATP12A;SLC46A1;SLC36A3
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.19928553539926702,-0.6063335088810509,0.9722222222222222,0.9938694132282668,1.0,6/23,23.73%,CAV1;ABCA12;NFKBIA;PON1;PTCH1;PPARG
prerank,regulation of postsynapse organization (GO:0099175),-0.1901423314565233,-0.6061069115599563,0.95,0.9932668881343435,1.0,8/28,31.76%,WNT5A;HOMER1;CDK5;VPS35;ABHD17C;CDK5R1;LZTS3;PPFIA2
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.22016734697661433,-0.6034407624634792,0.9722222222222222,0.9939528670303415,1.0,7/19,33.79%,SELL;GCNT1;SLC39A8;TNF;SELPLG;PODXL2;CX3CR1
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.21335390478872895,-0.6022539856926583,0.918918918918919,0.9937466986428614,1.0,6/18,29.16%,ADCY7;LILRB4;CHID1;MEFV;ZC3H12A;F2
prerank,response to exogenous dsRNA (GO:0043330),-0.1950095244388314,-0.6012371073883572,0.9135802469135802,0.9934726561587484,1.0,16/33,43.17%,IFNK;CAV1;IFNE;IRAK3;SLC3A2;IFNB1;DHX9;IFNA1;IFNA21;IFNA4;IFNA7;IFNA10;IFNA14;IFNA17;IFNA2;IFNA16
prerank,positive regulation of exosomal secretion (GO:1903543),-0.20964606310231113,-0.5993170497216194,0.9538461538461539,0.9936031134636013,1.0,4/15,27.95%,IFNG;ATP13A2;SDC1;STAM
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.22300809072271505,-0.5939223711879251,0.9333333333333333,0.9948814033270028,1.0,6/17,31.28%,SUV39H2;SUV39H1;SMYD2;PRDM9;KMT2D;KMT2A
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.15361822870951383,-0.5914477087973905,0.9886363636363636,0.9951512844380742,1.0,6/88,5.78%,KIF14;FBXL13;SKP2;FBXL18;PSMB9;PSMD14
prerank,cellular response to sterol (GO:0036315),0.18902492733198276,0.5891143424562697,1.0,0.9952265239110825,1.0,16/16,81.11%,OSBPL7;SMO;CES1;RORA;INSIG2;GRAMD1C;CYP7A1;GRAMD1A;RORC;DYNAP;LRP6;INSIG1;GPLD1;GRAMD1B;MLC1;PTCH1
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.16646159186521892,-0.587487684556099,0.9878048780487805,0.9944654042835316,1.0,3/63,2.21%,AREG;FOLR1;F5
prerank,COPII vesicle coating (GO:0048208),-0.16646159186521892,-0.587487684556099,0.9878048780487805,0.9944654042835316,1.0,3/63,2.21%,AREG;FOLR1;F5
prerank,vesicle coating (GO:0006901),-0.16646159186521892,-0.587487684556099,0.9878048780487805,0.9944654042835316,1.0,3/63,2.21%,AREG;FOLR1;F5
prerank,medium-chain fatty acid metabolic process (GO:0051791),0.1945215131897653,0.5841773801113059,0.975,0.9957739642107011,1.0,15/15,80.56%,CROT;ACADM;CES1;ABHD3;OLAH;CRAT;CYP4Z1;OXSM;ACAD9;ACOT7;GLYATL2;ABHD1;CYP4A11;CYP4A22;ABHD2
prerank,regulation of dendrite extension (GO:1903859),0.1751673713883015,0.5836606782185361,0.9629629629629629,0.9950516305636803,1.0,18/18,82.50%,SYT4;SYT1;OSTN;CPNE5;RNF157;ITSN2;NEDD4L;CPNE9;CPNE6;SMURF1;SYT17;SYT3;SYT2;RIMS2;UNC13A;RIMS1;PLAA;RASAL1
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),-0.1605455929066491,-0.5802097211727005,1.0,0.9962587714769023,1.0,15/75,20.82%,POLR2F;FGF19;ANOS1;TRIM71;FGF20;SHCBP1;GALNT3;FGF23;NCBP1;FGF3;FGFRL1;POLR2D;FGFR4;POLR2J;SPRED1
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.21037166209865787,-0.5770077540743234,0.963855421686747,0.9966623583439873,1.0,6/16,32.82%,PDGFRB;S100A11;MDK;CCL5;NRP1;IGF1
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.1854594674275888,-0.57496129691713,0.971830985915493,0.9966092880393496,1.0,2/23,5.21%,DNMT1;DNMT3B
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.13803377310349396,0.574890628184633,1.0,0.9965789903216223,1.0,10/42,19.04%,INO80B;DMAP1;SMARCA1;CHD3;ACTB;SMARCE1;ACTR6;ACTL6B;MBD3;SRCAP
prerank,apoptotic DNA fragmentation (GO:0006309),0.19698771304003165,0.574177224848966,0.88,0.99599228601083,1.0,15/15,80.31%,CASP3;DNASE1L3;CECR2;KPNA1;DNASE2;DFFB;DICER1;DFFA;EXOG;DNASE2B;HMGB2;KPNB1;HMGB1;FOXL2;ENDOG
prerank,positive regulation of dendrite extension (GO:1903861),0.1751596564633341,0.5698950321276381,1.0,0.996132371848622,1.0,17/17,82.50%,SYT4;SYT1;CPNE5;RNF157;ITSN2;NEDD4L;CPNE9;CPNE6;SMURF1;SYT17;SYT3;SYT2;RIMS2;UNC13A;RIMS1;PLAA;RASAL1
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.18629832042547873,-0.568452698602667,0.9878048780487805,0.9978018275997866,1.0,3/28,10.91%,IRAK2;HSPD1;IRAK1
prerank,peroxisomal membrane transport (GO:0015919),0.15042385219772184,0.5684415779097962,1.0,0.9956312136040495,1.0,10/27,24.17%,PEX19;PXMP2;RAB8B;ALDH3A2;ABCD4;PEX11B;PEX6;ABCD1;PEX12;PEX14
prerank,COPII-coated vesicle budding (GO:0090114),-0.15772497961955906,-0.5661142883300433,0.9876543209876543,0.9977570719092941,1.0,4/70,4.59%,AREG;FOLR1;F5;SEC23B
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.2075201851854045,-0.5659473842692955,0.9565217391304348,0.9971220042153667,1.0,8/17,41.47%,MBTPS2;RAN;ERLIN1;KPNB1;SEC14L2;ABCG1;LPCAT3;ERLIN2
prerank,positive regulation of growth (GO:0045927),0.1284159627592426,0.5649724429377742,1.0,0.9955185056368314,1.0,15/70,19.08%,AKAP6;LGI1;EGFR;WFS1;GH1;SFRP1;KLHL22;USP47;N6AMT1;PPM1F;BCL2;INS;SFRP2;TAF9B;ZNF639
prerank,linoleic acid metabolic process (GO:0043651),-0.184467286561387,-0.5600105653725379,0.971830985915493,0.9980055130290074,1.0,4/21,19.45%,ALOX12;ALOX12B;ALOXE3;CYP4A22
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.2130161179143188,-0.558492348440967,0.953125,0.9977311831251472,1.0,10/15,52.74%,GSTO2;ZC3H12A;ATF3;MAPK13;PPIF;ZFAND1;VCP;DHX36;HNRNPA1;GSTO1
prerank,"mRNA splicing, via spliceosome (GO:0000398)",-0.1308196089484719,-0.5549162724269261,1.0,0.9978979782253685,1.0,81/269,37.62%,POLR2F;U2AF1;CSTF2;RBM15;SRPK1;TGS1;DCPS;CPSF3;SMN1;SNRPD1;PPIH;RBMXL2;MAGOHB;SF3B3;RSRC1;SNRPF;SNRPG;ELAVL2;PABPC1;LSM7;WDR77;CSTF1;RBM41;NCBP1;PRPF40A;LSM8;POLR2D;ALYREF;LSM5;CLNS1A;SRSF9;PPIL1;PRPF4;PSPC1;EFTUD2;FUS;POLR2J;PRPF6;SNRPA1;WDR83;CRNKL1;POLR2I;CPSF2;MAGOH;LSM4;RNF113A;DDX39A;SNRPB;PRPF19;CSTF3;DHX8;SYNCRIP;GEMIN5;RBMXL3;CPSF4;CDC5L;GTF2F2;SNRPE;DHX9;SNRNP40;SNRPD3;CDK13;PTBP1;BUD31;SRPK2;AQR;HNRNPC;EIF4A3;RALY;HNRNPF;SNRPD2;NUDT21;SNRPB2;NONO;CTNNBL1;HNRNPR;PRMT5;RBM8A;TFIP11;HNRNPU;CDC40
prerank,phospholipid translocation (GO:0045332),0.15089724262841145,0.5533311751151698,1.0,0.9967198314216307,1.0,3/29,6.52%,PLSCR4;ATP8B2;P2RX7
prerank,nucleotide metabolic process (GO:0009117),-0.1813309337494566,-0.5522612448856977,0.9880952380952381,0.9978578037070845,1.0,11/23,44.74%,PNP;NUDT5;RNASEH2B;CTPS2;DCK;CMPK2;ME1;ENPP3;FHIT;CMPK1;DCTD
prerank,positive regulation of viral life cycle (GO:1903902),-0.19126415918852457,-0.5516158967966616,0.9857142857142858,0.9973056691541375,1.0,9/24,34.49%,LGALS1;P4HB;AXL;FMR1;VPS37B;KPNA2;TMPRSS4;TRIM11;CD74
prerank,regulation of cellular amide metabolic process (GO:0034248),-0.1816976001111445,-0.5495689481505048,0.9868421052631579,0.9971043722355851,1.0,8/31,29.54%,NANOS3;GRM5;EIF4E;NOLC1;PKP3;MAPKAPK5;GEMIN5;TIGAR
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.17830740248810836,-0.5484185544903455,0.9714285714285714,0.9966476885014335,1.0,5/26,20.39%,UCP1;TRAP1;SLC18A2;CYBA;MMP8
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.18827999416770858,-0.5473441988882055,0.9857142857142858,0.9961826595567632,1.0,4/20,25.23%,PRDX4;HBA1;PRDX5;HBQ1
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.17394600340635463,-0.5438021577190677,0.9868421052631579,0.9962692004402605,1.0,11/31,33.01%,CRB2;ANK1;MSN;SYNE4;PRKCI;CAMSAP3;DLG3;LIN7C;EZR;RAP2A;DLG1
prerank,copper ion homeostasis (GO:0055070),-0.20610830629522253,-0.5395764076888638,0.9857142857142858,0.9963824810510319,1.0,4/17,17.64%,ATP7B;XIAP;ABCB6;SLC31A1
prerank,histone lysine demethylation (GO:0070076),0.14280110181711847,0.5390664146330694,0.96875,0.9976837345808754,1.0,6/24,19.37%,PHF2;KDM5B;KDM3A;KDM2A;KDM5D;KDM4B
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.18767329855228249,-0.5349162464199367,1.0,0.9966074364595516,1.0,7/21,31.25%,CAV1;WNT8B;GSK3B;AXIN1;WNT3A;AMER1;PPP1CA
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.16713839141775516,-0.532813937600253,0.9746835443037974,0.9962822654858516,1.0,5/27,17.33%,AJUBA;TGFB1;BMP4;LIN28A;MYCN
prerank,iron-sulfur cluster assembly (GO:0016226),-0.19074977936425297,-0.5311741926089445,0.9714285714285714,0.9958905277517265,1.0,6/21,28.49%,CIAO1;BOLA2;GLRX3;FXN;NUBPL;HSPA9
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.1959038786653729,-0.5258438582116735,0.987012987012987,0.9960260784048369,1.0,1/16,1.40%,AMELX
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.2026883506215335,-0.5251869670650922,0.9861111111111112,0.9954476780862958,1.0,9/15,45.69%,BCL2L1;PRELID1;FXN;IGF1;OPA1;PPIF;TRIAP1;AKT1;GPX1
prerank,long-chain fatty acid metabolic process (GO:0001676),-0.13517044613824816,-0.5233230868021855,1.0,0.9950840438313026,1.0,39/82,46.22%,FAAH2;PNPLA3;ACSL6;ASAH2;CYP4F3;ALOX12;ASAH2B;AWAT1;CYP2D6;ALOX12B;ALOXE3;CYP4F11;CYP4A22;ACSL5;CYP1A2;CYP2D7;CYP4F2;CYP4A11;AIG1;ACSL3;GLYATL2;ACSBG2;ACSL4;DAGLA;HSD17B4;ACOT4;ACOT8;CPT2;PLA2G10;GSTP1;HACL1;FAAH;CYP2J2;ACSBG1;DAGLB;ELOVL3;ACOX1;GPX1;ACAD9
prerank,negative regulation of telomere maintenance (GO:0032205),0.16999785088847183,0.5167410061934782,1.0,0.9991844418192631,1.0,1/16,4.62%,TERF2IP
prerank,glycoprotein metabolic process (GO:0009100),-0.14740705609202126,-0.5150306168909479,1.0,0.9955762669583359,1.0,5/52,9.24%,MAN2A1;FUT8;ST8SIA6;STT3B;GCNT1
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.18063617010073363,-0.5140328873977371,0.96,0.9950126941427426,1.0,2/18,16.04%,NAF1;SLX1A
prerank,protein targeting to peroxisome (GO:0006625),0.12318957534478558,0.504728023355047,1.0,0.9993887824475118,1.0,10/29,24.17%,PEX19;PXMP2;RAB8B;ALDH3A2;PEX11B;PEX6;ABCD1;ZFAND6;PEX12;PEX14
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",-0.16299606676898543,-0.4894140404742092,1.0,0.9970570184804477,1.0,9/25,42.58%,SF3B3;PRPF4;PRPF6;WDR83;KHSRP;SNRNP40;SCAF11;TRA2B;LSM1
prerank,transcription by RNA polymerase III (GO:0006383),0.12354629663132533,0.48552778187609047,1.0,0.9998111542920473,1.0,4/27,14.21%,SNAPC2;POLR3GL;SNAPC5;ZNF345
prerank,regulation of intracellular protein transport (GO:0033157),-0.14554012690503762,-0.47266061894306155,0.9864864864864865,0.9976669650918437,1.0,11/31,41.56%,KIF20B;TGFB1;BMP4;ATP13A2;GCC2;UHMK1;LCP1;PDCD10;PCNT;ZFAND1;TPR
prerank,vacuolar acidification (GO:0007035),0.14441339979203147,0.47214768964564374,1.0,0.99952804197312,1.0,8/21,23.57%,TCIRG1;ATP6V0E2;ATP6V1H;ATP6V0A1;ATP6V0D1;CLN3;ATP6V0E1;CCDC115
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.14487581851615064,0.4339616835672354,1.0,0.9996478282743585,1.0,2/18,7.60%,UBB;RNF185
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.15012223095223348,-0.3851144347113408,1.0,0.999777846892078,1.0,8/16,45.75%,SRPRB;RAB3GAP2;SEC61G;SEC61A1;EDEM1;RAB10;SPCS2;SPCS1
